Compound ID,Uniprot,Target,E3 ligase,PDB,Name,Smiles,Warhead,Linker,E3_ligand,DC50 (nM),Dmax (%),Degradation,Assay (DC50/Dmax),Percent degradation (%),Assay (Percent degradation),"IC50 (nM, Protac to Target)","Assay (Protac to Target, IC50)","EC50 (nM, Protac to Target)","Assay (Protac to Target, EC50)","Kd (nM, Protac to Target)","Assay (Protac to Target, Kd)","Ki (nM, Protac to Target)","Assay (Protac to Target, Ki)","delta G (kcal/mol, Protac to Target)","delta H (kcal/mol, Protac to Target)","-T*delta S (kcal/mol, Protac to Target)","Assay (Protac to Target, G/H/-TS)","kon (1/Ms, Protac to Target)","koff (1/s, Protac to Target)","t1/2 (s, Protac to Target)","Assay (Protac to Target, kon/koff/t1/2)","IC50 (nM, Protac to E3)","Assay (Protac to E3, IC50)","EC50 (nM, Protac to E3)","Assay (Protac to E3, EC50)","Kd (nM, Protac to E3)","Assay (Protac to E3, Kd)","Ki (nM, Protac to E3)","Assay (Protac to E3, Ki)","delta G (kcal/mol, Protac to E3)","delta H (kcal/mol, Protac to E3)","-T*delta S (kcal/mol, Protac to E3)","Assay (Protac to E3, G/H/-TS)","kon (1/Ms, Protac to E3)","koff (1/s, Protac to E3)","t1/2 (s, Protac to E3)","Assay (Protac to E3, kon/koff/t1/2)","IC50 (nM, Ternary complex)","Assay (Ternary complex, IC50)","EC50 (nM, Ternary complex)","Assay (Ternary complex, EC50)","Kd (nM, Ternary complex)","Assay (Ternary complex, Kd)","Ki (nM, Ternary complex)","Assay (Ternary complex, Ki)","delta G (kcal/mol, Ternary complex)","delta H (kcal/mol, Ternary complex)","-T*delta S (kcal/mol, Ternary complex)","Assay (Ternary complex, G/H/-TS)","kon (1/Ms, Ternary complex)","koff (1/s, Ternary complex)","t1/2 (s, Ternary complex)","Assay (Ternary complex, kon/koff/t1/2)","IC50 (nM, Cellular activities)","Assay (Cellular activities, IC50)","EC50 (nM, Cellular activities)","Assay (Cellular activities, EC50)","GI50 (nM, Cellular activities)","Assay (Cellular activities, GI50)","ED50 (nM, Cellular activities)","Assay (Cellular activities, ED50)","GR50 (nM, Cellular activities)","Assay (Cellular activities, GR50)","PAMPA Papp (nm/s, Permeability)","Assay (Permeability, PAMPA Papp)","Caco-2 A2B Papp (nm/s, Permeability)","Assay (Permeability, Caco-2 A2B Papp)","Caco-2 B2A Papp (nm/s, Permeability)","Assay (Permeability, Caco-2 B2A Papp)",Article DOI,Molecular Weight,Exact Mass,XLogP3,Heavy Atom Count,Ring Count,Hydrogen Bond Acceptor Count,Hydrogen Bond Donor Count,Rotatable Bond Count,Topological Polar Surface Area,Molecular Formula,InChI,InChI Key
11,Q9H8M2,BRD9,VHL,,,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=CC(OC)=C1CN1CCN(CCOCCOCCOC2=CC(C3=C(C)N=CS3)=CC=C2CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)CC1,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=CC(OC)=C1CN1CCN(,CCOCCOCCO,C2=CC(C3=C(C)N=CS3)=CC=C2CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)CC1,560.0,80.0,0,Degradation of BRD9 in HeLa cells after 4 h treatment,,,,,,,8.8,ITC,,,-11.0,-11.4,0.44,ITC,,,,,,,,,87/70,ITC/FP,,,-9.64,-6.56,-3.1,ITC,,,,,,,,,83/60,ITC/FP,,,-9.7,-6.4,-3.3,ITC between VHL and BRD9-BD:PROTAC,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01413,1041.257,1040.48414,3.69,74,8,16,3,22,199.15,C54H69FN8O10S,"InChI=1S/C54H69FN8O10S/c1-34-47(74-33-58-34)35-8-9-36(28-57-49(65)43-27-38(64)30-63(43)51(67)48(53(2,3)4)59-52(68)54(55)11-12-54)44(24-35)73-23-22-72-21-20-71-19-18-61-14-16-62(17-15-61)32-42-45(69-6)25-37(26-46(42)70-7)41-31-60(5)50(66)40-29-56-13-10-39(40)41/h8-10,13,24-26,29,31,33,38,43,48,64H,11-12,14-23,27-28,30,32H2,1-7H3,(H,57,65)(H,59,68)/t38-,43+,48-/m1/s1",MXAKQOVZPDLCDK-UDVNCTHFSA-N
22,Q9H8M2,BRD9,VHL,,VZ185,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=CC(OC)=C1CN1CCN(CCCCCOC2=CC(C3=C(C)N=CS3)=CC=C2CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)CC1,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=CC(OC)=C1CN1CCN(,CCCCCO,C2=CC(C3=C(C)N=CS3)=CC=C2CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)CC1,1.76,95.0,1,Degradation of BRD9 in RI-1 cells after 8 h treatment,,,,,,,5.1,ITC,,,-11.35,-12.8,1.485,ITC,,,,,,,,,26/35,ITC/FP,,,-10.4,-7.04,-3.4,ITC,,,,,,,,,27/35,ITC/FP,,,-10.33,-5.1,-5.3,ITC between VHL and BRD9-BD:PROTAC,,,,,,,3/40,Inhibit proliferation of EOL-1/A-402 cells,,,,,,,0.01,Compounds were administered at 10000 nM and incubated for 5 h,,,,,10.1021/acs.jmedchem.8b01413,995.232,994.4786603,5.06,71,8,14,3,19,180.69,C53H67FN8O8S,"InChI=1S/C53H67FN8O8S/c1-33-46(71-32-57-33)34-11-12-35(27-56-48(64)42-26-37(63)29-62(42)50(66)47(52(2,3)4)58-51(67)53(54)14-15-53)43(23-34)70-22-10-8-9-17-60-18-20-61(21-19-60)31-41-44(68-6)24-36(25-45(41)69-7)40-30-59(5)49(65)39-28-55-16-13-38(39)40/h11-13,16,23-25,28,30,32,37,42,47,63H,8-10,14-15,17-22,26-27,29,31H2,1-7H3,(H,56,64)(H,58,67)/t37-,42+,47-/m1/s1",ZAGCLFXBHOXXEN-JPTLTNPLSA-N
22,Q9NPI1,BRD7,VHL,,VZ185,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=CC(OC)=C1CN1CCN(CCCCCOC2=CC(C3=C(C)N=CS3)=CC=C2CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)CC1,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=CC(OC)=C1CN1CCN(,CCCCCO,C2=CC(C3=C(C)N=CS3)=CC=C2CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)CC1,4.5,95.0,1,Degradation of BRD7 in RI-1 cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,26/35,ITC/FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3/40,Inhibit proliferation of EOL-1/A-402 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01413,995.232,994.4786603,5.06,71,8,14,3,19,180.69,C53H67FN8O8S,"InChI=1S/C53H67FN8O8S/c1-33-46(71-32-57-33)34-11-12-35(27-56-48(64)42-26-37(63)29-62(42)50(66)47(52(2,3)4)58-51(67)53(54)14-15-53)43(23-34)70-22-10-8-9-17-60-18-20-61(21-19-60)31-41-44(68-6)24-36(25-45(41)69-7)40-30-59(5)49(65)39-28-55-16-13-38(39)40/h11-13,16,23-25,28,30,32,37,42,47,63H,8-10,14-15,17-22,26-27,29,31H2,1-7H3,(H,56,64)(H,58,67)/t37-,42+,47-/m1/s1",ZAGCLFXBHOXXEN-JPTLTNPLSA-N
77,P03372,ER,VHL,,ERD-308,CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)C1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C)CCOC1=CC=C(C(=O)C2=C(C3=CC=C(O)C=C3)SC3=CC(O)=CC=C23)C=C1,,CCN(CCCCCOCC(=O)N,[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)C1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C)CCOC1=CC=C(C(=O)C2=C(C3=CC=C(O)C=C3)SC3=CC(O)=CC=C23)C=C1,0.17,95.0,1,Degradation of ER in MCF-7/T47D cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.77,Inhibit proliferation of MCF-7 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01572,1004.285,1003.422371,9.05,71,7,13,5,22,190.86,C55H65N5O9S2,"InChI=1S/C55H65N5O9S2/c1-7-59(26-28-69-43-22-17-37(18-23-43)49(65)48-44-24-21-41(62)30-46(44)71-51(48)39-15-19-40(61)20-16-39)25-9-8-10-27-68-32-47(64)58-52(55(4,5)6)54(67)60-31-42(63)29-45(60)53(66)57-34(2)36-11-13-38(14-12-36)50-35(3)56-33-70-50/h11-24,30,33-34,42,45,52,61-63H,7-10,25-29,31-32H2,1-6H3,(H,57,66)(H,58,64)/t34-,42+,45-,52+/m0/s1",BQXUPNKLZNSUMC-YUQWMIPFSA-N
118,P10275,AR,VHL,,ARD-61,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)N2CCC(N3CCC(C#CC4=CC=C(C(=O)N[C@H]5C(C)(C)[C@H](OC6=CC=C(C#N)C(Cl)=C6)C5(C)C)C=C4)CC3)CC2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](,CC(=O)N,2CCC(N3CCC(C#CC4=CC=C(C(=O)N[C@H]5C(C)(C)[C@H](OC6=CC=C(C#N)C(Cl)=C6)C5(C)C)C=C4)CC3)CC2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,7.2,95.0,1,Degradation of AR in LNCaP/VCaP AR+ cells after 6 h treatment,76/>95/>99,% AR degradation in LNCaP cells after 6 h treatment at 10/100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2月2日,Inhibit growth of LNCaP/VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01393,1095.808,1094.485495,9.31,78,9,12,3,14,194.23,C61H71ClN8O7S,"InChI=1S/C61H71ClN8O7S/c1-36(2)53(51-29-37(3)67-77-51)57(75)70-34-46(71)30-50(70)56(74)65-49(41-15-17-42(18-16-41)54-38(4)64-35-78-54)32-52(72)69-27-23-45(24-28-69)68-25-21-40(22-26-68)10-9-39-11-13-43(14-12-39)55(73)66-58-60(5,6)59(61(58,7)8)76-47-20-19-44(33-63)48(62)31-47/h11-20,29,31,35-36,40,45-46,49-50,53,58-59,71H,21-28,30,32,34H2,1-8H3,(H,65,74)(H,66,73)/t46-,49+,50+,53-,58-,59-/m1/s1",RGPUSLXMPBTXNU-MLMZQBPXSA-N
120,P10275,AR,VHL,,ARD-69,CC1=C(C2=CC=C([C@H](CC(=O)N3CCC(N4CCC(C#CC5=CC=C(C(=O)N[C@H]6C(C)(C)[C@H](OC7=CC=C(C#N)C(Cl)=C7)C6(C)C)C=C5)CC4)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](,CC(=O)N,3CCC(N4CCC(C#CC5=CC=C(C(=O)N[C@H]6C(C)(C)[C@H](OC7=CC=C(C#N)C(Cl)=C7)C6(C)C)C=C5)CC4)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C=C2)SC=N1,0.86,95.0,1,Degradation of AR in LNCaP/VCaP/22Rv1 cells after 24 h treatment,89/99/100,% AR degradation in LNCaP cells after 6 h treatment at 10/100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.25/0.34/183,Inhibit growth of LNCaP/VCaP/22Rv1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01631,1129.841,1128.507374,9.29,80,9,11,4,14,197.3,C62H74ClFN8O7S,"InChI=1S/C62H74ClFN8O7S/c1-37-51(80-36-66-37)41-17-15-40(16-18-41)48(67-54(76)49-31-45(73)35-72(49)55(77)52(59(2,3)4)68-58(78)62(64)25-26-62)33-50(74)71-29-23-44(24-30-71)70-27-21-39(22-28-70)10-9-38-11-13-42(14-12-38)53(75)69-56-60(5,6)57(61(56,7)8)79-46-20-19-43(34-65)47(63)32-46/h11-20,32,36,39,44-45,48-49,52,56-57,73H,21-31,33,35H2,1-8H3,(H,67,76)(H,68,78)(H,69,75)/t45-,48+,49+,52-,56-,57-/m1/s1",CWGVEMFBQJUWLU-RXFAPWBBSA-N
151,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCC3=CN(CCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COC,C3=CN(CCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=N3)C(C)(C)C)C=C2)SC=N1,518.0,91.0,0,Degradation of BRD4 in A375 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6620000,0.038,18.7,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,995.633,994.3497472,4.49,69,8,16,4,16,223.74,C48H55ClN12O6S2,"InChI=1S/C48H55ClN12O6S2/c1-26-28(3)69-47-40(26)41(31-12-14-33(49)15-13-31)53-36(44-57-55-29(4)61(44)47)19-38(63)50-16-17-59-21-34(56-58-59)23-67-24-39(64)54-43(48(5,6)7)46(66)60-22-35(62)18-37(60)45(65)51-20-30-8-10-32(11-9-30)42-27(2)52-25-68-42/h8-15,21,25,35-37,43,62H,16-20,22-24H2,1-7H3,(H,50,63)(H,51,65)(H,54,64)/t35-,36+,37+,43-/m1/s1",KEXVSUAHVFYWJC-AYWQWSHZSA-N
152,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCC3=CN(CCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOC,C3=CN(CCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=N3)C(C)(C)C)C=C2)SC=N1,726.0,78.0,0,Degradation of BRD4 in A375 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6340000,0.058,12.2,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,1039.686,1038.375962,4.34,72,8,17,4,19,232.97,C50H59ClN12O7S2,"InChI=1S/C50H59ClN12O7S2/c1-28-30(3)72-49-42(28)43(33-12-14-35(51)15-13-33)55-38(46-59-57-31(4)63(46)49)21-40(65)52-16-17-61-23-36(58-60-61)25-69-18-19-70-26-41(66)56-45(50(5,6)7)48(68)62-24-37(64)20-39(62)47(67)53-22-32-8-10-34(11-9-32)44-29(2)54-27-71-44/h8-15,23,27,37-39,45,64H,16-22,24-26H2,1-7H3,(H,52,65)(H,53,67)(H,56,66)/t37-,38+,39+,45-/m1/s1",LJQXZKRBYGZAEU-DPSJZEHMSA-N
153,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCC3=CN(CCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOC,C3=CN(CCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=N3)C(C)(C)C)C=C2)SC=N1,2260.0,69.0,0,Degradation of BRD4 in A375 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9640000,0.25,4.4,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,1083.739,1082.402177,4.19,75,8,18,4,22,242.2,C52H63ClN12O8S2,"InChI=1S/C52H63ClN12O8S2/c1-30-32(3)75-51-44(30)45(35-12-14-37(53)15-13-35)57-40(48-61-59-33(4)65(48)51)23-42(67)54-16-17-63-25-38(60-62-63)27-72-20-18-71-19-21-73-28-43(68)58-47(52(5,6)7)50(70)64-26-39(66)22-41(64)49(69)55-24-34-8-10-36(11-9-34)46-31(2)56-29-74-46/h8-15,25,29,39-41,47,66H,16-24,26-28H2,1-7H3,(H,54,67)(H,55,69)(H,58,68)/t39-,40+,41+,47-/m1/s1",IVAWBGJHAWQINS-XRFVFAKVSA-N
154,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCC3=CN(CCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCCOC,C3=CN(CCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=N3)C(C)(C)C)C=C2)SC=N1,10000.0,0.0,0,Degradation of BRD4 in A375 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3100000,0.13,5.5,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,1127.792,1126.428391,4.05,78,8,19,4,25,251.43,C54H67ClN12O9S2,"InChI=1S/C54H67ClN12O9S2/c1-32-34(3)78-53-46(32)47(37-12-14-39(55)15-13-37)59-42(50-63-61-35(4)67(50)53)25-44(69)56-16-17-65-27-40(62-64-65)29-75-22-20-73-18-19-74-21-23-76-30-45(70)60-49(54(5,6)7)52(72)66-28-41(68)24-43(66)51(71)57-26-36-8-10-38(11-9-36)48-33(2)58-31-77-48/h8-15,27,31,41-43,49,68H,16-26,28-30H2,1-7H3,(H,56,69)(H,57,71)(H,60,70)/t41-,42+,43+,49-/m1/s1",MEUHHKBLLJDOBF-ADSXHIEZSA-N
155,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOCC3=CN(CCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCCOCCOC,C3=CN(CCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=N3)C(C)(C)C)C=C2)SC=N1,10000.0,0.0,0,Degradation of BRD4 in A375 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N.D.,N.D.,2.0,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,1171.845,1170.454606,3.9,81,8,20,4,28,260.66,C56H71ClN12O10S2,"InChI=1S/C56H71ClN12O10S2/c1-34-36(3)81-55-48(34)49(39-12-14-41(57)15-13-39)61-44(52-65-63-37(4)69(52)55)27-46(71)58-16-17-67-29-42(64-66-67)31-78-24-22-76-20-18-75-19-21-77-23-25-79-32-47(72)62-51(56(5,6)7)54(74)68-30-43(70)26-45(68)53(73)59-28-38-8-10-40(11-9-38)50-35(2)60-33-80-50/h8-15,29,33,43-45,51,70H,16-28,30-32H2,1-7H3,(H,58,71)(H,59,73)(H,62,72)/t43-,44+,45+,51-/m1/s1",VACBBPVTGHKINF-WQZGMAASSA-N
159,P25440,BRD2,CRBN,,BD-764,CC1=NN=C2COCC3=C(SC(C#CC4=CN(CCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=C3CC3=CC=CC=C3)N12,CC1=NN=C2COCC3=C(SC(C#CC4=CN(,CCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=C3CC3=CC=CC=C3)N12,0.5,99.0,1,Degradation of BRD2 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,686.754,686.2059871,3.41,50,8,12,2,7,153.34,C36H30N8O5S,"InChI=1S/C36H30N8O5S/c1-21-40-41-30-20-49-19-26-25(16-22-6-3-2-4-7-22)29(50-36(26)43(21)30)12-10-23-17-38-42(18-23)15-14-37-27-9-5-8-24-32(27)35(48)44(34(24)47)28-11-13-31(45)39-33(28)46/h2-9,17-18,28,37H,11,13-16,19-20H2,1H3,(H,39,45,46)",OCRZEXONTRGXJJ-UHFFFAOYSA-N
159,Q15059,BRD3,CRBN,,BD-764,CC1=NN=C2COCC3=C(SC(C#CC4=CN(CCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=C3CC3=CC=CC=C3)N12,CC1=NN=C2COCC3=C(SC(C#CC4=CN(,CCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=C3CC3=CC=CC=C3)N12,0.5,98.0,1,Degradation of BRD3 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,686.754,686.2059871,3.41,50,8,12,2,7,153.34,C36H30N8O5S,"InChI=1S/C36H30N8O5S/c1-21-40-41-30-20-49-19-26-25(16-22-6-3-2-4-7-22)29(50-36(26)43(21)30)12-10-23-17-38-42(18-23)15-14-37-27-9-5-8-24-32(27)35(48)44(34(24)47)28-11-13-31(45)39-33(28)46/h2-9,17-18,28,37H,11,13-16,19-20H2,1H3,(H,39,45,46)",OCRZEXONTRGXJJ-UHFFFAOYSA-N
159,O60885,BRD4,CRBN,,BD-764,CC1=NN=C2COCC3=C(SC(C#CC4=CN(CCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=C3CC3=CC=CC=C3)N12,CC1=NN=C2COCC3=C(SC(C#CC4=CN(,CCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=C3CC3=CC=CC=C3)N12,0.2,98.0,1,Degradation of BRD4 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,686.754,686.2059871,3.41,50,8,12,2,7,153.34,C36H30N8O5S,"InChI=1S/C36H30N8O5S/c1-21-40-41-30-20-49-19-26-25(16-22-6-3-2-4-7-22)29(50-36(26)43(21)30)12-10-23-17-38-42(18-23)15-14-37-27-9-5-8-24-32(27)35(48)44(34(24)47)28-11-13-31(45)39-33(28)46/h2-9,17-18,28,37H,11,13-16,19-20H2,1H3,(H,39,45,46)",OCRZEXONTRGXJJ-UHFFFAOYSA-N
174,Q96SW2,CRBN,VHL,,TD-343,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,367.8,85.1,0,Degradation of CRBN in HEK293T cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41598-019-56177-5,876.002,875.3523765,2.33,62,6,14,5,19,234.9,C43H53N7O11S,"InChI=1S/C43H53N7O11S/c1-25-36(62-24-46-25)27-10-8-26(9-11-27)21-45-38(54)32-20-28(51)22-49(32)42(58)37(43(2,3)4)47-34(53)23-61-19-18-60-17-16-59-15-14-44-30-7-5-6-29-35(30)41(57)50(40(29)56)31-12-13-33(52)48-39(31)55/h5-11,24,28,31-32,37,44,51H,12-23H2,1-4H3,(H,45,54)(H,47,53)(H,48,52,55)/t28-,31?,32+,37-/m1/s1",JJODRHXPKVBYEY-JPQBYMPPSA-N
181,Q16539,p38alpha,VHL,,SJF-6693,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCOCCOCCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1,OCCOCCOCCC(=O)N,[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,40.1,92.6,1,Degradation of p38alpha in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1078.205,1077.411783,7.21,77,8,14,5,23,228.87,C56H61F2N7O11S,"InChI=1S/C56H61F2N7O11S/c1-33-49(77-32-61-33)35-8-6-34(7-9-35)30-60-51(68)43-27-39(66)31-65(43)52(69)50(55(2,3)4)64-48(67)17-21-73-22-23-74-24-25-75-47-29-42-40(28-46(47)72-5)44(16-20-59-42)76-45-15-14-38(26-41(45)58)63-54(71)56(18-19-56)53(70)62-37-12-10-36(57)11-13-37/h6-16,20,26,28-29,32,39,43,50,66H,17-19,21-25,27,30-31H2,1-5H3,(H,60,68)(H,62,70)(H,63,71)(H,64,67)/t39-,43+,50-/m1/s1",FCEBHUUCGVQXGJ-XPMRVQNBSA-N
181,O15264,p38delta,VHL,,SJF-6693,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCOCCOCCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1,OCCOCCOCCC(=O)N,[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,51.4,81.8,1,Degradation of p38delta in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1078.205,1077.411783,7.21,77,8,14,5,23,228.87,C56H61F2N7O11S,"InChI=1S/C56H61F2N7O11S/c1-33-49(77-32-61-33)35-8-6-34(7-9-35)30-60-51(68)43-27-39(66)31-65(43)52(69)50(55(2,3)4)64-48(67)17-21-73-22-23-74-24-25-75-47-29-42-40(28-46(47)72-5)44(16-20-59-42)76-45-15-14-38(26-41(45)58)63-54(71)56(18-19-56)53(70)62-37-12-10-36(57)11-13-37/h6-16,20,26,28-29,32,39,43,50,66H,17-19,21-25,27,30-31H2,1-5H3,(H,60,68)(H,62,70)(H,63,71)(H,64,67)/t39-,43+,50-/m1/s1",FCEBHUUCGVQXGJ-XPMRVQNBSA-N
182,Q16539,p38alpha,VHL,,SJF-6690,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCOCCOCCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1,OCCCOCCOCCC(=O)N,[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,18.8,99.4,1,Degradation of p38alpha in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1092.232,1091.427433,7.57,78,8,14,5,24,228.87,C57H63F2N7O11S,"InChI=1S/C57H63F2N7O11S/c1-34-50(78-33-62-34)36-9-7-35(8-10-36)31-61-52(69)44-28-40(67)32-66(44)53(70)51(56(2,3)4)65-49(68)18-24-75-26-25-74-22-6-23-76-48-30-43-41(29-47(48)73-5)45(17-21-60-43)77-46-16-15-39(27-42(46)59)64-55(72)57(19-20-57)54(71)63-38-13-11-37(58)12-14-38/h7-17,21,27,29-30,33,40,44,51,67H,6,18-20,22-26,28,31-32H2,1-5H3,(H,61,69)(H,63,71)(H,64,72)(H,65,68)/t40-,44+,51-/m1/s1",PCRYOGWRHSLIEZ-XZVMHGATSA-N
182,O15264,p38delta,VHL,,SJF-6690,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCOCCOCCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1,OCCCOCCOCCC(=O)N,[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,91.7,96.7,1,Degradation of p38delta in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1092.232,1091.427433,7.57,78,8,14,5,24,228.87,C57H63F2N7O11S,"InChI=1S/C57H63F2N7O11S/c1-34-50(78-33-62-34)36-9-7-35(8-10-36)31-61-52(69)44-28-40(67)32-66(44)53(70)51(56(2,3)4)65-49(68)18-24-75-26-25-74-22-6-23-76-48-30-43-41(29-47(48)73-5)45(17-21-60-43)77-46-16-15-39(27-42(46)59)64-55(72)57(19-20-57)54(71)63-38-13-11-37(58)12-14-38/h7-17,21,27,29-30,33,40,44,51,67H,6,18-20,22-26,28,31-32H2,1-5H3,(H,61,69)(H,63,71)(H,64,72)(H,65,68)/t40-,44+,51-/m1/s1",PCRYOGWRHSLIEZ-XZVMHGATSA-N
183,Q16539,p38alpha,VHL,,SJF-8240,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCOCCCOCCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1,OCCCOCCCOCCC(=O)N,[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,230.0,90.1,0,Degradation of p38alpha in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1106.259,1105.443083,7.93,79,8,14,5,25,228.87,C58H65F2N7O11S,"InChI=1S/C58H65F2N7O11S/c1-35-51(79-34-63-35)37-10-8-36(9-11-37)32-62-53(70)45-29-41(68)33-67(45)54(71)52(57(2,3)4)66-50(69)19-27-76-24-6-23-75-25-7-26-77-49-31-44-42(30-48(49)74-5)46(18-22-61-44)78-47-17-16-40(28-43(47)60)65-56(73)58(20-21-58)55(72)64-39-14-12-38(59)13-15-39/h8-18,22,28,30-31,34,41,45,52,68H,6-7,19-21,23-27,29,32-33H2,1-5H3,(H,62,70)(H,64,72)(H,65,73)(H,66,69)/t41-,45+,52-/m1/s1",SCUZPTNDZHEHLB-ZWUDBOSPSA-N
183,Q16539,p38alpha,VHL,,SJF-8240,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCOCCCOCCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1,OCCCOCCCOCCC(=O)N,[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,210.0,91.0,0,Degradation of p38alpha in MDA-MB-231 cells after 24 h treatment,,,,,,,5300,Kd was assessed by competition binding assays,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2017.09.010,1106.259,1105.443083,7.93,79,8,14,5,25,228.87,C58H65F2N7O11S,"InChI=1S/C58H65F2N7O11S/c1-35-51(79-34-63-35)37-10-8-36(9-11-37)32-62-53(70)45-29-41(68)33-67(45)54(71)52(57(2,3)4)66-50(69)19-27-76-24-6-23-75-25-7-26-77-49-31-44-42(30-48(49)74-5)46(18-22-61-44)78-47-17-16-40(28-43(47)60)65-56(73)58(20-21-58)55(72)64-39-14-12-38(59)13-15-39/h8-18,22,28,30-31,34,41,45,52,68H,6-7,19-21,23-27,29,32-33H2,1-5H3,(H,62,70)(H,64,72)(H,65,73)(H,66,69)/t41-,45+,52-/m1/s1",SCUZPTNDZHEHLB-ZWUDBOSPSA-N
183,O15264,p38delta,VHL,,SJF-8240,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCOCCCOCCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1,OCCCOCCCOCCC(=O)N,[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,456.0,54.3,0,Degradation of p38delta in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1106.259,1105.443083,7.93,79,8,14,5,25,228.87,C58H65F2N7O11S,"InChI=1S/C58H65F2N7O11S/c1-35-51(79-34-63-35)37-10-8-36(9-11-37)32-62-53(70)45-29-41(68)33-67(45)54(71)52(57(2,3)4)66-50(69)19-27-76-24-6-23-75-25-7-26-77-49-31-44-42(30-48(49)74-5)46(18-22-61-44)78-47-17-16-40(28-43(47)60)65-56(73)58(20-21-58)55(72)64-39-14-12-38(59)13-15-39/h8-18,22,28,30-31,34,41,45,52,68H,6-7,19-21,23-27,29,32-33H2,1-5H3,(H,62,70)(H,64,72)(H,65,73)(H,66,69)/t41-,45+,52-/m1/s1",SCUZPTNDZHEHLB-ZWUDBOSPSA-N
184,Q16539,p38alpha,VHL,,SJF-6696,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCCOCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1,OCCCCOCCCCOCC(=O)N,[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,9.5,99.6,1,Degradation of p38alpha in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1120.286,1119.458733,8.74,80,8,14,5,26,228.87,C59H67F2N7O11S,"InChI=1S/C59H67F2N7O11S/c1-36-52(80-35-64-36)38-12-10-37(11-13-38)32-63-54(71)46-29-42(69)33-68(46)55(72)53(58(2,3)4)67-51(70)34-77-26-7-6-24-76-25-8-9-27-78-50-31-45-43(30-49(50)75-5)47(20-23-62-45)79-48-19-18-41(28-44(48)61)66-57(74)59(21-22-59)56(73)65-40-16-14-39(60)15-17-40/h10-20,23,28,30-31,35,42,46,53,69H,6-9,21-22,24-27,29,32-34H2,1-5H3,(H,63,71)(H,65,73)(H,66,74)(H,67,70)/t42-,46+,53-/m1/s1",GXDYWQXTEYENEU-WFYKIECOSA-N
184,O15264,p38delta,VHL,,SJF-6696,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCCOCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1,OCCCCOCCCCOCC(=O)N,[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,1160.0,25.1,0,Degradation of p38delta in MDA-MB-231 cells,,,,,,,500,SPR,,,,,,,,,,,,,,,5000,SPR,,,,,,,,,,,,,,,1200,SPR,,,,,,,70100,0.072,8.0,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1120.286,1119.458733,8.74,80,8,14,5,26,228.87,C59H67F2N7O11S,"InChI=1S/C59H67F2N7O11S/c1-36-52(80-35-64-36)38-12-10-37(11-13-38)32-63-54(71)46-29-42(69)33-68(46)55(72)53(58(2,3)4)67-51(70)34-77-26-7-6-24-76-25-8-9-27-78-50-31-45-43(30-49(50)75-5)47(20-23-62-45)79-48-19-18-41(28-44(48)61)66-57(74)59(21-22-59)56(73)65-40-16-14-39(60)15-17-40/h10-20,23,28,30-31,35,42,46,53,69H,6-9,21-22,24-27,29,32-34H2,1-5H3,(H,63,71)(H,65,73)(H,66,74)(H,67,70)/t42-,46+,53-/m1/s1",GXDYWQXTEYENEU-WFYKIECOSA-N
185,Q16539,p38alpha,VHL,,SJF-6683,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCOCCOCCOC1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1,OCCOCCOCCO,C1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,45.9,34.5,0,Degradation of p38alpha in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1168.286,1167.422348,8.27,84,10,15,4,25,229.31,C62H63F2N7O12S,"InChI=1S/C62H63F2N7O12S/c1-36(2)55(71-33-40-7-5-6-8-45(40)58(71)74)59(75)70-34-44(72)29-49(70)57(73)66-32-39-10-9-38(56-37(3)67-35-84-56)27-52(39)81-25-23-79-21-22-80-24-26-82-54-31-48-46(30-53(54)78-4)50(17-20-65-48)83-51-16-15-43(28-47(51)64)69-61(77)62(18-19-62)60(76)68-42-13-11-41(63)12-14-42/h5-17,20,27-28,30-31,35-36,44,49,55,72H,18-19,21-26,29,32-34H2,1-4H3,(H,66,73)(H,68,76)(H,69,77)/t44-,49+,55+/m1/s1",LYUUIIZKBMBNQV-CHOFKVETSA-N
185,O15264,p38delta,VHL,,SJF-6683,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCOCCOCCOC1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1,OCCOCCOCCO,C1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,79.2,98.4,1,Degradation of p38delta in MDA-MB-231 cells,,,,,,,550,SPR,,,,,,,,,,,,,,,3500,SPR,,,,,,,,,,,,,,,436,SPR,,,,,,,39600,0.018,38.0,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1168.286,1167.422348,8.27,84,10,15,4,25,229.31,C62H63F2N7O12S,"InChI=1S/C62H63F2N7O12S/c1-36(2)55(71-33-40-7-5-6-8-45(40)58(71)74)59(75)70-34-44(72)29-49(70)57(73)66-32-39-10-9-38(56-37(3)67-35-84-56)27-52(39)81-25-23-79-21-22-80-24-26-82-54-31-48-46(30-53(54)78-4)50(17-20-65-48)83-51-16-15-43(28-47(51)64)69-61(77)62(18-19-62)60(76)68-42-13-11-41(63)12-14-42/h5-17,20,27-28,30-31,35-36,44,49,55,72H,18-19,21-26,29,32-34H2,1-4H3,(H,66,73)(H,68,76)(H,69,77)/t44-,49+,55+/m1/s1",LYUUIIZKBMBNQV-CHOFKVETSA-N
186,Q16539,p38alpha,VHL,,SJF-6677,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCCOCCCCOC1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1,OCCCCOCCCCO,C1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,127.0,25.3,0,Degradation of p38alpha in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1180.341,1179.458733,9.84,85,10,14,4,26,220.08,C64H67F2N7O11S,"InChI=1S/C64H67F2N7O11S/c1-38(2)57(73-35-42-11-5-6-12-47(42)60(73)76)61(77)72-36-46(74)31-51(72)59(75)68-34-41-14-13-40(58-39(3)69-37-85-58)29-54(41)82-27-9-7-25-81-26-8-10-28-83-56-33-50-48(32-55(56)80-4)52(21-24-67-50)84-53-20-19-45(30-49(53)66)71-63(79)64(22-23-64)62(78)70-44-17-15-43(65)16-18-44/h5-6,11-21,24,29-30,32-33,37-38,46,51,57,74H,7-10,22-23,25-28,31,34-36H2,1-4H3,(H,68,75)(H,70,78)(H,71,79)/t46-,51+,57+/m1/s1",LCBLIBYLVHDHMI-JCYIICMFSA-N
186,O15264,p38delta,VHL,,SJF-6677,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCCOCCCCOC1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1,OCCCCOCCCCO,C1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,106.0,43.5,0,Degradation of p38delta in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1180.341,1179.458733,9.84,85,10,14,4,26,220.08,C64H67F2N7O11S,"InChI=1S/C64H67F2N7O11S/c1-38(2)57(73-35-42-11-5-6-12-47(42)60(73)76)61(77)72-36-46(74)31-51(72)59(75)68-34-41-14-13-40(58-39(3)69-37-85-58)29-54(41)82-27-9-7-25-81-26-8-10-28-83-56-33-50-48(32-55(56)80-4)52(21-24-67-50)84-53-20-19-45(30-49(53)66)71-63(79)64(22-23-64)62(78)70-44-17-15-43(65)16-18-44/h5-6,11-21,24,29-30,32-33,37-38,46,51,57,74H,7-10,22-23,25-28,31,34-36H2,1-4H3,(H,68,75)(H,70,78)(H,71,79)/t46-,51+,57+/m1/s1",LCBLIBYLVHDHMI-JCYIICMFSA-N
187,Q16539,p38alpha,VHL,,BES-4612,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCOCCOCCCOC1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1,OCCCOCCOCCCO,C1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,760.0,16.8,0,Degradation of p38alpha in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1196.34,1195.453648,8.98,86,10,15,4,27,229.31,C64H67F2N7O12S,"InChI=1S/C64H67F2N7O12S/c1-38(2)57(73-35-42-9-5-6-10-47(42)60(73)76)61(77)72-36-46(74)31-51(72)59(75)68-34-41-12-11-40(58-39(3)69-37-86-58)29-54(41)83-25-7-23-81-27-28-82-24-8-26-84-56-33-50-48(32-55(56)80-4)52(19-22-67-50)85-53-18-17-45(30-49(53)66)71-63(79)64(20-21-64)62(78)70-44-15-13-43(65)14-16-44/h5-6,9-19,22,29-30,32-33,37-38,46,51,57,74H,7-8,20-21,23-28,31,34-36H2,1-4H3,(H,68,75)(H,70,78)(H,71,79)/t46-,51+,57+/m1/s1",RZMAGXNWPGZVNP-JCYIICMFSA-N
187,O15264,p38delta,VHL,,BES-4612,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCOCCOCCCOC1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1,OCCCOCCOCCCO,C1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,1890.0,78.7,0,Degradation of p38delta in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1196.34,1195.453648,8.98,86,10,15,4,27,229.31,C64H67F2N7O12S,"InChI=1S/C64H67F2N7O12S/c1-38(2)57(73-35-42-9-5-6-10-47(42)60(73)76)61(77)72-36-46(74)31-51(72)59(75)68-34-41-12-11-40(58-39(3)69-37-86-58)29-54(41)83-25-7-23-81-27-28-82-24-8-26-84-56-33-50-48(32-55(56)80-4)52(19-22-67-50)85-53-18-17-45(30-49(53)66)71-63(79)64(20-21-64)62(78)70-44-15-13-43(65)14-16-44/h5-6,9-19,22,29-30,32-33,37-38,46,51,57,74H,7-8,20-21,23-28,31,34-36H2,1-4H3,(H,68,75)(H,70,78)(H,71,79)/t46-,51+,57+/m1/s1",RZMAGXNWPGZVNP-JCYIICMFSA-N
188,Q16539,p38alpha,VHL,,SJF-6685,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCOCCCOCCCOC1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1,OCCCOCCCOCCCO,C1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,304.0,19.9,0,Degradation of p38alpha in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1210.367,1209.469298,9.34,87,10,15,4,28,229.31,C65H69F2N7O12S,"InChI=1S/C65H69F2N7O12S/c1-39(2)58(74-36-43-10-5-6-11-48(43)61(74)77)62(78)73-37-47(75)32-52(73)60(76)69-35-42-13-12-41(59-40(3)70-38-87-59)30-55(42)84-28-8-26-82-24-7-25-83-27-9-29-85-57-34-51-49(33-56(57)81-4)53(20-23-68-51)86-54-19-18-46(31-50(54)67)72-64(80)65(21-22-65)63(79)71-45-16-14-44(66)15-17-45/h5-6,10-20,23,30-31,33-34,38-39,47,52,58,75H,7-9,21-22,24-29,32,35-37H2,1-4H3,(H,69,76)(H,71,79)(H,72,80)/t47-,52+,58+/m1/s1",LVQCYBJKHQGJSR-LVSOZEIGSA-N
188,O15264,p38delta,VHL,,SJF-6685,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCOCCCOCCCOC1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1,OCCCOCCCOCCCO,C1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](C(C)C)N1CC2=CC=CC=C2C1=O,1140.0,33.5,0,Degradation of p38delta in MDA-MB-231 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-018-08027-7,1210.367,1209.469298,9.34,87,10,15,4,28,229.31,C65H69F2N7O12S,"InChI=1S/C65H69F2N7O12S/c1-39(2)58(74-36-43-10-5-6-11-48(43)61(74)77)62(78)73-37-47(75)32-52(73)60(76)69-35-42-13-12-41(59-40(3)70-38-87-59)30-55(42)84-28-8-26-82-24-7-25-83-27-9-29-85-57-34-51-49(33-56(57)81-4)53(20-23-68-51)86-54-19-18-46(31-50(54)67)72-64(80)65(21-22-65)63(79)71-45-16-14-44(66)15-17-45/h5-6,10-20,23,30-31,33-34,38-39,47,52,58,75H,7-9,21-22,24-29,32,35-37H2,1-4H3,(H,69,76)(H,71,79)(H,72,80)/t47-,52+,58+/m1/s1",LVQCYBJKHQGJSR-LVSOZEIGSA-N
208,O60885,BRD4,MDM2,,A1874,COC1=CC(C(=O)NCCOCCOCCOCCNC(=O)C[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)=CC=C1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(C2=CC=C(Cl)C=C2F)[C@H]1C1=CC=CC(Cl)=C1F,COC1=CC(,C(=O)NCCOCCOCCOCCNC(=O)C,[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)=CC=C1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(C2=CC=C(Cl)C=C2F)[C@H]1C1=CC=CC(Cl)=C1F,32.0,98.0,1,Degradation of BRD4 in HCT116 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,46.5/86.3/236,Inhibit viability of SJSA1/HCT116/A375 cells,,,,,,,,,,,,,,,10.1158/0008-5472.CAN-18-2918,1173.612,1171.352656,8.94,80,8,14,4,22,203.11,C58H62Cl3F2N9O7S,"InChI=1S/C58H62Cl3F2N9O7S/c1-32-33(2)80-56-48(32)51(35-11-14-37(59)15-12-35)67-44(53-71-70-34(3)72(53)56)29-47(73)65-19-21-77-23-25-79-26-24-78-22-20-66-54(74)36-13-18-43(45(27-36)76-7)68-55(75)52-49(39-9-8-10-41(61)50(39)63)58(31-64,46(69-52)30-57(4,5)6)40-17-16-38(60)28-42(40)62/h8-18,27-28,44,46,49,52,69H,19-26,29-30H2,1-7H3,(H,65,73)(H,66,74)(H,68,75)/t44-,46-,49-,52+,58-/m0/s1",IPNTVOAQOGRLQB-JJMBTQCASA-N
209,O60885,BRD4,VHL,,A743,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCOCCCOC3=CC=C(NC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCCCOCCCO,C3=CC=C(NC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)C=C3)C(C)(C)C)C=C2)SC=N1,23.1,89.0,1,Degradation of BRD4 in HCT116 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1158/0008-5472.CAN-18-2918,1092.786,1091.41643,7.71,76,8,15,4,22,211.49,C56H66ClN9O8S2,"InChI=1S/C56H66ClN9O8S2/c1-33-35(3)76-55-48(33)49(38-15-17-40(57)18-16-38)61-44(52-64-63-36(4)66(52)55)28-46(68)60-41-19-21-43(22-20-41)74-26-10-25-72-23-8-9-24-73-31-47(69)62-51(56(5,6)7)54(71)65-30-42(67)27-45(65)53(70)58-29-37-11-13-39(14-12-37)50-34(2)59-32-75-50/h11-22,32,42,44-45,51,67H,8-10,23-31H2,1-7H3,(H,58,70)(H,60,68)(H,62,69)/t42-,44+,45+,51-/m1/s1",LIRKMAWQWVEHBG-QEFNCWSLSA-N
214,Q06187,BTK,CRBN,,,NC(=O)C1=C(N)N([C@@H]2CCCN(C(=O)OCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,NC(=O)C1=C(N)N([C@@H]2CCCN(,C(=O)OCCOCCOCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,1487.0,64.0,0,Degradation of BTK in Ramos/THP-1 cells after 24 h treatment,,,,,,,1150,SPR,,,,,,,,,,,,,,,8800,SPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1073/pnas.1803662115,844.829,844.299196,3.2,61,7,14,4,16,239.74,C41H42F2N8O10,"InChI=1S/C41H42F2N8O10/c42-24-8-12-31(28(43)21-24)61-26-9-6-23(7-10-26)35-34(37(45)53)36(44)51(48-35)25-3-2-15-49(22-25)41(57)60-20-19-59-18-17-58-16-14-46-29-5-1-4-27-33(29)40(56)50(39(27)55)30-11-13-32(52)47-38(30)54/h1,4-10,12,21,25,30,46H,2-3,11,13-20,22,44H2,(H2,45,53)(H,47,52,54)/t25-,30?/m1/s1",MAECKIKUFSSWJT-GOWJNXQMSA-N
215,Q06187,BTK,CRBN,,,NC(=O)C1=C(N)N([C@@H]2CCCN(C(=O)OCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,NC(=O)C1=C(N)N([C@@H]2CCCN(,C(=O)OCCOCCOCCOCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,36.9,85.0,1,Degradation of BTK in Ramos/THP-1 cells after 24 h treatment,,,,,,,71,SPR,,,,,,,,,,,,,,,2500,SPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1073/pnas.1803662115,888.882,888.3254107,3.05,64,7,15,4,19,248.97,C43H46F2N8O11,"InChI=1S/C43H46F2N8O11/c44-26-8-12-33(30(45)23-26)64-28-9-6-25(7-10-28)37-36(39(47)55)38(46)53(50-37)27-3-2-15-51(24-27)43(59)63-22-21-62-20-19-61-18-17-60-16-14-48-31-5-1-4-29-35(31)42(58)52(41(29)57)32-11-13-34(54)49-40(32)56/h1,4-10,12,23,27,32,48H,2-3,11,13-22,24,46H2,(H2,47,55)(H,49,54,56)/t27-,32?/m1/s1",IDIGRNKYBBGIKH-XIDOUCRZSA-N
216,Q06187,BTK,CRBN,,,NC(=O)C1=C(N)N([C@@H]2CCCN(C(=O)COCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,NC(=O)C1=C(N)N([C@@H]2CCCN(,C(=O)COCCOCCOCCOCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,21.8,84.0,1,Degradation of BTK in Ramos/THP-1 cells after 24 h treatment,,,,,,,79,SPR,,,,,,,,,,,,,,,2700,SPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1073/pnas.1803662115,902.909,902.3410608,2.53,65,7,15,4,21,248.97,C44H48F2N8O11,"InChI=1S/C44H48F2N8O11/c45-27-8-12-34(31(46)23-27)65-29-9-6-26(7-10-29)39-38(41(48)57)40(47)54(51-39)28-3-2-15-52(24-28)36(56)25-64-22-21-63-20-19-62-18-17-61-16-14-49-32-5-1-4-30-37(32)44(60)53(43(30)59)33-11-13-35(55)50-42(33)58/h1,4-10,12,23,28,33,49H,2-3,11,13-22,24-25,47H2,(H2,48,57)(H,50,55,58)/t28-,33?/m1/s1",PZNXLFVCWNTMGE-TUDONDPESA-N
217,Q06187,BTK,CRBN,,,NC(=O)C1=C(N)N([C@@H]2CCCN(C(=O)OCCOCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,NC(=O)C1=C(N)N([C@@H]2CCCN(,C(=O)OCCOCCOCCOCCOCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,4.5,87.0,1,Degradation of BTK in Ramos/THP-1 cells after 24 h treatment,,,,,,,80,SPR,,,,,,,,,,,,,,,3600,SPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1073/pnas.1803662115,932.935,932.3516255,2.91,67,7,16,4,22,258.2,C45H50F2N8O12,"InChI=1S/C45H50F2N8O12/c46-28-8-12-35(32(47)25-28)67-30-9-6-27(7-10-30)39-38(41(49)57)40(48)55(52-39)29-3-2-15-53(26-29)45(61)66-24-23-65-22-21-64-20-19-63-18-17-62-16-14-50-33-5-1-4-31-37(33)44(60)54(43(31)59)34-11-13-36(56)51-42(34)58/h1,4-10,12,25,29,34,50H,2-3,11,13-24,26,48H2,(H2,49,57)(H,51,56,58)/t29-,34?/m1/s1",HIEUPGKCAGGMLO-QMUARQKKSA-N
218,Q06187,BTK,CRBN,,,NC(=O)C1=C(N)N([C@@H]2CCCN(C(=O)COCCOCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,NC(=O)C1=C(N)N([C@@H]2CCCN(,C(=O)COCCOCCOCCOCCOCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,5.9,85.0,1,Degradation of BTK in Ramos/THP-1 cells after 24 h treatment,,,,,,,74,SPR,,,,,,,,,,,,,,,3200,SPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1073/pnas.1803662115,946.962,946.3672755,2.39,68,7,16,4,24,258.2,C46H52F2N8O12,"InChI=1S/C46H52F2N8O12/c47-29-8-12-36(33(48)25-29)68-31-9-6-28(7-10-31)41-40(43(50)59)42(49)56(53-41)30-3-2-15-54(26-30)38(58)27-67-24-23-66-22-21-65-20-19-64-18-17-63-16-14-51-34-5-1-4-32-39(34)46(62)55(45(32)61)35-11-13-37(57)52-44(35)60/h1,4-10,12,25,30,35,51H,2-3,11,13-24,26-27,49H2,(H2,50,59)(H,52,57,60)/t30-,35?/m1/s1",PDQGUWCWGITGBA-OSRRZMJMSA-N
219,Q06187,BTK,CRBN,,,NC(=O)C1=C(N)N([C@@H]2CCCN(C(=O)OCCOCCOCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,NC(=O)C1=C(N)N([C@@H]2CCCN(,C(=O)OCCOCCOCCOCCOCCOCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,1.1,87.0,1,Degradation of BTK in Ramos/THP-1 cells after 24 h treatment,,,,,,,61,SPR,,,,,,,,,,,,,,,3000,SPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1073/pnas.1803662115,976.988,976.3778402,2.76,70,7,17,4,25,267.43,C47H54F2N8O13,"InChI=1S/C47H54F2N8O13/c48-30-8-12-37(34(49)27-30)70-32-9-6-29(7-10-32)41-40(43(51)59)42(50)57(54-41)31-3-2-15-55(28-31)47(63)69-26-25-68-24-23-67-22-21-66-20-19-65-18-17-64-16-14-52-35-5-1-4-33-39(35)46(62)56(45(33)61)36-11-13-38(58)53-44(36)60/h1,4-10,12,27,31,36,52H,2-3,11,13-26,28,50H2,(H2,51,59)(H,53,58,60)/t31-,36?/m1/s1",XXNGOJVDXDGATG-RACIXVTASA-N
220,Q06187,BTK,CRBN,,,NC(=O)C1=C(N)N([C@@H]2CCCN(C(=O)COCCOCCOCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,NC(=O)C1=C(N)N([C@@H]2CCCN(,C(=O)COCCOCCOCCOCCOCCOCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C2)N=C1C1=CC=C(OC2=CC=C(F)C=C2F)C=C1,9.7,85.0,1,Degradation of BTK in Ramos/THP-1 cells after 24 h treatment,,,,,,,138,SPR,,,,,,,,,,,,,,,3100,SPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1073/pnas.1803662115,991.015,990.3934903,2.24,71,7,17,4,27,267.43,C48H56F2N8O13,"InChI=1S/C48H56F2N8O13/c49-31-8-12-38(35(50)27-31)71-33-9-6-30(7-10-33)43-42(45(52)61)44(51)58(55-43)32-3-2-15-56(28-32)40(60)29-70-26-25-69-24-23-68-22-21-67-20-19-66-18-17-65-16-14-53-36-5-1-4-34-41(36)48(64)57(47(34)63)37-11-13-39(59)54-46(37)62/h1,4-10,12,27,32,37,53H,2-3,11,13-26,28-29,51H2,(H2,52,61)(H,54,59,62)/t32-,37?/m1/s1",VRWPZJRZYSWRQV-ZIQZBVCVSA-N
227,Q9UBN7,HDAC6,CRBN,,dHDAC6,O=C(CCCCCCC(=O)N/N=C/C1=CC=C(OCCOCCOCCN2C=C(CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1)NO,O=C(,CCCCCCC(=O)N/N=C/,C1=CC=C(OCCOCCOCCN2C=C(CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1)NO,34.0,70.5,0,Degradation of HDAC6 in MCF-7 cells after 12 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2018.05.057,775.82,775.3289386,1.0,56,5,15,5,23,244.77,C37H45N9O10,"InChI=1S/C37H45N9O10/c47-31-15-14-30(35(50)40-31)46-36(51)28-6-5-7-29(34(28)37(46)52)38-23-26-24-45(44-41-26)16-17-54-18-19-55-20-21-56-27-12-10-25(11-13-27)22-39-42-32(48)8-3-1-2-4-9-33(49)43-53/h5-7,10-13,22,24,30,38,53H,1-4,8-9,14-21,23H2,(H,42,48)(H,43,49)(H,40,47,50)/b39-22+",MHILTYZXXFOWJH-WVKHYPTHSA-N
227,Q9UBN7,HDAC6,CRBN,,dHDAC6,O=C(CCCCCCC(=O)N/N=C/C1=CC=C(OCCOCCOCCN2C=C(CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1)NO,O=C(,CCCCCCC(=O)N/N=C/,C1=CC=C(OCCOCCOCCN2C=C(CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1)NO,9.12,84.07,1,Degradation of HDAC6 in MM1S cells after 6 h treatment,47.9/73.5,% HDAC6 degradation in MM1S cells after 6 h treatment at 10/100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00516,775.82,775.3289386,1.0,56,5,15,5,23,244.77,C37H45N9O10,"InChI=1S/C37H45N9O10/c47-31-15-14-30(35(50)40-31)46-36(51)28-6-5-7-29(34(28)37(46)52)38-23-26-24-45(44-41-26)16-17-54-18-19-55-20-21-56-27-12-10-25(11-13-27)22-39-42-32(48)8-3-1-2-4-9-33(49)43-53/h5-7,10-13,22,24,30,38,53H,1-4,8-9,14-21,23H2,(H,42,48)(H,43,49)(H,40,47,50)/b39-22+",MHILTYZXXFOWJH-WVKHYPTHSA-N
256,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCCCCOC3=CC=C(N4C(=S)N(C5=CC=C(C#N)C(C(F)(F)F)=C5)C(=O)C4(C)C)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCCOCCCCCO,C3=CC=C(N4C(=S)N(C5=CC=C(C#N)C(C(F)(F)F)=C5)C(=O)C4(C)C)C=C3)C(C)(C)C)C=C2)SC=N1,15.0,76.0,0,Degradation of AR in VCaP cells after 20 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,<1,Compounds were administered at 10000 nM and incubated for 5 h,0.35,Compounds were administered at 10000 nM and incubated for 2 h,0.24,Compounds were administered at 10000 nM and incubated for 2 h,10.1038/s42003-018-0105-8; 10.1021/acsmedchemlett.0c00194,1020.21,1019.389689,7.45,71,6,12,3,21,186.66,C51H60F3N7O8S2,"InChI=1S/C51H60F3N7O8S2/c1-32-43(71-31-57-32)34-13-11-33(12-14-34)28-56-45(64)41-26-38(62)29-59(41)46(65)44(49(2,3)4)58-42(63)30-68-23-10-22-67-21-8-7-9-24-69-39-19-17-36(18-20-39)61-48(70)60(47(66)50(61,5)6)37-16-15-35(27-55)40(25-37)51(52,53)54/h11-20,25,31,38,41,44,62H,7-10,21-24,26,28-30H2,1-6H3,(H,56,64)(H,58,63)/t38-,41+,44-/m1/s1",MTZBLTXMAXNSIO-UMWCMSNQSA-N
257,P10275,AR,VHL,,ARCC-4,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCOC3=CC=C(C4=CC=C(N5C(=S)N(C6=CC=C(C#N)C(C(F)(F)F)=C6)C(=O)C5(C)C)C=C4)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCCCO,C3=CC=C(C4=CC=C(N5C(=S)N(C6=CC=C(C#N)C(C(F)(F)F)=C6)C(=O)C5(C)C)C=C4)C=C3)C(C)(C)C)C=C2)SC=N1,5.0,98.0,1,Degradation of AR in VCaP cells after 20 h treatment,,,36,Inhibition of AR by AR radioligand binding assays,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,150,Inhibit proliferation of VCaP cells,,,,,,,,,,,,,,,10.1038/s42003-018-0105-8,1024.201,1023.363474,8.51,72,7,11,3,17,177.43,C53H56F3N7O7S2,"InChI=1S/C53H56F3N7O7S2/c1-32-45(72-31-59-32)36-11-9-33(10-12-36)28-58-47(66)43-26-40(64)29-61(43)48(67)46(51(2,3)4)60-44(65)30-69-23-7-8-24-70-41-21-16-35(17-22-41)34-13-18-38(19-14-34)63-50(71)62(49(68)52(63,5)6)39-20-15-37(27-57)42(25-39)53(54,55)56/h9-22,25,31,40,43,46,64H,7-8,23-24,26,28-30H2,1-6H3,(H,58,66)(H,60,65)/t40-,43+,46-/m1/s1",DUPAJELXESPTNF-PPZGWQTASA-N
265,Q05397,FAK,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOC3=CC=C(NC4=NC=C(C(F)(F)F)C(NCC5=CC=CC(N(C)S(C)(=O)=O)=C5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCO,C3=CC=C(NC4=NC=C(C(F)(F)F)C(NCC5=CC=CC(N(C)S(C)(=O)=O)=C5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,23.2,99.0,1,Degradation of Fak in PC3 cells after 24 h treatment,,,10.7,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.8b08008,982.121,981.3488863,5.86,68,6,14,5,19,217.31,C46H54F3N9O8S2,"InChI=1S/C46H54F3N9O8S2/c1-28-39(67-27-53-28)31-12-10-29(11-13-31)22-51-42(61)37-21-34(59)25-58(37)43(62)40(45(2,3)4)55-38(60)26-65-18-19-66-35-16-14-32(15-17-35)54-44-52-24-36(46(47,48)49)41(56-44)50-23-30-8-7-9-33(20-30)57(5)68(6,63)64/h7-17,20,24,27,34,37,40,59H,18-19,21-23,25-26H2,1-6H3,(H,51,61)(H,55,60)(H2,50,52,54,56)/t34-,37+,40-/m1/s1",SSNVICBSSPQZQX-WPPCIPCFSA-N
266,Q05397,FAK,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOC3=CC=C(NC4=NC=C(C(F)(F)F)C(NCC5=CC=CC(N(C)S(C)(=O)=O)=C5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCCO,C3=CC=C(NC4=NC=C(C(F)(F)F)C(NCC5=CC=CC(N(C)S(C)(=O)=O)=C5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,7.6,99.0,1,Degradation of Fak in PC3 cells after 24 h treatment,,,14.7,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.8b08008,996.148,995.3645364,6.22,69,6,14,5,20,217.31,C47H56F3N9O8S2,"InChI=1S/C47H56F3N9O8S2/c1-29-40(68-28-54-29)32-13-11-30(12-14-32)23-52-43(62)38-22-35(60)26-59(38)44(63)41(46(2,3)4)56-39(61)27-66-19-8-20-67-36-17-15-33(16-18-36)55-45-53-25-37(47(48,49)50)42(57-45)51-24-31-9-7-10-34(21-31)58(5)69(6,64)65/h7,9-18,21,25,28,35,38,41,60H,8,19-20,22-24,26-27H2,1-6H3,(H,52,62)(H,56,61)(H2,51,53,55,57)/t35-,38+,41-/m1/s1",SHPXUUGJMCCMIO-LFHXYJAASA-N
267,Q05397,FAK,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCOCCOC3=CC=C(NC4=NC=C(C(F)(F)F)C(NCC5=CC=CC(N(C)S(C)(=O)=O)=C5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCOCCO,C3=CC=C(NC4=NC=C(C(F)(F)F)C(NCC5=CC=CC(N(C)S(C)(=O)=O)=C5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,3.0,99.0,1,Degradation of Fak in PC3 cells after 24 h treatment,,,6.5,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.8b08008,996.148,995.3645364,5.76,69,6,14,5,20,217.31,C47H56F3N9O8S2,"InChI=1S/C47H56F3N9O8S2/c1-29-40(68-28-54-29)32-12-10-30(11-13-32)24-52-43(62)38-23-35(60)27-59(38)44(63)41(46(2,3)4)56-39(61)18-19-66-20-21-67-36-16-14-33(15-17-36)55-45-53-26-37(47(48,49)50)42(57-45)51-25-31-8-7-9-34(22-31)58(5)69(6,64)65/h7-17,22,26,28,35,38,41,60H,18-21,23-25,27H2,1-6H3,(H,52,62)(H,56,61)(H2,51,53,55,57)/t35-,38+,41-/m1/s1",MVULIYLBRNHLEE-LFHXYJAASA-N
268,Q05397,FAK,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCOCCCOC3=CC=C(NC4=NC=C(C(F)(F)F)C(NCC5=CC=CC(N(C)S(C)(=O)=O)=C5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCOCCCO,C3=CC=C(NC4=NC=C(C(F)(F)F)C(NCC5=CC=CC(N(C)S(C)(=O)=O)=C5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,4.0,99.0,1,Degradation of Fak in PC3 cells after 24 h treatment,,,14.5,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.8b08008,1010.175,1009.380186,6.12,70,6,14,5,21,217.31,C48H58F3N9O8S2,"InChI=1S/C48H58F3N9O8S2/c1-30-41(69-29-55-30)33-13-11-31(12-14-33)25-53-44(63)39-24-36(61)28-60(39)45(64)42(47(2,3)4)57-40(62)19-22-67-20-8-21-68-37-17-15-34(16-18-37)56-46-54-27-38(48(49,50)51)43(58-46)52-26-32-9-7-10-35(23-32)59(5)70(6,65)66/h7,9-18,23,27,29,36,39,42,61H,8,19-22,24-26,28H2,1-6H3,(H,53,63)(H,57,62)(H2,52,54,56,58)/t36-,39+,42-/m1/s1",WVWFJWJYLUTFRG-QLMCDVMBSA-N
269,Q05397,FAK,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCOCCOCCOC3=CC=C(NC4=NC=C(C(F)(F)F)C(NCC5=CC=CC(N(C)S(C)(=O)=O)=C5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCOCCOCCO,C3=CC=C(NC4=NC=C(C(F)(F)F)C(NCC5=CC=CC(N(C)S(C)(=O)=O)=C5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,20.8,99.0,1,Degradation of Fak in PC3 cells after 24 h treatment,,,12.7,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.8b08008,1040.201,1039.390751,5.62,72,6,15,5,23,226.54,C49H60F3N9O9S2,"InChI=1S/C49H60F3N9O9S2/c1-31-42(71-30-56-31)34-12-10-32(11-13-34)26-54-45(64)40-25-37(62)29-61(40)46(65)43(48(2,3)4)58-41(63)18-19-68-20-21-69-22-23-70-38-16-14-35(15-17-38)57-47-55-28-39(49(50,51)52)44(59-47)53-27-33-8-7-9-36(24-33)60(5)72(6,66)67/h7-17,24,28,30,37,40,43,62H,18-23,25-27,29H2,1-6H3,(H,54,64)(H,58,63)(H2,53,55,57,59)/t37-,40+,43-/m1/s1",DRJLXMYTVYIROA-AKCINUCUSA-N
270,Q05397,FAK,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCOCCOCCOCCOCCOC3=CC=C(NC4=NC=C(C(F)(F)F)C(NCC5=CC=CC(N(C)S(C)(=O)=O)=C5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCOCCOCCOCCOCCO,C3=CC=C(NC4=NC=C(C(F)(F)F)C(NCC5=CC=CC(N(C)S(C)(=O)=O)=C5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,48.1,91.0,1,Degradation of Fak in PC3 cells after 24 h treatment,,,6.1,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.8b08008,1128.307,1127.443181,5.32,78,6,17,5,29,245.0,C53H68F3N9O11S2,"InChI=1S/C53H68F3N9O11S2/c1-35-46(77-34-60-35)38-12-10-36(11-13-38)30-58-49(68)44-29-41(66)33-65(44)50(69)47(52(2,3)4)62-45(67)18-19-72-20-21-73-22-23-74-24-25-75-26-27-76-42-16-14-39(15-17-42)61-51-59-32-43(53(54,55)56)48(63-51)57-31-37-8-7-9-40(28-37)64(5)78(6,70)71/h7-17,28,32,34,41,44,47,66H,18-27,29-31,33H2,1-6H3,(H,58,68)(H,62,67)(H2,57,59,61,63)/t41-,44+,47-/m1/s1",CVMXJJVQILKJCT-IIWOMYBWSA-N
271,Q05397,FAK,CRBN,,,CN(C1=CC=CC(CNC2=NC(NC3=CC=C(OCCCOCCC(=O)NCCOC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C=C3)=NC=C2C(F)(F)F)=C1)S(C)(=O)=O,CN(C1=CC=CC(CNC2=NC(NC3=CC=C(,OCCCOCCC(=O)NCCO,C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C=C3)=NC=C2C(F)(F)F)=C1)S(C)(=O)=O,8.2,98.0,1,Degradation of Fak in PC3 cells after 24 h treatment,,,11.3,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.8b08008,896.902,896.2774952,3.22,63,6,14,4,20,227.56,C41H43F3N8O10S,"InChI=1S/C41H43F3N8O10S/c1-51(63(2,58)59)27-7-3-6-25(22-27)23-46-36-30(41(42,43)44)24-47-40(50-36)48-26-10-12-28(13-11-26)61-19-5-18-60-20-16-33(53)45-17-21-62-32-9-4-8-29-35(32)39(57)52(38(29)56)31-14-15-34(54)49-37(31)55/h3-4,6-13,22,24,31H,5,14-21,23H2,1-2H3,(H,45,53)(H,49,54,55)(H2,46,47,48,50)",ATTMBNXPUWOYNQ-UHFFFAOYSA-N
272,Q05397,FAK,CRBN,,,CN(C1=CC=CC(CNC2=NC(NC3=CC=C(OCCOCCOCCC(=O)NCCOC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C=C3)=NC=C2C(F)(F)F)=C1)S(C)(=O)=O,CN(C1=CC=CC(CNC2=NC(NC3=CC=C(,OCCOCCOCCC(=O)NCCO,C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C=C3)=NC=C2C(F)(F)F)=C1)S(C)(=O)=O,26.7,99.0,1,Degradation of Fak in PC3 cells after 24 h treatment,,,4.7,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.8b08008,926.928,926.2880599,2.72,65,6,15,4,22,236.79,C42H45F3N8O11S,"InChI=1S/C42H45F3N8O11S/c1-52(65(2,59)60)28-6-3-5-26(23-28)24-47-37-31(42(43,44)45)25-48-41(51-37)49-27-9-11-29(12-10-27)63-22-21-62-20-19-61-17-15-34(54)46-16-18-64-33-8-4-7-30-36(33)40(58)53(39(30)57)32-13-14-35(55)50-38(32)56/h3-12,23,25,32H,13-22,24H2,1-2H3,(H,46,54)(H,50,55,56)(H2,47,48,49,51)",RKQPBRYWQQLESB-UHFFFAOYSA-N
273,Q05397,FAK,CRBN,,,CN(C1=CC=CC(CNC2=NC(NC3=CC=C(OCCOCCOCCOCCOCCC(=O)NCCOC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C=C3)=NC=C2C(F)(F)F)=C1)S(C)(=O)=O,CN(C1=CC=CC(CNC2=NC(NC3=CC=C(,OCCOCCOCCOCCOCCC(=O)NCCO,C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C=C3)=NC=C2C(F)(F)F)=C1)S(C)(=O)=O,10.0,87.0,1,Degradation of Fak in PC3 cells after 24 h treatment,,,9.7,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.8b08008,1015.034,1014.340489,2.42,71,6,17,4,28,255.25,C46H53F3N8O13S,"InChI=1S/C46H53F3N8O13S/c1-56(71(2,63)64)32-6-3-5-30(27-32)28-51-41-35(46(47,48)49)29-52-45(55-41)53-31-9-11-33(12-10-31)69-26-25-68-24-23-67-22-21-66-20-19-65-17-15-38(58)50-16-18-70-37-8-4-7-34-40(37)44(62)57(43(34)61)36-13-14-39(59)54-42(36)60/h3-12,27,29,36H,13-26,28H2,1-2H3,(H,50,58)(H,54,59,60)(H2,51,52,53,55)",QZQNVCJSORWNHR-UHFFFAOYSA-N
275,P00533,EGFR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOC3=CC=C(C4=CC=C5N=CN=C(NC6=CC=C(OCC7=CC=CC(F)=C7)C(Cl)=C6)C5=C4)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCO,C3=CC=C(C4=CC=C5N=CN=C(NC6=CC=C(OCC7=CC=CC(F)=C7)C(Cl)=C6)C5=C4)C=C3)C(C)(C)C)C=C2)SC=N1,39.2,97.6,1,Degradation of WT/Exon 20 Ins EGFR in OVCAR8/HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,102,Inhibit proliferation of SKBr3 cells,,,,,,,,,,,,,,,10.1016/j.chembiol.2017.09.009,1030.62,1029.366189,9.03,73,8,13,4,21,186.36,C55H57ClFN7O8S,"InChI=1S/C55H57ClFN7O8S/c1-34-50(73-33-61-34)38-10-8-35(9-11-38)28-58-53(67)47-27-42(65)29-64(47)54(68)51(55(2,3)4)63-49(66)31-70-21-20-69-22-23-71-43-16-12-37(13-17-43)39-14-18-46-44(25-39)52(60-32-59-46)62-41-15-19-48(45(56)26-41)72-30-36-6-5-7-40(57)24-36/h5-19,24-26,32-33,42,47,51,65H,20-23,27-31H2,1-4H3,(H,58,67)(H,63,66)(H,59,60,62)/t42-,47+,51-/m1/s1",ZSCOIFSUFMYZEZ-YSWDPXALSA-N
276,P00533,EGFR,VHL,,,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCCCOCCOCCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1,OCCCCCOCCOCCC(=O)N,[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,11.7,98.9,1,Degradation of Exon 19 del/L858R EGFR in HCC827/H3255 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2017.09.009,934.532,933.3661887,6.88,65,6,13,4,22,186.36,C47H57ClFN7O8S,"InChI=1S/C47H57ClFN7O8S/c1-29-42(65-28-53-29)31-11-9-30(10-12-31)25-50-45(59)38-22-33(57)26-56(38)46(60)43(47(2,3)4)55-41(58)15-18-63-20-19-62-16-7-6-8-17-64-40-23-34-37(24-39(40)61-5)51-27-52-44(34)54-32-13-14-36(49)35(48)21-32/h9-14,21,23-24,27-28,33,38,43,57H,6-8,15-20,22,25-26H2,1-5H3,(H,50,59)(H,55,58)(H,51,52,54)/t33-,38+,43-/m1/s1",NICKHWYZMNLEPJ-TZSMONEZSA-N
277,P00533,EGFR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCOCCCCOCCCCOC3=CC4=NC=NC(NC5=CC=C(F)C(Cl)=C5)=C4C=C3NC(=O)/C=C/CN(C)C)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3,C(=O)[C@@H](NC(=O)CCCCCOCCCCOCCCCO,C3=CC4=NC=NC(NC5=CC=C(F)C(Cl)=C5)=C4C=C3NC(=O)/C=C/CN(C)C)C(C)(C)C)C=C2)SC=N1,215.8,79.1,0,"Degradation of L858R, T790M EGFR in H1975 cells after 24 h treatment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2017.09.009,1086.773,1085.497537,7.81,76,6,14,5,29,209.47,C56H73ClFN9O8S,"InChI=1S/C56H73ClFN9O8S/c1-37-51(76-36-62-37)39-19-17-38(18-20-39)33-59-54(71)47-30-41(68)34-67(47)55(72)52(56(2,3)4)65-50(70)15-8-7-9-24-73-25-10-11-26-74-27-12-13-28-75-48-32-45-42(31-46(48)64-49(69)16-14-23-66(5)6)53(61-35-60-45)63-40-21-22-44(58)43(57)29-40/h14,16-22,29,31-32,35-36,41,47,52,68H,7-13,15,23-28,30,33-34H2,1-6H3,(H,59,71)(H,64,69)(H,65,70)(H,60,61,63)/b16-14+/t41-,47+,52-/m1/s1",BXHBYEPLXDQKAT-JYCNGAFSSA-N
280,Q06187,BTK,CRBN,,MT-540,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CCCCCCOCCOCC(=O)NC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(,CCCCCCOCCOCC(=O)N,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,80.6,96.0,1,Degradation of BTK in NAMALWA cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.biochem.8b00391,843.942,843.3704095,4.31,62,8,14,3,18,213.2,C45H49N9O8,"InChI=1S/C45H49N9O8/c46-41-39-40(29-13-15-32(16-14-29)62-31-9-4-3-5-10-31)51-54(42(39)48-28-47-41)30-19-22-52(23-20-30)21-6-1-2-7-24-60-25-26-61-27-37(56)49-34-12-8-11-33-38(34)45(59)53(44(33)58)35-17-18-36(55)50-43(35)57/h3-5,8-16,28,30,35H,1-2,6-7,17-27H2,(H,49,56)(H2,46,47,48)(H,50,55,57)",YFWKTWXPNMNMSC-UHFFFAOYSA-N
281,Q06187,BTK,CRBN,,MT-541,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CCCCOCCCCOCC(=O)NC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(,CCCCOCCCCOCC(=O)N,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,90.1,93.0,1,Degradation of BTK in NAMALWA cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.biochem.8b00391,843.942,843.3704095,4.31,62,8,14,3,18,213.2,C45H49N9O8,"InChI=1S/C45H49N9O8/c46-41-39-40(29-13-15-32(16-14-29)62-31-9-2-1-3-10-31)51-54(42(39)48-28-47-41)30-19-22-52(23-20-30)21-4-5-24-60-25-6-7-26-61-27-37(56)49-34-12-8-11-33-38(34)45(59)53(44(33)58)35-17-18-36(55)50-43(35)57/h1-3,8-16,28,30,35H,4-7,17-27H2,(H,49,56)(H2,46,47,48)(H,50,55,57)",JJEBSGCXKQODDX-UHFFFAOYSA-N
282,Q06187,BTK,CRBN,,MT-781,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CCCOCCCOCCC(=O)NC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(,CCCOCCCOCCC(=O)N,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,68.3,95.0,1,Degradation of BTK in NAMALWA cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.biochem.8b00391,829.915,829.3547595,3.5,61,8,14,3,17,213.2,C44H47N9O8,"InChI=1S/C44H47N9O8/c45-40-38-39(28-11-13-31(14-12-28)61-30-7-2-1-3-8-30)50-53(41(38)47-27-46-40)29-17-21-51(22-18-29)20-5-23-59-24-6-25-60-26-19-36(55)48-33-10-4-9-32-37(33)44(58)52(43(32)57)34-15-16-35(54)49-42(34)56/h1-4,7-14,27,29,34H,5-6,15-26H2,(H,48,55)(H2,45,46,47)(H,49,54,56)",CESHFJRNQNNGLW-UHFFFAOYSA-N
283,Q06187,BTK,CRBN,,MT-802,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CCOCCOCC(=O)NC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(,CCOCCOCC(=O)N,C2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,6.2,99.0,1,Degradation of BTK in NAMALWA cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2019.126877,787.834,787.3078093,2.33,58,8,14,3,14,213.2,C41H41N9O8,"InChI=1S/C41H41N9O8/c42-37-35-36(25-6-9-29(10-7-25)58-28-4-2-1-3-5-28)47-50(38(35)44-24-43-37)27-14-16-48(17-15-27)18-19-56-20-21-57-23-34(52)45-26-8-11-30-31(22-26)41(55)49(40(30)54)32-12-13-33(51)46-39(32)53/h1-11,22,24,27,32H,12-21,23H2,(H,45,52)(H2,42,43,44)(H,46,51,53)",AJTLGUJXIKEZCQ-UHFFFAOYSA-N
283,Q06187,BTK,CRBN,,MT-802,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CCOCCOCC(=O)NC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(,CCOCCOCC(=O)N,C2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,9.1,99.0,1,Degradation of BTK in NAMALWA/XLA cells after 24 h treatment,,,46.9,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.biochem.8b00391,787.834,787.3078093,2.33,58,8,14,3,14,213.2,C41H41N9O8,"InChI=1S/C41H41N9O8/c42-37-35-36(25-6-9-29(10-7-25)58-28-4-2-1-3-5-28)47-50(38(35)44-24-43-37)27-14-16-48(17-15-27)18-19-56-20-21-57-23-34(52)45-26-8-11-30-31(22-26)41(55)49(40(30)54)32-12-13-33(51)46-39(32)53/h1-11,22,24,27,32H,12-21,23H2,(H,45,52)(H2,42,43,44)(H,46,51,53)",AJTLGUJXIKEZCQ-UHFFFAOYSA-N
283,Q06187,BTK C481S,CRBN,,MT-802,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CCOCCOCC(=O)NC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(,CCOCCOCC(=O)N,C2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,14.9,99.0,1,Degradation of C481S BTK in XLA cells after 24 h treatment,,,20.9,Inhibition of C481S BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.biochem.8b00391,787.834,787.3078093,2.33,58,8,14,3,14,213.2,C41H41N9O8,"InChI=1S/C41H41N9O8/c42-37-35-36(25-6-9-29(10-7-25)58-28-4-2-1-3-5-28)47-50(38(35)44-24-43-37)27-14-16-48(17-15-27)18-19-56-20-21-57-23-34(52)45-26-8-11-30-31(22-26)41(55)49(40(30)54)32-12-13-33(51)46-39(32)53/h1-11,22,24,27,32H,12-21,23H2,(H,45,52)(H2,42,43,44)(H,46,51,53)",AJTLGUJXIKEZCQ-UHFFFAOYSA-N
284,Q06187,BTK,CRBN,,MT-809,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CCCCOCCCCOCC(=O)NC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(,CCCCOCCCCOCC(=O)N,C2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,11.6,99.0,1,Degradation of BTK in NAMALWA cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.biochem.8b00391,843.942,843.3704095,3.76,62,8,14,3,18,213.2,C45H49N9O8,"InChI=1S/C45H49N9O8/c46-41-39-40(29-10-13-33(14-11-29)62-32-8-2-1-3-9-32)51-54(42(39)48-28-47-41)31-18-21-52(22-19-31)20-4-5-23-60-24-6-7-25-61-27-38(56)49-30-12-15-34-35(26-30)45(59)53(44(34)58)36-16-17-37(55)50-43(36)57/h1-3,8-15,26,28,31,36H,4-7,16-25,27H2,(H,49,56)(H2,46,47,48)(H,50,55,57)",VPGHQPSPNUQPLG-UHFFFAOYSA-N
285,O15264,p38delta,CRBN,,SJF-8242,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCOCCCOCCC(=O)NCCOC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)C=CN=C2C=C1,OCCCOCCCOCCC(=O)NCCO,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,27.0,91.0,1,Degradation of p38delta in MDA-MB-231 cells after 24 h treatment,,,,,,,2000,Kd was assessed by competition binding assays,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2017.09.010,992.986,992.3403921,5.03,72,8,14,4,24,239.12,C51H50F2N6O13,"InChI=1S/C51H50F2N6O13/c1-67-41-28-34-36(54-19-15-38(34)72-39-13-11-32(27-35(39)53)57-50(66)51(17-18-51)49(65)56-31-9-7-30(52)8-10-31)29-42(41)70-24-4-23-68-21-3-22-69-25-16-43(60)55-20-26-71-40-6-2-5-33-45(40)48(64)59(47(33)63)37-12-14-44(61)58-46(37)62/h2,5-11,13,15,19,27-29,37H,3-4,12,14,16-18,20-26H2,1H3,(H,55,60)(H,56,65)(H,57,66)(H,58,61,62)",ZAJXSUNUSHEGCB-UHFFFAOYSA-N
329,P25440,BRD2,CRBN,,ARV-825,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NC1=CC=C(OCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NC1=CC=C(,OCCOCCOCCOCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C1)N=C2C1=CC=C(Cl)C=C1,6.0,83.0,1,Degradation of BRD2 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17/35,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,923.449,922.2875238,4.81,65,8,15,3,19,204.67,C46H47ClN8O9S,"InChI=1S/C46H47ClN8O9S/c1-26-27(2)65-46-39(26)41(29-7-9-30(47)10-8-29)50-35(42-53-52-28(3)54(42)46)25-38(57)49-31-11-13-32(14-12-31)64-24-23-63-22-21-62-20-19-61-18-17-48-34-6-4-5-33-40(34)45(60)55(44(33)59)36-15-16-37(56)51-43(36)58/h4-14,35-36,48H,15-25H2,1-3H3,(H,49,57)(H,51,56,58)/t35-,36?/m0/s1",RWLOGRLTDKDANT-TYIYNAFKSA-N
329,Q15059,BRD3,CRBN,,ARV-825,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NC1=CC=C(OCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NC1=CC=C(,OCCOCCOCCOCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C1)N=C2C1=CC=C(Cl)C=C1,0.8,98.0,1,Degradation of BRD3 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17/35,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,923.449,922.2875238,4.81,65,8,15,3,19,204.67,C46H47ClN8O9S,"InChI=1S/C46H47ClN8O9S/c1-26-27(2)65-46-39(26)41(29-7-9-30(47)10-8-29)50-35(42-53-52-28(3)54(42)46)25-38(57)49-31-11-13-32(14-12-31)64-24-23-63-22-21-62-20-19-61-18-17-48-34-6-4-5-33-40(34)45(60)55(44(33)59)36-15-16-37(56)51-43(36)58/h4-14,35-36,48H,15-25H2,1-3H3,(H,49,57)(H,51,56,58)/t35-,36?/m0/s1",RWLOGRLTDKDANT-TYIYNAFKSA-N
329,O60885,BRD4,CRBN,,ARV-825,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NC1=CC=C(OCCOCCOCCOCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NC1=CC=C(,OCCOCCOCCOCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C1)N=C2C1=CC=C(Cl)C=C1,0.6,97.0,1,Degradation of BRD4 short/long in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17/35,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,923.449,922.2875238,4.81,65,8,15,3,19,204.67,C46H47ClN8O9S,"InChI=1S/C46H47ClN8O9S/c1-26-27(2)65-46-39(26)41(29-7-9-30(47)10-8-29)50-35(42-53-52-28(3)54(42)46)25-38(57)49-31-11-13-32(14-12-31)64-24-23-63-22-21-62-20-19-61-18-17-48-34-6-4-5-33-40(34)45(60)55(44(33)59)36-15-16-37(56)51-43(36)58/h4-14,35-36,48H,15-25H2,1-3H3,(H,49,57)(H,51,56,58)/t35-,36?/m0/s1",RWLOGRLTDKDANT-TYIYNAFKSA-N
333,P11474,ERRalpha,VHL,,,COC1=CC(/C=C2\SC(=O)N(CCOCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)C2=O)=CC=C1OC1=CC=C(C#N)C=C1C(F)(F)F,COC1=CC(/C=C2\SC(=O)N(,CCOCCC(=O)N,[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)C2=O)=CC=C1OC1=CC=C(C#N)C=C1C(F)(F)F,100.0,86.0,1,Degradation of ERRalpha in MCF-7 cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/nchembio.1858,949.043,948.2798037,6.35,66,6,13,3,16,200.49,C46H47F3N6O9S2,"InChI=1S/C46H47F3N6O9S2/c1-26-39(65-25-52-26)30-10-6-27(7-11-30)23-51-41(58)33-21-31(56)24-55(33)43(60)40(45(2,3)4)53-38(57)14-16-63-17-15-54-42(59)37(66-44(54)61)20-28-8-13-35(36(19-28)62-5)64-34-12-9-29(22-50)18-32(34)46(47,48)49/h6-13,18-20,25,31,33,40,56H,14-17,21,23-24H2,1-5H3,(H,51,58)(H,53,57)/b37-20-/t31-,33+,40-/m1/s1",IIJORMBEWMYDEN-FRKKMCEPSA-N
334,O43353,RIPK2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOC3=CC4=NC=CC(NC5=CC=C6SC=NC6=C5)=C4C=C3S(=O)(=O)C(C)(C)C)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3,C(=O)[C@@H](NC(=O)COCCOCCOCCOCCO,C3=CC4=NC=CC(NC5=CC=C6SC=NC6=C5)=C4C=C3S(=O)(=O)C(C)(C)C)C(C)(C)C)C=C2)SC=N1,1.4,95.0,1,Degradation of RIPK2 in THP-1 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,656.0,Inhibition of VHL by competition binding assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/nchembio.1858,1060.331,1059.390419,5.91,73,7,17,4,24,229.73,C52H65N7O11S3,"InChI=1S/C52H65N7O11S3/c1-33-47(72-31-55-33)35-10-8-34(9-11-35)28-54-49(62)42-25-37(60)29-59(42)50(63)48(51(2,3)4)58-46(61)30-69-21-20-67-17-16-66-18-19-68-22-23-70-43-27-40-38(26-45(43)73(64,65)52(5,6)7)39(14-15-53-40)57-36-12-13-44-41(24-36)56-32-71-44/h8-15,24,26-27,31-32,37,42,48,60H,16-23,25,28-30H2,1-7H3,(H,53,57)(H,54,62)(H,58,61)/t37-,42+,48-/m1/s1",RIEGJNXDHULIKM-GPPJZCFZSA-N
335,P25440,BRD2,VHL,,MZ1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCCNC(=O)C,[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,40.0,98.0,1,Degradation of BRD2 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,69,ITC,,,-9.77,-7.76,-2.02,ITC,,,,,,,,,,,,,,,,,,,,,,,27/219,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,1002.661,1001.36948,4.96,69,7,15,4,20,211.49,C49H60ClN9O8S2,"InChI=1S/C49H60ClN9O8S2/c1-28-30(3)69-48-41(28)42(33-12-14-35(50)15-13-33)54-37(45-57-56-31(4)59(45)48)23-39(61)51-16-17-65-18-19-66-20-21-67-26-40(62)55-44(49(5,6)7)47(64)58-25-36(60)22-38(58)46(63)52-24-32-8-10-34(11-9-32)43-29(2)53-27-68-43/h8-15,27,36-38,44,60H,16-26H2,1-7H3,(H,51,61)(H,52,63)(H,55,62)/t36-,37+,38+,44-/m1/s1",PTAMRJLIOCHJMQ-PYNGZGNASA-N
335,Q15059,BRD3,VHL,,MZ1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCCNC(=O)C,[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,100.0,100.0,1,Degradation of BRD3 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,69,ITC,,,-9.77,-7.76,-2.02,ITC,,,,,,,,,,,,,,,,,,,,,,,27/219,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,1002.661,1001.36948,4.96,69,7,15,4,20,211.49,C49H60ClN9O8S2,"InChI=1S/C49H60ClN9O8S2/c1-28-30(3)69-48-41(28)42(33-12-14-35(50)15-13-33)54-37(45-57-56-31(4)59(45)48)23-39(61)51-16-17-65-18-19-66-20-21-67-26-40(62)55-44(49(5,6)7)47(64)58-25-36(60)22-38(58)46(63)52-24-32-8-10-34(11-9-32)43-29(2)53-27-68-43/h8-15,27,36-38,44,60H,16-26H2,1-7H3,(H,51,61)(H,52,63)(H,55,62)/t36-,37+,38+,44-/m1/s1",PTAMRJLIOCHJMQ-PYNGZGNASA-N
335,O60885,BRD4,VHL,,MZ1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCCNC(=O)C,[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,40.0,98.0,1,Degradation of BRD4 in A375 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9600000,0.015,54.8,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,1002.661,1001.36948,4.96,69,7,15,4,20,211.49,C49H60ClN9O8S2,"InChI=1S/C49H60ClN9O8S2/c1-28-30(3)69-48-41(28)42(33-12-14-35(50)15-13-33)54-37(45-57-56-31(4)59(45)48)23-39(61)51-16-17-65-18-19-66-20-21-67-26-40(62)55-44(49(5,6)7)47(64)58-25-36(60)22-38(58)46(63)52-24-32-8-10-34(11-9-32)43-29(2)53-27-68-43/h8-15,27,36-38,44,60H,16-26H2,1-7H3,(H,51,61)(H,52,63)(H,55,62)/t36-,37+,38+,44-/m1/s1",PTAMRJLIOCHJMQ-PYNGZGNASA-N
335,O60885,BRD4,VHL,,MZ1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCCNC(=O)C,[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,250.0,100.0,0,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95,ITC,,,,,,,,,,,,,,,,,,,,,,,0.11,Caco-2 A2B assay,9,Caco-2 B2A assay,10.1002/cmdc.202200615,1002.661,1001.36948,4.96,69,7,15,4,20,211.49,C49H60ClN9O8S2,"InChI=1S/C49H60ClN9O8S2/c1-28-30(3)69-48-41(28)42(33-12-14-35(50)15-13-33)54-37(45-57-56-31(4)59(45)48)23-39(61)51-16-17-65-18-19-66-20-21-67-26-40(62)55-44(49(5,6)7)47(64)58-25-36(60)22-38(58)46(63)52-24-32-8-10-34(11-9-32)43-29(2)53-27-68-43/h8-15,27,36-38,44,60H,16-26H2,1-7H3,(H,51,61)(H,52,63)(H,55,62)/t36-,37+,38+,44-/m1/s1",PTAMRJLIOCHJMQ-PYNGZGNASA-N
336,P25440,BRD2,VHL,,MZ2,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCCOCCNC(=O)C,[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,200.0,97.0,0,Degradation of BRD2 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,73,ITC,,,-9.75,-8.79,-0.96,ITC,,,,,,,,,,,,,,,,,,,,,,,123/1259,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912; 10.1021/acschembio.5b00216,1046.714,1045.395694,4.82,72,7,16,4,23,220.72,C51H64ClN9O9S2,"InChI=1S/C51H64ClN9O9S2/c1-30-32(3)72-50-43(30)44(35-12-14-37(52)15-13-35)56-39(47-59-58-33(4)61(47)50)25-41(63)53-16-17-67-18-19-68-20-21-69-22-23-70-28-42(64)57-46(51(5,6)7)49(66)60-27-38(62)24-40(60)48(65)54-26-34-8-10-36(11-9-34)45-31(2)55-29-71-45/h8-15,29,38-40,46,62H,16-28H2,1-7H3,(H,53,63)(H,54,65)(H,57,64)/t38-,39+,40+,46-/m1/s1",LSELSHXLKGXPPF-BOBBFQORSA-N
336,Q15059,BRD3,VHL,,MZ2,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCCOCCNC(=O)C,[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,316.0,99.0,0,Degradation of BRD3 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,73,ITC,,,-9.75,-8.79,-0.96,ITC,,,,,,,,,,,,,,,,,,,,,,,123/1259,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912; 10.1021/acschembio.5b00216,1046.714,1045.395694,4.82,72,7,16,4,23,220.72,C51H64ClN9O9S2,"InChI=1S/C51H64ClN9O9S2/c1-30-32(3)72-50-43(30)44(35-12-14-37(52)15-13-35)56-39(47-59-58-33(4)61(47)50)25-41(63)53-16-17-67-18-19-68-20-21-69-22-23-70-28-42(64)57-46(51(5,6)7)49(66)60-27-38(62)24-40(60)48(65)54-26-34-8-10-36(11-9-34)45-31(2)55-29-71-45/h8-15,29,38-40,46,62H,16-28H2,1-7H3,(H,53,63)(H,54,65)(H,57,64)/t38-,39+,40+,46-/m1/s1",LSELSHXLKGXPPF-BOBBFQORSA-N
339,O60885,BRD4,CRBN,6BOY,dBET6,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCCCCNC(=O)COC1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCCCCCCCCNC(=O)CO,C1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,6.0,97.0,1,Degradation of BRD4 in HEK293T cells after 3 h treatment,,,,,,,46,Kd of BRD4 BD1 was assessed by FP,,,,,,,,,,,,,,,264,FP,,,,,,,,,,,,,,,33,Kd was tested by AlphaLISA assay,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.1c00376,841.391,840.2820445,5.02,59,7,12,3,16,194.05,C42H45ClN8O7S,"InChI=1S/C42H45ClN8O7S/c1-23-24(2)59-42-35(23)37(26-13-15-27(43)16-14-26)46-29(38-49-48-25(3)50(38)42)21-33(53)44-19-8-6-4-5-7-9-20-45-34(54)22-58-31-12-10-11-28-36(31)41(57)51(40(28)56)30-17-18-32(52)47-39(30)55/h10-16,29-30H,4-9,17-22H2,1-3H3,(H,44,53)(H,45,54)(H,47,52,55)/t29-,30?/m0/s1",JGQPZPLJOBHHBK-UFXYQILXSA-N
363,P10275,AR,VHL,,ARD-266,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)N2CCC(C#CC3=CC=C(C(=O)N[C@H]4C(C)(C)[C@H](OC5=CC=C(C#N)C(Cl)=C5)C4(C)C)C=C3)CC2)C2=CC=CC=C2)C(C)C)=C1,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](,CC(=O)N,2CCC(C#CC3=CC=C(C(=O)N[C@H]4C(C)(C)[C@H](OC5=CC=C(C#N)C(Cl)=C5)C4(C)C)C=C3)CC2)C2=CC=CC=C2)C(C)C)=C1,0.5,95.0,1,Degradation of AR in LNCaP/VCaP/22Rv1 cells after 6 h treatment,90/>95/>99,% AR degradation in LNCaP cells after 6 h treatment at 10/100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2月6日,Inhibit growth of LNCaP/VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b01393,915.532,914.4133759,7.63,66,7,9,3,12,178.1,C52H59ClN6O7,"InChI=1S/C52H59ClN6O7/c1-31(2)45(43-25-32(3)57-66-43)48(64)59-30-38(60)26-42(59)47(63)55-41(35-11-9-8-10-12-35)28-44(61)58-23-21-34(22-24-58)14-13-33-15-17-36(18-16-33)46(62)56-49-51(4,5)50(52(49,6)7)65-39-20-19-37(29-54)40(53)27-39/h8-12,15-20,25,27,31,34,38,41-42,45,49-50,60H,21-24,26,28,30H2,1-7H3,(H,55,63)(H,56,62)/t38-,41+,42+,45-,49-,50-/m1/s1",RTNONCBKGZNCJS-LJLQSONVSA-N
556,Q00987,MDM2,CRBN,,,CCOC1=CC(C(C)(C)C)=CC=C1C1=N[C@@H](C2=CC=C(Cl)C=C2)[C@@H](C2=CC=C(Cl)C=C2)N1C(=O)N1CCN(CC#CC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)CC1,CCOC1=CC(,C(C)(C)C,)=CC=C1C1=N[C@@H](C2=CC=C(Cl)C=C2)[C@@H](C2=CC=C(Cl)C=C2)N1C(=O)N1CCN(CC#CC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)CC1,23.0,90.0,1,Degradation of MDM2 in RS4; 11 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2,Inhibit proliferation of RS4; 11 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2019.05.046,859.855,858.306324,7.3,61,8,7,1,7,114.86,C48H48Cl2N6O5,"InChI=1S/C48H48Cl2N6O5/c1-5-61-40-28-33(48(2,3)4)15-20-37(40)44-52-42(31-11-16-34(49)17-12-31)43(32-13-18-35(50)19-14-32)56(44)47(60)54-26-24-53(25-27-54)23-7-9-30-8-6-10-36-38(30)29-55(46(36)59)39-21-22-41(57)51-45(39)58/h6,8,10-20,28,39,42-43H,5,21-27,29H2,1-4H3,(H,51,57,58)/t39?,42-,43+/m0/s1",SXPSRFOBNYZXKH-UZLVNVLGSA-N
559,P00533,EGFR,CRBN,,,O=C1CCC(N2CC3=C(NC(=O)CCCCCCCN4CCN(C5=CC=C(NC6=CC7=C(N8CCC(CO)CC8)N=C(NC8=CC=C(F)C=C8)N=C7C=N6)N=C5)CC4)C=CC=C3C2=O)C(=O)N1,O=C1CCC(N2CC3=C(,NC(=O)CCCCCCCN,4CCN(C5=CC=C(NC6=CC7=C(N8CCC(CO)CC8)N=C(NC8=CC=C(F)C=C8)N=C7C=N6)N=C5)CC4)C=CC=C3C2=O)C(=O)N1,45.2,87.0,1,Degradation of EGFR in HCC827 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,180,Inhibit proliferation of HCC827 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112061,913.072,912.4558911,5.26,67,9,14,5,17,201.15,C49H57FN12O5,"InChI=1S/C49H57FN12O5/c50-33-10-12-34(13-11-33)53-49-55-40-29-52-43(27-37(40)46(58-49)61-21-18-32(31-63)19-22-61)56-42-16-14-35(28-51-42)60-25-23-59(24-26-60)20-5-3-1-2-4-9-44(64)54-39-8-6-7-36-38(39)30-62(48(36)67)41-15-17-45(65)57-47(41)66/h6-8,10-14,16,27-29,32,41,63H,1-5,9,15,17-26,30-31H2,(H,54,64)(H,51,52,56)(H,53,55,58)(H,57,65,66)",ZWLPWTDAYPOQGR-UHFFFAOYSA-N
567,P00533,EGFR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCN3CCN(C4=CC=C(NC5=CC6=C(N7CCC(CO)CC7)N=C(NC7=CC=C(F)C=C7)N=C6C=N5)N=C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCN,3CCN(C4=CC=C(NC5=CC6=C(N7CCC(CO)CC7)N=C(NC7=CC=C(F)C=C7)N=C6C=N5)N=C4)CC3)C(C)(C)C)C=C2)SC=N1,34.8,98.0,1,Degradation of EGFR in HCC827 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,220,Inhibit proliferation of HCC827 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112061,1070.354,1069.548412,7.67,77,9,16,6,20,217.2,C57H72FN13O5S,"InChI=1S/C57H72FN13O5S/c1-37-51(77-36-62-37)40-12-10-38(11-13-40)31-61-54(75)47-29-44(73)34-71(47)55(76)52(57(2,3)4)66-50(74)9-7-5-6-8-22-68-25-27-69(28-26-68)43-18-19-48(59-32-43)65-49-30-45-46(33-60-49)64-56(63-42-16-14-41(58)15-17-42)67-53(45)70-23-20-39(35-72)21-24-70/h10-19,30,32-33,36,39,44,47,52,72-73H,5-9,20-29,31,34-35H2,1-4H3,(H,61,75)(H,66,74)(H,59,60,65)(H,63,64,67)/t44-,47+,52-/m1/s1",LCTCXOPSLJEXKE-FEDPBZRBSA-N
697,Q07817,BCL-xL,VHL,,DT2216,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCC(=O)N3CCN(CC[C@H](CSC4=CC=CC=C4)NC4=CC=C(S(=O)(=O)NC(=O)C5=CC=C(N6CCN(CC7=C(C8=CC=C(Cl)C=C8)CCC(C)(C)C7)CC6)C=C5)C=C4S(=O)(=O)C(F)(F)F)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCC(=O)N,3CCN(CC[C@H](CSC4=CC=CC=C4)NC4=CC=C(S(=O)(=O)NC(=O)C5=CC=C(N6CCN(CC7=C(C8=CC=C(Cl)C=C8)CCC(C)(C)C7)CC6)C=C5)C=C4S(=O)(=O)C(F)(F)F)CC3)C(C)(C)C)C=C2)SC=N1,63.0,90.8,1,Degradation of BCL-xL in MOLT-4/platelets cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,52/23/160,Inhibit viability of MOLT-4/RS4;11/H146 cells,,,,,,,,,,,,,10.1038/s41591-019-0668-z,1542.39,1540.583436,12.83,105,10,17,5,28,251.07,C77H96ClF3N10O10S4,"InChI=1S/C77H96ClF3N10O10S4/c1-51(53-18-20-55(21-19-53)70-52(2)82-50-103-70)83-73(96)66-44-61(92)48-91(66)74(97)71(75(3,4)5)85-68(93)16-12-9-13-17-69(94)90-42-36-87(37-43-90)35-33-59(49-102-62-14-10-8-11-15-62)84-65-31-30-63(45-67(65)104(98,99)77(79,80)81)105(100,101)86-72(95)56-24-28-60(29-25-56)89-40-38-88(39-41-89)47-57-46-76(6,7)34-32-64(57)54-22-26-58(78)27-23-54/h8,10-11,14-15,18-31,45,50-51,59,61,66,71,84,92H,9,12-13,16-17,32-44,46-49H2,1-7H3,(H,83,96)(H,85,93)(H,86,95)/t51-,59+,61+,66-,71+/m0/s1",PXVFFBGSTYQHRO-REQIQPEASA-N
714,O43924,PDEdelta,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCOCCNC(=O)C4=CC=C(CN(CC5CCNCC5)S(=O)(=O)C5=CC=C(S(=O)(=O)N(CC6=CC=C(Cl)C=C6)C6CCCC6)C=C5)C=C4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(,NCCOCCOCCOCCOCCNC(=O),C4=CC=C(CN(CC5CCNCC5)S(=O)(=O)C5=CC=C(S(=O)(=O)N(CC6=CC=C(Cl)C=C6)C6CCCC6)C=C5)C=C4)=C3C2=O)C(=O)N1,48.0,83.4,1,Degradation of PDEdelta in Panc Tu-I cells after 24 h treatment,,,,,,,64.3,Kd was determined by competitive fluorescent polarization analysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.9,Kd between CRBN and the complex of protac and PDEdelta was tested by FP,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.201913904,1134.772,1133.400505,4.54,78,8,15,4,29,248.39,C55H68ClN7O13S2,"InChI=1S/C55H68ClN7O13S2/c56-43-14-10-40(11-15-43)38-62(44-4-1-2-5-44)78(71,72)46-18-16-45(17-19-46)77(69,70)61(37-41-22-24-57-25-23-41)36-39-8-12-42(13-9-39)52(65)59-27-29-74-31-33-76-35-34-75-32-30-73-28-26-58-48-7-3-6-47-51(48)55(68)63(54(47)67)49-20-21-50(64)60-53(49)66/h3,6-19,41,44,49,57-58H,1-2,4-5,20-38H2,(H,59,65)(H,60,64,66)",OWYXKRGXEAHYMU-UHFFFAOYSA-N
750,Q06187,BTK,VHL,,SJF638,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCN3CCC(N4N=C(C5=CC=C(OC6=CC=CC=C6)C=C5)C5=C(N)N=CN=C54)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCN,3CCC(N4N=C(C5=CC=C(OC6=CC=CC=C6)C=C5)C5=C(N)N=CN=C54)CC3)C(C)(C)C)C=C2)SC=N1,374.0,49.0,0,Degradation of BTK in NAMALWA cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2019.126877,945.16,944.4367153,5.34,68,8,15,4,18,212.18,C50H60N10O7S,"InChI=1S/C50H60N10O7S/c1-32-44(68-31-55-32)35-12-10-33(11-13-35)27-52-48(63)40-26-37(61)28-59(40)49(64)45(50(2,3)4)56-41(62)29-66-25-24-65-23-22-58-20-18-36(19-21-58)60-47-42(46(51)53-30-54-47)43(57-60)34-14-16-39(17-15-34)67-38-8-6-5-7-9-38/h5-17,30-31,36-37,40,45,61H,18-29H2,1-4H3,(H,52,63)(H,56,62)(H2,51,53,54)/t37-,40+,45-/m1/s1",RIOHYDUGYNZWPD-DIKPJKDTSA-N
751,Q06187,BTK,VHL,,SJF678,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](C(C)C)N3CC4=CC=CC=C4C3=O)C(OCCCCOCCCCN3CCC(N4N=C(C5=CC=C(OC6=CC=CC=C6)C=C5)C5=C(N)N=CN=C54)CC3)=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](C(C)C)N3CC4=CC=CC=C4C3=O)C(,OCCCCOCCCCN,3CCC(N4N=C(C5=CC=C(OC6=CC=CC=C6)C=C5)C5=C(N)N=CN=C54)CC3)=C2)SC=N1,162.0,50.0,0,Degradation of BTK in NAMALWA cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2019.126877,1061.323,1060.499316,7.88,77,10,15,3,22,203.39,C59H68N10O7S,"InChI=1S/C59H68N10O7S/c1-38(2)53(68-34-43-13-7-8-16-48(43)58(68)72)59(73)67-35-45(70)32-49(67)57(71)61-33-42-18-17-41(54-39(3)64-37-77-54)31-50(42)75-30-12-11-29-74-28-10-9-25-66-26-23-44(24-27-66)69-56-51(55(60)62-36-63-56)52(65-69)40-19-21-47(22-20-40)76-46-14-5-4-6-15-46/h4-8,13-22,31,36-38,44-45,49,53,70H,9-12,23-30,32-35H2,1-3H3,(H,61,71)(H2,60,62,63)/t45-,49+,53+/m1/s1",VFRJYHIRKCDWOQ-ABZCTAHRSA-N
753,Q06187,BTK,CRBN,,SJF608,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CCOCCOCCOC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(,CCOCCOCCO,C2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,8.3,91.0,1,Degradation of BTK in NAMALWA cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2019.126877,774.835,774.3125603,3.1,57,8,14,2,15,193.33,C41H42N8O8,"InChI=1S/C41H42N8O8/c42-37-35-36(26-6-8-29(9-7-26)57-28-4-2-1-3-5-28)46-49(38(35)44-25-43-37)27-14-16-47(17-15-27)18-19-54-20-21-55-22-23-56-30-10-11-31-32(24-30)41(53)48(40(31)52)33-12-13-34(50)45-39(33)51/h1-11,24-25,27,33H,12-23H2,(H2,42,43,44)(H,45,50,51)",KCRCMDOSXFUJPF-UHFFFAOYSA-N
754,Q06187,BTK,CRBN,,SJF620,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CCOCCOCCOC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)CC3=C2)CC1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(,CCOCCOCCO,C2=CC=C3C(=O)N(C4CCC(=O)NC4=O)CC3=C2)CC1,7.9,95.0,1,Degradation of BTK in NAMALWA cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2019.126877,760.852,760.3332957,3.15,56,8,13,2,15,176.26,C41H44N8O7,"InChI=1S/C41H44N8O7/c42-38-36-37(27-6-8-31(9-7-27)56-30-4-2-1-3-5-30)46-49(39(36)44-26-43-38)29-14-16-47(17-15-29)18-19-53-20-21-54-22-23-55-32-10-11-33-28(24-32)25-48(41(33)52)34-12-13-35(50)45-40(34)51/h1-11,24,26,29,34H,12-23,25H2,(H2,42,43,44)(H,45,50,51)",UJJYPBWMGIPXOE-UHFFFAOYSA-N
796,P51531,SMARCA2,VHL,6HAY,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCOCCOCCN3CCN(C4=CC(C5=CC=CC=C5O)=NN=C4N)CC3)=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(,OCCOCCOCCN,3CCN(C4=CC(C5=CC=CC=C5O)=NN=C4N)CC3)=C2)SC=N1,300.0,65.0,0,Degradation of SMARCA2 in MV-4-11 cells after 18 h treatment,,,2400/600,IC50 of SMARCA2 BD was tested by TR-FRET/AlphaLISA,,,4500,SPR in SMARCA2 BD,,,,,,,,,,,,,,,234/98,ITC/SPR,210.0,FP,-37.9,-21.0,-17.0,ITC,,,,,205/120,TR-FRET/AlphaLISA,,,49,ITC,48.0,FP,-41.8,-27.0,-15.0,ITC between VHL and PROTAC:SMARCA2,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-019-0294-6,918.106,917.4269591,3.22,65,7,15,5,19,217.83,C46H60FN9O8S,"InChI=1S/C46H60FN9O8S/c1-29-39(65-28-50-29)30-9-10-31(26-49-42(59)36-24-32(57)27-56(36)43(60)40(45(2,3)4)51-44(61)46(47)11-12-46)38(23-30)64-22-21-63-20-19-62-18-17-54-13-15-55(16-14-54)35-25-34(52-53-41(35)48)33-7-5-6-8-37(33)58/h5-10,23,25,28,32,36,40,57-58H,11-22,24,26-27H2,1-4H3,(H2,48,53)(H,49,59)(H,51,61)/t32-,36+,40-/m1/s1",QCULBRPVCWJUKY-OUMVKTTMSA-N
796,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCOCCOCCN3CCN(C4=CC(C5=CC=CC=C5O)=NN=C4N)CC3)=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(,OCCOCCOCCN,3CCN(C4=CC(C5=CC=CC=C5O)=NN=C4N)CC3)=C2)SC=N1,250.0,70.0,0,Degradation of SMARCA4 in MV-4-11 cells after 18 h treatment,,,3000/1300,IC50 of SMARCA4 BD was tested by TR-FRET/AlphaLISA,,,4800,SPR in SMARCA4 BD,,,,,,,,,,,,,,,234/98,ITC/SPR,210.0,FP,-37.9,-21.0,-17.0,ITC,,,,,230/330,TR-FRET/AlphaLISA,,,,,26.0,FP,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-019-0294-6,918.106,917.4269591,3.22,65,7,15,5,19,217.83,C46H60FN9O8S,"InChI=1S/C46H60FN9O8S/c1-29-39(65-28-50-29)30-9-10-31(26-49-42(59)36-24-32(57)27-56(36)43(60)40(45(2,3)4)51-44(61)46(47)11-12-46)38(23-30)64-22-21-63-20-19-62-18-17-54-13-15-55(16-14-54)35-25-34(52-53-41(35)48)33-7-5-6-8-37(33)58/h5-10,23,25,28,32,36,40,57-58H,11-22,24,26-27H2,1-4H3,(H2,48,53)(H,49,59)(H,51,61)/t32-,36+,40-/m1/s1",QCULBRPVCWJUKY-OUMVKTTMSA-N
797,P51531,SMARCA2,VHL,8G1P,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,CC1=C(C2=CC=C(,CNC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,221.0,53.0,0,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1130000,0.12,5.9,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,920.125,919.4214798,5.27,66,8,13,5,15,199.37,C49H58FN9O6S,"InChI=1S/C49H58FN9O6S/c1-30-42(66-29-53-30)33-13-14-34(26-52-45(62)39-24-35(60)28-59(39)46(63)43(48(2,3)4)54-47(64)49(50)16-17-49)41(23-33)65-22-15-31-9-11-32(12-10-31)27-57-18-20-58(21-19-57)38-25-37(55-56-44(38)51)36-7-5-6-8-40(36)61/h5-14,23,25,29,35,39,43,60-61H,15-22,24,26-28H2,1-4H3,(H2,51,56)(H,52,62)(H,54,64)/t35-,39+,43-/m1/s1",UTZVLJZPTDCKCT-XBPZXCMESA-N
825,P03372,ER,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCOC3=CC=C(/C=N/NC(=O)C4=CC=C(C(=O)C5=C(C6=CC=C(O)C=C6)SC6=CC(O)=CC=C56)C=C4)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCO,C3=CC=C(/C=N/NC(=O)C4=CC=C(C(=O)C5=C(C6=CC=C(O)C=C6)SC6=CC(O)=CC=C56)C=C4)C=C3)C(C)(C)C)C=C2)SC=N1,7.7,95.0,1,Degradation of ERalpha in MCF-7/T47D cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,69.1/65.2,Inhibit proliferation of MCF-7/T47D cells,,,,,,,,,,,,,,,10.1021/acschembio.0c00140,1035.258,1034.370669,9.25,74,8,13,6,18,219.85,C57H58N6O9S2,"InChI=1S/C57H58N6O9S2/c1-33(36-11-15-38(16-12-36)51-34(2)58-32-73-51)60-55(70)46-28-43(66)31-63(46)56(71)53(57(3,4)5)61-48(67)8-6-7-27-72-44-24-9-35(10-25-44)30-59-62-54(69)40-17-13-37(14-18-40)50(68)49-45-26-23-42(65)29-47(45)74-52(49)39-19-21-41(64)22-20-39/h9-26,29-30,32-33,43,46,53,64-66H,6-8,27-28,31H2,1-5H3,(H,60,70)(H,61,67)(H,62,69)/b59-30+/t33-,43+,46-,53+/m0/s1",VVAVIHDLCKOZJR-WFZPVKHBSA-N
920,P03372,ER,VHL,,AM-A3,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCOC3=CC=C(CCNC(=O)C4=CC=C(C(=O)C5=C(C6=CC=C(O)C=C6)SC6=CC(O)=CC=C56)C=C4)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCO,C3=CC=C(CCNC(=O)C4=CC=C(C(=O)C5=C(C6=CC=C(O)C=C6)SC6=CC(O)=CC=C56)C=C4)C=C3)C(C)(C)C)C=C2)SC=N1,1.1,98.0,1,Degradation of ERalpha in MCF-7 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,13.2/17,Inhibit proliferation of MCF-7/T47D cells,,,,,,,,,,,,,,,10.1021/acschembio.0c00140,1036.286,1035.391071,9.57,74,8,12,6,19,207.49,C58H61N5O9S2,"InChI=1S/C58H61N5O9S2/c1-34(37-11-15-39(16-12-37)52-35(2)60-33-73-52)61-56(70)47-30-44(66)32-63(47)57(71)54(58(3,4)5)62-49(67)8-6-7-29-72-45-24-9-36(10-25-45)27-28-59-55(69)41-17-13-38(14-18-41)51(68)50-46-26-23-43(65)31-48(46)74-53(50)40-19-21-42(64)22-20-40/h9-26,31,33-34,44,47,54,64-66H,6-8,27-30,32H2,1-5H3,(H,59,69)(H,61,70)(H,62,67)/t34-,44+,47-,54+/m0/s1",VXEYUCNJDJXFGM-BMAAPKIPSA-N
937,O75530,EED,VHL,,UNC6852,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCNC(=O)C3=CC=C(C4=CN=C(NCC5=CC=CO5)N5C=NN=C45)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCNC(=O),C3=CC=C(C4=CN=C(NCC5=CC=CO5)N5C=NN=C45)C=C3)C(C)(C)C)C=C2)SC=N1,790.0,92.0,0,Degradation of EED in HeLa/DB cells after 24 h treatment,,,247,IC50 of EED was tested by the TR-FRET assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3400/410,Inhibit proliferation of DB/Pfeiffer cells,,,,,,,,,,,,,10.1016/j.chembiol.2019.11.006,832.988,832.3479003,4.72,60,7,13,5,15,208.98,C43H48N10O6S,"InChI=1S/C43H48N10O6S/c1-26-36(60-25-48-26)29-11-9-27(10-12-29)20-45-40(57)34-19-31(54)23-52(34)41(58)37(43(2,3)4)50-35(55)8-5-17-44-39(56)30-15-13-28(14-16-30)33-22-47-42(53-24-49-51-38(33)53)46-21-32-7-6-18-59-32/h6-7,9-16,18,22,24-25,31,34,37,54H,5,8,17,19-21,23H2,1-4H3,(H,44,56)(H,45,57)(H,46,47)(H,50,55)/t31-,34+,37-/m1/s1",PPNNFXIBKLCMTI-WXEAQWFJSA-N
937,Q15910,EZH2,VHL,,UNC6852,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCNC(=O)C3=CC=C(C4=CN=C(NCC5=CC=CO5)N5C=NN=C45)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCNC(=O),C3=CC=C(C4=CN=C(NCC5=CC=CO5)N5C=NN=C45)C=C3)C(C)(C)C)C=C2)SC=N1,300.0,75.0,0,Degradation of EZH2 in HeLa/DB cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3400/410,Inhibit proliferation of DB/Pfeiffer cells,,,,,,,,,,,,,10.1016/j.chembiol.2019.11.006,832.988,832.3479003,4.72,60,7,13,5,15,208.98,C43H48N10O6S,"InChI=1S/C43H48N10O6S/c1-26-36(60-25-48-26)29-11-9-27(10-12-29)20-45-40(57)34-19-31(54)23-52(34)41(58)37(43(2,3)4)50-35(55)8-5-17-44-39(56)30-15-13-28(14-16-30)33-22-47-42(53-24-49-51-38(33)53)46-21-32-7-6-18-59-32/h6-7,9-16,18,22,24-25,31,34,37,54H,5,8,17,19-21,23H2,1-4H3,(H,44,56)(H,45,57)(H,46,47)(H,50,55)/t31-,34+,37-/m1/s1",PPNNFXIBKLCMTI-WXEAQWFJSA-N
937,Q15022,SUZ12,VHL,,UNC6852,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCNC(=O)C3=CC=C(C4=CN=C(NCC5=CC=CO5)N5C=NN=C45)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCNC(=O),C3=CC=C(C4=CN=C(NCC5=CC=CO5)N5C=NN=C45)C=C3)C(C)(C)C)C=C2)SC=N1,590.0,22.0,0,Degradation of SUZ12 in HeLa/DB cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3400/410,Inhibit proliferation of DB/Pfeiffer cells,,,,,,,,,,,,,10.1016/j.chembiol.2019.11.006,832.988,832.3479003,4.72,60,7,13,5,15,208.98,C43H48N10O6S,"InChI=1S/C43H48N10O6S/c1-26-36(60-25-48-26)29-11-9-27(10-12-29)20-45-40(57)34-19-31(54)23-52(34)41(58)37(43(2,3)4)50-35(55)8-5-17-44-39(56)30-15-13-28(14-16-30)33-22-47-42(53-24-49-51-38(33)53)46-21-32-7-6-18-59-32/h6-7,9-16,18,22,24-25,31,34,37,54H,5,8,17,19-21,23H2,1-4H3,(H,44,56)(H,45,57)(H,46,47)(H,50,55)/t31-,34+,37-/m1/s1",PPNNFXIBKLCMTI-WXEAQWFJSA-N
937,O75530,EED,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCNC(=O)C3=CC=C(C4=CN=C(NCC5=CC=CO5)N5C=NN=C45)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCNC(=O),C3=CC=C(C4=CN=C(NCC5=CC=CO5)N5C=NN=C45)C=C3)C(C)(C)C)C=C2)SC=N1,610.0,94.0,0,Degradation of EED in DB cells after 24h treatment,90,% EED protein degradation in DB cells at 3000 nM for 24h treatment,49.3,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.2c00804,832.988,832.3479003,4.72,60,7,13,5,15,208.98,C43H48N10O6S,"InChI=1S/C43H48N10O6S/c1-26-36(60-25-48-26)29-11-9-27(10-12-29)20-45-40(57)34-19-31(54)23-52(34)41(58)37(43(2,3)4)50-35(55)8-5-17-44-39(56)30-15-13-28(14-16-30)33-22-47-42(53-24-49-51-38(33)53)46-21-32-7-6-18-59-32/h6-7,9-16,18,22,24-25,31,34,37,54H,5,8,17,19-21,23H2,1-4H3,(H,44,56)(H,45,57)(H,46,47)(H,50,55)/t31-,34+,37-/m1/s1",PPNNFXIBKLCMTI-WXEAQWFJSA-N
937,Q15910,EZH2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCNC(=O)C3=CC=C(C4=CN=C(NCC5=CC=CO5)N5C=NN=C45)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCNC(=O),C3=CC=C(C4=CN=C(NCC5=CC=CO5)N5C=NN=C45)C=C3)C(C)(C)C)C=C2)SC=N1,670.0,96.0,0,Degradation of EZH2 in DB cells after 24h treatment,53,% EZH2 protein degradation in DB cells at 3000 nM for 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.2c00804,832.988,832.3479003,4.72,60,7,13,5,15,208.98,C43H48N10O6S,"InChI=1S/C43H48N10O6S/c1-26-36(60-25-48-26)29-11-9-27(10-12-29)20-45-40(57)34-19-31(54)23-52(34)41(58)37(43(2,3)4)50-35(55)8-5-17-44-39(56)30-15-13-28(14-16-30)33-22-47-42(53-24-49-51-38(33)53)46-21-32-7-6-18-59-32/h6-7,9-16,18,22,24-25,31,34,37,54H,5,8,17,19-21,23H2,1-4H3,(H,44,56)(H,45,57)(H,46,47)(H,50,55)/t31-,34+,37-/m1/s1",PPNNFXIBKLCMTI-WXEAQWFJSA-N
968,Q96SW2,CRBN,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCCOCCOCCCCCOCC(=O)NCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCCCCOCCOCCCCCOCC(=O)NCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,200.0,75.0,0,Degradation of CRBN in HeLa/HEK293 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmc.2019.02.048,1061.269,1060.493955,3.67,75,6,16,6,30,273.23,C53H72N8O13S,"InChI=1S/C53H72N8O13S/c1-34-46(75-33-57-34)36-16-14-35(15-17-36)29-56-48(66)41-28-37(62)30-60(41)52(70)47(53(2,3)4)58-44(65)32-74-25-10-6-8-23-72-27-26-71-22-7-5-9-24-73-31-43(64)55-21-20-54-39-13-11-12-38-45(39)51(69)61(50(38)68)40-18-19-42(63)59-49(40)67/h11-17,33,37,40-41,47,54,62H,5-10,18-32H2,1-4H3,(H,55,64)(H,56,66)(H,58,65)(H,59,63,67)/t37-,40?,41+,47-/m1/s1",PEZCAXDTKNFUCR-CTMFSBKBSA-N
979,O43353,RIPK2,IAP,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C1=NC(C(=O)C2=CC=C(F)C=C2)=CS1)C1CCN(C(=O)C2=CN=C(N3CCN(CCOC4=CC5=NC=NC(NC6=N[NH]C(C)=C6C)=C5C=C4S(=O)(=O)C(C)(C)C)CC3)N=C2)CC1,,CN[C@@H](C)C(=O)N,[C@H](C(=O)N1CCC[C@H]1C1=NC(C(=O)C2=CC=C(F)C=C2)=CS1)C1CCN(C(=O)C2=CN=C(N3CCN(CCOC4=CC5=NC=NC(NC6=N[NH]C(C)=C6C)=C5C=C4S(=O)(=O)C(C)(C)C)CC3)N=C2)CC1,12.6,69.2,0,Degradation of RIPK2 in hPBMC cells after 24 h treatment,,,251.2,IC50 of RIPK2 was tested by FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s42003-020-0868-6,1093.326,1092.458611,5.19,77,9,18,4,17,253.83,C53H65FN14O7S2,"InChI=1S/C53H65FN14O7S2/c1-31-32(2)63-64-46(31)62-47-38-25-43(77(73,74)53(4,5)6)42(26-39(38)58-30-59-47)75-24-23-65-19-21-67(22-20-65)52-56-27-36(28-57-52)50(71)66-17-14-34(15-18-66)44(61-48(70)33(3)55-7)51(72)68-16-8-9-41(68)49-60-40(29-76-49)45(69)35-10-12-37(54)13-11-35/h10-13,25-30,33-34,41,44,55H,8-9,14-24H2,1-7H3,(H,61,70)(H2,58,59,62,63,64)/t33-,41-,44-/m0/s1",HZMQXNZSFFXKMT-LCPJFFRWSA-N
980,O43353,RIPK2,cIAP1,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](NC(=O)C2=CN=C(N3CCN(CCCOC4=CC5=NC=NC(NC6=N[NH]C(C)=C6C)=C5C=C4S(=O)(=O)C(C)(C)C)CC3)C=N2)C[C@H]1C(=O)NC1=C(F)C=CC=C1F)C(C)(C)C,,CN[C@@H](C)C(=O)N,[C@H](C(=O)N1C[C@@H](NC(=O)C2=CN=C(N3CCN(CCCOC4=CC5=NC=NC(NC6=N[NH]C(C)=C6C)=C5C=C4S(=O)(=O)C(C)(C)C)CC3)C=N2)C[C@H]1C(=O)NC1=C(F)C=CC=C1F)C(C)(C)C,0.4,94.3,1,Degradation of RIPK2 in hPBMC cells after 24 h treatment,,,10,IC50 of RIPK2 was tested by FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s42003-020-0868-6,1045.232,1044.492768,4.73,74,7,16,6,17,261.76,C50H66F2N14O7S,"InChI=1S/C50H66F2N14O7S/c1-28-29(2)62-63-43(28)61-44-32-22-39(74(71,72)50(7,8)9)38(23-35(32)56-27-57-44)73-20-12-15-64-16-18-65(19-17-64)40-25-54-36(24-55-40)46(68)58-31-21-37(47(69)59-41-33(51)13-11-14-34(41)52)66(26-31)48(70)42(49(4,5)6)60-45(67)30(3)53-10/h11,13-14,22-25,27,30-31,37,42,53H,12,15-21,26H2,1-10H3,(H,58,68)(H,59,69)(H,60,67)(H2,56,57,61,62,63)/t30-,31-,37-,42+/m0/s1",CHNBEZLJAQUZEX-LFRONEFISA-N
1011,Q96SW2,CRBN,VHL,,TD-158,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,44.5,97.1,1,Degradation of CRBN in HEK293T cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41598-019-56177-5,842.032,841.3832827,5.37,60,6,11,5,17,207.21,C44H55N7O8S,"InChI=1S/C44H55N7O8S/c1-26-37(60-25-47-26)28-17-15-27(16-18-28)23-46-39(55)33-22-29(52)24-50(33)43(59)38(44(2,3)4)48-34(53)14-9-7-5-6-8-10-21-45-31-13-11-12-30-36(31)42(58)51(41(30)57)32-19-20-35(54)49-40(32)56/h11-13,15-18,25,29,32-33,38,45,52H,5-10,14,19-24H2,1-4H3,(H,46,55)(H,48,53)(H,49,54,56)/t29-,32?,33+,38-/m1/s1",UQJOJHWASBETAR-PHPCURKRSA-N
1012,Q96SW2,CRBN,VHL,,TD-165,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,20.4,99.6,1,Degradation of CRBN in HEK293T cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41598-019-56177-5,870.086,869.4145828,6.46,62,6,11,5,19,207.21,C46H59N7O8S,"InChI=1S/C46H59N7O8S/c1-28-39(62-27-49-28)30-19-17-29(18-20-30)25-48-41(57)35-24-31(54)26-52(35)45(61)40(46(2,3)4)50-36(55)16-11-9-7-5-6-8-10-12-23-47-33-15-13-14-32-38(33)44(60)53(43(32)59)34-21-22-37(56)51-42(34)58/h13-15,17-20,27,31,34-35,40,47,54H,5-12,16,21-26H2,1-4H3,(H,48,57)(H,50,55)(H,51,56,58)/t31-,34?,35+,40-/m1/s1",KSXVXTSIDVRZBR-IINAPWRYSA-N
1013,Q96SW2,CRBN,VHL,,TD-156,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,100.6,96.9,0,Degradation of CRBN in HEK293T cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41598-019-56177-5,813.978,813.3519826,4.29,58,6,11,5,15,207.21,C42H51N7O8S,"InChI=1S/C42H51N7O8S/c1-24-35(58-23-45-24)26-15-13-25(14-16-26)21-44-37(53)31-20-27(50)22-48(31)41(57)36(42(2,3)4)46-32(51)12-7-5-6-8-19-43-29-11-9-10-28-34(29)40(56)49(39(28)55)30-17-18-33(52)47-38(30)54/h9-11,13-16,23,27,30-31,36,43,50H,5-8,12,17-22H2,1-4H3,(H,44,53)(H,46,51)(H,47,52,54)/t27-,30?,31+,36-/m1/s1",NONAQRYFKJIZQD-AEXNMDALSA-N
1014,Q96SW2,CRBN,VHL,,TD-759,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCNC(=O)CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCCCNC(=O)CN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,28.8,98.4,1,Degradation of CRBN in HEK293T cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41598-019-56177-5,927.138,926.4360466,5.8,66,6,12,6,21,236.31,C48H62N8O9S,"InChI=1S/C48H62N8O9S/c1-29-41(66-28-52-29)31-19-17-30(18-20-31)25-51-43(61)36-24-32(57)27-55(36)47(65)42(48(2,3)4)53-37(58)16-11-9-7-5-6-8-10-12-23-49-39(60)26-50-34-15-13-14-33-40(34)46(64)56(45(33)63)35-21-22-38(59)54-44(35)62/h13-15,17-20,28,32,35-36,42,50,57H,5-12,16,21-27H2,1-4H3,(H,49,60)(H,51,61)(H,53,58)(H,54,59,62)/t32-,35?,36+,42-/m1/s1",FWZROUMFDYURRM-FYESNEIGSA-N
1015,Q96SW2,CRBN,VHL,,TD-760,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCCCNC(=O)CO,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,367.7,82.0,0,Degradation of CRBN in HEK293T cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41598-019-56177-5,928.122,927.4200622,5.24,66,6,12,5,21,233.51,C48H61N7O10S,"InChI=1S/C48H61N7O10S/c1-29-41(66-28-51-29)31-19-17-30(18-20-31)25-50-43(60)35-24-32(56)26-54(35)47(64)42(48(2,3)4)52-37(57)16-11-9-7-5-6-8-10-12-23-49-39(59)27-65-36-15-13-14-33-40(36)46(63)55(45(33)62)34-21-22-38(58)53-44(34)61/h13-15,17-20,28,32,34-35,42,56H,5-12,16,21-27H2,1-4H3,(H,49,59)(H,50,60)(H,52,57)(H,53,58,61)/t32-,34?,35+,42-/m1/s1",NANCWGWHLCCPLL-MSVILSSVSA-N
1016,Q96SW2,CRBN,VHL,,TD-033,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCC(=O)NC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCC(=O)N,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C(C)(C)C)C=C2)SC=N1,2546.1,77.9,0,Degradation of CRBN in HEK293T cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41598-019-56177-5,827.961,827.3312471,3.06,59,6,11,5,14,224.28,C42H49N7O9S,"InChI=1S/C42H49N7O9S/c1-23-35(59-22-44-23)25-15-13-24(14-16-25)20-43-37(54)30-19-26(50)21-48(30)41(58)36(42(2,3)4)46-32(52)12-7-5-6-11-31(51)45-28-10-8-9-27-34(28)40(57)49(39(27)56)29-17-18-33(53)47-38(29)55/h8-10,13-16,22,26,29-30,36,50H,5-7,11-12,17-21H2,1-4H3,(H,43,54)(H,45,51)(H,46,52)(H,47,53,55)/t26-,29?,30+,36-/m1/s1",ZBCXOELGHROVDK-FOLICCEFSA-N
1081,P15056,BRAF V600E,CRBN,,Pmd-PEG3-BI,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(C(=O)CCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(,C(=O)CCOCCOCCOCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,100.0,65.0,0,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,65,Inhibition of BRAF V600E,,,,,,,,,,,,,,,1520.0,FP,,,,,,,,,,,,,,,3750,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1001.083,1000.371315,3.08,71,8,16,3,22,236.59,C48H54F2N10O10S,"InChI=1S/C48H54F2N10O10S/c1-3-25-71(66,67)56-36-8-7-34(49)45(43(36)50)59-28-33(30-26-51-29-52-27-30)44-37(59)9-11-39(54-44)57(2)31-13-17-58(18-14-31)41(62)15-19-68-21-23-70-24-22-69-20-16-53-35-6-4-5-32-42(35)48(65)60(47(32)64)38-10-12-40(61)55-46(38)63/h4-9,11,26-29,31,38,53,56H,3,10,12-25H2,1-2H3,(H,55,61,63)",FMUGAZVOOIUFAT-UHFFFAOYSA-N
1098,P15056,BRAF V600E,CRBN,,P4B,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(C(=O)CCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(,C(=O)CCOCCOCCOCCOCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,15.0,82.0,1,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,12,Inhibition of BRAF V600E,,,5.6,SPR,,,,,,,1.4,0.77,,,900.0,FP,,,,,,,,,,,,,,,2570,FP,,,,,,,,,,,,,,,71/75/147,Inhibit proliferation of A375/WM266-4/RKO cells,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1045.136,1044.39753,2.93,74,8,17,3,25,245.82,C50H58F2N10O11S,"InChI=1S/C50H58F2N10O11S/c1-3-27-74(68,69)58-38-8-7-36(51)47(45(38)52)61-30-35(32-28-53-31-54-29-32)46-39(61)9-11-41(56-46)59(2)33-13-17-60(18-14-33)43(64)15-19-70-21-23-72-25-26-73-24-22-71-20-16-55-37-6-4-5-34-44(37)50(67)62(49(34)66)40-10-12-42(63)57-48(40)65/h4-9,11,28-31,33,40,55,58H,3,10,12-27H2,1-2H3,(H,57,63,65)",GJCIYFAPQUEGNE-UHFFFAOYSA-N
1099,P15056,BRAF V600E,CRBN,,P5B,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(C(=O)CCOCCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(,C(=O)CCOCCOCCOCCOCCOCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,70.0,82.0,1,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,25,Inhibition of BRAF V600E,,,,,,,,,,,,,,,850.0,FP,,,,,,,,,,,,,,,2170,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1089.189,1088.423745,2.78,77,8,18,3,28,255.05,C52H62F2N10O12S,"InChI=1S/C52H62F2N10O12S/c1-3-29-77(70,71)60-40-8-7-38(53)49(47(40)54)63-32-37(34-30-55-33-56-31-34)48-41(63)9-11-43(58-48)61(2)35-13-17-62(18-14-35)45(66)15-19-72-21-23-74-25-27-76-28-26-75-24-22-73-20-16-57-39-6-4-5-36-46(39)52(69)64(51(36)68)42-10-12-44(65)59-50(42)67/h4-9,11,30-33,35,42,57,60H,3,10,12-29H2,1-2H3,(H,59,65,67)",RQROXFBXOKHLAH-UHFFFAOYSA-N
1106,P15056,BRAF V600E,VHL,,VH-PEG4-BI,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(C(=O)CCOCCOCCOCCOCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)=CC=C32)=C1F,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(,C(=O)CCOCCOCCOCCOCCC(=O)N,[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)=CC=C32)=C1F,100.0,40.0,0,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,67,Inhibition of BRAF V600E,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1230.472,1229.521351,4.51,86,8,18,4,29,261.87,C60H77F2N11O11S2,"InChI=1S/C60H77F2N11O11S2/c1-7-30-86(79,80)69-47-13-12-46(61)55(53(47)62)72-36-45(42-33-63-37-64-34-42)54-48(72)14-15-50(67-54)70(6)43-16-20-71(21-17-43)52(76)19-23-82-25-27-84-29-28-83-26-24-81-22-18-51(75)68-57(60(3,4)5)59(78)73-35-44(74)31-49(73)58(77)65-32-40-8-10-41(11-9-40)56-39(2)66-38-85-56/h8-15,33-34,36-38,43-44,49,57,69,74H,7,16-32,35H2,1-6H3,(H,65,77)(H,68,75)/t44-,49+,57-/m1/s1",FFRMYNSJXNXLED-ZPPJDHJYSA-N
1154,Q9UBN7,HDAC6,CRBN,,,CCCCN(CC1=CC=C(C(=O)NO)C=C1)C(=O)NC1=CC=C(OCCN2C=C(CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1,,CCCCN,(CC1=CC=C(C(=O)NO)C=C1)C(=O)NC1=CC=C(OCCN2C=C(CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1,3.41,88.01,1,Degradation of HDAC6 in MM1S cells after 6 h treatment,62.1/81.3,% HDAC6 degradation in MM1S cells after 6 h treatment at 10/100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00516,737.774,737.2921592,2.28,54,6,12,5,15,217.19,C37H39N9O8,"InChI=1S/C37H39N9O8/c1-2-3-17-44(21-23-7-9-24(10-8-23)33(48)42-53)37(52)39-25-11-13-27(14-12-25)54-19-18-45-22-26(41-43-45)20-38-29-6-4-5-28-32(29)36(51)46(35(28)50)30-15-16-31(47)40-34(30)49/h4-14,22,30,38,53H,2-3,15-21H2,1H3,(H,39,52)(H,42,48)(H,40,47,49)",YVMSHPWOPPUCHZ-UHFFFAOYSA-N
1157,Q9UBN7,HDAC6,CRBN,,,CCCCN(CC1=CC=C(C(=O)NO)C=C1)C(=O)NC1=CC=C(OCCCCCN2C=C(CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1,CCCCN(CC1=CC=C(C(=O)NO)C=C1)C(=O)NC1=CC=C(,OCCCCC,N2C=C(CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1,1.64,86.26,1,Degradation of HDAC6 in MM1S cells after 6 h treatment,74.9/82.7,% HDAC6 degradation in MM1S cells after 6 h treatment at 10/100 nM,8.7,IC50 of HDAC6 was determined using a fluorescence-based assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,74.9,Inhibit proliferation of MM1S cells,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00516,779.855,779.3391094,3.35,57,6,12,5,18,217.19,C40H45N9O8,"InChI=1S/C40H45N9O8/c1-2-3-20-47(24-26-10-12-27(13-11-26)36(51)45-56)40(55)42-28-14-16-30(17-15-28)57-22-6-4-5-21-48-25-29(44-46-48)23-41-32-9-7-8-31-35(32)39(54)49(38(31)53)33-18-19-34(50)43-37(33)52/h7-17,25,33,41,56H,2-6,18-24H2,1H3,(H,42,55)(H,45,51)(H,43,50,52)",DQGQXFRCIYCGOE-UHFFFAOYSA-N
1157,Q9UBN7,HDAC6,CRBN,,,CCCCN(CC1=CC=C(C(=O)NO)C=C1)C(=O)NC1=CC=C(OCCCCCN2C=C(CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1,CCCCN(CC1=CC=C(C(=O)NO)C=C1)C(=O)NC1=CC=C(,OCCCCC,N2C=C(CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1,2.2,86.0,1,Degradation of HDAC6 in MM1S/Mouse 4935 cells after 4/6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,74.9,Inhibit proliferation of MM1S cells,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00046,779.855,779.3391094,3.35,57,6,12,5,18,217.19,C40H45N9O8,"InChI=1S/C40H45N9O8/c1-2-3-20-47(24-26-10-12-27(13-11-26)36(51)45-56)40(55)42-28-14-16-30(17-15-28)57-22-6-4-5-21-48-25-29(44-46-48)23-41-32-9-7-8-31-35(32)39(54)49(38(31)53)33-18-19-34(50)43-37(33)52/h7-17,25,33,41,56H,2-6,18-24H2,1H3,(H,42,55)(H,45,51)(H,43,50,52)",DQGQXFRCIYCGOE-UHFFFAOYSA-N
1162,Q9UBN7,HDAC6,CRBN,,,CCCCN(CC1=CC=C(C(=O)NO)C=C1)C(=O)NC1=CC=C(OCCN2C=C(CCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1,,CCCCN,(CC1=CC=C(C(=O)NO)C=C1)C(=O)NC1=CC=C(OCCN2C=C(CCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)N=N2)C=C1,2.54,86.3,1,Degradation of HDAC6 in MM1S cells after 6 h treatment,70.6/83.1,% HDAC6 degradation in MM1S cells after 6 h treatment at 10/100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.9b00516,765.828,765.3234593,3.1,56,6,12,5,17,217.19,C39H43N9O8,"InChI=1S/C39H43N9O8/c1-2-3-20-46(23-25-9-11-26(12-10-25)35(50)44-55)39(54)41-27-13-15-29(16-14-27)56-22-21-47-24-28(43-45-47)6-5-19-40-31-8-4-7-30-34(31)38(53)48(37(30)52)32-17-18-33(49)42-36(32)51/h4,7-16,24,32,40,55H,2-3,5-6,17-23H2,1H3,(H,41,54)(H,44,50)(H,42,49,51)",HKHMBOOYLKOYAW-UHFFFAOYSA-N
1181,Q9UBN7,HDAC6,VHL,,,CCCCN(CC1=CC=C(C(=O)NO)C=C1)C(=O)NC1=CC=C(OCCCCCCCCCCCN2C=C(CCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)N=N2)C=C1,CCCCN(CC1=CC=C(C(=O)NO)C=C1)C(=O)NC1=CC=C(,OCCCCCCCCCCC,N2C=C(CCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)N=N2)C=C1,7.1,90.0,1,Degradation of HDAC6 in MM1S/Mouse 4935 cells after 4/6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00046,1091.434,1090.603781,9.17,78,6,13,6,31,233.24,C59H82N10O8S,"InChI=1S/C59H82N10O8S/c1-6-7-33-67(38-44-23-27-46(28-24-44)55(72)65-76)58(75)62-47-29-31-50(32-30-47)77-35-18-14-12-10-8-9-11-13-17-34-68-39-48(64-66-68)19-15-16-20-52(71)63-54(59(3,4)5)57(74)69-40-49(70)36-51(69)56(73)60-37-43-21-25-45(26-22-43)53-42(2)61-41-78-53/h21-32,39,41,49,51,54,70,76H,6-20,33-38,40H2,1-5H3,(H,60,73)(H,62,75)(H,63,71)(H,65,72)/t49-,51+,54-/m1/s1",QLLXPSZTCLBVQY-UFUXGVROSA-N
1182,Q9UBN7,HDAC6,VHL,,,CCCCN(CC1=CC=C(C(=O)NO)C=C1)C(=O)NC1=CC=C(OCCCCCCCCCCCCN2C=C(CCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)N=N2)C=C1,CCCCN(CC1=CC=C(C(=O)NO)C=C1)C(=O)NC1=CC=C(,OCCCCCCCCCCCC,N2C=C(CCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)N=N2)C=C1,11.0,89.0,1,Degradation of HDAC6 in MM1S cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00046,1105.461,1104.619431,9.72,79,6,13,6,32,233.24,C60H84N10O8S,"InChI=1S/C60H84N10O8S/c1-6-7-34-68(39-45-24-28-47(29-25-45)56(73)66-77)59(76)63-48-30-32-51(33-31-48)78-36-19-15-13-11-9-8-10-12-14-18-35-69-40-49(65-67-69)20-16-17-21-53(72)64-55(60(3,4)5)58(75)70-41-50(71)37-52(70)57(74)61-38-44-22-26-46(27-23-44)54-43(2)62-42-79-54/h22-33,40,42,50,52,55,71,77H,6-21,34-39,41H2,1-5H3,(H,61,74)(H,63,76)(H,64,72)(H,66,73)/t50-,52+,55-/m1/s1",TXQZPPRNSVBETP-MXXGPWJYSA-N
1220,P00533,EGFR,CRBN,,,C=CC(=O)NC1=CC(NC2=NC=CC(C3=CN(C)C4=CC=CC=C34)=N2)=C(OC)C=C1N(C)CCN(C)CCOCCOCCOCCOCC(=O)NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,C=CC(=O)NC1=CC(NC2=NC=CC(C3=CN(C)C4=CC=CC=C34)=N2)=C(OC)C=C1,N(C)CCN(C)CCOCCOCCOCCOCC(=O)N,C1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,161.0,68.0,0,Degradation of EGFR in PC9 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,413/1344/657,Inhibit proliferation of PC9/HCC827/H1975 cells,,,,,,,,,,,,,,,10.1016/j.bmcl.2020.127167,961.09,960.4493881,2.29,70,7,16,4,26,220.05,C50H60N10O10,"InChI=1S/C50H60N10O10/c1-6-45(61)53-39-28-40(55-50-51-17-16-38(54-50)35-30-59(4)41-13-8-7-10-33(35)41)44(66-5)29-43(39)58(3)19-18-57(2)20-21-67-22-23-68-24-25-69-26-27-70-32-47(63)52-37-12-9-11-34-36(37)31-60(49(34)65)42-14-15-46(62)56-48(42)64/h6-13,16-17,28-30,42H,1,14-15,18-27,31-32H2,2-5H3,(H,52,63)(H,53,61)(H,51,54,55)(H,56,62,64)",MVXHKLZUALKPTB-UHFFFAOYSA-N
1223,Q06187,BTK,CRBN,,DD-03-171,CC1=C(NC(=O)C2=CC=C(C(C)(C)C)C=C2)C=CC=C1C1=CN(C)C(=O)C(NC2=CC=C(C(=O)N3CCN(CCCCCCNC(=O)CNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C=C2)=N1,CC1=C(NC(=O)C2=CC=C(C(C)(C)C)C=C2)C=CC=C1C1=CN(C)C(=O)C(NC2=CC=C(C(=O)N3CCN(,CCCCCCNC(=O)CN,C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C=C2)=N1,0.9,99.0,1,Degradation of BTK in Mino cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.crchbi.2022.100029,991.163,990.4752089,5.83,73,8,13,5,17,224.25,C55H62N10O8,"InChI=1S/C55H62N10O8/c1-34-39(12-10-14-41(34)60-49(68)35-16-20-37(21-17-35)55(2,3)4)43-33-62(5)54(73)48(59-43)58-38-22-18-36(19-23-38)51(70)64-30-28-63(29-31-64)27-9-7-6-8-26-56-46(67)32-57-42-15-11-13-40-47(42)53(72)65(52(40)71)44-24-25-45(66)61-50(44)69/h10-23,33,44,57H,6-9,24-32H2,1-5H3,(H,56,67)(H,58,59)(H,60,68)(H,61,66,69)",QBPVFCNYKUENHU-UHFFFAOYSA-N
1299,P09874,PARP1,CRBN,,iRucaparib-AP5,CN(CCOCCOCCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC1=CC=C(C2=C3CCNC(=O)C4=C3C(=CC(F)=C4)[NH]2)C=C1,CN(,CCOCCOCCOCCOCCOCCN,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC1=CC=C(C2=C3CCNC(=O)C4=C3C(=CC(F)=C4)[NH]2)C=C1,35.7,90.0,1,Degradation of PARP1 in Primary Cardiomyocytes after 24 h treatment,,,24.6,IC50 was tested by using a PARP universal chemiluminescent assay kit,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-019-0379-2,842.922,842.3650701,2.66,61,7,12,4,23,189.86,C44H51FN6O10,"InChI=1S/C44H51FN6O10/c1-50(27-28-5-7-29(8-6-28)40-31-11-12-47-41(53)33-25-30(45)26-35(48-40)38(31)33)14-16-58-18-20-60-22-24-61-23-21-59-19-17-57-15-13-46-34-4-2-3-32-39(34)44(56)51(43(32)55)36-9-10-37(52)49-42(36)54/h2-8,25-26,36,46,48H,9-24,27H2,1H3,(H,47,53)(H,49,52,54)",CDKSZVJXSCKNQN-UHFFFAOYSA-N
1300,P09874,PARP1,CRBN,,iRucaparib-AP6,CN(CCOCCOCCOCCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC1=CC=C(C2=C3CCNC(=O)C4=C3C(=CC(F)=C4)[NH]2)C=C1,CN(,CCOCCOCCOCCOCCOCCOCCN,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC1=CC=C(C2=C3CCNC(=O)C4=C3C(=CC(F)=C4)[NH]2)C=C1,81.8,92.0,1,Degradation of PARP1 in Primary Cardiomyocytes after 24 h treatment,,,28.5,IC50 was tested by using a PARP universal chemiluminescent assay kit,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-019-0379-2,886.975,886.3912848,2.51,64,7,13,4,26,199.09,C46H55FN6O11,"InChI=1S/C46H55FN6O11/c1-52(29-30-5-7-31(8-6-30)42-33-11-12-49-43(55)35-27-32(47)28-37(50-42)40(33)35)14-16-60-18-20-62-22-24-64-26-25-63-23-21-61-19-17-59-15-13-48-36-4-2-3-34-41(36)46(58)53(45(34)57)38-9-10-39(54)51-44(38)56/h2-8,27-28,38,48,50H,9-26,29H2,1H3,(H,49,55)(H,51,54,56)",YHMDCINUVWULST-UHFFFAOYSA-N
1360,Q07817,BCL-xL,CRBN,,PZ15227,CC1(C)CCC(C2=CC=C(Cl)C=C2)=C(CN2CCN(C3=CC=C(C(=O)NS(=O)(=O)C4=CC=C(N[C@H](CCN5CCN(C(=O)CCCN6C=C(COCCOCCNC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)N=N6)CC5)CSC5=CC=CC=C5)C(S(=O)(=O)C(F)(F)F)=C4)C=C3)CC2)C1,CC1(C)CCC(C2=CC=C(Cl)C=C2)=C(CN2CCN(C3=CC=C(C(=O)NS(=O)(=O)C4=CC=C(N[C@H](CCN5CCN(C(=O)CCCN6C=C(,COCCOCCN,C7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)N=N6)CC5)CSC5=CC=CC=C5)C(S(=O)(=O)C(F)(F)F)=C4)C=C3)CC2)C1,46.0,96.2,1,Degradation of BCL-xL in WI38 cells after 16 h treatment,,,,,,,,,1.9,Ki was tested by the AlphaScreen competitive binding assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,290/>10000/>3000,Inhibit viability of IR-SC/WI38/platelets cells,,,,,,,,,,,,,10.1038/s41467-020-15838-0,1484.157,1482.497791,8.88,102,11,21,4,30,284.19,C71H82ClF3N12O12S3,"InChI=1S/C71H82ClF3N12O12S3/c1-70(2)27-25-57(48-13-17-51(72)18-14-48)50(43-70)44-83-33-35-84(36-34-83)54-19-15-49(16-20-54)66(90)80-102(96,97)56-21-22-59(62(42-56)101(94,95)71(73,74)75)77-52(47-100-55-8-4-3-5-9-55)26-30-82-31-37-85(38-32-82)64(89)12-7-29-86-45-53(79-81-86)46-99-41-40-98-39-28-76-60-11-6-10-58-65(60)69(93)87(68(58)92)61-23-24-63(88)78-67(61)91/h3-6,8-11,13-22,42,45,52,61,76-77H,7,12,23-41,43-44,46-47H2,1-2H3,(H,80,90)(H,78,88,91)/t52-,61?/m1/s1",OWEARFNXBBNNKR-ADXOFTSBSA-N
1373,Q06187,BTK,VHL,,,C=CC(=O)N1C[C@@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C3=C(N)N=CN=C32)C[C@H]1C(=O)OCCOCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,C=CC(=O)N1C[C@@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C3=C(N)N=CN=C32)C[C@H]1,C(=O)OCCOCCOCC(=O)N,[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,136.0,88.0,0,Degradation of BTK in K562 cells after 18 h treatment,,,39,IC50 was tested by the HTRF KinEase assays,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/c9cc08238g,1029.19,1028.421459,4.99,74,8,17,4,20,255.55,C53H60N10O10S,"InChI=1S/C53H60N10O10S/c1-6-43(66)61-27-36(63-49-44(48(54)56-30-57-49)45(60-63)34-16-18-39(19-17-34)73-38-10-8-7-9-11-38)24-41(61)52(69)72-23-22-70-20-21-71-29-42(65)59-47(53(3,4)5)51(68)62-28-37(64)25-40(62)50(67)55-26-33-12-14-35(15-13-33)46-32(2)58-31-74-46/h6-19,30-31,36-37,40-41,47,64H,1,20-29H2,2-5H3,(H,55,67)(H,59,65)(H2,54,56,57)/t36-,37+,40-,41-,47+/m0/s1",JQIURFOHEWHROK-WNKYWPOYSA-N
1373,P51451,BLK,VHL,,,C=CC(=O)N1C[C@@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C3=C(N)N=CN=C32)C[C@H]1C(=O)OCCOCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,C=CC(=O)N1C[C@@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C3=C(N)N=CN=C32)C[C@H]1,C(=O)OCCOCCOCC(=O)N,[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C,220.0,75.0,0,Degradation of BLK in Ramos cells after 18 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/c9cc08238g,1029.19,1028.421459,4.99,74,8,17,4,20,255.55,C53H60N10O10S,"InChI=1S/C53H60N10O10S/c1-6-43(66)61-27-36(63-49-44(48(54)56-30-57-49)45(60-63)34-16-18-39(19-17-34)73-38-10-8-7-9-11-38)24-41(61)52(69)72-23-22-70-20-21-71-29-42(65)59-47(53(3,4)5)51(68)62-28-37(64)25-40(62)50(67)55-26-33-12-14-35(15-13-33)46-32(2)58-31-74-46/h6-19,30-31,36-37,40-41,47,64H,1,20-29H2,2-5H3,(H,55,67)(H,59,65)(H2,54,56,57)/t36-,37+,40-,41-,47+/m0/s1",JQIURFOHEWHROK-WNKYWPOYSA-N
1380,Q06187,BTK,CRBN,,NC-1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2[C@@H]1CCCN(C(=O)CCCCCCOCCOCCOCCOCCOC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2[C@@H]1CCCN(,C(=O)CCCCCCOCCOCCOCCOCCO,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C1,2.2,97.0,1,Degradation of BTK in Mino cells after 24 h treatment,,,16,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.9b13907,947.059,946.4225047,3.81,69,8,16,2,25,228.86,C50H58N8O11,"InChI=1S/C50H58N8O11/c51-46-44-45(34-16-18-37(19-17-34)69-36-11-4-3-5-12-36)55-58(47(44)53-33-52-46)35-10-9-22-56(32-35)42(60)15-6-1-2-7-23-64-24-25-65-26-27-66-28-29-67-30-31-68-40-14-8-13-38-43(40)50(63)57(49(38)62)39-20-21-41(59)54-48(39)61/h3-5,8,11-14,16-19,33,35,39H,1-2,6-7,9-10,15,20-32H2,(H2,51,52,53)(H,54,59,61)/t35-,39?/m1/s1",QSLUWEWRUWTRBT-QQKHLPPFSA-N
1381,Q06187,BTK,CRBN,,IR-1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2[C@@H]1CCCN(C(=O)/C=C/COCCOCCOCCOCCOCCOC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2[C@@H]1CCCN(,C(=O)/C=C/COCCOCCOCCOCCOCCO,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C1,8.6,91.0,1,Degradation of BTK in Mino cells after 24 h treatment,,,2,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.9b13907,947.015,946.3861192,2.37,69,8,17,2,24,238.09,C49H54N8O12,"InChI=1S/C49H54N8O12/c50-45-43-44(33-13-15-36(16-14-33)69-35-8-2-1-3-9-35)54-57(46(43)52-32-51-45)34-7-5-19-55(31-34)41(59)12-6-20-63-21-22-64-23-24-65-25-26-66-27-28-67-29-30-68-39-11-4-10-37-42(39)49(62)56(48(37)61)38-17-18-40(58)53-47(38)60/h1-4,6,8-16,32,34,38H,5,7,17-31H2,(H2,50,51,52)(H,53,58,60)/b12-6+/t34-,38?/m1/s1",AWOLTJZICWTLFS-AHDGVXFFSA-N
1382,Q06187,BTK,CRBN,,IR-2,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2[C@@H]1CCCN(C(=O)/C=C/CCCCOCCOCCOCCOCCOC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2[C@@H]1CCCN(,C(=O)/C=C/CCCCOCCOCCOCCOCCO,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C1,1.9,88.0,1,Degradation of BTK in Mino cells after 24 h treatment,,,14,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.9b13907,945.043,944.4068546,3.69,69,8,16,2,24,228.86,C50H56N8O11,"InChI=1S/C50H56N8O11/c51-46-44-45(34-16-18-37(19-17-34)69-36-11-4-3-5-12-36)55-58(47(44)53-33-52-46)35-10-9-22-56(32-35)42(60)15-6-1-2-7-23-64-24-25-65-26-27-66-28-29-67-30-31-68-40-14-8-13-38-43(40)50(63)57(49(38)62)39-20-21-41(59)54-48(39)61/h3-6,8,11-19,33,35,39H,1-2,7,9-10,20-32H2,(H2,51,52,53)(H,54,59,61)/b15-6+/t35-,39?/m1/s1",ZJJZBBBSQKVNHL-BYBNZYMESA-N
1383,Q06187,BTK,CRBN,,,N#C/C(=C/COCCOCCOCCOCCOCCOC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)C(=O)N1CCC[C@@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C3=C(N)N=CN=C32)C1,N#C/C(,=C/COCCOCCOCCOCCOCCO,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)C(=O)N1CCC[C@@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C3=C(N)N=CN=C32)C1,10.0,68.0,0,Degradation of BTK in Mino cells after 24 h treatment,,,12,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.9b13907,972.025,971.3813681,2.3,71,8,18,2,24,261.88,C50H53N9O12,"InChI=1S/C50H53N9O12/c51-30-34(48(62)57-18-5-6-35(31-57)59-46-43(45(52)53-32-54-46)44(56-59)33-11-13-37(14-12-33)71-36-7-2-1-3-8-36)17-19-65-20-21-66-22-23-67-24-25-68-26-27-69-28-29-70-40-10-4-9-38-42(40)50(64)58(49(38)63)39-15-16-41(60)55-47(39)61/h1-4,7-14,17,32,35,39H,5-6,15-16,18-29,31H2,(H2,52,53,54)(H,55,60,61)/b34-17-/t35-,39?/m1/s1",PVBBNEIMTQFCAP-YFDXCGLRSA-N
1384,Q06187,BTK,CRBN,,,N#C/C(=C/CCCCOCCOCCOCCOCCOC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)C(=O)N1CCC[C@@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C3=C(N)N=CN=C32)C1,N#C/C(,=C/CCCCOCCOCCOCCOCCO,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)C(=O)N1CCC[C@@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C3=C(N)N=CN=C32)C1,35.0,66.0,0,Degradation of BTK in Mino cells after 24 h treatment,,,1,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.9b13907,970.053,969.4021036,3.62,71,8,17,2,24,252.65,C51H55N9O11,"InChI=1S/C51H55N9O11/c52-31-35(49(63)58-21-8-10-36(32-58)60-47-44(46(53)54-33-55-47)45(57-60)34-15-17-38(18-16-34)71-37-11-4-1-5-12-37)9-3-2-6-22-66-23-24-67-25-26-68-27-28-69-29-30-70-41-14-7-13-39-43(41)51(65)59(50(39)64)40-19-20-42(61)56-48(40)62/h1,4-5,7,9,11-18,33,36,40H,2-3,6,8,10,19-30,32H2,(H2,53,54,55)(H,56,61,62)/b35-9-/t36-,40?/m1/s1",JLHRNNVFNFHLTO-BYLADGCCSA-N
1385,Q06187,BTK,CRBN,,,CC(C)(/C=C(/C#N)C(=O)N1CCC[C@@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C3=C(N)N=CN=C32)C1)CCCOCCOCCOCCOCCOC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,CC(C)(/C=C(/C#N)C(=O)N1CCC[C@@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C3=C(N)N=CN=C32)C1),CCCOCCOCCOCCOCCO,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,6.0,85.0,1,Degradation of BTK in Mino cells after 24 h treatment,,,0.4,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.9b13907,998.107,997.4334037,4.5,73,8,17,2,24,252.65,C53H59N9O11,"InChI=1S/C53H59N9O11/c1-53(2,20-8-22-68-23-24-69-25-26-70-27-28-71-29-30-72-42-13-6-12-40-44(42)52(67)61(51(40)66)41-18-19-43(63)58-49(41)64)31-36(32-54)50(65)60-21-7-9-37(33-60)62-48-45(47(55)56-34-57-48)46(59-62)35-14-16-39(17-15-35)73-38-10-4-3-5-11-38/h3-6,10-17,31,34,37,41H,7-9,18-30,33H2,1-2H3,(H2,55,56,57)(H,58,63,64)/b36-31-/t37-,41?/m1/s1",DEABZGHTSXTNRF-DTNILNBBSA-N
1429,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCCCCOC3=CC=C(N4C(=O)N(C5=CC=C(C#N)C(C(F)(F)F)=C5)C(=O)C4(C)C)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCCOCCCCCO,C3=CC=C(N4C(=O)N(C5=CC=C(C#N)C(C(F)(F)F)=C5)C(=O)C4(C)C)C=C3)C(C)(C)C)C=C2)SC=N1,50.0,70.0,0,Degradation of AR in LNCaP/VCaP cells after 2-4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00115,1004.142,1003.412532,6.85,71,6,12,3,21,203.73,C51H60F3N7O9S,"InChI=1S/C51H60F3N7O9S/c1-32-43(71-31-57-32)34-13-11-33(12-14-34)28-56-45(64)41-26-38(62)29-59(41)46(65)44(49(2,3)4)58-42(63)30-69-23-10-22-68-21-8-7-9-24-70-39-19-17-36(18-20-39)61-48(67)60(47(66)50(61,5)6)37-16-15-35(27-55)40(25-37)51(52,53)54/h11-20,25,31,38,41,44,62H,7-10,21-24,26,28-30H2,1-6H3,(H,56,64)(H,58,63)/t38-,41+,44-/m1/s1",JAJUSXSEHHKCEK-UMWCMSNQSA-N
1430,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCN3CCC(C4=CC=C(N5C(=S)N(C6=CC=C(C#N)C(C(F)(F)F)=C6)C(=O)C5(C)C)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCCOCCN,3CCC(C4=CC=C(N5C(=S)N(C6=CC=C(C#N)C(C(F)(F)F)=C6)C(=O)C5(C)C)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,501.0,70.0,0,Degradation of AR in LNCaP cells after 2-4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00115,1045.264,1044.421323,6.98,73,7,12,3,18,180.67,C53H63F3N8O7S2,"InChI=1S/C53H63F3N8O7S2/c1-33-45(73-32-59-33)37-10-8-34(9-11-37)29-58-47(67)43-27-41(65)30-62(43)48(68)46(51(2,3)4)60-44(66)31-71-24-7-23-70-25-22-61-20-18-36(19-21-61)35-12-15-39(16-13-35)64-50(72)63(49(69)52(64,5)6)40-17-14-38(28-57)42(26-40)53(54,55)56/h8-17,26,32,36,41,43,46,65H,7,18-25,27,29-31H2,1-6H3,(H,58,67)(H,60,66)/t41-,43+,46-/m1/s1",FDBSHOXCSNLRGD-LASKKICZSA-N
1431,P10275,AR,VHL,,,CC(C)(C)[C@H](NC(=O)COCCCCCOC1=CC=C(C(=O)N[C@H]2C(C)(C)[C@H](OC3=CC=C(C#N)C(Cl)=C3)C2(C)C)C=C1)C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=CN=CS2)C=C1,CC(C)(C)[C@H](,NC(=O)COCCCCCO,C1=CC=C(C(=O)N[C@H]2C(C)(C)[C@H](OC3=CC=C(C#N)C(Cl)=C3)C2(C)C)C=C1)C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=CN=CS2)C=C1,50.0,71.0,0,Degradation of AR in LNCaP cells after 2-4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00115,941.592,940.3960116,8.11,66,6,11,4,19,192.21,C50H61ClN6O8S,"InChI=1S/C50H61ClN6O8S/c1-48(2,3)42(45(62)57-28-35(58)23-39(57)44(61)54-26-31-11-13-32(14-12-31)40-27-53-30-66-40)55-41(59)29-63-21-9-8-10-22-64-36-18-15-33(16-19-36)43(60)56-46-49(4,5)47(50(46,6)7)65-37-20-17-34(25-52)38(51)24-37/h11-20,24,27,30,35,39,42,46-47,58H,8-10,21-23,26,28-29H2,1-7H3,(H,54,61)(H,55,59)(H,56,60)/t35-,39+,42-,46-,47-/m1/s1",AMPBLCGZRAITTM-RRMXYVBQSA-N
1432,P10275,AR,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCCNC3=CC=C(C(=O)N[C@H]4C(C)(C)[C@H](OC5=CC=C(C#N)C(Cl)=C5)C4(C)C)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCCCCN,C3=CC=C(C(=O)N[C@H]4C(C)(C)[C@H](OC5=CC=C(C#N)C(Cl)=C5)C4(C)C)C=C3)C(C)(C)C)C=C2)SC=N1,50.0,71.0,0,Degradation of AR in LNCaP cells after 2-4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00115,968.662,967.4432961,8.92,68,6,11,5,19,195.01,C52H66ClN7O7S,"InChI=1S/C52H66ClN7O7S/c1-31(33-13-15-34(16-14-33)43-32(2)56-30-68-43)57-46(64)41-25-38(61)28-60(41)47(65)44(50(3,4)5)58-42(62)29-66-24-12-10-11-23-55-37-20-17-35(18-21-37)45(63)59-48-51(6,7)49(52(48,8)9)67-39-22-19-36(27-54)40(53)26-39/h13-22,26,30-31,38,41,44,48-49,55,61H,10-12,23-25,28-29H2,1-9H3,(H,57,64)(H,58,62)(H,59,63)/t31-,38+,41-,44+,48-,49-/m0/s1",JQTRUKZGCBXQDD-IWHLCMBKSA-N
1433,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCC3=CC=C(C4=CC=C(C(=O)N[C@H]5C(C)(C)[C@H](OC6=CC=C(C#N)C(Cl)=C6)C5(C)C)C=C4)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCC,C3=CC=C(C4=CC=C(C(=O)N[C@H]5C(C)(C)[C@H](OC6=CC=C(C#N)C(Cl)=C6)C5(C)C)C=C4)C=C3)C(C)(C)C)C=C2)SC=N1,50.0,71.0,0,Degradation of AR in LNCaP cells after 2-4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00115,973.637,972.401097,9.35,69,7,10,4,16,182.98,C54H61ClN6O7S,"InChI=1S/C54H61ClN6O7S/c1-32-45(69-31-58-32)37-15-11-34(12-16-37)28-57-48(65)43-25-40(62)29-61(43)49(66)46(52(2,3)4)59-44(63)30-67-24-23-33-9-13-35(14-10-33)36-17-19-38(20-18-36)47(64)60-50-53(5,6)51(54(50,7)8)68-41-22-21-39(27-56)42(55)26-41/h9-22,26,31,40,43,46,50-51,62H,23-25,28-30H2,1-8H3,(H,57,65)(H,59,63)(H,60,64)/t40-,43+,46-,50-,51-/m1/s1",GPLDNHBAUYMIMT-XUDCYVGASA-N
1434,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCC3=CC=C(OC(=O)N[C@H]4C(C)(C)[C@H](OC5=CC=C(C#N)C(Cl)=C5)C4(C)C)C=C3)C(C)(C)C)C=C2)OC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COC,C3=CC=C(OC(=O)N[C@H]4C(C)(C)[C@H](OC5=CC=C(C#N)C(Cl)=C5)C4(C)C)C=C3)C(C)(C)C)C=C2)OC=N1,50.0,71.0,0,Degradation of AR in LNCaP cells after 2-4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00115,883.443,882.371905,6.95,63,6,11,4,14,205.35,C47H55ClN6O9,"InChI=1S/C47H55ClN6O9/c1-27-38(61-26-51-27)30-13-9-28(10-14-30)22-50-40(57)36-19-32(55)23-54(36)41(58)39(45(2,3)4)52-37(56)25-60-24-29-11-16-33(17-12-29)63-44(59)53-42-46(5,6)43(47(42,7)8)62-34-18-15-31(21-49)35(48)20-34/h9-18,20,26,32,36,39,42-43,55H,19,22-25H2,1-8H3,(H,50,57)(H,52,56)(H,53,59)/t32-,36+,39-,42-,43-/m1/s1",VEFDAFDSPLDCMS-RCOCDALESA-N
1461,Q9NWZ3,IRAK4,CRBN,,,O=C1CCC(N2C(=O)C3=CC=C(OCCOCCOCCN4CCN(CC5=CC=C6N=C(NC(=O)C7=CC=CC(C(F)(F)F)=C7)N([C@H]7CC[C@@H](CO)CC7)C6=C5)CC4)C=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=C(,OCCOCCOCCN,4CCN(CC5=CC=C6N=C(NC(=O)C7=CC=CC(C(F)(F)F)=C7)N([C@H]7CC[C@@H](CO)CC7)C6=C5)CC4)C=C3C2=O)C(=O)N1,30.0,70.0,0,Degradation of IRAK4 in MCF7 cells,,,<30,IC50 was tested by FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00385,903.956,903.3778609,3.46,65,8,13,3,17,184.87,C46H52F3N7O9,"InChI=1S/C46H52F3N7O9/c47-46(48,49)32-3-1-2-31(25-32)41(59)52-45-50-37-11-6-30(24-39(37)55(45)33-7-4-29(28-57)5-8-33)27-54-16-14-53(15-17-54)18-19-63-20-21-64-22-23-65-34-9-10-35-36(26-34)44(62)56(43(35)61)38-12-13-40(58)51-42(38)60/h1-3,6,9-11,24-26,29,33,38,57H,4-5,7-8,12-23,27-28H2,(H,50,52,59)(H,51,58,60)/t29-,33+,38?",DRSGINHARUFRQE-CDUPFHCPSA-N
1462,Q9NWZ3,IRAK4,CRBN,,,O=C1CCC(N2C(=O)C3=CC=C(OCCOCCOCCOCCN4CCN(CC5=CC=C6N=C(NC(=O)C7=CC=CC(C(F)(F)F)=C7)N([C@H]7CC[C@@H](CO)CC7)C6=C5)CC4)C=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=C(,OCCOCCOCCOCCN,4CCN(CC5=CC=C6N=C(NC(=O)C7=CC=CC(C(F)(F)F)=C7)N([C@H]7CC[C@@H](CO)CC7)C6=C5)CC4)C=C3C2=O)C(=O)N1,30.0,70.0,0,Degradation of IRAK4 in MCF7 cells,,,<30,IC50 was tested by FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00385,948.009,947.4040757,3.31,68,8,14,3,20,194.1,C48H56F3N7O10,"InChI=1S/C48H56F3N7O10/c49-48(50,51)34-3-1-2-33(27-34)43(61)54-47-52-39-11-6-32(26-41(39)57(47)35-7-4-31(30-59)5-8-35)29-56-16-14-55(15-17-56)18-19-65-20-21-66-22-23-67-24-25-68-36-9-10-37-38(28-36)46(64)58(45(37)63)40-12-13-42(60)53-44(40)62/h1-3,6,9-11,26-28,31,35,40,59H,4-5,7-8,12-25,29-30H2,(H,52,54,61)(H,53,60,62)/t31-,35+,40?",ADNQFJRANZZPKY-RGDYMFDWSA-N
1463,Q9NWZ3,IRAK4,CRBN,,,O=C1CCC(N2C(=O)C3=CC=C(N4CCC(CN5CCN(CC6=CC=C7N=C(NC(=O)C8=CC=CC(C(F)(F)F)=C8)N([C@H]8CC[C@@H](CO)CC8)C7=C6)CC5)CC4)C=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=C(N4CCC(CN5CCN(CC6=CC=C7N=C(NC(=O)C8=CC=CC(,C(F)(F)F,)=C8)N([C@H]8CC[C@@H](CO)CC8)C7=C6)CC5)CC4)C=C3C2=O)C(=O)N1,30.0,70.0,0,Degradation of IRAK4 in MCF7 cells,,,<30,IC50 was tested by FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00385,868.958,868.388366,4.65,63,9,11,3,10,160.42,C46H51F3N8O6,"InChI=1S/C46H51F3N8O6/c47-46(48,49)32-3-1-2-31(23-32)41(60)52-45-50-37-11-6-30(22-39(37)56(45)33-7-4-29(27-58)5-8-33)26-54-20-18-53(19-21-54)25-28-14-16-55(17-15-28)34-9-10-35-36(24-34)44(63)57(43(35)62)38-12-13-40(59)51-42(38)61/h1-3,6,9-11,22-24,28-29,33,38,58H,4-5,7-8,12-21,25-27H2,(H,50,52,60)(H,51,59,61)/t29-,33+,38?",RJDRFOSUZYUZBV-CDUPFHCPSA-N
1464,Q9NWZ3,IRAK4,CRBN,,,COC1=CC2=NN(C3CCN(CCOCCOC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)C=C2C=C1NC(=O)C1=CC=CC(C(F)(F)F)=N1,COC1=CC2=NN(C3CCN(,CCOCCO,C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)C=C2C=C1NC(=O)C1=CC=CC(C(F)(F)F)=N1,30.0,50.0,0,Degradation of IRAK4 in MCF7 cells,,,<30,IC50 was tested by FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00385,763.73,763.2577458,2.78,55,7,12,2,12,174.29,C37H36F3N7O8,"InChI=1S/C37H36F3N7O8/c1-53-30-19-27-21(17-28(30)42-33(49)26-3-2-4-31(41-26)37(38,39)40)20-46(44-27)22-9-11-45(12-10-22)13-14-54-15-16-55-23-5-6-24-25(18-23)36(52)47(35(24)51)29-7-8-32(48)43-34(29)50/h2-6,17-20,22,29H,7-16H2,1H3,(H,42,49)(H,43,48,50)",XXKSDGIIEAJWCB-UHFFFAOYSA-N
1465,Q9NWZ3,IRAK4,CRBN,,,COC1=CC2=NN(C3CCN(CCOCCOC4=CC=C5CN(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)C=C2C=C1NC(=O)C1=CC=CC(C(F)(F)F)=N1,COC1=CC2=NN(C3CCN(,CCOCCO,C4=CC=C5CN(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)C=C2C=C1NC(=O)C1=CC=CC(C(F)(F)F)=N1,30.0,50.0,0,Degradation of IRAK4 in MCF7 cells,,,<30,IC50 was tested by FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00385,749.747,749.2784812,2.83,54,7,11,2,12,157.22,C37H38F3N7O7,"InChI=1S/C37H38F3N7O7/c1-52-31-19-28-23(17-29(31)42-34(49)27-3-2-4-32(41-27)37(38,39)40)21-47(44-28)24-9-11-45(12-10-24)13-14-53-15-16-54-25-6-5-22-20-46(36(51)26(22)18-25)30-7-8-33(48)43-35(30)50/h2-6,17-19,21,24,30H,7-16,20H2,1H3,(H,42,49)(H,43,48,50)",KSDCGXPRMXBENQ-UHFFFAOYSA-N
1466,Q9NWZ3,IRAK4,CRBN,,,O=C1CCC(N2C(=O)C3=CC=C(OC4CCC(CN5CCN(CC6=CC=C7N=C(NC(=O)C8=CC=CC(C(F)(F)F)=C8)N([C@H]8CC[C@@H](CO)CC8)C7=C6)CC5)CC4)C=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=C(OC4CCC(CN5CCN(CC6=CC=C7N=C(NC(=O)C8=CC=CC(,C(F)(F)F,)=C8)N([C@H]8CC[C@@H](CO)CC8)C7=C6)CC5)CC4)C=C3C2=O)C(=O)N1,30.0,70.0,0,Degradation of IRAK4 in MCF7 cells,,,<30,IC50 was tested by FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.9b00385,883.969,883.3880317,5.28,64,9,11,3,11,166.41,C47H52F3N7O7,"InChI=1S/C47H52F3N7O7/c48-47(49,50)32-3-1-2-31(23-32)42(60)53-46-51-38-15-8-30(22-40(38)56(46)33-9-4-29(27-58)5-10-33)26-55-20-18-54(19-21-55)25-28-6-11-34(12-7-28)64-35-13-14-36-37(24-35)45(63)57(44(36)62)39-16-17-41(59)52-43(39)61/h1-3,8,13-15,22-24,28-29,33-34,39,58H,4-7,9-12,16-21,25-27H2,(H,51,53,60)(H,52,59,61)/t28?,29-,33+,34?,39?",LGAMKMQUDXCHFO-RIOIAMSCSA-N
1561,P10275,AR,CRBN,,,CC1(C)C(=O)N(C2=CC=C(C#N)C(C(F)(F)F)=C2)C(=S)N1C1=CC=C(OCCOCCOCCOCCOC2=CC=CC3=C2CN([C@H]2CCC(=O)NC2=O)C3=O)C=C1,CC1(C)C(=O)N(C2=CC=C(C#N)C(C(F)(F)F)=C2)C(=S)N1C1=CC=C(,OCCOCCOCCOCCO,C2=CC=CC3=C2CN([C@H]2CCC(=O)NC2=O)C3=O)C=C1,10.0,33.0,0,Degradation of AR in LNCaP cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00194,823.847,823.2498835,3.68,58,6,11,1,17,159.97,C40H40F3N5O9S,"InChI=1S/C40H40F3N5O9S/c1-39(2)37(52)47(27-7-6-25(23-44)31(22-27)40(41,42)43)38(58)48(39)26-8-10-28(11-9-26)56-20-18-54-16-14-53-15-17-55-19-21-57-33-5-3-4-29-30(33)24-46(36(29)51)32-12-13-34(49)45-35(32)50/h3-11,22,32H,12-21,24H2,1-2H3,(H,45,49,50)/t32-/m0/s1",OHIHMSVOYVOFIW-YTTGMZPUSA-N
1584,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCCCCOC3=CC=C(N4C(=S)N(C5=CN=C(C#N)C(C(F)(F)F)=C5)C(=O)C4(C)C)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCCOCCCCCO,C3=CC=C(N4C(=S)N(C5=CN=C(C#N)C(C(F)(F)F)=C5)C(=O)C4(C)C)C=C3)C(C)(C)C)C=C2)SC=N1,50.0,70.0,0,"Degradation of AR in LNCaP/VCaP cells using ELISA assay (DC50: 15min, Dmax: 4h)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00236,1021.198,1020.384938,6.71,71,6,13,3,21,199.55,C50H59F3N8O8S2,"InChI=1S/C50H59F3N8O8S2/c1-31-42(71-30-57-31)33-13-11-32(12-14-33)26-56-44(64)40-24-36(62)28-59(40)45(65)43(48(2,3)4)58-41(63)29-68-21-10-20-67-19-8-7-9-22-69-37-17-15-34(16-18-37)61-47(70)60(46(66)49(61,5)6)35-23-38(50(51,52)53)39(25-54)55-27-35/h11-18,23,27,30,36,40,43,62H,7-10,19-22,24,26,28-29H2,1-6H3,(H,56,64)(H,58,63)/t36-,40+,43-/m1/s1",SGTVGCRQPJCKNZ-QIWIAYTASA-N
1585,P10275,AR,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCCCCOC3=CC=C(N4C(=S)N(C5=CC=C(C#N)C(C(F)(F)F)=C5)C(=O)C4(C)C)C=C3F)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCCOCCCCCO,C3=CC=C(N4C(=S)N(C5=CC=C(C#N)C(C(F)(F)F)=C5)C(=O)C4(C)C)C=C3F)C(C)(C)C)C=C2)SC=N1,50.0,70.0,0,"Degradation of AR in LNCaP/VCaP cells using ELISA assay (DC50: 15min, Dmax: 4h)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00236,1052.227,1051.395917,7.95,73,6,12,3,21,186.66,C52H61F4N7O8S2,"InChI=1S/C52H61F4N7O8S2/c1-31(33-12-14-34(15-13-33)44-32(2)58-30-73-44)59-46(66)41-26-38(64)28-61(41)47(67)45(50(3,4)5)60-43(65)29-70-22-11-21-69-20-9-8-10-23-71-42-19-18-37(25-40(42)53)63-49(72)62(48(68)51(63,6)7)36-17-16-35(27-57)39(24-36)52(54,55)56/h12-19,24-25,30-31,38,41,45,64H,8-11,20-23,26,28-29H2,1-7H3,(H,59,66)(H,60,65)/t31-,38+,41-,45+/m0/s1",FLLKKIZFEMVEEL-OZSPHOIVSA-N
1586,P10275,AR,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCCCCOC3=C(F)C=C(N4C(=S)N(C5=CC=C(C#N)C(C(F)(F)F)=C5)C(=O)C4(C)C)C=C3F)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCCOCCCCCO,C3=C(F)C=C(N4C(=S)N(C5=CC=C(C#N)C(C(F)(F)F)=C5)C(=O)C4(C)C)C=C3F)C(C)(C)C)C=C2)SC=N1,50.0,70.0,0,"Degradation of AR in LNCaP/VCaP cells using ELISA assay (DC50: 15min, Dmax: 4h)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00236,1070.217,1069.386495,8.05,74,6,12,3,21,186.66,C52H60F5N7O8S2,"InChI=1S/C52H60F5N7O8S2/c1-30(32-12-14-33(15-13-32)44-31(2)59-29-74-44)60-46(67)41-25-37(65)27-62(41)47(68)45(50(3,4)5)61-42(66)28-71-20-11-19-70-18-9-8-10-21-72-43-39(53)23-36(24-40(43)54)64-49(73)63(48(69)51(64,6)7)35-17-16-34(26-58)38(22-35)52(55,56)57/h12-17,22-24,29-30,37,41,45,65H,8-11,18-21,25,27-28H2,1-7H3,(H,60,67)(H,61,66)/t30-,37+,41-,45+/m0/s1",DKNBVZGJLBYCQJ-YCDRFOERSA-N
1587,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCCCOC3=CC=C(N4C(=S)N(C5=CC=C(C#N)C(C(F)(F)F)=C5)C(=O)C4(C)C)C=C3F)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCCOCCCCO,C3=CC=C(N4C(=S)N(C5=CC=C(C#N)C(C(F)(F)F)=C5)C(=O)C4(C)C)C=C3F)C(C)(C)C)C=C2)SC=N1,50.0,71.0,0,"Degradation of AR in LNCaP/VCaP cells using ELISA assay (DC50: 15min, Dmax: 4h)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00236,1024.173,1023.364617,7.19,71,6,12,3,20,186.66,C50H57F4N7O8S2,"InChI=1S/C50H57F4N7O8S2/c1-30-42(71-29-57-30)32-12-10-31(11-13-32)26-56-44(64)39-24-36(62)27-59(39)45(65)43(48(2,3)4)58-41(63)28-68-20-9-19-67-18-7-8-21-69-40-17-16-35(23-38(40)51)61-47(70)60(46(66)49(61,5)6)34-15-14-33(25-55)37(22-34)50(52,53)54/h10-17,22-23,29,36,39,43,62H,7-9,18-21,24,26-28H2,1-6H3,(H,56,64)(H,58,63)/t36-,39+,43-/m1/s1",HVIFXYXSTAVNJM-IPQHXDNUSA-N
1588,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCCCOC3=CC=C(N4C(=S)N(C5=CN=C(C#N)C(C(F)(F)F)=C5)C(=O)C4(C)C)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCCOCCCCO,C3=CC=C(N4C(=S)N(C5=CN=C(C#N)C(C(F)(F)F)=C5)C(=O)C4(C)C)C=C3)C(C)(C)C)C=C2)SC=N1,50.0,71.0,0,"Degradation of AR in LNCaP/VCaP cells using ELISA assay (DC50: 15min, Dmax: 4h)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00236,1007.171,1006.369287,6.35,70,6,13,3,20,199.55,C49H57F3N8O8S2,"InChI=1S/C49H57F3N8O8S2/c1-30-41(70-29-56-30)32-12-10-31(11-13-32)25-55-43(63)39-23-35(61)27-58(39)44(64)42(47(2,3)4)57-40(62)28-67-20-9-19-66-18-7-8-21-68-36-16-14-33(15-17-36)60-46(69)59(45(65)48(60,5)6)34-22-37(49(50,51)52)38(24-53)54-26-34/h10-17,22,26,29,35,39,42,61H,7-9,18-21,23,25,27-28H2,1-6H3,(H,55,63)(H,57,62)/t35-,39+,42-/m1/s1",QRYUVTSBJUTMOL-DCFQOXSYSA-N
1589,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCCCOC3=CC=C(N4C(=S)N(C5=CC=C(C#N)C(Cl)=C5)C(=O)C4(C)C)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCCOCCCCO,C3=CC=C(N4C(=S)N(C5=CC=C(C#N)C(Cl)=C5)C(=O)C4(C)C)C=C3)C(C)(C)C)C=C2)SC=N1,50.0,71.0,0,"Degradation of AR in LNCaP/VCaP cells using ELISA assay (DC50: 15min, Dmax: 4h)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00236,972.631,971.3476815,6.83,67,6,12,3,20,186.66,C49H58ClN7O8S2,"InChI=1S/C49H58ClN7O8S2/c1-31-42(67-30-53-31)33-12-10-32(11-13-33)27-52-44(60)40-25-37(58)28-55(40)45(61)43(48(2,3)4)54-41(59)29-64-22-9-21-63-20-7-8-23-65-38-18-16-35(17-19-38)57-47(66)56(46(62)49(57,5)6)36-15-14-34(26-51)39(50)24-36/h10-19,24,30,37,40,43,58H,7-9,20-23,25,27-29H2,1-6H3,(H,52,60)(H,54,59)/t37-,40+,43-/m1/s1",HTGWWWOBPGTSLC-AKCINUCUSA-N
1590,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCOCCCCOC3=CC=C(C4=CC=C(N5C(=S)N(C6=CC=C(C#N)C(C(F)(F)F)=C6)C(=O)C5(C)C)C=C4)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCCOCCCCO,C3=CC=C(C4=CC=C(N5C(=S)N(C6=CC=C(C#N)C(C(F)(F)F)=C6)C(=O)C5(C)C)C=C4)C=C3)C(C)(C)C)C=C2)SC=N1,50.0,71.0,0,"Degradation of AR in LNCaP/VCaP cells using ELISA assay (DC50: 15min, Dmax: 4h)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00236,1082.281,1081.405339,8.72,76,7,12,3,21,186.66,C56H62F3N7O8S2,"InChI=1S/C56H62F3N7O8S2/c1-35-48(76-34-62-35)39-12-10-36(11-13-39)31-61-50(69)46-29-43(67)32-64(46)51(70)49(54(2,3)4)63-47(68)33-73-26-9-25-72-24-7-8-27-74-44-22-17-38(18-23-44)37-14-19-41(20-15-37)66-53(75)65(52(71)55(66,5)6)42-21-16-40(30-60)45(28-42)56(57,58)59/h10-23,28,34,43,46,49,67H,7-9,24-27,29,31-33H2,1-6H3,(H,61,69)(H,63,68)/t43-,46+,49-/m1/s1",IACCNUDTPQOEHL-YWIAGSDQSA-N
1649,Q07817,BCL-xL,VHL,6ZHC,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCOCCOCCOCCOCCOCCOCC#CC3=CC=C(OCCCC4=C(C(=O)O)N=C(N5CCC6=CC=CC(C(=O)NC7=NC8=CC=CC=C8S7)=C6C5)S4)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCOCCOCCOCCOCCOCCOCC#C,C3=CC=C(OCCCC4=C(C(=O)O)N=C(N5CCC6=CC=CC(C(=O)NC7=NC8=CC=CC=C8S7)=C6C5)S4)C=C3)C(C)(C)C)C=C2)SC=N1,4.8,76.0,0,Degradation of BCL-xL in THP-1 cells after 24 h treatment,,,0.6,IC50 was tested by HTRF assay,,,,,,,,,,,,,,,190.0,SPR,,,,,,,,,,,,,,,290,Titrations of PROTAC over an immobilised VCB surface in the presence of BCL-xL (SPR),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.0c00266,1329.631,1328.495612,8.07,93,9,20,5,34,271.66,C68H80N8O14S3,"InChI=1S/C68H80N8O14S3/c1-45-60(91-44-70-45)49-20-16-47(17-21-49)41-69-63(80)55-40-50(77)42-76(55)64(81)61(68(2,3)4)72-58(78)25-29-85-31-33-87-35-37-89-39-38-88-36-34-86-32-30-84-27-8-10-46-18-22-51(23-19-46)90-28-9-15-57-59(65(82)83)73-67(93-57)75-26-24-48-11-7-12-52(53(48)43-75)62(79)74-66-71-54-13-5-6-14-56(54)92-66/h5-7,11-14,16-23,44,50,55,61,77H,9,15,24-43H2,1-4H3,(H,69,80)(H,72,78)(H,82,83)(H,71,74,79)/t50-,55+,61-/m1/s1",LOJJAKUNUJJOKC-MXEISZGISA-N
1651,Q15059,BRD3,VHL,,MZP-61,CC(=O)N1C2=CC=C(C3=CC=C(C(=O)NCCOCCOCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=C3)C=C2[C@H](NC2=CC=C(Cl)C=C2)C[C@@H]1C,CC(=O)N1C2=CC=C(C3=CC=C(,C(=O)NCCOCCOCC(=O)N,[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=C3)C=C2[C@H](NC2=CC=C(Cl)C=C2)C[C@@H]1C,158.0,74.0,0,Degradation of BRD3 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,116,ITC,,,-9.46,-4.07,-5.39,ITC,,,,,,,,,,,,,,,,,,,,,,,575/676,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,992.64,991.4069106,6.71,70,7,11,5,18,191.53,C53H62ClN7O8S,"InChI=1S/C53H62ClN7O8S/c1-32-25-44(58-41-18-16-40(54)17-19-41)43-26-39(15-20-45(43)61(32)34(3)62)36-11-13-38(14-12-36)50(65)55-21-22-68-23-24-69-30-47(64)59-49(53(4,5)6)52(67)60-29-42(63)27-46(60)51(66)56-28-35-7-9-37(10-8-35)48-33(2)57-31-70-48/h7-20,26,31-32,42,44,46,49,58,63H,21-25,27-30H2,1-6H3,(H,55,65)(H,56,66)(H,59,64)/t32-,42+,44+,46-,49+/m0/s1",AIFXAXRMMBWMAG-OVLUFEKXSA-N
1651,O60885,BRD4,VHL,,MZP-61,CC(=O)N1C2=CC=C(C3=CC=C(C(=O)NCCOCCOCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=C3)C=C2[C@H](NC2=CC=C(Cl)C=C2)C[C@@H]1C,CC(=O)N1C2=CC=C(C3=CC=C(,C(=O)NCCOCCOCC(=O)N,[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=C3)C=C2[C@H](NC2=CC=C(Cl)C=C2)C[C@@H]1C,126.0,94.0,0,Degradation of BRD4 short/long in HeLa cells after 24 h treatment,,,,,,,3,Kd of BRD4 BD2 was tested by ITC,,,-11.7,-10.0,-1.71,ITC in BRD4 BD2,,,,,,,,,116,ITC,,,-9.46,-4.07,-5.39,ITC,,,,,,,,,781,Kd between VHL and the complex of protac and BRD4 BD2 was tested by ITC,,,-8.33,-7.02,-1.31,ITC between VHL and BRD4 BD2:PROTAC,,,,,,,575/676,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,992.64,991.4069106,6.71,70,7,11,5,18,191.53,C53H62ClN7O8S,"InChI=1S/C53H62ClN7O8S/c1-32-25-44(58-41-18-16-40(54)17-19-41)43-26-39(15-20-45(43)61(32)34(3)62)36-11-13-38(14-12-36)50(65)55-21-22-68-23-24-69-30-47(64)59-49(53(4,5)6)52(67)60-29-42(63)27-46(60)51(66)56-28-35-7-9-37(10-8-35)48-33(2)57-31-70-48/h7-20,26,31-32,42,44,46,49,58,63H,21-25,27-30H2,1-6H3,(H,55,65)(H,56,66)(H,59,64)/t32-,42+,44+,46-,49+/m0/s1",AIFXAXRMMBWMAG-OVLUFEKXSA-N
1652,Q15059,BRD3,VHL,,MZP-54,CC(=O)N1C2=CC=C(C3=CC=C(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=C3)C=C2[C@H](NC2=CC=C(Cl)C=C2)C[C@@H]1C,CC(=O)N1C2=CC=C(C3=CC=C(,C(=O)NCCOCCOCCOCC(=O)N,[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=C3)C=C2[C@H](NC2=CC=C(Cl)C=C2)C[C@@H]1C,50.0,91.0,1,Degradation of BRD3 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,105,ITC,,,-9.52,-6.18,-3.34,ITC,,,,,,,,,,,,,,,,,,,,,,,49/269,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,1036.693,1035.433125,6.56,73,7,12,5,21,200.76,C55H66ClN7O9S,"InChI=1S/C55H66ClN7O9S/c1-34-27-46(60-43-18-16-42(56)17-19-43)45-28-41(15-20-47(45)63(34)36(3)64)38-11-13-40(14-12-38)52(67)57-21-22-70-23-24-71-25-26-72-32-49(66)61-51(55(4,5)6)54(69)62-31-44(65)29-48(62)53(68)58-30-37-7-9-39(10-8-37)50-35(2)59-33-73-50/h7-20,28,33-34,44,46,48,51,60,65H,21-27,29-32H2,1-6H3,(H,57,67)(H,58,68)(H,61,66)/t34-,44+,46+,48-,51+/m0/s1",FYSWLIFIYIVHPI-DDWISSAJSA-N
1653,Q15059,BRD3,VHL,,MZP-55,CC(=O)N1C2=CC=C(C3=CC=C(C(=O)NCCOCCOCCOCCOCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=C3)C=C2[C@H](NC2=CC=C(Cl)C=C2)C[C@@H]1C,CC(=O)N1C2=CC=C(C3=CC=C(,C(=O)NCCOCCOCCOCCOCC(=O)N,[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=C3)C=C2[C@H](NC2=CC=C(Cl)C=C2)C[C@@H]1C,20.0,92.0,1,Degradation of BRD3 in HeLa cells after 24 h treatment,,,,,,,Nov-39,Kd of BRD3 BD1/2 was tested by ITC,,,0.926605505,0.956834532,3.2/3,ITC in BRD3 BD1/2,,,,,,,,,109,ITC,,,-9.5,-8.01,-1.5,ITC,,,,,,,,,152/434,Kd between VHL and the complex of protac and BRD3 BD1/2 was tested by ITC,,,1.068886338,0.563437926,3.781021898,ITC between VHL and BRD3 BD1/2:PROTAC,,,,,,,83/427,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,1080.746,1079.45934,6.41,76,7,13,5,24,209.99,C57H70ClN7O10S,"InChI=1S/C57H70ClN7O10S/c1-36-29-48(62-45-18-16-44(58)17-19-45)47-30-43(15-20-49(47)65(36)38(3)66)40-11-13-42(14-12-40)54(69)59-21-22-72-23-24-73-25-26-74-27-28-75-34-51(68)63-53(57(4,5)6)56(71)64-33-46(67)31-50(64)55(70)60-32-39-7-9-41(10-8-39)52-37(2)61-35-76-52/h7-20,30,35-36,46,48,50,53,62,67H,21-29,31-34H2,1-6H3,(H,59,69)(H,60,70)(H,63,68)/t36-,46+,48+,50-,53+/m0/s1",UHWNJFZTYJNBAN-HYXXSBGTSA-N
1653,O60885,BRD4,VHL,,MZP-55,CC(=O)N1C2=CC=C(C3=CC=C(C(=O)NCCOCCOCCOCCOCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=C3)C=C2[C@H](NC2=CC=C(Cl)C=C2)C[C@@H]1C,CC(=O)N1C2=CC=C(C3=CC=C(,C(=O)NCCOCCOCCOCCOCC(=O)N,[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=C3)C=C2[C@H](NC2=CC=C(Cl)C=C2)C[C@@H]1C,8.0,95.0,1,Degradation of BRD4 short/long in HeLa cells after 24 h treatment,,,,,,,Aug-39,Kd of BRD4 BD1/2 was tested by ITC,,,0.927927928,1.101851852,1.6/-0.33,ITC in BRD4 BD1/2,,,,,,,,,109,ITC,,,-9.5,-8.01,-1.5,ITC,,,,,,,,,221/183,Kd between VHL and the complex of protac and BRD4 BD1/2 was tested by ITC,,,0.990217391,0.32585752,4.092592593,ITC between VHL and BRD4 BD1/2:PROTAC,,,,,,,83/427,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,1080.746,1079.45934,6.41,76,7,13,5,24,209.99,C57H70ClN7O10S,"InChI=1S/C57H70ClN7O10S/c1-36-29-48(62-45-18-16-44(58)17-19-45)47-30-43(15-20-49(47)65(36)38(3)66)40-11-13-42(14-12-40)54(69)59-21-22-72-23-24-73-25-26-74-27-28-75-34-51(68)63-53(57(4,5)6)56(71)64-33-46(67)31-50(64)55(70)60-32-39-7-9-41(10-8-39)52-37(2)61-35-76-52/h7-20,30,35-36,46,48,50,53,62,67H,21-29,31-34H2,1-6H3,(H,59,69)(H,60,70)(H,63,68)/t36-,46+,48+,50-,53+/m0/s1",UHWNJFZTYJNBAN-HYXXSBGTSA-N
1654,P25440,BRD2,VHL,,MZ4,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCNC(=O)C,[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,631.0,93.0,0,Degradation of BRD2 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,147,ITC,,,-9.34,-5.72,-3.61,ITC,,,,,,,,,,,,,,,,,,,,,,,178/1445,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,958.608,957.3432648,5.11,66,7,14,4,17,202.26,C47H56ClN9O7S2,"InChI=1S/C47H56ClN9O7S2/c1-26-28(3)66-46-39(26)40(31-12-14-33(48)15-13-31)52-35(43-55-54-29(4)57(43)46)21-37(59)49-16-17-63-18-19-64-24-38(60)53-42(47(5,6)7)45(62)56-23-34(58)20-36(56)44(61)50-22-30-8-10-32(11-9-30)41-27(2)51-25-65-41/h8-15,25,34-36,42,58H,16-24H2,1-7H3,(H,49,59)(H,50,61)(H,53,60)/t34-,35+,36+,42-/m1/s1",UAQDCZFGBBSHLT-PBSGCNNPSA-N
1654,Q15059,BRD3,VHL,,MZ4,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCNC(=O)C,[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,316.0,97.0,0,Degradation of BRD3 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,147,ITC,,,-9.34,-5.72,-3.61,ITC,,,,,,,,,,,,,,,,,,,,,,,178/1445,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,958.608,957.3432648,5.11,66,7,14,4,17,202.26,C47H56ClN9O7S2,"InChI=1S/C47H56ClN9O7S2/c1-26-28(3)66-46-39(26)40(31-12-14-33(48)15-13-31)52-35(43-55-54-29(4)57(43)46)21-37(59)49-16-17-63-18-19-64-24-38(60)53-42(47(5,6)7)45(62)56-23-34(58)20-36(56)44(61)50-22-30-8-10-32(11-9-30)41-27(2)51-25-65-41/h8-15,25,34-36,42,58H,16-24H2,1-7H3,(H,49,59)(H,50,61)(H,53,60)/t34-,35+,36+,42-/m1/s1",UAQDCZFGBBSHLT-PBSGCNNPSA-N
1654,O60885,BRD4,VHL,,MZ4,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCNC(=O)C,[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,100.0,96.0,1,Degradation of BRD4 short/long in HeLa cells after 24 h treatment,,,,,,,17,ITC in BRD4 BD2,,,-10.6,-11.2,-0.65,ITC in BRD4 BD2,,,,,,,,,147,ITC,,,-9.34,-5.72,-3.61,ITC,,,,,,,,,26,Kd between VHL and MZ4-BRD4 BD2 was tested by ITC,,,-10.4,-5.36,-5.05,ITC between VHL and BRD4 BD2:PROTAC,,,,,,,178/1445,Inhibit proliferation of MV4;11/HL60 cells,,,,,,,,,,,,,10.1021/acs.jmedchem.6b01912,958.608,957.3432648,5.11,66,7,14,4,17,202.26,C47H56ClN9O7S2,"InChI=1S/C47H56ClN9O7S2/c1-26-28(3)66-46-39(26)40(31-12-14-33(48)15-13-31)52-35(43-55-54-29(4)57(43)46)21-37(59)49-16-17-63-18-19-64-24-38(60)53-42(47(5,6)7)45(62)56-23-34(58)20-36(56)44(61)50-22-30-8-10-32(11-9-30)41-27(2)51-25-65-41/h8-15,25,34-36,42,58H,16-24H2,1-7H3,(H,49,59)(H,50,61)(H,53,60)/t34-,35+,36+,42-/m1/s1",UAQDCZFGBBSHLT-PBSGCNNPSA-N
1655,Q05397,FAK,CRBN,,BI-3663,COC1=CC(C(=O)NCCOCCOCCOCCC(=O)NC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,COC1=CC(,C(=O)NCCOCCOCCOCCC(=O)N,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,13.0,93.0,1,Degradation of Fak in HLE/HuH-7/SNU-423 cells after 18 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>25119/>25119/19953,Inhibit proliferation of HLE/HuH-7/SNU-423 cells,,,,,,,,,,,1,Compounds were administered at 10000 nM and incubated for 2 h,17,Compounds were administered at 10000 nM and incubated for 2 h,10.1021/acs.jmedchem.8b01826,917.851,917.2843544,2.93,66,7,15,4,20,242.78,C44H42F3N7O12,"InChI=1S/C44H42F3N7O12/c1-62-33-22-25(8-10-28(33)51-43-49-23-27(44(45,46)47)40(53-43)66-32-7-2-4-24-9-12-31(55)36(24)32)38(58)48-15-17-64-19-21-65-20-18-63-16-14-35(57)50-29-6-3-5-26-37(29)42(61)54(41(26)60)30-11-13-34(56)52-39(30)59/h2-8,10,22-23,30H,9,11-21H2,1H3,(H,48,58)(H,50,57)(H,49,51,53)(H,52,56,59)",ADTXLFJKQHYGPM-UHFFFAOYSA-N
1655,Q05397,FAK,CRBN,,BI-3663,COC1=CC(C(=O)NCCOCCOCCOCCC(=O)NC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,COC1=CC(,C(=O)NCCOCCOCCOCCC(=O)N,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,32.0,89.0,1,Degradation of Fak in HUH-1/HepG2/SK-Hep-1 cells after 18 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,25119/>25119/1585,Inhibit proliferation of HUH-1/HepG2/SK-Hep-1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01826,917.851,917.2843544,2.93,66,7,15,4,20,242.78,C44H42F3N7O12,"InChI=1S/C44H42F3N7O12/c1-62-33-22-25(8-10-28(33)51-43-49-23-27(44(45,46)47)40(53-43)66-32-7-2-4-24-9-12-31(55)36(24)32)38(58)48-15-17-64-19-21-65-20-18-63-16-14-35(57)50-29-6-3-5-26-37(29)42(61)54(41(26)60)30-11-13-34(56)52-39(30)59/h2-8,10,22-23,30H,9,11-21H2,1H3,(H,48,58)(H,50,57)(H,49,51,53)(H,52,56,59)",ADTXLFJKQHYGPM-UHFFFAOYSA-N
1655,Q05397,FAK,CRBN,,BI-3663,COC1=CC(C(=O)NCCOCCOCCOCCC(=O)NC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,COC1=CC(,C(=O)NCCOCCOCCOCCC(=O)N,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,27.0,95.0,1,Degradation of Fak in A549/Hep3B2.1-7/SNU-387 cells after 18 h treatment,,,18,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>25119/25119,Inhibit proliferation of SNU-387/Hep3B2.1-7 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01826,917.851,917.2843544,2.93,66,7,15,4,20,242.78,C44H42F3N7O12,"InChI=1S/C44H42F3N7O12/c1-62-33-22-25(8-10-28(33)51-43-49-23-27(44(45,46)47)40(53-43)66-32-7-2-4-24-9-12-31(55)36(24)32)38(58)48-15-17-64-19-21-65-20-18-63-16-14-35(57)50-29-6-3-5-26-37(29)42(61)54(41(26)60)30-11-13-34(56)52-39(30)59/h2-8,10,22-23,30H,9,11-21H2,1H3,(H,48,58)(H,50,57)(H,49,51,53)(H,52,56,59)",ADTXLFJKQHYGPM-UHFFFAOYSA-N
1655,Q05397,FAK,CRBN,,BI-3663,COC1=CC(C(=O)NCCOCCOCCOCCC(=O)NC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,COC1=CC(,C(=O)NCCOCCOCCOCCC(=O)N,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,13.0,90.0,1,Degradation of Fak in HLF/SNU-398/HUCCT1 cells after 18 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>25119/>25119/>25119,Inhibit proliferation of HLF/SNU-398/HUCCT1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01826,917.851,917.2843544,2.93,66,7,15,4,20,242.78,C44H42F3N7O12,"InChI=1S/C44H42F3N7O12/c1-62-33-22-25(8-10-28(33)51-43-49-23-27(44(45,46)47)40(53-43)66-32-7-2-4-24-9-12-31(55)36(24)32)38(58)48-15-17-64-19-21-65-20-18-63-16-14-35(57)50-29-6-3-5-26-37(29)42(61)54(41(26)60)30-11-13-34(56)52-39(30)59/h2-8,10,22-23,30H,9,11-21H2,1H3,(H,48,58)(H,50,57)(H,49,51,53)(H,52,56,59)",ADTXLFJKQHYGPM-UHFFFAOYSA-N
1656,Q05397,FAK,VHL,,BI-0319,COC1=CC(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,COC1=CC(,C(=O)NCCOCCOCCOCC(=O)N,[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,32.0,98.0,1,Degradation of Fak in A549/Hep3B2.1-7/SNU-387 cells after 18 h treatment,,,19,Inhibition of Fak,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5012/6310,Inhibit proliferation of SNU-387/Hep3B2.1-7 cells,,,,,,,,,,,<1,Compounds were administered at 10000 nM and incubated for 2 h,11,Compounds were administered at 10000 nM and incubated for 2 h,10.1021/acs.jmedchem.8b01826,1061.15,1060.39761,5.49,75,7,16,5,23,241.76,C52H59F3N8O11S,"InChI=1S/C52H59F3N8O11S/c1-30-44(75-29-59-30)33-11-9-31(10-12-33)25-57-47(68)38-24-35(64)27-63(38)49(69)45(51(2,3)4)61-42(66)28-73-22-21-72-20-19-71-18-17-56-46(67)34-13-15-37(41(23-34)70-5)60-50-58-26-36(52(53,54)55)48(62-50)74-40-8-6-7-32-14-16-39(65)43(32)40/h6-13,15,23,26,29,35,38,45,64H,14,16-22,24-25,27-28H2,1-5H3,(H,56,67)(H,57,68)(H,61,66)(H,58,60,62)/t35-,38+,45-/m1/s1",UVVQLQQNGHYTOL-JIVXZRRKSA-N
1656,Q05397,FAK,VHL,,BI-0319,COC1=CC(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,COC1=CC(,C(=O)NCCOCCOCCOCC(=O)N,[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,25.0,85.0,1,Degradation of Fak in HLE/HuH-7/SNU-423 cells after 18 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10000/3981/6310,Inhibit proliferation of HLE/HuH-7/SNU-423 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01826,1061.15,1060.39761,5.49,75,7,16,5,23,241.76,C52H59F3N8O11S,"InChI=1S/C52H59F3N8O11S/c1-30-44(75-29-59-30)33-11-9-31(10-12-33)25-57-47(68)38-24-35(64)27-63(38)49(69)45(51(2,3)4)61-42(66)28-73-22-21-72-20-19-71-18-17-56-46(67)34-13-15-37(41(23-34)70-5)60-50-58-26-36(52(53,54)55)48(62-50)74-40-8-6-7-32-14-16-39(65)43(32)40/h6-13,15,23,26,29,35,38,45,64H,14,16-22,24-25,27-28H2,1-5H3,(H,56,67)(H,57,68)(H,61,66)(H,58,60,62)/t35-,38+,45-/m1/s1",UVVQLQQNGHYTOL-JIVXZRRKSA-N
1656,Q05397,FAK,VHL,,BI-0319,COC1=CC(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,COC1=CC(,C(=O)NCCOCCOCCOCC(=O)N,[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,10.0,99.0,1,Degradation of Fak in HLF/SNU-398/HUCCT1 cells after 18 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>25119/7943/6310,Inhibit proliferation of HLF/SNU-398/HUCCT1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01826,1061.15,1060.39761,5.49,75,7,16,5,23,241.76,C52H59F3N8O11S,"InChI=1S/C52H59F3N8O11S/c1-30-44(75-29-59-30)33-11-9-31(10-12-33)25-57-47(68)38-24-35(64)27-63(38)49(69)45(51(2,3)4)61-42(66)28-73-22-21-72-20-19-71-18-17-56-46(67)34-13-15-37(41(23-34)70-5)60-50-58-26-36(52(53,54)55)48(62-50)74-40-8-6-7-32-14-16-39(65)43(32)40/h6-13,15,23,26,29,35,38,45,64H,14,16-22,24-25,27-28H2,1-5H3,(H,56,67)(H,57,68)(H,61,66)(H,58,60,62)/t35-,38+,45-/m1/s1",UVVQLQQNGHYTOL-JIVXZRRKSA-N
1656,Q05397,FAK,VHL,,BI-0319,COC1=CC(C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,COC1=CC(,C(=O)NCCOCCOCCOCC(=O)N,[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)=CC=C1NC1=NC=C(C(F)(F)F)C(OC2=CC=CC3=C2C(=O)CC3)=N1,79.0,87.0,1,Degradation of Fak in HUH-1/HepG2/SK-Hep-1 cells after 18 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,19953/>25119/7943,Inhibit proliferation of HUH-1/HepG2/SK-Hep-1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.8b01826,1061.15,1060.39761,5.49,75,7,16,5,23,241.76,C52H59F3N8O11S,"InChI=1S/C52H59F3N8O11S/c1-30-44(75-29-59-30)33-11-9-31(10-12-33)25-57-47(68)38-24-35(64)27-63(38)49(69)45(51(2,3)4)61-42(66)28-73-22-21-72-20-19-71-18-17-56-46(67)34-13-15-37(41(23-34)70-5)60-50-58-26-36(52(53,54)55)48(62-50)74-40-8-6-7-32-14-16-39(65)43(32)40/h6-13,15,23,26,29,35,38,45,64H,14,16-22,24-25,27-28H2,1-5H3,(H,56,67)(H,57,68)(H,61,66)(H,58,60,62)/t35-,38+,45-/m1/s1",UVVQLQQNGHYTOL-JIVXZRRKSA-N
1658,P01116,KRAS G12C,VHL,,LC-2,C=C(F)C(=O)N1CCN(C2=NC(OC[C@@H]3CCCN3CCCOCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=NC3=C2CCN(C2=CC=CC4=CC=CC(Cl)=C24)C3)C[C@@H]1CC#N,C=C(F)C(=O)N1CCN(C2=NC(OC[C@@H]3CCCN3,CCCOCCC(=O)N,[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=NC3=C2CCN(C2=CC=CC4=CC=CC(Cl)=C24)C3)C[C@@H]1CC#N,250.0,90.0,0,Degradation of KRAS G12C in NCI-H23/NCI-H358 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acscentsci.0c00411,1132.805,1131.493121,7.27,80,9,15,3,20,209.69,C59H71ClFN11O7S,"InChI=1S/C59H71ClFN11O7S/c1-37(61)56(76)71-27-26-70(32-42(71)19-22-62)54-45-20-25-69(48-14-7-11-40-10-6-13-46(60)51(40)48)34-47(45)65-58(67-54)79-35-43-12-8-23-68(43)24-9-28-78-29-21-50(74)66-53(59(3,4)5)57(77)72-33-44(73)30-49(72)55(75)63-31-39-15-17-41(18-16-39)52-38(2)64-36-80-52/h6-7,10-11,13-18,36,42-44,49,53,73H,1,8-9,12,19-21,23-35H2,2-5H3,(H,63,75)(H,66,74)/t42-,43-,44+,49-,53+/m0/s1",ZCGQZLKPUVGCBQ-HLMPTVQRSA-N
1658,P01116,KRAS G12C,VHL,,LC-2,C=C(F)C(=O)N1CCN(C2=NC(OC[C@@H]3CCCN3CCCOCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=NC3=C2CCN(C2=CC=CC4=CC=CC(Cl)=C24)C3)C[C@@H]1CC#N,C=C(F)C(=O)N1CCN(C2=NC(OC[C@@H]3CCCN3,CCCOCCC(=O)N,[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=NC3=C2CCN(C2=CC=CC4=CC=CC(Cl)=C24)C3)C[C@@H]1CC#N,590.0,80.0,0,Degradation of KRAS G12C in NCI-H2030/MIA PaCa-2/SW1573 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3800/2900,Inhibit viability of NCI-H2030/NCI-H23 cells,,,,,,,,,,,,,10.1021/acscentsci.0c00411,1132.805,1131.493121,7.27,80,9,15,3,20,209.69,C59H71ClFN11O7S,"InChI=1S/C59H71ClFN11O7S/c1-37(61)56(76)71-27-26-70(32-42(71)19-22-62)54-45-20-25-69(48-14-7-11-40-10-6-13-46(60)51(40)48)34-47(45)65-58(67-54)79-35-43-12-8-23-68(43)24-9-28-78-29-21-50(74)66-53(59(3,4)5)57(77)72-33-44(73)30-49(72)55(75)63-31-39-15-17-41(18-16-39)52-38(2)64-36-80-52/h6-7,10-11,13-18,36,42-44,49,53,73H,1,8-9,12,19-21,23-35H2,2-5H3,(H,63,75)(H,66,74)/t42-,43-,44+,49-,53+/m0/s1",ZCGQZLKPUVGCBQ-HLMPTVQRSA-N
1659,P01116,KRAS G12C,VHL,,LC-3,C=C(F)C(=O)N1CCN(C2=NC(OC[C@@H]3CCCN3CCC(=O)NCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=NC3=C2CCN(C2=CC=CC4=CC=CC(Cl)=C24)C3)C[C@@H]1CC#N,C=C(F)C(=O)N1CCN(C2=NC(OC[C@@H]3CCCN3,CCC(=O)NCCC(=O)N,[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=NC3=C2CCN(C2=CC=CC4=CC=CC(Cl)=C24)C3)C[C@@H]1CC#N,640.0,85.0,0,Degradation of KRAS G12C in NCI-H2030 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acscentsci.0c00411,1145.804,1144.488369,6.31,81,9,15,4,19,229.56,C59H70ClFN12O7S,"InChI=1S/C59H70ClFN12O7S/c1-36(61)56(78)72-28-27-71(31-41(72)18-22-62)54-44-20-25-70(47-13-7-10-39-9-6-12-45(60)51(39)47)33-46(44)66-58(68-54)80-34-42-11-8-24-69(42)26-21-49(75)63-23-19-50(76)67-53(59(3,4)5)57(79)73-32-43(74)29-48(73)55(77)64-30-38-14-16-40(17-15-38)52-37(2)65-35-81-52/h6-7,9-10,12-17,35,41-43,48,53,74H,1,8,11,18-21,23-34H2,2-5H3,(H,63,75)(H,64,77)(H,67,76)/t41-,42-,43+,48-,53+/m0/s1",QSJKPPVXARILLJ-GYUTUTRISA-N
1660,P01116,KRAS G12C,VHL,,LC-4,C=C(F)C(=O)N1CCN(C2=NC(OC[C@@H]3CCCN3CCCCOCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=NC3=C2CCN(C2=CC=CC4=CC=CC(Cl)=C24)C3)C[C@@H]1CC#N,C=C(F)C(=O)N1CCN(C2=NC(OC[C@@H]3CCCN3,CCCCOCCC(=O)N,[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=NC3=C2CCN(C2=CC=CC4=CC=CC(Cl)=C24)C3)C[C@@H]1CC#N,880.0,90.0,0,Degradation of KRAS G12C in SW1573 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acscentsci.0c00411,1146.832,1145.508771,7.63,81,9,15,3,21,209.69,C60H73ClFN11O7S,"InChI=1S/C60H73ClFN11O7S/c1-38(62)57(77)72-28-27-71(33-43(72)20-23-63)55-46-21-26-70(49-15-9-12-41-11-8-14-47(61)52(41)49)35-48(46)66-59(68-55)80-36-44-13-10-25-69(44)24-6-7-29-79-30-22-51(75)67-54(60(3,4)5)58(78)73-34-45(74)31-50(73)56(76)64-32-40-16-18-42(19-17-40)53-39(2)65-37-81-53/h8-9,11-12,14-19,37,43-45,50,54,74H,1,6-7,10,13,20-22,24-36H2,2-5H3,(H,64,76)(H,67,75)/t43-,44-,45+,50-,54+/m0/s1",ZTFKFELOBVAACZ-JCKBJUPWSA-N
1661,P01116,KRAS G12C,VHL,,LC-5,C=C(F)C(=O)N1CCN(C2=NC(OC[C@@H]3CCCN3CCOCCOCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=NC3=C2CCN(C2=CC=CC4=CC=CC(Cl)=C24)C3)C[C@@H]1CC#N,C=C(F)C(=O)N1CCN(C2=NC(OC[C@@H]3CCCN3,CCOCCOCCC(=O)N,[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=NC3=C2CCN(C2=CC=CC4=CC=CC(Cl)=C24)C3)C[C@@H]1CC#N,10000.0,50.0,0,Degradation of KRAS G12C in SW1573 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acscentsci.0c00411,1162.831,1161.503685,6.77,82,9,16,3,22,218.92,C60H73ClFN11O8S,"InChI=1S/C60H73ClFN11O8S/c1-38(62)57(77)72-25-24-71(33-43(72)18-21-63)55-46-19-23-70(49-13-7-10-41-9-6-12-47(61)52(41)49)35-48(46)66-59(68-55)81-36-44-11-8-22-69(44)26-28-80-30-29-79-27-20-51(75)67-54(60(3,4)5)58(78)73-34-45(74)31-50(73)56(76)64-32-40-14-16-42(17-15-40)53-39(2)65-37-82-53/h6-7,9-10,12-17,37,43-45,50,54,74H,1,8,11,18-20,22-36H2,2-5H3,(H,64,76)(H,67,75)/t43-,44-,45+,50-,54+/m0/s1",LHQBPRGJSOSPMT-JCKBJUPWSA-N
1675,P09874,PARP1,CRBN,,SK-575,O=C(CCCCCCCCCCC(=O)N1CCN(C(=O)C2=CC(CC3=N[NH]C(=O)C4=CC=CC=C34)=CC=C2F)CC1)NCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,O=C(,CCCCCCCCCCC(=O)N,1CCN(C(=O)C2=CC(CC3=N[NH]C(=O)C4=CC=CC=C34)=CC=C2F)CC1)NCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,0.384,99.0,1,Degradation of PARP1 in HCC1937/22RV1/MDA-MB-468 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8410/12300/4360,Inhibit growth of HCC1937/22RV1/MDA-MB-468 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00821,876.987,876.3970389,5.03,64,7,10,4,19,211.05,C47H53FN8O8,"InChI=1S/C47H53FN8O8/c48-35-19-18-30(29-37-31-12-9-10-13-32(31)43(60)53-52-37)28-34(35)45(62)55-26-24-54(25-27-55)41(59)17-8-6-4-2-1-3-5-7-16-39(57)50-23-22-49-36-15-11-14-33-42(36)47(64)56(46(33)63)38-20-21-40(58)51-44(38)61/h9-15,18-19,28,38,49H,1-8,16-17,20-27,29H2,(H,50,57)(H,53,60)(H,51,58,61)",HPBWDZVXFSTVMR-UHFFFAOYSA-N
1675,P09874,PARP1,CRBN,,SK-575,O=C(CCCCCCCCCCC(=O)N1CCN(C(=O)C2=CC(CC3=N[NH]C(=O)C4=CC=CC=C34)=CC=C2F)CC1)NCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,O=C(,CCCCCCCCCCC(=O)N,1CCN(C(=O)C2=CC(CC3=N[NH]C(=O)C4=CC=CC=C34)=CC=C2F)CC1)NCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,0.578,99.0,1,Degradation of PARP1 in PC-3/LNCaP/MDA-MB-231 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5140/1440/4790,Inhibit growth of PC-3/LNCaP/MDA-MB-231 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00821,876.987,876.3970389,5.03,64,7,10,4,19,211.05,C47H53FN8O8,"InChI=1S/C47H53FN8O8/c48-35-19-18-30(29-37-31-12-9-10-13-32(31)43(60)53-52-37)28-34(35)45(62)55-26-24-54(25-27-55)41(59)17-8-6-4-2-1-3-5-7-16-39(57)50-23-22-49-36-15-11-14-33-42(36)47(64)56(46(33)63)38-20-21-40(58)51-44(38)61/h9-15,18-19,28,38,49H,1-8,16-17,20-27,29H2,(H,50,57)(H,53,60)(H,51,58,61)",HPBWDZVXFSTVMR-UHFFFAOYSA-N
1675,P09874,PARP1,CRBN,,SK-575,O=C(CCCCCCCCCCC(=O)N1CCN(C(=O)C2=CC(CC3=N[NH]C(=O)C4=CC=CC=C34)=CC=C2F)CC1)NCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,O=C(,CCCCCCCCCCC(=O)N,1CCN(C(=O)C2=CC(CC3=N[NH]C(=O)C4=CC=CC=C34)=CC=C2F)CC1)NCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,1.26,99.0,1,Degradation of PARP1 in MDA-MB-436/Capan-1/SW620 cells after 24 h treatment,,,2.3,IC50 was tested using a PARP1 activity assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,19/56/5130,Inhibit growth of MDA-MB-436/Capan-1/SW620 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c00821,876.987,876.3970389,5.03,64,7,10,4,19,211.05,C47H53FN8O8,"InChI=1S/C47H53FN8O8/c48-35-19-18-30(29-37-31-12-9-10-13-32(31)43(60)53-52-37)28-34(35)45(62)55-26-24-54(25-27-55)41(59)17-8-6-4-2-1-3-5-7-16-39(57)50-23-22-49-36-15-11-14-33-42(36)47(64)56(46(33)63)38-20-21-40(58)51-44(38)61/h9-15,18-19,28,38,49H,1-8,16-17,20-27,29H2,(H,50,57)(H,53,60)(H,51,58,61)",HPBWDZVXFSTVMR-UHFFFAOYSA-N
1716,Q9Y616,IRAK3,CRBN,,,CC(C)C1=C2C(N[C@H]3CC[C@@H](N4CCN(C(=O)CCC(=O)N5CCC(CN6CCN(C7=CC=C8C(=O)N(C9CCC(=O)NC9=O)C(=O)C8=C7)CC6)CC5)CC4)CC3)=NC=NN2C=C1,CC(C)C1=C2C(N[C@H]3CC[C@@H](N4CCN(,C(=O)CCC(=O)N,5CCC(CN6CCN(C7=CC=C8C(=O)N(C9CCC(=O)NC9=O)C(=O)C8=C7)CC6)CC5)CC4)CC3)=NC=NN2C=C1,52.0,74.0,0,Degradation of IRAK3 in THP1 cells after 16 h treatment,,,6.3,LanthaScreen Eu IRAK3 binding displacement assay using an Alexa Fluor conjugate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01125,864.065,863.4806287,2.44,63,9,13,2,11,176.11,C46H61N11O6,"InChI=1S/C46H61N11O6/c1-30(2)35-15-18-56-42(35)43(47-29-48-56)49-32-3-5-33(6-4-32)52-23-25-55(26-24-52)41(60)12-11-40(59)54-16-13-31(14-17-54)28-51-19-21-53(22-20-51)34-7-8-36-37(27-34)46(63)57(45(36)62)38-9-10-39(58)50-44(38)61/h7-8,15,18,27,29-33,38H,3-6,9-14,16-17,19-26,28H2,1-2H3,(H,47,48,49)(H,50,58,61)/t32-,33+,38?",PVLXFMAKABZOPF-YVLRYLSESA-N
1717,Q9Y616,IRAK3,CRBN,,,CC(C)C1=C2C(N[C@H]3CC[C@@H](N4CCN(C(=O)CCC(=O)N5CCC(CCN6CCN(C7=CC=C8C(=O)N(C9CCC(=O)NC9=O)C(=O)C8=C7)CC6)CC5)CC4)CC3)=NC=NN2C=C1,CC(C)C1=C2C(N[C@H]3CC[C@@H](N4CCN(,C(=O)CCC(=O)N,5CCC(CCN6CCN(C7=CC=C8C(=O)N(C9CCC(=O)NC9=O)C(=O)C8=C7)CC6)CC5)CC4)CC3)=NC=NN2C=C1,2.0,98.0,1,Degradation of IRAK3 in THP1 cells after 16 h treatment,,,4.9,LanthaScreen Eu IRAK3 binding displacement assay using an Alexa Fluor conjugate,,,34,Kd apparent of IRAK3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01125,878.092,877.4962787,2.8,64,9,13,2,12,176.11,C47H63N11O6,"InChI=1S/C47H63N11O6/c1-31(2)36-16-20-57-43(36)44(48-30-49-57)50-33-3-5-34(6-4-33)53-25-27-56(28-26-53)42(61)12-11-41(60)55-18-14-32(15-19-55)13-17-52-21-23-54(24-22-52)35-7-8-37-38(29-35)47(64)58(46(37)63)39-9-10-40(59)51-45(39)62/h7-8,16,20,29-34,39H,3-6,9-15,17-19,21-28H2,1-2H3,(H,48,49,50)(H,51,59,62)/t33-,34+,39?",ZUODKONSNNHSAJ-AMLBMYBGSA-N
1782,O14744,PRMT5,VHL,,MS4322,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOCC(=O)N3CC(NC4=CC(C(=O)NC[C@H](O)CN5CCC6=CC=CC=C6C5)=NC=N4)C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCCOCCOCC(=O)N,3CC(NC4=CC(C(=O)NC[C@H](O)CN5CCC6=CC=CC=C6C5)=NC=N4)C3)C(C)(C)C)C=C2)SC=N1,1100.0,74.0,0,Degradation of PRMT5 in MCF-7 cells after 6 d treatment,,,18,IC50 was assessed by a human PRMT5/MEP50 radioactive biochemical assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01111,1101.338,1100.536489,2.22,78,7,18,6,29,268.47,C55H76N10O12S,"InChI=1S/C55H76N10O12S/c1-36(38-10-12-40(13-11-38)50-37(2)59-35-78-50)60-53(71)46-24-43(66)31-65(46)54(72)51(55(3,4)5)62-48(68)32-76-22-20-74-18-16-73-17-19-75-21-23-77-33-49(69)64-28-42(29-64)61-47-25-45(57-34-58-47)52(70)56-26-44(67)30-63-15-14-39-8-6-7-9-41(39)27-63/h6-13,25,34-36,42-44,46,51,66-67H,14-24,26-33H2,1-5H3,(H,56,70)(H,60,71)(H,62,68)(H,57,58,61)/t36-,43+,44-,46-,51+/m0/s1",XUJMNOQMXWVXQE-STHBVIMFSA-N
1783,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C3=CC4=C(C=C3CS(C)(=O)=O)C3=CN(C)C(=O)C5=C3C(=C[NH]5)CN4C3=NC=C(F)C=C3F)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCCNC(=O),C3=CC4=C(C=C3CS(C)(=O)=O)C3=CN(C)C(=O)C5=C3C(=C[NH]5)CN4C3=NC=C(F)C=C3F)C(C)(C)C)C=C2)SC=N1,7.5,98.0,1,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,1.1/1.4,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,28,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01846,1102.253,1101.390002,2.66,77,8,16,5,21,256.48,C53H61F2N9O11S2,"InChI=1S/C53H61F2N9O11S2/c1-30-46(76-29-60-30)32-9-7-31(8-10-32)21-59-50(68)42-19-36(65)25-64(42)52(70)47(53(2,3)4)61-43(66)27-75-16-15-74-14-13-73-12-11-56-49(67)37-20-41-38(17-33(37)28-77(6,71)72)39-26-62(5)51(69)45-44(39)34(22-57-45)24-63(41)48-40(55)18-35(54)23-58-48/h7-10,17-18,20,22-23,26,29,36,42,47,57,65H,11-16,19,21,24-25,27-28H2,1-6H3,(H,56,67)(H,59,68)(H,61,66)/t36-,42+,47-/m1/s1",GPZQCKOJSPAJES-KFRCLFBHSA-N
1784,O60885,BRD4,VHL,7KHH,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCNC(=O)C3=CC4=C(C=C3CS(C)(=O)=O)C3=CN(C)C(=O)C5=C3C(=C[NH]5)CN4C3=NC=C(F)C=C3F)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCCCNC(=O),C3=CC4=C(C=C3CS(C)(=O)=O)C3=CN(C)C(=O)C5=C3C(=C[NH]5)CN4C3=NC=C(F)C=C3F)C(C)(C)C)C=C2)SC=N1,0.095,96.0,1,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,4.7/4.3,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,613.0,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.63,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01846,1096.337,1095.452209,6.78,77,8,13,5,21,228.79,C56H67F2N9O8S2,"InChI=1S/C56H67F2N9O8S2/c1-33-49(76-32-63-33)35-18-16-34(17-19-35)25-62-53(71)45-23-39(68)29-67(45)55(73)50(56(2,3)4)64-46(69)15-13-11-9-7-8-10-12-14-20-59-52(70)40-24-44-41(21-36(40)31-77(6,74)75)42-30-65(5)54(72)48-47(42)37(26-60-48)28-66(44)51-43(58)22-38(57)27-61-51/h16-19,21-22,24,26-27,30,32,39,45,50,60,68H,7-15,20,23,25,28-29,31H2,1-6H3,(H,59,70)(H,62,71)(H,64,69)/t39-,45+,50-/m1/s1",VTPSYVSGGUUAFN-GDNJTPAESA-N
1785,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C3=CC4=C(C=C3CS(C)(=O)=O)C3=CN(C)C(=O)C5=C3C(=C[NH]5)CN4C3=NC=C(F)C=C3F)C(C)(C)C)C(OC3CCNCC3)=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCCNC(=O),C3=CC4=C(C=C3CS(C)(=O)=O)C3=CN(C)C(=O)C5=C3C(=C[NH]5)CN4C3=NC=C(F)C=C3F)C(C)(C)C)C(OC3CCNCC3)=C2)SC=N1,180.0,99.0,0,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,1.2/1.6,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,383.0,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,220,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01846,1201.386,1200.458416,2.75,84,9,18,6,23,277.74,C58H70F2N10O12S2,"InChI=1S/C58H70F2N10O12S2/c1-33-51(83-32-66-33)34-7-8-35(47(20-34)82-40-9-11-61-12-10-40)24-65-55(74)46-22-39(71)28-70(46)57(76)52(58(2,3)4)67-48(72)30-81-18-17-80-16-15-79-14-13-62-54(73)41-23-45-42(19-36(41)31-84(6,77)78)43-29-68(5)56(75)50-49(43)37(25-63-50)27-69(45)53-44(60)21-38(59)26-64-53/h7-8,19-21,23,25-26,29,32,39-40,46,52,61,63,71H,9-18,22,24,27-28,30-31H2,1-6H3,(H,62,73)(H,65,74)(H,67,72)/t39-,46+,52-/m1/s1",QZSIUKWWOMOSBP-MHQZIYKSSA-N
1786,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCNC(=O)C3=CC4=C(C=C3CS(C)(=O)=O)C3=CN(C)C(=O)C5=C3C(=C[NH]5)CN4C3=NC=C(F)C=C3F)C(C)(C)C)C(OC3CCNCC3)=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCCCNC(=O),C3=CC4=C(C=C3CS(C)(=O)=O)C3=CN(C)C(=O)C5=C3C(=C[NH]5)CN4C3=NC=C(F)C=C3F)C(C)(C)C)C(OC3CCNCC3)=C2)SC=N1,3.4,98.0,1,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,2/2.7,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,40,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01846,1195.47,1194.520622,6.88,84,9,15,6,23,250.05,C61H76F2N10O9S2,"InChI=1S/C61H76F2N10O9S2/c1-36-54(83-35-69-36)37-16-17-38(50(24-37)82-43-18-21-64-22-19-43)28-68-58(77)49-26-42(74)32-73(49)60(79)55(61(2,3)4)70-51(75)15-13-11-9-7-8-10-12-14-20-65-57(76)44-27-48-45(23-39(44)34-84(6,80)81)46-33-71(5)59(78)53-52(46)40(29-66-53)31-72(48)56-47(63)25-41(62)30-67-56/h16-17,23-25,27,29-30,33,35,42-43,49,55,64,66,74H,7-15,18-22,26,28,31-32,34H2,1-6H3,(H,65,76)(H,68,77)(H,70,75)/t42-,49+,55-/m1/s1",QJBZJBJONOIDIV-GSTUPHOUSA-N
1787,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCC3=CC(N)=CC(OCCNC(=O)C4=CC5=C(C=C4CS(C)(=O)=O)C4=CN(C)C(=O)C6=C4C(=C[NH]6)CN5C4=NC=C(F)C=C4F)=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCC,C3=CC(N)=CC(OCCNC(=O)C4=CC5=C(C=C4CS(C)(=O)=O)C4=CN(C)C(=O)C6=C4C(=C[NH]6)CN5C4=NC=C(F)C=C4F)=C3)C(C)(C)C)C=C2)SC=N1,2.1,98.0,1,Degradation of BRD4 in EOL-1 cells 4 h treatment,,,7.2/8.1,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01846,1149.313,1148.405987,4.2,81,9,16,6,19,273.27,C57H62F2N10O10S2,"InChI=1S/C57H62F2N10O10S2/c1-31-50(80-30-65-31)34-9-7-32(8-10-34)22-64-54(73)46-20-39(70)26-69(46)56(75)51(57(2,3)4)66-47(71)28-78-13-11-33-15-38(60)19-40(16-33)79-14-12-61-53(72)41-21-45-42(17-35(41)29-81(6,76)77)43-27-67(5)55(74)49-48(43)36(23-62-49)25-68(45)52-44(59)18-37(58)24-63-52/h7-10,15-19,21,23-24,27,30,39,46,51,62,70H,11-14,20,22,25-26,28-29,60H2,1-6H3,(H,61,72)(H,64,73)(H,66,71)/t39-,46+,51-/m1/s1",UNADZUGJDDCVKE-RVLLIKLQSA-N
1788,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCC3=CC(O)=CC(OCCNC(=O)C4=CC5=C(C=C4CS(C)(=O)=O)C4=CN(C)C(=O)C6=C4C(=C[NH]6)CN5C4=NC=C(F)C=C4F)=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCC,C3=CC(O)=CC(OCCNC(=O)C4=CC5=C(C=C4CS(C)(=O)=O)C4=CN(C)C(=O)C6=C4C(=C[NH]6)CN5C4=NC=C(F)C=C4F)=C3)C(C)(C)C)C=C2)SC=N1,1.4,100.0,1,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,1.8/1.7,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,229.0,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01846,1150.297,1149.390002,4.52,81,9,16,6,19,267.48,C57H61F2N9O11S2,"InChI=1S/C57H61F2N9O11S2/c1-31-50(80-30-64-31)34-9-7-32(8-10-34)22-63-54(73)46-20-39(70)26-68(46)56(75)51(57(2,3)4)65-47(71)28-78-13-11-33-15-38(69)19-40(16-33)79-14-12-60-53(72)41-21-45-42(17-35(41)29-81(6,76)77)43-27-66(5)55(74)49-48(43)36(23-61-49)25-67(45)52-44(59)18-37(58)24-62-52/h7-10,15-19,21,23-24,27,30,39,46,51,61,69-70H,11-14,20,22,25-26,28-29H2,1-6H3,(H,60,72)(H,63,73)(H,65,71)/t39-,46+,51-/m1/s1",JQHNOZDZLLPAJF-RVLLIKLQSA-N
1790,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(C#CCN)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCCNC(=O)C,[C@@H]3N=C(C4=CC=C(C#CCN)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,930.0,79.0,0,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,60/22,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,610.0,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2600,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01845,1021.28,1020.435001,3.59,72,7,16,5,20,237.51,C52H64N10O8S2,"InChI=1S/C52H64N10O8S2/c1-31-33(3)72-51-44(31)45(37-14-10-35(11-15-37)9-8-18-53)57-40(48-60-59-34(4)62(48)51)26-42(64)54-19-20-68-21-22-69-23-24-70-29-43(65)58-47(52(5,6)7)50(67)61-28-39(63)25-41(61)49(66)55-27-36-12-16-38(17-13-36)46-32(2)56-30-71-46/h10-17,30,39-41,47,63H,18-29,53H2,1-7H3,(H,54,64)(H,55,66)(H,58,65)/t39-,40+,41+,47-/m1/s1",RJYPXJLNNMXFMD-XRFVFAKVSA-N
1791,O60885,BRD4,VHL,,,CNCCOC1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]1N=C(C2=CC=C(Cl)C=C2)C2=C(SC(C)=C2C)N2C(C)=NN=C12)C(C)(C)C,CNCCOC1=CC(C2=C(C)N=CS2)=CC=C1CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](,NC(=O)COCCOCCOCCNC(=O)C,[C@@H]1N=C(C2=CC=C(Cl)C=C2)C2=C(SC(C)=C2C)N2C(C)=NN=C12)C(C)(C)C,780.0,99.0,0,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,Oct-34,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,720.0,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2800,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01845,1075.756,1074.422243,4.51,74,7,17,5,24,232.75,C52H67ClN10O9S2,"InChI=1S/C52H67ClN10O9S2/c1-30-32(3)74-51-44(30)45(34-11-13-37(53)14-12-34)58-39(48-61-60-33(4)63(48)51)25-42(65)55-16-17-69-19-20-70-21-22-71-28-43(66)59-47(52(5,6)7)50(68)62-27-38(64)24-40(62)49(67)56-26-36-10-9-35(46-31(2)57-29-73-46)23-41(36)72-18-15-54-8/h9-14,23,29,38-40,47,54,64H,15-22,24-28H2,1-8H3,(H,55,65)(H,56,67)(H,59,66)/t38-,39+,40+,47-/m1/s1",AFQYUHBTQNKWIU-KVLVHDNBSA-N
1792,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C(OC3CCNCC3)=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCCNC(=O)C,[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C(OC3CCNCC3)=C2)SC=N1,350.0,100.0,0,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,Nov-35,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,520.0,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2700,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01845,1101.794,1100.437893,5.06,76,8,17,5,22,232.75,C54H69ClN10O9S2,"InChI=1S/C54H69ClN10O9S2/c1-31-33(3)76-53-46(31)47(35-10-12-38(55)13-11-35)60-41(50-63-62-34(4)65(50)53)26-44(67)57-18-19-71-20-21-72-22-23-73-29-45(68)61-49(54(5,6)7)52(70)64-28-39(66)25-42(64)51(69)58-27-37-9-8-36(48-32(2)59-30-75-48)24-43(37)74-40-14-16-56-17-15-40/h8-13,24,30,39-42,49,56,66H,14-23,25-29H2,1-7H3,(H,57,67)(H,58,69)(H,61,68)/t39-,41+,42+,49-/m1/s1",FOJOYRKGPBBUCX-BCSSRTCSSA-N
1793,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCC3=CC(N)=CC(OCCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCC,C3=CC(N)=CC(OCCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)=C3)C(C)(C)C)C=C2)SC=N1,85.0,98.0,1,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,208/69,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,135.0,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1300,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01845,1049.721,1048.385464,6.51,73,8,15,5,18,228.28,C53H61ClN10O7S2,"InChI=1S/C53H61ClN10O7S2/c1-29-31(3)73-52-45(29)46(35-12-14-37(54)15-13-35)59-41(49-62-61-32(4)64(49)52)24-43(66)56-17-19-71-40-21-34(20-38(55)22-40)16-18-70-27-44(67)60-48(53(5,6)7)51(69)63-26-39(65)23-42(63)50(68)57-25-33-8-10-36(11-9-33)47-30(2)58-28-72-47/h8-15,20-22,28,39,41-42,48,65H,16-19,23-27,55H2,1-7H3,(H,56,66)(H,57,68)(H,60,67)/t39-,41+,42+,48-/m1/s1",BVEMTZIKXNJFIM-NMNKMPBPSA-N
1794,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COC[C@@H]3CNC[C@H](COCCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COC[C@@H]3CNC[C@H](,COCCNC(=O)C,[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)C3)C(C)(C)C)C=C2)SC=N1,280.0,88.0,0,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,12/6.4,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,570.0,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3800,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01845,1041.742,1040.416764,5.33,72,8,15,5,18,214.29,C52H65ClN10O7S2,"InChI=1S/C52H65ClN10O7S2/c1-29-31(3)72-51-44(29)45(36-12-14-38(53)15-13-36)58-40(48-61-60-32(4)63(48)51)20-42(65)55-16-17-69-25-34-18-35(22-54-21-34)26-70-27-43(66)59-47(52(5,6)7)50(68)62-24-39(64)19-41(62)49(67)56-23-33-8-10-37(11-9-33)46-30(2)57-28-71-46/h8-15,28,34-35,39-41,47,54,64H,16-27H2,1-7H3,(H,55,65)(H,56,67)(H,59,66)/t34-,35+,39-,40+,41+,47-/m1/s1",XYRCFJBQFAIJBP-MFCIJMLGSA-N
1795,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCC3=CC(N)=CC(CCOCCOCC#CC4=CC=C(C5=N[C@@H](CC6=NC=CS6)C6=NN=C(C)N6C6=C5C(C)=C(C)S6)C=C4)=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCC3=CC(N)=CC(,CCOCCOCC#C,C4=CC=C(C5=N[C@@H](CC6=NC=CS6)C6=NN=C(C)N6C6=C5C(C)=C(C)S6)C=C4)=C3)C(C)(C)C)C=C2)SC=N1,87.0,100.0,1,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,55/40,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,440.0,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,480,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01845,1107.442,1106.432893,7.89,78,9,16,4,19,212.07,C59H66N10O6S3,"InChI=1S/C59H66N10O6S3/c1-35-37(3)78-58-51(35)52(64-47(31-50-61-21-26-76-50)55-67-66-38(4)69(55)58)43-15-10-39(11-16-43)9-8-22-74-24-25-75-23-20-42-27-41(28-45(60)29-42)14-19-49(71)65-54(59(5,6)7)57(73)68-33-46(70)30-48(68)56(72)62-32-40-12-17-44(18-13-40)53-36(2)63-34-77-53/h10-13,15-18,21,26-29,34,46-48,54,70H,14,19-20,22-25,30-33,60H2,1-7H3,(H,62,72)(H,65,71)/t46-,47+,48+,54-/m1/s1",MXYBZGJJYHQKSU-OSCONUCQSA-N
1796,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCC3=CC(N)=CC(CCOCCOCC#CC4=CC=C(C5=N[C@@H](CC(=O)NCCS(=O)(=O)O)C6=NN=C(C)N6C6=C5C(C)=C(C)S6)C=C4)=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCC3=CC(N)=CC(CCOCCOCC#CC4=CC=C(C5=N[C@@H](,CC(=O)NCCS(=O)(=O)O,)C6=NN=C(C)N6C6=C5C(C)=C(C)S6)C=C4)=C3)C(C)(C)C)C=C2)SC=N1,6500.0,100.0,0,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,18/13,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11000,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01845,1175.47,1174.443851,5.0,82,8,17,6,22,282.65,C59H70N10O10S3,"InChI=1S/C59H70N10O10S3/c1-35-37(3)81-58-51(35)52(64-47(55-67-66-38(4)69(55)58)31-50(72)61-21-26-82(75,76)77)43-15-10-39(11-16-43)9-8-22-78-24-25-79-23-20-42-27-41(28-45(60)29-42)14-19-49(71)65-54(59(5,6)7)57(74)68-33-46(70)30-48(68)56(73)62-32-40-12-17-44(18-13-40)53-36(2)63-34-80-53/h10-13,15-18,27-29,34,46-48,54,70H,14,19-26,30-33,60H2,1-7H3,(H,61,72)(H,62,73)(H,65,71)(H,75,76,77)/t46-,47+,48+,54-/m1/s1",JSCBAQVBPQZYHJ-OSCONUCQSA-N
1797,O60885,BRD4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCC#CC#CCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCC#CC#CCNC(=O)C,[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,7.2,99.0,1,Degradation of BRD4 in PC3-S1 cells after 4 h treatment,,,62/24,IC50 of BRD4 BD1/BD2 was tested by TR-FRET,,,,,,,,,,,,,,,470.0,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,67,Inhibit proliferation of PC3-S1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.0c01845,962.599,961.3170501,5.71,67,7,13,4,13,193.03,C49H52ClN9O6S2,"InChI=1S/C49H52ClN9O6S2/c1-28-30(3)67-48-41(28)42(33-16-18-35(50)19-17-33)54-37(45-57-56-31(4)59(45)48)23-39(61)51-20-10-8-9-11-21-65-26-40(62)55-44(49(5,6)7)47(64)58-25-36(60)22-38(58)46(63)52-24-32-12-14-34(15-13-32)43-29(2)53-27-66-43/h12-19,27,36-38,44,60H,20-26H2,1-7H3,(H,51,61)(H,52,63)(H,55,62)/t36-,37+,38+,44-/m1/s1",FXEIENSZGMCCEE-PYNGZGNASA-N
1834,P14902,IDO1,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCOCCOCCOCCOCCNCCNC4=NON=C4/C(=N\O)NC4=CC=C(F)C(Br)=C4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(,NCCOCCOCCOCCOCCOCCOCCOCCNCCN,C4=NON=C4/C(=N\O)NC4=CC=C(F)C(Br)=C4)=C3C2=O)C(=O)N1,2840.0,93.0,0,Degradation of IDO1 in HeLa cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,35380,Inhibit viability of HeLa cells,,,,,,,,,,,,,,,10.1016/j.apsb.2020.02.010,966.816,965.2930231,1.26,64,5,19,6,32,267.79,C40H53BrFN9O13,"InChI=1S/C40H53BrFN9O13/c41-29-26-27(4-5-30(29)42)46-37(48-56)35-36(50-64-49-35)45-9-8-43-10-12-57-14-16-59-18-20-61-22-24-63-25-23-62-21-19-60-17-15-58-13-11-44-31-3-1-2-28-34(31)40(55)51(39(28)54)32-6-7-33(52)47-38(32)53/h1-5,26,32,43-44,56H,6-25H2,(H,45,50)(H,46,48)(H,47,52,53)",BVQZWOPTIZSOAW-UHFFFAOYSA-N
1842,P35348,ADRA1A,CRBN,,,COC1=CC2=NC(N3CCN(C(=O)C4=CN(CCOCCOCCOCC(=O)NC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)=NC(N)=C2C=C1OC,COC1=CC2=NC(N3CCN(C(=O)C4=CN(,CCOCCOCCOCC(=O)N,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=N4)CC3)=NC(N)=C2C=C1OC,2860.0,94.0,0,Degradation of ADRA1A in HEK293 cells after 12 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6120,Inhibit proliferation of PC-3 cells,,,,,,,,,,,,,,,10.1016/j.apsb.2020.01.014,829.828,829.3143512,-0.23,60,7,18,3,17,264.86,C38H43N11O11,"InChI=1S/C38H43N11O11/c1-56-28-18-23-25(19-29(28)57-2)41-38(43-33(23)39)47-10-8-46(9-11-47)36(54)26-20-48(45-44-26)12-13-58-14-15-59-16-17-60-21-31(51)40-24-5-3-4-22-32(24)37(55)49(35(22)53)27-6-7-30(50)42-34(27)52/h3-5,18-20,27H,6-17,21H2,1-2H3,(H,40,51)(H2,39,41,43)(H,42,50,52)",SFODRSARUJDQSA-UHFFFAOYSA-N
1995,P00533,EGFR L858R/T790M,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCN3CCN(C4=CC=C(NC5=NC=C6N=C(NC7=CC=CC=C7)N(C7CCCC7)C6=N5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCN,3CCN(C4=CC=C(NC5=NC=C6N=C(NC7=CC=CC=C7)N(C7CCCC7)C6=N5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,126.2,90.3,0,Degradation of EGFR L858R/T790M in H1975 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,203,Inhibit proliferation of H1975 (EGFR L858R/T790M) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112781,995.312,994.5363697,8.54,72,9,14,5,19,185.77,C55H70N12O4S,"InChI=1S/C55H70N12O4S/c1-37-48(72-36-58-37)39-21-19-38(20-22-39)33-56-51(70)46-32-44(68)35-66(46)52(71)49(55(2,3)4)62-47(69)18-10-5-6-13-27-64-28-30-65(31-29-64)42-25-23-41(24-26-42)59-53-57-34-45-50(63-53)67(43-16-11-12-17-43)54(61-45)60-40-14-8-7-9-15-40/h7-9,14-15,19-26,34,36,43-44,46,49,68H,5-6,10-13,16-18,27-33,35H2,1-4H3,(H,56,70)(H,60,61)(H,62,69)(H,57,59,63)/t44-,46+,49-/m1/s1",MCPFQJKJCFMAIH-CRHSMECVSA-N
1995,P00533,EGFR e19d,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCN3CCN(C4=CC=C(NC5=NC=C6N=C(NC7=CC=CC=C7)N(C7CCCC7)C6=N5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCN,3CCN(C4=CC=C(NC5=NC=C6N=C(NC7=CC=CC=C7)N(C7CCCC7)C6=N5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,0.51,80.4,1,Degradation of EGFR del19 in HCC827 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.83,Inhibit proliferation of HCC827 (EGFRdel19) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112781,995.312,994.5363697,8.54,72,9,14,5,19,185.77,C55H70N12O4S,"InChI=1S/C55H70N12O4S/c1-37-48(72-36-58-37)39-21-19-38(20-22-39)33-56-51(70)46-32-44(68)35-66(46)52(71)49(55(2,3)4)62-47(69)18-10-5-6-13-27-64-28-30-65(31-29-64)42-25-23-41(24-26-42)59-53-57-34-45-50(63-53)67(43-16-11-12-17-43)54(61-45)60-40-14-8-7-9-15-40/h7-9,14-15,19-26,34,36,43-44,46,49,68H,5-6,10-13,16-18,27-33,35H2,1-4H3,(H,56,70)(H,60,61)(H,62,69)(H,57,59,63)/t44-,46+,49-/m1/s1",MCPFQJKJCFMAIH-CRHSMECVSA-N
1996,P00533,EGFR L858R/T790M,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCN3CCN(C4=CC=C(NC5=NC=C6N=C(NC7=CC=CC=C7)N(C7CCCC7)C6=N5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCN,3CCN(C4=CC=C(NC5=NC=C6N=C(NC7=CC=CC=C7)N(C7CCCC7)C6=N5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,151.2,80.3,0,Degradation of EGFR L858R/T790M in H1975 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,970,Inhibit proliferation of H1975 (EGFR L858R/T790M) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112781,1009.339,1008.55202,9.08,73,9,14,5,20,185.77,C56H72N12O4S,"InChI=1S/C56H72N12O4S/c1-38-49(73-37-59-38)40-22-20-39(21-23-40)34-57-52(71)47-33-45(69)36-67(47)53(72)50(56(2,3)4)63-48(70)19-11-6-5-7-14-28-65-29-31-66(32-30-65)43-26-24-42(25-27-43)60-54-58-35-46-51(64-54)68(44-17-12-13-18-44)55(62-46)61-41-15-9-8-10-16-41/h8-10,15-16,20-27,35,37,44-45,47,50,69H,5-7,11-14,17-19,28-34,36H2,1-4H3,(H,57,71)(H,61,62)(H,63,70)(H,58,60,64)/t45-,47+,50-/m1/s1",OAEOAAWVWTZNON-KHDRDAPVSA-N
1996,P00533,EGFR e19d,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCN3CCN(C4=CC=C(NC5=NC=C6N=C(NC7=CC=CC=C7)N(C7CCCC7)C6=N5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCN,3CCN(C4=CC=C(NC5=NC=C6N=C(NC7=CC=CC=C7)N(C7CCCC7)C6=N5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,3.54,74.8,0,Degradation of EGFR del19 in HCC827 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.76,Inhibit proliferation of HCC827 (EGFRdel19) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112781,1009.339,1008.55202,9.08,73,9,14,5,20,185.77,C56H72N12O4S,"InChI=1S/C56H72N12O4S/c1-38-49(73-37-59-38)40-22-20-39(21-23-40)34-57-52(71)47-33-45(69)36-67(47)53(72)50(56(2,3)4)63-48(70)19-11-6-5-7-14-28-65-29-31-66(32-30-65)43-26-24-42(25-27-43)60-54-58-35-46-51(64-54)68(44-17-12-13-18-44)55(62-46)61-41-15-9-8-10-16-41/h8-10,15-16,20-27,35,37,44-45,47,50,69H,5-7,11-14,17-19,28-34,36H2,1-4H3,(H,57,71)(H,61,62)(H,63,70)(H,58,60,64)/t45-,47+,50-/m1/s1",OAEOAAWVWTZNON-KHDRDAPVSA-N
1998,P00533,EGFR e19d,CRBN,,,CN(CCOCCOCCOCCN1CCN(C2=CC=C(NC3=NC=C4N=C(NC5=CC=CC=C5)N(C5CCCC5)C4=N3)C=C2)CC1)CC(=O)NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,CN(,CCOCCOCCOCCN,1CCN(C2=CC=C(NC3=NC=C4N=C(NC5=CC=CC=C5)N(C5CCCC5)C4=N3)C=C2)CC1)CC(=O)NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,1.91,82.0,1,Degradation of EGFR del19 in HCC827 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,Inhibit proliferation of HCC827 (EGFRdel19) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2020.112781,943.123,942.4864423,3.67,69,9,16,4,22,200.65,C50H62N12O7,"InChI=1S/C50H62N12O7/c1-58(34-45(64)54-41-13-7-12-39-40(41)33-61(48(39)66)43-18-19-44(63)56-47(43)65)24-26-67-28-30-69-31-29-68-27-25-59-20-22-60(23-21-59)37-16-14-36(15-17-37)52-49-51-32-42-46(57-49)62(38-10-5-6-11-38)50(55-42)53-35-8-3-2-4-9-35/h2-4,7-9,12-17,32,38,43H,5-6,10-11,18-31,33-34H2,1H3,(H,53,55)(H,54,64)(H,51,52,57)(H,56,63,65)",YTBOHZLAPNSENZ-UHFFFAOYSA-N
2003,Q92793,CBP,CRBN,,dCBP-1,CNC(=O)N1CCC2=C(C1)C(N1CCCC3=CC(C4=CN(C)N=C4)=C(C(F)F)C=C31)=NN2C1CCN(C(=O)CCOCCOCCOCCOCCNC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,CNC(=O)N1CCC2=C(C1)C(N1CCCC3=CC(C4=CN(C)N=C4)=C(C(F)F)C=C31)=NN2C1CCN(,C(=O)CCOCCOCCOCCOCCN,C2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,0.75,96.0,1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.8,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,1028.128,1027.472744,1.57,74,9,16,3,21,224.03,C51H63F2N11O10,"InChI=1S/C51H63F2N11O10/c1-54-51(70)61-17-11-41-40(31-61)47(62-14-3-4-32-26-37(33-29-56-59(2)30-33)38(46(52)53)28-43(32)62)58-64(41)35-9-15-60(16-10-35)45(66)12-18-71-20-22-73-24-25-74-23-21-72-19-13-55-34-5-6-36-39(27-34)50(69)63(49(36)68)42-7-8-44(65)57-48(42)67/h5-6,26-30,35,42,46,55H,3-4,7-25,31H2,1-2H3,(H,54,70)(H,57,65,67)",ILVRLRGBSSFKIE-UHFFFAOYSA-N
2003,Q09472,EP300,CRBN,,dCBP-1,CNC(=O)N1CCC2=C(C1)C(N1CCCC3=CC(C4=CN(C)N=C4)=C(C(F)F)C=C31)=NN2C1CCN(C(=O)CCOCCOCCOCCOCCNC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,CNC(=O)N1CCC2=C(C1)C(N1CCCC3=CC(C4=CN(C)N=C4)=C(C(F)F)C=C31)=NN2C1CCN(,C(=O)CCOCCOCCOCCOCCN,C2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CC1,1.85,90.0,1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,1028.128,1027.472744,1.57,74,9,16,3,21,224.03,C51H63F2N11O10,"InChI=1S/C51H63F2N11O10/c1-54-51(70)61-17-11-41-40(31-61)47(62-14-3-4-32-26-37(33-29-56-59(2)30-33)38(46(52)53)28-43(32)62)58-64(41)35-9-15-60(16-10-35)45(66)12-18-71-20-22-73-24-25-74-23-21-72-19-13-55-34-5-6-36-39(27-34)50(69)63(49(36)68)42-7-8-44(65)57-48(42)67/h5-6,26-30,35,42,46,55H,3-4,7-25,31H2,1-2H3,(H,54,70)(H,57,65,67)",ILVRLRGBSSFKIE-UHFFFAOYSA-N
2005,Q9NWZ3,IRAK4,CRBN,,,CC(C)NC1=CC(N2C=CC3=CC(C#N)=CN=C32)=NC=C1C(=O)N[C@H]1CC[C@H](C(=O)NCCCNC(=O)COC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,CC(C)NC1=CC(N2C=CC3=CC(C#N)=CN=C32)=NC=C1C(=O)N[C@H]1CC[C@H](,C(=O)NCCCNC(=O)CO,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,485.0,92.0,0,Degradation of IRAK4 in HEK293T cells after 24 h treatment,,,5,IC50 was assessed by Caliper biochemistry assay,,,,,,,,,,,,,,,,,,,490,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2020.08.010,816.876,816.3343584,2.64,60,7,13,5,14,246.61,C42H44N10O8,"InChI=1S/C42H44N10O8/c1-23(2)48-30-18-33(51-16-13-26-17-24(19-43)20-47-37(26)51)46-21-29(30)39(56)49-27-9-7-25(8-10-27)38(55)45-15-4-14-44-35(54)22-60-32-6-3-5-28-36(32)42(59)52(41(28)58)31-11-12-34(53)50-40(31)57/h3,5-6,13,16-18,20-21,23,25,27,31H,4,7-12,14-15,22H2,1-2H3,(H,44,54)(H,45,55)(H,46,48)(H,49,56)(H,50,53,57)/t25-,27-,31?",DHVQDOJINANBTP-NYHQYBDOSA-N
2006,Q9NWZ3,IRAK4,CRBN,,,CC(C)NC1=CC(N2C=CC3=CC(C#N)=CN=C32)=NC=C1C(=O)N[C@H]1CC[C@H](C(=O)NCCCCNC(=O)COC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,CC(C)NC1=CC(N2C=CC3=CC(C#N)=CN=C32)=NC=C1C(=O)N[C@H]1CC[C@H](,C(=O)NCCCCNC(=O)CO,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,190.0,93.0,0,Degradation of IRAK4 in HEK293T cells after 24 h treatment,,,7,IC50 was assessed by Caliper biochemistry assay,,,,,,,,,,,,,,,,,,,768,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2020.08.010,830.903,830.3500084,3.0,61,7,13,5,15,246.61,C43H46N10O8,"InChI=1S/C43H46N10O8/c1-24(2)49-31-19-34(52-17-14-27-18-25(20-44)21-48-38(27)52)47-22-30(31)40(57)50-28-10-8-26(9-11-28)39(56)46-16-4-3-15-45-36(55)23-61-33-7-5-6-29-37(33)43(60)53(42(29)59)32-12-13-35(54)51-41(32)58/h5-7,14,17-19,21-22,24,26,28,32H,3-4,8-13,15-16,23H2,1-2H3,(H,45,55)(H,46,56)(H,47,49)(H,50,57)(H,51,54,58)/t26-,28-,32?",HTWBTPRKNVRYHW-OAMJFVEXSA-N
2007,Q9NWZ3,IRAK4,CRBN,,,CC(C)NC1=CC(N2C=CC3=CC(C#N)=CN=C32)=NC=C1C(=O)N[C@H]1CC[C@H](C(=O)NCCCCCNC(=O)COC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,CC(C)NC1=CC(N2C=CC3=CC(C#N)=CN=C32)=NC=C1C(=O)N[C@H]1CC[C@H](,C(=O)NCCCCCNC(=O)CO,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,293.0,97.0,0,Degradation of IRAK4 in HEK293T cells after 24 h treatment,,,26,IC50 was assessed by Caliper biochemistry assay,,,,,,,,,,,,,,,,,,,1030,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2020.08.010,844.93,844.3656585,3.36,62,7,13,5,16,246.61,C44H48N10O8,"InChI=1S/C44H48N10O8/c1-25(2)50-32-20-35(53-18-15-28-19-26(21-45)22-49-39(28)53)48-23-31(32)41(58)51-29-11-9-27(10-12-29)40(57)47-17-5-3-4-16-46-37(56)24-62-34-8-6-7-30-38(34)44(61)54(43(30)60)33-13-14-36(55)52-42(33)59/h6-8,15,18-20,22-23,25,27,29,33H,3-5,9-14,16-17,24H2,1-2H3,(H,46,56)(H,47,57)(H,48,50)(H,51,58)(H,52,55,59)/t27-,29-,33?",NOGGUZVPDPKPMG-SNOFGSQBSA-N
2008,Q9NWZ3,IRAK4,CRBN,,,CC(C)NC1=CC(N2C=CC3=CC(C#N)=CN=C32)=NC=C1C(=O)N[C@H]1CC[C@H](C(=O)NCCOCCNC(=O)COC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,CC(C)NC1=CC(N2C=CC3=CC(C#N)=CN=C32)=NC=C1C(=O)N[C@H]1CC[C@H](,C(=O)NCCOCCNC(=O)CO,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,405.0,90.0,0,Degradation of IRAK4 in HEK293T cells after 24 h treatment,,,7,IC50 was assessed by Caliper biochemistry assay,,,,,,,,,,,,,,,,,,,609,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2020.08.010,846.902,846.3449231,2.14,62,7,14,5,16,255.84,C43H46N10O9,"InChI=1S/C43H46N10O9/c1-24(2)49-31-19-34(52-15-12-27-18-25(20-44)21-48-38(27)52)47-22-30(31)40(57)50-28-8-6-26(7-9-28)39(56)46-14-17-61-16-13-45-36(55)23-62-33-5-3-4-29-37(33)43(60)53(42(29)59)32-10-11-35(54)51-41(32)58/h3-5,12,15,18-19,21-22,24,26,28,32H,6-11,13-14,16-17,23H2,1-2H3,(H,45,55)(H,46,56)(H,47,49)(H,50,57)(H,51,54,58)/t26-,28-,32?",YNNBDJQWDDDBRU-OAMJFVEXSA-N
2009,Q9NWZ3,IRAK4,CRBN,,,CC(C)NC1=CC(N2C=CC3=CC(C#N)=CN=C32)=NC=C1C(=O)N[C@H]1CC[C@H](C(=O)NCCOCCOCCNC(=O)COC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,CC(C)NC1=CC(N2C=CC3=CC(C#N)=CN=C32)=NC=C1C(=O)N[C@H]1CC[C@H](,C(=O)NCCOCCOCCNC(=O)CO,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,7420.0,71.0,0,Degradation of IRAK4 in HEK293T cells after 24 h treatment,,,12,IC50 was assessed by Caliper biochemistry assay,,,,,,,,,,,,,,,,,,,680,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2020.08.010,890.955,890.3711378,1.99,65,7,15,5,19,265.07,C45H50N10O10,"InChI=1S/C45H50N10O10/c1-26(2)51-33-21-36(54-15-12-29-20-27(22-46)23-50-40(29)54)49-24-32(33)42(59)52-30-8-6-28(7-9-30)41(58)48-14-17-64-19-18-63-16-13-47-38(57)25-65-35-5-3-4-31-39(35)45(62)55(44(31)61)34-10-11-37(56)53-43(34)60/h3-5,12,15,20-21,23-24,26,28,30,34H,6-11,13-14,16-19,25H2,1-2H3,(H,47,57)(H,48,58)(H,49,51)(H,52,59)(H,53,56,60)/t28-,30-,34?",OLRLOHZCSMMOCS-BVRPOGDGSA-N
2038,Q00534,CDK6,VHL,,CST651,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CCOCCOCCOC5=CC(C6=C(C)N=CS6)=CC=C5CNC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@@H](NC(=O)C5(F)CC5)C(C)(C)C)CC4)C=N3)N=C2N(C2CCCC2)C1=O,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(,CCOCCOCCO,C5=CC(C6=C(C)N=CS6)=CC=C5CNC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@@H](NC(=O)C5(F)CC5)C(C)(C)C)CC4)C=N3)N=C2N(C2CCCC2)C1=O,5.1,95.0,1,Degradation of CDK6 in MM.1S cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,450,Inhibit viability of HEL cells,,,,,,,,,,,,,,,10.1039/d0sc00167h,1094.325,1093.521922,4.76,78,9,18,4,22,235.57,C56H72FN11O9S,"InChI=1S/C56H72FN11O9S/c1-34-42-31-60-54(64-49(42)68(39-9-7-8-10-39)51(72)46(34)36(3)69)62-45-14-13-40(30-58-45)66-19-17-65(18-20-66)21-22-75-23-24-76-25-26-77-44-27-37(47-35(2)61-33-78-47)11-12-38(44)29-59-50(71)43-28-41(70)32-67(43)52(73)48(55(4,5)6)63-53(74)56(57)15-16-56/h11-14,27,30-31,33,39,41,43,48,70H,7-10,15-26,28-29,32H2,1-6H3,(H,59,71)(H,63,74)(H,58,60,62,64)/t41-,43+,48-/m1/s1",WYPMPGWHIPETEB-VZUPZQALSA-N
2048,P15056,BRAF V600E,CRBN,,Pmd-PEG6-BI,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(C(=O)CCOCCOCCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(,C(=O)CCOCCOCCOCCOCCOCCOCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,90.0,84.0,1,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,83,Inhibition of BRAF V600E,,,,,,,,,,,,,,,1180.0,FP,,,,,,,,,,,,,,,3040,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1133.242,1132.44996,2.63,80,8,19,3,31,264.28,C54H66F2N10O13S,"InChI=1S/C54H66F2N10O13S/c1-3-31-80(72,73)62-42-8-7-40(55)51(49(42)56)65-34-39(36-32-57-35-58-33-36)50-43(65)9-11-45(60-50)63(2)37-13-17-64(18-14-37)47(68)15-19-74-21-23-76-25-27-78-29-30-79-28-26-77-24-22-75-20-16-59-41-6-4-5-38-48(41)54(71)66(53(38)70)44-10-12-46(67)61-52(44)69/h4-9,11,32-35,37,44,59,62H,3,10,12-31H2,1-2H3,(H,61,67,69)",PHBHADRVFSMQAN-UHFFFAOYSA-N
2049,P15056,BRAF V600E,CRBN,,Pmd-PEG8-BI,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(C(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(,C(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,45.0,65.0,0,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,85,Inhibition of BRAF V600E,,,,,,,,,,,,,,,1070.0,FP,,,,,,,,,,,,,,,2980,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1221.348,1220.502389,2.34,86,8,21,3,37,282.74,C58H74F2N10O15S,"InChI=1S/C58H74F2N10O15S/c1-3-35-86(76,77)66-46-8-7-44(59)55(53(46)60)69-38-43(40-36-61-39-62-37-40)54-47(69)9-11-49(64-54)67(2)41-13-17-68(18-14-41)51(72)15-19-78-21-23-80-25-27-82-29-31-84-33-34-85-32-30-83-28-26-81-24-22-79-20-16-63-45-6-4-5-42-52(45)58(75)70(57(42)74)48-10-12-50(71)65-56(48)73/h4-9,11,36-39,41,48,63,66H,3,10,12-35H2,1-2H3,(H,65,71,73)",UGQUDUNSDGAZIO-UHFFFAOYSA-N
2050,P15056,BRAF V600E,CRBN,,Pmd-1C-PEG3-1C-2C-BI,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(C(=O)CCC(=O)NCCCOCCOCCOCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(,C(=O)CCC(=O)NCCCOCCOCCOCCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,100.0,51.0,0,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,82,Inhibition of BRAF V600E,,,,,,,,,,,,,,,1010.0,FP,,,,,,,,,,,,,,,2460,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1100.216,1099.439729,3.04,78,8,17,4,27,265.69,C53H63F2N11O11S,"InChI=1S/C53H63F2N11O11S/c1-3-29-78(73,74)62-40-10-9-38(54)50(48(40)55)65-32-37(34-30-56-33-57-31-34)49-41(65)11-13-43(60-49)63(2)35-17-21-64(22-18-35)46(69)16-15-44(67)59-20-6-24-76-26-28-77-27-25-75-23-5-19-58-39-8-4-7-36-47(39)53(72)66(52(36)71)42-12-14-45(68)61-51(42)70/h4,7-11,13,30-33,35,42,58,62H,3,5-6,12,14-29H2,1-2H3,(H,59,67)(H,61,68,70)",GVOFKFUVWFBDKE-UHFFFAOYSA-N
2059,P15056,BRAF V600E,CRBN,,Pmd-PEG3-Dab#2,NC1=NC=CC(C2=C(C3=CC=CC(NS(=O)(=O)C4=C(F)C=CC=C4F)=C3F)N=C(C3CCN(C(=O)CCOCCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)S2)=N1,NC1=NC=CC(C2=C(C3=CC=CC(NS(=O)(=O)C4=C(F)C=CC=C4F)=C3F)N=C(C3CCN(,C(=O)CCOCCOCCOCCN,C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)S2)=N1,500.0,50.0,0,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,26,Inhibition of BRAF V600E,,,2.6,SPR,,,,,,,1.8,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1006.055,1005.276115,3.07,70,8,16,4,20,254.44,C46H46F3N9O10S2,"InChI=1S/C46H46F3N9O10S2/c47-29-6-3-7-30(48)41(29)70(64,65)56-32-9-2-5-28(38(32)49)39-40(33-12-16-52-46(50)53-33)69-43(55-39)26-13-18-57(19-14-26)36(60)15-20-66-22-24-68-25-23-67-21-17-51-31-8-1-4-27-37(31)45(63)58(44(27)62)34-10-11-35(59)54-42(34)61/h1-9,12,16,26,34,51,56H,10-11,13-15,17-25H2,(H2,50,52,53)(H,54,59,61)",TTXCLAHYGSGCRI-UHFFFAOYSA-N
2063,P15056,BRAF V600E,CRBN,,Pmd-DODA-C1-BI,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(CC(=O)NCCCOCCCCOCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(,CC(=O)NCCCOCCCCOCCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,25.0,71.0,0,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,25,Inhibition of BRAF V600E,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1042.18,1041.43425,4.61,74,8,16,4,25,239.39,C51H61F2N11O9S,"InChI=1S/C51H61F2N11O9S/c1-3-27-74(70,71)60-39-12-11-37(52)48(46(39)53)63-30-36(33-28-54-32-55-29-33)47-40(63)13-15-42(58-47)61(2)34-17-21-62(22-18-34)31-44(66)57-20-8-26-73-24-5-4-23-72-25-7-19-56-38-10-6-9-35-45(38)51(69)64(50(35)68)41-14-16-43(65)59-49(41)67/h6,9-13,15,28-30,32,34,41,56,60H,3-5,7-8,14,16-27,31H2,1-2H3,(H,57,66)(H,59,65,67)",DAQQIWJQNSGFLU-UHFFFAOYSA-N
2064,P15056,BRAF V600E,CRBN,,Pmd-PEG1-Trz-PEG2-BI,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(C(=O)CCOCCOCCN5C=C(COCCNC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)N=N5)CC4)=CC=C32)=C1F,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(,C(=O)CCOCCOCC,N5C=C(COCCNC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)N=N5)CC4)=CC=C32)=C1F,80.0,72.0,0,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,15,Inhibition of BRAF V600E,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1082.161,1081.404012,2.31,77,9,19,3,24,267.3,C51H57F2N13O10S,"InChI=1S/C51H57F2N13O10S/c1-3-25-77(72,73)60-39-8-7-37(52)48(46(39)53)65-29-36(32-26-54-31-55-27-32)47-40(65)9-11-42(57-47)62(2)34-13-17-63(18-14-34)44(68)15-20-74-23-24-75-22-19-64-28-33(59-61-64)30-76-21-16-56-38-6-4-5-35-45(38)51(71)66(50(35)70)41-10-12-43(67)58-49(41)69/h4-9,11,26-29,31,34,41,56,60H,3,10,12-25,30H2,1-2H3,(H,58,67,69)",VFSRJJPNEQKSQQ-UHFFFAOYSA-N
2065,P15056,BRAF V600E,CRBN,,Len(C)PEG4-BI,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(C(=O)CCOCCOCCOCCOCC#CC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,CCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C3=NC(N(C)C4CCN(,C(=O)CCOCCOCCOCCOCC#C,C5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)CC4)=CC=C32)=C1F,50.0,74.0,0,Degradation of BRAF V600E in A375 cells after 24 h treatment,,,90,Inhibition of BRAF V600E,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-020-0609-7,1026.133,1025.391716,2.64,73,8,15,2,22,216.72,C51H57F2N9O10S,"InChI=1S/C51H57F2N9O10S/c1-3-28-73(67,68)58-41-10-9-40(52)49(47(41)53)61-32-39(35-29-54-33-55-30-35)48-42(61)11-13-44(56-48)59(2)36-15-18-60(19-16-36)46(64)17-21-70-23-25-72-27-26-71-24-22-69-20-5-7-34-6-4-8-37-38(34)31-62(51(37)66)43-12-14-45(63)57-50(43)65/h4,6,8-11,13,29-30,32-33,36,43,58H,3,12,14-28,31H2,1-2H3,(H,57,63,65)",OURGGRRMESLKOS-UHFFFAOYSA-N
2073,P15056,BRAF G466V,VHL,,SJF-0628,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=C[NH]C3=NC=C(C4=CC=C(N5CCN(CC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4)C=C23)=C1F,,CCCS(=O)(=O)N,C1=CC=C(F)C(C(=O)C2=C[NH]C3=NC=C(C4=CC=C(N5CCN(CC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4)C=C23)=C1F,29.0,90.0,1,Degradation of BRAF G466V in H1666/CAL-12T cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-21159-7,1010.203,1009.379044,6.39,71,8,12,5,16,210.03,C51H57F2N9O7S2,"InChI=1S/C51H57F2N9O7S2/c1-6-21-71(68,69)59-40-16-15-39(52)43(44(40)53)45(65)38-26-55-48-37(38)22-34(25-54-48)32-11-13-35(14-12-32)61-19-17-60(18-20-61)28-42(64)58-47(51(3,4)5)50(67)62-27-36(63)23-41(62)49(66)56-24-31-7-9-33(10-8-31)46-30(2)57-29-70-46/h7-16,22,25-26,29,36,41,47,59,63H,6,17-21,23-24,27-28H2,1-5H3,(H,54,55)(H,56,66)(H,58,64)/t36-,41+,47-/m1/s1",MBCAVOCJJAQHHT-FGUOTCRGSA-N
2073,P15056,BRAF G469A,VHL,,SJF-0628,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=C[NH]C3=NC=C(C4=CC=C(N5CCN(CC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4)C=C23)=C1F,,CCCS(=O)(=O)N,C1=CC=C(F)C(C(=O)C2=C[NH]C3=NC=C(C4=CC=C(N5CCN(CC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4)C=C23)=C1F,15.0,95.0,1,Degradation of BRAF G469A in SK-MEL-246 cells,,,0.98,IC50 was assessed by radio labeled kinase assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,45,Inhibit growth of SK-MEL-246 cells,,,,,,,,,,,,,10.1038/s41467-021-21159-7,1010.203,1009.379044,6.39,71,8,12,5,16,210.03,C51H57F2N9O7S2,"InChI=1S/C51H57F2N9O7S2/c1-6-21-71(68,69)59-40-16-15-39(52)43(44(40)53)45(65)38-26-55-48-37(38)22-34(25-54-48)32-11-13-35(14-12-32)61-19-17-60(18-20-61)28-42(64)58-47(51(3,4)5)50(67)62-27-36(63)23-41(62)49(66)56-24-31-7-9-33(10-8-31)46-30(2)57-29-70-46/h7-16,22,25-26,29,36,41,47,59,63H,6,17-21,23-24,27-28H2,1-5H3,(H,54,55)(H,56,66)(H,58,64)/t36-,41+,47-/m1/s1",MBCAVOCJJAQHHT-FGUOTCRGSA-N
2073,P15056,BRAF V600E,VHL,,SJF-0628,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=C[NH]C3=NC=C(C4=CC=C(N5CCN(CC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4)C=C23)=C1F,,CCCS(=O)(=O)N,C1=CC=C(F)C(C(=O)C2=C[NH]C3=NC=C(C4=CC=C(N5CCN(CC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4)C=C23)=C1F,6.8,95.0,1,Degradation of BRAF V600E in SK-MEL-28 cells,,,1.87/24.4,IC50 was assessed by radio labeled kinase assay/Elisa Kinase inhibition Assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,37/218,Inhibit growth of SK-MEL-28/SK-MEL-239 C4 cells,,,,,,,,,,,,,10.1038/s41467-021-21159-7,1010.203,1009.379044,6.39,71,8,12,5,16,210.03,C51H57F2N9O7S2,"InChI=1S/C51H57F2N9O7S2/c1-6-21-71(68,69)59-40-16-15-39(52)43(44(40)53)45(65)38-26-55-48-37(38)22-34(25-54-48)32-11-13-35(14-12-32)61-19-17-60(18-20-61)28-42(64)58-47(51(3,4)5)50(67)62-27-36(63)23-41(62)49(66)56-24-31-7-9-33(10-8-31)46-30(2)57-29-70-46/h7-16,22,25-26,29,36,41,47,59,63H,6,17-21,23-24,27-28H2,1-5H3,(H,54,55)(H,56,66)(H,58,64)/t36-,41+,47-/m1/s1",MBCAVOCJJAQHHT-FGUOTCRGSA-N
2131,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCC3=CC=C(OCCN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,CC1=C(C2=CC=C(,CNC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCC3=CC=C(OCCN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,41.0,99.0,1,Degradation of SMARCA2 in A549 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00347,950.151,949.4320445,5.44,68,8,14,5,17,208.6,C50H60FN9O7S,"InChI=1S/C50H60FN9O7S/c1-31-43(68-30-54-31)33-11-12-34(28-53-46(63)40-26-35(61)29-60(40)47(64)44(49(2,3)4)55-48(65)50(51)16-17-50)42(25-33)67-23-15-32-9-13-36(14-10-32)66-24-22-58-18-20-59(21-19-58)39-27-38(56-57-45(39)52)37-7-5-6-8-41(37)62/h5-14,25,27,30,35,40,44,61-62H,15-24,26,28-29H2,1-4H3,(H2,52,57)(H,53,63)(H,55,65)/t35-,40+,44-/m1/s1",CVBRBVVZZZJXQO-HOPMZIQWSA-N
2131,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCC3=CC=C(OCCN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,CC1=C(C2=CC=C(,CNC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCC3=CC=C(OCCN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,26.0,99.0,1,Degradation of SMARCA4 in A549 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00347,950.151,949.4320445,5.44,68,8,14,5,17,208.6,C50H60FN9O7S,"InChI=1S/C50H60FN9O7S/c1-31-43(68-30-54-31)33-11-12-34(28-53-46(63)40-26-35(61)29-60(40)47(64)44(49(2,3)4)55-48(65)50(51)16-17-50)42(25-33)67-23-15-32-9-13-36(14-10-32)66-24-22-58-18-20-59(21-19-58)39-27-38(56-57-45(39)52)37-7-5-6-8-41(37)62/h5-14,25,27,30,35,40,44,61-62H,15-24,26,28-29H2,1-4H3,(H2,52,57)(H,53,63)(H,55,65)/t35-,40+,44-/m1/s1",CVBRBVVZZZJXQO-HOPMZIQWSA-N
2132,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCCOC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(,OCCCO,C3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,26.0,99.0,1,Degradation of SMARCA2 in A549 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00347,950.151,949.4320445,5.34,68,8,14,5,17,208.6,C50H60FN9O7S,"InChI=1S/C50H60FN9O7S/c1-31-43(68-30-54-31)33-12-13-34(27-53-46(63)40-25-35(61)29-60(40)47(64)44(49(2,3)4)55-48(65)50(51)16-17-50)42(24-33)67-23-7-22-66-36-14-10-32(11-15-36)28-58-18-20-59(21-19-58)39-26-38(56-57-45(39)52)37-8-5-6-9-41(37)62/h5-6,8-15,24,26,30,35,40,44,61-62H,7,16-23,25,27-29H2,1-4H3,(H2,52,57)(H,53,63)(H,55,65)/t35-,40+,44-/m1/s1",LPYXXDVKMQAWIP-HOPMZIQWSA-N
2132,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCCOC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(,OCCCO,C3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,16.0,100.0,1,Degradation of SMARCA4 in A549 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00347,950.151,949.4320445,5.34,68,8,14,5,17,208.6,C50H60FN9O7S,"InChI=1S/C50H60FN9O7S/c1-31-43(68-30-54-31)33-12-13-34(27-53-46(63)40-25-35(61)29-60(40)47(64)44(49(2,3)4)55-48(65)50(51)16-17-50)42(24-33)67-23-7-22-66-36-14-10-32(11-15-36)28-58-18-20-59(21-19-58)39-26-38(56-57-45(39)52)37-8-5-6-9-41(37)62/h5-6,8-15,24,26,30,35,40,44,61-62H,7,16-23,25,27-29H2,1-4H3,(H2,52,57)(H,53,63)(H,55,65)/t35-,40+,44-/m1/s1",LPYXXDVKMQAWIP-HOPMZIQWSA-N
2133,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCCC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,CC1=C(C2=CC=C(,CNC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCCC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,58.0,90.0,1,Degradation of SMARCA2 in A549 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00347,934.152,933.4371299,5.63,67,8,13,5,16,199.37,C50H60FN9O6S,"InChI=1S/C50H60FN9O6S/c1-31-43(67-30-54-31)34-15-16-35(27-53-46(63)40-25-36(61)29-60(40)47(64)44(49(2,3)4)55-48(65)50(51)17-18-50)42(24-34)66-23-7-8-32-11-13-33(14-12-32)28-58-19-21-59(22-20-58)39-26-38(56-57-45(39)52)37-9-5-6-10-41(37)62/h5-6,9-16,24,26,30,36,40,44,61-62H,7-8,17-23,25,27-29H2,1-4H3,(H2,52,57)(H,53,63)(H,55,65)/t36-,40+,44-/m1/s1",KKFAKGWHXAANIL-OTIWGHMISA-N
2133,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCCC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,CC1=C(C2=CC=C(,CNC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCCC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C=C3)=C2)SC=N1,25.0,92.0,1,Degradation of SMARCA4 in A549 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00347,934.152,933.4371299,5.63,67,8,13,5,16,199.37,C50H60FN9O6S,"InChI=1S/C50H60FN9O6S/c1-31-43(67-30-54-31)34-15-16-35(27-53-46(63)40-25-36(61)29-60(40)47(64)44(49(2,3)4)55-48(65)50(51)17-18-50)42(24-34)66-23-7-8-32-11-13-33(14-12-32)28-58-19-21-59(22-20-58)39-26-38(56-57-45(39)52)37-9-5-6-10-41(37)62/h5-6,9-16,24,26,30,36,40,44,61-62H,7-8,17-23,25,27-29H2,1-4H3,(H2,52,57)(H,53,63)(H,55,65)/t36-,40+,44-/m1/s1",KKFAKGWHXAANIL-OTIWGHMISA-N
2134,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C(F)=C3)=C2)SC=N1,CC1=C(C2=CC=C(,CNC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C(F)=C3)=C2)SC=N1,55.0,95.0,1,Degradation of SMARCA2 in A549 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00347,938.115,937.412058,5.37,67,8,13,5,15,199.37,C49H57F2N9O6S,"InChI=1S/C49H57F2N9O6S/c1-29-42(67-28-54-29)31-11-12-32(25-53-45(63)39-23-34(61)27-60(39)46(64)43(48(2,3)4)55-47(65)49(51)14-15-49)41(22-31)66-20-13-30-9-10-33(36(50)21-30)26-58-16-18-59(19-17-58)38-24-37(56-57-44(38)52)35-7-5-6-8-40(35)62/h5-12,21-22,24,28,34,39,43,61-62H,13-20,23,25-27H2,1-4H3,(H2,52,57)(H,53,63)(H,55,65)/t34-,39+,43-/m1/s1",TWFCHBNLUUPMHG-SQKKEFIPSA-N
2134,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C(F)=C3)=C2)SC=N1,CC1=C(C2=CC=C(,CNC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCC3=CC=C(CN4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)C(F)=C3)=C2)SC=N1,33.0,95.0,1,Degradation of SMARCA4 in A549 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.0c00347,938.115,937.412058,5.37,67,8,13,5,15,199.37,C49H57F2N9O6S,"InChI=1S/C49H57F2N9O6S/c1-29-42(67-28-54-29)31-11-12-32(25-53-45(63)39-23-34(61)27-60(39)46(64)43(48(2,3)4)55-47(65)49(51)14-15-49)41(22-31)66-20-13-30-9-10-33(36(50)21-30)26-58-16-18-59(19-17-58)38-24-37(56-57-44(38)52)35-7-5-6-8-40(35)62/h5-12,21-22,24,28,34,39,43,61-62H,13-20,23,25-27H2,1-4H3,(H2,52,57)(H,53,63)(H,55,65)/t34-,39+,43-/m1/s1",TWFCHBNLUUPMHG-SQKKEFIPSA-N
2217,Q9UM73,ALK,CRBN,,SIAIS091,CCC1=CC2=C(C=C1N1CCC(N3CCN(C(=O)CNC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)CC3)CC1)C(C)(C)C1=C(C2=O)C2=CC=C(C#N)C=C2[NH]1,CCC1=CC2=C(C=C1N1CCC(N3CCN(,C(=O)CN,C4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)CC3)CC1)C(C)(C)C1=C(C2=O)C2=CC=C(C#N)C=C2[NH]1,6.1,87.7,1,Degradation of ALK in SR cells,,,4.7,Inhibition of ALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.5,Inhibit proliferation of SR cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113335,780.93,780.3747666,4.86,58,9,9,3,7,161.95,C45H48N8O5,"InChI=1S/C45H48N8O5/c1-4-27-21-31-33(45(2,3)42-40(41(31)56)30-9-8-26(23-46)20-35(30)48-42)22-37(27)51-14-12-28(13-15-51)50-16-18-52(19-17-50)39(55)24-47-34-7-5-6-29-32(34)25-53(44(29)58)36-10-11-38(54)49-43(36)57/h5-9,20-22,28,36,47-48H,4,10-19,24-25H2,1-3H3,(H,49,54,57)",BWJIJVUAQRLZRJ-UHFFFAOYSA-N
2222,Q9UM73,ALK,CRBN,,SIAIS001,CCC1=CC2=C(C=C1N1CCC(N3CCN(CCCC#CC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)CC3)CC1)C(C)(C)C1=C(C2=O)C2=CC=C(C#N)C=C2[NH]1,CCC1=CC2=C(C=C1N1CCC(N3CCN(,CCCC#C,C4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)CC3)CC1)C(C)(C)C1=C(C2=O)C2=CC=C(C#N)C=C2[NH]1,3.9,70.3,0,Degradation of ALK in SR cells,,,3.3,Inhibition of ALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.9,Inhibit proliferation of SR cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113335,789.981,789.4002531,6.4,59,9,8,2,7,132.85,C48H51N7O4,"InChI=1S/C48H51N7O4/c1-4-31-26-36-38(48(2,3)45-43(44(36)57)35-13-12-30(28-49)25-39(35)50-45)27-41(31)54-19-16-33(17-20-54)53-23-21-52(22-24-53)18-7-5-6-9-32-10-8-11-34-37(32)29-55(47(34)59)40-14-15-42(56)51-46(40)58/h8,10-13,25-27,33,40,50H,4-5,7,14-24,29H2,1-3H3,(H,51,56,58)",OGAOHACYLUBWJQ-UHFFFAOYSA-N
2231,P00533,EGFR e19d,CRBN,,SIAIS125,C=CC(=O)NC1=CC2=C(NC3=CC=C(F)C(Cl)=C3)N=CN=C2C=C1OCCCN1CCN(C(=O)CCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,C=CC(=O)NC1=CC2=C(NC3=CC=C(F)C(Cl)=C3)N=CN=C2C=C1OCCCN1CCN(,C(=O)CCCCCN,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,100.0,40.0,0,Degradation of EGFR e19d in PC9 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.603/2.123,Inhibit proliferation of PC9/HCC827 cells expressing EGFR e19d,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113328,854.34,853.3114507,4.99,61,7,12,4,17,195.27,C43H45ClFN9O7,"InChI=1S/C43H45ClFN9O7/c1-2-36(55)50-33-23-28-32(47-25-48-40(28)49-26-11-12-30(45)29(44)22-26)24-35(33)61-21-7-16-52-17-19-53(20-18-52)38(57)10-4-3-5-15-46-31-9-6-8-27-39(31)43(60)54(42(27)59)34-13-14-37(56)51-41(34)58/h2,6,8-9,11-12,22-25,34,46H,1,3-5,7,10,13-21H2,(H,50,55)(H,47,48,49)(H,51,56,58)",UFVWZVUFBJDPFK-UHFFFAOYSA-N
2348,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCC#CC6=CC=CC7=C6CN(C6CCC(=O)NC6=O)C7=O)CC5)C=C4OC)N=C32)CC1,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(,C(=O)CCCC#C,C6=CC=CC7=C6CN(C6CCC(=O)NC6=O)C7=O)CC5)C=C4OC)N=C32)CC1,598.7,28.0,0,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,855.997,855.406795,3.31,63,8,12,3,11,188.17,C47H53N9O7,"InChI=1S/C47H53N9O7/c1-4-40(57)49-31-13-15-32(16-14-31)56-43(60)25-29(2)35-27-48-47(52-44(35)56)50-37-18-17-33(26-39(37)63-3)53-21-23-54(24-22-53)42(59)12-7-5-6-9-30-10-8-11-34-36(30)28-55(46(34)62)38-19-20-41(58)51-45(38)61/h8,10-11,17-18,25-27,31-32,38H,4-5,7,12-16,19-24,28H2,1-3H3,(H,49,57)(H,48,50,52)(H,51,58,61)/t31-,32+,38?",ILIHAEQFLUWMRH-HSWALOBVSA-N
2349,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCC#CC6=CC=CC7=C6CN(C6CCC(=O)NC6=O)C7=O)CC5)C=C4OC)N=C32)CC1,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(,C(=O)CCCCCC#C,C6=CC=CC7=C6CN(C6CCC(=O)NC6=O)C7=O)CC5)C=C4OC)N=C32)CC1,4.97,76.0,0,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,884.051,883.4380952,4.39,65,8,12,3,13,188.17,C49H57N9O7,"InChI=1S/C49H57N9O7/c1-4-42(59)51-33-15-17-34(18-16-33)58-45(62)27-31(2)37-29-50-49(54-46(37)58)52-39-20-19-35(28-41(39)65-3)55-23-25-56(26-24-55)44(61)14-9-7-5-6-8-11-32-12-10-13-36-38(32)30-57(48(36)64)40-21-22-43(60)53-47(40)63/h10,12-13,19-20,27-29,33-34,40H,4-7,9,14-18,21-26,30H2,1-3H3,(H,51,59)(H,50,52,54)(H,53,60,63)/t33-,34+,40?",QEDFXQXPBXHVGU-RMDMJGLRSA-N
2350,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCC#CC6=CC=CC7=C6CN(C6CCC(=O)NC6=O)C7=O)CC5)C=C4OC)N=C32)CC1,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(,C(=O)CCCCCCCC#C,C6=CC=CC7=C6CN(C6CCC(=O)NC6=O)C7=O)CC5)C=C4OC)N=C32)CC1,7.05,84.0,1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,912.105,911.4693953,5.47,67,8,12,3,15,188.17,C51H61N9O7,"InChI=1S/C51H61N9O7/c1-4-44(61)53-35-17-19-36(20-18-35)60-47(64)29-33(2)39-31-52-51(56-48(39)60)54-41-22-21-37(30-43(41)67-3)57-25-27-58(28-26-57)46(63)16-11-9-7-5-6-8-10-13-34-14-12-15-38-40(34)32-59(50(38)66)42-23-24-45(62)55-49(42)65/h12,14-15,21-22,29-31,35-36,42H,4-9,11,16-20,23-28,32H2,1-3H3,(H,53,61)(H,52,54,56)(H,55,62,65)/t35-,36+,42?",OEMAZTSGRNBCPF-HUPKRMINSA-N
2351,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCCCC#CC6=CC=CC7=C6CN(C6CCC(=O)NC6=O)C7=O)CC5)C=C4OC)N=C32)CC1,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(,C(=O)CCCCCCCCCC#C,C6=CC=CC7=C6CN(C6CCC(=O)NC6=O)C7=O)CC5)C=C4OC)N=C32)CC1,2.25,87.0,1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,940.159,939.5006954,6.56,69,8,12,3,17,188.17,C53H65N9O7,"InChI=1S/C53H65N9O7/c1-4-46(63)55-37-19-21-38(22-20-37)62-49(66)31-35(2)41-33-54-53(58-50(41)62)56-43-24-23-39(32-45(43)69-3)59-27-29-60(30-28-59)48(65)18-13-11-9-7-5-6-8-10-12-15-36-16-14-17-40-42(36)34-61(52(40)68)44-25-26-47(64)57-51(44)67/h14,16-17,23-24,31-33,37-38,44H,4-11,13,18-22,25-30,34H2,1-3H3,(H,55,63)(H,54,56,58)(H,57,64,67)/t37-,38+,44?",LUPSPQQYVRGZLI-FPDSPUJPSA-N
2352,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCC#CC6=CC=C7C(=O)N(C8CCC(=O)NC8=O)CC7=C6)CC5)C=C4OC)N=C32)CC1,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(,C(=O)CCCC#C,C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)CC7=C6)CC5)C=C4OC)N=C32)CC1,1.75,88.0,1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,1.6,Kd was determined by the KINOMEscan assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,110,Inhibit growth of COLO-205 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,855.997,855.406795,3.31,63,8,12,3,11,188.17,C47H53N9O7,"InChI=1S/C47H53N9O7/c1-4-40(57)49-32-11-13-33(14-12-32)56-43(60)24-29(2)36-27-48-47(52-44(36)56)50-37-17-15-34(26-39(37)63-3)53-20-22-54(23-21-53)42(59)9-7-5-6-8-30-10-16-35-31(25-30)28-55(46(35)62)38-18-19-41(58)51-45(38)61/h10,15-17,24-27,32-33,38H,4-5,7,9,11-14,18-23,28H2,1-3H3,(H,49,57)(H,48,50,52)(H,51,58,61)/t32-,33+,38?",LWHJKWAUKAHIGC-YVLRYLSESA-N
2353,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCC#CC6=CC=C7C(=O)N(C8CCC(=O)NC8=O)CC7=C6)CC5)C=C4OC)N=C32)CC1,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(,C(=O)CCCCCC#C,C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)CC7=C6)CC5)C=C4OC)N=C32)CC1,1.55,86.0,1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,884.051,883.4380952,4.39,65,8,12,3,13,188.17,C49H57N9O7,"InChI=1S/C49H57N9O7/c1-4-42(59)51-34-13-15-35(16-14-34)58-45(62)26-31(2)38-29-50-49(54-46(38)58)52-39-19-17-36(28-41(39)65-3)55-22-24-56(25-23-55)44(61)11-9-7-5-6-8-10-32-12-18-37-33(27-32)30-57(48(37)64)40-20-21-43(60)53-47(40)63/h12,17-19,26-29,34-35,40H,4-7,9,11,13-16,20-25,30H2,1-3H3,(H,51,59)(H,50,52,54)(H,53,60,63)/t34-,35+,40?",WLMZSJVDMUNOHX-UKMVIOKASA-N
2354,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCC#CC6=CC=C7C(=O)N(C8CCC(=O)NC8=O)CC7=C6)CC5)C=C4OC)N=C32)CC1,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(,C(=O)CCCCCCCC#C,C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)CC7=C6)CC5)C=C4OC)N=C32)CC1,3.04,85.0,1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,912.105,911.4693953,5.47,67,8,12,3,15,188.17,C51H61N9O7,"InChI=1S/C51H61N9O7/c1-4-44(61)53-36-15-17-37(18-16-36)60-47(64)28-33(2)40-31-52-51(56-48(40)60)54-41-21-19-38(30-43(41)67-3)57-24-26-58(27-25-57)46(63)13-11-9-7-5-6-8-10-12-34-14-20-39-35(29-34)32-59(50(39)66)42-22-23-45(62)55-49(42)65/h14,19-21,28-31,36-37,42H,4-9,11,13,15-18,22-27,32H2,1-3H3,(H,53,61)(H,52,54,56)(H,55,62,65)/t36-,37+,42?",VGMBSGNGVRXDBY-ILWCGICZSA-N
2355,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCCCC#CC6=CC=C7C(=O)N(C8CCC(=O)NC8=O)CC7=C6)CC5)C=C4OC)N=C32)CC1,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(,C(=O)CCCCCCCCCC#C,C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)CC7=C6)CC5)C=C4OC)N=C32)CC1,5.6,85.0,1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,940.159,939.5006954,6.56,69,8,12,3,17,188.17,C53H65N9O7,"InChI=1S/C53H65N9O7/c1-4-46(63)55-38-17-19-39(20-18-38)62-49(66)30-35(2)42-33-54-53(58-50(42)62)56-43-23-21-40(32-45(43)69-3)59-26-28-60(29-27-59)48(65)15-13-11-9-7-5-6-8-10-12-14-36-16-22-41-37(31-36)34-61(52(41)68)44-24-25-47(64)57-51(44)67/h16,21-23,30-33,38-39,44H,4-11,13,15,17-20,24-29,34H2,1-3H3,(H,55,63)(H,54,56,58)(H,57,64,67)/t38-,39+,44?",WNBZJWHJHXEDEO-GTFGDMOZSA-N
2356,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCC#CC6=CC=C7CN(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)C=C4OC)N=C32)CC1,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(,C(=O)CCCC#C,C6=CC=C7CN(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)C=C4OC)N=C32)CC1,3.31,77.0,0,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,855.997,855.406795,3.31,63,8,12,3,11,188.17,C47H53N9O7,"InChI=1S/C47H53N9O7/c1-4-40(57)49-32-12-14-33(15-13-32)56-43(60)24-29(2)36-27-48-47(52-44(36)56)50-37-17-16-34(26-39(37)63-3)53-20-22-54(23-21-53)42(59)9-7-5-6-8-30-10-11-31-28-55(46(62)35(31)25-30)38-18-19-41(58)51-45(38)61/h10-11,16-17,24-27,32-33,38H,4-5,7,9,12-15,18-23,28H2,1-3H3,(H,49,57)(H,48,50,52)(H,51,58,61)/t32-,33+,38?",IJOXNAXACYQBRL-YVLRYLSESA-N
2357,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCC#CC6=CC=C7CN(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)C=C4OC)N=C32)CC1,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(,C(=O)CCCCCC#C,C6=CC=C7CN(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)C=C4OC)N=C32)CC1,3.15,82.0,1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,6.5,Kd was determined by the KINOMEscan assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,250,Inhibit growth of COLO-205 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,884.051,883.4380952,4.39,65,8,12,3,13,188.17,C49H57N9O7,"InChI=1S/C49H57N9O7/c1-4-42(59)51-34-14-16-35(17-15-34)58-45(62)26-31(2)38-29-50-49(54-46(38)58)52-39-19-18-36(28-41(39)65-3)55-22-24-56(25-23-55)44(61)11-9-7-5-6-8-10-32-12-13-33-30-57(48(64)37(33)27-32)40-20-21-43(60)53-47(40)63/h12-13,18-19,26-29,34-35,40H,4-7,9,11,14-17,20-25,30H2,1-3H3,(H,51,59)(H,50,52,54)(H,53,60,63)/t34-,35+,40?",XWOZFCIASHOPCP-UKMVIOKASA-N
2358,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCC#CC6=CC=C7CN(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)C=C4OC)N=C32)CC1,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(,C(=O)CCCCCCCC#C,C6=CC=C7CN(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)C=C4OC)N=C32)CC1,7.03,84.0,1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,912.105,911.4693953,5.47,67,8,12,3,15,188.17,C51H61N9O7,"InChI=1S/C51H61N9O7/c1-4-44(61)53-36-16-18-37(19-17-36)60-47(64)28-33(2)40-31-52-51(56-48(40)60)54-41-21-20-38(30-43(41)67-3)57-24-26-58(27-25-57)46(63)13-11-9-7-5-6-8-10-12-34-14-15-35-32-59(50(66)39(35)29-34)42-22-23-45(62)55-49(42)65/h14-15,20-21,28-31,36-37,42H,4-9,11,13,16-19,22-27,32H2,1-3H3,(H,53,61)(H,52,54,56)(H,55,62,65)/t36-,37+,42?",ILQRGGWQVGLOSJ-ILWCGICZSA-N
2359,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCCCC#CC6=CC=C7CN(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)C=C4OC)N=C32)CC1,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(,C(=O)CCCCCCCCCC#C,C6=CC=C7CN(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)C=C4OC)N=C32)CC1,19.09,87.0,1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,940.159,939.5006954,6.56,69,8,12,3,17,188.17,C53H65N9O7,"InChI=1S/C53H65N9O7/c1-4-46(63)55-38-18-20-39(21-19-38)62-49(66)30-35(2)42-33-54-53(58-50(42)62)56-43-23-22-40(32-45(43)69-3)59-26-28-60(29-27-59)48(65)15-13-11-9-7-5-6-8-10-12-14-36-16-17-37-34-61(52(68)41(37)31-36)44-24-25-47(64)57-51(44)67/h16-17,22-23,30-33,38-39,44H,4-11,13,15,18-21,24-29,34H2,1-3H3,(H,55,63)(H,54,56,58)(H,57,64,67)/t38-,39+,44?",DTEBXQFNWWUSPH-GTFGDMOZSA-N
2360,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCC#CC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7)CC5)C=C4OC)N=C32)CC1,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(,C(=O)CCCC#C,C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7)CC5)C=C4OC)N=C32)CC1,30.28,64.0,0,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,855.997,855.406795,3.31,63,8,12,3,11,188.17,C47H53N9O7,"InChI=1S/C47H53N9O7/c1-4-39(57)49-32-13-15-33(16-14-32)56-42(60)25-29(2)35-27-48-47(52-44(35)56)50-36-18-17-34(26-38(36)63-3)53-21-23-54(24-22-53)41(59)12-7-5-6-9-30-10-8-11-31-28-55(46(62)43(30)31)37-19-20-40(58)51-45(37)61/h8,10-11,17-18,25-27,32-33,37H,4-5,7,12-16,19-24,28H2,1-3H3,(H,49,57)(H,48,50,52)(H,51,58,61)/t32-,33+,37?",RPGBSIRPMJGXHN-MBSVEICTSA-N
2361,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCC#CC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7)CC5)C=C4OC)N=C32)CC1,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(,C(=O)CCCCCC#C,C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7)CC5)C=C4OC)N=C32)CC1,31.35,72.0,0,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,884.051,883.4380952,4.39,65,8,12,3,13,188.17,C49H57N9O7,"InChI=1S/C49H57N9O7/c1-4-41(59)51-34-15-17-35(18-16-34)58-44(62)27-31(2)37-29-50-49(54-46(37)58)52-38-20-19-36(28-40(38)65-3)55-23-25-56(26-24-55)43(61)14-9-7-5-6-8-11-32-12-10-13-33-30-57(48(64)45(32)33)39-21-22-42(60)53-47(39)63/h10,12-13,19-20,27-29,34-35,39H,4-7,9,14-18,21-26,30H2,1-3H3,(H,51,59)(H,50,52,54)(H,53,60,63)/t34-,35+,39?",QKBCJYTUWJPJPK-DMBNOJOPSA-N
2362,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCC#CC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7)CC5)C=C4OC)N=C32)CC1,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(,C(=O)CCCCCCCC#C,C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7)CC5)C=C4OC)N=C32)CC1,46.0,73.0,0,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,912.105,911.4693953,5.47,67,8,12,3,15,188.17,C51H61N9O7,"InChI=1S/C51H61N9O7/c1-4-43(61)53-36-17-19-37(20-18-36)60-46(64)29-33(2)39-31-52-51(56-48(39)60)54-40-22-21-38(30-42(40)67-3)57-25-27-58(28-26-57)45(63)16-11-9-7-5-6-8-10-13-34-14-12-15-35-32-59(50(66)47(34)35)41-23-24-44(62)55-49(41)65/h12,14-15,21-22,29-31,36-37,41H,4-9,11,16-20,23-28,32H2,1-3H3,(H,53,61)(H,52,54,56)(H,55,62,65)/t36-,37+,41?",ZPUBDTHTIYULJM-WFMPFVDOSA-N
2363,P33981,TTK,CRBN,,,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(C(=O)CCCCCCCCCC#CC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7)CC5)C=C4OC)N=C32)CC1,CCC(=O)N[C@H]1CC[C@@H](N2C(=O)C=C(C)C3=CN=C(NC4=CC=C(N5CCN(,C(=O)CCCCCCCCCC#C,C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7)CC5)C=C4OC)N=C32)CC1,21.71,88.0,1,Degradation of TTK in COLO-205/HCT-116 cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01768,940.159,939.5006954,6.56,69,8,12,3,17,188.17,C53H65N9O7,"InChI=1S/C53H65N9O7/c1-4-45(63)55-38-19-21-39(22-20-38)62-48(66)31-35(2)41-33-54-53(58-50(41)62)56-42-24-23-40(32-44(42)69-3)59-27-29-60(30-28-59)47(65)18-13-11-9-7-5-6-8-10-12-15-36-16-14-17-37-34-61(52(68)49(36)37)43-25-26-46(64)57-51(43)67/h14,16-17,23-24,31-33,38-39,43H,4-11,13,18-22,25-30,34H2,1-3H3,(H,55,63)(H,54,56,58)(H,57,64,67)/t38-,39+,43?",RFDZITCLUUJECZ-FRBFHYLZSA-N
2411,P00533,EGFR e19d,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCN3C=C(COC4=CC5=NC=NC(NC6=CC=C(F)C(Cl)=C6)=C5C=C4NC(=O)/C=C/CN4CCCCC4)N=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCC,N3C=C(COC4=CC5=NC=NC(NC6=CC=C(F)C(Cl)=C6)=C5C=C4NC(=O)/C=C/CN4CCCCC4)N=N3)C(C)(C)C)C=C2)SC=N1,7.95,98.0,1,Degradation of EGFR del19 in HCC-827 cells after 72 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,36,Inhibit proliferation of HCC-827 (EGFRdel19) cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2022.105605,1091.756,1090.477805,7.83,77,8,15,5,23,221.72,C56H68ClFN12O6S,"InChI=1S/C56H68ClFN12O6S/c1-36-51(77-35-62-36)38-18-16-37(17-19-38)30-59-54(74)47-27-41(71)32-70(47)55(75)52(56(2,3)4)65-50(73)14-9-6-5-7-12-25-69-31-40(66-67-69)33-76-48-29-45-42(53(61-34-60-45)63-39-20-21-44(58)43(57)26-39)28-46(48)64-49(72)15-13-24-68-22-10-8-11-23-68/h13,15-21,26,28-29,31,34-35,41,47,52,71H,5-12,14,22-25,27,30,32-33H2,1-4H3,(H,59,74)(H,64,72)(H,65,73)(H,60,61,63)/b15-13+/t41-,47+,52-/m1/s1",BUDQKNIUFHYJQZ-ABSCMPNGSA-N
2414,P00533,EGFR e19d,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCN3C=C(COC4=CC5=NC=NC(NC6=CC=C(F)C(Cl)=C6)=C5C=C4NC(=O)/C=C/CN4CCCCC4)N=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCCC,N3C=C(COC4=CC5=NC=NC(NC6=CC=C(F)C(Cl)=C6)=C5C=C4NC(=O)/C=C/CN4CCCCC4)N=N3)C(C)(C)C)C=C2)SC=N1,3.57,91.0,1,Degradation of EGFR del19 in HCC-827 cells after 72 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6,Inhibit proliferation of HCC-827 (EGFRdel19) cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2022.105605,1133.837,1132.524755,9.46,80,8,15,5,26,221.72,C59H74ClFN12O6S,"InChI=1S/C59H74ClFN12O6S/c1-39-54(80-38-65-39)41-21-19-40(20-22-41)33-62-57(77)50-30-44(74)35-73(50)58(78)55(59(2,3)4)68-53(76)17-12-9-7-5-6-8-10-15-28-72-34-43(69-70-72)36-79-51-32-48-45(56(64-37-63-48)66-42-23-24-47(61)46(60)29-42)31-49(51)67-52(75)18-16-27-71-25-13-11-14-26-71/h16,18-24,29,31-32,34,37-38,44,50,55,74H,5-15,17,25-28,30,33,35-36H2,1-4H3,(H,62,77)(H,67,75)(H,68,76)(H,63,64,66)/b18-16+/t44-,50+,55-/m1/s1",RBUUUIFZYMVDPT-DLMBMICPSA-N
2424,O15379,HDAC3,VHL,,JPS014,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCOCC(=O)NC3=CC=C(C(=O)NC4=CC=CC=C4N)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCOCC(=O)N,C3=CC=C(C(=O)NC4=CC=CC=C4N)C=C3)C(C)(C)C)C=C2)SC=N1,640.0,59.0,0,Degradation of HDAC3 in HCT116 cells after 24 h treatment,,,140,IC50 of HDAC3-CoREST-LSD1 was assessed by a fluorescent HDAC assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c02179,854.087,853.4196682,5.85,61,5,10,6,20,205.08,C46H59N7O7S,"InChI=1S/C46H59N7O7S/c1-30-41(61-29-49-30)32-18-16-31(17-19-32)26-48-44(58)38-25-35(54)27-53(38)45(59)42(46(2,3)4)52-39(55)15-9-7-5-6-8-12-24-60-28-40(56)50-34-22-20-33(21-23-34)43(57)51-37-14-11-10-13-36(37)47/h10-11,13-14,16-23,29,35,38,42,54H,5-9,12,15,24-28,47H2,1-4H3,(H,48,58)(H,50,56)(H,51,57)(H,52,55)/t35-,38+,42-/m1/s1",QANLZMZKZIPVPD-DRTKLYQKSA-N
2424,Q13547,HDAC1,VHL,,JPS014,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCOCC(=O)NC3=CC=C(C(=O)NC4=CC=CC=C4N)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCOCC(=O)N,C3=CC=C(C(=O)NC4=CC=CC=C4N)C=C3)C(C)(C)C)C=C2)SC=N1,910.0,74.0,0,Degradation of HDAC1 in HCT116 cells after 24 h treatment,,,220,IC50 of HDAC1-CoREST-LSD1 was assessed by a fluorescent HDAC assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c02179,854.087,853.4196682,5.85,61,5,10,6,20,205.08,C46H59N7O7S,"InChI=1S/C46H59N7O7S/c1-30-41(61-29-49-30)32-18-16-31(17-19-32)26-48-44(58)38-25-35(54)27-53(38)45(59)42(46(2,3)4)52-39(55)15-9-7-5-6-8-12-24-60-28-40(56)50-34-22-20-33(21-23-34)43(57)51-37-14-11-10-13-36(37)47/h10-11,13-14,16-23,29,35,38,42,54H,5-9,12,15,24-28,47H2,1-4H3,(H,48,58)(H,50,56)(H,51,57)(H,52,55)/t35-,38+,42-/m1/s1",QANLZMZKZIPVPD-DRTKLYQKSA-N
2424,Q92769,HDAC2,VHL,,JPS014,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCOCC(=O)NC3=CC=C(C(=O)NC4=CC=CC=C4N)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCOCC(=O)N,C3=CC=C(C(=O)NC4=CC=CC=C4N)C=C3)C(C)(C)C)C=C2)SC=N1,4190.0,56.0,0,Degradation of HDAC2 in HCT116 cells after 24 h treatment,,,360,IC50 of HDAC2-CoREST-LSD1 was assessed by a fluorescent HDAC assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c02179,854.087,853.4196682,5.85,61,5,10,6,20,205.08,C46H59N7O7S,"InChI=1S/C46H59N7O7S/c1-30-41(61-29-49-30)32-18-16-31(17-19-32)26-48-44(58)38-25-35(54)27-53(38)45(59)42(46(2,3)4)52-39(55)15-9-7-5-6-8-12-24-60-28-40(56)50-34-22-20-33(21-23-34)43(57)51-37-14-11-10-13-36(37)47/h10-11,13-14,16-23,29,35,38,42,54H,5-9,12,15,24-28,47H2,1-4H3,(H,48,58)(H,50,56)(H,51,57)(H,52,55)/t35-,38+,42-/m1/s1",QANLZMZKZIPVPD-DRTKLYQKSA-N
2426,O15379,HDAC3,VHL,,JPS016,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCCCCCCOCC(=O)NC3=CC=C(C(=O)NC4=CC=CC=C4N)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCCCCCCCCOCC(=O)N,C3=CC=C(C(=O)NC4=CC=CC=C4N)C=C3)C(C)(C)C)C=C2)SC=N1,530.0,66.0,0,Degradation of HDAC3 in HCT116 cells after 24 h treatment,,,380,IC50 of HDAC3-CoREST-LSD1 was assessed by a fluorescent HDAC assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c02179,898.14,897.445883,6.16,64,5,11,6,23,214.31,C48H63N7O8S,"InChI=1S/C48H63N7O8S/c1-32-43(64-31-51-32)34-18-16-33(17-19-34)27-50-46(60)40-26-37(56)28-55(40)47(61)44(48(2,3)4)54-42(58)30-63-25-13-9-7-5-6-8-12-24-62-29-41(57)52-36-22-20-35(21-23-36)45(59)53-39-15-11-10-14-38(39)49/h10-11,14-23,31,37,40,44,56H,5-9,12-13,24-30,49H2,1-4H3,(H,50,60)(H,52,57)(H,53,59)(H,54,58)/t37-,40+,44-/m1/s1",BOXZMOCGSKLDAH-OUZJXKGJSA-N
2426,Q13547,HDAC1,VHL,,JPS016,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCCCCCCOCC(=O)NC3=CC=C(C(=O)NC4=CC=CC=C4N)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCCCCCCCCOCC(=O)N,C3=CC=C(C(=O)NC4=CC=CC=C4N)C=C3)C(C)(C)C)C=C2)SC=N1,550.0,77.0,0,Degradation of HDAC1 in HCT116 cells after 24 h treatment,,,570,IC50 of HDAC1-CoREST-LSD1 was assessed by a fluorescent HDAC assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c02179,898.14,897.445883,6.16,64,5,11,6,23,214.31,C48H63N7O8S,"InChI=1S/C48H63N7O8S/c1-32-43(64-31-51-32)34-18-16-33(17-19-34)27-50-46(60)40-26-37(56)28-55(40)47(61)44(48(2,3)4)54-42(58)30-63-25-13-9-7-5-6-8-12-24-62-29-41(57)52-36-22-20-35(21-23-36)45(59)53-39-15-11-10-14-38(39)49/h10-11,14-23,31,37,40,44,56H,5-9,12-13,24-30,49H2,1-4H3,(H,50,60)(H,52,57)(H,53,59)(H,54,58)/t37-,40+,44-/m1/s1",BOXZMOCGSKLDAH-OUZJXKGJSA-N
2438,O15379,HDAC3,VHL,,JPS035,CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1OCCCCCCCCCCCC(=O)NC1=CC=C(C(=O)NC2=CC=CC=C2N)C=C1)C(C)(C)C,CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1,OCCCCCCCCCCCC(=O)N,C1=CC=C(C(=O)NC2=CC=CC=C2N)C=C1)C(C)(C)C,1380.0,76.0,0,Degradation of HDAC3 in HCT116 cells after 24 h treatment,,,3810,IC50 of HDAC3-CoREST-LSD1 was assessed by a fluorescent HDAC assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c02179,896.168,895.4666184,7.56,64,5,10,6,22,205.08,C49H65N7O7S,"InChI=1S/C49H65N7O7S/c1-32-44(64-31-52-32)35-20-21-36(29-51-47(61)41-28-38(58)30-56(41)48(62)45(49(3,4)5)53-33(2)57)42(27-35)63-26-16-12-10-8-6-7-9-11-13-19-43(59)54-37-24-22-34(23-25-37)46(60)55-40-18-15-14-17-39(40)50/h14-15,17-18,20-25,27,31,38,41,45,58H,6-13,16,19,26,28-30,50H2,1-5H3,(H,51,61)(H,53,57)(H,54,59)(H,55,60)/t38-,41+,45-/m1/s1",XPJGKIYHVFVWKJ-XVYMMXEDSA-N
2438,Q13547,HDAC1,VHL,,JPS035,CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1OCCCCCCCCCCCC(=O)NC1=CC=C(C(=O)NC2=CC=CC=C2N)C=C1)C(C)(C)C,CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1,OCCCCCCCCCCCC(=O)N,C1=CC=C(C(=O)NC2=CC=CC=C2N)C=C1)C(C)(C)C,3580.0,68.0,0,Degradation of HDAC1 in HCT116 cells after 24 h treatment,,,1810,IC50 of HDAC1-CoREST-LSD1 was assessed by a fluorescent HDAC assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c02179,896.168,895.4666184,7.56,64,5,10,6,22,205.08,C49H65N7O7S,"InChI=1S/C49H65N7O7S/c1-32-44(64-31-52-32)35-20-21-36(29-51-47(61)41-28-38(58)30-56(41)48(62)45(49(3,4)5)53-33(2)57)42(27-35)63-26-16-12-10-8-6-7-9-11-13-19-43(59)54-37-24-22-34(23-25-37)46(60)55-40-18-15-14-17-39(40)50/h14-15,17-18,20-25,27,31,38,41,45,58H,6-13,16,19,26,28-30,50H2,1-5H3,(H,51,61)(H,53,57)(H,54,59)(H,55,60)/t38-,41+,45-/m1/s1",XPJGKIYHVFVWKJ-XVYMMXEDSA-N
2439,O15379,HDAC3,VHL,,JPS036,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCCCCCCCCCCC(=O)NC3=CC=C(C(=O)NC4=CC=CC=C4N)C=C3)=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(,OCCCCCCCCCCCC(=O)N,C3=CC=C(C(=O)NC4=CC=CC=C4N)C=C3)=C2)SC=N1,440.0,77.0,0,Degradation of HDAC3 in HCT116 cells after 24 h treatment,,,9670,IC50 of HDAC3-CoREST-LSD1 was assessed by a fluorescent HDAC assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c02179,940.196,939.4728467,8.28,67,6,10,6,23,205.08,C51H66FN7O7S,"InChI=1S/C51H66FN7O7S/c1-33-44(67-32-55-33)35-19-20-36(30-54-47(63)41-29-38(60)31-59(41)48(64)45(50(2,3)4)58-49(65)51(52)25-26-51)42(28-35)66-27-15-11-9-7-5-6-8-10-12-18-43(61)56-37-23-21-34(22-24-37)46(62)57-40-17-14-13-16-39(40)53/h13-14,16-17,19-24,28,32,38,41,45,60H,5-12,15,18,25-27,29-31,53H2,1-4H3,(H,54,63)(H,56,61)(H,57,62)(H,58,65)/t38-,41+,45-/m1/s1",NAADBQUVFJWCFU-XVYMMXEDSA-N
2495,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(NCCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(,NCCCN,C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,1.0,85.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,683.165,682.2306605,4.77,49,6,9,4,11,169.73,C36H35ClN6O6,"InChI=1S/C36H35ClN6O6/c37-30-19-27(10-4-22(30)20-38)49-26-11-7-24(8-12-26)41-33(45)21-2-5-23(6-3-21)39-16-1-17-40-25-9-13-28-29(18-25)36(48)43(35(28)47)31-14-15-32(44)42-34(31)46/h2-6,9-10,13,18-19,24,26,31,39-40H,1,7-8,11-12,14-17H2,(H,41,45)(H,42,44,46)/t24-,26-,31?",XLWFMSWFAKUJON-QYYYJOFJSA-N
2496,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(NCCCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(,NCCCCN,C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,1.1,89.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,697.192,696.2463106,5.13,50,6,9,4,12,169.73,C37H37ClN6O6,"InChI=1S/C37H37ClN6O6/c38-31-20-28(11-5-23(31)21-39)50-27-12-8-25(9-13-27)42-34(46)22-3-6-24(7-4-22)40-17-1-2-18-41-26-10-14-29-30(19-26)37(49)44(36(29)48)32-15-16-33(45)43-35(32)47/h3-7,10-11,14,19-20,25,27,32,40-41H,1-2,8-9,12-13,15-18H2,(H,42,46)(H,43,45,47)/t25-,27-,32?",SEKBVYVWYRALIG-COJZMJFXSA-N
2497,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(NCCCCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(,NCCCCCN,C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,0.2,95.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,711.219,710.2619606,5.49,51,6,9,4,13,169.73,C38H39ClN6O6,"InChI=1S/C38H39ClN6O6/c39-32-21-29(12-6-24(32)22-40)51-28-13-9-26(10-14-28)43-35(47)23-4-7-25(8-5-23)41-18-2-1-3-19-42-27-11-15-30-31(20-27)38(50)45(37(30)49)33-16-17-34(46)44-36(33)48/h4-8,11-12,15,20-21,26,28,33,41-42H,1-3,9-10,13-14,16-19H2,(H,43,47)(H,44,46,48)/t26-,28-,33?",FZVBQSWNRMPEHR-NBAFNCFLSA-N
2498,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(NCCCCCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(,NCCCCCCN,C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,0.6,99.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,725.246,724.2776107,5.84,52,6,9,4,14,169.73,C39H41ClN6O6,"InChI=1S/C39H41ClN6O6/c40-33-22-30(13-7-25(33)23-41)52-29-14-10-27(11-15-29)44-36(48)24-5-8-26(9-6-24)42-19-3-1-2-4-20-43-28-12-16-31-32(21-28)39(51)46(38(31)50)34-17-18-35(47)45-37(34)49/h5-9,12-13,16,21-22,27,29,34,42-43H,1-4,10-11,14-15,17-20H2,(H,44,48)(H,45,47,49)/t27-,29-,34?",SLYLTYLJUFVQPH-BKPPXGSPSA-N
2499,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(NCCCCCCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(,NCCCCCCCN,C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,0.7,99.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,739.273,738.2932608,6.38,53,6,9,4,15,169.73,C40H43ClN6O6,"InChI=1S/C40H43ClN6O6/c41-34-23-31(14-8-26(34)24-42)53-30-15-11-28(12-16-30)45-37(49)25-6-9-27(10-7-25)43-20-4-2-1-3-5-21-44-29-13-17-32-33(22-29)40(52)47(39(32)51)35-18-19-36(48)46-38(35)50/h6-10,13-14,17,22-23,28,30,35,43-44H,1-5,11-12,15-16,18-21H2,(H,45,49)(H,46,48,50)/t28-,30-,35?",KLUHWCISGKYNHH-KGNGEQPNSA-N
2500,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(NCCCCCCCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(,NCCCCCCCCN,C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,1.5,97.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,753.3,752.3089108,6.93,54,6,9,4,16,169.73,C41H45ClN6O6,"InChI=1S/C41H45ClN6O6/c42-35-24-32(15-9-27(35)25-43)54-31-16-12-29(13-17-31)46-38(50)26-7-10-28(11-8-26)44-21-5-3-1-2-4-6-22-45-30-14-18-33-34(23-30)41(53)48(40(33)52)36-19-20-37(49)47-39(36)51/h7-11,14-15,18,23-24,29,31,36,44-45H,1-6,12-13,16-17,19-22H2,(H,46,50)(H,47,49,51)/t29-,31-,36?",LIAPRZHHMHGLCS-NSGDDVBOSA-N
2501,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(NCCCCCCCCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(,NCCCCCCCCCN,C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,3.2,96.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,767.327,766.3245609,7.47,55,6,9,4,17,169.73,C42H47ClN6O6,"InChI=1S/C42H47ClN6O6/c43-36-25-33(16-10-28(36)26-44)55-32-17-13-30(14-18-32)47-39(51)27-8-11-29(12-9-27)45-22-6-4-2-1-3-5-7-23-46-31-15-19-34-35(24-31)42(54)49(41(34)53)37-20-21-38(50)48-40(37)52/h8-12,15-16,19,24-25,30,32,37,45-46H,1-7,13-14,17-18,20-23H2,(H,47,51)(H,48,50,52)/t30-,32-,37?",VSYZSMLAOKWORE-GUJMKDNBSA-N
2502,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(NCCCCCCCCCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(,NCCCCCCCCCCN,C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,1000.0,25.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,781.354,780.340211,8.01,56,6,9,4,18,169.73,C43H49ClN6O6,"InChI=1S/C43H49ClN6O6/c44-37-26-34(17-11-29(37)27-45)56-33-18-14-31(15-19-33)48-40(52)28-9-12-30(13-10-28)46-23-7-5-3-1-2-4-6-8-24-47-32-16-20-35-36(25-32)43(55)50(42(35)54)38-21-22-39(51)49-41(38)53/h9-13,16-17,20,25-26,31,33,38,46-47H,1-8,14-15,18-19,21-24H2,(H,48,52)(H,49,51,53)/t31-,33-,38?",RJFFRTWDHINENB-GCVZDEPESA-N
2503,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(NCCCCCCCCCCCNC4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(,NCCCCCCCCCCCN,C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C=C3)CC2)C=C1Cl,1000.0,42.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,795.381,794.355861,8.55,57,6,9,4,19,169.73,C44H51ClN6O6,"InChI=1S/C44H51ClN6O6/c45-38-27-35(18-12-30(38)28-46)57-34-19-15-32(16-20-34)49-41(53)29-10-13-31(14-11-29)47-24-8-6-4-2-1-3-5-7-9-25-48-33-17-21-36-37(26-33)44(56)51(43(36)55)39-22-23-40(52)50-42(39)54/h10-14,17-18,21,26-27,32,34,39,47-48H,1-9,15-16,19-20,22-25H2,(H,49,53)(H,50,52,54)/t32-,34-,39?",KPYLNSRIYNAOJF-RIZDTZEESA-N
2504,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCN(CCNC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C=C3)CC2)C=C1Cl,N#CC1=CC=C(O[C@H]2CC[C@H](,NC(=O),C3=CC=C(N4CCN(CCNC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C=C3)CC2)C=C1Cl,0.8,77.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,738.245,737.2728597,4.36,53,7,10,3,10,164.18,C39H40ClN7O6,"InChI=1S/C39H40ClN7O6/c40-33-22-30(9-3-25(33)23-41)53-29-10-4-26(5-11-29)43-36(49)24-1-7-28(8-2-24)46-19-17-45(18-20-46)16-15-42-27-6-12-31-32(21-27)39(52)47(38(31)51)34-13-14-35(48)44-37(34)50/h1-3,6-9,12,21-22,26,29,34,42H,4-5,10-11,13-20H2,(H,43,49)(H,44,48,50)/t26-,29-,34?",KUCKATJPXILIRH-BPHARUEYSA-N
2505,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCN(CCCNC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C=C3)CC2)C=C1Cl,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCN(,CCCN,C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C=C3)CC2)C=C1Cl,2.7,82.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,752.272,751.2885097,4.72,54,7,10,3,11,164.18,C40H42ClN7O6,"InChI=1S/C40H42ClN7O6/c41-34-23-31(10-4-26(34)24-42)54-30-11-5-27(6-12-30)44-37(50)25-2-8-29(9-3-25)47-20-18-46(19-21-47)17-1-16-43-28-7-13-32-33(22-28)40(53)48(39(32)52)35-14-15-36(49)45-38(35)51/h2-4,7-10,13,22-23,27,30,35,43H,1,5-6,11-12,14-21H2,(H,44,50)(H,45,49,51)/t27-,30-,35?",IOIPLMHHWKGICH-LFUVDIOQSA-N
2506,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCN(CCCCNC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C=C3)CC2)C=C1Cl,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCN(,CCCCN,C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C=C3)CC2)C=C1Cl,16.2,67.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,766.299,765.3041598,5.08,55,7,10,3,12,164.18,C41H44ClN7O6,"InChI=1S/C41H44ClN7O6/c42-35-24-32(11-5-27(35)25-43)55-31-12-6-28(7-13-31)45-38(51)26-3-9-30(10-4-26)48-21-19-47(20-22-48)18-2-1-17-44-29-8-14-33-34(23-29)41(54)49(40(33)53)36-15-16-37(50)46-39(36)52/h3-5,8-11,14,23-24,28,31,36,44H,1-2,6-7,12-13,15-22H2,(H,45,51)(H,46,50,52)/t28-,31-,36?",QFBDIBRAVHTJHW-HDGSNFBOSA-N
2507,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCN(CCCCCNC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C=C3)CC2)C=C1Cl,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCN(,CCCCCN,C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C=C3)CC2)C=C1Cl,0.9,85.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,780.326,779.3198099,5.44,56,7,10,3,13,164.18,C42H46ClN7O6,"InChI=1S/C42H46ClN7O6/c43-36-25-33(12-6-28(36)26-44)56-32-13-7-29(8-14-32)46-39(52)27-4-10-31(11-5-27)49-22-20-48(21-23-49)19-3-1-2-18-45-30-9-15-34-35(24-30)42(55)50(41(34)54)37-16-17-38(51)47-40(37)53/h4-6,9-12,15,24-25,29,32,37,45H,1-3,7-8,13-14,16-23H2,(H,46,52)(H,47,51,53)/t29-,32-,37?",RIBBYHBSLKRREX-MLUZTVPMSA-N
2508,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCN(CC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,N#CC1=CC=C(O[C@H]2CC[C@H](,NC(=O),C3=CC=C(N4CCN(CC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,0.2,97.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,792.337,791.3198099,5.25,57,8,10,2,9,155.39,C43H46ClN7O6,"InChI=1S/C43H46ClN7O6/c44-37-24-34(9-3-29(37)25-45)57-33-10-4-30(5-11-33)46-40(53)28-1-6-31(7-2-28)50-21-19-48(20-22-50)26-27-15-17-49(18-16-27)32-8-12-35-36(23-32)43(56)51(42(35)55)38-13-14-39(52)47-41(38)54/h1-3,6-9,12,23-24,27,30,33,38H,4-5,10-11,13-22,26H2,(H,46,53)(H,47,52,54)/t30-,33-,38?",QJZUVOHJKPMREF-SIOTYANSSA-N
2508,P10275,AR,CRBN,,TJA-107,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCN(CC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,N#CC1=CC=C(O[C@H]2CC[C@H](,NC(=O),C3=CC=C(N4CCN(CC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,155.3,90.0,0,Degradation of AR in human dermal papilla cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/smtd.202201293,792.337,791.3198099,5.25,57,8,10,2,9,155.39,C43H46ClN7O6,"InChI=1S/C43H46ClN7O6/c44-37-24-34(9-3-29(37)25-45)57-33-10-4-30(5-11-33)46-40(53)28-1-6-31(7-2-28)50-21-19-48(20-22-50)26-27-15-17-49(18-16-27)32-8-12-35-36(23-32)43(56)51(42(35)55)38-13-14-39(52)47-41(38)54/h1-3,6-9,12,23-24,27,30,33,38H,4-5,10-11,13-22,26H2,(H,46,53)(H,47,52,54)/t30-,33-,38?",QJZUVOHJKPMREF-SIOTYANSSA-N
2509,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCN(C5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,N#CC1=CC=C(O[C@H]2CC[C@H](,NC(=O),C3=CC=C(N4CCN(C5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,0.3,88.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.9,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,778.31,777.3041598,5.06,56,8,10,2,8,155.39,C42H44ClN7O6,"InChI=1S/C42H44ClN7O6/c43-36-24-33(9-3-27(36)25-44)56-32-10-4-28(5-11-32)45-39(52)26-1-6-29(7-2-26)48-19-21-49(22-20-48)30-15-17-47(18-16-30)31-8-12-34-35(23-31)42(55)50(41(34)54)37-13-14-38(51)46-40(37)53/h1-3,6-9,12,23-24,28,30,32,37H,4-5,10-11,13-22H2,(H,45,52)(H,46,51,53)/t28-,32-,37?",SRMKEEIRTHASLG-MVHOYPFPSA-N
2510,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,N#CC1=CC=C(O[C@H]2CC[C@H](,NC(=O),C3=CC=C(N4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,0.2,95.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9.7,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,778.31,777.3041598,5.06,56,8,10,2,8,155.39,C42H44ClN7O6,"InChI=1S/C42H44ClN7O6/c43-36-24-33(9-3-27(36)25-44)56-32-10-4-28(5-11-32)45-39(52)26-1-6-29(7-2-26)47-17-15-30(16-18-47)48-19-21-49(22-20-48)31-8-12-34-35(23-31)42(55)50(41(34)54)37-13-14-38(51)46-40(37)53/h1-3,6-9,12,23-24,28,30,32,37H,4-5,10-11,13-22H2,(H,45,52)(H,46,51,53)/t28-,32-,37?",ZEEFAZNIKLZENT-MVHOYPFPSA-N
2511,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCN(CC5CN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)C5)CC4)C=C3)CC2)C=C1Cl,N#CC1=CC=C(O[C@H]2CC[C@H](,NC(=O),C3=CC=C(N4CCN(CC5CN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)C5)CC4)C=C3)CC2)C=C1Cl,0.3,92.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.7,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,764.283,763.2885097,4.53,55,8,10,2,9,155.39,C41H42ClN7O6,"InChI=1S/C41H42ClN7O6/c42-35-20-32(9-3-27(35)21-43)55-31-10-4-28(5-11-31)44-38(51)26-1-6-29(7-2-26)47-17-15-46(16-18-47)22-25-23-48(24-25)30-8-12-33-34(19-30)41(54)49(40(33)53)36-13-14-37(50)45-39(36)52/h1-3,6-9,12,19-20,25,28,31,36H,4-5,10-11,13-18,22-24H2,(H,44,51)(H,45,50,52)/t28-,31-,36?",ZXOIALMBAAMQKG-HDGSNFBOSA-N
2512,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCN(C5CN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)C5)CC4)C=C3)CC2)C=C1Cl,N#CC1=CC=C(O[C@H]2CC[C@H](,NC(=O),C3=CC=C(N4CCN(C5CN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)C5)CC4)C=C3)CC2)C=C1Cl,0.1,76.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,750.256,749.2728597,4.34,54,8,10,2,8,155.39,C40H40ClN7O6,"InChI=1S/C40H40ClN7O6/c41-34-20-31(9-3-25(34)21-42)54-30-10-4-26(5-11-30)43-37(50)24-1-6-27(7-2-24)45-15-17-46(18-16-45)29-22-47(23-29)28-8-12-32-33(19-28)40(53)48(39(32)52)35-13-14-36(49)44-38(35)51/h1-3,6-9,12,19-20,26,29-30,35H,4-5,10-11,13-18,22-23H2,(H,43,50)(H,44,49,51)/t26-,30-,35?",IFCKDGNCNVHZTM-KEQPVMAKSA-N
2513,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)C2)C=C1Cl,N#CC1=CC=C(O[C@H]2CC[C@H](,NC(=O),C3=CC=C(N4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)C2)C=C1Cl,1000.0,20.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>1000,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,764.283,763.2885097,4.7,55,8,10,2,8,155.39,C41H42ClN7O6,"InChI=1S/C41H42ClN7O6/c42-35-23-32(8-3-26(35)24-43)55-31-9-4-27(21-31)44-38(51)25-1-5-28(6-2-25)46-15-13-29(14-16-46)47-17-19-48(20-18-47)30-7-10-33-34(22-30)41(54)49(40(33)53)36-11-12-37(50)45-39(36)52/h1-3,5-8,10,22-23,27,29,31,36H,4,9,11-21H2,(H,44,51)(H,45,50,52)/t27-,31-,36?/m0/s1",GXUBCAYGWJGCKT-SVYXOXRISA-N
2514,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@@H]2CCC[C@@H](NC(=O)C3=CC=C(N4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,N#CC1=CC=C(O[C@@H]2CCC[C@@H](,NC(=O),C3=CC=C(N4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,1000.0,45.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,792.337,791.3198099,5.42,57,8,10,2,8,155.39,C43H46ClN7O6,"InChI=1S/C43H46ClN7O6/c44-37-25-34(11-6-28(37)26-45)57-33-3-1-2-29(7-12-33)46-40(53)27-4-8-30(9-5-27)48-18-16-31(17-19-48)49-20-22-50(23-21-49)32-10-13-35-36(24-32)43(56)51(42(35)55)38-14-15-39(52)47-41(38)54/h4-6,8-11,13,24-25,29,31,33,38H,1-3,7,12,14-23H2,(H,46,53)(H,47,52,54)/t29-,33-,38?/m1/s1",VGXZUMFEKIFIQW-UCRZJGTBSA-N
2515,P10275,AR,CRBN,,,N#CC1=CC=C(O[C@H]2CCC[C@@H](NC(=O)C3=CC=C(N4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CCC2)C=C1Cl,N#CC1=CC=C(O[C@H]2CCC[C@@H](,NC(=O),C3=CC=C(N4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CCC2)C=C1Cl,1000.0,54.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,806.364,805.3354599,5.77,58,8,10,2,8,155.39,C44H48ClN7O6,"InChI=1S/C44H48ClN7O6/c45-38-26-35(13-9-29(38)27-46)58-34-5-1-3-30(4-2-6-34)47-41(54)28-7-10-31(11-8-28)49-19-17-32(18-20-49)50-21-23-51(24-22-50)33-12-14-36-37(25-33)44(57)52(43(36)56)39-15-16-40(53)48-42(39)55/h7-14,25-26,30,32,34,39H,1-6,15-24H2,(H,47,54)(H,48,53,55)/t30-,34+,39?",LOWACICYXXELEY-GDMVNCDBSA-N
2516,P10275,AR,CRBN,,,N#CC1=CC=C(OC2CCN(C(=O)C3=CC=C(N4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,,N#C,C1=CC=C(OC2CCN(C(=O)C3=CC=C(N4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,1000.0,19.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>1000,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,764.283,763.2885097,4.46,55,8,10,1,7,146.6,C41H42ClN7O6,"InChI=1S/C41H42ClN7O6/c42-35-24-32(7-3-27(35)25-43)55-31-13-17-48(18-14-31)39(52)26-1-4-28(5-2-26)45-15-11-29(12-16-45)46-19-21-47(22-20-46)30-6-8-33-34(23-30)41(54)49(40(33)53)36-9-10-37(50)44-38(36)51/h1-8,23-24,29,31,36H,9-22H2,(H,44,50,51)",RACWFSYZHXHUJV-UHFFFAOYSA-N
2517,P10275,AR,CRBN,,,N#CC1=CC=C(OC2CCCN(C(=O)C3=CC=C(N4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,,N#C,C1=CC=C(OC2CCCN(C(=O)C3=CC=C(N4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,1000.0,35.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>1000,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,778.31,777.3041598,4.82,56,8,10,1,7,146.6,C42H44ClN7O6,"InChI=1S/C42H44ClN7O6/c43-36-25-33(9-5-28(36)26-44)56-32-2-1-16-49(19-15-32)40(53)27-3-6-29(7-4-27)46-17-13-30(14-18-46)47-20-22-48(23-21-47)31-8-10-34-35(24-31)42(55)50(41(34)54)37-11-12-38(51)45-39(37)52/h3-10,24-25,30,32,37H,1-2,11-23H2,(H,45,51,52)",SWYBGHSSRFVKQG-UHFFFAOYSA-N
2518,P10275,AR,CRBN,,,N#CC1=CC=C(N[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,N#CC1=CC=C(N[C@H]2CC[C@H](,NC(=O),C3=CC=C(N4CCC(N5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)CC2)C=C1Cl,0.3,78.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16.6,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,777.326,776.3201442,5.07,56,8,10,3,8,158.19,C42H45ClN8O5,"InChI=1S/C42H45ClN8O5/c43-36-23-30(4-1-27(36)25-44)45-28-5-7-29(8-6-28)46-39(53)26-2-9-31(10-3-26)48-17-15-32(16-18-48)49-19-21-50(22-20-49)33-11-12-34-35(24-33)42(56)51(41(34)55)37-13-14-38(52)47-40(37)54/h1-4,9-12,23-24,28-29,32,37,45H,5-8,13-22H2,(H,46,53)(H,47,52,54)/t28-,29-,37?",IRDHCECVXOCRLY-QZHRDHLUSA-N
2519,P10275,AR,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCC(N4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](,NC(=O),C2=CC=C(N3CCC(N4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,0.09,99.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,791.353,790.3357943,5.21,57,8,10,2,8,149.4,C43H47ClN8O5,"InChI=1S/C43H47ClN8O5/c1-48(33-9-4-28(26-45)37(44)25-33)30-10-5-29(6-11-30)46-40(54)27-2-7-31(8-3-27)49-18-16-32(17-19-49)50-20-22-51(23-21-50)34-12-13-35-36(24-34)43(57)52(42(35)56)38-14-15-39(53)47-41(38)55/h2-4,7-9,12-13,24-25,29-30,32,38H,5-6,10-11,14-23H2,1H3,(H,46,54)(H,47,53,55)/t29-,30-,38?",BEEAHZAQHFFDHP-KIIACXQNSA-N
2519,P10275,AR T878A,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCC(N4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](,NC(=O),C2=CC=C(N3CCC(N4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,0.3,95.0,1,Degradation of AR T878A in LNCaP (AR T878A) cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15.3,Inhibit growth of LNCaP (AR T878A) cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,791.353,790.3357943,5.21,57,8,10,2,8,149.4,C43H47ClN8O5,"InChI=1S/C43H47ClN8O5/c1-48(33-9-4-28(26-45)37(44)25-33)30-10-5-29(6-11-30)46-40(54)27-2-7-31(8-3-27)49-18-16-32(17-19-49)50-20-22-51(23-21-50)34-12-13-35-36(24-34)43(57)52(42(35)56)38-14-15-39(53)47-41(38)55/h2-4,7-9,12-13,24-25,29-30,32,38H,5-6,10-11,14-23H2,1H3,(H,46,54)(H,47,53,55)/t29-,30-,38?",BEEAHZAQHFFDHP-KIIACXQNSA-N
2520,P10275,AR,CRBN,,,CCN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCC(N4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,,CCN,(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCC(N4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,0.1,99.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,805.38,804.3514443,5.58,58,8,10,2,9,149.4,C44H49ClN8O5,"InChI=1S/C44H49ClN8O5/c1-2-52(35-10-5-29(27-46)38(45)26-35)33-11-6-30(7-12-33)47-41(55)28-3-8-31(9-4-28)49-19-17-32(18-20-49)50-21-23-51(24-22-50)34-13-14-36-37(25-34)44(58)53(43(36)57)39-15-16-40(54)48-42(39)56/h3-5,8-10,13-14,25-26,30,32-33,39H,2,6-7,11-12,15-24H2,1H3,(H,47,55)(H,48,54,56)/t30-,33-,39?",VZVAWYNZTBXESG-BULKPCKOSA-N
2521,P10275,AR,CRBN,,,CCCN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCC(N4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,,CCCN,(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCC(N4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,1.4,88.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,83.5,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,819.407,818.3670944,6.1,59,8,10,2,10,149.4,C45H51ClN8O5,"InChI=1S/C45H51ClN8O5/c1-2-19-53(36-10-5-30(28-47)39(46)27-36)34-11-6-31(7-12-34)48-42(56)29-3-8-32(9-4-29)50-20-17-33(18-21-50)51-22-24-52(25-23-51)35-13-14-37-38(26-35)45(59)54(44(37)58)40-15-16-41(55)49-43(40)57/h3-5,8-10,13-14,26-27,31,33-34,40H,2,6-7,11-12,15-25H2,1H3,(H,48,56)(H,49,55,57)/t31-,34-,40?",FVEFTVCRDXCSLR-MLTFQQHKSA-N
2522,P10275,AR,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCN(CC4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](,NC(=O),C2=CC=C(N3CCN(CC4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,1.4,93.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,805.38,804.3514443,5.4,58,8,10,2,9,149.4,C44H49ClN8O5,"InChI=1S/C44H49ClN8O5/c1-49(34-9-4-30(26-46)38(45)25-34)32-10-5-31(6-11-32)47-41(55)29-2-7-33(8-3-29)52-22-20-50(21-23-52)27-28-16-18-51(19-17-28)35-12-13-36-37(24-35)44(58)53(43(36)57)39-14-15-40(54)48-42(39)56/h2-4,7-9,12-13,24-25,28,31-32,39H,5-6,10-11,14-23,27H2,1H3,(H,47,55)(H,48,54,56)/t31-,32-,39?",FSMCKEYFGVIYBM-WIDQNFKDSA-N
2523,P10275,AR,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCC(CN4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](,NC(=O),C2=CC=C(N3CCC(CN4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,0.5,96.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,805.38,804.3514443,5.4,58,8,10,2,9,149.4,C44H49ClN8O5,"InChI=1S/C44H49ClN8O5/c1-49(34-9-4-30(26-46)38(45)25-34)32-10-5-31(6-11-32)47-41(55)29-2-7-33(8-3-29)51-18-16-28(17-19-51)27-50-20-22-52(23-21-50)35-12-13-36-37(24-35)44(58)53(43(36)57)39-14-15-40(54)48-42(39)56/h2-4,7-9,12-13,24-25,28,31-32,39H,5-6,10-11,14-23,27H2,1H3,(H,47,55)(H,48,54,56)/t31-,32-,39?",XLQOXOVXCNIRJP-WIDQNFKDSA-N
2524,P10275,AR,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCN(C4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](,NC(=O),C2=CC=C(N3CCN(C4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,0.1,96.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.8,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,791.353,790.3357943,5.21,57,8,10,2,8,149.4,C43H47ClN8O5,"InChI=1S/C43H47ClN8O5/c1-48(33-9-4-28(26-45)37(44)25-33)30-10-5-29(6-11-30)46-40(54)27-2-7-31(8-3-27)50-20-22-51(23-21-50)32-16-18-49(19-17-32)34-12-13-35-36(24-34)43(57)52(42(35)56)38-14-15-39(53)47-41(38)55/h2-4,7-9,12-13,24-25,29-30,32,38H,5-6,10-11,14-23H2,1H3,(H,46,54)(H,47,53,55)/t29-,30-,38?",WHJVBMNCPUFBSX-KIIACXQNSA-N
2524,P10275,AR T878A,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCN(C4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](,NC(=O),C2=CC=C(N3CCN(C4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)CC3)C=C2)CC1,0.4,95.0,1,Degradation of AR T878A in LNCaP (AR T878A) cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,22.3,Inhibit growth of LNCaP (AR T878A) cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,791.353,790.3357943,5.21,57,8,10,2,8,149.4,C43H47ClN8O5,"InChI=1S/C43H47ClN8O5/c1-48(33-9-4-28(26-45)37(44)25-33)30-10-5-29(6-11-30)46-40(54)27-2-7-31(8-3-27)50-20-22-51(23-21-50)32-16-18-49(19-17-32)34-12-13-35-36(24-34)43(57)52(42(35)56)38-14-15-39(53)47-41(38)55/h2-4,7-9,12-13,24-25,29-30,32,38H,5-6,10-11,14-23H2,1H3,(H,46,54)(H,47,53,55)/t29-,30-,38?",WHJVBMNCPUFBSX-KIIACXQNSA-N
2525,P10275,AR,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCN(CC4CN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)C4)CC3)C=C2)CC1,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](,NC(=O),C2=CC=C(N3CCN(CC4CN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)C4)CC3)C=C2)CC1,0.01,99.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,777.326,776.3201442,4.69,56,8,10,2,9,149.4,C42H45ClN8O5,"InChI=1S/C42H45ClN8O5/c1-47(32-9-4-28(22-44)36(43)21-32)30-10-5-29(6-11-30)45-39(53)27-2-7-31(8-3-27)49-18-16-48(17-19-49)23-26-24-50(25-26)33-12-13-34-35(20-33)42(56)51(41(34)55)37-14-15-38(52)46-40(37)54/h2-4,7-9,12-13,20-21,26,29-30,37H,5-6,10-11,14-19,23-25H2,1H3,(H,45,53)(H,46,52,54)/t29-,30-,37?",YYULHFDWXXZSRM-VZASAIHWSA-N
2525,P10275,AR T878A,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCN(CC4CN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)C4)CC3)C=C2)CC1,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](,NC(=O),C2=CC=C(N3CCN(CC4CN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)C4)CC3)C=C2)CC1,0.9,99.0,1,Degradation of AR T878A in LNCaP (AR T878A) cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11.4,Inhibit growth of LNCaP (AR T878A) cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,777.326,776.3201442,4.69,56,8,10,2,9,149.4,C42H45ClN8O5,"InChI=1S/C42H45ClN8O5/c1-47(32-9-4-28(22-44)36(43)21-32)30-10-5-29(6-11-30)45-39(53)27-2-7-31(8-3-27)49-18-16-48(17-19-49)23-26-24-50(25-26)33-12-13-34-35(20-33)42(56)51(41(34)55)37-14-15-38(52)46-40(37)54/h2-4,7-9,12-13,20-21,26,29-30,37H,5-6,10-11,14-19,23-25H2,1H3,(H,45,53)(H,46,52,54)/t29-,30-,37?",YYULHFDWXXZSRM-VZASAIHWSA-N
2526,P10275,AR,CRBN,,ARD-2585,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCN(C4CN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)C4)CC3)C=C2)CC1,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](,NC(=O),C2=CC=C(N3CCN(C4CN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)C4)CC3)C=C2)CC1,0.04,99.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,763.299,762.3044942,4.5,55,8,10,2,8,149.4,C41H43ClN8O5,"InChI=1S/C41H43ClN8O5/c1-46(30-9-4-26(22-43)35(42)21-30)28-10-5-27(6-11-28)44-38(52)25-2-7-29(8-3-25)47-16-18-48(19-17-47)32-23-49(24-32)31-12-13-33-34(20-31)41(55)50(40(33)54)36-14-15-37(51)45-39(36)53/h2-4,7-9,12-13,20-21,27-28,32,36H,5-6,10-11,14-19,23-24H2,1H3,(H,44,52)(H,45,51,53)/t27-,28-,36?",LUCHABJUYSYJAT-RVWRWSNSSA-N
2526,P10275,AR T878A,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CCN(C4CN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)C4)CC3)C=C2)CC1,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](,NC(=O),C2=CC=C(N3CCN(C4CN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)C4)CC3)C=C2)CC1,0.1,98.0,1,Degradation of AR T878A in LNCaP (AR T878A) cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16.2,Inhibit growth of LNCaP (AR T878A) cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,763.299,762.3044942,4.5,55,8,10,2,8,149.4,C41H43ClN8O5,"InChI=1S/C41H43ClN8O5/c1-46(30-9-4-26(22-43)35(42)21-30)28-10-5-27(6-11-28)44-38(52)25-2-7-29(8-3-25)47-16-18-48(19-17-47)32-23-49(24-32)31-12-13-33-34(20-31)41(55)50(40(33)54)36-14-15-37(51)45-39(36)53/h2-4,7-9,12-13,20-21,27-28,32,36H,5-6,10-11,14-19,23-24H2,1H3,(H,44,52)(H,45,51,53)/t27-,28-,36?",LUCHABJUYSYJAT-RVWRWSNSSA-N
2527,P10275,AR,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CC(CN4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C3)C=C2)CC1,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](,NC(=O),C2=CC=C(N3CC(CN4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C3)C=C2)CC1,0.1,100.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.3,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,777.326,776.3201442,4.69,56,8,10,2,9,149.4,C42H45ClN8O5,"InChI=1S/C42H45ClN8O5/c1-47(32-9-4-28(22-44)36(43)21-32)30-10-5-29(6-11-30)45-39(53)27-2-7-31(8-3-27)50-24-26(25-50)23-48-16-18-49(19-17-48)33-12-13-34-35(20-33)42(56)51(41(34)55)37-14-15-38(52)46-40(37)54/h2-4,7-9,12-13,20-21,26,29-30,37H,5-6,10-11,14-19,23-25H2,1H3,(H,45,53)(H,46,52,54)/t29-,30-,37?",LOFIFWMXRZZLIL-VZASAIHWSA-N
2527,P10275,AR T878A,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CC(CN4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C3)C=C2)CC1,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](,NC(=O),C2=CC=C(N3CC(CN4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C3)C=C2)CC1,1.9,99.0,1,Degradation of AR T878A in LNCaP (AR T878A) cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11.6,Inhibit growth of LNCaP (AR T878A) cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,777.326,776.3201442,4.69,56,8,10,2,9,149.4,C42H45ClN8O5,"InChI=1S/C42H45ClN8O5/c1-47(32-9-4-28(22-44)36(43)21-32)30-10-5-29(6-11-30)45-39(53)27-2-7-31(8-3-27)50-24-26(25-50)23-48-16-18-49(19-17-48)33-12-13-34-35(20-33)42(56)51(41(34)55)37-14-15-38(52)46-40(37)54/h2-4,7-9,12-13,20-21,26,29-30,37H,5-6,10-11,14-19,23-25H2,1H3,(H,45,53)(H,46,52,54)/t29-,30-,37?",LOFIFWMXRZZLIL-VZASAIHWSA-N
2528,P10275,AR,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CC(N4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C3)C=C2)CC1,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](,NC(=O),C2=CC=C(N3CC(N4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C3)C=C2)CC1,0.2,96.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,763.299,762.3044942,4.5,55,8,10,2,8,149.4,C41H43ClN8O5,"InChI=1S/C41H43ClN8O5/c1-46(30-9-4-26(22-43)35(42)21-30)28-10-5-27(6-11-28)44-38(52)25-2-7-29(8-3-25)49-23-32(24-49)48-18-16-47(17-19-48)31-12-13-33-34(20-31)41(55)50(40(33)54)36-14-15-37(51)45-39(36)53/h2-4,7-9,12-13,20-21,27-28,32,36H,5-6,10-11,14-19,23-24H2,1H3,(H,44,52)(H,45,51,53)/t27-,28-,36?",RNZSZCNUPQYOIX-RVWRWSNSSA-N
2528,P10275,AR T878A,CRBN,,,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](NC(=O)C2=CC=C(N3CC(N4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C3)C=C2)CC1,CN(C1=CC=C(C#N)C(Cl)=C1)[C@H]1CC[C@H](,NC(=O),C2=CC=C(N3CC(N4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C3)C=C2)CC1,1.3,64.0,0,Degradation of AR T878A in LNCaP (AR T878A) cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,21.7,Inhibit growth of LNCaP (AR T878A) cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,763.299,762.3044942,4.5,55,8,10,2,8,149.4,C41H43ClN8O5,"InChI=1S/C41H43ClN8O5/c1-46(30-9-4-26(22-43)35(42)21-30)28-10-5-27(6-11-28)44-38(52)25-2-7-29(8-3-25)49-23-32(24-49)48-18-16-47(17-19-48)31-12-13-33-34(20-31)41(55)50(40(33)54)36-14-15-37(51)45-39(36)53/h2-4,7-9,12-13,20-21,27-28,32,36H,5-6,10-11,14-19,23-24H2,1H3,(H,44,52)(H,45,51,53)/t27-,28-,36?",RNZSZCNUPQYOIX-RVWRWSNSSA-N
2529,P10275,AR,CRBN,,,CC(O)(CS(=O)(=O)C1=CC=C(N2CCN(C3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)C=C1)C(=O)NC1=CC=C(C#N)C(C(F)(F)F)=C1,CC(O)(,CS(=O)(=O),C1=CC=C(N2CCN(C3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)C=C1)C(=O)NC1=CC=C(C#N)C(C(F)(F)F)=C1,1000.0,32.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>1000,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,835.862,835.2611169,2.72,59,7,12,3,9,200.53,C40H40F3N7O8S,"InChI=1S/C40H40F3N7O8S/c1-39(56,38(55)45-25-3-2-24(22-44)32(20-25)40(41,42)43)23-59(57,58)29-7-4-26(5-8-29)48-16-18-49(19-17-48)27-12-14-47(15-13-27)28-6-9-30-31(21-28)37(54)50(36(30)53)33-10-11-34(51)46-35(33)52/h2-9,20-21,27,33,56H,10-19,23H2,1H3,(H,45,55)(H,46,51,52)",RDTWXYREPJFRLJ-UHFFFAOYSA-N
2530,P10275,AR,CRBN,,,CC1(C)C(=O)N(C2=CC=C(C#N)C(C(F)(F)F)=C2)C(=S)N1C1=CC=C(C(=O)N2CCN(C3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)C(F)=C1,CC1(C)C(=O)N(C2=CC=C(C#N)C(,C(F)(F)F,)=C2)C(=S)N1C1=CC=C(C(=O)N2CCN(C3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)C(F)=C1,1000.0,14.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>1000,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,858.875,858.2571148,4.18,61,8,10,1,6,157.68,C42H38F4N8O6S,"InChI=1S/C42H38F4N8O6S/c1-41(2)39(60)52(26-4-3-23(22-47)31(20-26)42(44,45)46)40(61)54(41)27-6-8-29(32(43)21-27)36(57)51-17-15-50(16-18-51)24-11-13-49(14-12-24)25-5-7-28-30(19-25)38(59)53(37(28)58)33-9-10-34(55)48-35(33)56/h3-8,19-21,24,33H,9-18H2,1-2H3,(H,48,55,56)",GPZDKLVDAYMWLZ-UHFFFAOYSA-N
2531,P10275,AR,CRBN,,,N#CC1=NC=C(N2C(=O)C3(CCC3)N(C3=CC=C(C(=O)N4CCN(C5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C(F)=C3)C2=S)C=C1C(F)(F)F,N#CC1=NC=C(N2C(=O)C3(CCC3)N(C3=CC=C(C(=O)N4CCN(C5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C(F)=C3)C2=S)C=C1,C(F)(F)F,,1000.0,27.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>1000,Inhibit growth of VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c00900,871.874,871.2523638,3.55,62,9,11,1,6,170.57,C42H37F4N9O6S,"InChI=1S/C42H37F4N9O6S/c43-31-20-25(55-40(62)53(39(61)41(55)10-1-11-41)26-19-30(42(44,45)46)32(21-47)48-22-26)3-5-28(31)36(58)52-16-14-51(15-17-52)23-8-12-50(13-9-23)24-2-4-27-29(18-24)38(60)54(37(27)59)33-6-7-34(56)49-35(33)57/h2-5,18-20,22-23,33H,1,6-17H2,(H,49,56,57)",DTFBEQQOOYQAKH-UHFFFAOYSA-N
2625,P00533,EGFR L858R/T790M,VHL,,,C=CC(=O)N1CCC[C@H](N2C(NC3=CC=CC=C3)=NC3=CN=C(NC4=CC=C(N5CCN(CCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)N[C@@H](C)C6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4)N=C32)C1,C=CC(=O)N1CCC[C@H](N2C(NC3=CC=CC=C3)=NC3=CN=C(NC4=CC=C(N5CCN(,CCCCCCCC(=O)N,[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)N[C@@H](C)C6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4)N=C32)C1,1.56,86.0,1,Degradation of EGFR L858R/T790M in H1975 cells after 48 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,32/298/105,Inhibit proliferation of H1975 (EGFR L858R/T790M)/HCT116/SU-DHL-6 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01827,1092.429,1091.589134,8.86,79,9,15,5,21,206.08,C60H77N13O5S,"InChI=1S/C60H77N13O5S/c1-7-52(76)71-30-16-19-47(37-71)73-55-49(66-59(73)65-44-17-12-11-13-18-44)36-61-58(68-55)64-45-25-27-46(28-26-45)70-33-31-69(32-34-70)29-15-10-8-9-14-20-51(75)67-54(60(4,5)6)57(78)72-38-48(74)35-50(72)56(77)63-40(2)42-21-23-43(24-22-42)53-41(3)62-39-79-53/h7,11-13,17-18,21-28,36,39-40,47-48,50,54,74H,1,8-10,14-16,19-20,29-35,37-38H2,2-6H3,(H,63,77)(H,65,66)(H,67,75)(H,61,64,68)/t40-,47-,48+,50-,54+/m0/s1",RYXQXEGTLNBKEC-DKQRTKIFSA-N
2625,P00533,EGFR e19d,VHL,,,C=CC(=O)N1CCC[C@H](N2C(NC3=CC=CC=C3)=NC3=CN=C(NC4=CC=C(N5CCN(CCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)N[C@@H](C)C6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4)N=C32)C1,C=CC(=O)N1CCC[C@H](N2C(NC3=CC=CC=C3)=NC3=CN=C(NC4=CC=C(N5CCN(,CCCCCCCC(=O)N,[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)N[C@@H](C)C6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)CC5)C=C4)N=C32)C1,0.49,82.0,1,Degradation of EGFR e19d in HCC827 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.6/298/105,Inhibit proliferation of HCC827 (EGFR del19)/HCT116/SU-DHL-6 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.1c01827,1092.429,1091.589134,8.86,79,9,15,5,21,206.08,C60H77N13O5S,"InChI=1S/C60H77N13O5S/c1-7-52(76)71-30-16-19-47(37-71)73-55-49(66-59(73)65-44-17-12-11-13-18-44)36-61-58(68-55)64-45-25-27-46(28-26-45)70-33-31-69(32-34-70)29-15-10-8-9-14-20-51(75)67-54(60(4,5)6)57(78)72-38-48(74)35-50(72)56(77)63-40(2)42-21-23-43(24-22-42)53-41(3)62-39-79-53/h7,11-13,17-18,21-28,36,39-40,47-48,50,54,74H,1,8-10,14-16,19-20,29-35,37-38H2,2-6H3,(H,63,77)(H,65,66)(H,67,75)(H,61,64,68)/t40-,47-,48+,50-,54+/m0/s1",RYXQXEGTLNBKEC-DKQRTKIFSA-N
2672,P14679,TYR,CRBN,,,N[C@@H](CC1=CC=C(O)C(O)=C1)C(=O)NCCCCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,N[C@@H](CC1=CC=C(O)C(O)=C1),C(=O)NCCCCCN,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,50000.0,61.0,0,Degradation of TYR in A375 cells after 24 h treatment,,,112700,Inhibition of TYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113850,537.573,537.2223483,1.42,39,4,9,6,11,191.16,C27H31N5O7,"InChI=1S/C27H31N5O7/c28-17(13-15-7-9-20(33)21(34)14-15)24(36)30-12-3-1-2-11-29-18-6-4-5-16-23(18)27(39)32(26(16)38)19-8-10-22(35)31-25(19)37/h4-7,9,14,17,19,29,33-34H,1-3,8,10-13,28H2,(H,30,36)(H,31,35,37)/t17-,19?/m0/s1",GTUJRUVNUQLCDT-KKFHFHRHSA-N
2690,O60885,BRD4,CRBN,,WWL0245,CC[C@@H]1C2=NN=C(C)N2C2=CN=C(NC3=CC=C(C(=O)NC4CCN(C(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=C3OC)N=C2N1CC1CCCCC1,CC[C@@H]1C2=NN=C(C)N2C2=CN=C(NC3=CC=C(,C(=O)NC,4CCN(C(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=C3OC)N=C2N1CC1CCCCC1,1.0,99.0,1,Degradation of BRD4 in 22Rv1/VCaP cells after 24 h treatment,,,254,IC50 was assessed by a radiometric ATP-competitive kinase assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3/20.8/52.9,Inhibit proliferation of MV4-11/LNCaP/22Rv1 cells,,,,,,,,12a(WWL0245),,,,,,,10.1016/j.ejmech.2021.113922,873.972,873.3922076,4.21,64,9,15,3,12,223.18,C45H51N11O8,"InChI=1S/C45H51N11O8/c1-4-31-40-52-51-25(2)55(40)33-22-46-45(50-39(33)54(31)23-26-9-6-5-7-10-26)48-30-14-13-27(21-35(30)63-3)41(59)47-28-17-19-53(20-18-28)37(58)24-64-34-12-8-11-29-38(34)44(62)56(43(29)61)32-15-16-36(57)49-42(32)60/h8,11-14,21-22,26,28,31-32H,4-7,9-10,15-20,23-24H2,1-3H3,(H,47,59)(H,46,48,50)(H,49,57,60)/t31-,32?/m1/s1",AORZPRLVKUMTOJ-XGDNGBMYSA-N
2833,Q06187,BTK,CRBN,,,O=C(CNC1=NC=NC2=C1C(C(=O)C1=CC=C(OC3=CC=CC=C3)C=C1Cl)=C[NH]2)NCCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,O=C(CNC1=NC=NC2=C1C(C(=O)C1=CC=C(OC3=CC=CC=C3)C=C1Cl)=C[NH]2),NCCOCCOCCOCCN,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,28.5,67.1,0,Degradation of BTK in JeKo-1 cells after 24 h treatment,,,1931.5,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,853.289,852.2634172,3.82,61,7,14,5,21,232.27,C42H41ClN8O10,"InChI=1S/C42H41ClN8O10/c43-30-21-26(61-25-5-2-1-3-6-25)9-10-27(30)37(54)29-22-46-38-36(29)39(49-24-48-38)47-23-34(53)45-14-16-59-18-20-60-19-17-58-15-13-44-31-8-4-7-28-35(31)42(57)51(41(28)56)32-11-12-33(52)50-40(32)55/h1-10,21-22,24,32,44H,11-20,23H2,(H,45,53)(H,50,52,55)(H2,46,47,48,49)",YUNXARYSBTUJHY-UHFFFAOYSA-N
2834,Q06187,BTK,CRBN,,,O=C(CNC1=NC=NC2=C1C(C(=O)C1=CC=C(OC3=CC=CC=C3)C=C1Cl)=C[NH]2)NCCOCCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,O=C(CNC1=NC=NC2=C1C(C(=O)C1=CC=C(OC3=CC=CC=C3)C=C1Cl)=C[NH]2),NCCOCCOCCOCCOCCN,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,9.4,66.5,0,Degradation of BTK in JeKo-1 cells after 24 h treatment,,,2203.5,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,897.342,896.2896319,3.67,64,7,15,5,24,241.5,C44H45ClN8O11,"InChI=1S/C44H45ClN8O11/c45-32-23-28(64-27-5-2-1-3-6-27)9-10-29(32)39(56)31-24-48-40-38(31)41(51-26-50-40)49-25-36(55)47-14-16-61-18-20-63-22-21-62-19-17-60-15-13-46-33-8-4-7-30-37(33)44(59)53(43(30)58)34-11-12-35(54)52-42(34)57/h1-10,23-24,26,34,46H,11-22,25H2,(H,47,55)(H,52,54,57)(H2,48,49,50,51)",IVICRPGKKOLGDE-UHFFFAOYSA-N
2834,Q06187,BTK C481S,CRBN,,,O=C(CNC1=NC=NC2=C1C(C(=O)C1=CC=C(OC3=CC=CC=C3)C=C1Cl)=C[NH]2)NCCOCCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,O=C(CNC1=NC=NC2=C1C(C(=O)C1=CC=C(OC3=CC=CC=C3)C=C1Cl)=C[NH]2),NCCOCCOCCOCCOCCN,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,52.7,68.6,0,Degradation of BTK C481S in TMD8 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,897.342,896.2896319,3.67,64,7,15,5,24,241.5,C44H45ClN8O11,"InChI=1S/C44H45ClN8O11/c45-32-23-28(64-27-5-2-1-3-6-27)9-10-29(32)39(56)31-24-48-40-38(31)41(51-26-50-40)49-25-36(55)47-14-16-61-18-20-63-22-21-62-19-17-60-15-13-46-33-8-4-7-30-37(33)44(59)53(43(30)58)34-11-12-35(54)52-42(34)57/h1-10,23-24,26,34,46H,11-22,25H2,(H,47,55)(H,52,54,57)(H2,48,49,50,51)",IVICRPGKKOLGDE-UHFFFAOYSA-N
2835,Q06187,BTK,CRBN,,,O=C(CNC1=NC=NC2=C1C(C(=O)C1=CC=C(OC3=CC=CC=C3)C=C1Cl)=C[NH]2)NCCOCCOCCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,O=C(CNC1=NC=NC2=C1C(C(=O)C1=CC=C(OC3=CC=CC=C3)C=C1Cl)=C[NH]2),NCCOCCOCCOCCOCCOCCN,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,8.1,72.4,0,Degradation of BTK in JeKo-1 cells after 24 h treatment,,,1209.5,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,63.3,Inhibit proliferation of TMD8 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,941.395,940.3158467,3.52,67,7,16,5,27,250.73,C46H49ClN8O12,"InChI=1S/C46H49ClN8O12/c47-34-25-30(67-29-5-2-1-3-6-29)9-10-31(34)41(58)33-26-50-42-40(33)43(53-28-52-42)51-27-38(57)49-14-16-63-18-20-65-22-24-66-23-21-64-19-17-62-15-13-48-35-8-4-7-32-39(35)46(61)55(45(32)60)36-11-12-37(56)54-44(36)59/h1-10,25-26,28,36,48H,11-24,27H2,(H,49,57)(H,54,56,59)(H2,50,51,52,53)",SVBNVWQRLLLMHI-UHFFFAOYSA-N
2835,Q06187,BTK C481S,CRBN,,,O=C(CNC1=NC=NC2=C1C(C(=O)C1=CC=C(OC3=CC=CC=C3)C=C1Cl)=C[NH]2)NCCOCCOCCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,O=C(CNC1=NC=NC2=C1C(C(=O)C1=CC=C(OC3=CC=CC=C3)C=C1Cl)=C[NH]2),NCCOCCOCCOCCOCCOCCN,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,80.4,88.4,1,Degradation of BTK C481S in TMD8 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1689.3,Inhibit proliferation of TMD8 (BTK C481S) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,941.395,940.3158467,3.52,67,7,16,5,27,250.73,C46H49ClN8O12,"InChI=1S/C46H49ClN8O12/c47-34-25-30(67-29-5-2-1-3-6-29)9-10-31(34)41(58)33-26-50-42-40(33)43(53-28-52-42)51-27-38(57)49-14-16-63-18-20-65-22-24-66-23-21-64-19-17-62-15-13-48-35-8-4-7-32-39(35)46(61)55(45(32)60)36-11-12-37(56)54-44(36)59/h1-10,25-26,28,36,48H,11-24,27H2,(H,49,57)(H,54,56,59)(H2,50,51,52,53)",SVBNVWQRLLLMHI-UHFFFAOYSA-N
2836,Q06187,BTK,CRBN,,,O=C(CNC1=NC=NC2=C1C(C(=O)C1=CC=C(OC3=CC=CC=C3)C=C1Cl)=C[NH]2)NCCOCCOCCOCCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,O=C(CNC1=NC=NC2=C1C(C(=O)C1=CC=C(OC3=CC=CC=C3)C=C1Cl)=C[NH]2),NCCOCCOCCOCCOCCOCCOCCN,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,8.3,92.4,1,Degradation of BTK in JeKo-1 cells after 24 h treatment,,,1390.5,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,104.5,Inhibit proliferation of TMD8 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,985.448,984.3420614,3.37,70,7,17,5,30,259.96,C48H53ClN8O13,"InChI=1S/C48H53ClN8O13/c49-36-27-32(70-31-5-2-1-3-6-31)9-10-33(36)43(60)35-28-52-44-42(35)45(55-30-54-44)53-29-40(59)51-14-16-65-18-20-67-22-24-69-26-25-68-23-21-66-19-17-64-15-13-50-37-8-4-7-34-41(37)48(63)57(47(34)62)38-11-12-39(58)56-46(38)61/h1-10,27-28,30,38,50H,11-26,29H2,(H,51,59)(H,56,58,61)(H2,52,53,54,55)",WJQKJTMVUALADJ-UHFFFAOYSA-N
2836,Q06187,BTK C481S,CRBN,,,O=C(CNC1=NC=NC2=C1C(C(=O)C1=CC=C(OC3=CC=CC=C3)C=C1Cl)=C[NH]2)NCCOCCOCCOCCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,O=C(CNC1=NC=NC2=C1C(C(=O)C1=CC=C(OC3=CC=CC=C3)C=C1Cl)=C[NH]2),NCCOCCOCCOCCOCCOCCOCCN,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,52.3,84.8,1,Degradation of BTK C481S in TMD8 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,750,Inhibit proliferation of TMD8 (BTK C481S) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,985.448,984.3420614,3.37,70,7,17,5,30,259.96,C48H53ClN8O13,"InChI=1S/C48H53ClN8O13/c49-36-27-32(70-31-5-2-1-3-6-31)9-10-33(36)43(60)35-28-52-44-42(35)45(55-30-54-44)53-29-40(59)51-14-16-65-18-20-67-22-24-69-26-25-68-23-21-66-19-17-64-15-13-50-37-8-4-7-34-41(37)48(63)57(47(34)62)38-11-12-39(58)56-46(38)61/h1-10,27-28,30,38,50H,11-26,29H2,(H,51,59)(H,56,58,61)(H2,52,53,54,55)",WJQKJTMVUALADJ-UHFFFAOYSA-N
2840,Q06187,BTK,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCNC(=O)N[C@H]4CC[C@@H](NC5=NC=NC6=C5C(C(=O)C5=CC=C(OC7=CC=CC=C7)C=C5Cl)=C[NH]6)CC4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(,NCCOCCOCCOCCNC(=O)N,[C@H]4CC[C@@H](NC5=NC=NC6=C5C(C(=O)C5=CC=C(OC7=CC=CC=C7)C=C5Cl)=C[NH]6)CC4)=C3C2=O)C(=O)N1,32.3,76.9,0,Degradation of BTK in JeKo-1 cells after 24 h treatment,,,22.3,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,936.423,935.3369165,4.95,67,8,14,6,21,244.3,C47H50ClN9O10,"InChI=1S/C47H50ClN9O10/c48-35-25-31(67-30-5-2-1-3-6-30)13-14-32(35)41(59)34-26-51-42-40(34)43(53-27-52-42)54-28-9-11-29(12-10-28)55-47(63)50-18-20-65-22-24-66-23-21-64-19-17-49-36-8-4-7-33-39(36)46(62)57(45(33)61)37-15-16-38(58)56-44(37)60/h1-8,13-14,25-29,37,49H,9-12,15-24H2,(H2,50,55,63)(H,56,58,60)(H2,51,52,53,54)/t28-,29+,37?",HTWXOMYINZDUGN-JNLNXYSYSA-N
2840,Q06187,BTK C481S,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCNC(=O)N[C@H]4CC[C@@H](NC5=NC=NC6=C5C(C(=O)C5=CC=C(OC7=CC=CC=C7)C=C5Cl)=C[NH]6)CC4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(,NCCOCCOCCOCCNC(=O)N,[C@H]4CC[C@@H](NC5=NC=NC6=C5C(C(=O)C5=CC=C(OC7=CC=CC=C7)C=C5Cl)=C[NH]6)CC4)=C3C2=O)C(=O)N1,30.1,84.3,1,Degradation of BTK C481S in TMD8 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,936.423,935.3369165,4.95,67,8,14,6,21,244.3,C47H50ClN9O10,"InChI=1S/C47H50ClN9O10/c48-35-25-31(67-30-5-2-1-3-6-30)13-14-32(35)41(59)34-26-51-42-40(34)43(53-27-52-42)54-28-9-11-29(12-10-28)55-47(63)50-18-20-65-22-24-66-23-21-64-19-17-49-36-8-4-7-33-39(36)46(62)57(45(33)61)37-15-16-38(58)56-44(37)60/h1-8,13-14,25-29,37,49H,9-12,15-24H2,(H2,50,55,63)(H,56,58,60)(H2,51,52,53,54)/t28-,29+,37?",HTWXOMYINZDUGN-JNLNXYSYSA-N
2841,Q06187,BTK,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCOCCNC(=O)N[C@H]4CC[C@@H](NC5=NC=NC6=C5C(C(=O)C5=CC=C(OC7=CC=CC=C7)C=C5Cl)=C[NH]6)CC4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(,NCCOCCOCCOCCOCCNC(=O)N,[C@H]4CC[C@@H](NC5=NC=NC6=C5C(C(=O)C5=CC=C(OC7=CC=CC=C7)C=C5Cl)=C[NH]6)CC4)=C3C2=O)C(=O)N1,12.1,78.0,0,Degradation of BTK in JeKo-1 cells after 24 h treatment,,,6.9,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,39.5,Inhibit proliferation of TMD8 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,980.476,979.3631312,4.8,70,8,15,6,24,253.53,C49H54ClN9O11,"InChI=1S/C49H54ClN9O11/c50-37-27-33(70-32-5-2-1-3-6-32)13-14-34(37)43(61)36-28-53-44-42(36)45(55-29-54-44)56-30-9-11-31(12-10-30)57-49(65)52-18-20-67-22-24-69-26-25-68-23-21-66-19-17-51-38-8-4-7-35-41(38)48(64)59(47(35)63)39-15-16-40(60)58-46(39)62/h1-8,13-14,27-31,39,51H,9-12,15-26H2,(H2,52,57,65)(H,58,60,62)(H2,53,54,55,56)/t30-,31+,39?",QJZSKXPDZKWNIF-ZMZOSUEXSA-N
2841,Q06187,BTK C481S,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCOCCNC(=O)N[C@H]4CC[C@@H](NC5=NC=NC6=C5C(C(=O)C5=CC=C(OC7=CC=CC=C7)C=C5Cl)=C[NH]6)CC4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(,NCCOCCOCCOCCOCCNC(=O)N,[C@H]4CC[C@@H](NC5=NC=NC6=C5C(C(=O)C5=CC=C(OC7=CC=CC=C7)C=C5Cl)=C[NH]6)CC4)=C3C2=O)C(=O)N1,37.9,83.5,1,Degradation of BTK C481S in TMD8 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,290.1,Inhibit proliferation of TMD8 (BTK C481S) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,980.476,979.3631312,4.8,70,8,15,6,24,253.53,C49H54ClN9O11,"InChI=1S/C49H54ClN9O11/c50-37-27-33(70-32-5-2-1-3-6-32)13-14-34(37)43(61)36-28-53-44-42(36)45(55-29-54-44)56-30-9-11-31(12-10-30)57-49(65)52-18-20-67-22-24-69-26-25-68-23-21-66-19-17-51-38-8-4-7-35-41(38)48(64)59(47(35)63)39-15-16-40(60)58-46(39)62/h1-8,13-14,27-31,39,51H,9-12,15-26H2,(H2,52,57,65)(H,58,60,62)(H2,53,54,55,56)/t30-,31+,39?",QJZSKXPDZKWNIF-ZMZOSUEXSA-N
2842,Q06187,BTK,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCOCCOCCNC(=O)N[C@H]4CC[C@@H](NC5=NC=NC6=C5C(C(=O)C5=CC=C(OC7=CC=CC=C7)C=C5Cl)=C[NH]6)CC4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(,NCCOCCOCCOCCOCCOCCNC(=O)N,[C@H]4CC[C@@H](NC5=NC=NC6=C5C(C(=O)C5=CC=C(OC7=CC=CC=C7)C=C5Cl)=C[NH]6)CC4)=C3C2=O)C(=O)N1,41.9,93.0,1,Degradation of BTK in JeKo-1 cells after 24 h treatment,,,56.4,Inhibition of BTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,45.7,Inhibit proliferation of TMD8 cells,,,,,,,,,,,<0.53,Caco-2 A2B assay,7.5,Caco-2 B2A assay,10.1016/j.ejmech.2021.113820,1024.529,1023.389346,4.65,73,8,16,6,27,262.76,C51H58ClN9O12,"InChI=1S/C51H58ClN9O12/c52-39-29-35(73-34-5-2-1-3-6-34)13-14-36(39)45(63)38-30-55-46-44(38)47(57-31-56-46)58-32-9-11-33(12-10-32)59-51(67)54-18-20-69-22-24-71-26-28-72-27-25-70-23-21-68-19-17-53-40-8-4-7-37-43(40)50(66)61(49(37)65)41-15-16-42(62)60-48(41)64/h1-8,13-14,29-33,41,53H,9-12,15-28H2,(H2,54,59,67)(H,60,62,64)(H2,55,56,57,58)/t32-,33+,41?",OIAOFDRZXBDDRR-HYKUANOISA-N
2842,Q06187,BTK C481S,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCOCCOCCNC(=O)N[C@H]4CC[C@@H](NC5=NC=NC6=C5C(C(=O)C5=CC=C(OC7=CC=CC=C7)C=C5Cl)=C[NH]6)CC4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(,NCCOCCOCCOCCOCCOCCNC(=O)N,[C@H]4CC[C@@H](NC5=NC=NC6=C5C(C(=O)C5=CC=C(OC7=CC=CC=C7)C=C5Cl)=C[NH]6)CC4)=C3C2=O)C(=O)N1,42.9,90.7,1,Degradation of BTK C481S in TMD8 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,253.5,Inhibit proliferation of TMD8 (BTK C481S) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2021.113820,1024.529,1023.389346,4.65,73,8,16,6,27,262.76,C51H58ClN9O12,"InChI=1S/C51H58ClN9O12/c52-39-29-35(73-34-5-2-1-3-6-34)13-14-36(39)45(63)38-30-55-46-44(38)47(57-31-56-46)58-32-9-11-33(12-10-32)59-51(67)54-18-20-69-22-24-71-26-28-72-27-25-70-23-21-68-19-17-53-40-8-4-7-37-43(40)50(66)61(49(37)65)41-15-16-42(62)60-48(41)64/h1-8,13-14,29-33,41,53H,9-12,15-28H2,(H2,54,59,67)(H,60,62,64)(H2,55,56,57,58)/t32-,33+,41?",OIAOFDRZXBDDRR-HYKUANOISA-N
2842,Q06187,BTK,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCOCCOCCOCCOCCOCCNC(=O)N[C@H]4CC[C@@H](NC5=NC=NC6=C5C(C(=O)C5=CC=C(OC7=CC=CC=C7)C=C5Cl)=C[NH]6)CC4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(,NCCOCCOCCOCCOCCOCCNC(=O)N,[C@H]4CC[C@@H](NC5=NC=NC6=C5C(C(=O)C5=CC=C(OC7=CC=CC=C7)C=C5Cl)=C[NH]6)CC4)=C3C2=O)C(=O)N1,20.0,93.8,1,Degradation of BTK in JeKo-1 cells after 24 h treatment,86.5/88.6,% BTK degradation in JeKo-1 cells after 24 h treatment at 100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,45.7/1760.0,Inhibition of cell proliferation in JeKo-1/BTK C481S Ba/F3 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115403,1024.529,1023.389346,4.65,73,8,16,6,27,262.76,C51H58ClN9O12,"InChI=1S/C51H58ClN9O12/c52-39-29-35(73-34-5-2-1-3-6-34)13-14-36(39)45(63)38-30-55-46-44(38)47(57-31-56-46)58-32-9-11-33(12-10-32)59-51(67)54-18-20-69-22-24-71-26-28-72-27-25-70-23-21-68-19-17-53-40-8-4-7-37-43(40)50(66)61(49(37)65)41-15-16-42(62)60-48(41)64/h1-8,13-14,29-33,41,53H,9-12,15-28H2,(H2,54,59,67)(H,60,62,64)(H2,55,56,57,58)/t32-,33+,41?",OIAOFDRZXBDDRR-HYKUANOISA-N
2843,Q9UBN7,HDAC6,CRBN,,,O=C(CCCO/N=C1C(=C2/C(=O)N(CC3=CN(CCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)C3=CC=CC=C23)/NC2=CC=CC=C/12)NO,O=C(,CCCO/N=C,1C(=C2/C(=O)N(CC3=CN(CCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)N=N3)C3=CC=CC=C23)/NC2=CC=CC=C/12)NO,108.9,88.0,0,Degradation of HDAC6 in K562 cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.1c00681,802.805,802.2823228,1.71,59,8,15,5,15,238.78,C40H38N10O9,"InChI=1S/C40H38N10O9/c51-31-15-14-30(37(53)43-31)50-38(54)26-9-5-11-28(33(26)40(50)56)41-16-19-58-20-17-48-21-23(44-47-48)22-49-29-12-4-2-8-25(29)34(39(49)55)36-35(24-7-1-3-10-27(24)42-36)46-59-18-6-13-32(52)45-57/h1-5,7-12,21,30,41-42,57H,6,13-20,22H2,(H,45,52)(H,43,51,53)/b36-34-,46-35+",DLBCMVGHLAVPJQ-ZQEKUULESA-N
2857,P52333,JAK3,CRBN,,SJ10542,CCS(=O)(=O)N1CC(CC#N)(N2C=C(C3=NC(NC4=CC=C(C(=O)NCCCN5CCN(C6=CC=C(C7CCC(=O)NC7=O)C=C6)CC5)C=C4)=NC4=C3C=C[NH]4)C=N2)C1,CCS(=O)(=O)N1CC(CC#N)(N2C=C(C3=NC(NC4=CC=C(,C(=O)NCCCN,5CCN(C6=CC=C(C7CCC(=O)NC7=O)C=C6)CC5)C=C4)=NC4=C3C=C[NH]4)C=N2)C1,11.0,92.0,1,Degradation of JAK3 in PDX SJBALL020589 cells after 24 h treatment,,,,,,,0.056,Kd was assessed by KINOMEscan Assay,,,,,,,,,,,0.02,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,24/86.4,Inhibit viability of PDX SJBALL020589/MHH-CALL-4 cells,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00650,818.965,818.3434836,1.78,59,8,13,4,14,214.34,C41H46N12O5S,"InChI=1S/C41H46N12O5S/c1-2-59(57,58)52-26-41(27-52,15-16-42)53-25-30(24-45-53)36-34-14-18-43-37(34)49-40(48-36)46-31-8-4-29(5-9-31)38(55)44-17-3-19-50-20-22-51(23-21-50)32-10-6-28(7-11-32)33-12-13-35(54)47-39(33)56/h4-11,14,18,24-25,33H,2-3,12-13,15,17,19-23,26-27H2,1H3,(H,44,55)(H,47,54,56)(H2,43,46,48,49)",WBEBZVDAHMXWJN-UHFFFAOYSA-N
2857,O60674,JAK2,CRBN,,SJ10542,CCS(=O)(=O)N1CC(CC#N)(N2C=C(C3=NC(NC4=CC=C(C(=O)NCCCN5CCN(C6=CC=C(C7CCC(=O)NC7=O)C=C6)CC5)C=C4)=NC4=C3C=C[NH]4)C=N2)C1,CCS(=O)(=O)N1CC(CC#N)(N2C=C(C3=NC(NC4=CC=C(,C(=O)NCCCN,5CCN(C6=CC=C(C7CCC(=O)NC7=O)C=C6)CC5)C=C4)=NC4=C3C=C[NH]4)C=N2)C1,14.0,90.0,1,Degradation of JAK2 in PDX SJBALL020589/MHH-CALL-4 cells after 24 h treatment,,,,,,,0.022,Kd was assessed by KINOMEscan Assay,,,,,,,,,,,0.02,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,24/86.4,Inhibit viability of PDX SJBALL020589/MHH-CALL-4 cells,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00650,818.965,818.3434836,1.78,59,8,13,4,14,214.34,C41H46N12O5S,"InChI=1S/C41H46N12O5S/c1-2-59(57,58)52-26-41(27-52,15-16-42)53-25-30(24-45-53)36-34-14-18-43-37(34)49-40(48-36)46-31-8-4-29(5-9-31)38(55)44-17-3-19-50-20-22-51(23-21-50)32-10-6-28(7-11-32)33-12-13-35(54)47-39(33)56/h4-11,14,18,24-25,33H,2-3,12-13,15,17,19-23,26-27H2,1H3,(H,44,55)(H,47,54,56)(H2,43,46,48,49)",WBEBZVDAHMXWJN-UHFFFAOYSA-N
2878,P11362,FGFR1,VHL,,DGY-09-192,COC1=CC(OC)=C(Cl)C(NC(=O)N(C)C2=CC(NC3=CC=C(N4CCN(CC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=C3)=NC=N2)=C1Cl,COC1=CC(OC)=C(Cl)C(,NC(=O)N(C),C2=CC(NC3=CC=C(N4CCN(CC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=C3)=NC=N2)=C1Cl,4.35,85.0,1,Degradation of FGFR1 in CCLP1 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17,Inhibit proliferation of CCLP1 cells,,,,,,,,,,,,,,,10.1002/anie.202101328,1017.054,1015.36967,6.81,70,7,14,5,15,206.72,C49H59Cl2N11O7S,"InChI=1S/C49H59Cl2N11O7S/c1-28(30-9-11-31(12-10-30)44-29(2)54-27-70-44)55-46(65)35-21-34(63)24-62(35)47(66)45(49(3,4)5)57-40(64)25-60-17-19-61(20-18-60)33-15-13-32(14-16-33)56-38-23-39(53-26-52-38)59(6)48(67)58-43-41(50)36(68-7)22-37(69-8)42(43)51/h9-16,22-23,26-28,34-35,45,63H,17-21,24-25H2,1-8H3,(H,55,65)(H,57,64)(H,58,67)(H,52,53,56)/t28-,34+,35-,45+/m0/s1",WDBUEMWHXKHQNB-AURZXHAXSA-N
2878,P21802,FGFR2,VHL,,DGY-09-192,COC1=CC(OC)=C(Cl)C(NC(=O)N(C)C2=CC(NC3=CC=C(N4CCN(CC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=C3)=NC=N2)=C1Cl,COC1=CC(OC)=C(Cl)C(,NC(=O)N(C),C2=CC(NC3=CC=C(N4CCN(CC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=C3)=NC=N2)=C1Cl,70.0,74.0,0,Degradation of FGFR2 in KATO III cells after 6 h treatment,,,34,IC50 was assessed by Z'-LYTE kinase assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,Inhibit proliferation of KATO III cells,,,,,,,,,,,,,,,10.1002/anie.202101328,1017.054,1015.36967,6.81,70,7,14,5,15,206.72,C49H59Cl2N11O7S,"InChI=1S/C49H59Cl2N11O7S/c1-28(30-9-11-31(12-10-30)44-29(2)54-27-70-44)55-46(65)35-21-34(63)24-62(35)47(66)45(49(3,4)5)57-40(64)25-60-17-19-61(20-18-60)33-15-13-32(14-16-33)56-38-23-39(53-26-52-38)59(6)48(67)58-43-41(50)36(68-7)22-37(69-8)42(43)51/h9-16,22-23,26-28,34-35,45,63H,17-21,24-25H2,1-8H3,(H,55,65)(H,57,64)(H,58,67)(H,52,53,56)/t28-,34+,35-,45+/m0/s1",WDBUEMWHXKHQNB-AURZXHAXSA-N
2913,P14174,MIF,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCCCCCCCC(=O)NC4=CC=C(N5CC6=CC=C(O)C=C6OC5=O)C=C4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(,NCCCCCCCC(=O)N,C4=CC=C(N5CC6=CC=C(O)C=C6OC5=O)C=C4)=C3C2=O)C(=O)N1,100.0,90.0,1,Degradation of MIF in A549 cells after 12 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202101864,653.692,653.2485631,4.16,48,6,9,4,12,174.45,C35H35N5O8,"InChI=1S/C35H35N5O8/c41-24-15-10-21-20-39(35(47)48-28(21)19-24)23-13-11-22(12-14-23)37-29(42)9-4-2-1-3-5-18-36-26-8-6-7-25-31(26)34(46)40(33(25)45)27-16-17-30(43)38-32(27)44/h6-8,10-15,19,27,36,41H,1-5,9,16-18,20H2,(H,37,42)(H,38,43,44)",HAHDZDUOFHMMEA-UHFFFAOYSA-N
3018,P10275,AR-V7,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCOC3=CC=C(C4=CSC(N5CCOCC5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCO,C3=CC=C(C4=CSC(N5CCOCC5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,350.0,53.0,0,Degradation of AR-V7 in 22RV1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1360,Inhibit proliferation of 22Rv1 cells,,,,,,,,,,,,,10.1016/j.bmcl.2021.128448,775.01,774.3233253,5.44,54,6,11,3,13,146.22,C40H50N6O6S2,"InChI=1S/C40H50N6O6S2/c1-25(27-8-10-29(11-9-27)35-26(2)41-24-54-35)42-37(49)33-21-30(47)22-46(33)38(50)36(40(3,4)5)44-34(48)7-6-18-52-31-14-12-28(13-15-31)32-23-53-39(43-32)45-16-19-51-20-17-45/h8-15,23-25,30,33,36,47H,6-7,16-22H2,1-5H3,(H,42,49)(H,44,48)/t25-,30+,33-,36+/m0/s1",DNHMBIDODIOPOD-JJOXSQEKSA-N
3021,P10275,AR-V7,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCOC3=CC=C(C4=CSC(N5CCOCC5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCO,C3=CC=C(C4=CSC(N5CCOCC5)=N4)C=C3)C(C)(C)C)C=C2)SC=N1,320.0,67.0,0,Degradation of AR-V7 in 22RV1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,880,Inhibit proliferation of 22Rv1 cells,,,,,,,,,,,,,10.1016/j.bmcl.2021.128448,789.037,788.3389754,5.8,55,6,11,3,14,146.22,C41H52N6O6S2,"InChI=1S/C41H52N6O6S2/c1-26(28-9-11-30(12-10-28)36-27(2)42-25-55-36)43-38(50)34-22-31(48)23-47(34)39(51)37(41(3,4)5)45-35(49)8-6-7-19-53-32-15-13-29(14-16-32)33-24-54-40(44-33)46-17-20-52-21-18-46/h9-16,24-26,31,34,37,48H,6-8,17-23H2,1-5H3,(H,43,50)(H,45,49)/t26-,31+,34-,37+/m0/s1",GGBZAQUSRYNTSQ-ASCDMGAVSA-N
3053,P10275,AR,CRBN,,ARD-1676,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,C[C@H]1CC2(CCN(C3=CC=C(,C(=O)N,4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,0.1,99.0,1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11.5,Inhibit cell growth in the VCaP cells,,,,,,,,,,,0.07,permeability data in Caco-2 cells,0.13,permeability data in Caco-2 cells,10.1021/acs.jmedchem.3c01264,788.349,787.3248953,4.89,57,9,9,1,6,137.37,C44H46ClN7O5,"InChI=1S/C44H46ClN7O5/c1-27-21-44(26-51(27)34-7-4-30(22-46)37(45)20-34)12-16-49(17-13-44)33-5-2-29(3-6-33)41(55)50-14-10-28(11-15-50)23-48-24-31-18-35-36(19-32(31)25-48)43(57)52(42(35)56)38-8-9-39(53)47-40(38)54/h2-7,18-20,27-28,38H,8-17,21,23-26H2,1H3,(H,47,53,54)/t27-,38?/m0/s1",GAXWAKXJBZHVQF-ZVENJKCTSA-N
3053,P10275,AR T878A,CRBN,,ARD-1676,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,C[C@H]1CC2(CCN(C3=CC=C(,C(=O)N,4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,1.1,98.0,1,Degradation of AR in LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8,Inhibit cell growth in the VCaP cells,,,,,,,,,,,0.07,permeability data in Caco-2 cells,0.13,permeability data in Caco-2 cells,10.1021/acs.jmedchem.3c01264,788.349,787.3248953,4.89,57,9,9,1,6,137.37,C44H46ClN7O5,"InChI=1S/C44H46ClN7O5/c1-27-21-44(26-51(27)34-7-4-30(22-46)37(45)20-34)12-16-49(17-13-44)33-5-2-29(3-6-33)41(55)50-14-10-28(11-15-50)23-48-24-31-18-35-36(19-32(31)25-48)43(57)52(42(35)56)38-8-9-39(53)47-40(38)54/h2-7,18-20,27-28,38H,8-17,21,23-26H2,1H3,(H,47,53,54)/t27-,38?/m0/s1",GAXWAKXJBZHVQF-ZVENJKCTSA-N
3053,P10275,AR L702H and T878A,CRBN,,ARD-1676,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,C[C@H]1CC2(CCN(C3=CC=C(,C(=O)N,4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,8.0,95.0,1,Degradation of AR in MDA-Pca-2b cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.07,permeability data in Caco-2 cells,0.13,permeability data in Caco-2 cells,10.1021/acs.jmedchem.3c01264,788.349,787.3248953,4.89,57,9,9,1,6,137.37,C44H46ClN7O5,"InChI=1S/C44H46ClN7O5/c1-27-21-44(26-51(27)34-7-4-30(22-46)37(45)20-34)12-16-49(17-13-44)33-5-2-29(3-6-33)41(55)50-14-10-28(11-15-50)23-48-24-31-18-35-36(19-32(31)25-48)43(57)52(42(35)56)38-8-9-39(53)47-40(38)54/h2-7,18-20,27-28,38H,8-17,21,23-26H2,1H3,(H,47,53,54)/t27-,38?/m0/s1",GAXWAKXJBZHVQF-ZVENJKCTSA-N
3056,P10275,AR,CRBN,,ARD-1684,COC1(CN2CC3=CC4=C(C=C3C2)C(=O)N(C2CCC(=O)NC2=O)C4=O)CCN(C(=O)C2=CC=C(N3CCC4(CC3)C[C@H](C)N(C3=CC=C(C#N)C(Cl)=C3)C4)C=C2)CC1,,COC,1(CN2CC3=CC4=C(C=C3C2)C(=O)N(C2CCC(=O)NC2=O)C4=O)CCN(C(=O)C2=CC=C(N3CCC4(CC3)C[C@H](C)N(C3=CC=C(C#N)C(Cl)=C3)C4)C=C2)CC1,0.3,97.0,1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.9,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,818.375,817.3354599,4.37,59,9,10,1,7,146.6,C45H48ClN7O6,"InChI=1S/C45H48ClN7O6/c1-28-22-44(26-52(28)34-8-5-30(23-47)37(46)21-34)11-15-50(16-12-44)33-6-3-29(4-7-33)41(56)51-17-13-45(59-2,14-18-51)27-49-24-31-19-35-36(20-32(31)25-49)43(58)53(42(35)57)38-9-10-39(54)48-40(38)55/h3-8,19-21,28,38H,9-18,22,24-27H2,1-2H3,(H,48,54,55)/t28-,38?/m0/s1",MYAUGYDOTJZSSR-XRTOLJPQSA-N
3059,P10275,AR,CRBN,,ARD-1690,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)C4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,C[C@H]1CC2(CCN(C3=CC=C(,C(=O)N,4CC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)C4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,0.5,99.0,1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,25.7,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,760.295,759.2935951,4.18,55,9,9,1,6,137.37,C42H42ClN7O5,"InChI=1S/C42H42ClN7O5/c1-25-17-42(24-49(25)32-7-4-28(18-44)35(43)16-32)10-12-47(13-11-42)31-5-2-27(3-6-31)39(53)48-20-26(21-48)19-46-22-29-14-33-34(15-30(29)23-46)41(55)50(40(33)54)36-8-9-37(51)45-38(36)52/h2-7,14-16,25-26,36H,8-13,17,19-24H2,1H3,(H,45,51,52)/t25-,36?/m0/s1",SIFVRCPVOMAZLY-XFCCSEHESA-N
3065,P51617,IRAK1,VHL,,,COC1=CC(N2CCC(OCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC(=O)C1=CC=CC(C2=CC=N[NH]2)=N1,COC1=CC(N2CCC(,OCC(=O)N,[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC(=O)C1=CC=CC(C2=CC=N[NH]2)=N1,16.0,95.0,1,Degradation of IRAK1 in HEK293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00244,864.042,863.378866,4.63,62,7,12,5,14,204.0,C45H53N9O7S,"InChI=1S/C45H53N9O7S/c1-27-40(62-26-47-27)29-11-9-28(10-12-29)23-46-43(58)37-22-31(55)24-54(37)44(59)41(45(2,3)4)51-39(56)25-61-32-16-19-53(20-17-32)30-13-14-35(38(21-30)60-5)50-42(57)36-8-6-7-33(49-36)34-15-18-48-52-34/h6-15,18,21,26,31-32,37,41,55H,16-17,19-20,22-25H2,1-5H3,(H,46,58)(H,48,52)(H,50,57)(H,51,56)/t31-,37+,41-/m1/s1",PWCLOPMRUGHLET-SPVIJIGUSA-N
3066,P51617,IRAK1,VHL,,,COC1=CC(N2CCC(OCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC(=O)C1=CC=CC(C2=CC=N[NH]2)=N1,COC1=CC(N2CCC(,OCC(=O)N,[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC(=O)C1=CC=CC(C2=CC=N[NH]2)=N1,3.0,96.0,1,Degradation of IRAK1 in HEK293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00244,878.069,877.3945161,5.03,63,7,12,5,14,204.0,C46H55N9O7S,"InChI=1S/C46H55N9O7S/c1-27(29-10-12-30(13-11-29)41-28(2)47-26-63-41)49-44(59)38-23-32(56)24-55(38)45(60)42(46(3,4)5)52-40(57)25-62-33-17-20-54(21-18-33)31-14-15-36(39(22-31)61-6)51-43(58)37-9-7-8-34(50-37)35-16-19-48-53-35/h7-16,19,22,26-27,32-33,38,42,56H,17-18,20-21,23-25H2,1-6H3,(H,48,53)(H,49,59)(H,51,58)(H,52,57)/t27-,32+,38-,42+/m0/s1",MHRNVFQJUUXQIG-VIFUUBRESA-N
3067,P51617,IRAK1,VHL,,,COC1=CC(N2CCN(C(=O)OCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC(=O)C1=CC=CC(C2=CC=N[NH]2)=N1,COC1=CC(N2CCN(,C(=O)OCC(=O)N,[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC(=O)C1=CC=CC(C2=CC=N[NH]2)=N1,16.0,97.0,1,Degradation of IRAK1 in HEK293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00244,893.04,892.3690296,3.9,64,7,13,5,13,224.31,C45H52N10O8S,"InChI=1S/C45H52N10O8S/c1-27-39(64-26-47-27)29-11-9-28(10-12-29)23-46-42(59)36-22-31(56)24-55(36)43(60)40(45(2,3)4)51-38(57)25-63-44(61)54-19-17-53(18-20-54)30-13-14-34(37(21-30)62-5)50-41(58)35-8-6-7-32(49-35)33-15-16-48-52-33/h6-16,21,26,31,36,40,56H,17-20,22-25H2,1-5H3,(H,46,59)(H,48,52)(H,50,58)(H,51,57)/t31-,36+,40-/m1/s1",GGEHXEZNDKXJIX-OXGRJUKFSA-N
3068,P51617,IRAK1,VHL,,,COC1=CC(N2CCN(C(=O)OCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC(=O)C1=CC=CC(C2=CC=N[NH]2)=N1,COC1=CC(N2CCN(,C(=O)OCC(=O)N,[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC(=O)C1=CC=CC(C2=CC=N[NH]2)=N1,9.0,90.0,1,Degradation of IRAK1 in HEK293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00244,907.067,906.3846797,4.3,65,7,13,5,13,224.31,C46H54N10O8S,"InChI=1S/C46H54N10O8S/c1-27(29-10-12-30(13-11-29)40-28(2)47-26-65-40)49-43(60)37-23-32(57)24-56(37)44(61)41(46(3,4)5)52-39(58)25-64-45(62)55-20-18-54(19-21-55)31-14-15-35(38(22-31)63-6)51-42(59)36-9-7-8-33(50-36)34-16-17-48-53-34/h7-17,22,26-27,32,37,41,57H,18-21,23-25H2,1-6H3,(H,48,53)(H,49,60)(H,51,59)(H,52,58)/t27-,32+,37-,41+/m0/s1",MWQAAQOVPMFJQP-KTOUKBDOSA-N
3069,P51617,IRAK1,VHL,,,COC1=CC(N2CCC(OCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3F)C(C)(C)C)CC2)=CC=C1NC(=O)C1=CC=CC(C2=CC=N[NH]2)=N1,COC1=CC(N2CCC(,OCC(=O)N,[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3F)C(C)(C)C)CC2)=CC=C1NC(=O)C1=CC=CC(C2=CC=N[NH]2)=N1,13.0,96.0,1,Degradation of IRAK1 in HEK293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00244,882.032,881.3694442,4.73,63,7,12,5,14,204.0,C45H52FN9O7S,"InChI=1S/C45H52FN9O7S/c1-26-40(63-25-48-26)27-9-10-28(32(46)19-27)22-47-43(59)37-21-30(56)23-55(37)44(60)41(45(2,3)4)52-39(57)24-62-31-14-17-54(18-15-31)29-11-12-35(38(20-29)61-5)51-42(58)36-8-6-7-33(50-36)34-13-16-49-53-34/h6-13,16,19-20,25,30-31,37,41,56H,14-15,17-18,21-24H2,1-5H3,(H,47,59)(H,49,53)(H,51,58)(H,52,57)/t30-,37+,41-/m1/s1",NEMQBDGIUBMFBU-UAFBGOENSA-N
3070,P51617,IRAK1,VHL,,,COC1=CC(N2CC[C@@H](OCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)C[C@@H]2C)=CC=C1NC(=O)C1=CC=CC(C2=CC=N[NH]2)=N1,COC1=CC(N2CC[C@@H](,OCC(=O)N,[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)C[C@@H]2C)=CC=C1NC(=O)C1=CC=CC(C2=CC=N[NH]2)=N1,13.0,94.0,1,Degradation of IRAK1 in HEK293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00244,892.096,891.4101662,5.46,64,7,12,5,14,204.0,C47H57N9O7S,"InChI=1S/C47H57N9O7S/c1-27-21-34(18-20-55(27)32-15-16-37(40(22-32)62-7)52-44(59)38-10-8-9-35(51-38)36-17-19-49-54-36)63-25-41(58)53-43(47(4,5)6)46(61)56-24-33(57)23-39(56)45(60)50-28(2)30-11-13-31(14-12-30)42-29(3)48-26-64-42/h8-17,19,22,26-28,33-34,39,43,57H,18,20-21,23-25H2,1-7H3,(H,49,54)(H,50,60)(H,52,59)(H,53,58)/t27-,28-,33+,34+,39-,43+/m0/s1",ITIRIVDRAPMHII-LHJQLXEHSA-N
3071,P51617,IRAK1,VHL,,,COC1=CC(N2CC[C@@H](OCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)[C@H](C)C2)=CC=C1NC(=O)C1=CC=CC(C2=CC=N[NH]2)=N1,COC1=CC(N2CC[C@@H](,OCC(=O)N,[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)[C@H](C)C2)=CC=C1NC(=O)C1=CC=CC(C2=CC=N[NH]2)=N1,21.0,96.0,1,Degradation of IRAK1 in HEK293T cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.1c00244,892.096,891.4101662,5.46,64,7,12,5,14,204.0,C47H57N9O7S,"InChI=1S/C47H57N9O7S/c1-27-23-55(32-15-16-36(40(21-32)62-7)52-44(59)37-10-8-9-34(51-37)35-17-19-49-54-35)20-18-39(27)63-25-41(58)53-43(47(4,5)6)46(61)56-24-33(57)22-38(56)45(60)50-28(2)30-11-13-31(14-12-30)42-29(3)48-26-64-42/h8-17,19,21,26-28,33,38-39,43,57H,18,20,22-25H2,1-7H3,(H,49,54)(H,50,60)(H,52,59)(H,53,58)/t27-,28+,33-,38+,39-,43-/m1/s1",GHFASOYKYKNVGE-YLSOEQEJSA-N
3120,Q00987,MDM2,MDM2,,,CCOC1=CC(C(C)(C)C)=CC=C1C1=NC(C2=CC=C(Cl)C=C2)C(C2=CC=C(Cl)C=C2)N1C(=O)N1CCN(CC(=O)NCCOCCOCCOCCNC(=O)CN2CCN(C(=O)N3C(C4=CC=C(C(C)(C)C)C=C4OCC)=NC(C4=CC=C(Cl)C=C4)C3C3=CC=C(Cl)C=C3)CC2=O)C(=O)C1,CCOC1=CC(C(C)(C)C)=CC=C1C1=NC(C2=CC=C(Cl)C=C2)C(C2=CC=C(Cl)C=C2)N1C(=O)N1CCN(,CC(=O)NCCOCCOCCOCCNC(=O)CN,2CCN(C(=O)N3C(C4=CC=C(C(C)(C)C)C=C4OCC)=NC(C4=CC=C(Cl)C=C4)C3C3=CC=C(Cl)C=C3)CC2=O)C(=O)C1,1010.0,95.0,0,Degradation of MDM2 in A549 cells after 24 h treatment,,,,,,,,,100.0,MDM2-P53 competitive binding activities were tested by FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1000/3300/1900,Inhibit proliferation of A549/HepG2/HCT116 cells,,,,,,,,,,,0.06,Compounds were administered at 10000 nM and incubated for 2 h,0.02,Compounds were administered at 10000 nM and incubated for 2 h,10.1016/j.apsb.2020.11.022,1459.411,1456.538814,11.32,101,10,13,2,26,216.79,C76H88Cl4N10O11,"InChI=1S/C76H88Cl4N10O11/c1-9-100-61-43-53(75(3,4)5)19-29-59(61)71-83-67(49-11-21-55(77)22-12-49)69(51-15-25-57(79)26-16-51)89(71)73(95)87-35-33-85(65(93)47-87)45-63(91)81-31-37-97-39-41-99-42-40-98-38-32-82-64(92)46-86-34-36-88(48-66(86)94)74(96)90-70(52-17-27-58(80)28-18-52)68(50-13-23-56(78)24-14-50)84-72(90)60-30-20-54(76(6,7)8)44-62(60)101-10-2/h11-30,43-44,67-70H,9-10,31-42,45-48H2,1-8H3,(H,81,91)(H,82,92)",BYXQFJDQDXLTHH-UHFFFAOYSA-N
3149,P04035,HMGCR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCNC(=O)O[C@H]3C[C@@H](C)C=C4C=C[C@H](C)[C@H](CCC(O)C[C@@H](O)CC(=O)O)[C@H]43)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCCCNC(=O)O,[C@H]3C[C@@H](C)C=C4C=C[C@H](C)[C@H](CCC(O)C[C@@H](O)CC(=O)O)[C@H]43)C(C)(C)C)C=C2)SC=N1,120.0,76.0,0,Degradation of HMGCR in HepG2 cells after 16 h treatment,,,250,Inhibition of HMGCR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,18.22,Caco-2 A2B assay,,,10.1016/j.apsb.2020.11.001,978.307,977.5547647,7.73,69,5,11,7,25,227.72,C53H79N5O10S,"InChI=1S/C53H79N5O10S/c1-33-25-38-19-16-34(2)42(23-22-39(59)27-40(60)29-46(63)64)47(38)44(26-33)68-52(67)54-24-14-12-10-8-7-9-11-13-15-45(62)57-49(53(4,5)6)51(66)58-31-41(61)28-43(58)50(65)55-30-36-17-20-37(21-18-36)48-35(3)56-32-69-48/h16-21,25,32-34,39-44,47,49,59-61H,7-15,22-24,26-31H2,1-6H3,(H,54,67)(H,55,65)(H,57,62)(H,63,64)/t33-,34-,39?,40+,41+,42-,43-,44-,47-,49+/m0/s1",YASBQIQZXTUKLR-SHAIEYSUSA-N
3150,O60885,BRD4,CRBN,,CFT-1297,CC1=NN=C2N1C1=CC=C(C3=CN(CCCCCCCN4CCC(C5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)CC4)N=C3)C=C1C(C1=CC=C(Cl)C=C1)=NC21CC1,CC1=NN=C2N1C1=CC=C(C3=CN(,CCCCCCCN,4CCC(C5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)CC4)N=C3)C=C1C(C1=CC=C(Cl)C=C1)=NC21CC1,5.0,97.0,1,Degradation of BRD4 in HEK293T cells after 3 h treatment,,,,,,,58,Kd of BRD4 BD1 was assessed by FP,,,,,,,,,,,,,,,2100,FP,,,,,,,,,,,,,,,4,Kd was tested by AlphaLISA assay,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.1c00376,824.43,823.3725141,5.95,60,10,10,1,12,130.61,C47H50ClN9O3,"InChI=1S/C47H50ClN9O3/c1-30-52-53-46-47(20-21-47)51-43(32-10-13-35(48)14-11-32)38-26-33(12-15-40(38)57(30)46)34-27-49-55(28-34)23-6-4-2-3-5-22-54-24-18-31(19-25-54)36-8-7-9-37-39(36)29-56(45(37)60)41-16-17-42(58)50-44(41)59/h7-15,26-28,31,41H,2-6,16-25,29H2,1H3,(H,50,58,59)",SDKKICDYRHTFNX-UHFFFAOYSA-N
3171,P10275,AR,CRBN,,,CC1(C)C(=O)N(C2=CC=C(C#N)C(C(F)(F)F)=C2)C(=S)N1C1=CC=C(C2=CC=C(O[C@@H]3CCN(C(=O)C4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C3)C=C2)C=C1,CC1(C)C(=O)N(C2=CC=C(C#N)C(,C(F)(F)F,)=C2)C(=S)N1C1=CC=C(C2=CC=C(O[C@@H]3CCN(C(=O)C4CCN(C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)C(=O)C6=C5)CC4)C3)C=C2)C=C1,75.0,85.0,1,Degradation of AR in A549/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/ardp.202100467,917.967,917.2818523,6.0,66,9,10,1,8,163.67,C48H42F3N7O7S,"InChI=1S/C48H42F3N7O7S/c1-47(2)45(64)56(33-10-5-30(25-52)38(24-33)48(49,50)51)46(66)58(47)31-8-3-27(4-9-31)28-6-12-34(13-7-28)65-35-19-22-55(26-35)42(61)29-17-20-54(21-18-29)32-11-14-36-37(23-32)44(63)57(43(36)62)39-15-16-40(59)53-41(39)60/h3-14,23-24,29,35,39H,15-22,26H2,1-2H3,(H,53,59,60)/t35-,39?/m1/s1",PMTYRQFZOZEPEI-QQKHLPPFSA-N
3213,Q07817,BCL-xL,VHL,,PPC5,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCC(=O)N3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCC(=O)N,3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,316.2,56.0,0,Degradation of BCL-xL in 293T cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1599.442,1597.604899,10.87,109,11,19,5,28,263.54,C79H99ClF3N11O11S4,"InChI=1S/C79H99ClF3N11O11S4/c1-53(55-15-17-57(18-16-55)72-54(2)84-52-107-72)85-75(99)68-45-63(95)49-94(68)76(100)73(77(3,4)5)87-70(96)13-10-14-71(97)93-39-35-91(36-40-93)51-78(6)31-29-66(56-19-23-60(80)24-20-56)59(47-78)48-90-33-37-92(38-34-90)62-25-21-58(22-26-62)74(98)88-109(103,104)65-27-28-67(69(46-65)108(101,102)79(81,82)83)86-61(30-32-89-41-43-105-44-42-89)50-106-64-11-8-7-9-12-64/h7-9,11-12,15-28,46,52-53,61,63,68,73,86,95H,10,13-14,29-45,47-51H2,1-6H3,(H,85,99)(H,87,96)(H,88,98)/t53-,61+,63+,68-,73+,78?/m0/s1",BRIZMACXBJUXJT-UWPVXNPMSA-N
3214,Q07817,BCL-xL,VHL,,PPC6,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCC(=O)N3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCC(=O)N,3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,39.9,91.0,1,Degradation of BCL-xL in 293T cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1613.469,1611.620549,11.23,110,11,19,5,29,263.54,C80H101ClF3N11O11S4,"InChI=1S/C80H101ClF3N11O11S4/c1-54(56-16-18-58(19-17-56)73-55(2)85-53-108-73)86-76(100)69-46-64(96)50-95(69)77(101)74(78(3,4)5)88-71(97)14-10-11-15-72(98)94-40-36-92(37-41-94)52-79(6)32-30-67(57-20-24-61(81)25-21-57)60(48-79)49-91-34-38-93(39-35-91)63-26-22-59(23-27-63)75(99)89-110(104,105)66-28-29-68(70(47-66)109(102,103)80(82,83)84)87-62(31-33-90-42-44-106-45-43-90)51-107-65-12-8-7-9-13-65/h7-9,12-13,16-29,47,53-54,62,64,69,74,87,96H,10-11,14-15,30-46,48-52H2,1-6H3,(H,86,100)(H,88,97)(H,89,99)/t54-,62+,64+,69-,74+,79?/m0/s1",KVQKGBLSBLWZKE-AAWIYDMSSA-N
3215,P10415,BCL2,VHL,,PPC7,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCC(=O)N3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCC(=O)N,3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,179.9,79.0,0,Degradation of BCL2 in 293T cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1627.496,1625.636199,11.77,111,11,19,5,30,263.54,C81H103ClF3N11O11S4,"InChI=1S/C81H103ClF3N11O11S4/c1-55(57-17-19-59(20-18-57)74-56(2)86-54-109-74)87-77(101)70-47-65(97)51-96(70)78(102)75(79(3,4)5)89-72(98)15-11-8-12-16-73(99)95-41-37-93(38-42-95)53-80(6)33-31-68(58-21-25-62(82)26-22-58)61(49-80)50-92-35-39-94(40-36-92)64-27-23-60(24-28-64)76(100)90-111(105,106)67-29-30-69(71(48-67)110(103,104)81(83,84)85)88-63(32-34-91-43-45-107-46-44-91)52-108-66-13-9-7-10-14-66/h7,9-10,13-14,17-30,48,54-55,63,65,70,75,88,97H,8,11-12,15-16,31-47,49-53H2,1-6H3,(H,87,101)(H,89,98)(H,90,100)/t55-,63+,65+,70-,75+,80?/m0/s1",XXWWYTHQXVIKLW-WGWDJEQESA-N
3215,Q07817,BCL-xL,VHL,,PPC7,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCC(=O)N3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCC(=O)N,3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,12.8,85.0,1,Degradation of BCL-xL in 293T cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1627.496,1625.636199,11.77,111,11,19,5,30,263.54,C81H103ClF3N11O11S4,"InChI=1S/C81H103ClF3N11O11S4/c1-55(57-17-19-59(20-18-57)74-56(2)86-54-109-74)87-77(101)70-47-65(97)51-96(70)78(102)75(79(3,4)5)89-72(98)15-11-8-12-16-73(99)95-41-37-93(38-42-95)53-80(6)33-31-68(58-21-25-62(82)26-22-58)61(49-80)50-92-35-39-94(40-36-92)64-27-23-60(24-28-64)76(100)90-111(105,106)67-29-30-69(71(48-67)110(103,104)81(83,84)85)88-63(32-34-91-43-45-107-46-44-91)52-108-66-13-9-7-10-14-66/h7,9-10,13-14,17-30,48,54-55,63,65,70,75,88,97H,8,11-12,15-16,31-47,49-53H2,1-6H3,(H,87,101)(H,89,98)(H,90,100)/t55-,63+,65+,70-,75+,80?/m0/s1",XXWWYTHQXVIKLW-WGWDJEQESA-N
3216,P10415,BCL2,VHL,,PPC8,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCC(=O)N3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCC(=O)N,3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,54.0,94.0,1,Degradation of BCL2 in 293T cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1641.523,1639.65185,12.31,112,11,19,5,31,263.54,C82H105ClF3N11O11S4,"InChI=1S/C82H105ClF3N11O11S4/c1-56(58-18-20-60(21-19-58)75-57(2)87-55-110-75)88-78(102)71-48-66(98)52-97(71)79(103)76(80(3,4)5)90-73(99)16-12-7-8-13-17-74(100)96-42-38-94(39-43-96)54-81(6)34-32-69(59-22-26-63(83)27-23-59)62(50-81)51-93-36-40-95(41-37-93)65-28-24-61(25-29-65)77(101)91-112(106,107)68-30-31-70(72(49-68)111(104,105)82(84,85)86)89-64(33-35-92-44-46-108-47-45-92)53-109-67-14-10-9-11-15-67/h9-11,14-15,18-31,49,55-56,64,66,71,76,89,98H,7-8,12-13,16-17,32-48,50-54H2,1-6H3,(H,88,102)(H,90,99)(H,91,101)/t56-,64+,66+,71-,76+,81?/m0/s1",KQEMZZJSHJCPSI-KGENNJKMSA-N
3216,Q07817,BCL-xL,VHL,,PPC8,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCC(=O)N3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCC(=O)N,3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,12.9,94.0,1,Degradation of BCL-xL in 293T cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1641.523,1639.65185,12.31,112,11,19,5,31,263.54,C82H105ClF3N11O11S4,"InChI=1S/C82H105ClF3N11O11S4/c1-56(58-18-20-60(21-19-58)75-57(2)87-55-110-75)88-78(102)71-48-66(98)52-97(71)79(103)76(80(3,4)5)90-73(99)16-12-7-8-13-17-74(100)96-42-38-94(39-43-96)54-81(6)34-32-69(59-22-26-63(83)27-23-59)62(50-81)51-93-36-40-95(41-37-93)65-28-24-61(25-29-65)77(101)91-112(106,107)68-30-31-70(72(49-68)111(104,105)82(84,85)86)89-64(33-35-92-44-46-108-47-45-92)53-109-67-14-10-9-11-15-67/h9-11,14-15,18-31,49,55-56,64,66,71,76,89,98H,7-8,12-13,16-17,32-48,50-54H2,1-6H3,(H,88,102)(H,90,99)(H,91,101)/t56-,64+,66+,71-,76+,81?/m0/s1",KQEMZZJSHJCPSI-KGENNJKMSA-N
3217,P10415,BCL2,VHL,,PPC9,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCC(=O)N3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCC(=O)N,3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,316.2,79.0,0,Degradation of BCL2 in 293T cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1655.55,1653.6675,12.86,113,11,19,5,32,263.54,C83H107ClF3N11O11S4,"InChI=1S/C83H107ClF3N11O11S4/c1-57(59-19-21-61(22-20-59)76-58(2)88-56-111-76)89-79(103)72-49-67(99)53-98(72)80(104)77(81(3,4)5)91-74(100)17-13-8-7-9-14-18-75(101)97-43-39-95(40-44-97)55-82(6)35-33-70(60-23-27-64(84)28-24-60)63(51-82)52-94-37-41-96(42-38-94)66-29-25-62(26-30-66)78(102)92-113(107,108)69-31-32-71(73(50-69)112(105,106)83(85,86)87)90-65(34-36-93-45-47-109-48-46-93)54-110-68-15-11-10-12-16-68/h10-12,15-16,19-32,50,56-57,65,67,72,77,90,99H,7-9,13-14,17-18,33-49,51-55H2,1-6H3,(H,89,103)(H,91,100)(H,92,102)/t57-,65+,67+,72-,77+,82?/m0/s1",YCSHJMBQFQHZEP-BMNBLYSOSA-N
3217,Q07817,BCL-xL,VHL,,PPC9,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCC(=O)N3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCC(=O)N,3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,12.8,96.0,1,Degradation of BCL-xL in 293T cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1655.55,1653.6675,12.86,113,11,19,5,32,263.54,C83H107ClF3N11O11S4,"InChI=1S/C83H107ClF3N11O11S4/c1-57(59-19-21-61(22-20-59)76-58(2)88-56-111-76)89-79(103)72-49-67(99)53-98(72)80(104)77(81(3,4)5)91-74(100)17-13-8-7-9-14-18-75(101)97-43-39-95(40-44-97)55-82(6)35-33-70(60-23-27-64(84)28-24-60)63(51-82)52-94-37-41-96(42-38-94)66-29-25-62(26-30-66)78(102)92-113(107,108)69-31-32-71(73(50-69)112(105,106)83(85,86)87)90-65(34-36-93-45-47-109-48-46-93)54-110-68-15-11-10-12-16-68/h10-12,15-16,19-32,50,56-57,65,67,72,77,90,99H,7-9,13-14,17-18,33-49,51-55H2,1-6H3,(H,89,103)(H,91,100)(H,92,102)/t57-,65+,67+,72-,77+,82?/m0/s1",YCSHJMBQFQHZEP-BMNBLYSOSA-N
3218,P10415,BCL2,VHL,,PPC10,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCC(=O)N3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCC(=O)N,3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,354.8,69.0,0,Degradation of BCL2 in 293T cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1669.577,1667.68315,13.4,114,11,19,5,33,263.54,C84H109ClF3N11O11S4,"InChI=1S/C84H109ClF3N11O11S4/c1-58(60-20-22-62(23-21-60)77-59(2)89-57-112-77)90-80(104)73-50-68(100)54-99(73)81(105)78(82(3,4)5)92-75(101)18-14-9-7-8-10-15-19-76(102)98-44-40-96(41-45-98)56-83(6)36-34-71(61-24-28-65(85)29-25-61)64(52-83)53-95-38-42-97(43-39-95)67-30-26-63(27-31-67)79(103)93-114(108,109)70-32-33-72(74(51-70)113(106,107)84(86,87)88)91-66(35-37-94-46-48-110-49-47-94)55-111-69-16-12-11-13-17-69/h11-13,16-17,20-33,51,57-58,66,68,73,78,91,100H,7-10,14-15,18-19,34-50,52-56H2,1-6H3,(H,90,104)(H,92,101)(H,93,103)/t58-,66+,68+,73-,78+,83?/m0/s1",CGIQKSDNJNCLMP-PVVVILJQSA-N
3218,Q07817,BCL-xL,VHL,,PPC10,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCC(=O)N3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCC(=O)N,3CCN(CC4(C)CCC(C5=CC=C(Cl)C=C5)=C(CN5CCN(C6=CC=C(C(=O)NS(=O)(=O)C7=CC=C(N[C@H](CCN8CCOCC8)CSC8=CC=CC=C8)C(S(=O)(=O)C(F)(F)F)=C7)C=C6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,12.1,81.0,1,Degradation of BCL-xL in 293T cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-021-27210-x,1669.577,1667.68315,13.4,114,11,19,5,33,263.54,C84H109ClF3N11O11S4,"InChI=1S/C84H109ClF3N11O11S4/c1-58(60-20-22-62(23-21-60)77-59(2)89-57-112-77)90-80(104)73-50-68(100)54-99(73)81(105)78(82(3,4)5)92-75(101)18-14-9-7-8-10-15-19-76(102)98-44-40-96(41-45-98)56-83(6)36-34-71(61-24-28-65(85)29-25-61)64(52-83)53-95-38-42-97(43-39-95)67-30-26-63(27-31-67)79(103)93-114(108,109)70-32-33-72(74(51-70)113(106,107)84(86,87)88)91-66(35-37-94-46-48-110-49-47-94)55-111-69-16-12-11-13-17-69/h11-13,16-17,20-33,51,57-58,66,68,73,78,91,100H,7-10,14-15,18-19,34-50,52-56H2,1-6H3,(H,90,104)(H,92,101)(H,93,103)/t58-,66+,68+,73-,78+,83?/m0/s1",CGIQKSDNJNCLMP-PVVVILJQSA-N
3245,P61964,WDR5,VHL,7JTO,MS33,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCC(=O)NCCN3CCN(CC4=CC=CC(C5=CC=C(N6CCN(C)CC6)C(NC(=O)C6=C[NH]C(=O)C=C6C(F)(F)F)=C5)=C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCCC(=O)NCCN,3CCN(CC4=CC=CC(C5=CC=C(N6CCN(C)CC6)C(NC(=O)C6=C[NH]C(=O)C=C6C(F)(F)F)=C5)=C4)CC3)C(C)(C)C)C=C2)SC=N1,260.0,71.0,0,Degradation of WDR5 in MV4;11 cells after 18 h treatment,,,,,,,120,ITC,,,,,,,,,,,,,,,870,ITC,,,,,,,,,,,,,,,520,Kd between VHL and the complex of protac and WDR5 was tested by ITC,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1126/scitranslmed.abj1578,1208.507,1207.6228,7.09,86,8,13,6,25,215.65,C64H84F3N11O7S,"InChI=1S/C64H84F3N11O7S/c1-43-58(86-42-71-43)46-20-18-44(19-21-46)38-70-61(84)54-36-49(79)41-78(54)62(85)59(63(2,3)4)73-56(81)17-12-10-8-6-7-9-11-16-55(80)68-24-25-75-28-30-76(31-29-75)40-45-14-13-15-47(34-45)48-22-23-53(77-32-26-74(5)27-33-77)52(35-48)72-60(83)50-39-69-57(82)37-51(50)64(65,66)67/h13-15,18-23,34-35,37,39,42,49,54,59,79H,6-12,16-17,24-33,36,38,40-41H2,1-5H3,(H,68,80)(H,69,82)(H,70,84)(H,72,83)(H,73,81)/t49-,54+,59-/m1/s1",GLYGYEQLMMPSAW-QWQPEEPRSA-N
3254,P61964,WDR5,VHL,,MS132,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CNC(=O)C3=CC=C(F)C(C4=CC=C(N5C[C@H](C)N(C)[C@H](C)C5)C(NC(=O)C5=C[NH]C(=O)C=C5C(F)(F)F)=C4)=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](N,C(=O)CNC(=O)C,3=CC=C(F)C(C4=CC=C(N5C[C@H](C)N(C)[C@H](C)C5)C(NC(=O)C5=C[NH]C(=O)C=C5C(F)(F)F)=C4)=C3)C(C)(C)C)C=C2)SC=N1,92.0,73.0,0,Degradation of WDR5 in MIA PaCa-2 cells after 18 h treatment,,,,,,,122,ITC,,,,,,,,,,,,,,,534,ITC,,,,,,,,,,,,,,,232,ITC,,,,,,,,,,,,,,,5700/4000/9200,Inhibit proliferation of MIA PaCa-2/BxPC-3/HPAF-II cells,,,,,,,,,,,10.1021/acs.jmedchem.3c01521,1016.132,1015.403779,5.11,72,7,11,6,13,209.17,C51H57F4N9O7S,"InChI=1S/C51H57F4N9O7S/c1-27-23-63(24-28(2)62(27)7)40-15-13-32(17-39(40)60-47(69)36-21-56-42(66)19-37(36)51(53,54)55)35-16-33(12-14-38(35)52)46(68)58-22-43(67)61-45(50(4,5)6)49(71)64-25-34(65)18-41(64)48(70)57-20-30-8-10-31(11-9-30)44-29(3)59-26-72-44/h8-17,19,21,26-28,34,41,45,65H,18,20,22-25H2,1-7H3,(H,56,66)(H,57,70)(H,58,68)(H,60,69)(H,61,67)/t27-,28+,34-,41+,45-/m1/s1",OJCYPKZNPSJLGY-KQNJQULYSA-N
3255,P61964,WDR5,VHL,7JTP,MS67,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CNC(=O)C3=CC=C(F)C(C4=CC=C(N5C[C@H](C)N(C)[C@H](C)C5)C(NC(=O)C5=C[NH]C(=O)C=C5C(F)(F)F)=C4)=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](N,C(=O)CNC(=O)C,3=CC=C(F)C(C4=CC=C(N5C[C@H](C)N(C)[C@H](C)C5)C(NC(=O)C5=C[NH]C(=O)C=C5C(F)(F)F)=C4)=C3)C(C)(C)C)C=C2)SC=N1,3.7,94.0,1,Degradation of WDR5 in MV4;11/MIA PaCa-2 cells after 18 h treatment,,,,,,,63,ITC,,,,,,,,,,,,,,,140,ITC,,,,,,,,,,,,,,,52,Kd between VHL and the complex of protac and WDR5 was tested by ITC,,,,,,,,,,,,,,,15/38/110,Inhibit growth of MV4;11/EOL-1/MOLM13 cells,,,,,,,,,,,10.1126/scitranslmed.abj1578,1030.159,1029.419429,5.52,73,7,11,6,13,209.17,C52H59F4N9O7S,"InChI=1S/C52H59F4N9O7S/c1-27-23-64(24-28(2)63(27)8)41-16-14-33(18-40(41)61-48(70)37-21-57-43(67)20-38(37)52(54,55)56)36-17-34(13-15-39(36)53)47(69)58-22-44(68)62-46(51(5,6)7)50(72)65-25-35(66)19-42(65)49(71)60-29(3)31-9-11-32(12-10-31)45-30(4)59-26-73-45/h9-18,20-21,26-29,35,42,46,66H,19,22-25H2,1-8H3,(H,57,67)(H,58,69)(H,60,71)(H,61,70)(H,62,68)/t27-,28+,29-,35+,42-,46+/m0/s1",HBHSDSLZXDASLT-FLKKWHKHSA-N
3258,P51531,SMARCA2,VHL,,AU-15330,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CN3CCN(C4=CC(C5=CC=CC=C5O)=NN=C4N)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CN,3CCN(C4=CC(C5=CC=CC=C5O)=NN=C4N)CC3)C(C)(C)C)C=C2)SC=N1,85.0,96.0,1,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5740000,0.034,20.2,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,755.946,755.3577367,3.25,54,6,12,5,10,190.14,C39H49N9O5S,"InChI=1S/C39H49N9O5S/c1-23(25-10-12-26(13-11-25)34-24(2)41-22-54-34)42-37(52)31-18-27(49)20-48(31)38(53)35(39(3,4)5)43-33(51)21-46-14-16-47(17-15-46)30-19-29(44-45-36(30)40)28-8-6-7-9-32(28)50/h6-13,19,22-23,27,31,35,49-50H,14-18,20-21H2,1-5H3,(H2,40,45)(H,42,52)(H,43,51)/t23-,27+,31-,35+/m0/s1",HDCCMCFIGHIDJR-TUDDPRDOSA-N
3259,Q03111,MLLT1,CRBN,,,C[C@H]1CCCN1CC1=NC2=CC=C(NC(=O)C3=CC=C4C(=C3)C=NN4CCCCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C2[NH]1,C[C@H]1CCCN1CC1=NC2=CC=C(NC(=O)C3=CC=C4C(=C3)C=NN4,CCCCCCCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C2[NH]1,37.0,95.0,1,Degradation of ENL in MV4;11 cells after 24 h treatment,,,170,Inhibition of ENL YEATS-H3K27ac interaction was tested by an Alpha assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,320/570/1100,Inhibit proliferation of Molm-13/MV4;11/Kasumi-1 cells,,,,,,,,,,,,,10.1186/s13045-022-01258-8,757.896,757.3700156,5.64,56,8,10,4,15,174.42,C42H47N9O5,"InChI=1S/C42H47N9O5/c1-26-10-9-20-49(26)25-36-46-31-15-14-29(23-33(31)47-36)45-39(53)27-13-16-34-28(22-27)24-44-50(34)21-7-5-3-2-4-6-19-43-32-12-8-11-30-38(32)42(56)51(41(30)55)35-17-18-37(52)48-40(35)54/h8,11-16,22-24,26,35,43H,2-7,9-10,17-21,25H2,1H3,(H,45,53)(H,46,47)(H,48,52,54)/t26-,35?/m0/s1",SCZWWJDUQGVEMY-HJYWNDIWSA-N
3260,Q03111,MLLT1,CRBN,,,C[C@H]1CCCN1CC1=NC2=CC=C(NC(=O)C3=CC=C4C(=C3)C=NN4CCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C2[NH]1,C[C@H]1CCCN1CC1=NC2=CC=C(NC(=O)C3=CC=C4C(=C3)C=NN4,CCCCCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C2[NH]1,50.0,68.0,0,Degradation of ENL in MV4;11 cells after 24 h treatment,,,100,Inhibition of ENL YEATS-H3K27ac interaction was tested by an Alpha assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,490/1600/19000,Inhibit proliferation of Molm-13/MV4;11/Kasumi-1 cells,,,,,,,,,,,,,10.1186/s13045-022-01258-8,729.842,729.3387155,4.56,54,8,10,4,13,174.42,C40H43N9O5,"InChI=1S/C40H43N9O5/c1-24-8-7-18-47(24)23-34-44-29-13-12-27(21-31(29)45-34)43-37(51)25-11-14-32-26(20-25)22-42-48(32)19-5-3-2-4-17-41-30-10-6-9-28-36(30)40(54)49(39(28)53)33-15-16-35(50)46-38(33)52/h6,9-14,20-22,24,33,41H,2-5,7-8,15-19,23H2,1H3,(H,43,51)(H,44,45)(H,46,50,52)/t24-,33?/m0/s1",PCQKARKEVDFIEV-PPVAYSNCSA-N
3261,Q03111,MLLT1,CRBN,,,C[C@H]1CCCN1CC1=NC2=CC=C(NC(=O)C3=CC=C4C(=C3)C=NN4CCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C2[NH]1,C[C@H]1CCCN1CC1=NC2=CC=C(NC(=O)C3=CC=C4C(=C3)C=NN4,CCCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)C=C2[NH]1,72.0,89.0,1,Degradation of ENL in MV4;11 cells after 24 h treatment,,,610,Inhibition of ENL YEATS-H3K27ac interaction was tested by an Alpha assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2100/1200/50000,Inhibit proliferation of Molm-13/MV4;11/Kasumi-1 cells,,,,,,,,,,,,,10.1186/s13045-022-01258-8,701.788,701.3074153,3.85,52,8,10,4,11,174.42,C38H39N9O5,"InChI=1S/C38H39N9O5/c1-22-6-5-16-45(22)21-32-42-27-11-10-25(19-29(27)43-32)41-35(49)23-9-12-30-24(18-23)20-40-46(30)17-3-2-15-39-28-8-4-7-26-34(28)38(52)47(37(26)51)31-13-14-33(48)44-36(31)50/h4,7-12,18-20,22,31,39H,2-3,5-6,13-17,21H2,1H3,(H,41,49)(H,42,43)(H,44,48,50)/t22-,31?/m0/s1",BQKBBOYUPLMTRW-DEUJGTPJSA-N
3262,O60885,BRD4,FEM1B,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCOCCNC(=O)CN1CCOC3=CC(N(CCC#N)C(=O)CCl)=CC=C31)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCCOCCNC(=O)CN,1CCOC3=CC(N(CCC#N)C(=O)CCl)=CC=C31)N=C2C1=CC=C(Cl)C=C1,810.0,71.0,0,Degradation of BRD4 in HEK293T cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.1c03980,806.777,805.2328418,3.73,55,6,12,2,15,167.07,C38H41Cl2N9O5S,"InChI=1S/C38H41Cl2N9O5S/c1-23-24(2)55-38-35(23)36(26-5-7-27(40)8-6-26)44-29(37-46-45-25(3)49(37)38)20-32(50)42-12-16-53-17-13-43-33(51)22-47-15-18-54-31-19-28(9-10-30(31)47)48(14-4-11-41)34(52)21-39/h5-10,19,29H,4,12-18,20-22H2,1-3H3,(H,42,50)(H,43,51)/t29-/m0/s1",QVNLOGQWJMAEJT-LJAQVGFWSA-N
3262,O60885,BRD4,FEM1B,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCOCCNC(=O)CN1CCOC3=CC(N(CCC#N)C(=O)CCl)=CC=C31)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCCOCCNC(=O)CN,1CCOC3=CC(N(CCC#N)C(=O)CCl)=CC=C31)N=C2C1=CC=C(Cl)C=C1,820.0,81.0,0,Degradation of BRD4 in HEK293T cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.1c03980,806.777,805.2328418,3.73,55,6,12,2,15,167.07,C38H41Cl2N9O5S,"InChI=1S/C38H41Cl2N9O5S/c1-23-24(2)55-38-35(23)36(26-5-7-27(40)8-6-26)44-29(37-46-45-25(3)49(37)38)20-32(50)42-12-16-53-17-13-43-33(51)22-47-15-18-54-31-19-28(9-10-30(31)47)48(14-4-11-41)34(52)21-39/h5-10,19,29H,4,12-18,20-22H2,1-3H3,(H,42,50)(H,43,51)/t29-/m0/s1",QVNLOGQWJMAEJT-LJAQVGFWSA-N
3263,O60885,BRD4,FEM1B,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCNC(=O)CN1CCOC3=CC(N(CCC#N)C(=O)CCl)=CC=C31)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCCCCCNC(=O)CN,1CCOC3=CC(N(CCC#N)C(=O)CCl)=CC=C31)N=C2C1=CC=C(Cl)C=C1,250.0,94.0,0,Degradation of BRD4 in HEK293T cells after 8 h treatment,,,1500,Inhibit FEM1B-FNIP1 degron fluorescence polarization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.1c03980,804.805,803.2535772,4.94,55,6,11,2,15,157.84,C39H43Cl2N9O4S,"InChI=1S/C39H43Cl2N9O4S/c1-24-25(2)55-39-36(24)37(27-8-10-28(41)11-9-27)45-30(38-47-46-26(3)50(38)39)21-33(51)43-15-5-4-6-16-44-34(52)23-48-18-19-54-32-20-29(12-13-31(32)48)49(17-7-14-42)35(53)22-40/h8-13,20,30H,4-7,15-19,21-23H2,1-3H3,(H,43,51)(H,44,52)/t30-/m0/s1",IEXUFNUFUSSKQI-PMERELPUSA-N
3264,O60885,BRD4,FEM1B,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCOCCOCCNC(=O)CN1CCOC3=CC(N(CCC#N)C(=O)CCl)=CC=C31)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCCOCCOCCNC(=O)CN,1CCOC3=CC(N(CCC#N)C(=O)CCl)=CC=C31)N=C2C1=CC=C(Cl)C=C1,1100.0,85.0,0,Degradation of BRD4 in HEK293T cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.1c03980,850.83,849.2590565,3.58,58,6,13,2,18,176.3,C40H45Cl2N9O6S,"InChI=1S/C40H45Cl2N9O6S/c1-25-26(2)58-40-37(25)38(28-5-7-29(42)8-6-28)46-31(39-48-47-27(3)51(39)40)22-34(52)44-12-16-55-19-20-56-17-13-45-35(53)24-49-15-18-57-33-21-30(9-10-32(33)49)50(14-4-11-43)36(54)23-41/h5-10,21,31H,4,12-20,22-24H2,1-3H3,(H,44,52)(H,45,53)/t31-/m0/s1",CPDVGNBJFIONLX-HKBQPEDESA-N
3265,O60885,BRD4,FEM1B,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCOCCOCCOCCNC(=O)CN1CCOC3=CC(N(CCC#N)C(=O)CCl)=CC=C31)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCCOCCOCCOCCNC(=O)CN,1CCOC3=CC(N(CCC#N)C(=O)CCl)=CC=C31)N=C2C1=CC=C(Cl)C=C1,3600.0,60.0,0,Degradation of BRD4 in HEK293T cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.1c03980,894.883,893.2852713,3.43,61,6,14,2,21,185.53,C42H49Cl2N9O7S,"InChI=1S/C42H49Cl2N9O7S/c1-27-28(2)61-42-39(27)40(30-5-7-31(44)8-6-30)48-33(41-50-49-29(3)53(41)42)24-36(54)46-12-16-57-19-21-59-22-20-58-17-13-47-37(55)26-51-15-18-60-35-23-32(9-10-34(35)51)52(14-4-11-45)38(56)25-43/h5-10,23,33H,4,12-22,24-26H2,1-3H3,(H,46,54)(H,47,55)/t33-/m0/s1",QMBOIOPJFSHXPV-XIFFEERXSA-N
3266,O60885,BRD4,FEM1B,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCOCCOCCOCCOCCNC(=O)CN1CCOC3=CC(N(CCC#N)C(=O)CCl)=CC=C31)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCCOCCOCCOCCOCCNC(=O)CN,1CCOC3=CC(N(CCC#N)C(=O)CCl)=CC=C31)N=C2C1=CC=C(Cl)C=C1,1600.0,80.0,0,Degradation of BRD4 in HEK293T cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.1c03980,938.936,937.311486,3.28,64,6,15,2,24,194.76,C44H53Cl2N9O8S,"InChI=1S/C44H53Cl2N9O8S/c1-29-30(2)64-44-41(29)42(32-5-7-33(46)8-6-32)50-35(43-52-51-31(3)55(43)44)26-38(56)48-12-16-59-19-21-61-23-24-62-22-20-60-17-13-49-39(57)28-53-15-18-63-37-25-34(9-10-36(37)53)54(14-4-11-47)40(58)27-45/h5-10,25,35H,4,12-24,26-28H2,1-3H3,(H,48,56)(H,49,57)/t35-/m0/s1",UUCUKSPUFPMKNK-DHUJRADRSA-N
3270,P10275,AR,CRBN,,ARV-110,N#CC1=CC=C(O[C@H]2CC[C@H](NC(=O)C3=CC=C(N4CCC(CN5CCN(C6=CC7=C(C=C6F)C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)CC4)N=N3)CC2)C=C1Cl,N#CC1=CC=C(O[C@H]2CC[C@H](,NC(=O),C3=CC=C(N4CCC(CN5CCN(C6=CC7=C(C=C6F)C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)CC4)N=N3)CC2)C=C1Cl,3.6,92.0,1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,41/32,Inhibit of cell growth of VCaP/LNCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00118,812.303,811.300886,3.94,58,8,12,2,9,181.17,C41H43ClFN9O6,"InChI=1S/C41H43ClFN9O6/c42-31-19-28(4-1-25(31)22-44)58-27-5-2-26(3-6-27)45-38(54)33-7-9-36(48-47-33)51-13-11-24(12-14-51)23-49-15-17-50(18-16-49)35-21-30-29(20-32(35)43)40(56)52(41(30)57)34-8-10-37(53)46-39(34)55/h1,4,7,9,19-21,24,26-27,34H,2-3,5-6,8,10-18,23H2,(H,45,54)(H,46,53,55)/t26-,27-,34?",CLCTZVRHDOAUGJ-SYVGMNBRSA-N
3300,Q13164,ERK5,VHL,,PPM-3,COC1=CC(N2CCN(CCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC1=NC=C2C(=N1)N(C)C1=CC=CC=C1C(=O)N2C,COC1=CC(N2CCN(,CCCCCCC(=O)N,[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC1=NC=C2C(=N1)N(C)C1=CC=CC=C1C(=O)N2C,41.4,91.4,1,Degradation of ERK5 in A375/H1975/HepG2 cells after 12h treatment,,,62.4,IC50 of ERK5 (nM),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00864,1000.284,999.5152999,7.13,72,8,14,4,17,188.7,C54H69N11O6S,"InChI=1S/C54H69N11O6S/c1-34(36-18-20-37(21-19-36)47-35(2)56-33-72-47)57-50(68)43-30-39(66)32-65(43)52(70)48(54(3,4)5)59-46(67)17-11-9-10-14-24-63-25-27-64(28-26-63)38-22-23-41(45(29-38)71-8)58-53-55-31-44-49(60-53)61(6)42-16-13-12-15-40(42)51(69)62(44)7/h12-13,15-16,18-23,29,31,33-34,39,43,48,66H,9-11,14,17,24-28,30,32H2,1-8H3,(H,57,68)(H,59,67)(H,55,58,60)/t34-,39+,43-,48+/m0/s1",QGJQNPNZAYRDMS-OESUUHGFSA-N
3300,Q13164,ERK5,VHL,,PPM-3,COC1=CC(N2CCN(CCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC1=NC=C2C(=N1)N(C)C1=CC=CC=C1C(=O)N2C,COC1=CC(N2CCN(,CCCCCCC(=O)N,[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)CC2)=CC=C1NC1=NC=C2C(=N1)N(C)C1=CC=CC=C1C(=O)N2C,22.7,86.7,1,Degradation of ERK5 in MDA-MB-231/PC-3/HCT116 cells after 12h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00864,1000.284,999.5152999,7.13,72,8,14,4,17,188.7,C54H69N11O6S,"InChI=1S/C54H69N11O6S/c1-34(36-18-20-37(21-19-36)47-35(2)56-33-72-47)57-50(68)43-30-39(66)32-65(43)52(70)48(54(3,4)5)59-46(67)17-11-9-10-14-24-63-25-27-64(28-26-63)38-22-23-41(45(29-38)71-8)58-53-55-31-44-49(60-53)61(6)42-16-13-12-15-40(42)51(69)62(44)7/h12-13,15-16,18-23,29,31,33-34,39,43,48,66H,9-11,14,17,24-28,30,32H2,1-8H3,(H,57,68)(H,59,67)(H,55,58,60)/t34-,39+,43-,48+/m0/s1",QGJQNPNZAYRDMS-OESUUHGFSA-N
3319,Q86X55,CARM1,VHL,,,CNCCN1CCC(C2=CC(CN(C)C(=O)C3=CC=CC(OC4=CC=C(OCC(=O)N5CCC(CN6CCC(CN7CCN(CC(=O)N[C@H](C(=O)N8C[C@H](O)C[C@H]8C(=O)N[C@@H](C)C8=CC=C(C9=C(C)N=CS9)C=C8)C(C)(C)C)CC7)CC6)CC5)C=C4)=C3)=CC=N2)CC1,,CNCCN,1CCC(C2=CC(CN(C)C(=O)C3=CC=CC(OC4=CC=C(OCC(=O)N5CCC(CN6CCC(CN7CCN(CC(=O)N[C@H](C(=O)N8C[C@H](O)C[C@H]8C(=O)N[C@@H](C)C8=CC=C(C9=C(C)N=CS9)C=C8)C(C)(C)C)CC7)CC6)CC5)C=C4)=C3)=CC=N2)CC1,8.1,97.0,1,Degradation of CARM1 in MCF7 Cells (nM),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00982,1279.708,1278.735129,6.91,92,10,16,4,24,208.59,C71H98N12O8S,"InChI=1S/C71H98N12O8S/c1-49(54-11-13-56(14-12-54)66-50(2)74-48-92-66)75-68(87)63-41-58(84)45-83(63)70(89)67(71(3,4)5)76-64(85)46-81-37-35-80(36-38-81)44-51-20-28-79(29-21-51)43-52-22-32-82(33-23-52)65(86)47-90-59-15-17-60(18-16-59)91-61-10-8-9-57(40-61)69(88)77(7)42-53-19-26-73-62(39-53)55-24-30-78(31-25-55)34-27-72-6/h8-19,26,39-40,48-49,51-52,55,58,63,67,72,84H,20-25,27-38,41-47H2,1-7H3,(H,75,87)(H,76,85)/t49-,58+,63-,67+/m0/s1",UVTQPVBDGGQLTA-YSPOSDDXSA-N
3322,Q86X55,CARM1,VHL,,,CNCCN1CCC(C2=CC(CN(C)C(=O)C3=CC=CC(OC4=CC=C(CCC(=O)N5CCC(CN6CCC(CN7CCN(CC(=O)N[C@H](C(=O)N8C[C@H](O)C[C@H]8C(=O)N[C@@H](C)C8=CC=C(C9=C(C)N=CS9)C=C8)C(C)(C)C)CC7)CC6)CC5)C=C4)=C3)=CC=N2)CC1,,CNCCN,1CCC(C2=CC(CN(C)C(=O)C3=CC=CC(OC4=CC=C(CCC(=O)N5CCC(CN6CCC(CN7CCN(CC(=O)N[C@H](C(=O)N8C[C@H](O)C[C@H]8C(=O)N[C@@H](C)C8=CC=C(C9=C(C)N=CS9)C=C8)C(C)(C)C)CC7)CC6)CC5)C=C4)=C3)=CC=N2)CC1,8.8,98.0,1,Degradation of CARM1 in MCF7 Cells (nM),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00982,1277.736,1276.755865,7.1,92,10,15,4,24,199.36,C72H100N12O7S,"InChI=1S/C72H100N12O7S/c1-50(56-14-16-58(17-15-56)67-51(2)75-49-92-67)76-69(88)64-43-60(85)47-84(64)71(90)68(72(3,4)5)77-65(86)48-82-39-37-81(38-40-82)46-53-22-30-80(31-23-53)45-54-24-34-83(35-25-54)66(87)20-13-52-11-18-61(19-12-52)91-62-10-8-9-59(42-62)70(89)78(7)44-55-21-28-74-63(41-55)57-26-32-79(33-27-57)36-29-73-6/h8-12,14-19,21,28,41-42,49-50,53-54,57,60,64,68,73,85H,13,20,22-27,29-40,43-48H2,1-7H3,(H,76,88)(H,77,86)/t50-,60+,64-,68+/m0/s1",WRQKOZXHYYEKER-KLLGSTGQSA-N
3327,P10275,AR,CRBN,,ARD-1631,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(C(=O)N5CCC(N6CC7=CC8=C(C=C7C6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(,C(=O)N,5CCC(N6CC7=CC8=C(C=C7C6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,9.7,89.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,760.295,759.2935951,4.27,55,9,9,1,5,137.37,C42H42ClN7O5,"InChI=1S/C42H42ClN7O5/c43-35-21-32(6-3-27(35)22-44)48-18-13-42(25-48)11-16-46(17-12-42)30-4-1-26(2-5-30)39(53)47-14-9-31(10-15-47)49-23-28-19-33-34(20-29(28)24-49)41(55)50(40(33)54)36-7-8-37(51)45-38(36)52/h1-6,19-21,31,36H,7-18,23-25H2,(H,45,51,52)",NCYQVXBQCGPHHH-UHFFFAOYSA-N
3328,P10275,AR,CRBN,,ARD-1632,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(C(=O)N5CCC(CN6CC7=CC8=C(C=C7C6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(,C(=O)N,5CCC(CN6CC7=CC8=C(C=C7C6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,5.7,88.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,774.322,773.3092452,4.46,56,9,9,1,6,137.37,C43H44ClN7O5,"InChI=1S/C43H44ClN7O5/c44-36-21-33(6-3-29(36)22-45)50-18-13-43(26-50)11-16-48(17-12-43)32-4-1-28(2-5-32)40(54)49-14-9-27(10-15-49)23-47-24-30-19-34-35(20-31(30)25-47)42(56)51(41(34)55)37-7-8-38(52)46-39(37)53/h1-6,19-21,27,37H,7-18,23-26H2,(H,46,52,53)",DNYOJYXHYCVJKW-UHFFFAOYSA-N
3329,P10275,AR,CRBN,,ARD-1633,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(C(=O)N5CCC(CCN6CC7=CC8=C(C=C7C6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(,C(=O)N,5CCC(CCN6CC7=CC8=C(C=C7C6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,92.0,78.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,788.349,787.3248953,4.81,57,9,9,1,7,137.37,C44H46ClN7O5,"InChI=1S/C44H46ClN7O5/c45-37-23-34(6-3-30(37)24-46)51-20-14-44(27-51)12-18-49(19-13-44)33-4-1-29(2-5-33)41(55)50-16-10-28(11-17-50)9-15-48-25-31-21-35-36(22-32(31)26-48)43(57)52(42(35)56)38-7-8-39(53)47-40(38)54/h1-6,21-23,28,38H,7-20,25-27H2,(H,47,53,54)",QWGRMVRMZJRYBH-UHFFFAOYSA-N
3330,P10275,AR,CRBN,,ARD-1628,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(C(=O)N5CCC(N6CCC7=CC8=C(C=C7C6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(,C(=O)N,5CCC(N6CCC7=CC8=C(C=C7C6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,73.0,63.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,774.322,773.3092452,4.73,56,9,9,1,5,137.37,C43H44ClN7O5,"InChI=1S/C43H44ClN7O5/c44-36-23-33(6-3-29(36)24-45)50-20-14-43(26-50)12-18-47(19-13-43)31-4-1-27(2-5-31)40(54)48-16-10-32(11-17-48)49-15-9-28-21-34-35(22-30(28)25-49)42(56)51(41(34)55)37-7-8-38(52)46-39(37)53/h1-6,21-23,32,37H,7-20,25-26H2,(H,46,52,53)",WISQYAWVRSJAJK-UHFFFAOYSA-N
3331,P10275,AR,CRBN,,ARD-1629,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(C(=O)N5CCC(CN6CCC7=CC8=C(C=C7C6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(,C(=O)N,5CCC(CN6CCC7=CC8=C(C=C7C6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,25.0,53.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,788.349,787.3248953,4.92,57,9,9,1,6,137.37,C44H46ClN7O5,"InChI=1S/C44H46ClN7O5/c45-37-23-34(6-3-31(37)24-46)51-20-14-44(27-51)12-18-49(19-13-44)33-4-1-29(2-5-33)41(55)50-16-9-28(10-17-50)25-48-15-11-30-21-35-36(22-32(30)26-48)43(57)52(42(35)56)38-7-8-39(53)47-40(38)54/h1-6,21-23,28,38H,7-20,25-27H2,(H,47,53,54)",SXZKGSBCJAOABL-UHFFFAOYSA-N
3332,P10275,AR,CRBN,,ARD-1630,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(C(=O)N5CCC(CCN6CCC7=CC8=C(C=C7C6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(,C(=O)N,5CCC(CCN6CCC7=CC8=C(C=C7C6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,125.0,79.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,802.376,801.3405453,5.28,58,9,9,1,7,137.37,C45H48ClN7O5,"InChI=1S/C45H48ClN7O5/c46-38-25-35(6-3-32(38)26-47)52-22-15-45(28-52)13-20-50(21-14-45)34-4-1-30(2-5-34)42(56)51-18-10-29(11-19-51)9-16-49-17-12-31-23-36-37(24-33(31)27-49)44(58)53(43(36)57)39-7-8-40(54)48-41(39)55/h1-6,23-25,29,39H,7-22,27-28H2,(H,48,54,55)",AJLHRCDOQDFNEX-UHFFFAOYSA-N
3333,P10275,AR,CRBN,,ARD-4050,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(C(=O)N5CCC(N6CCC7=CC8=C(C=C7CC6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(,C(=O)N,5CCC(N6CCC7=CC8=C(C=C7CC6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,18.0,81.0,1,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,788.349,787.3248953,5.19,57,9,9,1,5,137.37,C44H46ClN7O5,"InChI=1S/C44H46ClN7O5/c45-37-25-34(6-3-31(37)26-46)51-22-15-44(27-51)13-20-49(21-14-44)32-4-1-28(2-5-32)41(55)50-18-11-33(12-19-50)48-16-9-29-23-35-36(24-30(29)10-17-48)43(57)52(42(35)56)38-7-8-39(53)47-40(38)54/h1-6,23-25,33,38H,7-22,27H2,(H,47,53,54)",DVJGBZOCDDYJLY-UHFFFAOYSA-N
3334,P10275,AR,CRBN,,ARD-4051,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(C(=O)N5CCC(CN6CCC7=CC8=C(C=C7CC6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(,C(=O)N,5CCC(CN6CCC7=CC8=C(C=C7CC6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,51.0,51.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,802.376,801.3405453,5.38,58,9,9,1,6,137.37,C45H48ClN7O5,"InChI=1S/C45H48ClN7O5/c46-38-25-35(6-3-33(38)26-47)52-22-15-45(28-52)13-20-50(21-14-45)34-4-1-30(2-5-34)42(56)51-18-9-29(10-19-51)27-49-16-11-31-23-36-37(24-32(31)12-17-49)44(58)53(43(36)57)39-7-8-40(54)48-41(39)55/h1-6,23-25,29,39H,7-22,27-28H2,(H,48,54,55)",VOHRGIXPJZQORO-UHFFFAOYSA-N
3335,P10275,AR,CRBN,,ARD-4052,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(C(=O)N5CCC(CCN6CCC7=CC8=C(C=C7CC6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,N#CC1=CC=C(N2CCC3(CCN(C4=CC=C(,C(=O)N,5CCC(CCN6CCC7=CC8=C(C=C7CC6)C(=O)N(C6CCC(=O)NC6=O)C8=O)CC5)C=C4)CC3)C2)C=C1Cl,3000.0,76.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,816.403,815.3561954,5.74,59,9,9,1,7,137.37,C46H50ClN7O5,"InChI=1S/C46H50ClN7O5/c47-39-27-36(6-3-34(39)28-48)53-24-16-46(29-53)14-22-51(23-15-46)35-4-1-31(2-5-35)43(57)52-20-10-30(11-21-52)9-17-50-18-12-32-25-37-38(26-33(32)13-19-50)45(59)54(44(37)58)40-7-8-41(55)49-42(40)56/h1-6,25-27,30,40H,7-24,29H2,(H,49,55,56)",PUTPSSPEPURXTK-UHFFFAOYSA-N
3336,P10275,AR,CRBN,,ARD-1719,C[C@@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,C[C@@H]1CC2(CCN(C3=CC=C(,C(=O)N,4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,385.0,81.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,788.349,787.3248953,4.89,57,9,9,1,6,137.37,C44H46ClN7O5,"InChI=1S/C44H46ClN7O5/c1-27-21-44(26-51(27)34-7-4-30(22-46)37(45)20-34)12-16-49(17-13-44)33-5-2-29(3-6-33)41(55)50-14-10-28(11-15-50)23-48-24-31-18-35-36(19-32(31)25-48)43(57)52(42(35)56)38-8-9-39(53)47-40(38)54/h2-7,18-20,27-28,38H,8-17,21,23-26H2,1H3,(H,47,53,54)/t27-,38?/m1/s1",GAXWAKXJBZHVQF-FFTVHEIDSA-N
3337,P10275,AR,CRBN,,ARD-1693,CC[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,CC[C@H]1CC2(CCN(C3=CC=C(C(=O)N4,CCC,(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,0.2,99.0,1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,23,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,802.376,801.3405453,5.42,58,9,9,1,7,137.37,C45H48ClN7O5,"InChI=1S/C45H48ClN7O5/c1-2-33-22-45(27-52(33)35-8-5-30(23-47)38(46)21-35)13-17-50(18-14-45)34-6-3-29(4-7-34)42(56)51-15-11-28(12-16-51)24-49-25-31-19-36-37(20-32(31)26-49)44(58)53(43(36)57)39-9-10-40(54)48-41(39)55/h3-8,19-21,28,33,39H,2,9-18,22,24-27H2,1H3,(H,48,54,55)/t33-,39?/m0/s1",AWHKRHYGENDDAD-YNWFVEANSA-N
3338,P10275,AR,CRBN,,ARD-1671,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(N5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,C[C@H]1CC2(CCN(C3=CC=C(,C(=O)N,4CCC(N5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,0.4,91.0,1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16.5,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,774.322,773.3092452,4.7,56,9,9,1,5,137.37,C43H44ClN7O5,"InChI=1S/C43H44ClN7O5/c1-26-21-43(25-50(26)33-7-4-28(22-45)36(44)20-33)12-16-47(17-13-43)31-5-2-27(3-6-31)40(54)48-14-10-32(11-15-48)49-23-29-18-34-35(19-30(29)24-49)42(56)51(41(34)55)37-8-9-38(52)46-39(37)53/h2-7,18-20,26,32,37H,8-17,21,23-25H2,1H3,(H,46,52,53)/t26-,37?/m0/s1",RMWRKGGZMDZIQO-XVNGORCSSA-N
3339,P10275,AR,CRBN,,ARD-1689,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CC(N5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)C4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,C[C@H]1CC2(CCN(C3=CC=C(,C(=O)N,4CC(N5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)C4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,0.7,89.0,1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,85,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,746.268,745.2779451,3.98,54,9,9,1,5,137.37,C41H40ClN7O5,"InChI=1S/C41H40ClN7O5/c1-24-17-41(23-48(24)30-7-4-26(18-43)34(42)16-30)10-12-45(13-11-41)29-5-2-25(3-6-29)38(52)47-21-31(22-47)46-19-27-14-32-33(15-28(27)20-46)40(54)49(39(32)53)35-8-9-36(50)44-37(35)51/h2-7,14-16,24,31,35H,8-13,17,19-23H2,1H3,(H,44,50,51)/t24-,35?/m0/s1",PGGVAVRBFXQAOY-FRIBFZOTSA-N
3340,P10275,AR,CRBN,,ARD-1683,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(F)(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,C[C@H]1CC2(CCN(C3=CC=C(,C(=O)N,4CCC(F)(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,0.9,99.0,1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,18,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,806.339,805.3154734,4.86,58,9,9,1,6,137.37,C44H45ClFN7O5,"InChI=1S/C44H45ClFN7O5/c1-27-21-43(25-52(27)33-7-4-29(22-47)36(45)20-33)10-14-50(15-11-43)32-5-2-28(3-6-32)40(56)51-16-12-44(46,13-17-51)26-49-23-30-18-34-35(19-31(30)24-49)42(58)53(41(34)57)37-8-9-38(54)48-39(37)55/h2-7,18-20,27,37H,8-17,21,23-26H2,1H3,(H,48,54,55)/t27-,37?/m0/s1",IJKCXDOACVWFTB-YTCZSSRZSA-N
3341,P10275,AR,CRBN,,ARD-1694,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(C)(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,C[C@H]1CC2(CCN(C3=CC=C(,C(=O)N,4CCC(C)(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,3.8,97.0,1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,42,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,802.376,801.3405453,5.28,58,9,9,1,6,137.37,C45H48ClN7O5,"InChI=1S/C45H48ClN7O5/c1-28-22-45(27-52(28)34-8-5-30(23-47)37(46)21-34)13-17-50(18-14-45)33-6-3-29(4-7-33)41(56)51-15-11-44(2,12-16-51)26-49-24-31-19-35-36(20-32(31)25-49)43(58)53(42(35)57)38-9-10-39(54)48-40(38)55/h3-8,19-21,28,38H,9-18,22,24-27H2,1-2H3,(H,48,54,55)/t28-,38?/m0/s1",YECMHOCJNONAQJ-XRTOLJPQSA-N
3342,P10275,AR,CRBN,,ARD-1705,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(O)(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,C[C@H]1CC2(CCN(C3=CC=C(,C(=O)N,4CCC(O)(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,290.0,71.0,0,Degradation of AR in VCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,804.348,803.3198099,3.83,58,9,10,2,6,157.6,C44H46ClN7O6,"InChI=1S/C44H46ClN7O6/c1-27-21-43(25-51(27)33-7-4-29(22-46)36(45)20-33)10-14-49(15-11-43)32-5-2-28(3-6-32)40(55)50-16-12-44(58,13-17-50)26-48-23-30-18-34-35(19-31(30)24-48)42(57)52(41(34)56)37-8-9-38(53)47-39(37)54/h2-7,18-20,27,37,58H,8-17,21,23-26H2,1H3,(H,47,53,54)/t27-,37?/m0/s1",FTLFVUZDLOWJLU-YTCZSSRZSA-N
3343,P10275,AR,CRBN,,ARD-7063,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)N=N3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,C[C@H]1CC2(CCN(C3=CC=C(,C(=O)N,4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)N=N3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,2.7,99.0,1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,20,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,790.325,789.3153932,3.48,57,9,11,1,6,163.15,C42H44ClN9O5,"InChI=1S/C42H44ClN9O5/c1-25-19-42(24-51(25)30-3-2-27(20-44)33(43)18-30)10-14-49(15-11-42)36-6-4-34(46-47-36)41(57)50-12-8-26(9-13-50)21-48-22-28-16-31-32(17-29(28)23-48)40(56)52(39(31)55)35-5-7-37(53)45-38(35)54/h2-4,6,16-18,25-26,35H,5,7-15,19,21-24H2,1H3,(H,45,53,54)/t25-,35?/m0/s1",YXANKPHSGKSVAX-LLIHCOLESA-N
3344,P10275,AR,CRBN,,ARD-7064,C[C@H]1CC2(CCN(C3=CN=C(C(=O)N4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=N3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,C[C@H]1CC2(CCN(C3=CN=C(,C(=O)N,4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=N3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,4.6,99.0,1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,790.325,789.3153932,3.42,57,9,11,1,6,163.15,C42H44ClN9O5,"InChI=1S/C42H44ClN9O5/c1-25-17-42(24-51(25)30-3-2-27(18-44)33(43)16-30)8-12-49(13-9-42)36-20-45-34(19-46-36)41(57)50-10-6-26(7-11-50)21-48-22-28-14-31-32(15-29(28)23-48)40(56)52(39(31)55)35-4-5-37(53)47-38(35)54/h2-3,14-16,19-20,25-26,35H,4-13,17,21-24H2,1H3,(H,47,53,54)/t25-,35?/m0/s1",KBVMPLTYXHSHLH-LLIHCOLESA-N
3345,P10275,AR,CRBN,,ARD-4055,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)N=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,C[C@H]1CC2(CCN(C3=CC=C(,C(=O)N,4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)N=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,15.6,99.0,1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,46,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,789.337,788.3201442,4.15,57,9,10,1,6,150.26,C43H45ClN8O5,"InChI=1S/C43H45ClN8O5/c1-26-19-43(25-51(26)31-3-2-28(20-45)35(44)18-31)10-14-49(15-11-43)32-4-5-36(46-21-32)42(57)50-12-8-27(9-13-50)22-48-23-29-16-33-34(17-30(29)24-48)41(56)52(40(33)55)37-6-7-38(53)47-39(37)54/h2-5,16-18,21,26-27,37H,6-15,19,22-25H2,1H3,(H,47,53,54)/t26-,37?/m0/s1",IBCRRCGKMSVYRY-XVNGORCSSA-N
3346,P10275,AR,CRBN,,ARD-4056,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=N3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,C[C@H]1CC2(CCN(C3=CC=C(,C(=O)N,4CCC(CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)C=N3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,2.3,99.0,1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11,Inhibit cell growth in the VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01264,789.337,788.3201442,4.15,57,9,10,1,6,150.26,C43H45ClN8O5,"InChI=1S/C43H45ClN8O5/c1-26-19-43(25-51(26)32-4-2-28(20-45)35(44)18-32)10-14-49(15-11-43)37-6-3-29(21-46-37)40(55)50-12-8-27(9-13-50)22-48-23-30-16-33-34(17-31(30)24-48)42(57)52(41(33)56)36-5-7-38(53)47-39(36)54/h2-4,6,16-18,21,26-27,36H,5,7-15,19,22-25H2,1H3,(H,47,53,54)/t26-,36?/m0/s1",KYXYESGJSUXASK-FDLYHPRCSA-N
3362,Q16342,PDCD2,CRBN,,,C[C@H](NC(=O)C1=CC=C2C(C3=CC=C(C(F)(F)F)C=C3)=CC=CC2=C1)C1=CC=CC(NC2CCN(C(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,C[C@H](NC(=O)C1=CC=C2C(C3=CC=C(,C(F)(F)F,)C=C3)=CC=CC2=C1)C1=CC=CC(NC2CCN(C(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,2.0,96.7,1,Degradation of PDCD2 in MOLT-4 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202308292,832.836,832.2832322,6.09,61,8,9,3,10,167.11,C45H39F3N6O7,"InChI=1S/C45H39F3N6O7/c1-25(49-41(57)28-13-16-32-27(23-28)5-2-6-31(32)26-11-14-29(15-12-26)45(46,47)48)34-8-4-10-37(51-34)50-30-19-21-53(22-20-30)39(56)24-61-36-9-3-7-33-40(36)44(60)54(43(33)59)35-17-18-38(55)52-42(35)58/h2-16,23,25,30,35H,17-22,24H2,1H3,(H,49,57)(H,50,51)(H,52,55,58)/t25-,35?/m0/s1",FHYJXONYZYZLTJ-LLIHCOLESA-N
3366,P03372,ERalpha,CRBN,,ERD-838,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(C2CCN(C3=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C3)CC2)C4)C(=O)N1,,,,1000.0,32.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,680.805,680.2998704,5.59,51,9,7,2,5,110.26,C42H40N4O5,"InChI=1S/C42H40N4O5/c47-32-11-13-34-27(20-32)8-12-33(25-4-2-1-3-5-25)39(34)26-6-9-30(10-7-26)44-18-16-31(17-19-44)45-23-28-21-35-36(22-29(28)24-45)42(51)46(41(35)50)37-14-15-38(48)43-40(37)49/h1-7,9-11,13,20-22,31,33,37,39,47H,8,12,14-19,23-24H2,(H,43,48,49)/t33-,37?,39+/m1/s1",STHPOQGBRMGDBA-XANLJJFCSA-N
3367,P03372,ERalpha,CRBN,,ERD-821,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC2CCN(C3=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C3)CC2)C4)C(=O)N1,,,,415.0,65.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,694.832,694.3155204,5.78,52,9,7,2,6,110.26,C43H42N4O5,"InChI=1S/C43H42N4O5/c48-33-11-13-35-29(20-33)8-12-34(27-4-2-1-3-5-27)40(35)28-6-9-32(10-7-28)46-18-16-26(17-19-46)23-45-24-30-21-36-37(22-31(30)25-45)43(52)47(42(36)51)38-14-15-39(49)44-41(38)50/h1-7,9-11,13,20-22,26,34,38,40,48H,8,12,14-19,23-25H2,(H,44,49,50)/t34-,38?,40+/m1/s1",IOOQRZXUJWIKSK-AZISWICNSA-N
3368,P03372,ERalpha,CRBN,,ERD-839,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CCC2CCN(C3=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C3)CC2)C4)C(=O)N1,O=C1,CCC,(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CCC2CCN(C3=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C3)CC2)C4)C(=O)N1,1000.0,50.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,708.859,708.3311705,6.14,53,9,7,2,7,110.26,C44H44N4O5,"InChI=1S/C44H44N4O5/c49-34-11-13-36-30(22-34)8-12-35(28-4-2-1-3-5-28)41(36)29-6-9-33(10-7-29)47-20-17-27(18-21-47)16-19-46-25-31-23-37-38(24-32(31)26-46)44(53)48(43(37)52)39-14-15-40(50)45-42(39)51/h1-7,9-11,13,22-24,27,35,39,41,49H,8,12,14-21,25-26H2,(H,45,50,51)/t35-,39?,41+/m1/s1",YWCHTWJTAVEIKG-OCRFBPLNSA-N
3369,P03372,ERalpha,CRBN,,ERD-840,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CCCC2CCN(C3=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C3)CC2)C4)C(=O)N1,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(,CCCC,2CCN(C3=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C3)CC2)C4)C(=O)N1,171.0,79.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,722.886,722.3468206,6.49,54,9,7,2,8,110.26,C45H46N4O5,"InChI=1S/C45H46N4O5/c50-35-13-15-37-31(23-35)10-14-36(29-6-2-1-3-7-29)42(37)30-8-11-34(12-9-30)48-21-18-28(19-22-48)5-4-20-47-26-32-24-38-39(25-33(32)27-47)45(54)49(44(38)53)40-16-17-41(51)46-43(40)52/h1-3,6-9,11-13,15,23-25,28,36,40,42,50H,4-5,10,14,16-22,26-27H2,(H,46,51,52)/t36-,40?,42+/m1/s1",VSVKGKAVEFCRLD-FFWRRKSCSA-N
3370,P03372,ERalpha,CRBN,,ERD-841,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CCCCC2CCN(C3=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C3)CC2)C4)C(=O)N1,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(,CCCCC,2CCN(C3=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C3)CC2)C4)C(=O)N1,236.0,67.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,736.913,736.3624706,7.04,55,9,7,2,9,110.26,C46H48N4O5,"InChI=1S/C46H48N4O5/c51-36-14-16-38-32(24-36)11-15-37(30-7-2-1-3-8-30)43(38)31-9-12-35(13-10-31)49-22-19-29(20-23-49)6-4-5-21-48-27-33-25-39-40(26-34(33)28-48)46(55)50(45(39)54)41-17-18-42(52)47-44(41)53/h1-3,7-10,12-14,16,24-26,29,37,41,43,51H,4-6,11,15,17-23,27-28H2,(H,47,52,53)/t37-,41?,43+/m1/s1",SQPYBBMCORULCB-OUFUGTNJSA-N
3371,P03372,ERalpha,CRBN,,ERD-842,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CCCCCC2CCN(C3=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C3)CC2)C4)C(=O)N1,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(,CCCCCC,2CCN(C3=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C3)CC2)C4)C(=O)N1,31.0,106.0,1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,750.94,750.3781207,7.58,56,9,7,2,10,110.26,C47H50N4O5,"InChI=1S/C47H50N4O5/c52-37-15-17-39-33(25-37)12-16-38(31-8-4-1-5-9-31)44(39)32-10-13-36(14-11-32)50-23-20-30(21-24-50)7-3-2-6-22-49-28-34-26-40-41(27-35(34)29-49)47(56)51(46(40)55)42-18-19-43(53)48-45(42)54/h1,4-5,8-11,13-15,17,25-27,30,38,42,44,52H,2-3,6-7,12,16,18-24,28-29H2,(H,48,53,54)/t38-,42?,44+/m1/s1",IVGNPUWRFBJCCN-WWEQOKPKSA-N
3372,P03372,ERalpha,CRBN,,ERD-843,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CCCCCCC2CCN(C3=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C3)CC2)C4)C(=O)N1,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(,CCCCCCC,2CCN(C3=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C3)CC2)C4)C(=O)N1,129.0,101.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,764.967,764.3937708,8.12,57,9,7,2,11,110.26,C48H52N4O5,"InChI=1S/C48H52N4O5/c53-38-16-18-40-34(26-38)13-17-39(32-9-5-3-6-10-32)45(40)33-11-14-37(15-12-33)51-24-21-31(22-25-51)8-4-1-2-7-23-50-29-35-27-41-42(28-36(35)30-50)48(57)52(47(41)56)43-19-20-44(54)49-46(43)55/h3,5-6,9-12,14-16,18,26-28,31,39,43,45,53H,1-2,4,7-8,13,17,19-25,29-30H2,(H,49,54,55)/t39-,43?,45+/m1/s1",PQNOZPBSZAWSGX-GDIQCRDJSA-N
3373,P03372,ERalpha,CRBN,,ERD-2218,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(C2CN(CC3CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)C2)C4)C(=O)N1,,,,989.0,50.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,749.912,749.3577196,5.66,56,10,8,2,7,113.5,C46H47N5O5,"InChI=1S/C46H47N5O5/c52-36-11-13-38-31(20-36)8-12-37(29-4-2-1-3-5-29)43(38)30-6-9-34(10-7-30)49-18-16-28(17-19-49)23-48-26-35(27-48)50-24-32-21-39-40(22-33(32)25-50)46(56)51(45(39)55)41-14-15-42(53)47-44(41)54/h1-7,9-11,13,20-22,28,35,37,41,43,52H,8,12,14-19,23-27H2,(H,47,53,54)/t37-,41?,43+/m1/s1",XMQFHNQKUCBVPQ-OUFUGTNJSA-N
3374,P03372,ERalpha,CRBN,,ERD-9038,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC2CN(CC3CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)C2)C4)C(=O)N1,,,,21.0,59.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,763.939,763.3733697,5.85,57,10,8,2,8,113.5,C47H49N5O5,"InChI=1S/C47H49N5O5/c53-37-11-13-39-33(20-37)8-12-38(31-4-2-1-3-5-31)44(39)32-6-9-36(10-7-32)51-18-16-29(17-19-51)23-49-24-30(25-49)26-50-27-34-21-40-41(22-35(34)28-50)47(57)52(46(40)56)42-14-15-43(54)48-45(42)55/h1-7,9-11,13,20-22,29-30,38,42,44,53H,8,12,14-19,23-28H2,(H,48,54,55)/t38-,42?,44+/m1/s1",JOPGQIZLLSYHFY-WWEQOKPKSA-N
3375,P03372,ERalpha,CRBN,,ERD-2217,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(C2CCN(CC3CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)CC2)C4)C(=O)N1,,,,2.3,84.0,1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,777.966,777.3890197,6.37,58,10,8,2,7,113.5,C48H51N5O5,"InChI=1S/C48H51N5O5/c54-38-11-13-40-33(24-38)8-12-39(31-4-2-1-3-5-31)45(40)32-6-9-36(10-7-32)51-22-16-30(17-23-51)27-50-20-18-37(19-21-50)52-28-34-25-41-42(26-35(34)29-52)48(58)53(47(41)57)43-14-15-44(55)49-46(43)56/h1-7,9-11,13,24-26,30,37,39,43,45,54H,8,12,14-23,27-29H2,(H,49,55,56)/t39-,43?,45+/m1/s1",LJVKRQPLCQUUFT-GDIQCRDJSA-N
3376,P03372,ERalpha,CRBN,,ERD-9033,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC2CCN(CC3CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)CC2)C4)C(=O)N1,,,,4.3,79.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,791.993,791.4046698,6.56,59,10,8,2,8,113.5,C49H53N5O5,"InChI=1S/C49H53N5O5/c55-39-11-13-41-35(24-39)8-12-40(33-4-2-1-3-5-33)46(41)34-6-9-38(10-7-34)53-22-18-32(19-23-53)27-51-20-16-31(17-21-51)28-52-29-36-25-42-43(26-37(36)30-52)49(59)54(48(42)58)44-14-15-45(56)50-47(44)57/h1-7,9-11,13,24-26,31-32,40,44,46,55H,8,12,14-23,27-30H2,(H,50,56,57)/t40-,44?,46+/m1/s1",GLIOFKBFGNGYKR-GVRKZEHUSA-N
3377,P03372,ERalpha,CRBN,,ERD-2141,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(C2CCN(CC3CN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)C3)CC2)C4)C(=O)N1,,,,295.0,57.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,749.912,749.3577196,5.66,56,10,8,2,7,113.5,C46H47N5O5,"InChI=1S/C46H47N5O5/c52-36-11-13-38-31(20-36)8-12-37(29-4-2-1-3-5-29)43(38)30-6-9-34(10-7-30)49-24-28(25-49)23-48-18-16-35(17-19-48)50-26-32-21-39-40(22-33(32)27-50)46(56)51(45(39)55)41-14-15-42(53)47-44(41)54/h1-7,9-11,13,20-22,28,35,37,41,43,52H,8,12,14-19,23-27H2,(H,47,53,54)/t37-,41?,43+/m1/s1",GDRMTFAUTGSZHO-OUFUGTNJSA-N
3378,P03372,ERalpha,CRBN,,ERD-2142,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC2CCN(CC3CN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)C3)CC2)C4)C(=O)N1,,,,19.0,64.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,763.939,763.3733697,5.85,57,10,8,2,8,113.5,C47H49N5O5,"InChI=1S/C47H49N5O5/c53-37-11-13-39-33(20-37)8-12-38(31-4-2-1-3-5-31)44(39)32-6-9-36(10-7-32)51-25-30(26-51)24-49-18-16-29(17-19-49)23-50-27-34-21-40-41(22-35(34)28-50)47(57)52(46(40)56)42-14-15-43(54)48-45(42)55/h1-7,9-11,13,20-22,29-30,38,42,44,53H,8,12,14-19,23-28H2,(H,48,54,55)/t38-,42?,44+/m1/s1",HVMKSQIOKMVOOE-WWEQOKPKSA-N
3379,P03372,ERalpha,CRBN,,ERD-849,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC2CN(C(=O)C3CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)C2)C4)C(=O)N1,O=C1CCC(N2,C(=O)C,3=CC4=C(C=C3C2=O)CN(CC2CN(C(=O)C3CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)C2)C4)C(=O)N1,6.0,84.0,1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,777.922,777.3526342,5.02,58,10,8,2,7,130.57,C47H47N5O6,"InChI=1S/C47H47N5O6/c53-36-11-13-38-32(20-36)8-12-37(29-4-2-1-3-5-29)43(38)30-6-9-35(10-7-30)50-18-16-31(17-19-50)45(56)51-24-28(25-51)23-49-26-33-21-39-40(22-34(33)27-49)47(58)52(46(39)57)41-14-15-42(54)48-44(41)55/h1-7,9-11,13,20-22,28,31,37,41,43,53H,8,12,14-19,23-27H2,(H,48,54,55)/t37-,41?,43+/m1/s1",KWHREFRVFQGWOC-OUFUGTNJSA-N
3380,P03372,ERalpha,CRBN,,ERD-9115,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(C2CCN(C(=O)C3CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)CC2)C4)C(=O)N1,O=C1CCC(N2,C(=O)C,3=CC4=C(C=C3C2=O)CN(C2CCN(C(=O)C3CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)CC2)C4)C(=O)N1,1.6,95.0,1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,791.949,791.3682843,5.54,59,10,8,2,6,130.57,C48H49N5O6,"InChI=1S/C48H49N5O6/c54-37-11-13-39-32(24-37)8-12-38(29-4-2-1-3-5-29)44(39)30-6-9-35(10-7-30)50-20-16-31(17-21-50)46(57)51-22-18-36(19-23-51)52-27-33-25-40-41(26-34(33)28-52)48(59)53(47(40)58)42-14-15-43(55)49-45(42)56/h1-7,9-11,13,24-26,31,36,38,42,44,54H,8,12,14-23,27-28H2,(H,49,55,56)/t38-,42?,44+/m1/s1",BAWWFFPYQBHNQE-WWEQOKPKSA-N
3381,P03372,ERalpha,CRBN,,ERD-10108,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC2CCN(C(=O)C3CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)CC2)C4)C(=O)N1,O=C1CCC(N2,C(=O)C,3=CC4=C(C=C3C2=O)CN(CC2CCN(C(=O)C3CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)CC2)C4)C(=O)N1,13.0,76.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,805.976,805.3839344,5.73,60,10,8,2,7,130.57,C49H51N5O6,"InChI=1S/C49H51N5O6/c55-38-11-13-40-34(24-38)8-12-39(31-4-2-1-3-5-31)45(40)32-6-9-37(10-7-32)52-22-18-33(19-23-52)47(58)53-20-16-30(17-21-53)27-51-28-35-25-41-42(26-36(35)29-51)49(60)54(48(41)59)43-14-15-44(56)50-46(43)57/h1-7,9-11,13,24-26,30,33,39,43,45,55H,8,12,14-23,27-29H2,(H,50,56,57)/t39-,43?,45+/m1/s1",YHTOZJXOOFKGHU-GDIQCRDJSA-N
3382,P03372,ERalpha,CRBN,,ERD-846,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(C(=O)C2CCN(CC3CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)CC2)C4)C(=O)N1,O=C1CCC(N2,C(=O)C,3=CC4=C(C=C3C2=O)CN(C(=O)C2CCN(CC3CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)CC2)C4)C(=O)N1,9.7,63.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,805.976,805.3839344,5.73,60,10,8,2,7,130.57,C49H51N5O6,"InChI=1S/C49H51N5O6/c55-38-11-13-40-34(24-38)8-12-39(31-4-2-1-3-5-31)45(40)32-6-9-37(10-7-32)52-22-16-30(17-23-52)27-51-20-18-33(19-21-51)47(58)53-28-35-25-41-42(26-36(35)29-53)49(60)54(48(41)59)43-14-15-44(56)50-46(43)57/h1-7,9-11,13,24-26,30,33,39,43,45,55H,8,12,14-23,27-29H2,(H,50,56,57)/t39-,43?,45+/m1/s1",NJBVKJIGWSMPIW-GDIQCRDJSA-N
3383,P03372,ERalpha,CRBN,,ERD-9096,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC2CCN(C(=O)C3CN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)C3)CC2)C4)C(=O)N1,O=C1CCC(N2,C(=O)C,3=CC4=C(C=C3C2=O)CN(CC2CCN(C(=O)C3CN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)C3)CC2)C4)C(=O)N1,32.0,87.0,1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,777.922,777.3526342,5.02,58,10,8,2,7,130.57,C47H47N5O6,"InChI=1S/C47H47N5O6/c53-36-11-13-38-31(20-36)8-12-37(29-4-2-1-3-5-29)43(38)30-6-9-35(10-7-30)51-26-34(27-51)45(56)50-18-16-28(17-19-50)23-49-24-32-21-39-40(22-33(32)25-49)47(58)52(46(39)57)41-14-15-42(54)48-44(41)55/h1-7,9-11,13,20-22,28,34,37,41,43,53H,8,12,14-19,23-27H2,(H,48,54,55)/t37-,41?,43+/m1/s1",YCBIOWPIZXJGRB-OUFUGTNJSA-N
3384,P03372,ERalpha,CRBN,,ERD-2270,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(C(=O)C2CCN(CC3CN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)C3)CC2)C4)C(=O)N1,O=C1CCC(N2,C(=O)C,3=CC4=C(C=C3C2=O)CN(C(=O)C2CCN(CC3CN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)C3)CC2)C4)C(=O)N1,1000.0,40.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,777.922,777.3526342,5.02,58,10,8,2,7,130.57,C47H47N5O6,"InChI=1S/C47H47N5O6/c53-36-11-13-38-32(20-36)8-12-37(29-4-2-1-3-5-29)43(38)30-6-9-35(10-7-30)50-24-28(25-50)23-49-18-16-31(17-19-49)45(56)51-26-33-21-39-40(22-34(33)27-51)47(58)52(46(39)57)41-14-15-42(54)48-44(41)55/h1-7,9-11,13,20-22,28,31,37,41,43,53H,8,12,14-19,23-27H2,(H,48,54,55)/t37-,41?,43+/m1/s1",JSOJSELRECLYBC-OUFUGTNJSA-N
3385,P03372,ERalpha,CRBN,,ERD-853,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC(=O)N2CC3(C2)CN(C2=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C2)C3)C4)C(=O)N1,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(,CC(=O)N,2CC3(C2)CN(C2=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C2)C3)C4)C(=O)N1,11.0,65.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,735.841,735.305684,4.23,55,10,8,2,6,130.57,C44H41N5O6,"InChI=1S/C44H41N5O6/c50-32-11-13-34-28(16-32)8-12-33(26-4-2-1-3-5-26)40(34)27-6-9-31(10-7-27)47-22-44(23-47)24-48(25-44)39(52)21-46-19-29-17-35-36(18-30(29)20-46)43(55)49(42(35)54)37-14-15-38(51)45-41(37)53/h1-7,9-11,13,16-18,33,37,40,50H,8,12,14-15,19-25H2,(H,45,51,53)/t33-,37?,40+/m1/s1",DYJMBAGARLOCGL-OYKJAVFLSA-N
3386,P03372,ERalpha,CRBN,,ERD-854,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC(=O)N2CCC3(C2)CN(C2=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C2)C3)C4)C(=O)N1,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(,CC(=O)N,2CCC3(C2)CN(C2=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C2)C3)C4)C(=O)N1,1000.0,23.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,749.868,749.3213341,4.58,56,10,8,2,6,130.57,C45H43N5O6,"InChI=1S/C45H43N5O6/c51-33-11-13-35-29(18-33)8-12-34(27-4-2-1-3-5-27)41(35)28-6-9-32(10-7-28)49-25-45(26-49)16-17-48(24-45)40(53)23-47-21-30-19-36-37(20-31(30)22-47)44(56)50(43(36)55)38-14-15-39(52)46-42(38)54/h1-7,9-11,13,18-20,34,38,41,51H,8,12,14-17,21-26H2,(H,46,52,54)/t34-,38?,41+/m1/s1",WBCDANJGKYYWKX-OFEAQGJVSA-N
3387,P03372,ERalpha,CRBN,,ERD-855,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC(=O)N2CC3(CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)C3)C2)C4)C(=O)N1,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(,CC(=O)N,2CC3(CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)C3)C2)C4)C(=O)N1,4.0,63.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,749.868,749.3213341,4.58,56,10,8,2,6,130.57,C45H43N5O6,"InChI=1S/C45H43N5O6/c51-33-11-13-35-29(18-33)8-12-34(27-4-2-1-3-5-27)41(35)28-6-9-32(10-7-28)48-17-16-45(24-48)25-49(26-45)40(53)23-47-21-30-19-36-37(20-31(30)22-47)44(56)50(43(36)55)38-14-15-39(52)46-42(38)54/h1-7,9-11,13,18-20,34,38,41,51H,8,12,14-17,21-26H2,(H,46,52,54)/t34-,38?,41+/m1/s1",JLTNQZFNQLUGOC-OFEAQGJVSA-N
3388,P03372,ERalpha,CRBN,,ERD-856,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC(=O)N2CCC3(CC2)CN(C2=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C2)C3)C4)C(=O)N1,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(,CC(=O)N,2CCC3(CC2)CN(C2=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C2)C3)C4)C(=O)N1,1.8,68.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,763.895,763.3369842,4.94,57,10,8,2,6,130.57,C46H45N5O6,"InChI=1S/C46H45N5O6/c52-34-11-13-36-30(20-34)8-12-35(28-4-2-1-3-5-28)42(36)29-6-9-33(10-7-29)50-26-46(27-50)16-18-49(19-17-46)41(54)25-48-23-31-21-37-38(22-32(31)24-48)45(57)51(44(37)56)39-14-15-40(53)47-43(39)55/h1-7,9-11,13,20-22,35,39,42,52H,8,12,14-19,23-27H2,(H,47,53,55)/t35-,39?,42+/m1/s1",JSLJXCMFGCYXEV-HJNPNHQXSA-N
3389,P03372,ERalpha,CRBN,,ERD-1152,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC(=O)N2CC3(CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)C2)C4)C(=O)N1,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(,CC(=O)N,2CC3(CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)C2)C4)C(=O)N1,2.8,71.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,763.895,763.3369842,4.94,57,10,8,2,6,130.57,C46H45N5O6,"InChI=1S/C46H45N5O6/c52-34-11-13-36-30(20-34)8-12-35(28-4-2-1-3-5-28)42(36)29-6-9-33(10-7-29)49-18-16-46(17-19-49)26-50(27-46)41(54)25-48-23-31-21-37-38(22-32(31)24-48)45(57)51(44(37)56)39-14-15-40(53)47-43(39)55/h1-7,9-11,13,20-22,35,39,42,52H,8,12,14-19,23-27H2,(H,47,53,55)/t35-,39?,42+/m1/s1",VTOSAOJQRFRJRP-HJNPNHQXSA-N
3390,P03372,ERalpha,CRBN,,ERD-857,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC(=O)N2CCC3(CC2)CCN(C2=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C2)C3)C4)C(=O)N1,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(,CC(=O)N,2CCC3(CC2)CCN(C2=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C2)C3)C4)C(=O)N1,18.0,58.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,777.922,777.3526342,5.3,58,10,8,2,6,130.57,C47H47N5O6,"InChI=1S/C47H47N5O6/c53-35-11-13-37-31(22-35)8-12-36(29-4-2-1-3-5-29)43(37)30-6-9-34(10-7-30)51-21-18-47(28-51)16-19-50(20-17-47)42(55)27-49-25-32-23-38-39(24-33(32)26-49)46(58)52(45(38)57)40-14-15-41(54)48-44(40)56/h1-7,9-11,13,22-24,36,40,43,53H,8,12,14-21,25-28H2,(H,48,54,56)/t36-,40?,43+/m1/s1",IICKZTABJMLFAS-YNXYBLEHSA-N
3391,P03372,ERalpha,CRBN,,ERD-851,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC(=O)N2CCC3(CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)C2)C4)C(=O)N1,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(,CC(=O)N,2CCC3(CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)C2)C4)C(=O)N1,4.6,75.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,777.922,777.3526342,5.3,58,10,8,2,6,130.57,C47H47N5O6,"InChI=1S/C47H47N5O6/c53-35-11-13-37-31(22-35)8-12-36(29-4-2-1-3-5-29)43(37)30-6-9-34(10-7-30)50-19-16-47(17-20-50)18-21-51(28-47)42(55)27-49-25-32-23-38-39(24-33(32)26-49)46(58)52(45(38)57)40-14-15-41(54)48-44(40)56/h1-7,9-11,13,22-24,36,40,43,53H,8,12,14-21,25-28H2,(H,48,54,56)/t36-,40?,43+/m1/s1",CMXBIGSUZMPPRI-YNXYBLEHSA-N
3392,P03372,ERalpha,CRBN,,ERD-1173,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC(=O)N2CCC3(CC2)CCN(C2=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C2)CC3)C4)C(=O)N1,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(,CC(=O)N,2CCC3(CC2)CCN(C2=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C2)CC3)C4)C(=O)N1,5.5,90.0,1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,791.949,791.3682843,5.65,59,10,8,2,6,130.57,C48H49N5O6,"InChI=1S/C48H49N5O6/c54-36-11-13-38-32(24-36)8-12-37(30-4-2-1-3-5-30)44(38)31-6-9-35(10-7-31)51-20-16-48(17-21-51)18-22-52(23-19-48)43(56)29-50-27-33-25-39-40(26-34(33)28-50)47(59)53(46(39)58)41-14-15-42(55)49-45(41)57/h1-7,9-11,13,24-26,37,41,44,54H,8,12,14-23,27-29H2,(H,49,55,57)/t37-,41?,44+/m1/s1",QSLOGDDNCAUEOM-ALPHEJHSSA-N
3393,P03372,ERalpha,CRBN,,ERD-852,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(CC(=O)N2CCCC3(CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)C2)C4)C(=O)N1,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(,CC(=O)N,2CCCC3(CCN(C5=CC=C([C@@H]6C7=CC=C(O)C=C7CC[C@@H]6C6=CC=CC=C6)C=C5)CC3)C2)C4)C(=O)N1,393.0,58.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,791.949,791.3682843,5.65,59,10,8,2,6,130.57,C48H49N5O6,"InChI=1S/C48H49N5O6/c54-36-12-14-38-32(23-36)9-13-37(30-5-2-1-3-6-30)44(38)31-7-10-35(11-8-31)51-21-18-48(19-22-51)17-4-20-52(29-48)43(56)28-50-26-33-24-39-40(25-34(33)27-50)47(59)53(46(39)58)41-15-16-42(55)49-45(41)57/h1-3,5-8,10-12,14,23-25,37,41,44,54H,4,9,13,15-22,26-29H2,(H,49,55,57)/t37-,41?,44+/m1/s1",CXVXDOPSPYRBNI-ALPHEJHSSA-N
3394,P03372,ERalpha,CRBN,,ERD-858,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(C(=O)CN2CCC3(CC2)CCN(C2=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C2)CC3)C4)C(=O)N1,O=C1CCC(N2C(=O)C3=CC4=C(C=C3C2=O)CN(,C(=O)CN,2CCC3(CC2)CCN(C2=CC=C([C@@H]5C6=CC=C(O)C=C6CC[C@@H]5C5=CC=CC=C5)C=C2)CC3)C4)C(=O)N1,1000.0,16.0,0,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,791.949,791.3682843,5.65,59,10,8,2,6,130.57,C48H49N5O6,"InChI=1S/C48H49N5O6/c54-36-11-13-38-32(24-36)8-12-37(30-4-2-1-3-5-30)44(38)31-6-9-35(10-7-31)51-22-18-48(19-23-51)16-20-50(21-17-48)29-43(56)52-27-33-25-39-40(26-34(33)28-52)47(59)53(46(39)58)41-14-15-42(55)49-45(41)57/h1-7,9-11,13,24-26,37,41,44,54H,8,12,14-23,27-29H2,(H,49,55,57)/t37-,41?,44+/m1/s1",UPQRJEMPJLRIMJ-ALPHEJHSSA-N
3395,P03372,ERalpha,CRBN,,ERD-876,C[C@@H]1CC2=C([NH]C3=CC=CC=C23)[C@@H](C2=C(F)C=C(N3CCC4(CCN(C(=O)CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)CC3)C=C2F)N1CC(F)(F)CO,C[C@@H]1CC2=C([NH]C3=CC=CC=C23)[C@@H](C2=C(F)C=C(N3CCC4(CCN(C(=O)CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)CC3)C=C2F)N1,CC(F)(F)CO,,0.1,97.0,1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,883.944,883.3680452,4.32,64,10,9,3,8,149.6,C47H49F4N7O6,"InChI=1S/C47H49F4N7O6/c1-26-16-31-30-4-2-3-5-36(30)52-41(31)42(57(26)24-47(50,51)25-59)40-34(48)19-29(20-35(40)49)55-12-8-46(9-13-55)10-14-56(15-11-46)39(61)23-54-21-27-17-32-33(18-28(27)22-54)45(64)58(44(32)63)37-6-7-38(60)53-43(37)62/h2-5,17-20,26,37,42,52,59H,6-16,21-25H2,1H3,(H,53,60,62)/t26-,37?,42-/m1/s1",SEHKDMKQRSFFAP-NIFBIGKZSA-N
3396,P03372,ERalpha,CRBN,,ERD-2279,C[C@@H]1CC2=C([NH]C3=CC=CC=C23)[C@@H](C2=C(F)C=C(N3CCC4(CCN(C(=O)CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)CC3)C=C2F)N1CC(C)(C)F,C[C@@H]1CC2=C([NH]C3=CC=CC=C23)[C@@H](C2=C(F)C=C(N3CCC4(CCN(C(=O)CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)CC3)C=C2F)N1,CC(C)(C)F,,0.8,83.0,1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,863.982,863.3982024,5.3,63,10,8,2,7,129.37,C48H52F3N7O5,"InChI=1S/C48H52F3N7O5/c1-27-18-32-31-6-4-5-7-37(31)52-42(32)43(57(27)26-47(2,3)51)41-35(49)21-30(22-36(41)50)55-14-10-48(11-15-55)12-16-56(17-13-48)40(60)25-54-23-28-19-33-34(20-29(28)24-54)46(63)58(45(33)62)38-8-9-39(59)53-44(38)61/h4-7,19-22,27,38,43,52H,8-18,23-26H2,1-3H3,(H,53,59,61)/t27-,38?,43-/m1/s1",VLJYPDPFDHUAPD-UKIYHOJXSA-N
3397,P03372,ERalpha,CRBN,,ERD-1099,C[C@@H]1CC2=C([NH]C3=CC=CC=C23)[C@@H](C2=C(F)C=C(N3CCC4(CCN(C(=O)CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)CC3)C=C2F)N1CC(F)F,C[C@@H]1CC2=C([NH]C3=CC=CC=C23)[C@@H](C2=C(F)C=C(N3CCC4(CCN(,C(=O)CN,5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)CC3)C=C2F)N1CC(F)F,0.8,106.0,1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,853.918,853.3574805,5.19,62,10,8,2,7,129.37,C46H47F4N7O5,"InChI=1S/C46H47F4N7O5/c1-25-16-30-29-4-2-3-5-35(29)51-41(30)42(56(25)23-37(49)50)40-33(47)19-28(20-34(40)48)54-12-8-46(9-13-54)10-14-55(15-11-46)39(59)24-53-21-26-17-31-32(18-27(26)22-53)45(62)57(44(31)61)36-6-7-38(58)52-43(36)60/h2-5,17-20,25,36-37,42,51H,6-16,21-24H2,1H3,(H,52,58,60)/t25-,36?,42-/m1/s1",BQMMQVMQKXUBSK-GVFWYEFESA-N
3398,P03372,ERalpha,CRBN,,ERD-3327,C[C@@H]1CC2=C(C=CC3=C2C=N[NH]3)[C@@H](C2=CC=C(N3CCC4(CCN(C(=O)CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)CC3)C=N2)N1CC(F)(F)F,C[C@@H]1CC2=C(C=CC3=C2C=N[NH]3)[C@@H](C2=CC=C(N3CCC4(CCN(C(=O)CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)CC3)C=N2)N1,CC(F)(F)F,,3.8,107.0,1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,837.904,837.3574002,3.68,61,10,10,2,6,155.15,C44H46F3N9O5,"InChI=1S/C44H46F3N9O5/c1-25-16-30-29(3-5-34-33(30)20-49-51-34)39(55(25)24-44(45,46)47)35-4-2-28(19-48-35)53-12-8-43(9-13-53)10-14-54(15-11-43)38(58)23-52-21-26-17-31-32(18-27(26)22-52)42(61)56(41(31)60)36-6-7-37(57)50-40(36)59/h2-5,17-20,25,36,39H,6-16,21-24H2,1H3,(H,49,51)(H,50,57,59)/t25-,36?,39+/m1/s1",WAIHYAJCHLPMKK-BABVPROQSA-N
3399,P03372,ERalpha,CRBN,,ERD-809,C[C@@H]1CC2=C(C=CC3=C2C=N[NH]3)[C@@H](C2=C(F)C=C(N3CCC4(CCN(C(=O)CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)CC3)C=C2F)N1CC(F)(F)F,C[C@@H]1CC2=C(C=CC3=C2C=N[NH]3)[C@@H](C2=C(F)C=C(N3CCC4(CCN(C(=O)CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)CC3)C=C2F)N1,CC(F)(F)F,,2.0,88.0,1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,872.896,872.3433076,4.92,63,10,9,2,6,142.26,C45H45F5N8O5,"InChI=1S/C45H45F5N8O5/c1-24-14-29-28(2-3-35-32(29)19-51-53-35)40(57(24)23-45(48,49)50)39-33(46)17-27(18-34(39)47)55-10-6-44(7-11-55)8-12-56(13-9-44)38(60)22-54-20-25-15-30-31(16-26(25)21-54)43(63)58(42(30)62)36-4-5-37(59)52-41(36)61/h2-3,15-19,24,36,40H,4-14,20-23H2,1H3,(H,51,53)(H,52,59,61)/t24-,36?,40+/m1/s1",LXFAGTBVIUWBOR-MJRZQNSGSA-N
3400,P03372,ERalpha,CRBN,,ERD-3111,C[C@@H]1CC2=C(C=CC3=C2C=N[NH]3)[C@@H](C2=C(F)C=C(N3CCC4(CCN(C(=O)CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)CC3)C=C2F)N1CC(F)F,C[C@@H]1CC2=C(C=CC3=C2C=N[NH]3)[C@@H](C2=C(F)C=C(N3CCC4(CCN(,C(=O)CN,5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)CC3)C=C2F)N1CC(F)F,0.5,91.0,1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,854.906,854.3527295,4.66,62,10,9,2,7,142.26,C45H46F4N8O5,"InChI=1S/C45H46F4N8O5/c1-24-14-29-28(2-3-35-32(29)19-50-52-35)41(56(24)22-37(48)49)40-33(46)17-27(18-34(40)47)54-10-6-45(7-11-54)8-12-55(13-9-45)39(59)23-53-20-25-15-30-31(16-26(25)21-53)44(62)57(43(30)61)36-4-5-38(58)51-42(36)60/h2-3,15-19,24,36-37,41H,4-14,20-23H2,1H3,(H,50,52)(H,51,58,60)/t24-,36?,41+/m1/s1",RASJDLFEGKXLIV-LQFKIQTBSA-N
3401,P03372,ERalpha,CRBN,,ERD-576,C[C@@H]1CC2=C(C=CC3=C2C=N[NH]3)[C@@H](C2=CC=C(N3CCC4(CCN(C(=O)CN5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)CC3)C=N2)N1CC(F)F,C[C@@H]1CC2=C(C=CC3=C2C=N[NH]3)[C@@H](C2=CC=C(N3CCC4(CCN(,C(=O)CN,5CC6=CC7=C(C=C6C5)C(=O)N(C5CCC(=O)NC5=O)C7=O)CC4)CC3)C=N2)N1CC(F)F,14.0,112.0,1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,819.914,819.366822,3.42,60,10,10,2,7,155.15,C44H47F2N9O5,"InChI=1S/C44H47F2N9O5/c1-25-16-30-29(3-5-34-33(30)20-48-50-34)40(54(25)23-37(45)46)35-4-2-28(19-47-35)52-12-8-44(9-13-52)10-14-53(15-11-44)39(57)24-51-21-26-17-31-32(18-27(26)22-51)43(60)55(42(31)59)36-6-7-38(56)49-41(36)58/h2-5,17-20,25,36-37,40H,6-16,21-24H2,1H3,(H,48,50)(H,49,56,58)/t25-,36?,40+/m1/s1",IJLLDTDBKVJVRA-DPUXDYCHSA-N
3402,P03372,ERalpha,CRBN,,ERD-570,COC1=CC(N2CCC3(CCN(C(=O)CN4CC5=CC6=C(C=C5C4)C(=O)N(C4CCC(=O)NC4=O)C6=O)CC3)CC2)=CC=C1[C@@H]1C2=CC=C3[NH]N=CC3=C2C[C@@H](C)N1CC(F)F,COC1=CC(N2CCC3(CCN(,C(=O)CN,4CC5=CC6=C(C=C5C4)C(=O)N(C4CCC(=O)NC4=O)C6=O)CC3)CC2)=CC=C1[C@@H]1C2=CC=C3[NH]N=CC3=C2C[C@@H](C)N1CC(F)F,1.4,82.0,1,Degradation of ERalpha in MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01186,848.952,848.3821378,4.43,62,10,10,2,8,151.49,C46H50F2N8O6,"InChI=1S/C46H50F2N8O6/c1-26-17-32-30(5-6-36-35(32)21-49-51-36)42(55(26)24-39(47)48)31-4-3-29(20-38(31)62-2)53-13-9-46(10-14-53)11-15-54(16-12-46)41(58)25-52-22-27-18-33-34(19-28(27)23-52)45(61)56(44(33)60)37-7-8-40(57)50-43(37)59/h3-6,18-21,26,37,39,42H,7-17,22-25H2,1-2H3,(H,49,51)(H,50,57,59)/t26-,37?,42+/m1/s1",ZHYXPILHQRRHFF-UYFBRPAHSA-N
3417,O15379,HDAC3,VHL,,,CCCNNC(=O)C1=CC=C(NC(=O)CCCCCCCCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)C=C1,CCCNNC(=O)C1=CC=C(,NC(=O)CCCCCCCCC(=O)N,[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)C=C1,0.6,90.0,1,Degradation of HDAC3 in THP-1 cells after 24 h treatment,86/17,% HDAC3 degradation at 500/5000 nM in THP-1 cells,40,Inhibitory of HDAC3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202310059,804.071,803.4404037,6.27,57,4,9,6,20,181.86,C43H61N7O6S,"InChI=1S/C43H61N7O6S/c1-7-24-45-49-40(54)32-20-22-33(23-21-32)47-36(52)14-12-10-8-9-11-13-15-37(53)48-39(43(4,5)6)42(56)50-26-34(51)25-35(50)41(55)46-28(2)30-16-18-31(19-17-30)38-29(3)44-27-57-38/h16-23,27-28,34-35,39,45,51H,7-15,24-26H2,1-6H3,(H,46,55)(H,47,52)(H,48,53)(H,49,54)/t28-,34+,35-,39+/m0/s1",QVKJJUGUFZBXRO-UNVCQTPUSA-N
3417,Q9BY41,HDAC8,VHL,,,CCCNNC(=O)C1=CC=C(NC(=O)CCCCCCCCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)C=C1,CCCNNC(=O)C1=CC=C(,NC(=O)CCCCCCCCC(=O)N,[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)C=C1,75.0,94.0,1,Degradation of HDAC8 in THP-1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202310059,804.071,803.4404037,6.27,57,4,9,6,20,181.86,C43H61N7O6S,"InChI=1S/C43H61N7O6S/c1-7-24-45-49-40(54)32-20-22-33(23-21-32)47-36(52)14-12-10-8-9-11-13-15-37(53)48-39(43(4,5)6)42(56)50-26-34(51)25-35(50)41(55)46-28(2)30-16-18-31(19-17-30)38-29(3)44-27-57-38/h16-23,27-28,34-35,39,45,51H,7-15,24-26H2,1-6H3,(H,46,55)(H,47,52)(H,48,53)(H,49,54)/t28-,34+,35-,39+/m0/s1",QVKJJUGUFZBXRO-UNVCQTPUSA-N
3423,P07900,HSP90alpha,CRBN,,,CC(C)C1=CC(C(=O)N2CC3=CC=C(CN4CCN(CCCCCCC(=O)NC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=C3C2)=CC=C1O,CC(C)C1=CC(C(=O)N2CC3=CC=C(CN4CCN(,CCCCCCC(=O)N,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=C3C2)=CC=C1O,295.0,66.4,0,Degradation of HSP90alpha in MCF-7 cells after 8 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,51480/16460/8930,Inhibit cell growth in MDA-MB-231/MDA-MB-468/MCF-7 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115690,762.908,762.3740979,4.04,56,7,9,3,13,159.67,C43H50N6O7,"InChI=1S/C43H50N6O7/c1-27(2)33-23-29(13-15-36(33)50)41(54)48-25-30-12-11-28(22-31(30)26-48)24-47-20-18-46(19-21-47)17-6-4-3-5-10-37(51)44-34-9-7-8-32-39(34)43(56)49(42(32)55)35-14-16-38(52)45-40(35)53/h7-9,11-13,15,22-23,27,35,50H,3-6,10,14,16-21,24-26H2,1-2H3,(H,44,51)(H,45,52,53)",LHEOCGZFVGFDNZ-UHFFFAOYSA-N
3435,Q9Y2I7,PIKfyve,VHL,,PIK5-12d,CC1=CC=CC(/C=N/NC2=CC(N3CCOCC3)=NC(OCCC3=CC=C(NC(=O)CCCCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=C3)=N2)=C1,CC1=CC=CC(/C=N/NC2=CC(N3CCOCC3)=NC(OCCC3=CC=C(,NC(=O)CCCCC(=O)N,[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=C3)=N2)=C1,1.48,97.9,1,Degradation of PIKfyve in VCaP cells after 24h treatment,97/91,% PIKfyve degradation of  in VCaP cells after 24h treatment with 100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,522.3,Inhibit cell proliferation in VCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00912,973.214,972.4680154,6.7,70,7,14,5,20,212.6,C52H64N10O7S,"InChI=1S/C52H64N10O7S/c1-34-9-8-10-38(27-34)31-55-60-43-29-44(61-22-25-68-26-23-61)58-51(57-43)69-24-21-36-15-19-40(20-16-36)56-45(64)11-6-7-12-46(65)59-48(52(3,4)5)50(67)62-32-41(63)28-42(62)49(66)53-30-37-13-17-39(18-14-37)47-35(2)54-33-70-47/h8-10,13-20,27,29,31,33,41-42,48,63H,6-7,11-12,21-26,28,30,32H2,1-5H3,(H,53,66)(H,56,64)(H,59,65)(H,57,58,60)/b55-31+/t41-,42+,48-/m1/s1",BQGREFVYIDLIFJ-CATAWDBESA-N
3499,Q15004,PCLAF,CRBN,,,C[C@@H]1CCC2[C@@H](C)[C@@H](OCCN(CCO[C@H]3O[C@@H]4O[C@@]5(C)CCC6[C@H](C)CCC([C@H]3C)[C@]64OO5)C(=O)CCCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)O[C@@H]3O[C@@]4(C)CCC1[C@@]23OO4,C[C@@H]1CCC2[C@@H](C)[C@@H](OCCN(CCO[C@H]3O[C@@H]4O[C@@]5(C)CCC6[C@H](C)CCC([C@H]3C)[C@]64OO5),C(=O)CCCCCCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)O[C@@H]3O[C@@]4(C)CCC1[C@@]23OO4,54.92,95.0,1,Degradation of PCLAF in RS4;11 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,50.6/235.3/342.8,Inhibit cell proliferation in RS4;11/RPMI8226/U266 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00824,1035.242,1034.546368,7.9,74,13,16,2,18,208.19,C55H78N4O15,"InChI=1S/C55H78N4O15/c1-31-16-18-38-33(3)48(67-50-54(38)36(31)22-24-52(5,69-50)71-73-54)65-29-27-58(28-30-66-49-34(4)39-19-17-32(2)37-23-25-53(6)70-51(68-49)55(37,39)74-72-53)43(61)15-10-8-7-9-11-26-56-40-14-12-13-35-44(40)47(64)59(46(35)63)41-20-21-42(60)57-45(41)62/h12-14,31-34,36-39,41,48-51,56H,7-11,15-30H2,1-6H3,(H,57,60,62)/t31-,32-,33-,34-,36?,37?,38?,39?,41?,48+,49+,50-,51-,52-,53-,54-,55-/m1/s1",ZLJLKXURBBWTFW-RJHWUJBZSA-N
3516,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,1000.0,19.0,0,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,751.914,751.3264365,3.09,54,6,12,5,11,201.48,C39H45N9O5S,"InChI=1S/C39H45N9O5S/c1-22(24-10-12-25(13-11-24)34-23(2)41-21-54-34)43-37(52)31-16-27(49)20-48(31)38(53)35(39(3,4)5)44-33(51)14-15-47-19-26(18-42-47)29-17-30(45-46-36(29)40)28-8-6-7-9-32(28)50/h6-13,17-19,21-22,27,31,35,49-50H,14-16,20H2,1-5H3,(H2,40,46)(H,43,52)(H,44,51)/t22-,27+,31-,35+/m0/s1",WMEBCPXSPHQTBP-CRWYZYDWSA-N
3516,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,1000.0,0.0,0,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,751.914,751.3264365,3.09,54,6,12,5,11,201.48,C39H45N9O5S,"InChI=1S/C39H45N9O5S/c1-22(24-10-12-25(13-11-24)34-23(2)41-21-54-34)43-37(52)31-16-27(49)20-48(31)38(53)35(39(3,4)5)44-33(51)14-15-47-19-26(18-42-47)29-17-30(45-46-36(29)40)28-8-6-7-9-32(28)50/h6-13,17-19,21-22,27,31,35,49-50H,14-16,20H2,1-5H3,(H2,40,46)(H,43,52)(H,44,51)/t22-,27+,31-,35+/m0/s1",WMEBCPXSPHQTBP-CRWYZYDWSA-N
3517,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,132.0,88.0,0,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,765.941,765.3420866,3.45,55,6,12,5,12,201.48,C40H47N9O5S,"InChI=1S/C40H47N9O5S/c1-23(25-12-14-26(15-13-25)35-24(2)42-22-55-35)44-38(53)32-17-28(50)21-49(32)39(54)36(40(3,4)5)45-34(52)11-8-16-48-20-27(19-43-48)30-18-31(46-47-37(30)41)29-9-6-7-10-33(29)51/h6-7,9-10,12-15,18-20,22-23,28,32,36,50-51H,8,11,16-17,21H2,1-5H3,(H2,41,47)(H,44,53)(H,45,52)/t23-,28+,32-,36+/m0/s1",QNAUPOPGMKWGCH-AQTHQPNVSA-N
3517,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,463.0,84.0,0,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,765.941,765.3420866,3.45,55,6,12,5,12,201.48,C40H47N9O5S,"InChI=1S/C40H47N9O5S/c1-23(25-12-14-26(15-13-25)35-24(2)42-22-55-35)44-38(53)32-17-28(50)21-49(32)39(54)36(40(3,4)5)45-34(52)11-8-16-48-20-27(19-43-48)30-18-31(46-47-37(30)41)29-9-6-7-10-33(29)51/h6-7,9-10,12-15,18-20,22-23,28,32,36,50-51H,8,11,16-17,21H2,1-5H3,(H2,41,47)(H,44,53)(H,45,52)/t23-,28+,32-,36+/m0/s1",QNAUPOPGMKWGCH-AQTHQPNVSA-N
3518,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,134.0,85.0,0,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,779.968,779.3577367,3.81,56,6,12,5,13,201.48,C41H49N9O5S,"InChI=1S/C41H49N9O5S/c1-24(26-13-15-27(16-14-26)36-25(2)43-23-56-36)45-39(54)33-18-29(51)22-50(33)40(55)37(41(3,4)5)46-35(53)12-8-9-17-49-21-28(20-44-49)31-19-32(47-48-38(31)42)30-10-6-7-11-34(30)52/h6-7,10-11,13-16,19-21,23-24,29,33,37,51-52H,8-9,12,17-18,22H2,1-5H3,(H2,42,48)(H,45,54)(H,46,53)/t24-,29+,33-,37+/m0/s1",ZRDNEVGTKURPRA-QSRUXFIBSA-N
3518,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,1000.0,57.0,0,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,779.968,779.3577367,3.81,56,6,12,5,13,201.48,C41H49N9O5S,"InChI=1S/C41H49N9O5S/c1-24(26-13-15-27(16-14-26)36-25(2)43-23-56-36)45-39(54)33-18-29(51)22-50(33)40(55)37(41(3,4)5)46-35(53)12-8-9-17-49-21-28(20-44-49)31-19-32(47-48-38(31)42)30-10-6-7-11-34(30)52/h6-7,10-11,13-16,19-21,23-24,29,33,37,51-52H,8-9,12,17-18,22H2,1-5H3,(H2,42,48)(H,45,54)(H,46,53)/t24-,29+,33-,37+/m0/s1",ZRDNEVGTKURPRA-QSRUXFIBSA-N
3519,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,12.0,93.0,1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,793.995,793.3733867,4.16,57,6,12,5,14,201.48,C42H51N9O5S,"InChI=1S/C42H51N9O5S/c1-25(27-14-16-28(17-15-27)37-26(2)44-24-57-37)46-40(55)34-19-30(52)23-51(34)41(56)38(42(3,4)5)47-36(54)13-7-6-10-18-50-22-29(21-45-50)32-20-33(48-49-39(32)43)31-11-8-9-12-35(31)53/h8-9,11-12,14-17,20-22,24-25,30,34,38,52-53H,6-7,10,13,18-19,23H2,1-5H3,(H2,43,49)(H,46,55)(H,47,54)/t25-,30+,34-,38+/m0/s1",NVZBZJSNIZDMHZ-IKYVMSNGSA-N
3519,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,1000.0,73.0,0,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,793.995,793.3733867,4.16,57,6,12,5,14,201.48,C42H51N9O5S,"InChI=1S/C42H51N9O5S/c1-25(27-14-16-28(17-15-27)37-26(2)44-24-57-37)46-40(55)34-19-30(52)23-51(34)41(56)38(42(3,4)5)47-36(54)13-7-6-10-18-50-22-29(21-45-50)32-20-33(48-49-39(32)43)31-11-8-9-12-35(31)53/h8-9,11-12,14-17,20-22,24-25,30,34,38,52-53H,6-7,10,13,18-19,23H2,1-5H3,(H2,43,49)(H,46,55)(H,47,54)/t25-,30+,34-,38+/m0/s1",NVZBZJSNIZDMHZ-IKYVMSNGSA-N
3520,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,16.0,89.0,1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,808.022,807.3890368,4.71,58,6,12,5,15,201.48,C43H53N9O5S,"InChI=1S/C43H53N9O5S/c1-26(28-15-17-29(18-16-28)38-27(2)45-25-58-38)47-41(56)35-20-31(53)24-52(35)42(57)39(43(3,4)5)48-37(55)14-8-6-7-11-19-51-23-30(22-46-51)33-21-34(49-50-40(33)44)32-12-9-10-13-36(32)54/h9-10,12-13,15-18,21-23,25-26,31,35,39,53-54H,6-8,11,14,19-20,24H2,1-5H3,(H2,44,50)(H,47,56)(H,48,55)/t26-,31+,35-,39+/m0/s1",RVGZNDYILKOBGV-SZKWLDFMSA-N
3520,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,212.0,81.0,0,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,808.022,807.3890368,4.71,58,6,12,5,15,201.48,C43H53N9O5S,"InChI=1S/C43H53N9O5S/c1-26(28-15-17-29(18-16-28)38-27(2)45-25-58-38)47-41(56)35-20-31(53)24-52(35)42(57)39(43(3,4)5)48-37(55)14-8-6-7-11-19-51-23-30(22-46-51)33-21-34(49-50-40(33)44)32-12-9-10-13-36(32)54/h9-10,12-13,15-18,21-23,25-26,31,35,39,53-54H,6-8,11,14,19-20,24H2,1-5H3,(H2,44,50)(H,47,56)(H,48,55)/t26-,31+,35-,39+/m0/s1",RVGZNDYILKOBGV-SZKWLDFMSA-N
3521,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,3.0,95.0,1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,822.049,821.4046869,5.25,59,6,12,5,16,201.48,C44H55N9O5S,"InChI=1S/C44H55N9O5S/c1-27(29-16-18-30(19-17-29)39-28(2)46-26-59-39)48-42(57)36-21-32(54)25-53(36)43(58)40(44(3,4)5)49-38(56)15-9-7-6-8-12-20-52-24-31(23-47-52)34-22-35(50-51-41(34)45)33-13-10-11-14-37(33)55/h10-11,13-14,16-19,22-24,26-27,32,36,40,54-55H,6-9,12,15,20-21,25H2,1-5H3,(H2,45,51)(H,48,57)(H,49,56)/t27-,32+,36-,40+/m0/s1",UAHMFJLWVDFQBK-STCARXAESA-N
3521,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,23.0,90.0,1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,822.049,821.4046869,5.25,59,6,12,5,16,201.48,C44H55N9O5S,"InChI=1S/C44H55N9O5S/c1-27(29-16-18-30(19-17-29)39-28(2)46-26-59-39)48-42(57)36-21-32(54)25-53(36)43(58)40(44(3,4)5)49-38(56)15-9-7-6-8-12-20-52-24-31(23-47-52)34-22-35(50-51-41(34)45)33-13-10-11-14-37(33)55/h10-11,13-14,16-19,22-24,26-27,32,36,40,54-55H,6-9,12,15,20-21,25H2,1-5H3,(H2,45,51)(H,48,57)(H,49,56)/t27-,32+,36-,40+/m0/s1",UAHMFJLWVDFQBK-STCARXAESA-N
3522,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,3.0,95.0,1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,836.076,835.4203369,5.79,60,6,12,5,17,201.48,C45H57N9O5S,"InChI=1S/C45H57N9O5S/c1-28(30-17-19-31(20-18-30)40-29(2)47-27-60-40)49-43(58)37-22-33(55)26-54(37)44(59)41(45(3,4)5)50-39(57)16-10-8-6-7-9-13-21-53-25-32(24-48-53)35-23-36(51-52-42(35)46)34-14-11-12-15-38(34)56/h11-12,14-15,17-20,23-25,27-28,33,37,41,55-56H,6-10,13,16,21-22,26H2,1-5H3,(H2,46,52)(H,49,58)(H,50,57)/t28-,33+,37-,41+/m0/s1",NAAJTPJKFIVOCL-LVMPZMPGSA-N
3522,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,31.0,93.0,1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,836.076,835.4203369,5.79,60,6,12,5,17,201.48,C45H57N9O5S,"InChI=1S/C45H57N9O5S/c1-28(30-17-19-31(20-18-30)40-29(2)47-27-60-40)49-43(58)37-22-33(55)26-54(37)44(59)41(45(3,4)5)50-39(57)16-10-8-6-7-9-13-21-53-25-32(24-48-53)35-23-36(51-52-42(35)46)34-14-11-12-15-38(34)56/h11-12,14-15,17-20,23-25,27-28,33,37,41,55-56H,6-10,13,16,21-22,26H2,1-5H3,(H2,46,52)(H,49,58)(H,50,57)/t28-,33+,37-,41+/m0/s1",NAAJTPJKFIVOCL-LVMPZMPGSA-N
3523,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,2.0,93.0,1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,850.103,849.435987,6.33,61,6,12,5,18,201.48,C46H59N9O5S,"InChI=1S/C46H59N9O5S/c1-29(31-18-20-32(21-19-31)41-30(2)48-28-61-41)50-44(59)38-23-34(56)27-55(38)45(60)42(46(3,4)5)51-40(58)17-11-9-7-6-8-10-14-22-54-26-33(25-49-54)36-24-37(52-53-43(36)47)35-15-12-13-16-39(35)57/h12-13,15-16,18-21,24-26,28-29,34,38,42,56-57H,6-11,14,17,22-23,27H2,1-5H3,(H2,47,53)(H,50,59)(H,51,58)/t29-,34+,38-,42+/m0/s1",DOMKEVZKZDAYBX-NXUMEATPSA-N
3523,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,8.0,94.0,1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,850.103,849.435987,6.33,61,6,12,5,18,201.48,C46H59N9O5S,"InChI=1S/C46H59N9O5S/c1-29(31-18-20-32(21-19-31)41-30(2)48-28-61-41)50-44(59)38-23-34(56)27-55(38)45(60)42(46(3,4)5)51-40(58)17-11-9-7-6-8-10-14-22-54-26-33(25-49-54)36-24-37(52-53-43(36)47)35-15-12-13-16-39(35)57/h12-13,15-16,18-21,24-26,28-29,34,38,42,56-57H,6-11,14,17,22-23,27H2,1-5H3,(H2,47,53)(H,50,59)(H,51,58)/t29-,34+,38-,42+/m0/s1",DOMKEVZKZDAYBX-NXUMEATPSA-N
3524,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,6.0,93.0,1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,864.13,863.4516371,6.87,62,6,12,5,19,201.48,C47H61N9O5S,"InChI=1S/C47H61N9O5S/c1-30(32-19-21-33(22-20-32)42-31(2)49-29-62-42)51-45(60)39-24-35(57)28-56(39)46(61)43(47(3,4)5)52-41(59)18-12-10-8-6-7-9-11-15-23-55-27-34(26-50-55)37-25-38(53-54-44(37)48)36-16-13-14-17-40(36)58/h13-14,16-17,19-22,25-27,29-30,35,39,43,57-58H,6-12,15,18,23-24,28H2,1-5H3,(H2,48,54)(H,51,60)(H,52,59)/t30-,35+,39-,43+/m0/s1",NKSDXVLDAPUIEJ-LHSLIBFUSA-N
3524,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,47.0,87.0,1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,864.13,863.4516371,6.87,62,6,12,5,19,201.48,C47H61N9O5S,"InChI=1S/C47H61N9O5S/c1-30(32-19-21-33(22-20-32)42-31(2)49-29-62-42)51-45(60)39-24-35(57)28-56(39)46(61)43(47(3,4)5)52-41(59)18-12-10-8-6-7-9-11-15-23-55-27-34(26-50-55)37-25-38(53-54-44(37)48)36-16-13-14-17-40(36)58/h13-14,16-17,19-22,25-27,29-30,35,39,43,57-58H,6-12,15,18,23-24,28H2,1-5H3,(H2,48,54)(H,51,60)(H,52,59)/t30-,35+,39-,43+/m0/s1",NKSDXVLDAPUIEJ-LHSLIBFUSA-N
3525,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCCCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,3.0,95.0,1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,878.157,877.4672871,7.41,63,6,12,5,20,201.48,C48H63N9O5S,"InChI=1S/C48H63N9O5S/c1-31(33-20-22-34(23-21-33)43-32(2)50-30-63-43)52-46(61)40-25-36(58)29-57(40)47(62)44(48(3,4)5)53-42(60)19-13-11-9-7-6-8-10-12-16-24-56-28-35(27-51-56)38-26-39(54-55-45(38)49)37-17-14-15-18-41(37)59/h14-15,17-18,20-23,26-28,30-31,36,40,44,58-59H,6-13,16,19,24-25,29H2,1-5H3,(H2,49,55)(H,52,61)(H,53,60)/t31-,36+,40-,44+/m0/s1",VFCKFYFVFDCREF-UOKCIILFSA-N
3525,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCCCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,13.0,96.0,1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,878.157,877.4672871,7.41,63,6,12,5,20,201.48,C48H63N9O5S,"InChI=1S/C48H63N9O5S/c1-31(33-20-22-34(23-21-33)43-32(2)50-30-63-43)52-46(61)40-25-36(58)29-57(40)47(62)44(48(3,4)5)53-42(60)19-13-11-9-7-6-8-10-12-16-24-56-28-35(27-51-56)38-26-39(54-55-45(38)49)37-17-14-15-18-41(37)59/h14-15,17-18,20-23,26-28,30-31,36,40,44,58-59H,6-13,16,19,24-25,29H2,1-5H3,(H2,49,55)(H,52,61)(H,53,60)/t31-,36+,40-,44+/m0/s1",VFCKFYFVFDCREF-UOKCIILFSA-N
3526,P51531,SMARCA2,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](,CC(=O)NCCCCCC,N2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,18.0,86.0,1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,875.069,874.3948504,4.21,63,7,14,5,18,227.51,C46H54N10O6S,"InChI=1S/C46H54N10O6S/c1-27(2)42(40-19-28(3)54-62-40)46(61)56-25-33(57)20-38(56)45(60)51-36(30-13-15-31(16-14-30)43-29(4)49-26-63-43)22-41(59)48-17-9-5-6-10-18-55-24-32(23-50-55)35-21-37(52-53-44(35)47)34-11-7-8-12-39(34)58/h7-8,11-16,19,21,23-24,26-27,33,36,38,42,57-58H,5-6,9-10,17-18,20,22,25H2,1-4H3,(H2,47,53)(H,48,59)(H,51,60)/t33-,36+,38+,42+/m1/s1",AJYXITCISXKKRG-NRMCDFMFSA-N
3526,P51532,SMARCA4,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](,CC(=O)NCCCCCC,N2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,213.0,84.0,0,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,875.069,874.3948504,4.21,63,7,14,5,18,227.51,C46H54N10O6S,"InChI=1S/C46H54N10O6S/c1-27(2)42(40-19-28(3)54-62-40)46(61)56-25-33(57)20-38(56)45(60)51-36(30-13-15-31(16-14-30)43-29(4)49-26-63-43)22-41(59)48-17-9-5-6-10-18-55-24-32(23-50-55)35-21-37(52-53-44(35)47)34-11-7-8-12-39(34)58/h7-8,11-16,19,21,23-24,26-27,33,36,38,42,57-58H,5-6,9-10,17-18,20,22,25H2,1-4H3,(H2,47,53)(H,48,59)(H,51,60)/t33-,36+,38+,42+/m1/s1",AJYXITCISXKKRG-NRMCDFMFSA-N
3527,P51531,SMARCA2,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](,CC(=O)NCCCCCCC,N2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,96.0,91.0,1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,889.096,888.4105005,4.75,64,7,14,5,19,227.51,C47H56N10O6S,"InChI=1S/C47H56N10O6S/c1-28(2)43(41-20-29(3)55-63-41)47(62)57-26-34(58)21-39(57)46(61)52-37(31-14-16-32(17-15-31)44-30(4)50-27-64-44)23-42(60)49-18-10-6-5-7-11-19-56-25-33(24-51-56)36-22-38(53-54-45(36)48)35-12-8-9-13-40(35)59/h8-9,12-17,20,22,24-25,27-28,34,37,39,43,58-59H,5-7,10-11,18-19,21,23,26H2,1-4H3,(H2,48,54)(H,49,60)(H,52,61)/t34-,37+,39+,43+/m1/s1",DUKQQJLHIWJHMV-JTPFYNRPSA-N
3527,P51532,SMARCA4,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](,CC(=O)NCCCCCCC,N2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,91.0,92.0,1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,889.096,888.4105005,4.75,64,7,14,5,19,227.51,C47H56N10O6S,"InChI=1S/C47H56N10O6S/c1-28(2)43(41-20-29(3)55-63-41)47(62)57-26-34(58)21-39(57)46(61)52-37(31-14-16-32(17-15-31)44-30(4)50-27-64-44)23-42(60)49-18-10-6-5-7-11-19-56-25-33(24-51-56)36-22-38(53-54-45(36)48)35-12-8-9-13-40(35)59/h8-9,12-17,20,22,24-25,27-28,34,37,39,43,58-59H,5-7,10-11,18-19,21,23,26H2,1-4H3,(H2,48,54)(H,49,60)(H,52,61)/t34-,37+,39+,43+/m1/s1",DUKQQJLHIWJHMV-JTPFYNRPSA-N
3528,P51531,SMARCA2,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](,CC(=O)NCCCCCCCC,N2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,67.0,91.0,1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,903.123,902.4261506,5.29,65,7,14,5,20,227.51,C48H58N10O6S,"InChI=1S/C48H58N10O6S/c1-29(2)44(42-21-30(3)56-64-42)48(63)58-27-35(59)22-40(58)47(62)53-38(32-15-17-33(18-16-32)45-31(4)51-28-65-45)24-43(61)50-19-11-7-5-6-8-12-20-57-26-34(25-52-57)37-23-39(54-55-46(37)49)36-13-9-10-14-41(36)60/h9-10,13-18,21,23,25-26,28-29,35,38,40,44,59-60H,5-8,11-12,19-20,22,24,27H2,1-4H3,(H2,49,55)(H,50,61)(H,53,62)/t35-,38+,40+,44+/m1/s1",WZAJDWUHOWVKTB-SZNIMANLSA-N
3528,P51532,SMARCA4,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](,CC(=O)NCCCCCCCC,N2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,66.0,93.0,1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,903.123,902.4261506,5.29,65,7,14,5,20,227.51,C48H58N10O6S,"InChI=1S/C48H58N10O6S/c1-29(2)44(42-21-30(3)56-64-42)48(63)58-27-35(59)22-40(58)47(62)53-38(32-15-17-33(18-16-32)45-31(4)51-28-65-45)24-43(61)50-19-11-7-5-6-8-12-20-57-26-34(25-52-57)37-23-39(54-55-46(37)49)36-13-9-10-14-41(36)60/h9-10,13-18,21,23,25-26,28-29,35,38,40,44,59-60H,5-8,11-12,19-20,22,24,27H2,1-4H3,(H2,49,55)(H,50,61)(H,53,62)/t35-,38+,40+,44+/m1/s1",WZAJDWUHOWVKTB-SZNIMANLSA-N
3529,P51531,SMARCA2,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](,CC(=O)NCCCCCCCCC,N2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,71.0,94.0,1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,917.15,916.4418006,5.83,66,7,14,5,21,227.51,C49H60N10O6S,"InChI=1S/C49H60N10O6S/c1-30(2)45(43-22-31(3)57-65-43)49(64)59-28-36(60)23-41(59)48(63)54-39(33-16-18-34(19-17-33)46-32(4)52-29-66-46)25-44(62)51-20-12-8-6-5-7-9-13-21-58-27-35(26-53-58)38-24-40(55-56-47(38)50)37-14-10-11-15-42(37)61/h10-11,14-19,22,24,26-27,29-30,36,39,41,45,60-61H,5-9,12-13,20-21,23,25,28H2,1-4H3,(H2,50,56)(H,51,62)(H,54,63)/t36-,39+,41+,45+/m1/s1",OLNHVDRHEGVZMV-YOKDRVLNSA-N
3529,P51532,SMARCA4,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](,CC(=O)NCCCCCCCCC,N2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,75.0,94.0,1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,917.15,916.4418006,5.83,66,7,14,5,21,227.51,C49H60N10O6S,"InChI=1S/C49H60N10O6S/c1-30(2)45(43-22-31(3)57-65-43)49(64)59-28-36(60)23-41(59)48(63)54-39(33-16-18-34(19-17-33)46-32(4)52-29-66-46)25-44(62)51-20-12-8-6-5-7-9-13-21-58-27-35(26-53-58)38-24-40(55-56-47(38)50)37-14-10-11-15-42(37)61/h10-11,14-19,22,24,26-27,29-30,36,39,41,45,60-61H,5-9,12-13,20-21,23,25,28H2,1-4H3,(H2,50,56)(H,51,62)(H,54,63)/t36-,39+,41+,45+/m1/s1",OLNHVDRHEGVZMV-YOKDRVLNSA-N
3530,P51531,SMARCA2,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](,CC(=O)NCCCCCCCCCC,N2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,37.0,95.0,1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,931.177,930.4574507,6.37,67,7,14,5,22,227.51,C50H62N10O6S,"InChI=1S/C50H62N10O6S/c1-31(2)46(44-23-32(3)58-66-44)50(65)60-29-37(61)24-42(60)49(64)55-40(34-17-19-35(20-18-34)47-33(4)53-30-67-47)26-45(63)52-21-13-9-7-5-6-8-10-14-22-59-28-36(27-54-59)39-25-41(56-57-48(39)51)38-15-11-12-16-43(38)62/h11-12,15-20,23,25,27-28,30-31,37,40,42,46,61-62H,5-10,13-14,21-22,24,26,29H2,1-4H3,(H2,51,57)(H,52,63)(H,55,64)/t37-,40+,42+,46+/m1/s1",MZJPOLYUIZRRPP-REZXPVIVSA-N
3530,P51532,SMARCA4,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](,CC(=O)NCCCCCCCCCC,N2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,53.0,93.0,1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,931.177,930.4574507,6.37,67,7,14,5,22,227.51,C50H62N10O6S,"InChI=1S/C50H62N10O6S/c1-31(2)46(44-23-32(3)58-66-44)50(65)60-29-37(61)24-42(60)49(64)55-40(34-17-19-35(20-18-34)47-33(4)53-30-67-47)26-45(63)52-21-13-9-7-5-6-8-10-14-22-59-28-36(27-54-59)39-25-41(56-57-48(39)51)38-15-11-12-16-43(38)62/h11-12,15-20,23,25,27-28,30-31,37,40,42,46,61-62H,5-10,13-14,21-22,24,26,29H2,1-4H3,(H2,51,57)(H,52,63)(H,55,64)/t37-,40+,42+,46+/m1/s1",MZJPOLYUIZRRPP-REZXPVIVSA-N
3531,P51531,SMARCA2,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](,CC(=O)NCCCCCCCCCCCC,N2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,46.0,93.0,1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,959.231,958.4887508,7.46,69,7,14,5,24,227.51,C52H66N10O6S,"InChI=1S/C52H66N10O6S/c1-33(2)48(46-25-34(3)60-68-46)52(67)62-31-39(63)26-44(62)51(66)57-42(36-19-21-37(22-20-36)49-35(4)55-32-69-49)28-47(65)54-23-15-11-9-7-5-6-8-10-12-16-24-61-30-38(29-56-61)41-27-43(58-59-50(41)53)40-17-13-14-18-45(40)64/h13-14,17-22,25,27,29-30,32-33,39,42,44,48,63-64H,5-12,15-16,23-24,26,28,31H2,1-4H3,(H2,53,59)(H,54,65)(H,57,66)/t39-,42+,44+,48+/m1/s1",MLZVIASYUVCSEA-XOZNCJPQSA-N
3531,P51532,SMARCA4,VHL,,,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCCCCCCCCCN2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,CC1=NOC([C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](,CC(=O)NCCCCCCCCCCCC,N2C=C(C3=CC(C4=CC=CC=C4O)=NN=C3N)C=N2)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,90.0,89.0,1,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,959.231,958.4887508,7.46,69,7,14,5,24,227.51,C52H66N10O6S,"InChI=1S/C52H66N10O6S/c1-33(2)48(46-25-34(3)60-68-46)52(67)62-31-39(63)26-44(62)51(66)57-42(36-19-21-37(22-20-36)49-35(4)55-32-69-49)28-47(65)54-23-15-11-9-7-5-6-8-10-12-16-24-61-30-38(29-56-61)41-27-43(58-59-50(41)53)40-17-13-14-18-45(40)64/h13-14,17-22,25,27,29-30,32-33,39,42,44,48,63-64H,5-12,15-16,23-24,26,28,31H2,1-4H3,(H2,53,59)(H,54,65)(H,57,66)/t39-,42+,44+,48+/m1/s1",MLZVIASYUVCSEA-XOZNCJPQSA-N
3532,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,455.0,70.5,0,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,870.046,869.3894307,2.75,62,6,15,5,19,229.17,C44H55N9O8S,"InChI=1S/C44H55N9O8S/c1-27(29-10-12-30(13-11-29)39-28(2)46-26-62-39)48-42(57)36-20-32(54)24-53(36)43(58)40(44(3,4)5)49-38(56)25-61-19-18-60-17-16-59-15-14-52-23-31(22-47-52)34-21-35(50-51-41(34)45)33-8-6-7-9-37(33)55/h6-13,21-23,26-27,32,36,40,54-55H,14-20,24-25H2,1-5H3,(H2,45,51)(H,48,57)(H,49,56)/t27-,32+,36-,40+/m0/s1",AKBJWICECZPIMD-STCARXAESA-N
3532,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,1000.0,46.5,0,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,870.046,869.3894307,2.75,62,6,15,5,19,229.17,C44H55N9O8S,"InChI=1S/C44H55N9O8S/c1-27(29-10-12-30(13-11-29)39-28(2)46-26-62-39)48-42(57)36-20-32(54)24-53(36)43(58)40(44(3,4)5)49-38(56)25-61-19-18-60-17-16-59-15-14-52-23-31(22-47-52)34-21-35(50-51-41(34)45)33-8-6-7-9-37(33)55/h6-13,21-23,26-27,32,36,40,54-55H,14-20,24-25H2,1-5H3,(H2,45,51)(H,48,57)(H,49,56)/t27-,32+,36-,40+/m0/s1",AKBJWICECZPIMD-STCARXAESA-N
3533,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCOCCOCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCOCCOCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,313.0,76.5,0,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,840.02,839.378866,2.8,60,6,14,5,17,219.94,C43H53N9O7S,"InChI=1S/C43H53N9O7S/c1-26(28-10-12-29(13-11-28)38-27(2)45-25-60-38)47-41(56)35-20-31(53)24-52(35)42(57)39(43(3,4)5)48-37(55)14-16-58-18-19-59-17-15-51-23-30(22-46-51)33-21-34(49-50-40(33)44)32-8-6-7-9-36(32)54/h6-13,21-23,25-26,31,35,39,53-54H,14-20,24H2,1-5H3,(H2,44,50)(H,47,56)(H,48,55)/t26-,31+,35-,39+/m0/s1",HSTRRNDJSXXGTP-SZKWLDFMSA-N
3533,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCOCCOCCN3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCOCCOCC,N3C=C(C4=CC(C5=CC=CC=C5O)=NN=C4N)C=N3)C(C)(C)C)C=C2)SC=N1,1000.0,58.5,0,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,840.02,839.378866,2.8,60,6,14,5,17,219.94,C43H53N9O7S,"InChI=1S/C43H53N9O7S/c1-26(28-10-12-29(13-11-28)38-27(2)45-25-60-38)47-41(56)35-20-31(53)24-52(35)42(57)39(43(3,4)5)48-37(55)14-16-58-18-19-59-17-15-51-23-30(22-46-51)33-21-34(49-50-40(33)44)32-8-6-7-9-36(32)54/h6-13,21-23,25-26,31,35,39,53-54H,14-20,24H2,1-5H3,(H2,44,50)(H,47,56)(H,48,55)/t26-,31+,35-,39+/m0/s1",HSTRRNDJSXXGTP-SZKWLDFMSA-N
3534,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCN3CCN(CCCN4C=C(C5=CC(C6=CC=CC=C6O)=NN=C5N)C=N4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCN,3CCN(CCCN4C=C(C5=CC(C6=CC=CC=C6O)=NN=C5N)C=N4)CC3)C(C)(C)C)C=C2)SC=N1,682.0,62.0,0,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,878.117,877.442135,3.3,63,7,14,5,15,207.96,C46H59N11O5S,"InChI=1S/C46H59N11O5S/c1-29(31-11-13-32(14-12-31)41-30(2)48-28-63-41)50-44(61)38-23-34(58)27-57(38)45(62)42(46(3,4)5)51-40(60)15-18-55-21-19-54(20-22-55)16-8-17-56-26-33(25-49-56)36-24-37(52-53-43(36)47)35-9-6-7-10-39(35)59/h6-7,9-14,24-26,28-29,34,38,42,58-59H,8,15-23,27H2,1-5H3,(H2,47,53)(H,50,61)(H,51,60)/t29-,34+,38-,42+/m0/s1",PTCYFAOYSKJZCC-NXUMEATPSA-N
3534,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCN3CCN(CCCN4C=C(C5=CC(C6=CC=CC=C6O)=NN=C5N)C=N4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCN,3CCN(CCCN4C=C(C5=CC(C6=CC=CC=C6O)=NN=C5N)C=N4)CC3)C(C)(C)C)C=C2)SC=N1,585.0,76.0,0,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,878.117,877.442135,3.3,63,7,14,5,15,207.96,C46H59N11O5S,"InChI=1S/C46H59N11O5S/c1-29(31-11-13-32(14-12-31)41-30(2)48-28-63-41)50-44(61)38-23-34(58)27-57(38)45(62)42(46(3,4)5)51-40(60)15-18-55-21-19-54(20-22-55)16-8-17-56-26-33(25-49-56)36-24-37(52-53-43(36)47)35-9-6-7-10-39(35)59/h6-7,9-14,24-26,28-29,34,38,42,58-59H,8,15-23,27H2,1-5H3,(H2,47,53)(H,50,61)(H,51,60)/t29-,34+,38-,42+/m0/s1",PTCYFAOYSKJZCC-NXUMEATPSA-N
3535,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCN3CCC(CCCN4C=C(C5=CC(C6=CC=CC=C6O)=NN=C5N)C=N4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCN,3CCC(CCCN4C=C(C5=CC(C6=CC=CC=C6O)=NN=C5N)C=N4)CC3)C(C)(C)C)C=C2)SC=N1,1000.0,12.0,0,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,877.129,876.446886,4.59,63,7,13,5,15,204.72,C47H60N10O5S,"InChI=1S/C47H60N10O5S/c1-29(32-12-14-33(15-13-32)42-30(2)49-28-63-42)51-45(61)39-23-35(58)27-57(39)46(62)43(47(3,4)5)52-41(60)18-22-55-20-16-31(17-21-55)9-8-19-56-26-34(25-50-56)37-24-38(53-54-44(37)48)36-10-6-7-11-40(36)59/h6-7,10-15,24-26,28-29,31,35,39,43,58-59H,8-9,16-23,27H2,1-5H3,(H2,48,54)(H,51,61)(H,52,60)/t29-,35+,39-,43+/m0/s1",UUUQRHRNYAGRFZ-UWCRVIMOSA-N
3535,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCN3CCC(CCCN4C=C(C5=CC(C6=CC=CC=C6O)=NN=C5N)C=N4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCN,3CCC(CCCN4C=C(C5=CC(C6=CC=CC=C6O)=NN=C5N)C=N4)CC3)C(C)(C)C)C=C2)SC=N1,1000.0,0.0,0,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,877.129,876.446886,4.59,63,7,13,5,15,204.72,C47H60N10O5S,"InChI=1S/C47H60N10O5S/c1-29(32-12-14-33(15-13-32)42-30(2)49-28-63-42)51-45(61)39-23-35(58)27-57(39)46(62)43(47(3,4)5)52-41(60)18-22-55-20-16-31(17-21-55)9-8-19-56-26-34(25-50-56)37-24-38(53-54-44(37)48)36-10-6-7-11-40(36)59/h6-7,10-15,24-26,28-29,31,35,39,43,58-59H,8-9,16-23,27H2,1-5H3,(H2,48,54)(H,51,61)(H,52,60)/t29-,35+,39-,43+/m0/s1",UUUQRHRNYAGRFZ-UWCRVIMOSA-N
3536,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCN3CCC(N4C=C(C5=CC(C6=CC=CC=C6O)=NN=C5N)C=N4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCN,3CCC(N4C=C(C5=CC(C6=CC=CC=C6O)=NN=C5N)C=N4)CC3)C(C)(C)C)C=C2)SC=N1,6.0,94.0,1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,877.129,876.446886,4.73,63,7,13,5,15,204.72,C47H60N10O5S,"InChI=1S/C47H60N10O5S/c1-29(31-14-16-32(17-15-31)42-30(2)49-28-63-42)51-45(61)39-23-35(58)27-56(39)46(62)43(47(3,4)5)52-41(60)13-7-6-10-20-55-21-18-34(19-22-55)57-26-33(25-50-57)37-24-38(53-54-44(37)48)36-11-8-9-12-40(36)59/h8-9,11-12,14-17,24-26,28-29,34-35,39,43,58-59H,6-7,10,13,18-23,27H2,1-5H3,(H2,48,54)(H,51,61)(H,52,60)/t29-,35+,39-,43+/m0/s1",ONPKOOOYNSWZGQ-UWCRVIMOSA-N
3536,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCN3CCC(N4C=C(C5=CC(C6=CC=CC=C6O)=NN=C5N)C=N4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCN,3CCC(N4C=C(C5=CC(C6=CC=CC=C6O)=NN=C5N)C=N4)CC3)C(C)(C)C)C=C2)SC=N1,248.0,77.0,0,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,877.129,876.446886,4.73,63,7,13,5,15,204.72,C47H60N10O5S,"InChI=1S/C47H60N10O5S/c1-29(31-14-16-32(17-15-31)42-30(2)49-28-63-42)51-45(61)39-23-35(58)27-56(39)46(62)43(47(3,4)5)52-41(60)13-7-6-10-20-55-21-18-34(19-22-55)57-26-33(25-50-57)37-24-38(53-54-44(37)48)36-11-8-9-12-40(36)59/h8-9,11-12,14-17,24-26,28-29,34-35,39,43,58-59H,6-7,10,13,18-23,27H2,1-5H3,(H2,48,54)(H,51,61)(H,52,60)/t29-,35+,39-,43+/m0/s1",ONPKOOOYNSWZGQ-UWCRVIMOSA-N
3537,P51531,SMARCA2,VHL,,SMD-3040,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3CC[C@H](CN4CC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H],(C)NC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3CC[C@H](CN4CC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,12.0,91.0,1,Degradation of SMARCA2 proteins by the HiBit degradation assay/in SK-Mel-28 cells for 24h/in SK-Mel-5 cells for 24h/in H838 cells for 24h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,943.232,942.4938362,5.75,68,9,13,5,12,204.72,C52H66N10O5S,"InChI=1S/C52H66N10O5S/c1-31(34-14-16-35(17-15-34)45-32(2)54-30-68-45)56-49(66)43-22-39(63)27-61(43)50(67)46(51(3,4)5)57-48(65)36-12-10-33(11-13-36)25-60-28-52(29-60)20-18-38(19-21-52)62-26-37(24-55-62)41-23-42(58-59-47(41)53)40-8-6-7-9-44(40)64/h6-9,14-17,23-24,26,30-31,33,36,38-39,43,46,63-64H,10-13,18-22,25,27-29H2,1-5H3,(H2,53,59)(H,56,66)(H,57,65)/t31-,33-,36-,39+,43-,46+/m0/s1",GMCWCUOAGNWNLO-YTZIVEPUSA-N
3537,P51532,SMARCA4,VHL,,SMD-3040,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3CC[C@H](CN4CC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H],(C)NC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3CC[C@H](CN4CC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,1000.0,44.0,0,Degradation of SMARCA4 proteins by the HiBit degradation assay/in SK-Mel-28 cells for 24h ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,943.232,942.4938362,5.75,68,9,13,5,12,204.72,C52H66N10O5S,"InChI=1S/C52H66N10O5S/c1-31(34-14-16-35(17-15-34)45-32(2)54-30-68-45)56-49(66)43-22-39(63)27-61(43)50(67)46(51(3,4)5)57-48(65)36-12-10-33(11-13-36)25-60-28-52(29-60)20-18-38(19-21-52)62-26-37(24-55-62)41-23-42(58-59-47(41)53)40-8-6-7-9-44(40)64/h6-9,14-17,23-24,26,30-31,33,36,38-39,43,46,63-64H,10-13,18-22,25,27-29H2,1-5H3,(H2,53,59)(H,56,66)(H,57,65)/t31-,33-,36-,39+,43-,46+/m0/s1",GMCWCUOAGNWNLO-YTZIVEPUSA-N
3538,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3CC[C@H](CN4CCC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)CC4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H],(C)NC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3CC[C@H](CN4CCC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)CC4)CC3)C(C)(C)C)C=C2)SC=N1,5.0,90.0,1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,971.286,970.5251363,6.47,70,9,13,5,12,204.72,C54H70N10O5S,"InChI=1S/C54H70N10O5S/c1-33(36-14-16-37(17-15-36)47-34(2)56-32-70-47)58-51(68)45-26-41(65)31-63(45)52(69)48(53(3,4)5)59-50(67)38-12-10-35(11-13-38)29-62-24-22-54(23-25-62)20-18-40(19-21-54)64-30-39(28-57-64)43-27-44(60-61-49(43)55)42-8-6-7-9-46(42)66/h6-9,14-17,27-28,30,32-33,35,38,40-41,45,48,65-66H,10-13,18-26,29,31H2,1-5H3,(H2,55,61)(H,58,68)(H,59,67)/t33-,35-,38-,41+,45-,48+/m0/s1",UVAFNIDORKJQQG-VZZHBTBASA-N
3538,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3CC[C@H](CN4CCC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)CC4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H],(C)NC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3CC[C@H](CN4CCC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)CC4)CC3)C(C)(C)C)C=C2)SC=N1,219.0,66.0,0,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,971.286,970.5251363,6.47,70,9,13,5,12,204.72,C54H70N10O5S,"InChI=1S/C54H70N10O5S/c1-33(36-14-16-37(17-15-36)47-34(2)56-32-70-47)58-51(68)45-26-41(65)31-63(45)52(69)48(53(3,4)5)59-50(67)38-12-10-35(11-13-38)29-62-24-22-54(23-25-62)20-18-40(19-21-54)64-30-39(28-57-64)43-27-44(60-61-49(43)55)42-8-6-7-9-46(42)66/h6-9,14-17,27-28,30,32-33,35,38,40-41,45,48,65-66H,10-13,18-26,29,31H2,1-5H3,(H2,55,61)(H,58,68)(H,59,67)/t33-,35-,38-,41+,45-,48+/m0/s1",UVAFNIDORKJQQG-VZZHBTBASA-N
3539,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3CCC(N4CC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H],(C)NC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3CCC(N4CC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,25.0,85.0,1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,929.205,928.4781861,5.56,67,9,13,5,11,204.72,C51H64N10O5S,"InChI=1S/C51H64N10O5S/c1-30(32-10-12-33(13-11-32)44-31(2)53-29-67-44)55-48(65)42-22-38(62)26-60(42)49(66)45(50(3,4)5)56-47(64)34-14-16-36(17-15-34)59-27-51(28-59)20-18-37(19-21-51)61-25-35(24-54-61)40-23-41(57-58-46(40)52)39-8-6-7-9-43(39)63/h6-13,23-25,29-30,34,36-38,42,45,62-63H,14-22,26-28H2,1-5H3,(H2,52,58)(H,55,65)(H,56,64)/t30-,34?,36?,38+,42-,45+/m0/s1",MXFZXZUWICUBOI-VVBCONDBSA-N
3539,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3CCC(N4CC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H],(C)NC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3CCC(N4CC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)C4)CC3)C(C)(C)C)C=C2)SC=N1,1000.0,55.0,0,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,929.205,928.4781861,5.56,67,9,13,5,11,204.72,C51H64N10O5S,"InChI=1S/C51H64N10O5S/c1-30(32-10-12-33(13-11-32)44-31(2)53-29-67-44)55-48(65)42-22-38(62)26-60(42)49(66)45(50(3,4)5)56-47(64)34-14-16-36(17-15-34)59-27-51(28-59)20-18-37(19-21-51)61-25-35(24-54-61)40-23-41(57-58-46(40)52)39-8-6-7-9-43(39)63/h6-13,23-25,29-30,34,36-38,42,45,62-63H,14-22,26-28H2,1-5H3,(H2,52,58)(H,55,65)(H,56,64)/t30-,34?,36?,38+,42-,45+/m0/s1",MXFZXZUWICUBOI-VVBCONDBSA-N
3540,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3CCC(N4CCC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)CC4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H],(C)NC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3CCC(N4CCC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)CC4)CC3)C(C)(C)C)C=C2)SC=N1,34.0,90.0,1,Degradation of SMARCA2 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,957.259,956.5094863,6.27,69,9,13,5,11,204.72,C53H68N10O5S,"InChI=1S/C53H68N10O5S/c1-32(34-10-12-35(13-11-34)46-33(2)55-31-69-46)57-50(67)44-26-40(64)30-62(44)51(68)47(52(3,4)5)58-49(66)36-14-16-38(17-15-36)61-24-22-53(23-25-61)20-18-39(19-21-53)63-29-37(28-56-63)42-27-43(59-60-48(42)54)41-8-6-7-9-45(41)65/h6-13,27-29,31-32,36,38-40,44,47,64-65H,14-26,30H2,1-5H3,(H2,54,60)(H,57,67)(H,58,66)/t32-,36?,38?,40+,44-,47+/m0/s1",GEFVFURTMGEFHQ-FIHKADGOSA-N
3540,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3CCC(N4CCC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)CC4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H],(C)NC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3CCC(N4CCC5(CCC(N6C=C(C7=CC(C8=CC=CC=C8O)=NN=C7N)C=N6)CC5)CC4)CC3)C(C)(C)C)C=C2)SC=N1,315.0,72.0,0,Degradation of SMARCA4 proteins by the HiBit degradation assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00953,957.259,956.5094863,6.27,69,9,13,5,11,204.72,C53H68N10O5S,"InChI=1S/C53H68N10O5S/c1-32(34-10-12-35(13-11-34)46-33(2)55-31-69-46)57-50(67)44-26-40(64)30-62(44)51(68)47(52(3,4)5)58-49(66)36-14-16-38(17-15-36)61-24-22-53(23-25-61)20-18-39(19-21-53)63-29-37(28-56-63)42-27-43(59-60-48(42)54)41-8-6-7-9-45(41)65/h6-13,27-29,31-32,36,38-40,44,47,64-65H,14-26,30H2,1-5H3,(H2,54,60)(H,57,67)(H,58,66)/t32-,36?,38?,40+,44-,47+/m0/s1",GEFVFURTMGEFHQ-FIHKADGOSA-N
3553,Q06187,BTK,CRBN,,,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CC2=CC=C(C#CC3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)N=C2)CC1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CC2=CC=C(,C#CC,3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)N=C2)CC1,51.1,97.75,1,Degradation of BTK in Ramos cells after 24 h treatment,62.68,% BTK degradation in Ramos cells after 24 h treatment at 100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115664,840.945,840.3496145,4.94,63,10,13,2,8,181.77,C48H44N10O5,"InChI=1S/C48H44N10O5/c49-44-42-43(32-8-13-37(14-9-32)63-36-4-2-1-3-5-36)54-58(45(42)52-29-51-44)34-20-22-55(23-21-34)28-31-7-11-33(50-27-31)10-6-30-18-24-56(25-19-30)35-12-15-38-39(26-35)48(62)57(47(38)61)40-16-17-41(59)53-46(40)60/h1-5,7-9,11-15,26-27,29-30,34,40H,16-25,28H2,(H2,49,51,52)(H,53,59,60)",XMWSKICAFPPYSY-UHFFFAOYSA-N
3554,Q06187,BTK,CRBN,,,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(C(=O)C2=CC=C(N3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)N=C2)CC1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(,C(=O),C2=CC=C(N3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)N=C2)CC1,26.87,97.78,1,Degradation of BTK in Ramos cells after 24 h treatment,71.7,% BTK degradation in Ramos cells after 24 h treatment at 100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115664,831.894,831.324128,3.82,62,10,14,2,8,202.08,C45H41N11O6,"InChI=1S/C45H41N11O6/c46-40-38-39(27-6-10-32(11-7-27)62-31-4-2-1-3-5-31)51-56(41(38)49-26-48-40)29-16-18-54(19-17-29)43(59)28-8-14-36(47-25-28)53-22-20-52(21-23-53)30-9-12-33-34(24-30)45(61)55(44(33)60)35-13-15-37(57)50-42(35)58/h1-12,14,24-26,29,35H,13,15-23H2,(H2,46,48,49)(H,50,57,58)",JNESGEBHIQTVTD-UHFFFAOYSA-N
3555,Q06187,BTK,CRBN,,,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(C(=O)CN2CCN(CC3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)CC1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(,C(=O)CN,2CCN(CC3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)CC1,6.11,99.73,1,Degradation of BTK in Ramos/Mino cells after 24 h treatment,99.68,% BTK degradation in Ramos cells after 24 h treatment at 100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115664,865.996,865.4023784,3.63,64,10,14,2,10,192.43,C47H51N11O6,"InChI=1S/C47H51N11O6/c48-43-41-42(31-6-9-35(10-7-31)64-34-4-2-1-3-5-34)52-58(44(41)50-29-49-43)32-16-20-56(21-17-32)40(60)28-54-24-22-53(23-25-54)27-30-14-18-55(19-15-30)33-8-11-36-37(26-33)47(63)57(46(36)62)38-12-13-39(59)51-45(38)61/h1-11,26,29-30,32,38H,12-25,27-28H2,(H2,48,49,50)(H,51,59,61)",LFNMIAGMJGUCIW-UHFFFAOYSA-N
3556,Q06187,BTK,CRBN,,,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(C(=O)CN2CCN(CC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C3)CC2)CC1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(,C(=O)CN,2CCN(CC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C3)CC2)CC1,3.18,99.99,1,Degradation of BTK in Ramos/Mino cells after 24 h treatment,99.42,% BTK degradation in Ramos cells after 24 h treatment at 100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115664,837.942,837.3710782,2.91,62,10,14,2,10,192.43,C45H47N11O6,"InChI=1S/C45H47N11O6/c46-41-39-40(29-6-9-33(10-7-29)62-32-4-2-1-3-5-32)50-56(42(39)48-27-47-41)30-14-16-53(17-15-30)38(58)26-52-20-18-51(19-21-52)23-28-24-54(25-28)31-8-11-34-35(22-31)45(61)55(44(34)60)36-12-13-37(57)49-43(36)59/h1-11,22,27-28,30,36H,12-21,23-26H2,(H2,46,47,48)(H,49,57,59)",SPGWKNITNYHIGX-UHFFFAOYSA-N
3558,Q06187,BTK,CRBN,,,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(C(=O)CN2CCN(CC3CCN(C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)CC1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(,C(=O)CN,2CCN(CC3CCN(C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)CC1,9.37,99.51,1,Degradation of BTK in Ramos/Mino cells after 24 h treatment,90.96,% BTK degradation in Ramos cells after 24 h treatment at 100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115664,865.996,865.4023784,3.63,64,10,14,2,10,192.43,C47H51N11O6,"InChI=1S/C47H51N11O6/c48-43-41-42(31-9-11-34(12-10-31)64-33-5-2-1-3-6-33)52-58(44(41)50-29-49-43)32-17-21-56(22-18-32)39(60)28-54-25-23-53(24-26-54)27-30-15-19-55(20-16-30)36-8-4-7-35-40(36)47(63)57(46(35)62)37-13-14-38(59)51-45(37)61/h1-12,29-30,32,37H,13-28H2,(H2,48,49,50)(H,51,59,61)",FCQYWOVXHUEFAG-UHFFFAOYSA-N
3559,Q06187,BTK,CRBN,,,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(C(=O)CN2CCN(CC3CN(C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C3)CC2)CC1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(,C(=O)CN,2CCN(CC3CN(C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C3)CC2)CC1,7.27,99.7,1,Degradation of BTK in Ramos/Mino cells after 24 h treatment,67.51,% BTK degradation in Ramos cells after 24 h treatment at 100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115664,837.942,837.3710782,2.91,62,10,14,2,10,192.43,C45H47N11O6,"InChI=1S/C45H47N11O6/c46-41-39-40(29-9-11-32(12-10-29)62-31-5-2-1-3-6-31)50-56(42(39)48-27-47-41)30-15-17-53(18-16-30)37(58)26-52-21-19-51(20-22-52)23-28-24-54(25-28)34-8-4-7-33-38(34)45(61)55(44(33)60)35-13-14-36(57)49-43(35)59/h1-12,27-28,30,35H,13-26H2,(H2,46,47,48)(H,49,57,59)",BZECJEIHNUUQGB-UHFFFAOYSA-N
3562,Q06187,BTK,CRBN,,,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CC2=CC=C(C#CC3CCN(C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)N=C2)CC1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(CC2=CC=C(,C#CC,3CCN(C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)N=C2)CC1,46.1,95.01,1,Degradation of BTK in Ramos cells after 24 h treatment,58.57,% BTK degradation in Ramos cells after 24 h treatment at 100 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115664,840.945,840.3496145,4.94,63,10,13,2,8,181.77,C48H44N10O5,"InChI=1S/C48H44N10O5/c49-44-42-43(32-11-15-36(16-12-32)63-35-5-2-1-3-6-35)54-58(45(42)52-29-51-44)34-21-23-55(24-22-34)28-31-10-14-33(50-27-31)13-9-30-19-25-56(26-20-30)38-8-4-7-37-41(38)48(62)57(47(37)61)39-17-18-40(59)53-46(39)60/h1-8,10-12,14-16,27,29-30,34,39H,17-26,28H2,(H2,49,51,52)(H,53,59,60)",QSCOJWKWSHBBPQ-UHFFFAOYSA-N
3565,Q9UBN7,HDAC6,CRBN,,,O=C(CCCCCCNC(=O)C1=CC=C(NC(=O)CCCCCCCNC(=O)COC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1)NO,O=C(CCCCCCNC(=O)C1=CC=C(,NC(=O)CCCCCCCNC(=O)CO,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1)NO,3.46,84.47,1,Degradation of HDAC6 in HL-60 cells after 6h treatment,,,4.86,Inhibit of HDAC6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,31170/17550/24460,Inhibition of cell proliferation of MV4-11/Molm-13/SKNO-1 cells,400,dose-dependent alpha-tubulin hyperacetylation,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01659,734.807,734.3275417,2.05,53,4,10,6,21,229.41,C37H46N6O10,"InChI=1S/C37H46N6O10/c44-29(40-25-17-15-24(16-18-25)34(48)39-22-9-5-3-7-14-31(46)42-52)13-6-2-1-4-8-21-38-32(47)23-53-28-12-10-11-26-33(28)37(51)43(36(26)50)27-19-20-30(45)41-35(27)49/h10-12,15-18,27,52H,1-9,13-14,19-23H2,(H,38,47)(H,39,48)(H,40,44)(H,42,46)(H,41,45,49)",FQLCLMHMOFLVSV-UHFFFAOYSA-N
3566,P50750,CDK9,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCCN4C=C(CCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(,OCCCCC,N4C=C(CCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,130.0,67.5,0,Degradation of CDK9 in MOLM-13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,240/1290/500,Cell cytotoxicity (IC50) was determined in MV4-11 cells after 48 h treatment/Post-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h/No-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h,,,,,,,,,,,,,,,10.1021/acsmedchemlett.3c00082,847.761,846.2771491,4.41,59,7,12,4,17,213.61,C40H44Cl2N10O7,"InChI=1S/C40H44Cl2N10O7/c41-27-10-7-11-28(42)34(27)37(55)45-29-22-43-48-35(29)38(56)44-24-15-19-50(20-16-24)17-4-2-8-25-23-51(49-47-25)18-3-1-5-21-59-31-12-6-9-26-33(31)40(58)52(39(26)57)30-13-14-32(53)46-36(30)54/h6-7,9-12,22-24,30H,1-5,8,13-21H2,(H,43,48)(H,44,56)(H,45,55)(H,46,53,54)",WQYDJYODLBQPRD-UHFFFAOYSA-N
3567,P50750,CDK9,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCN4C=C(CCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(,OCCCC,N4C=C(CCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,70.0,79.1,0,Degradation of CDK9 in MOLM-13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,190/720/500,Cell cytotoxicity (IC50) was determined in MV4-11 cells after 48 h treatment/Post-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h/No-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h,,,,,,,,,,,,,,,10.1021/acsmedchemlett.3c00082,833.734,832.261499,4.05,58,7,12,4,16,213.61,C39H42Cl2N10O7,"InChI=1S/C39H42Cl2N10O7/c40-26-9-6-10-27(41)33(26)36(54)44-28-21-42-47-34(28)37(55)43-23-14-18-49(19-15-23)16-2-1-7-24-22-50(48-46-24)17-3-4-20-58-30-11-5-8-25-32(30)39(57)51(38(25)56)29-12-13-31(52)45-35(29)53/h5-6,8-11,21-23,29H,1-4,7,12-20H2,(H,42,47)(H,43,55)(H,44,54)(H,45,52,53)",RWZUENRHOXLKRD-UHFFFAOYSA-N
3568,P50750,CDK9,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCN4C=C(CCCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCN4C=C(,CCCCCN,5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,400.0,58.6,0,Degradation of CDK9 in MOLM-13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,190/690/400,Cell cytotoxicity (IC50) was determined in MV4-11 cells after 48 h treatment/Post-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h/No-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h,,,,,,,,,,,,,,,10.1021/acsmedchemlett.3c00082,847.761,846.2771491,4.41,59,7,12,4,17,213.61,C40H44Cl2N10O7,"InChI=1S/C40H44Cl2N10O7/c41-27-10-7-11-28(42)34(27)37(55)45-29-22-43-48-35(29)38(56)44-24-15-19-50(20-16-24)17-3-1-2-8-25-23-51(49-47-25)18-4-5-21-59-31-12-6-9-26-33(31)40(58)52(39(26)57)30-13-14-32(53)46-36(30)54/h6-7,9-12,22-24,30H,1-5,8,13-21H2,(H,43,48)(H,44,56)(H,45,55)(H,46,53,54)",IFGRJEDDLDJVFO-UHFFFAOYSA-N
3569,P50750,CDK9,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCCCCCN4C=C(CCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(,OCCCCCCCC,N4C=C(CCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,60.0,88.3,1,Degradation of CDK9 in MOLM-13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,50/250/100,Cell cytotoxicity (IC50) was determined in MV4-11 cells after 48 h treatment/Post-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h/No-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h,,,,,,,,,,,,,,,10.1021/acsmedchemlett.3c00082,861.788,860.2927992,5.13,60,7,12,4,18,213.61,C41H46Cl2N10O7,"InChI=1S/C41H46Cl2N10O7/c42-28-10-8-11-29(43)35(28)38(56)46-30-23-44-49-36(30)39(57)45-25-15-19-51(20-16-25)21-17-26-24-52(50-48-26)18-5-3-1-2-4-6-22-60-32-12-7-9-27-34(32)41(59)53(40(27)58)31-13-14-33(54)47-37(31)55/h7-12,23-25,31H,1-6,13-22H2,(H,44,49)(H,45,57)(H,46,56)(H,47,54,55)",KQYIIOGMBKKCCZ-UHFFFAOYSA-N
3570,P50750,CDK9,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCCN4C=C(CCCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(,OCCCCC,N4C=C(CCCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,950.0,68.5,0,Degradation of CDK9 in MOLM-13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,130/450/260,Cell cytotoxicity (IC50) was determined in MV4-11 cells after 48 h treatment/Post-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h/No-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h,,,,,,,,,,,,,,,10.1021/acsmedchemlett.3c00082,861.788,860.2927992,4.77,60,7,12,4,18,213.61,C41H46Cl2N10O7,"InChI=1S/C41H46Cl2N10O7/c42-28-11-8-12-29(43)35(28)38(56)46-30-23-44-49-36(30)39(57)45-25-16-20-51(21-17-25)18-4-1-3-9-26-24-52(50-48-26)19-5-2-6-22-60-32-13-7-10-27-34(32)41(59)53(40(27)58)31-14-15-33(54)47-37(31)55/h7-8,10-13,23-25,31H,1-6,9,14-22H2,(H,44,49)(H,45,57)(H,46,56)(H,47,54,55)",RVWBTXSGZFJYEH-UHFFFAOYSA-N
3571,P50750,CDK9,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCN4C=C(CCCCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCN4C=C(,CCCCCCN,5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,100.0,75.3,0,Degradation of CDK9 in MOLM-13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,70/260/120,Cell cytotoxicity (IC50) was determined in MV4-11 cells after 48 h treatment/Post-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h/No-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h,,,,,,,,,,,,,,,10.1021/acsmedchemlett.3c00082,861.788,860.2927992,4.95,60,7,12,4,18,213.61,C41H46Cl2N10O7,"InChI=1S/C41H46Cl2N10O7/c42-28-11-8-12-29(43)35(28)38(56)46-30-23-44-49-36(30)39(57)45-25-16-20-51(21-17-25)18-4-2-1-3-9-26-24-52(50-48-26)19-5-6-22-60-32-13-7-10-27-34(32)41(59)53(40(27)58)31-14-15-33(54)47-37(31)55/h7-8,10-13,23-25,31H,1-6,9,14-22H2,(H,44,49)(H,45,57)(H,46,56)(H,47,54,55)",ZIUVTWBLWUJBEY-UHFFFAOYSA-N
3572,P50750,CDK9,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCCCCCN4C=C(CCCCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(,OCCCCCCCC,N4C=C(CCCCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,70.0,86.2,1,Degradation of CDK9 in MOLM-13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,70/340/230,Cell cytotoxicity (IC50) was determined in MV4-11 cells after 48 h treatment/Post-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h/No-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h,,,,,,,,,,,,,,,10.1021/acsmedchemlett.3c00082,917.896,916.3553994,6.75,64,7,12,4,22,213.61,C45H54Cl2N10O7,"InChI=1S/C45H54Cl2N10O7/c46-32-15-12-16-33(47)39(32)42(60)50-34-27-48-53-40(34)43(61)49-29-20-24-55(25-21-29)22-8-5-3-7-13-30-28-56(54-52-30)23-9-4-1-2-6-10-26-64-36-17-11-14-31-38(36)45(63)57(44(31)62)35-18-19-37(58)51-41(35)59/h11-12,14-17,27-29,35H,1-10,13,18-26H2,(H,48,53)(H,49,61)(H,50,60)(H,51,58,59)",RFWQGGOBVSJKDT-UHFFFAOYSA-N
3573,P50750,CDK9,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCCCCN4C=C(CCCCCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(,OCCCCCCC,N4C=C(CCCCCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,60.0,78.0,0,Degradation of CDK9 in MOLM-13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,60/110/90,Cell cytotoxicity (IC50) was determined in MV4-11 cells after 48 h treatment/Post-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h/No-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h,,,,,,,,,,,,,,,10.1021/acsmedchemlett.3c00082,917.896,916.3553994,6.75,64,7,12,4,22,213.61,C45H54Cl2N10O7,"InChI=1S/C45H54Cl2N10O7/c46-32-15-12-16-33(47)39(32)42(60)50-34-27-48-53-40(34)43(61)49-29-20-24-55(25-21-29)22-8-4-1-3-7-13-30-28-56(54-52-30)23-9-5-2-6-10-26-64-36-17-11-14-31-38(36)45(63)57(44(31)62)35-18-19-37(58)51-41(35)59/h11-12,14-17,27-29,35H,1-10,13,18-26H2,(H,48,53)(H,49,61)(H,50,60)(H,51,58,59)",UJUPYASGRVZCKP-UHFFFAOYSA-N
3574,P50750,CDK9,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCN4C=C(CCCCCCCCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCN4C=C(,CCCCCCCCCCN,5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,40.0,88.6,1,Degradation of CDK9 in MOLM-13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/20/20,Cell cytotoxicity (IC50) was determined in MV4-11 cells after 48 h treatment/Post-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h/No-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h,,,,,,,,,,,,,,,10.1021/acsmedchemlett.3c00082,917.896,916.3553994,7.12,64,7,12,4,22,213.61,C45H54Cl2N10O7,"InChI=1S/C45H54Cl2N10O7/c46-32-15-12-16-33(47)39(32)42(60)50-34-27-48-53-40(34)43(61)49-29-20-24-55(25-21-29)22-8-6-4-2-1-3-5-7-13-30-28-56(54-52-30)23-9-10-26-64-36-17-11-14-31-38(36)45(63)57(44(31)62)35-18-19-37(58)51-41(35)59/h11-12,14-17,27-29,35H,1-10,13,18-26H2,(H,48,53)(H,49,61)(H,50,60)(H,51,58,59)",CSNPVEIUSQQSBW-UHFFFAOYSA-N
3575,P50750,CDK9,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCCCCCCN4C=C(CCCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(,OCCCCCCC,N4C=C(CCCCCN5CCC(NC(=O)C6=C(NC(=O)C7=C(Cl)C=CC=C7Cl)C=N[NH]6)CC5)N=N4)=C3C2=O)C(=O)N1,100.0,70.1,0,Degradation of CDK9 in MOLM-13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,50/80/80,Cell cytotoxicity (IC50) was determined in MV4-11 cells after 48 h treatment/Post-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h/No-WO IC50 was determined after 6 h treatment and a total incubation time of 48 h,,,,,,,,,,,,,,,10.1021/acsmedchemlett.3c00082,889.842,888.3240993,5.66,62,7,12,4,20,213.61,C43H50Cl2N10O7,"InChI=1S/C43H50Cl2N10O7/c44-30-13-10-14-31(45)37(30)40(58)48-32-25-46-51-38(32)41(59)47-27-18-22-53(23-19-27)20-6-4-5-11-28-26-54(52-50-28)21-7-2-1-3-8-24-62-34-15-9-12-29-36(34)43(61)55(42(29)60)33-16-17-35(56)49-39(33)57/h9-10,12-15,25-27,33H,1-8,11,16-24H2,(H,46,51)(H,47,59)(H,48,58)(H,49,56,57)",VUUHHNWFNGGVNN-UHFFFAOYSA-N
3603,P51531,SMARCA2,VHL,8G1Q,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3=CC=NC(N4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H],(C)NC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3=CC=NC(N4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)=C3)C(C)(C)C)C=C2)SC=N1,28.0,98.0,1,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3520000,0.017,41.5,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,819.005,818.3686357,4.23,59,7,13,5,10,203.03,C43H50N10O5S,"InChI=1S/C43H50N10O5S/c1-25(27-10-12-28(13-11-27)37-26(2)46-24-59-37)47-41(57)34-21-30(54)23-53(34)42(58)38(43(3,4)5)48-40(56)29-14-15-45-36(20-29)52-18-16-51(17-19-52)33-22-32(49-50-39(33)44)31-8-6-7-9-35(31)55/h6-15,20,22,24-25,30,34,38,54-55H,16-19,21,23H2,1-5H3,(H2,44,50)(H,47,57)(H,48,56)/t25-,30+,34-,38+/m0/s1",UTVJRQFHWBOCCR-IKYVMSNGSA-N
3604,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3=CC=CC(N4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H],(C)NC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3=CC=CC(N4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)=N3)C(C)(C)C)C=C2)SC=N1,95.0,95.0,1,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,870000,0.031,24.3,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,819.005,818.3686357,4.56,59,7,13,5,10,203.03,C43H50N10O5S,"InChI=1S/C43H50N10O5S/c1-25(27-13-15-28(16-14-27)37-26(2)45-24-59-37)46-41(57)34-21-29(54)23-53(34)42(58)38(43(3,4)5)48-40(56)31-10-8-12-36(47-31)52-19-17-51(18-20-52)33-22-32(49-50-39(33)44)30-9-6-7-11-35(30)55/h6-16,22,24-25,29,34,38,54-55H,17-21,23H2,1-5H3,(H2,44,50)(H,46,57)(H,48,56)/t25-,29+,34-,38+/m0/s1",CPUGPFMQNPPUFH-XYOATWAASA-N
3605,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3=CC=C(N4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)N=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H],(C)NC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3=CC=C(N4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)N=C3)C(C)(C)C)C=C2)SC=N1,10000.0,0.0,0,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N.D.,N.D.,2.0,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,819.005,818.3686357,4.23,59,7,13,5,10,203.03,C43H50N10O5S,"InChI=1S/C43H50N10O5S/c1-25(27-10-12-28(13-11-27)37-26(2)46-24-59-37)47-41(57)34-20-30(54)23-53(34)42(58)38(43(3,4)5)48-40(56)29-14-15-36(45-22-29)52-18-16-51(17-19-52)33-21-32(49-50-39(33)44)31-8-6-7-9-35(31)55/h6-15,21-22,24-25,30,34,38,54-55H,16-20,23H2,1-5H3,(H2,44,50)(H,47,57)(H,48,56)/t25-,30+,34-,38+/m0/s1",LYDAUMKICSLYRP-IKYVMSNGSA-N
3606,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3=CC=CC(N4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H],(C)NC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3=CC=CC(N4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)=C3)C(C)(C)C)C=C2)SC=N1,99.0,96.0,1,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,590000,0.039,18.1,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,818.017,817.3733867,4.97,59,7,12,5,10,190.14,C44H51N9O5S,"InChI=1S/C44H51N9O5S/c1-26(28-13-15-29(16-14-28)38-27(2)46-25-59-38)47-42(57)36-22-32(54)24-53(36)43(58)39(44(3,4)5)48-41(56)30-9-8-10-31(21-30)51-17-19-52(20-18-51)35-23-34(49-50-40(35)45)33-11-6-7-12-37(33)55/h6-16,21,23,25-26,32,36,39,54-55H,17-20,22,24H2,1-5H3,(H2,45,50)(H,47,57)(H,48,56)/t26-,32+,36-,39+/m0/s1",VJSRTKOZKJSNOV-ZNWVETRHSA-N
3607,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3=CSC(N4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H],(C)NC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3=CSC(N4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)=N3)C(C)(C)C)C=C2)SC=N1,112.0,96.0,0,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2070000,0.09,7.4,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,825.034,824.3250566,4.66,58,7,14,5,10,203.03,C41H48N10O5S2,"InChI=1S/C41H48N10O5S2/c1-23(25-10-12-26(13-11-25)34-24(2)43-22-58-34)44-38(55)32-18-27(52)20-51(32)39(56)35(41(3,4)5)46-37(54)30-21-57-40(45-30)50-16-14-49(15-17-50)31-19-29(47-48-36(31)42)28-8-6-7-9-33(28)53/h6-13,19,21-23,27,32,35,52-53H,14-18,20H2,1-5H3,(H2,42,48)(H,44,55)(H,46,54)/t23-,27+,32-,35+/m0/s1",QSIFVPKHIDVWQB-OFGFXWDRSA-N
3608,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CC3=CC=NC(N4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H],(C)NC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CC3=CC=NC(N4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)=C3)C(C)(C)C)C=C2)SC=N1,850.0,55.0,0,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2170000,0.19,3.6,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,833.032,832.3842858,4.17,60,7,13,5,11,203.03,C44H52N10O5S,"InChI=1S/C44H52N10O5S/c1-26(29-10-12-30(13-11-29)39-27(2)47-25-60-39)48-42(58)35-22-31(55)24-54(35)43(59)40(44(3,4)5)49-38(57)21-28-14-15-46-37(20-28)53-18-16-52(17-19-53)34-23-33(50-51-41(34)45)32-8-6-7-9-36(32)56/h6-15,20,23,25-26,31,35,40,55-56H,16-19,21-22,24H2,1-5H3,(H2,45,51)(H,48,58)(H,49,57)/t26-,31+,35-,40+/m0/s1",JSJNRSSILOESKP-JQJHNVGOSA-N
3609,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCC3=CC=NC(N4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CC,C3=CC=NC(N4CCN(C5=CC(C6=CC=CC=C6O)=NN=C5N)CC4)=C3)C(C)(C)C)C=C2)SC=N1,379.0,80.0,0,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3700000,0.11,6.3,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,847.059,846.3999358,4.46,61,7,13,5,12,203.03,C45H54N10O5S,"InChI=1S/C45H54N10O5S/c1-27(30-11-13-31(14-12-30)40-28(2)48-26-61-40)49-43(59)36-23-32(56)25-55(36)44(60)41(45(3,4)5)50-39(58)15-10-29-16-17-47-38(22-29)54-20-18-53(19-21-54)35-24-34(51-52-42(35)46)33-8-6-7-9-37(33)57/h6-9,11-14,16-17,22,24,26-27,32,36,41,56-57H,10,15,18-21,23,25H2,1-5H3,(H2,46,52)(H,49,59)(H,50,58)/t27-,32+,36-,41+/m0/s1",XMIOCXZSPKUWLC-SFQXCRKHSA-N
3610,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3=CC=CC(N4CCN(C5=NC(C6=CC=CC=C6O)=NN=C5N)CC4)=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H],(C)NC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3=CC=CC(N4CCN(C5=NC(C6=CC=CC=C6O)=NN=C5N)CC4)=N3)C(C)(C)C)C=C2)SC=N1,372.0,74.0,0,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N.D.,N.D.,2.0,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,819.993,819.3638847,4.25,59,7,14,5,10,215.92,C42H49N11O5S,"InChI=1S/C42H49N11O5S/c1-24(26-13-15-27(16-14-26)34-25(2)44-23-59-34)45-40(57)31-21-28(54)22-53(31)41(58)35(42(3,4)5)47-39(56)30-10-8-12-33(46-30)51-17-19-52(20-18-51)38-36(43)49-50-37(48-38)29-9-6-7-11-32(29)55/h6-16,23-24,28,31,35,54-55H,17-22H2,1-5H3,(H2,43,49)(H,45,57)(H,47,56)/t24-,28+,31-,35+/m0/s1",YFJUNDZEBBSSOT-JMUDFPMGSA-N
3611,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3=CC=NC(N4CCN(C5=CN=NC(C6=CC=CC=C6O)=C5)CC4)=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H],(C)NC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3=CC=NC(N4CCN(C5=CN=NC(C6=CC=CC=C6O)=C5)CC4)=C3)C(C)(C)C)C=C2)SC=N1,469.0,65.0,0,Degradation of SMARCA2 in A375 cells after 2 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,350000,0.08,8.4,SPR,,,,,,,,,,,,,,,,,10.1038/s41467-023-39904-5,803.99,803.3577367,4.58,58,7,12,4,10,177.01,C43H49N9O5S,"InChI=1S/C43H49N9O5S/c1-26(28-10-12-29(13-11-28)38-27(2)45-25-58-38)47-41(56)35-22-32(53)24-52(35)42(57)39(43(3,4)5)48-40(55)30-14-15-44-37(20-30)51-18-16-50(17-19-51)31-21-34(49-46-23-31)33-8-6-7-9-36(33)54/h6-15,20-21,23,25-26,32,35,39,53-54H,16-19,22,24H2,1-5H3,(H,47,56)(H,48,55)/t26-,32+,35-,39+/m0/s1",CZPJJHAGQOTYEJ-GNAZCYGUSA-N
3614,P08581,c-Met,CRBN,,,N#CC1=CC=CC(C2=NN(CC3=CC=CC(C4=NC=C(OCC5CCN(CCCCC(=O)NC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)C=N4)=C3)C(=O)C=C2)=C1,N#CC1=CC=CC(C2=NN(CC3=CC=CC(C4=NC=C(OCC5CCN(,CCCCC(=O)N,C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)C=N4)=C3)C(=O)C=C2)=C1,3.1,99.0,1,Degradation of c-MET in EBC-1/Hs746T cells after 72 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9.45/76.3/413,Inhibit proliferation of EBC-1/Hs746T/A549 cells,,,,,,,,,,,,,,,10.1016/j.apsb.2023.01.014,833.906,833.3285447,3.63,62,8,13,2,14,209.58,C46H43N9O7,"InChI=1S/C46H43N9O7/c47-24-30-6-3-8-32(22-30)36-13-16-41(58)54(52-36)27-31-7-4-9-33(23-31)43-48-25-34(26-49-43)62-28-29-17-20-53(21-18-29)19-2-1-12-39(56)50-37-11-5-10-35-42(37)46(61)55(45(35)60)38-14-15-40(57)51-44(38)59/h3-11,13,16,22-23,25-26,29,38H,1-2,12,14-15,17-21,27-28H2,(H,50,56)(H,51,57,59)",UGRBBCCLXHIOQB-UHFFFAOYSA-N
3621,P08581,c-Met,CRBN,,,N#CC1=CC=CC(C2=NN(CC3=CC=CC(C4=NC=C(OCC5CCN(CC(=O)NCCOCCNC6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)C=N4)=C3)C(=O)C=C2)=C1,N#CC1=CC=CC(C2=NN(CC3=CC=CC(C4=NC=C(OCC5CCN(,CC(=O)NCCOCCN,C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)C=N4)=C3)C(=O)C=C2)=C1,0.69,99.0,1,Degradation of c-MET in EBC-1/Hs746T cells after 72 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.34/5.89/511,Inhibit proliferation of EBC-1/Hs746T/A549 cells,,,,,,,,,,,,,,,10.1016/j.apsb.2023.01.014,878.947,878.3500084,2.43,65,8,15,3,17,230.84,C47H46N10O8,"InChI=1S/C47H46N10O8/c48-24-31-3-1-5-33(21-31)39-9-12-43(60)56(54-39)27-32-4-2-6-34(22-32)44-51-25-36(26-52-44)65-29-30-13-17-55(18-14-30)28-42(59)50-16-20-64-19-15-49-35-7-8-37-38(23-35)47(63)57(46(37)62)40-10-11-41(58)53-45(40)61/h1-9,12,21-23,25-26,30,40,49H,10-11,13-20,27-29H2,(H,50,59)(H,53,58,61)",BKRHXSCTDWOIHA-UHFFFAOYSA-N
3623,P08581,c-Met,CRBN,,,N#CC1=CC=CC(C2=NN(CC3=CC=CC(C4=NC=C(OCC5CCN(CC(=O)NCCOCCOCCOCCNC6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)C=N4)=C3)C(=O)C=C2)=C1,N#CC1=CC=CC(C2=NN(CC3=CC=CC(C4=NC=C(OCC5CCN(,CC(=O)NCCOCCOCCOCCN,C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)C=N4)=C3)C(=O)C=C2)=C1,1.7,99.0,1,Degradation of c-MET in EBC-1/Hs746T cells after 72 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.61/7.72/433,Inhibit proliferation of EBC-1/Hs746T/A549 cells,,,,,,,,,,,,,,,10.1016/j.apsb.2023.01.014,967.053,966.4024379,2.14,71,8,17,3,23,249.3,C51H54N10O10,"InChI=1S/C51H54N10O10/c52-28-35-3-1-5-37(25-35)43-9-12-47(64)60(58-43)31-36-4-2-6-38(26-36)48-55-29-40(30-56-48)71-33-34-13-17-59(18-14-34)32-46(63)54-16-20-69-22-24-70-23-21-68-19-15-53-39-7-8-41-42(27-39)51(67)61(50(41)66)44-10-11-45(62)57-49(44)65/h1-9,12,25-27,29-30,34,44,53H,10-11,13-24,31-33H2,(H,54,63)(H,57,62,65)",LJVOTWPXASNBJI-UHFFFAOYSA-N
3625,P08581,c-Met,CRBN,,,N#CC1=CC=CC(C2=NN(CC3=CC=CC(C4=NC=C(OCC5CCN(CC(=O)N6CCN(CCNC7=CC=C8C(=O)N(C9CCC(=O)NC9=O)C(=O)C8=C7)CC6)CC5)C=N4)=C3)C(=O)C=C2)=C1,N#CC1=CC=CC(C2=NN(CC3=CC=CC(C4=NC=C(OCC5CCN(,CC(=O)N,6CCN(CCNC7=CC=C8C(=O)N(C9CCC(=O)NC9=O)C(=O)C8=C7)CC6)CC5)C=N4)=C3)C(=O)C=C2)=C1,0.83,99.0,1,Degradation of c-MET in EBC-1/Hs746T cells after 72 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.44/3.88/665,Inhibit proliferation of EBC-1/Hs746T/A549 cells,,,,,,,,,,,,,,,10.1016/j.apsb.2023.01.014,904.001,903.3816429,2.57,67,9,15,2,14,216.06,C49H49N11O7,"InChI=1S/C49H49N11O7/c50-26-33-3-1-5-35(23-33)41-9-12-44(62)59(55-41)29-34-4-2-6-36(24-34)46-52-27-38(28-53-46)67-31-32-13-16-57(17-14-32)30-45(63)58-21-19-56(20-22-58)18-15-51-37-7-8-39-40(25-37)49(66)60(48(39)65)42-10-11-43(61)54-47(42)64/h1-9,12,23-25,27-28,32,42,51H,10-11,13-22,29-31H2,(H,54,61,64)",USNPVGJUXHCJDF-UHFFFAOYSA-N
3626,P08581,c-Met,CRBN,,,N#CC1=CC=CC(C2=NN(CC3=CC=CC(C4=NC=C(OCC5CCN(CC(=O)N6CCN(C7=CC=C8C(=O)N(C9CCC(=O)NC9=O)C(=O)C8=C7)CC6)CC5)C=N4)=C3)C(=O)C=C2)=C1,N#CC1=CC=CC(C2=NN(CC3=CC=CC(C4=NC=C(OCC5CCN(,CC(=O)N,6CCN(C7=CC=C8C(=O)N(C9CCC(=O)NC9=O)C(=O)C8=C7)CC6)CC5)C=N4)=C3)C(=O)C=C2)=C1,0.44,99.0,1,Degradation of c-MET in EBC-1/Hs746T cells after 72 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.11/3.50/377,Inhibit proliferation of EBC-1/Hs746T/A549 cells,,,,,,,,,,,,,,,10.1016/j.apsb.2023.01.014,860.932,860.3394437,2.68,64,9,14,1,11,204.03,C47H44N10O7,"InChI=1S/C47H44N10O7/c48-24-31-3-1-5-33(21-31)39-9-12-42(59)56(52-39)27-32-4-2-6-34(22-32)44-49-25-36(26-50-44)64-29-30-13-15-53(16-14-30)28-43(60)55-19-17-54(18-20-55)35-7-8-37-38(23-35)47(63)57(46(37)62)40-10-11-41(58)51-45(40)61/h1-9,12,21-23,25-26,30,40H,10-11,13-20,27-29H2,(H,51,58,61)",ONBFXZQYDXKUOB-UHFFFAOYSA-N
3643,P15170,GSPT1,CRBN,,,COCCN(C)CC1=CC(NC(=O)CCC2=CC=C3CN(C4CCC(=O)NC4=O)C(=O)C3=C2)=CC(Cl)=C1C,,COCCN(C)C,C1=CC(NC(=O)CCC2=CC=C3CN(C4CCC(=O)NC4=O)C(=O)C3=C2)=CC(Cl)=C1C,35.0,81.65,1,Degradation of GSPT1 in U937 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,190/6/27,Inhibit the growth of U937/MOLT-4/MV4-11 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115580,541.048,540.2139478,1.93,38,4,6,2,10,108.05,C28H33ClN4O5,"InChI=1S/C28H33ClN4O5/c1-17-20(15-32(2)10-11-38-3)13-21(14-23(17)29)30-25(34)8-5-18-4-6-19-16-33(28(37)22(19)12-18)24-7-9-26(35)31-27(24)36/h4,6,12-14,24H,5,7-11,15-16H2,1-3H3,(H,30,34)(H,31,35,36)",BSFAJHWUNIDRJW-UHFFFAOYSA-N
3680,P10275,AR,CRBN,,ARD-2051,C[C@H]1CC2(CCN(C3=CC=C(C(=O)N4CCN(C5CN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)C5)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,C[C@H]1CC2(CCN(C3=CC=C(,C(=O)N,4CCN(C5CN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)C5)CC4)C=C3)CC2)CN1C1=CC=C(C#N)C(Cl)=C1,0.6,97.0,1,Degradation of AR in VCaP/LNCaP cells after 24 h treatment,>95/>95/>95,% AR degradation in VCaP cells at 10/100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10月13日,Inhibit of cell growth of VCaP/LNCaP cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00405,789.337,788.3201442,4.51,57,9,10,1,6,140.61,C43H45ClN8O5,"InChI=1S/C43H45ClN8O5/c1-27-22-43(26-51(27)32-7-4-29(23-45)36(44)21-32)12-14-47(15-13-43)30-5-2-28(3-6-30)40(55)49-18-16-48(17-19-49)33-24-50(25-33)31-8-9-34-35(20-31)42(57)52(41(34)56)37-10-11-38(53)46-39(37)54/h2-9,20-21,27,33,37H,10-19,22,24-26H2,1H3,(H,46,53,54)/t27-,37?/m0/s1",WBMJNGGUHCHFHY-YTCZSSRZSA-N
3730,Q14145,KEAP1,CRBN,,SD2267,CC1=CC=C(C(CC(=O)O)C2=CC(OCCCCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=C3C(=C2)N=NN3C)C=C1CN1C[C@@H](C)OC2=CC=CC=C2S1(=O)=O,CC1=CC=C(C(CC(=O)O)C2=CC(,OCCCCCCCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=C3C(=C2)N=NN3C)C=C1CN1C[C@@H](C)OC2=CC=CC=C2S1(=O)=O,8.1,82.3,1,Degradation of KEAP1 in HepG2/AML12 cells after 24 h treatment,64,% KEAP1 degradation in HepG2 cells after 6 h treatment at 1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,57.7,FRET-based competition assay,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.redox.2023.102783,920.058,919.3574619,6.43,66,8,13,3,18,219.43,C48H53N7O10S,"InChI=1S/C48H53N7O10S/c1-29-17-18-31(23-33(29)28-54-27-30(2)65-39-15-8-9-16-41(39)66(54,62)63)35(26-43(57)58)32-24-37-45(53(3)52-51-37)40(25-32)64-22-11-7-5-4-6-10-21-49-36-14-12-13-34-44(36)48(61)55(47(34)60)38-19-20-42(56)50-46(38)59/h8-9,12-18,23-25,30,35,38,49H,4-7,10-11,19-22,26-28H2,1-3H3,(H,57,58)(H,50,56,59)/t30-,35?,38?/m1/s1",VXOYJRRGTMUDKQ-AXOGOZOFSA-N
3743,P25440,BRD2,CRBN,,BD-7102,CC1=NN=C2COCC3=C(SC(C#CC4=CN(CC5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,CC1=NN=C2COCC3=C(SC(,C#C,C4=CN(CC5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,0.3,97.0,1,Degradation of BRD2 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,712.792,712.2216371,3.03,52,9,12,1,6,144.55,C38H32N8O5S,"InChI=1S/C38H32N8O5S/c1-22-41-42-32-21-51-20-28-27(14-23-6-3-2-4-7-23)31(52-38(28)45(22)32)12-10-24-15-39-44(18-24)19-25-16-43(17-25)29-9-5-8-26-34(29)37(50)46(36(26)49)30-11-13-33(47)40-35(30)48/h2-9,15,18,25,30H,11,13-14,16-17,19-21H2,1H3,(H,40,47,48)",YINXRHBANVHQMY-UHFFFAOYSA-N
3743,Q15059,BRD3,CRBN,,BD-7102,CC1=NN=C2COCC3=C(SC(C#CC4=CN(CC5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,CC1=NN=C2COCC3=C(SC(,C#C,C4=CN(CC5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,0.4,98.0,1,Degradation of BRD3 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,712.792,712.2216371,3.03,52,9,12,1,6,144.55,C38H32N8O5S,"InChI=1S/C38H32N8O5S/c1-22-41-42-32-21-51-20-28-27(14-23-6-3-2-4-7-23)31(52-38(28)45(22)32)12-10-24-15-39-44(18-24)19-25-16-43(17-25)29-9-5-8-26-34(29)37(50)46(36(26)49)30-11-13-33(47)40-35(30)48/h2-9,15,18,25,30H,11,13-14,16-17,19-21H2,1H3,(H,40,47,48)",YINXRHBANVHQMY-UHFFFAOYSA-N
3743,O60885,BRD4,CRBN,,BD-7102,CC1=NN=C2COCC3=C(SC(C#CC4=CN(CC5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,CC1=NN=C2COCC3=C(SC(,C#C,C4=CN(CC5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,0.1,98.0,1,Degradation of BRD4 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,712.792,712.2216371,3.03,52,9,12,1,6,144.55,C38H32N8O5S,"InChI=1S/C38H32N8O5S/c1-22-41-42-32-21-51-20-28-27(14-23-6-3-2-4-7-23)31(52-38(28)45(22)32)12-10-24-15-39-44(18-24)19-25-16-43(17-25)29-9-5-8-26-34(29)37(50)46(36(26)49)30-11-13-33(47)40-35(30)48/h2-9,15,18,25,30H,11,13-14,16-17,19-21H2,1H3,(H,40,47,48)",YINXRHBANVHQMY-UHFFFAOYSA-N
3744,P25440,BRD2,CRBN,,BD-7163,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CCN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)N=C4)=C3CC3=CC=CC=C3)N12,CC1=NN=C2COCC3=C(SC(,C#C,C4=CN(C5CCN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)N=C4)=C3CC3=CC=CC=C3)N12,50.0,68.0,0,Degradation of BRD2 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,726.819,726.2372872,3.52,53,9,12,1,5,144.55,C39H34N8O5S,"InChI=1S/C39H34N8O5S/c1-23-42-43-33-22-52-21-29-28(18-24-6-3-2-4-7-24)32(53-39(29)46(23)33)12-10-25-19-40-45(20-25)26-14-16-44(17-15-26)30-9-5-8-27-35(30)38(51)47(37(27)50)31-11-13-34(48)41-36(31)49/h2-9,19-20,26,31H,11,13-18,21-22H2,1H3,(H,41,48,49)",LBOQQOZSFDCXGL-UHFFFAOYSA-N
3744,Q15059,BRD3,CRBN,,BD-7163,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CCN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)N=C4)=C3CC3=CC=CC=C3)N12,CC1=NN=C2COCC3=C(SC(,C#C,C4=CN(C5CCN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)N=C4)=C3CC3=CC=CC=C3)N12,101.0,56.0,0,Degradation of BRD3 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,726.819,726.2372872,3.52,53,9,12,1,5,144.55,C39H34N8O5S,"InChI=1S/C39H34N8O5S/c1-23-42-43-33-22-52-21-29-28(18-24-6-3-2-4-7-24)32(53-39(29)46(23)33)12-10-25-19-40-45(20-25)26-14-16-44(17-15-26)30-9-5-8-27-35(30)38(51)47(37(27)50)31-11-13-34(48)41-36(31)49/h2-9,19-20,26,31H,11,13-18,21-22H2,1H3,(H,41,48,49)",LBOQQOZSFDCXGL-UHFFFAOYSA-N
3744,O60885,BRD4,CRBN,,BD-7163,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CCN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)N=C4)=C3CC3=CC=CC=C3)N12,CC1=NN=C2COCC3=C(SC(,C#C,C4=CN(C5CCN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)N=C4)=C3CC3=CC=CC=C3)N12,0.4,98.0,1,Degradation of BRD4 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,726.819,726.2372872,3.52,53,9,12,1,5,144.55,C39H34N8O5S,"InChI=1S/C39H34N8O5S/c1-23-42-43-33-22-52-21-29-28(18-24-6-3-2-4-7-24)32(53-39(29)46(23)33)12-10-25-19-40-45(20-25)26-14-16-44(17-15-26)30-9-5-8-27-35(30)38(51)47(37(27)50)31-11-13-34(48)41-36(31)49/h2-9,19-20,26,31H,11,13-18,21-22H2,1H3,(H,41,48,49)",LBOQQOZSFDCXGL-UHFFFAOYSA-N
3745,O60885,BRD4,CRBN,,BD-7148,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,CC1=NN=C2COCC3=C(SC(,C#C,C4=CN(C5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,0.9,99.0,1,Degradation of BRD4 in MV4;11/RS4;11/HL60 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,698.765,698.2059871,2.81,51,9,12,1,5,144.55,C37H30N8O5S,"InChI=1S/C37H30N8O5S/c1-21-40-41-31-20-50-19-27-26(14-22-6-3-2-4-7-22)30(51-37(27)44(21)31)12-10-23-15-38-43(16-23)24-17-42(18-24)28-9-5-8-25-33(28)36(49)45(35(25)48)29-11-13-32(46)39-34(29)47/h2-9,15-16,24,29H,11,13-14,17-20H2,1H3,(H,39,46,47)",JTXHXYXYGGEYBL-UHFFFAOYSA-N
3745,O60885,BRD4,CRBN,,BD-7148,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,CC1=NN=C2COCC3=C(SC(,C#C,C4=CN(C5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,13.0,92.0,1,Degradation of BRD4 in MOLM13/MDA-MB-231/MDA-MB-453 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,698.765,698.2059871,2.81,51,9,12,1,5,144.55,C37H30N8O5S,"InChI=1S/C37H30N8O5S/c1-21-40-41-31-20-50-19-27-26(14-22-6-3-2-4-7-22)30(51-37(27)44(21)31)12-10-23-15-38-43(16-23)24-17-42(18-24)28-9-5-8-25-33(28)36(49)45(35(25)48)29-11-13-32(46)39-34(29)47/h2-9,15-16,24,29H,11,13-14,17-20H2,1H3,(H,39,46,47)",JTXHXYXYGGEYBL-UHFFFAOYSA-N
3745,O60885,BRD4,CRBN,,BD-7148,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,CC1=NN=C2COCC3=C(SC(,C#C,C4=CN(C5CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,3.5,90.0,1,Degradation of BRD4 in MCF-7/T47D cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,698.765,698.2059871,2.81,51,9,12,1,5,144.55,C37H30N8O5S,"InChI=1S/C37H30N8O5S/c1-21-40-41-31-20-50-19-27-26(14-22-6-3-2-4-7-22)30(51-37(27)44(21)31)12-10-23-15-38-43(16-23)24-17-42(18-24)28-9-5-8-25-33(28)36(49)45(35(25)48)29-11-13-32(46)39-34(29)47/h2-9,15-16,24,29H,11,13-14,17-20H2,1H3,(H,39,46,47)",JTXHXYXYGGEYBL-UHFFFAOYSA-N
3746,P25440,BRD2,CRBN,,BD-7162,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)C5)N=C4)=C3CC3=CC=CC=C3)N12,CC1=NN=C2COCC3=C(SC(,C#C,C4=CN(C5CN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)C5)N=C4)=C3CC3=CC=CC=C3)N12,0.2,99.0,1,Degradation of BRD2 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,698.765,698.2059871,2.81,51,9,12,1,5,144.55,C37H30N8O5S,"InChI=1S/C37H30N8O5S/c1-21-40-41-32-20-50-19-29-27(13-22-5-3-2-4-6-22)31(51-37(29)44(21)32)11-7-23-15-38-43(16-23)25-17-42(18-25)24-8-9-26-28(14-24)36(49)45(35(26)48)30-10-12-33(46)39-34(30)47/h2-6,8-9,14-16,25,30H,10,12-13,17-20H2,1H3,(H,39,46,47)",OJCRNHCUTYXXFI-UHFFFAOYSA-N
3746,Q15059,BRD3,CRBN,,BD-7162,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)C5)N=C4)=C3CC3=CC=CC=C3)N12,CC1=NN=C2COCC3=C(SC(,C#C,C4=CN(C5CN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)C5)N=C4)=C3CC3=CC=CC=C3)N12,0.7,99.0,1,Degradation of BRD3 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,698.765,698.2059871,2.81,51,9,12,1,5,144.55,C37H30N8O5S,"InChI=1S/C37H30N8O5S/c1-21-40-41-32-20-50-19-29-27(13-22-5-3-2-4-6-22)31(51-37(29)44(21)32)11-7-23-15-38-43(16-23)25-17-42(18-25)24-8-9-26-28(14-24)36(49)45(35(26)48)30-10-12-33(46)39-34(30)47/h2-6,8-9,14-16,25,30H,10,12-13,17-20H2,1H3,(H,39,46,47)",OJCRNHCUTYXXFI-UHFFFAOYSA-N
3746,O60885,BRD4,CRBN,,BD-7162,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5CN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)C5)N=C4)=C3CC3=CC=CC=C3)N12,CC1=NN=C2COCC3=C(SC(,C#C,C4=CN(C5CN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)C5)N=C4)=C3CC3=CC=CC=C3)N12,0.3,98.0,1,Degradation of BRD4 in MV4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,698.765,698.2059871,2.81,51,9,12,1,5,144.55,C37H30N8O5S,"InChI=1S/C37H30N8O5S/c1-21-40-41-32-20-50-19-29-27(13-22-5-3-2-4-6-22)31(51-37(29)44(21)32)11-7-23-15-38-43(16-23)25-17-42(18-25)24-8-9-26-28(14-24)36(49)45(35(26)48)30-10-12-33(46)39-34(30)47/h2-6,8-9,14-16,25,30H,10,12-13,17-20H2,1H3,(H,39,46,47)",OJCRNHCUTYXXFI-UHFFFAOYSA-N
3747,O60885,BRD4,CRBN,,BD-9136,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5(CCN6CCN(C)CC6)CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,CC1=NN=C2COCC3=C(SC(C#CC4=CN(C5(,CCN,6CCN(C)CC6)CN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)N=C4)=C3CC3=CC=CC=C3)N12,0.5,99.0,1,Degradation of BRD4 in HL60/RS4;11/MDA-MB-231 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00520,824.968,824.3216855,2.84,60,10,14,1,8,151.03,C44H44N10O5S,"InChI=1S/C44H44N10O5S/c1-28-47-48-37-25-59-24-33-32(21-29-7-4-3-5-8-29)36(60-43(33)53(28)37)13-11-30-22-45-52(23-30)44(15-16-50-19-17-49(2)18-20-50)26-51(27-44)34-10-6-9-31-39(34)42(58)54(41(31)57)35-12-14-38(55)46-40(35)56/h3-10,22-23,35H,12,14-21,24-27H2,1-2H3,(H,46,55,56)",WNTMFWJFGDGXOH-UHFFFAOYSA-N
3781,P11802,CDK4,CRBN,,,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC(=O)NCCCCCCNC(=O)COC5=CC=C6C(=C5)CCCN6C(=O)CCl)CC4)N=C3)N=C2N(C2CCCC2)C1=O,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(,CC(=O)NCCCCCCNC(=O)CO,C5=CC=C6C(=C5)CCCN6C(=O)CCl)CC4)N=C3)N=C2N(C2CCCC2)C1=O,6500.0,89.0,0,Degradation of CDK4 in MDA-MB-231 cells after 12 h treatment,,,6.14,Inhibition activity of聽PARP1聽assay was carried out by Bioduro-Sundia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1540/850/830,Inhibit proliferation of MDA-MB-231/MV4-11/H1299 cells,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106637,869.468,868.4151072,4.44,62,7,13,3,18,183.99,C45H57ClN10O6,"InChI=1S/C45H57ClN10O6/c1-30-36-27-50-45(52-43(36)56(34-11-5-6-12-34)44(61)42(30)31(2)57)51-33-13-16-38(49-26-33)54-22-20-53(21-23-54)28-39(58)47-17-7-3-4-8-18-48-40(59)29-62-35-14-15-37-32(24-35)10-9-19-55(37)41(60)25-46/h13-16,24,26-27,34H,3-12,17-23,25,28-29H2,1-2H3,(H,47,58)(H,48,59)(H,50,51,52)",MWWRAAJVIJQVSY-UHFFFAOYSA-N
3781,Q00534,CDK6,CRBN,,,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CC(=O)NCCCCCCNC(=O)COC5=CC=C6C(=C5)CCCN6C(=O)CCl)CC4)N=C3)N=C2N(C2CCCC2)C1=O,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(,CC(=O)NCCCCCCNC(=O)CO,C5=CC=C6C(=C5)CCCN6C(=O)CCl)CC4)N=C3)N=C2N(C2CCCC2)C1=O,8000.0,83.0,0,Degradation of CDK6 in MDA-MB-231 cells after 12 h treatment,,,13.97,Inhibition activity of聽PARP1聽assay was carried out by Bioduro-Sundia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106637,869.468,868.4151072,4.44,62,7,13,3,18,183.99,C45H57ClN10O6,"InChI=1S/C45H57ClN10O6/c1-30-36-27-50-45(52-43(36)56(34-11-5-6-12-34)44(61)42(30)31(2)57)51-33-13-16-38(49-26-33)54-22-20-53(21-23-54)28-39(58)47-17-7-3-4-8-18-48-40(59)29-62-35-14-15-37-32(24-35)10-9-19-55(37)41(60)25-46/h13-16,24,26-27,34H,3-12,17-23,25,28-29H2,1-2H3,(H,47,58)(H,48,59)(H,50,51,52)",MWWRAAJVIJQVSY-UHFFFAOYSA-N
3804,Q92793,CBP,CRBN,,JET-129,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,1.7,66.0,0,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,196,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,795.857,795.3128947,2.39,59,9,12,3,9,197.82,C43H41N9O7,"InChI=1S/C43H41N9O7/c1-24(53)50-17-12-35-31(23-50)39(49-52(35)27-13-18-59-19-14-27)28-5-2-4-25-20-34(47-22-30(25)28)26-8-9-33(46-21-26)40(55)45-16-15-44-32-7-3-6-29-38(32)43(58)51(42(29)57)36-10-11-37(54)48-41(36)56/h2-9,20-22,27,36,44H,10-19,23H2,1H3,(H,45,55)(H,48,54,56)",HKMUULSLHVOHMZ-UHFFFAOYSA-N
3805,Q92793,CBP,CRBN,,JET-142,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,1.2,71.0,0,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,809.884,809.3285447,2.74,60,9,12,3,10,197.82,C44H43N9O7,"InChI=1S/C44H43N9O7/c1-25(54)51-18-13-36-32(24-51)40(50-53(36)28-14-19-60-20-15-28)29-6-2-5-26-21-35(48-23-31(26)29)27-9-10-34(47-22-27)41(56)46-17-4-16-45-33-8-3-7-30-39(33)44(59)52(43(30)58)37-11-12-38(55)49-42(37)57/h2-3,5-10,21-23,28,37,45H,4,11-20,24H2,1H3,(H,46,56)(H,49,55,57)",GRTUCEOYBLSCJP-UHFFFAOYSA-N
3805,Q09472,EP300,CRBN,,JET-142,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,0.7,90.0,1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,809.884,809.3285447,2.74,60,9,12,3,10,197.82,C44H43N9O7,"InChI=1S/C44H43N9O7/c1-25(54)51-18-13-36-32(24-51)40(50-53(36)28-14-19-60-20-15-28)29-6-2-5-26-21-35(48-23-31(26)29)27-9-10-34(47-22-27)41(56)46-17-4-16-45-33-8-3-7-30-39(33)44(59)52(43(30)58)37-11-12-38(55)49-42(37)57/h2-3,5-10,21-23,28,37,45H,4,11-20,24H2,1H3,(H,46,56)(H,49,55,57)",GRTUCEOYBLSCJP-UHFFFAOYSA-N
3806,Q92793,CBP,CRBN,,JET-130,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,1.3,70.0,0,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.4,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,823.911,823.3441948,3.1,61,9,12,3,11,197.82,C45H45N9O7,"InChI=1S/C45H45N9O7/c1-26(55)52-19-14-37-33(25-52)41(51-54(37)29-15-20-61-21-16-29)30-7-4-6-27-22-36(49-24-32(27)30)28-10-11-35(48-23-28)42(57)47-18-3-2-17-46-34-9-5-8-31-40(34)45(60)53(44(31)59)38-12-13-39(56)50-43(38)58/h4-11,22-24,29,38,46H,2-3,12-21,25H2,1H3,(H,47,57)(H,50,56,58)",VQVZAQCNYUSBIJ-UHFFFAOYSA-N
3806,Q09472,EP300,CRBN,,JET-130,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,0.8,77.0,0,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,823.911,823.3441948,3.1,61,9,12,3,11,197.82,C45H45N9O7,"InChI=1S/C45H45N9O7/c1-26(55)52-19-14-37-33(25-52)41(51-54(37)29-15-20-61-21-16-29)30-7-4-6-27-22-36(49-24-32(27)30)28-10-11-35(48-23-28)42(57)47-18-3-2-17-46-34-9-5-8-31-40(34)45(60)53(44(31)59)38-12-13-39(56)50-43(38)58/h4-11,22-24,29,38,46H,2-3,12-21,25H2,1H3,(H,47,57)(H,50,56,58)",VQVZAQCNYUSBIJ-UHFFFAOYSA-N
3807,Q92793,CBP,CRBN,,JET-135,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCCCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,1.0,92.0,1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.2,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,837.938,837.3598448,3.46,62,9,12,3,12,197.82,C46H47N9O7,"InChI=1S/C46H47N9O7/c1-27(56)53-20-15-38-34(26-53)42(52-55(38)30-16-21-62-22-17-30)31-8-5-7-28-23-37(50-25-33(28)31)29-11-12-36(49-24-29)43(58)48-19-4-2-3-18-47-35-10-6-9-32-41(35)46(61)54(45(32)60)39-13-14-40(57)51-44(39)59/h5-12,23-25,30,39,47H,2-4,13-22,26H2,1H3,(H,48,58)(H,51,57,59)",HYHSJYMZWGTVLB-UHFFFAOYSA-N
3807,Q09472,EP300,CRBN,,JET-135,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCCCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,0.3,95.0,1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,837.938,837.3598448,3.46,62,9,12,3,12,197.82,C46H47N9O7,"InChI=1S/C46H47N9O7/c1-27(56)53-20-15-38-34(26-53)42(52-55(38)30-16-21-62-22-17-30)31-8-5-7-28-23-37(50-25-33(28)31)29-11-12-36(49-24-29)43(58)48-19-4-2-3-18-47-35-10-6-9-32-41(35)46(61)54(45(32)60)39-13-14-40(57)51-44(39)59/h5-12,23-25,30,39,47H,2-4,13-22,26H2,1H3,(H,48,58)(H,51,57,59)",HYHSJYMZWGTVLB-UHFFFAOYSA-N
3808,Q92793,CBP,CRBN,,JET-131,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCCCCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,0.6,99.0,1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.3,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,851.965,851.3754949,3.82,63,9,12,3,13,197.82,C47H49N9O7,"InChI=1S/C47H49N9O7/c1-28(57)54-21-16-39-35(27-54)43(53-56(39)31-17-22-63-23-18-31)32-9-6-8-29-24-38(51-26-34(29)32)30-12-13-37(50-25-30)44(59)49-20-5-3-2-4-19-48-36-11-7-10-33-42(36)47(62)55(46(33)61)40-14-15-41(58)52-45(40)60/h6-13,24-26,31,40,48H,2-5,14-23,27H2,1H3,(H,49,59)(H,52,58,60)",AXPGRWCCCLWKQJ-UHFFFAOYSA-N
3808,Q09472,EP300,CRBN,,JET-131,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCCCCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,0.6,87.0,1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,851.965,851.3754949,3.82,63,9,12,3,13,197.82,C47H49N9O7,"InChI=1S/C47H49N9O7/c1-28(57)54-21-16-39-35(27-54)43(53-56(39)31-17-22-63-23-18-31)32-9-6-8-29-24-38(51-26-34(29)32)30-12-13-37(50-25-30)44(59)49-20-5-3-2-4-19-48-36-11-7-10-33-42(36)47(62)55(46(33)61)40-14-15-41(58)52-45(40)60/h6-13,24-26,31,40,48H,2-5,14-23,27H2,1H3,(H,49,59)(H,52,58,60)",AXPGRWCCCLWKQJ-UHFFFAOYSA-N
3809,Q92793,CBP,CRBN,,JET-136,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCCCCCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,1.2,99.0,1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.6,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,865.992,865.391145,4.36,64,9,12,3,14,197.82,C48H51N9O7,"InChI=1S/C48H51N9O7/c1-29(58)55-22-17-40-36(28-55)44(54-57(40)32-18-23-64-24-19-32)33-10-7-9-30-25-39(52-27-35(30)33)31-13-14-38(51-26-31)45(60)50-21-6-4-2-3-5-20-49-37-12-8-11-34-43(37)48(63)56(47(34)62)41-15-16-42(59)53-46(41)61/h7-14,25-27,32,41,49H,2-6,15-24,28H2,1H3,(H,50,60)(H,53,59,61)",IDFDLTKSQGRMMG-UHFFFAOYSA-N
3809,Q09472,EP300,CRBN,,JET-136,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCCCCCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,2.3,87.0,1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,865.992,865.391145,4.36,64,9,12,3,14,197.82,C48H51N9O7,"InChI=1S/C48H51N9O7/c1-29(58)55-22-17-40-36(28-55)44(54-57(40)32-18-23-64-24-19-32)33-10-7-9-30-25-39(52-27-35(30)33)31-13-14-38(51-26-31)45(60)50-21-6-4-2-3-5-20-49-37-12-8-11-34-43(37)48(63)56(47(34)62)41-15-16-42(59)53-46(41)61/h7-14,25-27,32,41,49H,2-6,15-24,28H2,1H3,(H,50,60)(H,53,59,61)",IDFDLTKSQGRMMG-UHFFFAOYSA-N
3810,Q92793,CBP,CRBN,,JET-132,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCCCCCCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,0.2,99.0,1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,880.019,879.406795,4.9,65,9,12,3,15,197.82,C49H53N9O7,"InChI=1S/C49H53N9O7/c1-30(59)56-23-18-41-37(29-56)45(55-58(41)33-19-24-65-25-20-33)34-11-8-10-31-26-40(53-28-36(31)34)32-14-15-39(52-27-32)46(61)51-22-7-5-3-2-4-6-21-50-38-13-9-12-35-44(38)49(64)57(48(35)63)42-16-17-43(60)54-47(42)62/h8-15,26-28,33,42,50H,2-7,16-25,29H2,1H3,(H,51,61)(H,54,60,62)",GRCWKRCQBMPDDA-UHFFFAOYSA-N
3810,Q09472,EP300,CRBN,,JET-132,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCCCCCCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,1.6,97.0,1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,880.019,879.406795,4.9,65,9,12,3,15,197.82,C49H53N9O7,"InChI=1S/C49H53N9O7/c1-30(59)56-23-18-41-37(29-56)45(55-58(41)33-19-24-65-25-20-33)34-11-8-10-31-26-40(53-28-36(31)34)32-14-15-39(52-27-32)46(61)51-22-7-5-3-2-4-6-21-50-38-13-9-12-35-44(38)49(64)57(48(35)63)42-16-17-43(60)54-47(42)62/h8-15,26-28,33,42,50H,2-7,16-25,29H2,1H3,(H,51,61)(H,54,60,62)",GRCWKRCQBMPDDA-UHFFFAOYSA-N
3811,Q92793,CBP,CRBN,,JET-145,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCC,C5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,3.3,95.0,1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.5,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,780.886,780.3383811,2.52,58,9,10,2,9,168.72,C44H44N8O6,"InChI=1S/C44H44N8O6/c1-26(53)50-18-14-38-35(24-50)41(49-52(38)30-15-19-58-20-16-30)31-8-3-6-28-21-37(47-23-33(28)31)29-10-11-36(46-22-29)42(55)45-17-4-7-27-5-2-9-32-34(27)25-51(44(32)57)39-12-13-40(54)48-43(39)56/h2-3,5-6,8-11,21-23,30,39H,4,7,12-20,24-25H2,1H3,(H,45,55)(H,48,54,56)",IIMIYRHGPQNUTI-UHFFFAOYSA-N
3811,Q09472,EP300,CRBN,,JET-145,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCC,C5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,0.3,99.0,1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,780.886,780.3383811,2.52,58,9,10,2,9,168.72,C44H44N8O6,"InChI=1S/C44H44N8O6/c1-26(53)50-18-14-38-35(24-50)41(49-52(38)30-15-19-58-20-16-30)31-8-3-6-28-21-37(47-23-33(28)31)29-10-11-36(46-22-29)42(55)45-17-4-7-27-5-2-9-32-34(27)25-51(44(32)57)39-12-13-40(54)48-43(39)56/h2-3,5-6,8-11,21-23,30,39H,4,7,12-20,24-25H2,1H3,(H,45,55)(H,48,54,56)",IIMIYRHGPQNUTI-UHFFFAOYSA-N
3812,Q92793,CBP,CRBN,,JET-146,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCCC,C5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,0.2,80.0,1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,794.913,794.3540312,2.88,59,9,10,2,10,168.72,C45H46N8O6,"InChI=1S/C45H46N8O6/c1-27(54)51-19-15-39-36(25-51)42(50-53(39)31-16-20-59-21-17-31)32-9-5-8-29-22-38(48-24-34(29)32)30-11-12-37(47-23-30)43(56)46-18-3-2-6-28-7-4-10-33-35(28)26-52(45(33)58)40-13-14-41(55)49-44(40)57/h4-5,7-12,22-24,31,40H,2-3,6,13-21,25-26H2,1H3,(H,46,56)(H,49,55,57)",HLFIMIUCZKHKSI-UHFFFAOYSA-N
3812,Q09472,EP300,CRBN,,JET-146,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCCC,C5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,0.1,99.0,1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,794.913,794.3540312,2.88,59,9,10,2,10,168.72,C45H46N8O6,"InChI=1S/C45H46N8O6/c1-27(54)51-19-15-39-36(25-51)42(50-53(39)31-16-20-59-21-17-31)32-9-5-8-29-22-38(48-24-34(29)32)30-11-12-37(47-23-30)43(56)46-18-3-2-6-28-7-4-10-33-35(28)26-52(45(33)58)40-13-14-41(55)49-44(40)57/h4-5,7-12,22-24,31,40H,2-3,6,13-21,25-26H2,1H3,(H,46,56)(H,49,55,57)",HLFIMIUCZKHKSI-UHFFFAOYSA-N
3813,Q92793,CBP,CRBN,,JET-147,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCCC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCCCC,C5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,0.2,99.0,1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.2,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,808.94,808.3696813,3.42,60,9,10,2,11,168.72,C46H48N8O6,"InChI=1S/C46H48N8O6/c1-28(55)52-20-16-40-37(26-52)43(51-54(40)32-17-21-60-22-18-32)33-10-6-9-30-23-39(49-25-35(30)33)31-12-13-38(48-24-31)44(57)47-19-4-2-3-7-29-8-5-11-34-36(29)27-53(46(34)59)41-14-15-42(56)50-45(41)58/h5-6,8-13,23-25,32,41H,2-4,7,14-22,26-27H2,1H3,(H,47,57)(H,50,56,58)",WBYWTMBEFZPCDI-UHFFFAOYSA-N
3813,Q09472,EP300,CRBN,,JET-147,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCCCC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCCCC,C5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,0.1,99.0,1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,808.94,808.3696813,3.42,60,9,10,2,11,168.72,C46H48N8O6,"InChI=1S/C46H48N8O6/c1-28(55)52-20-16-40-37(26-52)43(51-54(40)32-17-21-60-22-18-32)33-10-6-9-30-23-39(49-25-35(30)33)31-12-13-38(48-24-31)44(57)47-19-4-2-3-7-29-8-5-11-34-36(29)27-53(46(34)59)41-14-15-42(56)50-45(41)58/h5-6,8-13,23-25,32,41H,2-4,7,14-22,26-27H2,1H3,(H,47,57)(H,50,56,58)",WBYWTMBEFZPCDI-UHFFFAOYSA-N
3814,Q92793,CBP,CRBN,,JET-156,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCNC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCN,C5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,0.6,99.0,1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,781.874,781.3336301,1.89,58,9,11,3,9,180.75,C43H43N9O6,"InChI=1S/C43H43N9O6/c1-25(53)50-17-12-37-33(23-50)40(49-52(37)28-13-18-58-19-14-28)29-5-2-4-26-20-36(47-22-31(26)29)27-8-9-35(46-21-27)41(55)45-16-15-44-34-7-3-6-30-32(34)24-51(43(30)57)38-10-11-39(54)48-42(38)56/h2-9,20-22,28,38,44H,10-19,23-24H2,1H3,(H,45,55)(H,48,54,56)",MYMXYDSTYJHREL-UHFFFAOYSA-N
3814,Q09472,EP300,CRBN,,JET-156,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCNC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCN,C5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,1.8,97.0,1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,781.874,781.3336301,1.89,58,9,11,3,9,180.75,C43H43N9O6,"InChI=1S/C43H43N9O6/c1-25(53)50-17-12-37-33(23-50)40(49-52(37)28-13-18-58-19-14-28)29-5-2-4-26-20-36(47-22-31(26)29)27-8-9-35(46-21-27)41(55)45-16-15-44-34-7-3-6-30-32(34)24-51(43(30)57)38-10-11-39(54)48-42(38)56/h2-9,20-22,28,38,44H,10-19,23-24H2,1H3,(H,45,55)(H,48,54,56)",MYMXYDSTYJHREL-UHFFFAOYSA-N
3815,Q92793,CBP,CRBN,,JET-153,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCNC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCCN,C5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,0.2,98.0,1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,795.901,795.3492802,2.8,59,9,11,3,10,180.75,C44H45N9O6,"InChI=1S/C44H45N9O6/c1-26(54)51-18-13-38-34(24-51)41(50-53(38)29-14-19-59-20-15-29)30-6-2-5-27-21-37(48-23-32(27)30)28-9-10-36(47-22-28)42(56)46-17-4-16-45-35-8-3-7-31-33(35)25-52(44(31)58)39-11-12-40(55)49-43(39)57/h2-3,5-10,21-23,29,39,45H,4,11-20,24-25H2,1H3,(H,46,56)(H,49,55,57)",XETBTLFBEYTSGJ-UHFFFAOYSA-N
3815,Q09472,EP300,CRBN,,JET-153,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCNC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCCN,C5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)N=C4)=NC=C13)=NN2C1CCOCC1,1.8,95.0,1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,795.901,795.3492802,2.8,59,9,11,3,10,180.75,C44H45N9O6,"InChI=1S/C44H45N9O6/c1-26(54)51-18-13-38-34(24-51)41(50-53(38)29-14-19-59-20-15-29)30-6-2-5-27-21-37(48-23-32(27)30)28-9-10-36(47-22-28)42(56)46-17-4-16-45-35-8-3-7-31-33(35)25-52(44(31)58)39-11-12-40(55)49-43(39)57/h2-3,5-10,21-23,29,39,45H,4,11-20,24-25H2,1H3,(H,46,56)(H,49,55,57)",XETBTLFBEYTSGJ-UHFFFAOYSA-N
3816,Q92793,CBP,CRBN,,JET-157,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCNC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)CC6=C5)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCN,C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)CC6=C5)N=C4)=NC=C13)=NN2C1CCOCC1,1.1,80.0,1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,781.874,781.3336301,1.89,58,9,11,3,9,180.75,C43H43N9O6,"InChI=1S/C43H43N9O6/c1-25(53)50-16-11-37-34(24-50)40(49-52(37)30-12-17-58-18-13-30)32-4-2-3-26-20-36(47-22-33(26)32)27-5-8-35(46-21-27)41(55)45-15-14-44-29-6-7-31-28(19-29)23-51(43(31)57)38-9-10-39(54)48-42(38)56/h2-8,19-22,30,38,44H,9-18,23-24H2,1H3,(H,45,55)(H,48,54,56)",XHEUEZODLRVMMV-UHFFFAOYSA-N
3816,Q09472,EP300,CRBN,,JET-157,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCNC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)CC6=C5)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCN,C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)CC6=C5)N=C4)=NC=C13)=NN2C1CCOCC1,5.1,73.0,0,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,781.874,781.3336301,1.89,58,9,11,3,9,180.75,C43H43N9O6,"InChI=1S/C43H43N9O6/c1-25(53)50-16-11-37-34(24-50)40(49-52(37)30-12-17-58-18-13-30)32-4-2-3-26-20-36(47-22-33(26)32)27-5-8-35(46-21-27)41(55)45-15-14-44-29-6-7-31-28(19-29)23-51(43(31)57)38-9-10-39(54)48-42(38)56/h2-8,19-22,30,38,44H,9-18,23-24H2,1H3,(H,45,55)(H,48,54,56)",XHEUEZODLRVMMV-UHFFFAOYSA-N
3817,Q92793,CBP,CRBN,,JET-158,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCNC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)CC6=C5)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCCN,C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)CC6=C5)N=C4)=NC=C13)=NN2C1CCOCC1,0.1,99.0,1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,795.901,795.3492802,2.8,59,9,11,3,10,180.75,C44H45N9O6,"InChI=1S/C44H45N9O6/c1-26(54)51-17-12-38-35(25-51)41(50-53(38)31-13-18-59-19-14-31)33-5-2-4-27-21-37(48-23-34(27)33)28-6-9-36(47-22-28)42(56)46-16-3-15-45-30-7-8-32-29(20-30)24-52(44(32)58)39-10-11-40(55)49-43(39)57/h2,4-9,20-23,31,39,45H,3,10-19,24-25H2,1H3,(H,46,56)(H,49,55,57)",JJWLIXJPPKOFQJ-UHFFFAOYSA-N
3817,Q09472,EP300,CRBN,,JET-158,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NCCCNC5=CC=C6C(=O)N(C7CCC(=O)NC7=O)CC6=C5)N=C4)=NC=C13)=NN2C1CCOCC1,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(,C(=O)NCCCN,C5=CC=C6C(=O)N(C7CCC(=O)NC7=O)CC6=C5)N=C4)=NC=C13)=NN2C1CCOCC1,0.3,99.0,1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,795.901,795.3492802,2.8,59,9,11,3,10,180.75,C44H45N9O6,"InChI=1S/C44H45N9O6/c1-26(54)51-17-12-38-35(25-51)41(50-53(38)31-13-18-59-19-14-31)33-5-2-4-27-21-37(48-23-34(27)33)28-6-9-36(47-22-28)42(56)46-16-3-15-45-30-7-8-32-29(20-30)24-52(44(32)58)39-10-11-40(55)49-43(39)57/h2,4-9,20-23,31,39,45H,3,10-19,24-25H2,1H3,(H,46,56)(H,49,55,57)",JJWLIXJPPKOFQJ-UHFFFAOYSA-N
3818,Q92793,CBP,CRBN,,JET-179,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CCC(NC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,,CC(=O)N,1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CCC(NC6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,1.8,86.0,1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,68,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,835.922,835.3441948,2.57,62,10,12,2,7,189.03,C46H45N9O7,"InChI=1S/C46H45N9O7/c1-26(56)53-19-14-38-34(25-53)42(51-55(38)30-15-20-62-21-16-30)31-5-2-4-27-22-37(48-24-33(27)31)28-8-9-36(47-23-28)45(60)52-17-12-29(13-18-52)49-35-7-3-6-32-41(35)46(61)54(44(32)59)39-10-11-40(57)50-43(39)58/h2-9,22-24,29-30,39,49H,10-21,25H2,1H3,(H,50,57,58)",GQZPPJBTNANHER-UHFFFAOYSA-N
3819,Q92793,CBP,CRBN,,JET-181,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NC5CCN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,,CC(=O)N,1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NC5CCN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,0.2,99.0,1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.6,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,835.922,835.3441948,2.53,62,10,12,2,7,189.03,C46H45N9O7,"InChI=1S/C46H45N9O7/c1-26(56)53-19-14-37-34(25-53)42(51-55(37)30-15-20-62-21-16-30)31-5-2-4-27-22-36(48-24-33(27)31)28-8-9-35(47-23-28)43(58)49-29-12-17-52(18-13-29)38-7-3-6-32-41(38)46(61)54(45(32)60)39-10-11-40(57)50-44(39)59/h2-9,22-24,29-30,39H,10-21,25H2,1H3,(H,49,58)(H,50,57,59)",XPOGTFDQDPCEDH-UHFFFAOYSA-N
3819,Q09472,EP300,CRBN,,JET-181,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NC5CCN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,,CC(=O)N,1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NC5CCN(C6=CC=CC7=C6C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,1.6,99.0,1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,835.922,835.3441948,2.53,62,10,12,2,7,189.03,C46H45N9O7,"InChI=1S/C46H45N9O7/c1-26(56)53-19-14-37-34(25-53)42(51-55(37)30-15-20-62-21-16-30)31-5-2-4-27-22-36(48-24-33(27)31)28-8-9-35(47-23-28)43(58)49-29-12-17-52(18-13-29)38-7-3-6-32-41(38)46(61)54(45(32)60)39-10-11-40(57)50-44(39)59/h2-9,22-24,29-30,39H,10-21,25H2,1H3,(H,49,58)(H,50,57,59)",XPOGTFDQDPCEDH-UHFFFAOYSA-N
3820,Q92793,CBP,CRBN,,JET-184,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CCC(C6CN(C7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)C6)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,,CC(=O)N,1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CCC(C6CN(C7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)C6)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,3.7,85.0,1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,875.987,875.3754949,2.93,65,11,12,1,7,180.24,C49H49N9O7,"InChI=1S/C49H49N9O7/c1-28(59)55-19-14-40-37(27-55)45(53-58(40)33-15-20-65-21-16-33)34-5-2-4-30-22-39(51-24-36(30)34)31-8-9-38(50-23-31)48(63)54-17-12-29(13-18-54)32-25-56(26-32)41-7-3-6-35-44(41)49(64)57(47(35)62)42-10-11-43(60)52-46(42)61/h2-9,22-24,29,32-33,42H,10-21,25-27H2,1H3,(H,52,60,61)",ZXEZOPTWSHMEHU-UHFFFAOYSA-N
3821,Q92793,CBP,CRBN,,JET-185,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CCC(C6CCN(C7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,,CC(=O)N,1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CCC(C6CCN(C7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,40.0,58.0,0,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,24,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,904.041,903.406795,3.65,67,11,12,1,7,180.24,C51H53N9O7,"InChI=1S/C51H53N9O7/c1-30(61)58-23-16-42-39(29-58)47(55-60(42)35-17-24-67-25-18-35)36-5-2-4-33-26-41(53-28-38(33)36)34-8-9-40(52-27-34)50(65)57-21-14-32(15-22-57)31-12-19-56(20-13-31)43-7-3-6-37-46(43)51(66)59(49(37)64)44-10-11-45(62)54-48(44)63/h2-9,26-28,31-32,35,44H,10-25,29H2,1H3,(H,54,62,63)",ITSNPCRTAAEVPC-UHFFFAOYSA-N
3822,Q92793,CBP,CRBN,,JET-188,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CCC6(CC5)CC(NC5=CC=CC7=C5C(=O)N(C5CCC(=O)NC5=O)C7=O)C6)N=C4)=NC=C13)=NN2C1CCOCC1,,CC(=O)N,1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CCC6(CC5)CC(NC5=CC=CC7=C5C(=O)N(C5CCC(=O)NC5=O)C7=O)C6)N=C4)=NC=C13)=NN2C1CCOCC1,1.7,96.0,1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,51,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,875.987,875.3754949,3.18,65,11,12,2,7,189.03,C49H49N9O7,"InChI=1S/C49H49N9O7/c1-28(59)56-17-12-40-36(27-56)44(54-58(40)32-13-20-65-21-14-32)33-5-2-4-29-22-39(51-26-35(29)33)30-8-9-38(50-25-30)47(63)55-18-15-49(16-19-55)23-31(24-49)52-37-7-3-6-34-43(37)48(64)57(46(34)62)41-10-11-42(60)53-45(41)61/h2-9,22,25-26,31-32,41,52H,10-21,23-24,27H2,1H3,(H,53,60,61)",CLMAGEKQBJFDQU-UHFFFAOYSA-N
3822,Q09472,EP300,CRBN,,JET-188,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CCC6(CC5)CC(NC5=CC=CC7=C5C(=O)N(C5CCC(=O)NC5=O)C7=O)C6)N=C4)=NC=C13)=NN2C1CCOCC1,,CC(=O)N,1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CCC6(CC5)CC(NC5=CC=CC7=C5C(=O)N(C5CCC(=O)NC5=O)C7=O)C6)N=C4)=NC=C13)=NN2C1CCOCC1,9.3,51.0,0,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,875.987,875.3754949,3.18,65,11,12,2,7,189.03,C49H49N9O7,"InChI=1S/C49H49N9O7/c1-28(59)56-17-12-40-36(27-56)44(54-58(40)32-13-20-65-21-14-32)33-5-2-4-29-22-39(51-26-35(29)33)30-8-9-38(50-25-30)47(63)55-18-15-49(16-19-55)23-31(24-49)52-37-7-3-6-34-43(37)48(64)57(46(34)62)41-10-11-42(60)53-45(41)61/h2-9,22,25-26,31-32,41,52H,10-21,23-24,27H2,1H3,(H,53,60,61)",CLMAGEKQBJFDQU-UHFFFAOYSA-N
3824,Q92793,CBP,CRBN,,JET-192,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CC6(CCC(NC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)C5)N=C4)=NC=C13)=NN2C1CCOCC1,,CC(=O)N,1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CC6(CCC(NC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)C5)N=C4)=NC=C13)=NN2C1CCOCC1,4.8,81.0,1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,44,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,875.987,875.3754949,3.18,65,11,12,2,7,189.03,C49H49N9O7,"InChI=1S/C49H49N9O7/c1-28(59)55-19-14-40-36(25-55)44(54-58(40)32-15-20-65-21-16-32)33-5-2-4-29-22-39(51-24-35(29)33)30-8-9-38(50-23-30)47(63)56-26-49(27-56)17-12-31(13-18-49)52-37-7-3-6-34-43(37)48(64)57(46(34)62)41-10-11-42(60)53-45(41)61/h2-9,22-24,31-32,41,52H,10-21,25-27H2,1H3,(H,53,60,61)",HMLXCHFBGHUPHQ-UHFFFAOYSA-N
3824,Q09472,EP300,CRBN,,JET-192,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CC6(CCC(NC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)C5)N=C4)=NC=C13)=NN2C1CCOCC1,,CC(=O)N,1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CC6(CCC(NC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)C5)N=C4)=NC=C13)=NN2C1CCOCC1,25.0,62.0,0,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,875.987,875.3754949,3.18,65,11,12,2,7,189.03,C49H49N9O7,"InChI=1S/C49H49N9O7/c1-28(59)55-19-14-40-36(25-55)44(54-58(40)32-15-20-65-21-16-32)33-5-2-4-29-22-39(51-24-35(29)33)30-8-9-38(50-23-30)47(63)56-26-49(27-56)17-12-31(13-18-49)52-37-7-3-6-34-43(37)48(64)57(46(34)62)41-10-11-42(60)53-45(41)61/h2-9,22-24,31-32,41,52H,10-21,25-27H2,1H3,(H,53,60,61)",HMLXCHFBGHUPHQ-UHFFFAOYSA-N
3825,Q92793,CBP,CRBN,,JET-193,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CC6(CC(NC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)C6)C5)N=C4)=NC=C13)=NN2C1CCOCC1,,CC(=O)N,1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CC6(CC(NC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)C6)C5)N=C4)=NC=C13)=NN2C1CCOCC1,0.3,99.0,1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11.3,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,847.933,847.3441948,2.46,63,11,12,2,7,189.03,C47H45N9O7,"InChI=1S/C47H45N9O7/c1-26(57)53-15-12-38-34(23-53)42(52-56(38)30-13-16-63-17-14-30)31-5-2-4-27-18-37(49-22-33(27)31)28-8-9-36(48-21-28)45(61)54-24-47(25-54)19-29(20-47)50-35-7-3-6-32-41(35)46(62)55(44(32)60)39-10-11-40(58)51-43(39)59/h2-9,18,21-22,29-30,39,50H,10-17,19-20,23-25H2,1H3,(H,51,58,59)",ANFFPFFAJDSUIN-UHFFFAOYSA-N
3825,Q09472,EP300,CRBN,,JET-193,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CC6(CC(NC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)C6)C5)N=C4)=NC=C13)=NN2C1CCOCC1,,CC(=O)N,1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)N5CC6(CC(NC7=CC=CC8=C7C(=O)N(C7CCC(=O)NC7=O)C8=O)C6)C5)N=C4)=NC=C13)=NN2C1CCOCC1,1.1,95.0,1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,847.933,847.3441948,2.46,63,11,12,2,7,189.03,C47H45N9O7,"InChI=1S/C47H45N9O7/c1-26(57)53-15-12-38-34(23-53)42(52-56(38)30-13-16-63-17-14-30)31-5-2-4-27-18-37(49-22-33(27)31)28-8-9-36(48-21-28)45(61)54-24-47(25-54)19-29(20-47)50-35-7-3-6-32-41(35)46(62)55(44(32)60)39-10-11-40(58)51-43(39)59/h2-9,18,21-22,29-30,39,50H,10-17,19-20,23-25H2,1H3,(H,51,58,59)",ANFFPFFAJDSUIN-UHFFFAOYSA-N
3826,Q92793,CBP,CRBN,,JET-200,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,,CC(=O)N,1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,1.0,99.0,1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1,Inhibit of cell growth of RS4;11 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,835.922,835.3441948,2.53,62,10,12,2,7,189.03,C46H45N9O7,"InChI=1S/C46H45N9O7/c1-26(56)53-18-13-39-36(25-53)42(51-55(39)30-14-19-62-20-15-30)32-4-2-3-27-21-38(48-24-35(27)32)28-5-8-37(47-23-28)43(58)49-29-11-16-52(17-12-29)31-6-7-33-34(22-31)46(61)54(45(33)60)40-9-10-41(57)50-44(40)59/h2-8,21-24,29-30,40H,9-20,25H2,1H3,(H,49,58)(H,50,57,59)",YDXGLXSGGLHGPG-UHFFFAOYSA-N
3826,Q09472,EP300,CRBN,,JET-200,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,,CC(=O)N,1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,1.9,99.0,1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,835.922,835.3441948,2.53,62,10,12,2,7,189.03,C46H45N9O7,"InChI=1S/C46H45N9O7/c1-26(56)53-18-13-39-36(25-53)42(51-55(39)30-14-19-62-20-15-30)32-4-2-3-27-21-38(48-24-35(27)32)28-5-8-37(47-23-28)43(58)49-29-11-16-52(17-12-29)31-6-7-33-34(22-31)46(61)54(45(33)60)40-9-10-41(57)50-44(40)59/h2-8,21-24,29-30,40H,9-20,25H2,1H3,(H,49,58)(H,50,57,59)",YDXGLXSGGLHGPG-UHFFFAOYSA-N
3827,Q92793,CBP,CRBN,,JET-209,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)CC7=C6)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,,CC(=O)N,1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)CC7=C6)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,0.1,99.0,1,Degradation of CBP in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,19.7/0.04/0.54,Inhibit of cell growth of RS4;11/MV4;11/HL-60 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,821.939,821.3649302,2.58,61,10,11,2,7,171.96,C46H47N9O6,"InChI=1S/C46H47N9O6/c1-27(56)53-18-13-40-37(26-53)43(51-55(40)32-14-19-61-20-15-32)35-4-2-3-28-22-39(48-24-36(28)35)29-5-8-38(47-23-29)44(58)49-31-11-16-52(17-12-31)33-6-7-34-30(21-33)25-54(46(34)60)41-9-10-42(57)50-45(41)59/h2-8,21-24,31-32,41H,9-20,25-26H2,1H3,(H,49,58)(H,50,57,59)",OGNHAQXAAGMVOV-UHFFFAOYSA-N
3827,Q09472,EP300,CRBN,,JET-209,CC(=O)N1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)CC7=C6)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,,CC(=O)N,1CCC2=C(C1)C(C1=CC=CC3=CC(C4=CC=C(C(=O)NC5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)CC7=C6)CC5)N=C4)=NC=C13)=NN2C1CCOCC1,0.2,99.0,1,Degradation of p300 in RS4;11 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3,Inhibit of cell growth of MOLM-13 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00492,821.939,821.3649302,2.58,61,10,11,2,7,171.96,C46H47N9O6,"InChI=1S/C46H47N9O6/c1-27(56)53-18-13-40-37(26-53)43(51-55(40)32-14-19-61-20-15-32)35-4-2-3-28-22-39(48-24-36(28)35)29-5-8-38(47-23-29)44(58)49-31-11-16-52(17-12-31)33-6-7-34-30(21-33)25-54(46(34)60)41-9-10-42(57)50-45(41)59/h2-8,21-24,31-32,41H,9-20,25-26H2,1H3,(H,49,58)(H,50,57,59)",OGNHAQXAAGMVOV-UHFFFAOYSA-N
3832,P37840,Alpha-syn,CRBN,,,O=C(CNC1=CC=CC(C2=CC(C3=CC=C4OCOC4=C3)=N[NH]2)=C1)NCCOCCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,O=C(CNC1=CC=CC(C2=CC(C3=CC=C4OCOC4=C3)=N[NH]2)=C1),NCCOCCOCCOCCN,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,7510.0,89.0,0,"Degradation of alphaSyn in Snca OE-PFF seeding HEK293T cells after 48 h treatment/Immunoblot and dot blot (native, conformation-specific) analysis ofHEK293T cells",,,,,,,1161,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00274,767.796,767.2914905,2.67,56,7,13,5,19,211.54,C39H41N7O10,"InChI=1S/C39H41N7O10/c47-34-10-8-31(37(49)43-34)46-38(50)27-5-2-6-28(36(27)39(46)51)40-11-13-52-15-17-54-18-16-53-14-12-41-35(48)22-42-26-4-1-3-24(19-26)29-21-30(45-44-29)25-7-9-32-33(20-25)56-23-55-32/h1-7,9,19-21,31,40,42H,8,10-18,22-23H2,(H,41,48)(H,44,45)(H,43,47,49)",IYFKRANQUJUTKF-UHFFFAOYSA-N
3889,P21802,FGFR2,CRBN,,LC-MB12,COC1=CC(OC)=C(Cl)C(NC(=O)N(C)C2=CC(NC3=CC=C(N4CCN(C(=O)C5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)=NC=N2)=C1Cl,COC1=CC(OC)=C(Cl)C(,NC(=O)N(C),C2=CC(NC3=CC=C(N4CCN(C(=O)C5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)C=C3)=NC=N2)=C1Cl,11.8,80.0,1,Degradation of FGFR2 in KATO III cells after 6 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.3/29.1/3.7,Inhibit the proliferation of Ba/F3-TEL-FGFR2/KATO III/SNU16 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00150,899.793,898.2720637,4.23,63,8,13,3,10,198.95,C43H44Cl2N10O8,"InChI=1S/C43H44Cl2N10O8/c1-51(43(61)50-38-36(44)31(62-2)21-32(63-3)37(38)45)34-22-33(46-23-47-34)48-25-4-6-26(7-5-25)53-16-18-54(19-17-53)40(58)24-12-14-52(15-13-24)27-8-9-28-29(20-27)42(60)55(41(28)59)30-10-11-35(56)49-39(30)57/h4-9,20-24,30H,10-19H2,1-3H3,(H,50,61)(H,46,47,48)(H,49,56,57)",BUEXWHUMUYQITQ-UHFFFAOYSA-N
3901,Q06187,BTK,CRBN,,PTD1,C[C@H]1CN(C(=O)CCCCCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,C[C@H]1CN(,C(=O)CCCCCCCCCN,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,31.2,94.0,1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,1034.232,1033.517408,5.71,76,10,15,4,18,224.41,C57H67N11O8,"InChI=1S/C57H67N11O8/c1-35-32-64(49(71)15-10-8-6-5-7-9-11-21-58-42-14-12-13-40-50(42)56(76)68(53(40)73)44-17-19-48(70)62-52(44)72)23-24-65(35)38-16-18-47(60-31-38)61-43-27-37(33-63(4)54(43)74)39-20-22-59-51(41(39)34-69)67-26-25-66-45(55(67)75)28-36-29-57(2,3)30-46(36)66/h12-14,16,18,20,22,27-28,31,33,35,44,58,69H,5-11,15,17,19,21,23-26,29-30,32,34H2,1-4H3,(H,60,61)(H,62,70,72)/t35-,44?/m0/s1",NOYFZERQOYOFSG-FZXGYKHYSA-N
3902,Q06187,BTK,CRBN,,PTD2,C[C@H]1CN(C(=O)CCCCCCOCCOCC(=O)NC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,C[C@H]1CN(,C(=O)CCCCCCOCCOCC(=O)N,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,6.6,97.1,1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,1094.24,1093.502152,3.01,80,10,17,4,20,259.94,C58H67N11O11,"InChI=1S/C58H67N11O11/c1-35-31-65(50(73)12-7-5-6-8-23-79-24-25-80-34-49(72)62-42-11-9-10-40-51(42)57(78)69(54(40)75)44-14-16-48(71)63-53(44)74)19-20-66(35)38-13-15-47(60-30-38)61-43-26-37(32-64(4)55(43)76)39-17-18-59-52(41(39)33-70)68-22-21-67-45(56(68)77)27-36-28-58(2,3)29-46(36)67/h9-11,13,15,17-18,26-27,30,32,35,44,70H,5-8,12,14,16,19-25,28-29,31,33-34H2,1-4H3,(H,60,61)(H,62,72)(H,63,71,74)/t35-,44?/m0/s1",YEEWMSGCZCRCGP-FZXGYKHYSA-N
3904,Q06187,BTK,CRBN,,PTD4,C[C@H]1CN(CCCCCCOCCOCC(=O)NC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,C[C@H]1CN(,CCCCCCOCCOCC(=O)N,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,7.0,95.6,1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,1066.23,1065.507237,3.44,78,10,17,4,20,242.87,C57H67N11O10,"InChI=1S/C57H67N11O10/c1-35-31-64(18-7-5-6-8-23-77-24-25-78-34-49(71)61-42-11-9-10-40-50(42)56(76)68(53(40)73)44-13-15-48(70)62-52(44)72)19-20-65(35)38-12-14-47(59-30-38)60-43-26-37(32-63(4)54(43)74)39-16-17-58-51(41(39)33-69)67-22-21-66-45(55(67)75)27-36-28-57(2,3)29-46(36)66/h9-12,14,16-17,26-27,30,32,35,44,69H,5-8,13,15,18-25,28-29,31,33-34H2,1-4H3,(H,59,60)(H,61,71)(H,62,70,72)/t35-,44?/m0/s1",RMZBDXZBUMCJJL-FZXGYKHYSA-N
3905,Q06187,BTK,CRBN,,PTD5,CN1C=C(C2=CC=NC(N3CCN4C(=CC5=C4CC(C)(C)C5)C3=O)=C2CO)C=C(NC2=CC=C(N3CCN(C(=O)CCCCCCOCCOCC(=O)NC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C=N2)C1=O,CN1C=C(C2=CC=NC(N3CCN4C(=CC5=C4CC(C)(C)C5)C3=O)=C2CO)C=C(NC2=CC=C(N3CCN(,C(=O)CCCCCCOCCOCC(=O)N,C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C=N2)C1=O,4.0,98.3,1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,1080.213,1079.486502,2.58,79,10,17,4,20,259.94,C57H65N11O11,"InChI=1S/C57H65N11O11/c1-57(2)29-35-28-44-55(76)67(23-22-66(44)45(35)30-57)51-40(33-69)38(16-17-58-51)36-27-42(54(75)63(3)32-36)60-46-14-12-37(31-59-46)64-18-20-65(21-19-64)49(72)11-6-4-5-7-24-78-25-26-79-34-48(71)61-41-10-8-9-39-50(41)56(77)68(53(39)74)43-13-15-47(70)62-52(43)73/h8-10,12,14,16-17,27-28,31-32,43,69H,4-7,11,13,15,18-26,29-30,33-34H2,1-3H3,(H,59,60)(H,61,71)(H,62,70,73)",XLGXYNSRFYOHBS-UHFFFAOYSA-N
3906,Q06187,BTK,CRBN,,PTD6,CN1C=C(C2=CC=NC(N3CCN4C(=CC5=C4CC(C)(C)C5)C3=O)=C2CO)C=C(NC2=CC=C(N3CCN(CCCCCCOCCOCC(=O)NC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C=N2)C1=O,CN1C=C(C2=CC=NC(N3CCN4C(=CC5=C4CC(C)(C)C5)C3=O)=C2CO)C=C(NC2=CC=C(N3CCN(,CCCCCCOCCOCC(=O)N,C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C=N2)C1=O,5.3,97.2,1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,1052.203,1051.491587,3.0,77,10,17,4,20,242.87,C56H65N11O10,"InChI=1S/C56H65N11O10/c1-56(2)29-35-28-44-54(74)66(23-22-65(44)45(35)30-56)50-40(33-68)38(15-16-57-50)36-27-42(53(73)62(3)32-36)59-46-13-11-37(31-58-46)64-20-18-63(19-21-64)17-6-4-5-7-24-76-25-26-77-34-48(70)60-41-10-8-9-39-49(41)55(75)67(52(39)72)43-12-14-47(69)61-51(43)71/h8-11,13,15-16,27-28,31-32,43,68H,4-7,12,14,17-26,29-30,33-34H2,1-3H3,(H,58,59)(H,60,70)(H,61,69,71)",ZWXDWXHNSALXLR-UHFFFAOYSA-N
3907,Q06187,BTK,CRBN,,PTD7,CN1C=C(C2=CC=NC(N3CCN4C(=CC5=C4CC(C)(C)C5)C3=O)=C2CO)C=C(NC2=CC=C(N3CCN(C(=O)CCCCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C=N2)C1=O,CN1C=C(C2=CC=NC(N3CCN4C(=CC5=C4CC(C)(C)C5)C3=O)=C2CO)C=C(NC2=CC=C(N3CCN(,C(=O)CCCCCCN,C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C=N2)C1=O,2.0,96.9,1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,978.124,977.4548078,3.65,72,10,15,4,15,224.41,C53H59N11O8,"InChI=1S/C53H59N11O8/c1-53(2)27-32-26-41-51(71)63(24-23-62(41)42(32)28-53)47-37(31-65)35(16-18-55-47)33-25-39(50(70)59(3)30-33)57-43-14-12-34(29-56-43)60-19-21-61(22-20-60)45(67)11-6-4-5-7-17-54-38-10-8-9-36-46(38)52(72)64(49(36)69)40-13-15-44(66)58-48(40)68/h8-10,12,14,16,18,25-26,29-30,40,54,65H,4-7,11,13,15,17,19-24,27-28,31H2,1-3H3,(H,56,57)(H,58,66,68)",WQCUYCXVAFPYDC-UHFFFAOYSA-N
3908,Q06187,BTK,CRBN,,PTD8,C[C@H]1CN(C(=O)CCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,C[C@H]1CN(,C(=O)CCCCCCN,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,3.2,95.0,1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,992.151,991.4704579,4.09,73,10,15,4,15,224.41,C54H61N11O8,"InChI=1S/C54H61N11O8/c1-32-29-61(46(68)12-7-5-6-8-18-55-39-11-9-10-37-47(39)53(73)65(50(37)70)41-14-16-45(67)59-49(41)69)20-21-62(32)35-13-15-44(57-28-35)58-40-24-34(30-60(4)51(40)71)36-17-19-56-48(38(36)31-66)64-23-22-63-42(52(64)72)25-33-26-54(2,3)27-43(33)63/h9-11,13,15,17,19,24-25,28,30,32,41,55,66H,5-8,12,14,16,18,20-23,26-27,29,31H2,1-4H3,(H,57,58)(H,59,67,69)/t32-,41?/m0/s1",NCZRXARMAOKBHX-IROIYFLTSA-N
3909,Q06187,BTK,CRBN,,PTD9,C[C@H]1CN(C(=O)CCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,C[C@H]1CN(,C(=O)CCCN,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,0.9,95.7,1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,950.07,949.4235077,2.83,70,10,15,4,12,224.41,C51H55N11O8,"InChI=1S/C51H55N11O8/c1-29-26-58(43(65)9-6-15-52-36-8-5-7-34-44(36)50(70)62(47(34)67)38-11-13-42(64)56-46(38)66)17-18-59(29)32-10-12-41(54-25-32)55-37-21-31(27-57(4)48(37)68)33-14-16-53-45(35(33)28-63)61-20-19-60-39(49(61)69)22-30-23-51(2,3)24-40(30)60/h5,7-8,10,12,14,16,21-22,25,27,29,38,52,63H,6,9,11,13,15,17-20,23-24,26,28H2,1-4H3,(H,54,55)(H,56,64,66)/t29-,38?/m0/s1",HSWPRTMIJULITP-SYOBGBQASA-N
3910,Q06187,BTK,CRBN,,PTD10,C[C@H]1CN(C(=O)CNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,C[C@H]1CN(,C(=O)CN,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,0.5,97.1,1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,97,Inhibit of BTK of HEK293 cells,,,2.28,TR-FRET,,,,,,,,,,,107.0,Inhibit of CRBN of HEK293 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4/2.2,Inhibition of TMD8/Mino cells growth after 48h treatment,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,922.016,921.3922076,2.57,68,10,15,4,10,224.41,C49H51N11O8,"InChI=1S/C49H51N11O8/c1-27-24-56(41(63)23-51-34-7-5-6-32-42(34)48(68)60(45(32)65)36-9-11-40(62)54-44(36)64)14-15-57(27)30-8-10-39(52-22-30)53-35-18-29(25-55(4)46(35)66)31-12-13-50-43(33(31)26-61)59-17-16-58-37(47(59)67)19-28-20-49(2,3)21-38(28)58/h5-8,10,12-13,18-19,22,25,27,36,51,61H,9,11,14-17,20-21,23-24,26H2,1-4H3,(H,52,53)(H,54,62,64)/t27-,36?/m0/s1",DGDYTCIJBXSVPQ-XLYAUNJQSA-N
3911,Q06187,BTK,CRBN,,PTD11,C[C@H]1CN(C(=O)CCOCCOCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,C[C@H]1CN(,C(=O)CCOCCOCCN,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,1.3,96.1,1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,1024.149,1023.460287,2.18,75,10,17,4,17,242.87,C54H61N11O10,"InChI=1S/C54H61N11O10/c1-32-29-61(46(68)13-20-74-22-23-75-21-15-55-39-7-5-6-37-47(39)53(73)65(50(37)70)41-9-11-45(67)59-49(41)69)16-17-62(32)35-8-10-44(57-28-35)58-40-24-34(30-60(4)51(40)71)36-12-14-56-48(38(36)31-66)64-19-18-63-42(52(64)72)25-33-26-54(2,3)27-43(33)63/h5-8,10,12,14,24-25,28,30,32,41,55,66H,9,11,13,15-23,26-27,29,31H2,1-4H3,(H,57,58)(H,59,67,69)/t32-,41?/m0/s1",FVLYVMPYPNMLBF-IROIYFLTSA-N
3912,Q06187,BTK,CRBN,,PTD12,C[C@H]1CN(C(=O)CNC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,C[C@H]1CN(,C(=O)CN,C2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,3.6,89.8,1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,908.033,907.412943,2.07,67,10,14,4,10,207.34,C49H53N11O7,"InChI=1S/C49H53N11O7/c1-28-24-56(43(63)23-51-36-7-5-6-33-34(36)26-60(46(33)65)38-9-11-42(62)54-45(38)64)14-15-57(28)31-8-10-41(52-22-31)53-37-18-30(25-55(4)47(37)66)32-12-13-50-44(35(32)27-61)59-17-16-58-39(48(59)67)19-29-20-49(2,3)21-40(29)58/h5-8,10,12-13,18-19,22,25,28,38,51,61H,9,11,14-17,20-21,23-24,26-27H2,1-4H3,(H,52,53)(H,54,62,64)/t28-,38?/m0/s1",KFODTDSGVNLISY-XRTOLJPQSA-N
3913,Q06187,BTK,CRBN,,PTD13,C[C@H]1CN(C(=O)C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,C[C@H]1CN(,C(=O),C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,3000.0,30.1,0,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,320,Inhibit of BTK of HEK293 cells,,,0.86,TR-FRET,,,,,,,,,,,7000.0,Inhibit of CRBN of HEK293 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,892.974,892.3656585,1.97,66,10,14,3,8,212.38,C48H48N10O8,"InChI=1S/C48H48N10O8/c1-26-23-54(43(62)31-6-5-7-32-40(31)47(66)58(44(32)63)35-9-11-39(60)52-42(35)61)14-15-55(26)29-8-10-38(50-22-29)51-34-18-28(24-53(4)45(34)64)30-12-13-49-41(33(30)25-59)57-17-16-56-36(46(57)65)19-27-20-48(2,3)21-37(27)56/h5-8,10,12-13,18-19,22,24,26,35,59H,9,11,14-17,20-21,23,25H2,1-4H3,(H,50,51)(H,52,60,61)/t26-,35?/m0/s1",TZJCAGSJIMIXFS-HJYWNDIWSA-N
3914,Q06187,BTK,CRBN,,PTD14,C[C@H]1CN(C(=O)COC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,C[C@H]1CN(,C(=O)CO,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,1.7,96.2,1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,923.0,922.3762232,2.01,68,10,15,3,10,221.61,C49H50N10O9,"InChI=1S/C49H50N10O9/c1-27-23-55(41(62)26-68-38-7-5-6-32-42(38)48(67)59(45(32)64)35-9-11-40(61)53-44(35)63)14-15-56(27)30-8-10-39(51-22-30)52-34-18-29(24-54(4)46(34)65)31-12-13-50-43(33(31)25-60)58-17-16-57-36(47(58)66)19-28-20-49(2,3)21-37(28)57/h5-8,10,12-13,18-19,22,24,27,35,60H,9,11,14-17,20-21,23,25-26H2,1-4H3,(H,51,52)(H,53,61,63)/t27-,35?/m0/s1",ACFXVKUYZHYIDS-UAJNXHJVSA-N
3915,Q06187,BTK,CRBN,,PTD15,C[C@H]1CN(C(=O)CCCCCCCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,C[C@H]1CN(,C(=O)CCCCCCCCCCCN,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,113.0,89.0,0,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,3200,Inhibit of BTK of HEK293 cells,,,107,TR-FRET,,,,,,,,,,,5000.0,Inhibit of CRBN of HEK293 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,1062.286,1061.548708,6.79,78,10,15,4,20,224.41,C59H71N11O8,"InChI=1S/C59H71N11O8/c1-37-34-66(51(73)17-12-10-8-6-5-7-9-11-13-23-60-44-16-14-15-42-52(44)58(78)70(55(42)75)46-19-21-50(72)64-54(46)74)25-26-67(37)40-18-20-49(62-33-40)63-45-29-39(35-65(4)56(45)76)41-22-24-61-53(43(41)36-71)69-28-27-68-47(57(69)77)30-38-31-59(2,3)32-48(38)68/h14-16,18,20,22,24,29-30,33,35,37,46,60,71H,5-13,17,19,21,23,25-28,31-32,34,36H2,1-4H3,(H,62,63)(H,64,72,74)/t37-,46?/m0/s1",HYZMVIWTOQSXRR-YLKGYVPLSA-N
3916,Q06187,BTK,CRBN,,PTD16,C[C@H]1CN(C(=O)CNC2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,C[C@H]1CN(,C(=O)CN,C2=CC=C3C(=O)N(C4CCC(=O)NC4=O)C(=O)C3=C2)CCN1C1=CC=C(NC2=CC(C3=CC=NC(N4CCN5C(=CC6=C5CC(C)(C)C6)C4=O)=C3CO)=CN(C)C2=O)N=C1,0.9,97.3,1,Degradation of BTK in Ramos/JeKo-1 cells after 17 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00176,922.016,921.3922076,2.02,68,10,15,4,10,224.41,C49H51N11O8,"InChI=1S/C49H51N11O8/c1-27-24-56(42(63)23-51-30-5-7-33-34(19-30)46(66)60(45(33)65)37-8-10-41(62)54-44(37)64)13-14-57(27)31-6-9-40(52-22-31)53-36-17-29(25-55(4)47(36)67)32-11-12-50-43(35(32)26-61)59-16-15-58-38(48(59)68)18-28-20-49(2,3)21-39(28)58/h5-7,9,11-12,17-19,22,25,27,37,51,61H,8,10,13-16,20-21,23-24,26H2,1-4H3,(H,52,53)(H,54,62,64)/t27-,37?/m0/s1",QOXMMJLQRKLFLI-YTCZSSRZSA-N
3940,Q86WV6,STING,VHL,,UNC8885,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(C(=O)NCCCCC(=O)N[C@@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(,C(=O)NCCCCC(=O)N,[C@@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,3017.0,91.78,0,Degradation of STING in Caki-1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1007/s00018-023-04796-7,1362.63,1361.649168,5.04,98,10,22,7,29,344.23,C69H87N17O11S,"InChI=1S/C69H87N17O11S/c1-10-85-52(31-41(3)79-85)64(92)77-67-75-50-34-47(62(90)71-22-13-12-17-56(88)76-60(69(6,7)8)66(94)84-39-48(87)37-51(84)63(91)72-38-44-18-20-45(21-19-44)59-43(5)73-40-98-59)36-54(95-9)57(50)82(67)24-14-15-25-83-58-49(74-68(83)78-65(93)53-32-42(4)80-86(53)11-2)33-46(61(70)89)35-55(58)97-28-16-23-81-26-29-96-30-27-81/h14-15,18-21,31-36,40,48,51,60,87H,10-13,16-17,22-30,37-39H2,1-9H3,(H2,70,89)(H,71,90)(H,72,91)(H,76,88)(H,74,78,93)(H,75,77,92)/b15-14+/t48-,51+,60+/m1/s1",AMAUGUBSDJILRS-YVKNYCLZSA-N
3941,Q86WV6,STING,VHL,,UNC8957,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(C(=O)NCCOCCC(=O)N[C@@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(,C(=O)NCCOCCC(=O)N,[C@@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,3340.0,88.84,0,Degradation of STING in Caki-1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1007/s00018-023-04796-7,1378.629,1377.644082,4.18,99,10,23,7,30,353.46,C69H87N17O12S,"InChI=1S/C69H87N17O12S/c1-10-85-52(31-41(3)79-85)64(92)77-67-75-50-34-47(62(90)71-20-28-96-27-19-56(88)76-60(69(6,7)8)66(94)84-39-48(87)37-51(84)63(91)72-38-44-15-17-45(18-16-44)59-43(5)73-40-99-59)36-54(95-9)57(50)82(67)22-12-13-23-83-58-49(74-68(83)78-65(93)53-32-42(4)80-86(53)11-2)33-46(61(70)89)35-55(58)98-26-14-21-81-24-29-97-30-25-81/h12-13,15-18,31-36,40,48,51,60,87H,10-11,14,19-30,37-39H2,1-9H3,(H2,70,89)(H,71,90)(H,72,91)(H,76,88)(H,74,78,93)(H,75,77,92)/b13-12+/t48-,51+,60+/m1/s1",ZLDHPMABKBJAKO-IWHWSUNXSA-N
3942,Q86WV6,STING,VHL,,UNC8958,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(C(=O)NCCCOCCC(=O)N[C@@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(,C(=O)NCCCOCCC(=O)N,[C@@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,2568.0,84.21,0,Degradation of STING in Caki-1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1007/s00018-023-04796-7,1392.656,1391.659732,4.53,100,10,23,7,31,353.46,C70H89N17O12S,"InChI=1S/C70H89N17O12S/c1-10-86-53(32-42(3)80-86)65(93)78-68-76-51-35-48(63(91)72-21-14-27-97-29-20-57(89)77-61(70(6,7)8)67(95)85-40-49(88)38-52(85)64(92)73-39-45-16-18-46(19-17-45)60-44(5)74-41-100-60)37-55(96-9)58(51)83(68)23-12-13-24-84-59-50(75-69(84)79-66(94)54-33-43(4)81-87(54)11-2)34-47(62(71)90)36-56(59)99-28-15-22-82-25-30-98-31-26-82/h12-13,16-19,32-37,41,49,52,61,88H,10-11,14-15,20-31,38-40H2,1-9H3,(H2,71,90)(H,72,91)(H,73,92)(H,77,89)(H,75,79,94)(H,76,78,93)/b13-12+/t49-,52+,61+/m1/s1",SKGNNCJNUBGYLI-YSRBMLRJSA-N
3943,Q86WV6,STING,VHL,,UNC8899,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(C(=O)NCCOCCOCCC(=O)N[C@@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(,C(=O)NCCOCCOCCC(=O)N,[C@@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,1097.0,99.94,0,Degradation of STING in Caki-1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1007/s00018-023-04796-7,1422.682,1421.670297,4.03,102,10,24,7,33,362.69,C71H91N17O13S,"InChI=1S/C71H91N17O13S/c1-10-87-54(33-43(3)81-87)66(94)79-69-77-52-36-49(64(92)73-20-28-99-32-31-98-27-19-58(90)78-62(71(6,7)8)68(96)86-41-50(89)39-53(86)65(93)74-40-46-15-17-47(18-16-46)61-45(5)75-42-102-61)38-56(97-9)59(52)84(69)22-12-13-23-85-60-51(76-70(85)80-67(95)55-34-44(4)82-88(55)11-2)35-48(63(72)91)37-57(60)101-26-14-21-83-24-29-100-30-25-83/h12-13,15-18,33-38,42,50,53,62,89H,10-11,14,19-32,39-41H2,1-9H3,(H2,72,91)(H,73,92)(H,74,93)(H,78,90)(H,76,80,95)(H,77,79,94)/b13-12+/t50-,53+,62+/m1/s1",YHNIOHUOOHUSHO-NWDQLGOLSA-N
3944,Q86WV6,STING,VHL,,UNC8972,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(C(=O)NCCOCCOCCOCC(=O)N[C@@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(,C(=O)NCCOCCOCCOCC(=O)N,[C@@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,2470.0,89.41,0,Degradation of STING in Caki-1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1007/s00018-023-04796-7,1452.708,1451.680862,3.98,104,10,25,7,35,371.92,C72H93N17O14S,"InChI=1S/C72H93N17O14S/c1-10-88-55(33-44(3)82-88)67(95)80-70-78-53-36-50(65(93)74-19-26-99-29-30-101-31-32-102-42-59(91)79-63(72(6,7)8)69(97)87-41-51(90)39-54(87)66(94)75-40-47-15-17-48(18-16-47)62-46(5)76-43-104-62)38-57(98-9)60(53)85(70)21-12-13-22-86-61-52(77-71(86)81-68(96)56-34-45(4)83-89(56)11-2)35-49(64(73)92)37-58(61)103-25-14-20-84-23-27-100-28-24-84/h12-13,15-18,33-38,43,51,54,63,90H,10-11,14,19-32,39-42H2,1-9H3,(H2,73,92)(H,74,93)(H,75,94)(H,79,91)(H,77,81,96)(H,78,80,95)/b13-12+/t51-,54+,63+/m1/s1",IOBMLPNSOHTLEO-KDNOMDFQSA-N
3945,Q86WV6,STING,VHL,,UNC8900,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(C(=O)NCCOCCOCCOCCOCCC(=O)N[C@@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(,C(=O)NCCOCCOCCOCCOCCC(=O)N,[C@@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,924.0,97.65,0,Degradation of STING in Caki-1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1007/s00018-023-04796-7,1510.788,1509.722726,3.73,108,10,26,7,39,381.15,C75H99N17O15S,"InChI=1S/C75H99N17O15S/c1-10-91-58(37-47(3)85-91)70(98)83-73-81-56-40-53(42-60(101-9)63(56)88(73)22-12-13-23-89-64-55(80-74(89)84-71(99)59-38-48(4)86-92(59)11-2)39-52(67(76)95)41-61(64)107-26-14-21-87-24-29-104-30-25-87)68(96)77-20-28-103-32-34-106-36-35-105-33-31-102-27-19-62(94)82-66(75(6,7)8)72(100)90-45-54(93)43-57(90)69(97)78-44-50-15-17-51(18-16-50)65-49(5)79-46-108-65/h12-13,15-18,37-42,46,54,57,66,93H,10-11,14,19-36,43-45H2,1-9H3,(H2,76,95)(H,77,96)(H,78,97)(H,82,94)(H,80,84,99)(H,81,83,98)/b13-12+/t54-,57+,66+/m1/s1",IADMWNJOSJGQFE-DAWJDFRTSA-N
3946,Q86WV6,STING,VHL,,UNC8910,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(C(=O)NCCOCCOCCOCCOCCOCCOCCC(=O)N[C@@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(,C(=O)NCCOCCOCCOCCOCCOCCOCCC(=O)N,[C@@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,4610.0,80.87,0,Degradation of STING in Caki-1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1007/s00018-023-04796-7,1598.894,1597.775156,3.44,114,10,28,7,45,399.61,C79H107N17O17S,"InChI=1S/C79H107N17O17S/c1-10-95-62(41-51(3)89-95)74(102)87-77-85-60-44-57(46-64(105-9)67(60)92(77)22-12-13-23-93-68-59(84-78(93)88-75(103)63-42-52(4)90-96(63)11-2)43-56(71(80)99)45-65(68)113-26-14-21-91-24-29-108-30-25-91)72(100)81-20-28-107-32-34-110-36-38-112-40-39-111-37-35-109-33-31-106-27-19-66(98)86-70(79(6,7)8)76(104)94-49-58(97)47-61(94)73(101)82-48-54-15-17-55(18-16-54)69-53(5)83-50-114-69/h12-13,15-18,41-46,50,58,61,70,97H,10-11,14,19-40,47-49H2,1-9H3,(H2,80,99)(H,81,100)(H,82,101)(H,86,98)(H,84,88,103)(H,85,87,102)/b13-12+/t58-,61+,70+/m1/s1",JNALTWZFLHQBFT-VLNSOFBDSA-N
3947,Q86WV6,STING,VHL,,UNC9036,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(C(=O)NCCCCCCCCC(=O)N[C@@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(,C(=O)NCCCCCCCCC(=O)N,[C@@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=CC(OC)=C2N1C/C=C/CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(C(N)=O)=CC(OCCCN3CCOCC3)=C21,227.0,91.68,0,Degradation of STING in Caki-1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1007/s00018-023-04796-7,1418.738,1417.711768,7.02,102,10,22,7,33,344.23,C73H95N17O11S,"InChI=1S/C73H95N17O11S/c1-10-89-56(35-45(3)83-89)68(96)81-71-79-54-38-51(66(94)75-26-17-15-13-12-14-16-21-60(92)80-64(73(6,7)8)70(98)88-43-52(91)41-55(88)67(95)76-42-48-22-24-49(25-23-48)63-47(5)77-44-102-63)40-58(99-9)61(54)86(71)28-18-19-29-87-62-53(78-72(87)82-69(97)57-36-46(4)84-90(57)11-2)37-50(65(74)93)39-59(62)101-32-20-27-85-30-33-100-34-31-85/h18-19,22-25,35-40,44,52,55,64,91H,10-17,20-21,26-34,41-43H2,1-9H3,(H2,74,93)(H,75,94)(H,76,95)(H,80,92)(H,78,82,97)(H,79,81,96)/b19-18+/t52-,55+,64+/m1/s1",BDSHEGJPPSYXPH-MGKALCIBSA-N
3997,Q06187,BTK,CRBN,,,O=C1CCC(N2C(=O)C3=CC=C(N4CCC(CCN5CCC(CC(=O)N[C@H]6CC[C@@H](NC7=NC=NC8=C7C(C(=O)C7=CC=C(OC9=CC=CC=C9)C=C7Cl)=C[NH]8)CC6)CC5)CC4)C=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=C(N4CCC(CCN5CCC(,CC(=O)N,[C@H]6CC[C@@H](NC7=NC=NC8=C7C(C(=O)C7=CC=C(OC9=CC=CC=C9)C=C7Cl)=C[NH]8)CC6)CC5)CC4)C=C3C2=O)C(=O)N1,8.8,94.1,1,Degradation of BTK in JeKo-1 cells after 24 h treatment,85.0/82.5,% BTK degradation in JeKo-1 cells after 24 h treatment at 100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15.4/82.1/59.5,Inhibition of cell proliferation in OCI-ly10/TMD8/JeKo-1 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115403,954.529,953.3991228,6.97,69,10,12,4,14,199.03,C52H56ClN9O7,"InChI=1S/C52H56ClN9O7/c53-42-28-37(69-36-4-2-1-3-5-36)11-13-39(42)47(65)41-29-54-48-46(41)49(56-30-55-48)58-34-8-6-33(7-9-34)57-45(64)26-32-17-22-60(23-18-32)21-16-31-19-24-61(25-20-31)35-10-12-38-40(27-35)52(68)62(51(38)67)43-14-15-44(63)59-50(43)66/h1-5,10-13,27-34,43H,6-9,14-26H2,(H,57,64)(H,59,63,66)(H2,54,55,56,58)/t33-,34+,43?",VWELFQOMWDAJDG-TWZCHNMGSA-N
3998,Q06187,BTK,CRBN,,,O=C1CCC(N2C(=O)C3=CC(F)=C(N4CCC(CCN5CCC(CC(=O)N[C@H]6CC[C@@H](NC7=NC=NC8=C7C(C(=O)C7=CC=C(OC9=CC=CC=C9)C=C7Cl)=C[NH]8)CC6)CC5)CC4)C=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC(F)=C(N4CCC(CCN5CCC(,CC(=O)N,[C@H]6CC[C@@H](NC7=NC=NC8=C7C(C(=O)C7=CC=C(OC9=CC=CC=C9)C=C7Cl)=C[NH]8)CC6)CC5)CC4)C=C3C2=O)C(=O)N1,9.3,93.6,1,Degradation of BTK in JeKo-1 cells after 24 h treatment,87.0/88.5,% BTK degradation in JeKo-1 cells after 24 h treatment at 100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,28.2/47.0/116.5,Inhibition of cell proliferation in OCI-ly10/TMD8/JeKo-1 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115403,972.519,971.389701,7.07,70,10,12,4,14,199.03,C52H55ClFN9O7,"InChI=1S/C52H55ClFN9O7/c53-40-25-35(70-34-4-2-1-3-5-34)10-11-36(40)47(66)39-28-55-48-46(39)49(57-29-56-48)59-33-8-6-32(7-9-33)58-45(65)24-31-15-20-61(21-16-31)19-14-30-17-22-62(23-18-30)43-27-38-37(26-41(43)54)51(68)63(52(38)69)42-12-13-44(64)60-50(42)67/h1-5,10-11,25-33,42H,6-9,12-24H2,(H,58,65)(H,60,64,67)(H2,55,56,57,59)/t32-,33+,42?",DXWNLVKIDXFRLV-GJYNQWBJSA-N
3999,Q06187,BTK,CRBN,,,O=C1CCC(N2CC3=CC=C(N4CCC(CCN5CCC(CC(=O)N[C@H]6CC[C@@H](NC7=NC=NC8=C7C(C(=O)C7=CC=C(OC9=CC=CC=C9)C=C7Cl)=C[NH]8)CC6)CC5)CC4)C=C3C2=O)C(=O)N1,O=C1CCC(N2CC3=CC=C(N4CCC(CCN5CCC(,CC(=O)N,[C@H]6CC[C@@H](NC7=NC=NC8=C7C(C(=O)C7=CC=C(OC9=CC=CC=C9)C=C7Cl)=C[NH]8)CC6)CC5)CC4)C=C3C2=O)C(=O)N1,7.4,90.6,1,Degradation of BTK in JeKo-1 cells after 24 h treatment,83.0/87.0,% BTK degradation in JeKo-1 cells after 24 h treatment at 100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.9/9.3/34.4,Inhibition of cell proliferation in OCI-ly10/TMD8/JeKo-1 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115403,940.546,939.4198583,7.02,68,10,11,4,14,181.96,C52H58ClN9O6,"InChI=1S/C52H58ClN9O6/c53-43-28-39(68-38-4-2-1-3-5-38)12-13-40(43)48(65)42-29-54-49-47(42)50(56-31-55-49)58-36-9-7-35(8-10-36)57-46(64)26-33-17-22-60(23-18-33)21-16-32-19-24-61(25-20-32)37-11-6-34-30-62(52(67)41(34)27-37)44-14-15-45(63)59-51(44)66/h1-6,11-13,27-29,31-33,35-36,44H,7-10,14-26,30H2,(H,57,64)(H,59,63,66)(H2,54,55,56,58)/t35-,36+,44?",JHVZXEQESAUISG-GAOBAYOOSA-N
4000,Q06187,BTK,CRBN,,,O=C1CCC(N2CC3=CC(N4CCC(CCN5CCC(CC(=O)N[C@H]6CC[C@@H](NC7=NC=NC8=C7C(C(=O)C7=CC=C(OC9=CC=CC=C9)C=C7Cl)=C[NH]8)CC6)CC5)CC4)=CC=C3C2=O)C(=O)N1,O=C1CCC(N2CC3=CC(N4CCC(CCN5CCC(,CC(=O)N,[C@H]6CC[C@@H](NC7=NC=NC8=C7C(C(=O)C7=CC=C(OC9=CC=CC=C9)C=C7Cl)=C[NH]8)CC6)CC5)CC4)=CC=C3C2=O)C(=O)N1,10.1,90.1,1,Degradation of BTK in JeKo-1 cells after 24 h treatment,80.4/86.0,% BTK degradation in JeKo-1 cells after 24 h treatment at 100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15.7/15.5,Inhibition of cell proliferation in OCI-ly10/TMD8 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115403,940.546,939.4198583,7.02,68,10,11,4,14,181.96,C52H58ClN9O6,"InChI=1S/C52H58ClN9O6/c53-43-28-39(68-38-4-2-1-3-5-38)11-13-41(43)48(65)42-29-54-49-47(42)50(56-31-55-49)58-36-8-6-35(7-9-36)57-46(64)26-33-17-22-60(23-18-33)21-16-32-19-24-61(25-20-32)37-10-12-40-34(27-37)30-62(52(40)67)44-14-15-45(63)59-51(44)66/h1-5,10-13,27-29,31-33,35-36,44H,6-9,14-26,30H2,(H,57,64)(H,59,63,66)(H2,54,55,56,58)/t35-,36+,44?",MZOWIXBWDNSXQH-GAOBAYOOSA-N
4001,Q06187,BTK,CRBN,,,O=C1CCC(N2CC3=CC(N4CCC(CCN5CCC(CC(=O)N[C@H]6CC[C@@H](NC7=NC=NC8=C7C(C(=O)C7=CC=C(OC9=CC=CC=C9)C=C7Cl)=C[NH]8)CC6)CC5)CC4)=C(F)C=C3C2=O)C(=O)N1,O=C1CCC(N2CC3=CC(N4CCC(CCN5CCC(,CC(=O)N,[C@H]6CC[C@@H](NC7=NC=NC8=C7C(C(=O)C7=CC=C(OC9=CC=CC=C9)C=C7Cl)=C[NH]8)CC6)CC5)CC4)=C(F)C=C3C2=O)C(=O)N1,7.0,96.5,1,Degradation of BTK in JeKo-1 cells after 24 h treatment,91.0/89.0,% BTK degradation in JeKo-1 cells after 24 h treatment at 100/1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3/4.5/38.1,Inhibition of cell proliferation in OCI-ly10/TMD8/JeKo-1 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115403,958.536,957.4104364,7.13,69,10,11,4,14,181.96,C52H57ClFN9O6,"InChI=1S/C52H57ClFN9O6/c53-41-26-37(69-36-4-2-1-3-5-36)10-11-38(41)48(66)40-28-55-49-47(40)50(57-30-56-49)59-35-8-6-34(7-9-35)58-46(65)24-32-15-20-61(21-16-32)19-14-31-17-22-62(23-18-31)44-25-33-29-63(52(68)39(33)27-42(44)54)43-12-13-45(64)60-51(43)67/h1-5,10-11,25-28,30-32,34-35,43H,6-9,12-24,29H2,(H,58,65)(H,60,64,67)(H2,55,56,57,59)/t34-,35+,43?",YWMGYZOTBRTAPC-IMTSFBIHSA-N
4002,Q9UM73,ALK,CRBN,,AP-1,COC1=CC(N2CCN(C(=O)CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1,COC1=CC(N2CCN(C(=O)CNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2S,(=O)(=O)C(C)C,)=N1,4.6,92.28,1,Degradation of ALK in Karpas299/H3122 cells after 16 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1469/2704/>200000,Inhibition of cell viability in Karpas299/THP-1/HeLa cells after 60/60/48 h treatment,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106556,830.324,829.2409079,5.0,58,7,14,4,12,212.34,C39H40ClN9O8S,"InChI=1S/C39H40ClN9O8S/c1-22(2)58(55,56)31-10-5-4-8-27(31)43-35-25(40)20-42-39(46-35)44-26-12-11-23(19-30(26)57-3)47-15-17-48(18-16-47)33(51)21-41-28-9-6-7-24-34(28)38(54)49(37(24)53)29-13-14-32(50)45-36(29)52/h4-12,19-20,22,29,41H,13-18,21H2,1-3H3,(H,45,50,52)(H2,42,43,44,46)",MCCIEZLYIAJGSE-UHFFFAOYSA-N
4033,Q9BY41,HDAC8,CRBN,,,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(C(=O)NCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(,C(=O)NCCN,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,53.0,95.0,1,Degradation of HDAC8 in MDA-MB-231 cells after 24 h treatment,90/93,% HDAC8 degradation in MDA-MB-231 cells after 24 h treatment at 1000/10000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106546,600.584,600.1856285,2.6,44,5,9,4,11,180.44,C31H28N4O9,"InChI=1S/C31H28N4O9/c1-43-23-11-9-19(31(41)42)15-24(23)44-16-17-5-7-18(8-6-17)27(37)33-14-13-32-21-4-2-3-20-26(21)30(40)35(29(20)39)22-10-12-25(36)34-28(22)38/h2-9,11,15,22,32H,10,12-14,16H2,1H3,(H,33,37)(H,41,42)(H,34,36,38)",OVGJMQWPRUXZPK-UHFFFAOYSA-N
4033,Q9UBN7,HDAC6,CRBN,,,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(C(=O)NCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(,C(=O)NCCN,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,1812.0,59.0,0,Degradation of HDAC6 in MDA-MB-231 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106546,600.584,600.1856285,2.6,44,5,9,4,11,180.44,C31H28N4O9,"InChI=1S/C31H28N4O9/c1-43-23-11-9-19(31(41)42)15-24(23)44-16-17-5-7-18(8-6-17)27(37)33-14-13-32-21-4-2-3-20-26(21)30(40)35(29(20)39)22-10-12-25(36)34-28(22)38/h2-9,11,15,22,32H,10,12-14,16H2,1H3,(H,33,37)(H,41,42)(H,34,36,38)",OVGJMQWPRUXZPK-UHFFFAOYSA-N
4034,Q9BY41,HDAC8,CRBN,,,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(C(=O)NCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(,C(=O)NCCCCN,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,119.0,96.0,0,Degradation of HDAC8 in MDA-MB-231 cells after 24 h treatment,83/75,% HDAC8 degradation in MDA-MB-231 cells after 24 h treatment at 1000/10000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106546,628.638,628.2169286,3.31,46,5,9,4,13,180.44,C33H32N4O9,"InChI=1S/C33H32N4O9/c1-45-25-13-11-21(33(43)44)17-26(25)46-18-19-7-9-20(10-8-19)29(39)35-16-3-2-15-34-23-6-4-5-22-28(23)32(42)37(31(22)41)24-12-14-27(38)36-30(24)40/h4-11,13,17,24,34H,2-3,12,14-16,18H2,1H3,(H,35,39)(H,43,44)(H,36,38,40)",SFAZMJOUZPQYHW-UHFFFAOYSA-N
4034,Q9UBN7,HDAC6,CRBN,,,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(C(=O)NCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(,C(=O)NCCCCN,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,1114.0,55.0,0,Degradation of HDAC6 in MDA-MB-231 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106546,628.638,628.2169286,3.31,46,5,9,4,13,180.44,C33H32N4O9,"InChI=1S/C33H32N4O9/c1-45-25-13-11-21(33(43)44)17-26(25)46-18-19-7-9-20(10-8-19)29(39)35-16-3-2-15-34-23-6-4-5-22-28(23)32(42)37(31(22)41)24-12-14-27(38)36-30(24)40/h4-11,13,17,24,34H,2-3,12,14-16,18H2,1H3,(H,35,39)(H,43,44)(H,36,38,40)",SFAZMJOUZPQYHW-UHFFFAOYSA-N
4035,Q9BY41,HDAC8,CRBN,,,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(C(=O)NCCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(,C(=O)NCCCCCCN,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,14.0,91.0,1,Degradation of HDAC8 in MDA-MB-231 cells after 24 h treatment,94/44,% HDAC8 degradation in MDA-MB-231 cells after 24 h treatment at 1000/10000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106546,656.692,656.2482287,4.03,48,5,9,4,15,180.44,C35H36N4O9,"InChI=1S/C35H36N4O9/c1-47-27-15-13-23(35(45)46)19-28(27)48-20-21-9-11-22(12-10-21)31(41)37-18-5-3-2-4-17-36-25-8-6-7-24-30(25)34(44)39(33(24)43)26-14-16-29(40)38-32(26)42/h6-13,15,19,26,36H,2-5,14,16-18,20H2,1H3,(H,37,41)(H,45,46)(H,38,40,42)",OHGZHFFSUIAVDY-UHFFFAOYSA-N
4035,Q9UBN7,HDAC6,CRBN,,,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(C(=O)NCCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(,C(=O)NCCCCCCN,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,129.0,71.0,0,Degradation of HDAC6 in MDA-MB-231 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106546,656.692,656.2482287,4.03,48,5,9,4,15,180.44,C35H36N4O9,"InChI=1S/C35H36N4O9/c1-47-27-15-13-23(35(45)46)19-28(27)48-20-21-9-11-22(12-10-21)31(41)37-18-5-3-2-4-17-36-25-8-6-7-24-30(25)34(44)39(33(24)43)26-14-16-29(40)38-32(26)42/h6-13,15,19,26,36H,2-5,14,16-18,20H2,1H3,(H,37,41)(H,45,46)(H,38,40,42)",OHGZHFFSUIAVDY-UHFFFAOYSA-N
4036,Q9BY41,HDAC8,CRBN,,,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(C(=O)NCCCCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(,C(=O)NCCCCCCCCN,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,1.8,97.0,1,Degradation of HDAC8 in MDA-MB-231/T-cell leukemia Jurkat cells after 24 h treatment,94/62,% HDAC8 degradation in MDA-MB-231 cells after 24 h treatment at 1000/10000 nM,1600,Inhibition of HDAC8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2400,Inhibition of cell proliferation in Jurkat cells,,,,,,,,,,,10.1016/j.bioorg.2023.106546,684.746,684.2795289,5.11,50,5,9,4,17,180.44,C37H40N4O9,"InChI=1S/C37H40N4O9/c1-49-29-17-15-25(37(47)48)21-30(29)50-22-23-11-13-24(14-12-23)33(43)39-20-7-5-3-2-4-6-19-38-27-10-8-9-26-32(27)36(46)41(35(26)45)28-16-18-31(42)40-34(28)44/h8-15,17,21,28,38H,2-7,16,18-20,22H2,1H3,(H,39,43)(H,47,48)(H,40,42,44)",NIPLZZSOGWKOEY-UHFFFAOYSA-N
4036,Q9UBN7,HDAC6,CRBN,,,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(C(=O)NCCCCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,COC1=CC=C(C(=O)O)C=C1OCC1=CC=C(,C(=O)NCCCCCCCCN,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,38.0,69.0,0,Degradation of HDAC6 in MDA-MB-231/T-cell leukemia Jurkat cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bioorg.2023.106546,684.746,684.2795289,5.11,50,5,9,4,17,180.44,C37H40N4O9,"InChI=1S/C37H40N4O9/c1-49-29-17-15-25(37(47)48)21-30(29)50-22-23-11-13-24(14-12-23)33(43)39-20-7-5-3-2-4-6-19-38-27-10-8-9-26-32(27)36(46)41(35(26)45)28-16-18-31(42)40-34(28)44/h8-15,17,21,28,38H,2-7,16,18-20,22H2,1H3,(H,39,43)(H,47,48)(H,40,42,44)",NIPLZZSOGWKOEY-UHFFFAOYSA-N
4075,P50750,CDK9,CRBN,,,O=C(COC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)NCCCCCCCCCCC(=O)N1CCC(NC(=O)C2=N[NH]C=C2NC(=O)C2=C(Cl)C=CC=C2Cl)CC1,O=C(COC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O),NCCCCCCCCCCC(=O)N,1CCC(NC(=O)C2=N[NH]C=C2NC(=O)C2=C(Cl)C=CC=C2Cl)CC1,140.0,93.1,0,Degradation of CDK942/CDK955 in MOLM13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.21,Inhibition of cell proliferation of Molm13 cells,400,Inhibition of cell viability of MV-411 cells after treatment for 6h,,,,,,,,,,,,,10.1016/j.ejmech.2023.115342,879.799,878.2921305,5.45,61,6,10,5,19,229.07,C42H48Cl2N8O9,"InChI=1S/C42H48Cl2N8O9/c43-27-12-10-13-28(44)36(27)39(57)48-29-23-46-50-37(29)40(58)47-25-18-21-51(22-19-25)34(55)15-7-5-3-1-2-4-6-8-20-45-33(54)24-61-31-14-9-11-26-35(31)42(60)52(41(26)59)30-16-17-32(53)49-38(30)56/h9-14,23,25,30H,1-8,15-22,24H2,(H,45,54)(H,46,50)(H,47,58)(H,48,57)(H,49,53,56)",DZJCTNGKFRUZQI-UHFFFAOYSA-N
4077,P50750,CDK9,CRBN,,,O=C(CNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)NCCCCCCCCCCC(=O)N1CCC(NC(=O)C2=N[NH]C=C2NC(=O)C2=C(Cl)C=CC=C2Cl)CC1,O=C(CNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O),NCCCCCCCCCCC(=O)N,1CCC(NC(=O)C2=N[NH]C=C2NC(=O)C2=C(Cl)C=CC=C2Cl)CC1,30.0,91.6,1,Degradation of CDK942/CDK955 in MOLM13 cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.12,Inhibition of cell proliferation of Molm13 cells,200,Inhibition of cell viability of MV-411 cells after treatment for 6h,,,,,,,,,,,,,10.1016/j.ejmech.2023.115342,878.815,877.3081149,6.01,61,6,10,6,19,231.87,C42H49Cl2N9O8,"InChI=1S/C42H49Cl2N9O8/c43-27-12-10-13-28(44)36(27)39(58)49-30-23-47-51-37(30)40(59)48-25-18-21-52(22-19-25)34(56)15-7-5-3-1-2-4-6-8-20-45-33(55)24-46-29-14-9-11-26-35(29)42(61)53(41(26)60)31-16-17-32(54)50-38(31)57/h9-14,23,25,31,46H,1-8,15-22,24H2,(H,45,55)(H,47,51)(H,48,59)(H,49,58)(H,50,54,57)",SRUVBNFPTDBESG-UHFFFAOYSA-N
4114,Q9C5S2,IRE1alpha,CRBN,,CPD-2828,CC1=C(CC(=O)N2CCC(C3=CC=C(NC4CCC(=O)NC4=O)C=C3)CC2)C(=O)OC2=C(C=O)C(O)=CC=C12,CC1=C(,CC(=O)N,2CCC(C3=CC=C(NC4CCC(=O)NC4=O)C=C3)CC2)C(=O)OC2=C(C=O)C(O)=CC=C12,1300.0,65.0,0,Degradation of IRE1alpha in HEK293T cells after 24h treatment,,,800,Inhibition of IRE1alpha,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.3c00084,531.565,531.2005503,2.34,39,5,8,3,6,146.02,C29H29N3O7,"InChI=1S/C29H29N3O7/c1-16-20-6-8-24(34)22(15-33)27(20)39-29(38)21(16)14-26(36)32-12-10-18(11-13-32)17-2-4-19(5-3-17)30-23-7-9-25(35)31-28(23)37/h2-6,8,15,18,23,30,34H,7,9-14H2,1H3,(H,31,35,37)",JUIHFQABBIMEAQ-UHFFFAOYSA-N
4138,Q13490,cIAP1,VHL,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](OC2=CC=CC(OCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=C2)C[C@H]1C(=O)N[C@@H]1CCCC2=CC=CC=C21)C1CCCCC1,,CN[C@@H](C)C(=O)N,[C@H](C(=O)N1C[C@@H](OC2=CC=CC(OCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=C2)C[C@H]1C(=O)N[C@@H]1CCCC2=CC=CC=C21)C1CCCCC1,2.4,99.0,1,Degradation of cIAP1 in MM.1S cells after 16h treatment,95,% cIAP1 degradation in MM.1S cells after 100 nM treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2540/1140/8.5,Inhibition of cell growth in RPMI-8826/JJN3/NCI-H929 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01817,1103.441,1102.592547,8.1,79,8,12,6,21,220.63,C61H82N8O9S,"InChI=1S/C61H82N8O9S/c1-37(40-26-28-43(29-27-40)54-38(2)63-36-79-54)64-57(73)50-31-44(70)34-68(50)60(76)55(61(4,5)6)66-52(71)25-13-14-30-77-45-21-16-22-46(32-45)78-47-33-51(58(74)65-49-24-15-20-41-17-11-12-23-48(41)49)69(35-47)59(75)53(42-18-9-8-10-19-42)67-56(72)39(3)62-7/h11-12,16-17,21-23,26-29,32,36-37,39,42,44,47,49-51,53,55,62,70H,8-10,13-15,18-20,24-25,30-31,33-35H2,1-7H3,(H,64,73)(H,65,74)(H,66,71)(H,67,72)/t37-,39-,44+,47-,49+,50-,51-,53-,55+/m0/s1",SMENADKMMXTZAZ-FMVATYOPSA-N
4138,Q13489,cIAP2,VHL,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](OC2=CC=CC(OCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=C2)C[C@H]1C(=O)N[C@@H]1CCCC2=CC=CC=C21)C1CCCCC1,,CN[C@@H](C)C(=O)N,[C@H](C(=O)N1C[C@@H](OC2=CC=CC(OCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=C2)C[C@H]1C(=O)N[C@@H]1CCCC2=CC=CC=C21)C1CCCCC1,6.2,90.0,1,Degradation of cIAP2 in MM.1S cells after 16h treatment,79,% cIAP2 degradation in MM.1S cells after 100 nM treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1170/2.1/420,Inhibition of cell growth in HEL/MOLM13/K562 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01817,1103.441,1102.592547,8.1,79,8,12,6,21,220.63,C61H82N8O9S,"InChI=1S/C61H82N8O9S/c1-37(40-26-28-43(29-27-40)54-38(2)63-36-79-54)64-57(73)50-31-44(70)34-68(50)60(76)55(61(4,5)6)66-52(71)25-13-14-30-77-45-21-16-22-46(32-45)78-47-33-51(58(74)65-49-24-15-20-41-17-11-12-23-48(41)49)69(35-47)59(75)53(42-18-9-8-10-19-42)67-56(72)39(3)62-7/h11-12,16-17,21-23,26-29,32,36-37,39,42,44,47,49-51,53,55,62,70H,8-10,13-15,18-20,24-25,30-31,33-35H2,1-7H3,(H,64,73)(H,65,74)(H,66,71)(H,67,72)/t37-,39-,44+,47-,49+,50-,51-,53-,55+/m0/s1",SMENADKMMXTZAZ-FMVATYOPSA-N
4138,P98170,XIAP,VHL,,,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](OC2=CC=CC(OCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=C2)C[C@H]1C(=O)N[C@@H]1CCCC2=CC=CC=C21)C1CCCCC1,,CN[C@@H](C)C(=O)N,[C@H](C(=O)N1C[C@@H](OC2=CC=CC(OCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)=C2)C[C@H]1C(=O)N[C@@H]1CCCC2=CC=CC=C21)C1CCCCC1,0.7,99.0,1,Degradation of XIAP in MM.1S cells after 16h treatment,93,% XIAP degradation in MM.1S cells after 100 nM treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1690/1.6/510,Inhibition of cell growth in SUDHL4/SUDHL6/DB cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01817,1103.441,1102.592547,8.1,79,8,12,6,21,220.63,C61H82N8O9S,"InChI=1S/C61H82N8O9S/c1-37(40-26-28-43(29-27-40)54-38(2)63-36-79-54)64-57(73)50-31-44(70)34-68(50)60(76)55(61(4,5)6)66-52(71)25-13-14-30-77-45-21-16-22-46(32-45)78-47-33-51(58(74)65-49-24-15-20-41-17-11-12-23-48(41)49)69(35-47)59(75)53(42-18-9-8-10-19-42)67-56(72)39(3)62-7/h11-12,16-17,21-23,26-29,32,36-37,39,42,44,47,49-51,53,55,62,70H,8-10,13-15,18-20,24-25,30-31,33-35H2,1-7H3,(H,64,73)(H,65,74)(H,66,71)(H,67,72)/t37-,39-,44+,47-,49+,50-,51-,53-,55+/m0/s1",SMENADKMMXTZAZ-FMVATYOPSA-N
4179,Q08881,ITK,CRBN,,,CN(CCOCCOCC(=O)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,CN(,CCOCCOCC(=O)N,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,220.5,75.0,0,Degradation of ITK in Jurkat cells after 16h treatment,,,46.4,Inhibition of ITK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,807.909,807.3704095,3.14,59,7,12,4,17,209.95,C42H49N9O8,"InChI=1S/C42H49N9O8/c1-42(2)16-14-28-31(22-42)47-48-37(28)39(55)44-27-23-43-50(24-27)32(26-8-5-4-6-9-26)15-17-49(3)18-19-58-20-21-59-25-35(53)45-30-11-7-10-29-36(30)41(57)51(40(29)56)33-12-13-34(52)46-38(33)54/h4-11,23-24,32-33H,12-22,25H2,1-3H3,(H,44,55)(H,45,53)(H,47,48)(H,46,52,54)/t32-,33?/m0/s1",ZWQJQEMPNYBFQE-JEFWXSHNSA-N
4180,Q08881,ITK,CRBN,,,CN(CCOCCOCCOCC(=O)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,CN(,CCOCCOCCOCC(=O)N,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,352.6,75.0,0,Degradation of ITK in Jurkat cells after 16h treatment,,,44.5,Inhibition of ITK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,851.962,851.3966243,3.0,62,7,13,4,20,219.18,C44H53N9O9,"InChI=1S/C44H53N9O9/c1-44(2)16-14-30-33(24-44)49-50-39(30)41(57)46-29-25-45-52(26-29)34(28-8-5-4-6-9-28)15-17-51(3)18-19-60-20-21-61-22-23-62-27-37(55)47-32-11-7-10-31-38(32)43(59)53(42(31)58)35-12-13-36(54)48-40(35)56/h4-11,25-26,34-35H,12-24,27H2,1-3H3,(H,46,57)(H,47,55)(H,49,50)(H,48,54,56)/t34-,35?/m0/s1",SEPZFBBSIBKESI-SFCXHYMASA-N
4181,Q08881,ITK,CRBN,,,CN(CCOCCOCCOCCOCC(=O)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,CN(,CCOCCOCCOCCOCC(=O)N,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,286.2,75.0,0,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,896.015,895.422839,2.85,65,7,14,4,23,228.41,C46H57N9O10,"InChI=1S/C46H57N9O10/c1-46(2)16-14-32-35(26-46)51-52-41(32)43(59)48-31-27-47-54(28-31)36(30-8-5-4-6-9-30)15-17-53(3)18-19-62-20-21-63-22-23-64-24-25-65-29-39(57)49-34-11-7-10-33-40(34)45(61)55(44(33)60)37-12-13-38(56)50-42(37)58/h4-11,27-28,36-37H,12-26,29H2,1-3H3,(H,48,59)(H,49,57)(H,51,52)(H,50,56,58)/t36-,37?/m0/s1",ADRHCEUDBUBWKX-NWDJCJOJSA-N
4182,Q08881,ITK,CRBN,,,CN(CCOCCNC(=O)CNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,CN(,CCOCCNC(=O)CN,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,32.7,99.0,1,Degradation of ITK in Jurkat cells after 16h treatment,,,20,Inhibition of ITK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,806.925,806.3863939,3.41,59,7,12,5,17,212.75,C42H50N10O7,"InChI=1S/C42H50N10O7/c1-42(2)16-14-28-31(22-42)48-49-37(28)39(56)46-27-23-45-51(25-27)32(26-8-5-4-6-9-26)15-18-50(3)19-21-59-20-17-43-35(54)24-44-30-11-7-10-29-36(30)41(58)52(40(29)57)33-12-13-34(53)47-38(33)55/h4-11,23,25,32-33,44H,12-22,24H2,1-3H3,(H,43,54)(H,46,56)(H,48,49)(H,47,53,55)/t32-,33?/m0/s1",LOJMZDCMSCZZAJ-JEFWXSHNSA-N
4183,Q08881,ITK,CRBN,,,CN(CCOCCOCCNC(=O)CNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,CN(,CCOCCOCCNC(=O)CN,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,32.7,95.0,1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,850.978,850.4126087,3.26,62,7,13,5,20,221.98,C44H54N10O8,"InChI=1S/C44H54N10O8/c1-44(2)16-14-30-33(24-44)50-51-39(30)41(58)48-29-25-47-53(27-29)34(28-8-5-4-6-9-28)15-18-52(3)19-21-62-23-22-61-20-17-45-37(56)26-46-32-11-7-10-31-38(32)43(60)54(42(31)59)35-12-13-36(55)49-40(35)57/h4-11,25,27,34-35,46H,12-24,26H2,1-3H3,(H,45,56)(H,48,58)(H,50,51)(H,49,55,57)/t34-,35?/m0/s1",SGUKLZBZSKIVPN-SFCXHYMASA-N
4184,Q08881,ITK,CRBN,,,CN(CCOCCOCCOCCNC(=O)CNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,CN(,CCOCCOCCOCCNC(=O)CN,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,62.2,93.0,1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,895.031,894.4388234,3.12,65,7,14,5,23,231.21,C46H58N10O9,"InChI=1S/C46H58N10O9/c1-46(2)16-14-32-35(26-46)52-53-41(32)43(60)50-31-27-49-55(29-31)36(30-8-5-4-6-9-30)15-18-54(3)19-21-64-23-25-65-24-22-63-20-17-47-39(58)28-48-34-11-7-10-33-40(34)45(62)56(44(33)61)37-12-13-38(57)51-42(37)59/h4-11,27,29,36-37,48H,12-26,28H2,1-3H3,(H,47,58)(H,50,60)(H,52,53)(H,51,57,59)/t36-,37?/m0/s1",KDCYYVAKGGBCRY-NWDJCJOJSA-N
4185,Q08881,ITK,CRBN,,,CN(CCOCCC(=O)NC1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,CN(,CCOCCC(=O)N,C1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,15.6,97.0,1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,777.883,777.3598448,2.64,57,7,11,4,15,200.72,C41H47N9O7,"InChI=1S/C41H47N9O7/c1-41(2)16-13-29-31(22-41)46-47-36(29)38(54)44-27-23-42-49(24-27)32(25-7-5-4-6-8-25)14-17-48(3)18-20-57-19-15-35(52)43-26-9-10-28-30(21-26)40(56)50(39(28)55)33-11-12-34(51)45-37(33)53/h4-10,21,23-24,32-33H,11-20,22H2,1-3H3,(H,43,52)(H,44,54)(H,46,47)(H,45,51,53)/t32-,33?/m0/s1",POZBIGMNEGXRFC-JEFWXSHNSA-N
4186,Q08881,ITK,CRBN,,,CN(CCOCCOCC(=O)NC1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,CN(,CCOCCOCC(=O)N,C1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,26.7,95.0,1,Degradation of ITK in Jurkat cells after 16h treatment,,,24.1,Inhibition of ITK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,807.909,807.3704095,2.59,59,7,12,4,17,209.95,C42H49N9O8,"InChI=1S/C42H49N9O8/c1-42(2)15-13-30-32(22-42)47-48-37(30)39(55)45-28-23-43-50(24-28)33(26-7-5-4-6-8-26)14-16-49(3)17-18-58-19-20-59-25-36(53)44-27-9-10-29-31(21-27)41(57)51(40(29)56)34-11-12-35(52)46-38(34)54/h4-10,21,23-24,33-34H,11-20,22,25H2,1-3H3,(H,44,53)(H,45,55)(H,47,48)(H,46,52,54)/t33-,34?/m0/s1",YRMYHBHIFJXIGI-CDRRMRQFSA-N
4187,Q08881,ITK,CRBN,,,CN(CCOCCOCCOCC(=O)NC1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,CN(,CCOCCOCCOCC(=O)N,C1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,94.1,93.0,1,Degradation of ITK in Jurkat cells after 16h treatment,,,23.4,Inhibition of ITK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,851.962,851.3966243,2.44,62,7,13,4,20,219.18,C44H53N9O9,"InChI=1S/C44H53N9O9/c1-44(2)15-13-32-34(24-44)49-50-39(32)41(57)47-30-25-45-52(26-30)35(28-7-5-4-6-8-28)14-16-51(3)17-18-60-19-20-61-21-22-62-27-38(55)46-29-9-10-31-33(23-29)43(59)53(42(31)58)36-11-12-37(54)48-40(36)56/h4-10,23,25-26,35-36H,11-22,24,27H2,1-3H3,(H,46,55)(H,47,57)(H,49,50)(H,48,54,56)/t35-,36?/m0/s1",RSIUYCUBMQDZLI-TYIYNAFKSA-N
4188,Q08881,ITK,CRBN,,,CN(CCOCCOCCOCCOCC(=O)NC1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,CN(,CCOCCOCCOCCOCC(=O)N,C1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,105.9,92.0,0,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,896.015,895.422839,2.3,65,7,14,4,23,228.41,C46H57N9O10,"InChI=1S/C46H57N9O10/c1-46(2)15-13-34-36(26-46)51-52-41(34)43(59)49-32-27-47-54(28-32)37(30-7-5-4-6-8-30)14-16-53(3)17-18-62-19-20-63-21-22-64-23-24-65-29-40(57)48-31-9-10-33-35(25-31)45(61)55(44(33)60)38-11-12-39(56)50-42(38)58/h4-10,25,27-28,37-38H,11-24,26,29H2,1-3H3,(H,48,57)(H,49,59)(H,51,52)(H,50,56,58)/t37-,38?/m0/s1",DKWMHDBRVHNYTN-AIQPRDSRSA-N
4189,Q08881,ITK,CRBN,,,CN(CCCCC(=O)NC1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,CN(,CCCCC(=O)N,C1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,5.3,90.0,1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,761.884,761.3649302,3.5,56,7,10,4,14,191.49,C41H47N9O6,"InChI=1S/C41H47N9O6/c1-41(2)18-16-29-31(22-41)46-47-36(29)38(54)44-27-23-42-49(24-27)32(25-9-5-4-6-10-25)17-20-48(3)19-8-7-11-34(51)43-26-12-13-28-30(21-26)40(56)50(39(28)55)33-14-15-35(52)45-37(33)53/h4-6,9-10,12-13,21,23-24,32-33H,7-8,11,14-20,22H2,1-3H3,(H,43,51)(H,44,54)(H,46,47)(H,45,52,53)/t32-,33?/m0/s1",LEUWQTQWZRMFBC-JEFWXSHNSA-N
4191,Q08881,ITK,CRBN,,,CN(CCCCCCC(=O)NC1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,CN(,CCCCCCC(=O)N,C1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,9.0,90.0,1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,789.938,789.3962304,4.4,58,7,10,4,16,191.49,C43H51N9O6,"InChI=1S/C43H51N9O6/c1-43(2)20-18-31-33(24-43)48-49-38(31)40(56)46-29-25-44-51(26-29)34(27-11-7-6-8-12-27)19-22-50(3)21-10-5-4-9-13-36(53)45-28-14-15-30-32(23-28)42(58)52(41(30)57)35-16-17-37(54)47-39(35)55/h6-8,11-12,14-15,23,25-26,34-35H,4-5,9-10,13,16-22,24H2,1-3H3,(H,45,53)(H,46,56)(H,48,49)(H,47,54,55)/t34-,35?/m0/s1",ZLOIRWPQMNYBGL-SFCXHYMASA-N
4192,Q08881,ITK,CRBN,,,CN(CCCCCCCCC(=O)NC1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,CN(,CCCCCCCCC(=O)N,C1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,5.5,93.0,1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,817.992,817.4275305,5.49,60,7,10,4,18,191.49,C45H55N9O6,"InChI=1S/C45H55N9O6/c1-45(2)22-20-33-35(26-45)50-51-40(33)42(58)48-31-27-46-53(28-31)36(29-13-9-8-10-14-29)21-24-52(3)23-12-7-5-4-6-11-15-38(55)47-30-16-17-32-34(25-30)44(60)54(43(32)59)37-18-19-39(56)49-41(37)57/h8-10,13-14,16-17,25,27-28,36-37H,4-7,11-12,15,18-24,26H2,1-3H3,(H,47,55)(H,48,58)(H,50,51)(H,49,56,57)/t36-,37?/m0/s1",VBMKCGVNGRQNJV-NWDJCJOJSA-N
4193,Q08881,ITK,CRBN,,,CN(CCCCCCCCCCC(=O)NC1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,CN(,CCCCCCCCCCC(=O)N,C1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1)CC[C@@H](C1=CC=CC=C1)N1C=C(NC(=O)C2=N[NH]C3=C2CCC(C)(C)C3)C=N1,75.4,82.0,1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,846.046,845.4588306,6.57,62,7,10,4,20,191.49,C47H59N9O6,"InChI=1S/C47H59N9O6/c1-47(2)24-22-35-37(28-47)52-53-42(35)44(60)50-33-29-48-55(30-33)38(31-15-11-10-12-16-31)23-26-54(3)25-14-9-7-5-4-6-8-13-17-40(57)49-32-18-19-34-36(27-32)46(62)56(45(34)61)39-20-21-41(58)51-43(39)59/h10-12,15-16,18-19,27,29-30,38-39H,4-9,13-14,17,20-26,28H2,1-3H3,(H,49,57)(H,50,60)(H,52,53)(H,51,58,59)/t38-,39?/m0/s1",FXHSLFPHSQGRHN-SQTCDLSVSA-N
4194,Q08881,ITK,CRBN,,,CC1(C)CCC2=C(C1)[NH]N=C2C(=O)NC1=CN([C@@H](CCN2CCN(CCC3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)C2=CC=CC=C2)N=C1,CC1(C)CCC2=C(C1)[NH]N=C2,C(=O)N,C1=CN([C@@H](CCN2CCN(CCC3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)C2=CC=CC=C2)N=C1,3.6,95.0,1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,35.2,Inhibition activity of IL2 secretion in Jurkat cells,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,829.019,828.4435149,4.72,61,9,11,3,12,168.87,C46H56N10O5,"InChI=1S/C46H56N10O5/c1-46(2)17-12-35-37(27-46)50-51-41(35)43(59)48-32-28-47-55(29-32)38(31-6-4-3-5-7-31)16-19-53-24-22-52(23-25-53)18-13-30-14-20-54(21-15-30)33-8-9-34-36(26-33)45(61)56(44(34)60)39-10-11-40(57)49-42(39)58/h3-9,26,28-30,38-39H,10-25,27H2,1-2H3,(H,48,59)(H,50,51)(H,49,57,58)/t38-,39?/m0/s1",QEXIHSMROQCLDO-SQTCDLSVSA-N
4195,Q08881,ITK,CRBN,,,CC1(C)CCC2=C(C1)[NH]N=C2C(=O)NC1=CN([C@@H](CCN2CCN(CC3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)C2=CC=CC=C2)N=C1,CC1(C)CCC2=C(C1)[NH]N=C2,C(=O)N,C1=CN([C@@H](CCN2CCN(CC3CCN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)CC3)CC2)C2=CC=CC=C2)N=C1,29.3,90.0,1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,814.992,814.4278648,4.36,60,9,11,3,11,168.87,C45H54N10O5,"InChI=1S/C45H54N10O5/c1-45(2)16-12-34-36(25-45)49-50-40(34)42(58)47-31-26-46-54(28-31)37(30-6-4-3-5-7-30)15-17-51-20-22-52(23-21-51)27-29-13-18-53(19-14-29)32-8-9-33-35(24-32)44(60)55(43(33)59)38-10-11-39(56)48-41(38)57/h3-9,24,26,28-29,37-38H,10-23,25,27H2,1-2H3,(H,47,58)(H,49,50)(H,48,56,57)/t37-,38?/m0/s1",MANMYZQCTDYCCS-AIQPRDSRSA-N
4196,Q08881,ITK,CRBN,,,CC1(C)CCC2=C(C1)[NH]N=C2C(=O)NC1=CN([C@@H](CCN2CCN(CCC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C3)CC2)C2=CC=CC=C2)N=C1,CC1(C)CCC2=C(C1)[NH]N=C2,C(=O)N,C1=CN([C@@H](CCN2CCN(CCC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C3)CC2)C2=CC=CC=C2)N=C1,142.0,90.0,0,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,800.965,800.4122148,4.0,59,9,11,3,12,168.87,C44H52N10O5,"InChI=1S/C44H52N10O5/c1-44(2)15-12-33-35(23-44)48-49-39(33)41(57)46-30-24-45-53(27-30)36(29-6-4-3-5-7-29)14-17-51-20-18-50(19-21-51)16-13-28-25-52(26-28)31-8-9-32-34(22-31)43(59)54(42(32)58)37-10-11-38(55)47-40(37)56/h3-9,22,24,27-28,36-37H,10-21,23,25-26H2,1-2H3,(H,46,57)(H,48,49)(H,47,55,56)/t36-,37?/m0/s1",TXNMTSWVZKOGFM-NWDJCJOJSA-N
4197,Q08881,ITK,CRBN,,,CC1(C)CCC2=C(C1)[NH]N=C2C(=O)NC1=CN([C@@H](CCN2CCN(CC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C3)CC2)C2=CC=CC=C2)N=C1,CC1(C)CCC2=C(C1)[NH]N=C2,C(=O)N,C1=CN([C@@H](CCN2CCN(CC3CN(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)C(=O)C5=C4)C3)CC2)C2=CC=CC=C2)N=C1,10.0,85.0,1,Degradation of ITK in Jurkat cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c02078,786.938,786.3965647,3.64,58,9,11,3,11,168.87,C43H50N10O5,"InChI=1S/C43H50N10O5/c1-43(2)14-12-32-34(21-43)47-48-38(32)40(56)45-29-22-44-52(26-29)35(28-6-4-3-5-7-28)13-15-49-16-18-50(19-17-49)23-27-24-51(25-27)30-8-9-31-33(20-30)42(58)53(41(31)57)36-10-11-37(54)46-39(36)55/h3-9,20,22,26-27,35-36H,10-19,21,23-25H2,1-2H3,(H,45,56)(H,47,48)(H,46,54,55)/t35-,36?/m0/s1",JGLKHXACODUKAA-TYIYNAFKSA-N
4237,Q8TBX8,PIP4K2C,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCCCCCC(=O)N3CCC4(CC3)CCN(C3=CN=CC(NC5=NC=C(Cl)C(C6=CC=CC(C7=CC=CC=C7)=C6)=N5)=C3)C4=O)=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(,OCCCCCCC(=O)N,3CCC4(CC3)CCN(C3=CN=CC(NC5=NC=C(Cl)C(C6=CC=CC(C7=CC=CC=C7)=C6)=N5)=C3)C4=O)=C2)SC=N1,107.0,70.0,0,Degradation of PIP4K2C in MOLT4 cells after 6h treatment,,,,,,,625,KD ELECT assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/anie.202302364,1153.823,1152.482221,8.51,82,10,13,4,20,212.18,C62H70ClFN10O7S,"InChI=1S/C62H70ClFN10O7S/c1-39-53(82-38-68-39)43-18-19-44(33-66-55(77)49-32-47(75)37-74(49)56(78)54(60(2,3)4)71-57(79)62(64)20-21-62)50(30-43)81-28-11-6-5-10-17-51(76)72-25-22-61(23-26-72)24-27-73(58(61)80)46-31-45(34-65-35-46)69-59-67-36-48(63)52(70-59)42-16-12-15-41(29-42)40-13-8-7-9-14-40/h7-9,12-16,18-19,29-31,34-36,38,47,49,54,75H,5-6,10-11,17,20-28,32-33,37H2,1-4H3,(H,66,77)(H,71,79)(H,67,69,70)/t47-,49+,54-/m1/s1",VCOSWEBKUXOFPA-PHCPANOJSA-N
4242,Q07889,SOS1,VHL,,ZZ151,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1C1CCN(C(=O)CCCCCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)CC1,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1C1CCN(,C(=O)CCCCCC(=O)N,[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)CC1,15.7,100.0,1,Degradation of SOS1 in NCI-H358 cells after 24h treatment,83.9/98.2,% SOS1 protein degradation in NCI-H358 cells at 100/1000 nM,,,,,93,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8.13,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00075,1028.256,1027.496537,7.97,73,7,12,5,17,205.0,C54H68F3N9O6S,"InChI=1S/C54H68F3N9O6S/c1-30(34-14-16-36(17-15-34)48-32(3)59-29-73-48)61-51(70)44-25-40(67)28-66(44)52(71)49(53(5,6)7)64-46(68)12-10-9-11-13-47(69)65-20-18-35(19-21-65)41-26-42-43(27-45(41)72-8)62-33(4)63-50(42)60-31(2)37-22-38(54(55,56)57)24-39(58)23-37/h14-17,22-24,26-27,29-31,35,40,44,49,67H,9-13,18-21,25,28,58H2,1-8H3,(H,61,70)(H,64,68)(H,60,62,63)/t30-,31+,40+,44-,49+/m0/s1",IIUMLDLNPGCAPX-GGCSJQPYSA-N
4247,Q07889,SOS1,VHL,,,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1C1CCN(C(=O)COCCCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)CC1,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1C1CCN(,C(=O)COCCCC(=O)N,[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)CC1,49.3,97.9,1,Degradation of SOS1 in NCI-H358 cells after 24h treatment,54.6/90.2,% SOS1 protein degradation in NCI-H358 cells at 100/1000 nM,,,,,155,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17.4,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c00075,1030.228,1029.475801,7.03,73,7,13,5,17,214.23,C53H66F3N9O7S,"InChI=1S/C53H66F3N9O7S/c1-29(33-11-13-35(14-12-33)47-31(3)58-28-73-47)60-50(69)43-23-39(66)26-65(43)51(70)48(52(5,6)7)63-45(67)10-9-19-72-27-46(68)64-17-15-34(16-18-64)40-24-41-42(25-44(40)71-8)61-32(4)62-49(41)59-30(2)36-20-37(53(54,55)56)22-38(57)21-36/h11-14,20-22,24-25,28-30,34,39,43,48,66H,9-10,15-19,23,26-27,57H2,1-8H3,(H,60,69)(H,63,67)(H,59,61,62)/t29-,30+,39+,43-,48+/m0/s1",AIHGVELLLJOFHL-AHHHCUNGSA-N
4266,O75530,EED,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3C[C@@H](NC(=O)C4=CC=C(C5=CN=C(NCC6=CC=CO6)N6C=NN=C56)C=C4)C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(,CNC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3C[C@@H](NC(=O)C4=CC=C(C5=CN=C(NCC6=CC=CO6)N6C=NN=C56)C=C4)C3)C(C)(C)C)C=C2)SC=N1,111.0,84.0,0,Degradation of EED in DB cells after 24h treatment,,,47,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.2c00804,844.999,844.3479003,4.95,61,8,13,5,13,208.98,C44H48N10O6S,"InChI=1S/C44H48N10O6S/c1-25-36(61-24-48-25)28-9-7-26(8-10-28)19-45-41(58)35-18-32(55)22-53(35)42(59)37(44(2,3)4)51-40(57)30-16-31(17-30)50-39(56)29-13-11-27(12-14-29)34-21-47-43(54-23-49-52-38(34)54)46-20-33-6-5-15-60-33/h5-15,21,23-24,30-32,35,37,55H,16-20,22H2,1-4H3,(H,45,58)(H,46,47)(H,50,56)(H,51,57)/t30-,31+,32-,35+,37-/m1/s1",ARONHQOAKYUHEE-AOBTXCIISA-N
4266,Q15910,EZH2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3C[C@@H](NC(=O)C4=CC=C(C5=CN=C(NCC6=CC=CO6)N6C=NN=C56)C=C4)C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(,CNC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3C[C@@H](NC(=O)C4=CC=C(C5=CN=C(NCC6=CC=CO6)N6C=NN=C56)C=C4)C3)C(C)(C)C)C=C2)SC=N1,275.0,86.0,0,Degradation of EZH2 in DB cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.2c00804,844.999,844.3479003,4.95,61,8,13,5,13,208.98,C44H48N10O6S,"InChI=1S/C44H48N10O6S/c1-25-36(61-24-48-25)28-9-7-26(8-10-28)19-45-41(58)35-18-32(55)22-53(35)42(59)37(44(2,3)4)51-40(57)30-16-31(17-30)50-39(56)29-13-11-27(12-14-29)34-21-47-43(54-23-49-52-38(34)54)46-20-33-6-5-15-60-33/h5-15,21,23-24,30-32,35,37,55H,16-20,22H2,1-4H3,(H,45,58)(H,46,47)(H,50,56)(H,51,57)/t30-,31+,32-,35+,37-/m1/s1",ARONHQOAKYUHEE-AOBTXCIISA-N
4266,Q15022,SUZ12,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3C[C@@H](NC(=O)C4=CC=C(C5=CN=C(NCC6=CC=CO6)N6C=NN=C56)C=C4)C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(,CNC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3C[C@@H](NC(=O)C4=CC=C(C5=CN=C(NCC6=CC=CO6)N6C=NN=C56)C=C4)C3)C(C)(C)C)C=C2)SC=N1,0.0,44.0,0,Degradation of SUZ12 in DB cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.2c00804,844.999,844.3479003,4.95,61,8,13,5,13,208.98,C44H48N10O6S,"InChI=1S/C44H48N10O6S/c1-25-36(61-24-48-25)28-9-7-26(8-10-28)19-45-41(58)35-18-32(55)22-53(35)42(59)37(44(2,3)4)51-40(57)30-16-31(17-30)50-39(56)29-13-11-27(12-14-29)34-21-47-43(54-23-49-52-38(34)54)46-20-33-6-5-15-60-33/h5-15,21,23-24,30-32,35,37,55H,16-20,22H2,1-4H3,(H,45,58)(H,46,47)(H,50,56)(H,51,57)/t30-,31+,32-,35+,37-/m1/s1",ARONHQOAKYUHEE-AOBTXCIISA-N
4267,O75530,EED,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3C[C@H](NC(=O)C4=CC=C(C5=CN=C(NCC6=CC=CO6)N6C=NN=C56)C=C4)C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(,CNC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3C[C@H](NC(=O)C4=CC=C(C5=CN=C(NCC6=CC=CO6)N6C=NN=C56)C=C4)C3)C(C)(C)C)C=C2)SC=N1,67.0,64.0,0,Degradation of EED in DB cells after 24h treatment,,,33,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.2c00804,844.999,844.3479003,4.95,61,8,13,5,13,208.98,C44H48N10O6S,"InChI=1S/C44H48N10O6S/c1-25-36(61-24-48-25)28-9-7-26(8-10-28)19-45-41(58)35-18-32(55)22-53(35)42(59)37(44(2,3)4)51-40(57)30-16-31(17-30)50-39(56)29-13-11-27(12-14-29)34-21-47-43(54-23-49-52-38(34)54)46-20-33-6-5-15-60-33/h5-15,21,23-24,30-32,35,37,55H,16-20,22H2,1-4H3,(H,45,58)(H,46,47)(H,50,56)(H,51,57)/t30-,31-,32-,35+,37-/m1/s1",ARONHQOAKYUHEE-RQQRUTLXSA-N
4267,Q15910,EZH2,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3C[C@H](NC(=O)C4=CC=C(C5=CN=C(NCC6=CC=CO6)N6C=NN=C56)C=C4)C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(,CNC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3C[C@H](NC(=O)C4=CC=C(C5=CN=C(NCC6=CC=CO6)N6C=NN=C56)C=C4)C3)C(C)(C)C)C=C2)SC=N1,0.0,15.0,0,Degradation of EZH2 in DB cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.2c00804,844.999,844.3479003,4.95,61,8,13,5,13,208.98,C44H48N10O6S,"InChI=1S/C44H48N10O6S/c1-25-36(61-24-48-25)28-9-7-26(8-10-28)19-45-41(58)35-18-32(55)22-53(35)42(59)37(44(2,3)4)51-40(57)30-16-31(17-30)50-39(56)29-13-11-27(12-14-29)34-21-47-43(54-23-49-52-38(34)54)46-20-33-6-5-15-60-33/h5-15,21,23-24,30-32,35,37,55H,16-20,22H2,1-4H3,(H,45,58)(H,46,47)(H,50,56)(H,51,57)/t30-,31-,32-,35+,37-/m1/s1",ARONHQOAKYUHEE-RQQRUTLXSA-N
4267,Q15022,SUZ12,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3C[C@H](NC(=O)C4=CC=C(C5=CN=C(NCC6=CC=CO6)N6C=NN=C56)C=C4)C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(,CNC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)[C@H]3C[C@H](NC(=O)C4=CC=C(C5=CN=C(NCC6=CC=CO6)N6C=NN=C56)C=C4)C3)C(C)(C)C)C=C2)SC=N1,0.0,29.0,0,Degradation of SUZ12 in DB cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.2c00804,844.999,844.3479003,4.95,61,8,13,5,13,208.98,C44H48N10O6S,"InChI=1S/C44H48N10O6S/c1-25-36(61-24-48-25)28-9-7-26(8-10-28)19-45-41(58)35-18-32(55)22-53(35)42(59)37(44(2,3)4)51-40(57)30-16-31(17-30)50-39(56)29-13-11-27(12-14-29)34-21-47-43(54-23-49-52-38(34)54)46-20-33-6-5-15-60-33/h5-15,21,23-24,30-32,35,37,55H,16-20,22H2,1-4H3,(H,45,58)(H,46,47)(H,50,56)(H,51,57)/t30-,31-,32-,35+,37-/m1/s1",ARONHQOAKYUHEE-RQQRUTLXSA-N
4268,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCOC3=CC=C(C4CCN(C5=NN6C(=NN=C6C(F)(F)F)CC5)CC4)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCCCO,C3=CC=C(C4CCN(C5=NN6C(=NN=C6C(F)(F)F)CC5)CC4)C=C3)C(C)(C)C)C=C2)SC=N1,2120.0,88.0,0,Degradation of AR in LNCaP/CWR22Rv1/VCaP cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6587/4134/5454,Inhibit cell growth in LNCaP/CWR22Rv1/VCaP cells,,,,,,,,,,,,,,,10.1016/j.ebiom.2023.104500,908.061,907.4026362,5.11,64,7,13,3,15,176.4,C45H56F3N9O6S,"InChI=1S/C45H56F3N9O6S/c1-28-39(64-27-50-28)32-9-7-29(8-10-32)24-49-41(60)35-23-33(58)25-56(35)42(61)40(44(2,3)4)51-38(59)26-62-21-5-6-22-63-34-13-11-30(12-14-34)31-17-19-55(20-18-31)37-16-15-36-52-53-43(45(46,47)48)57(36)54-37/h7-14,27,31,33,35,40,58H,5-6,15-26H2,1-4H3,(H,49,60)(H,51,59)/t33-,35+,40-/m1/s1",BLWSMGOTKQNWIF-LJWMJXRYSA-N
4268,P10275,AR-V7,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCOC3=CC=C(C4CCN(C5=NN6C(=NN=C6C(F)(F)F)CC5)CC4)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCCCO,C3=CC=C(C4CCN(C5=NN6C(=NN=C6C(F)(F)F)CC5)CC4)C=C3)C(C)(C)C)C=C2)SC=N1,290.0,63.0,0,Degradation of AR V7 in CWR22Rv1/VCaP cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ebiom.2023.104500,908.061,907.4026362,5.11,64,7,13,3,15,176.4,C45H56F3N9O6S,"InChI=1S/C45H56F3N9O6S/c1-28-39(64-27-50-28)32-9-7-29(8-10-32)24-49-41(60)35-23-33(58)25-56(35)42(61)40(44(2,3)4)51-38(59)26-62-21-5-6-22-63-34-13-11-30(12-14-34)31-17-19-55(20-18-31)37-16-15-36-52-53-43(45(46,47)48)57(36)54-37/h7-14,27,31,33,35,40,58H,5-6,15-26H2,1-4H3,(H,49,60)(H,51,59)/t33-,35+,40-/m1/s1",BLWSMGOTKQNWIF-LJWMJXRYSA-N
4269,P10275,AR,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCCCOC3=CC=C(C4CCN(C5=NN6C(=NN=C6C(F)(F)F)CC5)CC4)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@H](O)CN3C(=O)[C@@H](,NC(=O)COCCCCCCO,C3=CC=C(C4CCN(C5=NN6C(=NN=C6C(F)(F)F)CC5)CC4)C=C3)C(C)(C)C)C=C2)SC=N1,6100.0,85.0,0,Degradation of AR in LNCaP/CWR22Rv1/VCaP cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6360/6921/3057,Inhibit cell growth in LNCaP/CWR22Rv1/VCaP cells,,,,,,,,,,,,,,,10.1016/j.ebiom.2023.104500,936.115,935.4339363,5.82,66,7,13,3,17,176.4,C47H60F3N9O6S,"InChI=1S/C47H60F3N9O6S/c1-30-41(66-29-52-30)34-11-9-31(10-12-34)26-51-43(62)37-25-35(60)27-58(37)44(63)42(46(2,3)4)53-40(61)28-64-23-7-5-6-8-24-65-36-15-13-32(14-16-36)33-19-21-57(22-20-33)39-18-17-38-54-55-45(47(48,49)50)59(38)56-39/h9-16,29,33,35,37,42,60H,5-8,17-28H2,1-4H3,(H,51,62)(H,53,61)/t35-,37-,42+/m0/s1",XXORMIPKQOJWQL-FFHGCIBJSA-N
4269,P10275,AR-V7,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@H](O)CN3C(=O)[C@@H](NC(=O)COCCCCCCOC3=CC=C(C4CCN(C5=NN6C(=NN=C6C(F)(F)F)CC5)CC4)C=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@H](O)CN3C(=O)[C@@H](,NC(=O)COCCCCCCO,C3=CC=C(C4CCN(C5=NN6C(=NN=C6C(F)(F)F)CC5)CC4)C=C3)C(C)(C)C)C=C2)SC=N1,1890.0,99.0,0,Degradation of AR V7 in CWR22Rv1/VCaP cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ebiom.2023.104500,936.115,935.4339363,5.82,66,7,13,3,17,176.4,C47H60F3N9O6S,"InChI=1S/C47H60F3N9O6S/c1-30-41(66-29-52-30)34-11-9-31(10-12-34)26-51-43(62)37-25-35(60)27-58(37)44(63)42(46(2,3)4)53-40(61)28-64-23-7-5-6-8-24-65-36-15-13-32(14-16-36)33-19-21-57(22-20-33)39-18-17-38-54-55-45(47(48,49)50)59(38)56-39/h9-16,29,33,35,37,42,60H,5-8,17-28H2,1-4H3,(H,51,62)(H,53,61)/t35-,37-,42+/m0/s1",XXORMIPKQOJWQL-FFHGCIBJSA-N
4270,P10275,AR,CRBN,,,O=C1CCC(N2CC3=C(NC(=O)COCCCCOC4=CC=C(C5CCN(C6=NN7C(=NN=C7C(F)(F)F)CC6)CC5)C=C4)C=CC=C3C2=O)C(=O)N1,O=C1CCC(N2CC3=C(,NC(=O)COCCCCO,C4=CC=C(C5CCN(C6=NN7C(=NN=C7C(F)(F)F)CC6)CC5)C=C4)C=CC=C3C2=O)C(=O)N1,3410.0,99.0,0,Degradation of AR in LNCaP/CWR22Rv1/VCaP cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,464/71/448,Inhibit cell growth in LNCaP/CWR22Rv1/VCaP cells,,,,,,,,,,,,,,,10.1016/j.ebiom.2023.104500,736.752,736.2944656,2.15,53,7,11,2,11,160.35,C36H39F3N8O6,"InChI=1S/C36H39F3N8O6/c37-36(38,39)35-43-42-29-11-12-30(44-47(29)35)45-16-14-23(15-17-45)22-6-8-24(9-7-22)53-19-2-1-18-52-21-32(49)40-27-5-3-4-25-26(27)20-46(34(25)51)28-10-13-31(48)41-33(28)50/h3-9,23,28H,1-2,10-21H2,(H,40,49)(H,41,48,50)",LCTDAEHHXXZLPR-UHFFFAOYSA-N
4270,P10275,AR-V7,CRBN,,,O=C1CCC(N2CC3=C(NC(=O)COCCCCOC4=CC=C(C5CCN(C6=NN7C(=NN=C7C(F)(F)F)CC6)CC5)C=C4)C=CC=C3C2=O)C(=O)N1,O=C1CCC(N2CC3=C(,NC(=O)COCCCCO,C4=CC=C(C5CCN(C6=NN7C(=NN=C7C(F)(F)F)CC6)CC5)C=C4)C=CC=C3C2=O)C(=O)N1,11.0,91.0,1,Degradation of AR V7 in CWR22Rv1/VCaP cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ebiom.2023.104500,736.752,736.2944656,2.15,53,7,11,2,11,160.35,C36H39F3N8O6,"InChI=1S/C36H39F3N8O6/c37-36(38,39)35-43-42-29-11-12-30(44-47(29)35)45-16-14-23(15-17-45)22-6-8-24(9-7-22)53-19-2-1-18-52-21-32(49)40-27-5-3-4-25-26(27)20-46(34(25)51)28-10-13-31(48)41-33(28)50/h3-9,23,28H,1-2,10-21H2,(H,40,49)(H,41,48,50)",LCTDAEHHXXZLPR-UHFFFAOYSA-N
4285,P50750,CDK9,Keap1,,,COC1=CC(/C=C/C(=O)N2CCC=CC2=O)=CC(OC)=C1OCCOCCNC(=O)CN1CCC(C(=O)NC2=NC=C(SCC3=NC=C(C(C)(C)C)O3)S2)CC1,COC1=CC(/C=C/C(=O)N2CCC=CC2=O)=CC(OC)=C1,OCCOCCNC(=O)CN,1CCC(C(=O)NC2=NC=C(SCC3=NC=C(C(C)(C)C)O3)S2)CC1,15.0,87.0,1,Degradation of CDK9 in MOLT4 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,120,EC50 were determined by MTS assay,,,,,,,,,,,,,10.1016/j.chembiol.2023.01.004,810.996,810.3080692,4.49,56,5,14,2,18,174.66,C39H50N6O9S2,"InChI=1S/C39H50N6O9S2/c1-39(2,3)30-22-41-32(54-30)25-55-35-23-42-38(56-35)43-37(49)27-11-15-44(16-12-27)24-31(46)40-13-17-52-18-19-53-36-28(50-4)20-26(21-29(36)51-5)9-10-34(48)45-14-7-6-8-33(45)47/h6,8-10,20-23,27H,7,11-19,24-25H2,1-5H3,(H,40,46)(H,42,43,49)/b10-9+",VJANLMROQUGZQD-MDZDMXLPSA-N
4286,P50750,CDK9,Keap1,,,COC1=CC(/C=C/C(=O)N2CCC=CC2=O)=CC(OC)=C1OCCOCCOCCNC(=O)CN1CCC(C(=O)NC2=NC=C(SCC3=NC=C(C(C)(C)C)O3)S2)CC1,COC1=CC(/C=C/C(=O)N2CCC=CC2=O)=CC(OC)=C1,OCCOCCOCCNC(=O)CN,1CCC(C(=O)NC2=NC=C(SCC3=NC=C(C(C)(C)C)O3)S2)CC1,12.0,93.0,1,Degradation of CDK9 in MOLT4 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,138,EC50 were determined by MTS assay,,,,,,,,,,,,,10.1016/j.chembiol.2023.01.004,855.049,854.3342839,4.35,59,5,15,2,21,183.89,C41H54N6O10S2,"InChI=1S/C41H54N6O10S2/c1-41(2,3)32-24-43-34(57-32)27-58-37-25-44-40(59-37)45-39(51)29-11-15-46(16-12-29)26-33(48)42-13-17-54-18-19-55-20-21-56-38-30(52-4)22-28(23-31(38)53-5)9-10-36(50)47-14-7-6-8-35(47)49/h6,8-10,22-25,29H,7,11-21,26-27H2,1-5H3,(H,42,48)(H,44,45,51)/b10-9+",TXKCUGSZTOPCDO-MDZDMXLPSA-N
4287,P50750,CDK9,Keap1,,,COC1=CC(/C=C/C(=O)N2CCC=CC2=O)=CC(OC)=C1OCCOCCOCCOCCNC(=O)CN1CCC(C(=O)NC2=NC=C(SCC3=NC=C(C(C)(C)C)O3)S2)CC1,COC1=CC(/C=C/C(=O)N2CCC=CC2=O)=CC(OC)=C1,OCCOCCOCCOCCNC(=O)CN,1CCC(C(=O)NC2=NC=C(SCC3=NC=C(C(C)(C)C)O3)S2)CC1,10.0,96.0,1,Degradation of CDK9 in MOLT4 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,132,EC50 were determined by MTS assay,,,,,,,,,,,,,10.1016/j.chembiol.2023.01.004,899.102,898.3604987,4.2,62,5,16,2,24,193.12,C43H58N6O11S2,"InChI=1S/C43H58N6O11S2/c1-43(2,3)34-26-45-36(60-34)29-61-39-27-46-42(62-39)47-41(53)31-11-15-48(16-12-31)28-35(50)44-13-17-56-18-19-57-20-21-58-22-23-59-40-32(54-4)24-30(25-33(40)55-5)9-10-38(52)49-14-7-6-8-37(49)51/h6,8-10,24-27,31H,7,11-23,28-29H2,1-5H3,(H,44,50)(H,46,47,53)/b10-9+",RZZUETFFPWLZJB-MDZDMXLPSA-N
4288,P50750,CDK9,Keap1,,,COC1=CC(/C=C/C(=O)N2CCC=CC2=O)=CC(OC)=C1OCCCCCCCCNC(=O)CN1CCC(C(=O)NC2=NC=C(SCC3=NC=C(C(C)(C)C)O3)S2)CC1,COC1=CC(/C=C/C(=O)N2CCC=CC2=O)=CC(OC)=C1,OCCCCCCCCNC(=O)CN,1CCC(C(=O)NC2=NC=C(SCC3=NC=C(C(C)(C)C)O3)S2)CC1,102.0,74.0,0,Degradation of CDK9 in MOLT4 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,318,EC50 were determined by MTS assay,,,,,,,,,,,,,10.1016/j.chembiol.2023.01.004,851.105,850.3757548,7.15,59,5,13,2,21,165.43,C43H58N6O8S2,"InChI=1S/C43H58N6O8S2/c1-43(2,3)34-26-45-36(57-34)29-58-39-27-46-42(59-39)47-41(53)31-17-21-48(22-18-31)28-35(50)44-19-11-8-6-7-9-13-23-56-40-32(54-4)24-30(25-33(40)55-5)15-16-38(52)49-20-12-10-14-37(49)51/h10,14-16,24-27,31H,6-9,11-13,17-23,28-29H2,1-5H3,(H,44,50)(H,46,47,53)/b16-15+",RATDLIDZDBRMJD-FOCLMDBBSA-N
4289,P50750,CDK9,Keap1,,,COC1=CC(/C=C/C(=O)N2CCC=CC2=O)=CC(OC)=C1OCCOCCOCC(=O)N1CCC(C(=O)NC2=NC=C(SCC3=NC=C(C(C)(C)C)O3)S2)CC1,COC1=CC(/C=C/C(=O)N2CCC=CC2=O)=CC(OC)=C1,OCCOCCOCC(=O)N,1CCC(C(=O)NC2=NC=C(SCC3=NC=C(C(C)(C)C)O3)S2)CC1,28.0,87.0,1,Degradation of CDK9 in MOLT4 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,119,EC50 were determined by MTS assay,,,,,,,,,,,,,10.1016/j.chembiol.2023.01.004,811.98,811.2920848,4.49,56,5,14,1,18,171.86,C39H49N5O10S2,"InChI=1S/C39H49N5O10S2/c1-39(2,3)30-22-40-31(54-30)25-55-35-23-41-38(56-35)42-37(48)27-11-14-43(15-12-27)34(47)24-52-17-16-51-18-19-53-36-28(49-4)20-26(21-29(36)50-5)9-10-33(46)44-13-7-6-8-32(44)45/h6,8-10,20-23,27H,7,11-19,24-25H2,1-5H3,(H,41,42,48)/b10-9+",ZBRDTLMHOHYRGL-MDZDMXLPSA-N
4290,P50750,CDK9,Keap1,,,COC1=CC(/C=C/C(=O)N2CCC=CC2=O)=CC(OC)=C1OCCOCCOCCOCC(=O)N1CCC(C(=O)NC2=NC=C(SCC3=NC=C(C(C)(C)C)O3)S2)CC1,COC1=CC(/C=C/C(=O)N2CCC=CC2=O)=CC(OC)=C1,OCCOCCOCCOCC(=O)N,1CCC(C(=O)NC2=NC=C(SCC3=NC=C(C(C)(C)C)O3)S2)CC1,15.0,92.0,1,Degradation of CDK9 in MOLT4 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,107,EC50 were determined by MTS assay,,,,,,,,,,,,,10.1016/j.chembiol.2023.01.004,856.033,855.3182995,4.34,59,5,15,1,21,181.09,C41H53N5O11S2,"InChI=1S/C41H53N5O11S2/c1-41(2,3)32-24-42-33(57-32)27-58-37-25-43-40(59-37)44-39(50)29-11-14-45(15-12-29)36(49)26-55-19-18-53-16-17-54-20-21-56-38-30(51-4)22-28(23-31(38)52-5)9-10-35(48)46-13-7-6-8-34(46)47/h6,8-10,22-25,29H,7,11-21,26-27H2,1-5H3,(H,43,44,50)/b10-9+",LWSHARCZUPCYNR-MDZDMXLPSA-N
4291,P50750,CDK9,Keap1,,,COC1=CC(/C=C/C(=O)N2CCC=CC2=O)=CC(OC)=C1OCCN1CCN(C(=O)CN2CCC(C(=O)NC3=NC=C(SCC4=NC=C(C(C)(C)C)O4)S3)CC2)CC1,COC1=CC(/C=C/C(=O)N2CCC=CC2=O)=CC(OC)=C1,OCCN,1CCN(C(=O)CN2CCC(C(=O)NC3=NC=C(SCC4=NC=C(C(C)(C)C)O4)S3)CC2)CC1,9.0,96.0,1,Degradation of CDK9 in MOLT4 cells after 16h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,28,EC50 were determined by MTS assay,,,,,,,,,,,,,10.1016/j.chembiol.2023.01.004,836.05,835.3397037,4.64,58,6,14,1,15,159.88,C41H53N7O8S2,"InChI=1S/C41H53N7O8S2/c1-41(2,3)32-24-42-33(56-32)27-57-37-25-43-40(58-37)44-39(52)29-11-14-46(15-12-29)26-36(51)47-18-16-45(17-19-47)20-21-55-38-30(53-4)22-28(23-31(38)54-5)9-10-35(50)48-13-7-6-8-34(48)49/h6,8-10,22-25,29H,7,11-21,26-27H2,1-5H3,(H,43,44,52)/b10-9+",FNMOBNDTZONNKY-MDZDMXLPSA-N
4293,O60885,BRD4,VHL,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCOC1=NOC([C@@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(Cl)C=C3)C(C)C)=C1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCCCCCO,C1=NOC([C@@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)C3=CC=C(Cl)C=C3)C(C)C)=C1)N=C2C1=CC=C(Cl)C=C1,190.0,80.0,0,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,187,ITC,,,,,,,,,,,,,,,,,,,,,,,0.05,Caco-2 A2B assay,16,Caco-2 B2A assay,10.1002/cmdc.202200615,903.934,902.3107577,7.03,62,7,12,3,16,177.07,C45H52Cl2N8O6S,"InChI=1S/C45H52Cl2N8O6S/c1-24(2)39(44(59)54-23-33(56)20-35(54)43(58)49-26(4)29-10-14-31(46)15-11-29)36-22-38(53-61-36)60-19-9-7-8-18-48-37(57)21-34-42-52-51-28(6)55(42)45-40(25(3)27(5)62-45)41(50-34)30-12-16-32(47)17-13-30/h10-17,22,24,26,33-35,39,56H,7-9,18-21,23H2,1-6H3,(H,48,57)(H,49,58)/t26-,33+,34-,35-,39-/m0/s1",MEHBZJQWERYZKL-VBKHBCKHSA-N
4294,O60885,BRD4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(OCCCCCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)=NO3)C(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(,OCCCCCNC(=O)C,[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)=NO3)C(C)C)C=C2)SC=N1,4.0,99.0,1,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6,ITC,,,,,,,,,,,,,,,,,,,,,,,N.D.,Caco-2 A2B assay,N.D.,Caco-2 B2A assay,10.1002/cmdc.202200615,966.631,965.3483502,7.49,67,8,14,3,17,189.96,C49H56ClN9O6S2,"InChI=1S/C49H56ClN9O6S2/c1-26(2)42(48(63)58-24-36(60)21-38(58)47(62)53-28(4)32-11-13-34(14-12-32)45-29(5)52-25-66-45)39-23-41(57-65-39)64-20-10-8-9-19-51-40(61)22-37-46-56-55-31(7)59(46)49-43(27(3)30(6)67-49)44(54-37)33-15-17-35(50)18-16-33/h11-18,23,25-26,28,36-38,42,60H,8-10,19-22,24H2,1-7H3,(H,51,61)(H,53,62)/t28-,36+,37-,38-,42+/m0/s1",KXHYUMQIBXKYPG-KOMHUTCNSA-N
4295,O60885,BRD4,VHL,,,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(Cl)C=C2OCCOCCOCCOCCNC(=O)C[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C(C)C)=C1,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(Cl)C=C2,OCCOCCOCCOCCNC(=O)C,[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C(C)C)=C1,210.0,89.0,0,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,33,ITC,,,,,,,,,,,,,,,,,,,,,,,0.07,Caco-2 A2B assay,20,Caco-2 B2A assay,10.1002/cmdc.202200615,1008.039,1006.358102,5.58,69,7,15,3,22,204.76,C49H60Cl2N8O9S,"InChI=1S/C49H60Cl2N8O9S/c1-27(2)43(41-22-28(3)57-68-41)48(63)58-26-36(60)24-39(58)47(62)53-30(5)37-13-12-35(51)23-40(37)67-21-20-66-19-18-65-17-16-64-15-14-52-42(61)25-38-46-56-55-32(7)59(46)49-44(29(4)31(6)69-49)45(54-38)33-8-10-34(50)11-9-33/h8-13,22-23,27,30,36,38-39,43,60H,14-21,24-26H2,1-7H3,(H,52,61)(H,53,62)/t30-,36+,38-,39-,43+/m0/s1",QMDXZTNQRYGNEC-SKEOZXKHSA-N
4296,O60885,BRD4,VHL,,,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(C)N=CS3)C=C2OCCOCCOCCOCCNC(=O)C[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C(C)C)=C1,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(C)N=CS3)C=C2,OCCOCCOCCOCCNC(=O)C,[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C(C)C)=C1,16.0,82.0,1,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4,ITC,,,,,,,,,,,,,,,,,,,,,,,0.07,Caco-2 A2B assay,11,Caco-2 B2A assay,10.1002/cmdc.202200615,1070.736,1069.395694,6.04,74,8,17,3,23,217.65,C53H64ClN9O9S2,"InChI=1S/C53H64ClN9O9S2/c1-29(2)46(44-23-30(3)61-72-44)52(67)62-27-39(64)25-42(62)51(66)57-32(5)40-14-11-37(49-33(6)56-28-73-49)24-43(40)71-22-21-70-20-19-69-18-17-68-16-15-55-45(65)26-41-50-60-59-35(8)63(50)53-47(31(4)34(7)74-53)48(58-41)36-9-12-38(54)13-10-36/h9-14,23-24,28-29,32,39,41-42,46,64H,15-22,25-27H2,1-8H3,(H,55,65)(H,57,66)/t32-,39+,41-,42-,46+/m0/s1",UIERTIMQQRRSTO-BEDMWFMASA-N
4297,O60885,BRD4,VHL,,,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCNC(=O)C[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C2=CC=C(Cl)C=C2)C(C)C)=C1,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](,CC(=O)NCCCCNC(=O)C,[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C2=CC=C(Cl)C=C2)C(C)C)=C1,190.0,80.0,0,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,63,ITC,,,,,,,,,,,,,,,,,,,,,,,0.06,Caco-2 A2B assay,7.5,Caco-2 B2A assay,10.1002/cmdc.202200615,930.96,929.3216568,5.65,64,7,12,4,16,196.94,C46H53Cl2N9O6S,"InChI=1S/C46H53Cl2N9O6S/c1-24(2)40(37-19-25(3)55-63-37)45(62)56-23-33(58)20-36(56)44(61)52-34(29-9-13-31(47)14-10-29)21-38(59)49-17-7-8-18-50-39(60)22-35-43-54-53-28(6)57(43)46-41(26(4)27(5)64-46)42(51-35)30-11-15-32(48)16-12-30/h9-16,19,24,33-36,40,58H,7-8,17-18,20-23H2,1-6H3,(H,49,59)(H,50,60)(H,52,61)/t33-,34+,35+,36+,40-/m1/s1",STGFOSWNXWQTTP-LADHRSEISA-N
4298,O60885,BRD4,VHL,,,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCOCCOCCNC(=O)C[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C2=CC=C(Cl)C=C2)C(C)C)=C1,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](,CC(=O)NCCOCCOCCNC(=O)C,[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C2=CC=C(Cl)C=C2)C(C)C)=C1,1500.0,100.0,0,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,64,ITC,,,,,,,,,,,,,,,,,,,,,,,0.06,Caco-2 A2B assay,6,Caco-2 B2A assay,10.1002/cmdc.202200615,991.012,989.3427861,4.64,68,7,14,4,20,215.4,C48H57Cl2N9O8S,"InChI=1S/C48H57Cl2N9O8S/c1-26(2)42(39-21-27(3)57-67-39)47(64)58-25-35(60)22-38(58)46(63)54-36(31-7-11-33(49)12-8-31)23-40(61)51-15-17-65-19-20-66-18-16-52-41(62)24-37-45-56-55-30(6)59(45)48-43(28(4)29(5)68-48)44(53-37)32-9-13-34(50)14-10-32/h7-14,21,26,35-38,42,60H,15-20,22-25H2,1-6H3,(H,51,61)(H,52,62)(H,54,63)/t35-,36+,37+,38+,42-/m1/s1",MIHQDVSIMCDUSP-PXYAPSQZSA-N
4299,O60885,BRD4,VHL,,,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCOCCOCCOCCNC(=O)C[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C2=CC=C(Cl)C=C2)C(C)C)=C1,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](,CC(=O)NCCOCCOCCOCCNC(=O)C,[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C2=CC=C(Cl)C=C2)C(C)C)=C1,1100.0,100.0,0,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,43,ITC,,,,,,,,,,,,,,,,,,,,,,,0.04,Caco-2 A2B assay,5.5,Caco-2 B2A assay,10.1002/cmdc.202200615,1035.065,1033.369001,4.49,71,7,15,4,23,224.63,C50H61Cl2N9O9S,"InChI=1S/C50H61Cl2N9O9S/c1-28(2)44(41-23-29(3)59-70-41)49(66)60-27-37(62)24-40(60)48(65)56-38(33-7-11-35(51)12-8-33)25-42(63)53-15-17-67-19-21-69-22-20-68-18-16-54-43(64)26-39-47-58-57-32(6)61(47)50-45(30(4)31(5)71-50)46(55-39)34-9-13-36(52)14-10-34/h7-14,23,28,37-40,44,62H,15-22,24-27H2,1-6H3,(H,53,63)(H,54,64)(H,56,65)/t37-,38+,39+,40+,44-/m1/s1",VPCHZAQARNLMRU-YLIPSVQPSA-N
4300,O60885,BRD4,VHL,,,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCCCNC(=O)C[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](,CC(=O)NCCCCNC(=O)C,[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,320.0,94.0,0,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10,ITC,,,,,,,,,,,,,,,,,,,,,,,0.08,Caco-2 A2B assay,2,Caco-2 B2A assay,10.1002/cmdc.202200615,993.657,992.3592492,6.11,69,8,14,4,17,209.83,C50H57ClN10O6S2,"InChI=1S/C50H57ClN10O6S2/c1-26(2)43(40-20-27(3)59-67-40)49(66)60-24-36(62)21-39(60)48(65)56-37(32-10-12-34(13-11-32)46-29(5)54-25-68-46)22-41(63)52-18-8-9-19-53-42(64)23-38-47-58-57-31(7)61(47)50-44(28(4)30(6)69-50)45(55-38)33-14-16-35(51)17-15-33/h10-17,20,25-26,36-39,43,62H,8-9,18-19,21-24H2,1-7H3,(H,52,63)(H,53,64)(H,56,65)/t36-,37+,38+,39+,43-/m1/s1",KRPIEYYWXMOWMP-CFAWEHKJSA-N
4301,O60885,BRD4,VHL,,,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCOCCOCCNC(=O)C[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](,CC(=O)NCCOCCOCCNC(=O)C,[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,570.0,79.0,0,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,14,ITC,,,,,,,,,,,,,,,,,,,,,,,0.07,Caco-2 A2B assay,2.2,Caco-2 B2A assay,10.1002/cmdc.202200615,1053.709,1052.380379,5.1,73,8,16,4,21,228.29,C52H61ClN10O8S2,"InChI=1S/C52H61ClN10O8S2/c1-28(2)45(42-22-29(3)61-71-42)51(68)62-26-38(64)23-41(62)50(67)58-39(34-8-10-36(11-9-34)48-31(5)56-27-72-48)24-43(65)54-16-18-69-20-21-70-19-17-55-44(66)25-40-49-60-59-33(7)63(49)52-46(30(4)32(6)73-52)47(57-40)35-12-14-37(53)15-13-35/h8-15,22,27-28,38-41,45,64H,16-21,23-26H2,1-7H3,(H,54,65)(H,55,66)(H,58,67)/t38-,39+,40+,41+,45-/m1/s1",PMMBPUFPJGYZDS-NNYWTZBRSA-N
4302,O60885,BRD4,VHL,,,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(=O)NCCOCCOCCOCCNC(=O)C[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](,CC(=O)NCCOCCOCCOCCNC(=O)C,[C@@H]2N=C(C3=CC=C(Cl)C=C3)C3=C(SC(C)=C3C)N3C(C)=NN=C23)C2=CC=C(C3=C(C)N=CS3)C=C2)C(C)C)=C1,560.0,93.0,0,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6,ITC,,,,,,,,,,,,,,,,,,,,,,,0.08,Caco-2 A2B assay,1.8,Caco-2 B2A assay,10.1002/cmdc.202200615,1097.762,1096.406593,4.95,76,8,17,4,24,237.52,C54H65ClN10O9S2,"InChI=1S/C54H65ClN10O9S2/c1-30(2)47(44-24-31(3)63-74-44)53(70)64-28-40(66)25-43(64)52(69)60-41(36-8-10-38(11-9-36)50-33(5)58-29-75-50)26-45(67)56-16-18-71-20-22-73-23-21-72-19-17-57-46(68)27-42-51-62-61-35(7)65(51)54-48(32(4)34(6)76-54)49(59-42)37-12-14-39(55)15-13-37/h8-15,24,29-30,40-43,47,66H,16-23,25-28H2,1-7H3,(H,56,67)(H,57,68)(H,60,69)/t40-,41+,42+,43+,47-/m1/s1",COKARWVIPXUBBF-RBFTVJCPSA-N
4303,O60885,BRD4,VHL,,,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(C#CCOCCOCCOCCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=CS3)C=C2)C(C)C)=C1,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(,C#CCOCCOCCOCCNC(=O)C,[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=CS3)C=C2)C(C)C)=C1,16.0,98.0,1,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8,ITC,,,,,,,,,,,,,,,,,,,,,,,0.06,Caco-2 A2B assay,8.9,Caco-2 B2A assay,10.1002/cmdc.202200615,1050.705,1049.36948,5.9,73,8,16,3,20,208.42,C53H60ClN9O8S2,"InChI=1S/C53H60ClN9O8S2/c1-30(2)46(44-25-31(3)61-71-44)52(67)62-28-40(64)26-43(62)51(66)57-33(5)36-10-12-38(13-11-36)49-41(56-29-72-49)9-8-19-68-21-23-70-24-22-69-20-18-55-45(65)27-42-50-60-59-35(7)63(50)53-47(32(4)34(6)73-53)48(58-42)37-14-16-39(54)17-15-37/h10-17,25,29-30,33,40,42-43,46,64H,18-24,26-28H2,1-7H3,(H,55,65)(H,57,66)/t33-,40+,42-,43-,46+/m0/s1",WUYXNOSTUQQLBT-RXJHFLANSA-N
4304,O60885,BRD4,VHL,,,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(C#CCOCCOCCOCCOCCNC(=O)C[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=CS3)C=C2)C(C)C)=C1,CC1=NOC([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](C)C2=CC=C(C3=C(,C#CCOCCOCCOCCOCCNC(=O)C,[C@@H]4N=C(C5=CC=C(Cl)C=C5)C5=C(SC(C)=C5C)N5C(C)=NN=C45)N=CS3)C=C2)C(C)C)=C1,40.0,100.0,1,Degradation of BRD4 in A549 cells after 4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4,ITC,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1002/cmdc.202200615,1094.758,1093.395694,5.75,76,8,17,3,23,217.65,C55H64ClN9O9S2,"InChI=1S/C55H64ClN9O9S2/c1-32(2)48(46-27-33(3)63-74-46)54(69)64-30-42(66)28-45(64)53(68)59-35(5)38-10-12-40(13-11-38)51-43(58-31-75-51)9-8-19-70-21-23-72-25-26-73-24-22-71-20-18-57-47(67)29-44-52-62-61-37(7)65(52)55-49(34(4)36(6)76-55)50(60-44)39-14-16-41(56)17-15-39/h10-17,27,31-32,35,42,44-45,48,66H,18-26,28-30H2,1-7H3,(H,57,67)(H,59,68)/t35-,42+,44-,45-,48+/m0/s1",YLFPZGFBGPLUOM-YIFYIKBSSA-N
4308,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NC1CCN(C(=O)COC3=CC=CC(N4CCC(=O)NC4=O)=C3C)CC1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NC,1CCN(C(=O)COC3=CC=CC(N4CCC(=O)NC4=O)=C3C)CC1)N=C2C1=CC=C(Cl)C=C1,0.022,97.0,1,Degradation of BRD4 in MV4; 11 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01941,743.29,742.245265,4.08,52,7,10,2,8,151.12,C37H39ClN8O5S,"InChI=1S/C37H39ClN8O5S/c1-20-22(3)52-36-33(20)34(24-8-10-25(38)11-9-24)40-27(35-43-42-23(4)46(35)36)18-31(48)39-26-12-15-44(16-13-26)32(49)19-51-29-7-5-6-28(21(29)2)45-17-14-30(47)41-37(45)50/h5-11,26-27H,12-19H2,1-4H3,(H,39,48)(H,41,47,50)/t27-/m0/s1",RGTZCSFQBVIJHW-MHZLTWQESA-N
4321,P42229,STAT5,CRBN,,,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(Br)C=C1,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(,CCC(=O)NCCCC#C,C1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(Br)C=C1,230.0,95.0,0,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1051.901,1050.219818,5.07,69,7,9,5,14,222.83,C48H50BrF2N6O10PS,"InChI=1S/C48H50BrF2N6O10PS/c1-47(2,3)41(54-43(61)38-26-29-25-30(13-19-37(29)69-38)48(50,51)68(65,66)67)46(64)56-23-8-12-36(56)45(63)55(32-16-14-31(49)15-17-32)24-21-39(58)52-22-6-4-5-9-28-10-7-11-33-34(28)27-57(44(33)62)35-18-20-40(59)53-42(35)60/h7,10-11,13-17,19,25-26,35-36,41H,4,6,8,12,18,20-24,27H2,1-3H3,(H,52,58)(H,54,61)(H,53,59,60)(H2,65,66,67)/t35?,36-,41+/m0/s1",LKAGUNLLLAEGQP-DCCNWUIXSA-N
4321,P42229,STAT5,CRBN,,AK-021,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(Br)C=C1,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(,CCC(=O)NCCCC#C,C1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(Br)C=C1,500.0,95.0,0,Degradation of STAT5 in KU812 CML cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-022-01248-4,1051.901,1050.219818,5.07,69,7,9,5,14,222.83,C48H50BrF2N6O10PS,"InChI=1S/C48H50BrF2N6O10PS/c1-47(2,3)41(54-43(61)38-26-29-25-30(13-19-37(29)69-38)48(50,51)68(65,66)67)46(64)56-23-8-12-36(56)45(63)55(32-16-14-31(49)15-17-32)24-21-39(58)52-22-6-4-5-9-28-10-7-11-33-34(28)27-57(44(33)62)35-18-20-40(59)53-42(35)60/h7,10-11,13-17,19,25-26,35-36,41H,4,6,8,12,18,20-24,27H2,1-3H3,(H,52,58)(H,54,61)(H,53,59,60)(H2,65,66,67)/t35?,36-,41+/m0/s1",LKAGUNLLLAEGQP-DCCNWUIXSA-N
4325,P42229,STAT5,CRBN,,,CN(CCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C(=O)CCN(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(C)(C)C)C1=CC=C(Br)C=C1,CN(CCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O),C(=O)CCN(C(=O),[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(C)(C)C)C1=CC=C(Br)C=C1,190.0,95.0,0,Degradation of STAT5 in SKNO1 cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01665,1065.928,1064.235468,5.25,70,7,9,4,14,214.04,C49H52BrF2N6O10PS,"InChI=1S/C49H52BrF2N6O10PS/c1-48(2,3)42(54-44(62)39-27-30-26-31(14-20-38(30)70-39)49(51,52)69(66,67)68)47(65)57-24-9-13-37(57)46(64)56(33-17-15-32(50)16-18-33)25-22-41(60)55(4)23-7-5-6-10-29-11-8-12-34-35(29)28-58(45(34)63)36-19-21-40(59)53-43(36)61/h8,11-12,14-18,20,26-27,36-37,42H,5,7,9,13,19,21-25,28H2,1-4H3,(H,54,62)(H,53,59,61)(H2,66,67,68)/t36?,37-,42+/m0/s1",LMDQPXIZTVECEI-KUYIJJHHSA-N
4325,P42229,STAT5,CRBN,,AK-027,CN(CCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C(=O)CCN(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(C)(C)C)C1=CC=C(Br)C=C1,CN(CCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O),C(=O)CCN(C(=O),[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(C)(C)C)C1=CC=C(Br)C=C1,380.0,95.0,0,Degradation of STAT5 in KU812 CML cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-022-01248-4,1065.928,1064.235468,5.25,70,7,9,4,14,214.04,C49H52BrF2N6O10PS,"InChI=1S/C49H52BrF2N6O10PS/c1-48(2,3)42(54-44(62)39-27-30-26-31(14-20-38(30)70-39)49(51,52)69(66,67)68)47(65)57-24-9-13-37(57)46(64)56(33-17-15-32(50)16-18-33)25-22-41(60)55(4)23-7-5-6-10-29-11-8-12-34-35(29)28-58(45(34)63)36-19-21-40(59)53-43(36)61/h8,11-12,14-18,20,26-27,36-37,42H,5,7,9,13,19,21-25,28H2,1-4H3,(H,54,62)(H,53,59,61)(H2,66,67,68)/t36?,37-,42+/m0/s1",LMDQPXIZTVECEI-KUYIJJHHSA-N
4343,P42229,STAT5,CRBN,,AK-028,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(CCC(=O)NCCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(C2=NC=CS2)C=C1,CC(C)(C)[C@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(=O)N1CCC[C@H]1C(=O)N(,CCC(=O)NCCCC#C,C1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C1=CC=C(C2=NC=CS2)C=C1,400.0,95.0,0,Degradation of STAT5 in KU812 CML cells after 18h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-022-01248-4,1056.12,1055.292276,5.07,73,8,11,5,15,235.72,C51H52F2N7O10PS2,"InChI=1S/C51H52F2N7O10PS2/c1-50(2,3)43(57-45(64)40-28-32-27-33(15-19-39(32)73-40)51(52,53)71(68,69)70)49(67)59-24-8-12-38(59)48(66)58(34-16-13-31(14-17-34)46-55-23-26-72-46)25-21-41(61)54-22-6-4-5-9-30-10-7-11-35-36(30)29-60(47(35)65)37-18-20-42(62)56-44(37)63/h7,10-11,13-17,19,23,26-28,37-38,43H,4,6,8,12,18,20-22,24-25,29H2,1-3H3,(H,54,61)(H,57,64)(H,56,62,63)(H2,68,69,70)/t37?,38-,43+/m0/s1",WUADASPIHZQGRY-WZPNQEGDSA-N
4355,P42229,STAT5,CRBN,,AK-2292,CN(CCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C(=O)CCN(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(C)(C)C)C1=CC=C(C2=NC=CS2)C=C1,CN(CCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O),C(=O)CCN(C(=O),[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(C)(C)C)C1=CC=C(C2=NC=CS2)C=C1,160.0,95.0,0,Degradation of STAT5 in KU812/PBMC cells after 18h treatment,,,,,,,,,500.0,Binding affinity of STAT5A,,,,,,,,,,,,,,,170.0,Binding affinity of CRBN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.06,Caco-2 A2B assay,0.09,Caco-2 B2A assay,10.1038/s41589-022-01248-4,1070.147,1069.307926,5.25,74,8,11,4,15,226.93,C52H54F2N7O10PS2,"InChI=1S/C52H54F2N7O10PS2/c1-51(2,3)44(57-46(65)41-29-33-28-34(16-20-40(33)74-41)52(53,54)72(69,70)71)50(68)60-25-9-13-39(60)49(67)59(35-17-14-32(15-18-35)47-55-23-27-73-47)26-22-43(63)58(4)24-7-5-6-10-31-11-8-12-36-37(31)30-61(48(36)66)38-19-21-42(62)56-45(38)64/h8,11-12,14-18,20,23,27-29,38-39,44H,5,7,9,13,19,21-22,24-26,30H2,1-4H3,(H,57,65)(H,56,62,64)(H2,69,70,71)/t38?,39-,44+/m0/s1",LOPYPDQOHNOVBM-QOIUHGAOSA-N
4355,P51692,STAT5B,CRBN,,AK-2292,CN(CCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O)C(=O)CCN(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(C)(C)C)C1=CC=C(C2=NC=CS2)C=C1,CN(CCCC#CC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O),C(=O)CCN(C(=O),[C@@H]1CCCN1C(=O)[C@@H](NC(=O)C1=CC2=CC(C(F)(F)P(=O)(O)O)=CC=C2S1)C(C)(C)C)C1=CC=C(C2=NC=CS2)C=C1,110.0,95.0,0,Degradation of STAT5 in KU812/PBMC cells after 18h treatment,,,,,,,,,200.0,Binding affinity of STAT5B,,,,,,,,,,,,,,,170.0,Binding affinity of CRBN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41589-022-01248-4,1070.147,1069.307926,5.25,74,8,11,4,15,226.93,C52H54F2N7O10PS2,"InChI=1S/C52H54F2N7O10PS2/c1-51(2,3)44(57-46(65)41-29-33-28-34(16-20-40(33)74-41)52(53,54)72(69,70)71)50(68)60-25-9-13-39(60)49(67)59(35-17-14-32(15-18-35)47-55-23-27-73-47)26-22-43(63)58(4)24-7-5-6-10-31-11-8-12-36-37(31)30-61(48(36)66)38-19-21-42(62)56-45(38)64/h8,11-12,14-18,20,23,27-29,38-39,44H,5,7,9,13,19,21-22,24-26,30H2,1-4H3,(H,57,65)(H,56,62,64)(H2,69,70,71)/t38?,39-,44+/m0/s1",LOPYPDQOHNOVBM-QOIUHGAOSA-N
4359,P00918,CA2,CRBN,,,NS(=O)(=O)C1=CC=C(C(=O)NCCCOCCCCOCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,NS(=O)(=O)C1=CC=C(,C(=O)NCCCOCCCCOCCCN,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,5.0,96.0,1,Degradation of hCAII in HEK293 cells after 24h treatment,,,<20,Inhibit of hCA2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01843,643.719,643.2311988,1.33,45,4,10,4,17,203.3,C30H37N5O9S,"InChI=1S/C30H37N5O9S/c31-45(41,42)21-10-8-20(9-11-21)27(37)33-15-5-19-44-17-2-1-16-43-18-4-14-32-23-7-3-6-22-26(23)30(40)35(29(22)39)24-12-13-25(36)34-28(24)38/h3,6-11,24,32H,1-2,4-5,12-19H2,(H,33,37)(H2,31,41,42)(H,34,36,38)",RBECNOZCCFLMDH-UHFFFAOYSA-N
4360,P00918,CA2,CRBN,,,NS(=O)(=O)C1=CC=C(C(=O)NCCCOCCOCCOCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,NS(=O)(=O)C1=CC=C(,C(=O)NCCCOCCOCCOCCCN,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,245.0,86.0,0,Degradation of hCAII in HEK293 cells after 24h treatment,,,<20,Inhibit of hCA2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01843,659.718,659.2261134,0.47,46,4,11,4,18,212.53,C30H37N5O10S,"InChI=1S/C30H37N5O10S/c31-46(41,42)21-8-6-20(7-9-21)27(37)33-13-3-15-44-17-19-45-18-16-43-14-2-12-32-23-5-1-4-22-26(23)30(40)35(29(22)39)24-10-11-25(36)34-28(24)38/h1,4-9,24,32H,2-3,10-19H2,(H,33,37)(H2,31,41,42)(H,34,36,38)",QQTRJZGGTODEON-UHFFFAOYSA-N
4361,P00918,CA2,CRBN,,,NS(=O)(=O)C1=CC=C(C(=O)NCCCCCCCCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,NS(=O)(=O)C1=CC=C(,C(=O)NCCCCCCCCCCCCN,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)C=C1,0.5,100.0,1,Degradation of hCAII in HEK293 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01843,639.775,639.2726697,4.88,45,4,8,4,17,184.84,C32H41N5O7S,"InChI=1S/C32H41N5O7S/c33-45(43,44)23-16-14-22(15-17-23)29(39)35-21-10-8-6-4-2-1-3-5-7-9-20-34-25-13-11-12-24-28(25)32(42)37(31(24)41)26-18-19-27(38)36-30(26)40/h11-17,26,34H,1-10,18-21H2,(H,35,39)(H2,33,43,44)(H,36,38,40)",AZBRPAQQOMDJLZ-UHFFFAOYSA-N
4401,P08581,c-Met,CRBN,,PRO-6E,C[C@@H](OC1=CC(C2=CN(C3CCN(C(=O)CCCCCCCOC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)N=C2)=CN=C1N)C1=C(Cl)C=CC(F)=C1Cl,C[C@@H](OC1=CC(C2=CN(C3CCN(,C(=O)CCCCCCCO,C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)N=C2)=CN=C1N)C1=C(Cl)C=CC(F)=C1Cl,203.0,82.8,0,Degradation of MET in MKN-45 cells after 48h treatment,,,,,,,5380,Binding affinity of MET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,347,Inhibition of cell proliferation of MKN-45 cells for 72h,,,,,,,,,,,,,,,10.1111/cas.15733,848.76,847.2663303,5.58,59,7,11,2,15,179.05,C42H44Cl2FN7O7,"InChI=1S/C42H44Cl2FN7O7/c1-24(36-29(43)11-12-30(45)38(36)44)59-33-20-25(21-47-39(33)46)26-22-48-51(23-26)27-15-17-50(18-16-27)35(54)10-5-3-2-4-6-19-58-32-9-7-8-28-37(32)42(57)52(41(28)56)31-13-14-34(53)49-40(31)55/h7-9,11-12,20-24,27,31H,2-6,10,13-19H2,1H3,(H2,46,47)(H,49,53,55)/t24-,31?/m1/s1",JSQFSAUVTNADLF-LZDHLTRGSA-N
4507,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCN,3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,10000.0,0.0,0,Degradation of NAMPT in A2780 cells after 24h treatment,,,120,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,930.211,929.4291874,4.34,65,6,11,5,18,206.27,C47H63N9O7S2,"InChI=1S/C47H63N9O7S2/c1-32(35-13-15-36(16-14-35)42-33(2)50-31-64-42)51-44(59)40-27-38(57)30-56(40)45(60)43(47(3,4)5)53-41(58)12-8-6-7-9-22-54-23-25-55(26-24-54)65(62,63)39-19-17-37(18-20-39)52-46(61)49-29-34-11-10-21-48-28-34/h10-11,13-21,28,31-32,38,40,43,57H,6-9,12,22-27,29-30H2,1-5H3,(H,51,59)(H,53,58)(H2,49,52,61)/t32-,38+,40-,43+/m0/s1",XWTKYEZDEXRCBK-RVCBHFSWSA-N
4508,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCN,3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,101.0,0.0,0,Degradation of NAMPT in A2780 cells after 24h treatment,,,100,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.9,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,944.238,943.4448374,4.88,66,6,11,5,19,206.27,C48H65N9O7S2,"InChI=1S/C48H65N9O7S2/c1-33(36-14-16-37(17-15-36)43-34(2)51-32-65-43)52-45(60)41-28-39(58)31-57(41)46(61)44(48(3,4)5)54-42(59)13-9-7-6-8-10-23-55-24-26-56(27-25-55)66(63,64)40-20-18-38(19-21-40)53-47(62)50-30-35-12-11-22-49-29-35/h11-12,14-22,29,32-33,39,41,44,58H,6-10,13,23-28,30-31H2,1-5H3,(H,52,60)(H,54,59)(H2,50,53,62)/t33-,39+,41-,44+/m0/s1",QUQLWEYDHCPEGN-QYMKNGPYSA-N
4509,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCN,3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,0.17,93.0,1,Degradation of NAMPT in A2780 cells after 24h treatment,,,150,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,958.265,957.4604875,5.43,67,6,11,5,20,206.27,C49H67N9O7S2,"InChI=1S/C49H67N9O7S2/c1-34(37-15-17-38(18-16-37)44-35(2)52-33-66-44)53-46(61)42-29-40(59)32-58(42)47(62)45(49(3,4)5)55-43(60)14-10-8-6-7-9-11-24-56-25-27-57(28-26-56)67(64,65)41-21-19-39(20-22-41)54-48(63)51-31-36-13-12-23-50-30-36/h12-13,15-23,30,33-34,40,42,45,59H,6-11,14,24-29,31-32H2,1-5H3,(H,53,61)(H,55,60)(H2,51,54,63)/t34-,40+,42-,45+/m0/s1",OFDVMTIVOGMTRU-CZSAYBOZSA-N
4510,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCCN,3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,1.5,92.0,1,Degradation of NAMPT in A2780 cells after 24h treatment,,,190,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,972.292,971.4761375,5.97,68,6,11,5,21,206.27,C50H69N9O7S2,"InChI=1S/C50H69N9O7S2/c1-35(38-16-18-39(19-17-38)45-36(2)53-34-67-45)54-47(62)43-30-41(60)33-59(43)48(63)46(50(3,4)5)56-44(61)15-11-9-7-6-8-10-12-25-57-26-28-58(29-27-57)68(65,66)42-22-20-40(21-23-42)55-49(64)52-32-37-14-13-24-51-31-37/h13-14,16-24,31,34-35,41,43,46,60H,6-12,15,25-30,32-33H2,1-5H3,(H,54,62)(H,56,61)(H2,52,55,64)/t35-,41+,43-,46+/m0/s1",FWVYIAMLXGSLBA-ACVSEINWSA-N
4511,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCCCN,3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,4.6,70.0,0,Degradation of NAMPT in A2780 cells after 24h treatment,,,230,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,30,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,986.319,985.4917876,6.51,69,6,11,5,22,206.27,C51H71N9O7S2,"InChI=1S/C51H71N9O7S2/c1-36(39-17-19-40(20-18-39)46-37(2)54-35-68-46)55-48(63)44-31-42(61)34-60(44)49(64)47(51(3,4)5)57-45(62)16-12-10-8-6-7-9-11-13-26-58-27-29-59(30-28-58)69(66,67)43-23-21-41(22-24-43)56-50(65)53-33-38-15-14-25-52-32-38/h14-15,17-25,32,35-36,42,44,47,61H,6-13,16,26-31,33-34H2,1-5H3,(H,55,63)(H,57,62)(H2,53,56,65)/t36-,42+,44-,47+/m0/s1",UVIVLGHOUAQSRA-MFUWQLKVSA-N
4512,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCCCCN,3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,2.4,98.0,1,Degradation of NAMPT in A2780 cells after 24h treatment,,,310,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,30,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,1000.346,999.5074377,7.05,70,6,11,5,23,206.27,C52H73N9O7S2,"InChI=1S/C52H73N9O7S2/c1-37(40-18-20-41(21-19-40)47-38(2)55-36-69-47)56-49(64)45-32-43(62)35-61(45)50(65)48(52(3,4)5)58-46(63)17-13-11-9-7-6-8-10-12-14-27-59-28-30-60(31-29-59)70(67,68)44-24-22-42(23-25-44)57-51(66)54-34-39-16-15-26-53-33-39/h15-16,18-26,33,36-37,43,45,48,62H,6-14,17,27-32,34-35H2,1-5H3,(H,56,64)(H,58,63)(H2,54,57,66)/t37-,43+,45-,48+/m0/s1",ULJQYAQDSOFCIJ-OFXOIJPASA-N
4513,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCN,3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,101.0,0.0,0,Degradation of NAMPT in A2780 cells after 24h treatment,,,160,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5512,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,904.129,903.3771518,2.68,63,6,12,5,16,215.5,C44H57N9O8S2,"InChI=1S/C44H57N9O8S2/c1-29(32-8-10-33(11-9-32)39-30(2)47-28-62-39)48-41(56)37-23-35(54)26-53(37)42(57)40(44(3,4)5)50-38(55)27-61-22-21-51-17-19-52(20-18-51)63(59,60)36-14-12-34(13-15-36)49-43(58)46-25-31-7-6-16-45-24-31/h6-16,24,28-29,35,37,40,54H,17-23,25-27H2,1-5H3,(H,48,56)(H,50,55)(H2,46,49,58)/t29-,35+,37-,40+/m0/s1",FZHPTHJRGGLHBL-QUOGVQPDSA-N
4514,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCN,3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,101.0,0.0,0,Degradation of NAMPT in A2780 cells after 24h treatment,,,150,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1227,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,948.182,947.4033665,2.53,66,6,13,5,19,224.73,C46H61N9O9S2,"InChI=1S/C46H61N9O9S2/c1-31(34-8-10-35(11-9-34)41-32(2)49-30-65-41)50-43(58)39-25-37(56)28-55(39)44(59)42(46(3,4)5)52-40(57)29-64-24-23-63-22-21-53-17-19-54(20-18-53)66(61,62)38-14-12-36(13-15-38)51-45(60)48-27-33-7-6-16-47-26-33/h6-16,26,30-31,37,39,42,56H,17-25,27-29H2,1-5H3,(H,50,58)(H,52,57)(H2,48,51,60)/t31-,37+,39-,42+/m0/s1",HKOMBGDHYJAELG-XMJUXVDFSA-N
4515,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCCN,3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,93.0,83.0,1,Degradation of NAMPT in A2780 cells after 24h treatment,,,130,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,56,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,992.235,991.4295813,2.38,69,6,14,5,22,233.96,C48H65N9O10S2,"InChI=1S/C48H65N9O10S2/c1-33(36-8-10-37(11-9-36)43-34(2)51-32-68-43)52-45(60)41-27-39(58)30-57(41)46(61)44(48(3,4)5)54-42(59)31-67-26-25-66-24-23-65-22-21-55-17-19-56(20-18-55)69(63,64)40-14-12-38(13-15-40)53-47(62)50-29-35-7-6-16-49-28-35/h6-16,28,32-33,39,41,44,58H,17-27,29-31H2,1-5H3,(H,52,60)(H,54,59)(H2,50,53,62)/t33-,39+,41-,44+/m0/s1",MDJQPVDBUJDBNX-QYMKNGPYSA-N
4516,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCCOCCN,3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,19.0,92.0,1,Degradation of NAMPT in A2780 cells after 24h treatment,,,130,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,173,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,1036.288,1035.455796,2.24,72,6,15,5,25,243.19,C50H69N9O11S2,"InChI=1S/C50H69N9O11S2/c1-35(38-8-10-39(11-9-38)45-36(2)53-34-71-45)54-47(62)43-29-41(60)32-59(43)48(63)46(50(3,4)5)56-44(61)33-70-28-27-69-26-25-68-24-23-67-22-21-57-17-19-58(20-18-57)72(65,66)42-14-12-40(13-15-42)55-49(64)52-31-37-7-6-16-51-30-37/h6-16,30,34-35,41,43,46,60H,17-29,31-33H2,1-5H3,(H,54,62)(H,56,61)(H2,52,55,64)/t35-,41+,43-,46+/m0/s1",NVLIYOBRPUSFFX-ACVSEINWSA-N
4517,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOCCN3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCCOCCOCCN,3CCN(S(=O)(=O)C4=CC=C(NC(=O)NCC5=CC=CN=C5)C=C4)CC3)C(C)(C)C)C=C2)SC=N1,22.0,90.0,1,Degradation of NAMPT in A2780 cells after 24h treatment,,,190,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,133,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,1080.341,1079.482011,2.09,75,6,16,5,28,252.42,C52H73N9O12S2,"InChI=1S/C52H73N9O12S2/c1-37(40-8-10-41(11-9-40)47-38(2)55-36-74-47)56-49(64)45-31-43(62)34-61(45)50(65)48(52(3,4)5)58-46(63)35-73-30-29-72-28-27-71-26-25-70-24-23-69-22-21-59-17-19-60(20-18-59)75(67,68)44-14-12-42(13-15-44)57-51(66)54-33-39-7-6-16-53-32-39/h6-16,32,36-37,43,45,48,62H,17-31,33-35H2,1-5H3,(H,56,64)(H,58,63)(H2,54,57,66)/t37-,43+,45-,48+/m0/s1",XRLBKHJZDZFNAM-OFXOIJPASA-N
4518,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCN3C=C(CCN4CCN(S(=O)(=O)C5=CC=C(NC(=O)NCC6=CC=CN=C6)C=C5)CC4)N=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCC,N3C=C(CCN4CCN(S(=O)(=O)C5=CC=C(NC(=O)NCC6=CC=CN=C6)C=C5)CC4)N=N3)C(C)(C)C)C=C2)SC=N1,500.0,91.0,0,Degradation of NAMPT in A2780 cells after 24h treatment,,,120,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,433,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,999.234,998.4254989,2.37,70,7,15,5,19,246.21,C48H62N12O8S2,"InChI=1S/C48H62N12O8S2/c1-32(35-8-10-36(11-9-35)43-33(2)51-31-69-43)52-45(63)41-25-39(61)29-60(41)46(64)44(48(3,4)5)54-42(62)30-68-24-23-58-28-38(55-56-58)16-18-57-19-21-59(22-20-57)70(66,67)40-14-12-37(13-15-40)53-47(65)50-27-34-7-6-17-49-26-34/h6-15,17,26,28,31-32,39,41,44,61H,16,18-25,27,29-30H2,1-5H3,(H,52,63)(H,54,62)(H2,50,53,65)/t32-,39+,41-,44+/m0/s1",IOAUOUBJRZKDGR-YBQSWKSMSA-N
4519,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCN3C=C(CCN4CCN(S(=O)(=O)C5=CC=C(NC(=O)NCC6=CC=CN=C6)C=C5)CC4)N=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCC,N3C=C(CCN4CCN(S(=O)(=O)C5=CC=C(NC(=O)NCC6=CC=CN=C6)C=C5)CC4)N=N3)C(C)(C)C)C=C2)SC=N1,500.0,87.0,0,Degradation of NAMPT in A2780 cells after 24h treatment,,,190,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,737,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,1043.287,1042.451714,2.22,73,7,16,5,22,255.44,C50H66N12O9S2,"InChI=1S/C50H66N12O9S2/c1-34(37-8-10-38(11-9-37)45-35(2)53-33-72-45)54-47(65)43-27-41(63)31-62(43)48(66)46(50(3,4)5)56-44(64)32-71-26-25-70-24-23-60-30-40(57-58-60)16-18-59-19-21-61(22-20-59)73(68,69)42-14-12-39(13-15-42)55-49(67)52-29-36-7-6-17-51-28-36/h6-15,17,28,30,33-34,41,43,46,63H,16,18-27,29,31-32H2,1-5H3,(H,54,65)(H,56,64)(H2,52,55,67)/t34-,41+,43-,46+/m0/s1",ZOJKJHCLSCQUOK-TZYAYNJLSA-N
4520,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCN3C=C(CCN4CCN(S(=O)(=O)C5=CC=C(NC(=O)NCC6=CC=CN=C6)C=C5)CC4)N=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCC,N3C=C(CCN4CCN(S(=O)(=O)C5=CC=C(NC(=O)NCC6=CC=CN=C6)C=C5)CC4)N=N3)C(C)(C)C)C=C2)SC=N1,500.0,97.0,0,Degradation of NAMPT in A2780 cells after 24h treatment,,,94,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,487,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,1087.34,1086.477928,2.08,76,7,17,5,25,264.67,C52H70N12O10S2,"InChI=1S/C52H70N12O10S2/c1-36(39-8-10-40(11-9-39)47-37(2)55-35-75-47)56-49(67)45-29-43(65)33-64(45)50(68)48(52(3,4)5)58-46(66)34-74-28-27-73-26-25-72-24-23-62-32-42(59-60-62)16-18-61-19-21-63(22-20-61)76(70,71)44-14-12-41(13-15-44)57-51(69)54-31-38-7-6-17-53-30-38/h6-15,17,30,32,35-36,43,45,48,65H,16,18-29,31,33-34H2,1-5H3,(H,56,67)(H,58,66)(H2,54,57,69)/t36-,43+,45-,48+/m0/s1",HHLYGKNZIUCQMF-YPVOJFEDSA-N
4521,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCN3C=C(CCN4CCN(S(=O)(=O)C5=CC=C(NC(=O)NCC6=CC=CN=C6)C=C5)CC4)N=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCCOCC,N3C=C(CCN4CCN(S(=O)(=O)C5=CC=C(NC(=O)NCC6=CC=CN=C6)C=C5)CC4)N=N3)C(C)(C)C)C=C2)SC=N1,500.0,84.0,0,Degradation of NAMPT in A2780 cells after 24h treatment,,,83,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,401,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,1131.393,1130.504143,1.93,79,7,18,5,28,273.9,C54H74N12O11S2,"InChI=1S/C54H74N12O11S2/c1-38(41-8-10-42(11-9-41)49-39(2)57-37-78-49)58-51(69)47-31-45(67)35-66(47)52(70)50(54(3,4)5)60-48(68)36-77-30-29-76-28-27-75-26-25-74-24-23-64-34-44(61-62-64)16-18-63-19-21-65(22-20-63)79(72,73)46-14-12-43(13-15-46)59-53(71)56-33-40-7-6-17-55-32-40/h6-15,17,32,34,37-38,45,47,50,67H,16,18-31,33,35-36H2,1-5H3,(H,58,69)(H,60,68)(H2,56,59,71)/t38-,45+,47-,50+/m0/s1",PPXNGQMBEYFGAO-ZLVPICEKSA-N
4522,P43490,NAMPT,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOCCN3C=C(CCN4CCN(S(=O)(=O)C5=CC=C(NC(=O)NCC6=CC=CN=C6)C=C5)CC4)N=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCCOCCOCC,N3C=C(CCN4CCN(S(=O)(=O)C5=CC=C(NC(=O)NCC6=CC=CN=C6)C=C5)CC4)N=N3)C(C)(C)C)C=C2)SC=N1,500.0,80.0,0,Degradation of NAMPT in A2780 cells after 24h treatment,,,970,Inhibit of NAMPT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,477,Inhibition of cell proliferation of A2780 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01990,1175.446,1174.530358,1.78,82,7,19,5,31,283.13,C56H78N12O12S2,"InChI=1S/C56H78N12O12S2/c1-40(43-8-10-44(11-9-43)51-41(2)59-39-81-51)60-53(71)49-33-47(69)37-68(49)54(72)52(56(3,4)5)62-50(70)38-80-32-31-79-30-29-78-28-27-77-26-25-76-24-23-66-36-46(63-64-66)16-18-65-19-21-67(22-20-65)82(74,75)48-14-12-45(13-15-48)61-55(73)58-35-42-7-6-17-57-34-42/h6-15,17,34,36,39-40,47,49,52,69H,16,18-33,35,37-38H2,1-5H3,(H,60,71)(H,62,70)(H2,58,61,73)/t40-,47+,49-,52+/m0/s1",WGKKCFYLKUUWSZ-YUNFSWSQSA-N
4550,O14965,AURKA,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(OCCOCCOCCOCCNC(=O)[C@]4(CC5=CC=CC(NC6=NC=CS6)=N5)CC[C@@H](OC5=CC=CC(Cl)=C5F)CC4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(,OCCOCCOCCOCCNC(=O),[C@]4(CC5=CC=CC(NC6=NC=CS6)=N5)CC[C@@H](OC5=CC=CC(Cl)=C5F)CC4)=C3C2=O)C(=O)N1,3.9,89.0,1,Degradation of AURKA in NGP cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.115033,893.391,892.2668686,4.58,62,7,14,3,21,196.61,C43H46ClFN6O10S,"InChI=1S/C43H46ClFN6O10S/c44-30-6-3-8-33(37(30)45)61-28-12-14-43(15-13-28,26-27-4-1-9-34(48-27)49-42-47-17-25-62-42)41(56)46-16-18-57-19-20-58-21-22-59-23-24-60-32-7-2-5-29-36(32)40(55)51(39(29)54)31-10-11-35(52)50-38(31)53/h1-9,17,25,28,31H,10-16,18-24,26H2,(H,46,56)(H,47,48,49)(H,50,52,53)/t28-,31?,43-",YDRHAKKUUAJFHB-YCDNTZAYSA-N
4564,Q13547,HDAC1,VHL,,JMC-137,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCN3C=C(CCCOC(=O)NCC4=CC=C(C(=O)NC5=CC=CC=C5N)C=C4)N=N3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCC,N3C=C(CCCOC(=O)NCC4=CC=C(C(=O)NC5=CC=CC=C5N)C=C4)N=N3)C(C)(C)C)C=C2)SC=N1,2840.0,62.0,0,Degradation of HDAC 1 in HCT116 cells after 24h treatment,,,1040,Inhibit of HDAC1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/d2md00199c,977.246,976.4993155,6.9,70,6,13,6,24,235.79,C52H68N10O7S,"InChI=1S/C52H68N10O7S/c1-35-46(70-34-56-35)38-23-19-36(20-24-38)30-54-49(66)44-29-41(63)33-62(44)50(67)47(52(2,3)4)58-45(64)18-10-8-6-5-7-9-13-27-61-32-40(59-60-61)15-14-28-69-51(68)55-31-37-21-25-39(26-22-37)48(65)57-43-17-12-11-16-42(43)53/h11-12,16-17,19-26,32,34,41,44,47,63H,5-10,13-15,18,27-31,33,53H2,1-4H3,(H,54,66)(H,55,68)(H,57,65)(H,58,64)/t41-,44+,47-/m1/s1",HWEFEZUTECUWNS-IIWOMYBWSA-N
4567,O60885,BRD4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)C3C[C@@H](O)CN3C(=O)[C@H](NC(=O)COCCOCCOCCNC(=O)C[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](C)NC(=O)C3C[C@@H](O)CN3C(=O)[C@H](,NC(=O)COCCOCCOCCNC(=O)C,[C@@H]3N=C(C4=CC=C(Cl)C=C4)C4=C(SC(C)=C4C)N4C(C)=NN=C34)C(C)(C)C)C=C2)SC=N1,31.23,77.47,0,Degradation of BRD4 in MCF-7 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.2c10177,1016.688,1015.38513,5.37,70,7,15,4,20,211.49,C50H62ClN9O8S2,"InChI=1S/C50H62ClN9O8S2/c1-28-31(4)70-49-42(28)43(34-13-15-36(51)16-14-34)55-38(46-58-57-32(5)60(46)49)24-40(62)52-17-18-66-19-20-67-21-22-68-26-41(63)56-45(50(6,7)8)48(65)59-25-37(61)23-39(59)47(64)54-29(2)33-9-11-35(12-10-33)44-30(3)53-27-69-44/h9-16,27,29,37-39,45,61H,17-26H2,1-8H3,(H,52,62)(H,54,64)(H,56,63)/t29-,37+,38-,39?,45-/m0/s1",SLPWRCRRHVRNRM-ANFJVDRGSA-N
4577,P00338,LDHA,VHL,,MS6105,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCCC(=O)NCCCCC#CC3=CC=CC(C4=NN(C5=NC(C(=O)O)=CS5)C(CC5CC5)=C4CC4=CC=C(S(N)(=O)=O)C=C4)=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCCCCC(=O)NCCCCC#C,C3=CC=CC(C4=NN(C5=NC(C(=O)O)=CS5)C(CC5CC5)=C4CC4=CC=C(S(N)(=O)=O)C=C4)=C3)C(C)(C)C)C=C2)SC=N1,38.0,93.0,1,Degradation of LDHA in PANC1 cells after 48h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16100/12200/>13000,Inhibition of cell proliferation of PANC1/MiaPaca2/BxPC3 cells,,,,,,,,,,,10.1021/acs.jmedchem.2c01505,1228.618,1227.531938,11.81,86,8,14,6,30,268.9,C65H81N9O9S3,"InChI=1S/C65H81N9O9S3/c1-43-59(85-42-69-43)48-30-26-47(27-31-48)39-68-61(78)55-38-50(75)40-73(55)62(79)60(65(2,3)4)71-57(77)23-16-11-9-7-5-6-8-10-15-22-56(76)67-34-17-13-12-14-19-44-20-18-21-49(35-44)58-52(36-45-28-32-51(33-29-45)86(66,82)83)54(37-46-24-25-46)74(72-58)64-70-53(41-84-64)63(80)81/h18,20-21,26-33,35,41-42,46,50,55,60,75H,5-13,15-17,22-25,34,36-40H2,1-4H3,(H,67,76)(H,68,78)(H,71,77)(H,80,81)(H2,66,82,83)/t50-,55+,60-/m1/s1",APEYSKGQWJKJAZ-LCLGPXMOSA-N
4577,P07195,LDHB,VHL,,MS6105,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)CCCCCCCCCCCC(=O)NCCCCC#CC3=CC=CC(C4=NN(C5=NC(C(=O)O)=CS5)C(CC5CC5)=C4CC4=CC=C(S(N)(=O)=O)C=C4)=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)CCCCCCCCCCCC(=O)NCCCCC#C,C3=CC=CC(C4=NN(C5=NC(C(=O)O)=CS5)C(CC5CC5)=C4CC4=CC=C(S(N)(=O)=O)C=C4)=C3)C(C)(C)C)C=C2)SC=N1,74.0,86.0,1,Degradation of LDHB in PANC1 cells after 48h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01505,1228.618,1227.531938,11.81,86,8,14,6,30,268.9,C65H81N9O9S3,"InChI=1S/C65H81N9O9S3/c1-43-59(85-42-69-43)48-30-26-47(27-31-48)39-68-61(78)55-38-50(75)40-73(55)62(79)60(65(2,3)4)71-57(77)23-16-11-9-7-5-6-8-10-15-22-56(76)67-34-17-13-12-14-19-44-20-18-21-49(35-44)58-52(36-45-28-32-51(33-29-45)86(66,82)83)54(37-46-24-25-46)74(72-58)64-70-53(41-84-64)63(80)81/h18,20-21,26-33,35,41-42,46,50,55,60,75H,5-13,15-17,22-25,34,36-40H2,1-4H3,(H,67,76)(H,68,78)(H,71,77)(H,80,81)(H2,66,82,83)/t50-,55+,60-/m1/s1",APEYSKGQWJKJAZ-LCLGPXMOSA-N
4601,Q9BY41,HDAC8,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCC4=CN(CCCCOC5=CC=C(CN6C=CC7=CC=C(C(=O)NO)C=C76)C=C5)N=N4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(NCC4=CN(,CCCCO,C5=CC=C(CN6C=CC7=CC=C(C(=O)NO)C=C76)C=C5)N=N4)=C3C2=O)C(=O)N1,470.0,90.21,0,Degradation of HDAC8 in A549 cells,30.6/83.6,% HDAC8 protein degradation in A549聽cells at 200/2000聽nM for 20聽h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7110,Inhibition of cell proliferation of CCK-8 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c00739,690.717,690.2550454,2.73,51,7,12,4,13,189.78,C36H34N8O7,"InChI=1S/C36H34N8O7/c45-31-13-12-29(34(47)38-31)44-35(48)27-4-3-5-28(32(27)36(44)49)37-19-25-21-43(41-39-25)15-1-2-17-51-26-10-6-22(7-11-26)20-42-16-14-23-8-9-24(18-30(23)42)33(46)40-50/h3-11,14,16,18,21,29,37,50H,1-2,12-13,15,17,19-20H2,(H,40,46)(H,38,45,47)",SUEXREHSPDZBHX-UHFFFAOYSA-N
4602,Q9BY41,HDAC8,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCC4=CN(CCCCCOC5=CC=C(CN6C=CC7=CC=C(C(=O)NO)C=C76)C=C5)N=N4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(NCC4=CN(,CCCCCO,C5=CC=C(CN6C=CC7=CC=C(C(=O)NO)C=C76)C=C5)N=N4)=C3C2=O)C(=O)N1,620.0,90.16,0,Degradation of HDAC8 in A549 cells,39.5/85.9,% HDAC8 protein degradation in A549聽cells at 200/2000聽nM for 20聽h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12520,Inhibition of cell proliferation of CCK-8 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c00739,704.744,704.2706955,3.09,52,7,12,4,14,189.78,C37H36N8O7,"InChI=1S/C37H36N8O7/c46-32-14-13-30(35(48)39-32)45-36(49)28-5-4-6-29(33(28)37(45)50)38-20-26-22-44(42-40-26)16-2-1-3-18-52-27-11-7-23(8-12-27)21-43-17-15-24-9-10-25(19-31(24)43)34(47)41-51/h4-12,15,17,19,22,30,38,51H,1-3,13-14,16,18,20-21H2,(H,41,47)(H,39,46,48)",VXKRNJLOBYGLJC-UHFFFAOYSA-N
4604,Q9BY41,HDAC8,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(NCC4=CN(CCOCCOC5=CC=C(CN6C=CC7=CC=C(C(=O)NO)C=C76)C=C5)N=N4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(NCC4=CN(,CCOCCO,C5=CC=C(CN6C=CC7=CC=C(C(=O)NO)C=C76)C=C5)N=N4)=C3C2=O)C(=O)N1,580.0,95.0,0,Degradation of HDAC8 in A549 cells,39.7/85.4,% HDAC8 protein degradation in A549聽cells at 200/2000聽nM for 20聽h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9550,Inhibition of cell proliferation of CCK-8 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c00739,706.716,706.24996,1.87,52,7,13,4,14,199.01,C36H34N8O8,"InChI=1S/C36H34N8O8/c45-31-11-10-29(34(47)38-31)44-35(48)27-2-1-3-28(32(27)36(44)49)37-19-25-21-43(41-39-25)14-15-51-16-17-52-26-8-4-22(5-9-26)20-42-13-12-23-6-7-24(18-30(23)42)33(46)40-50/h1-9,12-13,18,21,29,37,50H,10-11,14-17,19-20H2,(H,40,46)(H,38,45,47)",OCXICBCMNKOWFI-UHFFFAOYSA-N
4649,Q14145,KEAP1,CRBN,,,CC1=CC=C(C(CC(=O)O)C2=CC(OCCCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=C3C(=C2)N=NN3C)C=C1CN1C[C@@H](C)OC2=CC=CC=C2S1(=O)=O,CC1=CC=C(C(CC(=O)O)C2=CC(,OCCCCCCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=C3C(=C2)N=NN3C)C=C1CN1C[C@@H](C)OC2=CC=CC=C2S1(=O)=O,11.0,94.0,1,Degradation of KEAP1 in HEK293T cells after 24h treatment,,,46,Binding affinity of KEAP1-Kelch domain,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,<0.005,parallel artificial membrane permeability assay,,,,,10.1016/j.redox.2022.102552,906.031,905.3418118,5.89,65,8,13,3,17,219.43,C47H51N7O10S,"InChI=1S/C47H51N7O10S/c1-28-16-17-30(22-32(28)27-53-26-29(2)64-38-14-7-8-15-40(38)65(53,61)62)34(25-42(56)57)31-23-36-44(52(3)51-50-36)39(24-31)63-21-10-6-4-5-9-20-48-35-13-11-12-33-43(35)47(60)54(46(33)59)37-18-19-41(55)49-45(37)58/h7-8,11-17,22-24,29,34,37,48H,4-6,9-10,18-21,25-27H2,1-3H3,(H,56,57)(H,49,55,58)/t29-,34?,37?/m1/s1",WZSDKFOIVKEWJJ-URGMBGNWSA-N
4659,Q9UBN7,HDAC6,CRBN,,,CC1=NC2=CC(NC(=O)CCCCCCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=CC=C2N1CC1=CC=C(C(=O)NO)C=C1F,CC1=NC2=CC(,NC(=O)CCCCCCCNC(=O)CO,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=CC=C2N1CC1=CC=C(C(=O)NO)C=C1F,19.39,92.77,1,Degradation of HDAC6 in HL-60 cells after 6h treatment,,,4.54,Inhibit of HDAC6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>50000/>50000/>50000,Inhibition of cell proliferation of MV4-11/Molm-13/SKNO-1 cells,5500,dose-dependent alpha-tubulin hyperacetylation,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01659,769.787,769.2871541,2.8,56,6,11,5,16,218.13,C39H40FN7O9,"InChI=1S/C39H40FN7O9/c1-22-42-28-19-25(13-14-29(28)46(22)20-24-12-11-23(18-27(24)40)36(51)45-55)43-32(48)10-5-3-2-4-6-17-41-34(50)21-56-31-9-7-8-26-35(31)39(54)47(38(26)53)30-15-16-33(49)44-37(30)52/h7-9,11-14,18-19,30,55H,2-6,10,15-17,20-21H2,1H3,(H,41,50)(H,43,48)(H,45,51)(H,44,49,52)",HFDHVDIXYSXIRN-UHFFFAOYSA-N
4679,P11802,CDK4,VHL,,MS28,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(C(=O)CCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=N3)N=C2N(C2CCCC2)C1=O,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(,C(=O)CCCCCC(=O)N,[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=N3)N=C2N(C2CCCC2)C1=O,10000.0,50.0,0,Degradation of CDK4 in Calu-1 cells after 8h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1000/750,Inhibition of cell proliferation of Calu-1/NCI-H2110 cells,,,,,,,,,,,10.1021/jacs.2c09255,1002.256,1001.494564,4.95,72,8,15,4,17,224.95,C53H67N11O7S,"InChI=1S/C53H67N11O7S/c1-32-40-29-56-52(60-48(40)64(37-12-10-11-13-37)50(70)45(32)34(3)65)58-42-21-20-38(28-54-42)61-22-24-62(25-23-61)44(68)15-9-7-8-14-43(67)59-47(53(4,5)6)51(71)63-30-39(66)26-41(63)49(69)55-27-35-16-18-36(19-17-35)46-33(2)57-31-72-46/h16-21,28-29,31,37,39,41,47,66H,7-15,22-27,30H2,1-6H3,(H,55,69)(H,59,67)(H,54,56,58,60)/t39-,41+,47-/m1/s1",MWVNDEBEHBRZEC-WWTLGBROSA-N
4679,Q00534,CDK6,VHL,,MS28,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(C(=O)CCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=N3)N=C2N(C2CCCC2)C1=O,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(,C(=O)CCCCCC(=O)N,[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)C=N3)N=C2N(C2CCCC2)C1=O,10000.0,50.0,0,Degradation of CDK6 in Calu-1 cells after 8h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacs.2c09255,1002.256,1001.494564,4.95,72,8,15,4,17,224.95,C53H67N11O7S,"InChI=1S/C53H67N11O7S/c1-32-40-29-56-52(60-48(40)64(37-12-10-11-13-37)50(70)45(32)34(3)65)58-42-21-20-38(28-54-42)61-22-24-62(25-23-61)44(68)15-9-7-8-14-43(67)59-47(53(4,5)6)51(71)63-30-39(66)26-41(63)49(69)55-27-35-16-18-36(19-17-35)46-33(2)57-31-72-46/h16-21,28-29,31,37,39,41,47,66H,7-15,22-27,30H2,1-6H3,(H,55,69)(H,59,67)(H,54,56,58,60)/t39-,41+,47-/m1/s1",MWVNDEBEHBRZEC-WWTLGBROSA-N
4715,P29597,TYK2,VHL,,,CNC(=O)C1=CN=C(NC2=CC=C(C(=O)NCCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)C=N2)C=C1NC1=CC=CC(C(=O)NC)=C1OC,CNC(=O)C1=CN=C(NC2=CC=C(,C(=O)NCCCCCCCCCC(=O)N,[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)C=N2)C=C1NC1=CC=CC(C(=O)NC)=C1OC,230.0,77.0,0,Degradation of TYK2 in Jurkat cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2022.129083,1032.282,1031.505129,7.14,74,6,14,8,24,258.0,C54H69N11O8S,"InChI=1S/C54H69N11O8S/c1-33-47(74-32-61-33)35-21-19-34(20-22-35)28-60-52(71)42-26-37(66)31-65(42)53(72)48(54(2,3)4)64-45(67)18-13-11-9-8-10-12-14-25-57-49(68)36-23-24-43(58-29-36)63-44-27-41(39(30-59-44)51(70)56-6)62-40-17-15-16-38(46(40)73-7)50(69)55-5/h15-17,19-24,27,29-30,32,37,42,48,66H,8-14,18,25-26,28,31H2,1-7H3,(H,55,69)(H,56,70)(H,57,68)(H,60,71)(H,64,67)(H2,58,59,62,63)/t37-,42+,48-/m1/s1",GGLGXBGGASXSIW-GPPJZCFZSA-N
4718,P29597,TYK2,VHL,,,CNC(=O)C1=CC=CC(NC2=CC(NC3=CC=C(C(=O)NCCCCCCCCCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=N3)=NC=C2C(N)=O)=C1OC,CNC(=O)C1=CC=CC(NC2=CC(NC3=CC=C(,C(=O)NCCCCCCCCCC(=O)N,[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=N3)=NC=C2C(N)=O)=C1OC,23.0,85.0,1,Degradation of TYK2 in Jurkat cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2022.129083,1018.255,1017.489479,6.74,73,6,14,8,24,271.99,C53H67N11O8S,"InChI=1S/C53H67N11O8S/c1-32-46(73-31-60-32)34-20-18-33(19-21-34)27-59-51(70)41-25-36(65)30-64(41)52(71)47(53(2,3)4)63-44(66)17-12-10-8-7-9-11-13-24-56-49(68)35-22-23-42(57-28-35)62-43-26-40(38(29-58-43)48(54)67)61-39-16-14-15-37(45(39)72-6)50(69)55-5/h14-16,18-23,26,28-29,31,36,41,47,65H,7-13,17,24-25,27,30H2,1-6H3,(H2,54,67)(H,55,69)(H,56,68)(H,59,70)(H,63,66)(H2,57,58,61,62)/t36-,41+,47-/m1/s1",QYKZIZGHSUMTGL-FGUOTCRGSA-N
4718,P23458,JAK1,VHL,,,CNC(=O)C1=CC=CC(NC2=CC(NC3=CC=C(C(=O)NCCCCCCCCCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=N3)=NC=C2C(N)=O)=C1OC,CNC(=O)C1=CC=CC(NC2=CC(NC3=CC=C(,C(=O)NCCCCCCCCCC(=O)N,[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)C=N3)=NC=C2C(N)=O)=C1OC,1095.0,49.0,0,Degradation of JAK1 in Jurkat cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2022.129083,1018.255,1017.489479,6.74,73,6,14,8,24,271.99,C53H67N11O8S,"InChI=1S/C53H67N11O8S/c1-32-46(73-31-60-32)34-20-18-33(19-21-34)27-59-51(70)41-25-36(65)30-64(41)52(71)47(53(2,3)4)63-44(66)17-12-10-8-7-9-11-13-24-56-49(68)35-22-23-42(57-28-35)62-43-26-40(38(29-58-43)48(54)67)61-39-16-14-15-37(45(39)72-6)50(69)55-5/h14-16,18-23,26,28-29,31,36,41,47,65H,7-13,17,24-25,27,30H2,1-6H3,(H2,54,67)(H,55,69)(H,56,68)(H,59,70)(H,63,66)(H2,57,58,61,62)/t36-,41+,47-/m1/s1",QYKZIZGHSUMTGL-FGUOTCRGSA-N
4719,P29597,TYK2,VHL,,,CNC(=O)C1=CN=C(NC2=CC=C(C(=O)NCCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)C=N2)C=C1NC1=CC=CC(C2=NN(C)C=N2)=C1OC,CNC(=O)C1=CN=C(NC2=CC=C(,C(=O)NCCCCCCCCCC(=O)N,[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)C=N2)C=C1NC1=CC=CC(C2=NN(C)C=N2)=C1OC,14.0,78.0,0,Degradation of TYK2 in Jurkat cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2022.129083,1056.308,1055.516363,7.61,76,7,16,7,24,259.61,C55H69N13O7S,"InChI=1S/C55H69N13O7S/c1-34-48(76-33-62-34)36-21-19-35(20-22-36)28-60-53(73)43-26-38(69)31-68(43)54(74)49(55(2,3)4)65-46(70)18-13-11-9-8-10-12-14-25-57-51(71)37-23-24-44(58-29-37)64-45-27-42(40(30-59-45)52(72)56-5)63-41-17-15-16-39(47(41)75-7)50-61-32-67(6)66-50/h15-17,19-24,27,29-30,32-33,38,43,49,69H,8-14,18,25-26,28,31H2,1-7H3,(H,56,72)(H,57,71)(H,60,73)(H,65,70)(H2,58,59,63,64)/t38-,43+,49-/m1/s1",ZQBPERKIXUCCNQ-DXGZDBETSA-N
4719,P23458,JAK1,VHL,,,CNC(=O)C1=CN=C(NC2=CC=C(C(=O)NCCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)C=N2)C=C1NC1=CC=CC(C2=NN(C)C=N2)=C1OC,CNC(=O)C1=CN=C(NC2=CC=C(,C(=O)NCCCCCCCCCC(=O)N,[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C4=C(C)N=CS4)C=C3)C(C)(C)C)C=N2)C=C1NC1=CC=CC(C2=NN(C)C=N2)=C1OC,10000.0,25.0,0,Degradation of JAK1 in Jurkat cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.bmcl.2022.129083,1056.308,1055.516363,7.61,76,7,16,7,24,259.61,C55H69N13O7S,"InChI=1S/C55H69N13O7S/c1-34-48(76-33-62-34)36-21-19-35(20-22-36)28-60-53(73)43-26-38(69)31-68(43)54(74)49(55(2,3)4)65-46(70)18-13-11-9-8-10-12-14-25-57-51(71)37-23-24-44(58-29-37)64-45-27-42(40(30-59-45)52(72)56-5)63-41-17-15-16-39(47(41)75-7)50-61-32-67(6)66-50/h15-17,19-24,27,29-30,32-33,38,43,49,69H,8-14,18,25-26,28,31H2,1-7H3,(H,56,72)(H,57,71)(H,60,73)(H,65,70)(H2,58,59,63,64)/t38-,43+,49-/m1/s1",ZQBPERKIXUCCNQ-DXGZDBETSA-N
4837,P51531,SMARCA2,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(N4CCC(CN5CCC(O[C@H]6C[C@H](OC7=CC(N8C9CCC8CN(C8=CC(C%10=CC=CC=C%10O)=NN=C8N)C9)=CC=N7)C6)CC5)CC4)=NO3)C(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H],(C)NC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(N4CCC(CN5CCC(O[C@H]6C[C@H](OC7=CC(N8C9CCC8CN(C8=CC(C%10=CC=CC=C%10O)=NN=C8N)C9)=CC=N7)C6)CC5)CC4)=NO3)C(C)C)C=C2)SC=N1,0.039,96.0,1,Degradation of SMARCA2 in SW1573 cells after 20h treatment,,,,,,,93,Binding affinity of SMARCA2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-022-34562-5,1121.423,1120.568064,7.46,81,12,18,4,17,224.9,C61H76N12O7S,"InChI=1S/C61H76N12O7S/c1-36(2)57(61(77)72-34-45(74)26-52(72)60(76)65-37(3)40-9-11-41(12-10-40)58-38(4)64-35-81-58)54-30-55(68-80-54)70-23-16-39(17-24-70)31-69-21-18-46(19-22-69)78-47-27-48(28-47)79-56-25-42(15-20-63-56)73-43-13-14-44(73)33-71(32-43)51-29-50(66-67-59(51)62)49-7-5-6-8-53(49)75/h5-12,15,20,25,29-30,35-37,39,43-48,52,57,74-75H,13-14,16-19,21-24,26-28,31-34H2,1-4H3,(H2,62,67)(H,65,76)/t37-,43?,44?,45+,47-,48-,52-,57+/m0/s1",QQVCUSPUMMUFTD-JBVRKRIASA-N
4837,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(N4CCC(CN5CCC(O[C@H]6C[C@H](OC7=CC(N8C9CCC8CN(C8=CC(C%10=CC=CC=C%10O)=NN=C8N)C9)=CC=N7)C6)CC5)CC4)=NO3)C(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H],(C)NC(=O),[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](C3=CC(N4CCC(CN5CCC(O[C@H]6C[C@H](OC7=CC(N8C9CCC8CN(C8=CC(C%10=CC=CC=C%10O)=NN=C8N)C9)=CC=N7)C6)CC5)CC4)=NO3)C(C)C)C=C2)SC=N1,1.1,92.0,1,Degradation of SMARCA4 in SW1573 cells after 20h treatment,,,,,,,65,Binding affinity of SMARCA4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-022-34562-5,1121.423,1120.568064,7.46,81,12,18,4,17,224.9,C61H76N12O7S,"InChI=1S/C61H76N12O7S/c1-36(2)57(61(77)72-34-45(74)26-52(72)60(76)65-37(3)40-9-11-41(12-10-40)58-38(4)64-35-81-58)54-30-55(68-80-54)70-23-16-39(17-24-70)31-69-21-18-46(19-22-69)78-47-27-48(28-47)79-56-25-42(15-20-63-56)73-43-13-14-44(73)33-71(32-43)51-29-50(66-67-59(51)62)49-7-5-6-8-53(49)75/h5-12,15,20,25,29-30,35-37,39,43-48,52,57,74-75H,13-14,16-19,21-24,26-28,31-34H2,1-4H3,(H2,62,67)(H,65,76)/t37-,43?,44?,45+,47-,48-,52-,57+/m0/s1",QQVCUSPUMMUFTD-JBVRKRIASA-N
4868,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCC(=O)NCCCOC1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCC(=O)NCCCO,C1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,97.1,88.0,1,Degradation of BRD4 in MDA-MB-231 cells after 8h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01218,771.256,770.2037941,2.87,54,7,12,3,11,194.05,C37H35ClN8O7S,"InChI=1S/C37H35ClN8O7S/c1-18-19(2)54-37-30(18)32(21-8-10-22(38)11-9-21)41-24(33-44-43-20(3)45(33)37)16-28(48)40-17-29(49)39-14-5-15-53-26-7-4-6-23-31(26)36(52)46(35(23)51)25-12-13-27(47)42-34(25)50/h4,6-11,24-25H,5,12-17H2,1-3H3,(H,39,49)(H,40,48)(H,42,47,50)/t24-,25?/m0/s1",FZPFOKCSBXRUCY-SKCDSABHSA-N
4869,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCC(=O)NCCCCOC1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCC(=O)NCCCCO,C1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,134.0,79.0,0,Degradation of BRD4 in MDA-MB-231 cells after 8h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01218,785.283,784.2194442,3.22,55,7,12,3,12,194.05,C38H37ClN8O7S,"InChI=1S/C38H37ClN8O7S/c1-19-20(2)55-38-31(19)33(22-9-11-23(39)12-10-22)42-25(34-45-44-21(3)46(34)38)17-29(49)41-18-30(50)40-15-4-5-16-54-27-8-6-7-24-32(27)37(53)47(36(24)52)26-13-14-28(48)43-35(26)51/h6-12,25-26H,4-5,13-18H2,1-3H3,(H,40,50)(H,41,49)(H,43,48,51)/t25-,26?/m0/s1",DZBLWYQPZXUQGG-PMCHYTPCSA-N
4870,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCC(=O)NCCCCCOC1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCC(=O)NCCCCCO,C1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,184.0,86.0,0,Degradation of BRD4 in MDA-MB-231 cells after 8h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01218,799.31,798.2350943,3.58,56,7,12,3,13,194.05,C39H39ClN8O7S,"InChI=1S/C39H39ClN8O7S/c1-20-21(2)56-39-32(20)34(23-10-12-24(40)13-11-23)43-26(35-46-45-22(3)47(35)39)18-30(50)42-19-31(51)41-16-5-4-6-17-55-28-9-7-8-25-33(28)38(54)48(37(25)53)27-14-15-29(49)44-36(27)52/h7-13,26-27H,4-6,14-19H2,1-3H3,(H,41,51)(H,42,50)(H,44,49,52)/t26-,27?/m0/s1",ILDJWQYNDNRRFS-QBHOUYDASA-N
4873,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)N1CCN(CC(=O)NCCCOC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)N1CCN(,CC(=O)NCCCO,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC1)N=C2C1=CC=C(Cl)C=C1,239.0,81.0,0,Degradation of BRD4 in MDA-MB-231 cells after 8h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01218,840.363,839.2616434,2.86,59,8,13,2,11,188.5,C41H42ClN9O7S,"InChI=1S/C41H42ClN9O7S/c1-22-23(2)59-41-34(22)36(25-8-10-26(42)11-9-25)44-28(37-47-46-24(3)50(37)41)20-33(54)49-17-15-48(16-18-49)21-32(53)43-14-5-19-58-30-7-4-6-27-35(30)40(57)51(39(27)56)29-12-13-31(52)45-38(29)55/h4,6-11,28-29H,5,12-21H2,1-3H3,(H,43,53)(H,45,52,55)/t28-,29?/m0/s1",ITDXUECDKFMKGU-XLTVJXRZSA-N
4874,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)N1CCN(CC(=O)NCCCCOC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)N1CCN(,CC(=O)NCCCCO,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC1)N=C2C1=CC=C(Cl)C=C1,89.9,78.0,0,Degradation of BRD4 in MDA-MB-231 cells after 8h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01218,854.39,853.2772934,3.22,60,8,13,2,12,188.5,C42H44ClN9O7S,"InChI=1S/C42H44ClN9O7S/c1-23-24(2)60-42-35(23)37(26-9-11-27(43)12-10-26)45-29(38-48-47-25(3)51(38)42)21-34(55)50-18-16-49(17-19-50)22-33(54)44-15-4-5-20-59-31-8-6-7-28-36(31)41(58)52(40(28)57)30-13-14-32(53)46-39(30)56/h6-12,29-30H,4-5,13-22H2,1-3H3,(H,44,54)(H,46,53,56)/t29-,30?/m0/s1",LAECKGLWOSIZEO-UFXYQILXSA-N
4875,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)N1CCN(CC(=O)NCCCCCOC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)N1CCN(,CC(=O)NCCCCCO,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC1)N=C2C1=CC=C(Cl)C=C1,60.0,94.0,1,Degradation of BRD4 in MDA-MB-231 cells after 8h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01218,868.417,867.2929435,3.57,61,8,13,2,13,188.5,C43H46ClN9O7S,"InChI=1S/C43H46ClN9O7S/c1-24-25(2)61-43-36(24)38(27-10-12-28(44)13-11-27)46-30(39-49-48-26(3)52(39)43)22-35(56)51-19-17-50(18-20-51)23-34(55)45-16-5-4-6-21-60-32-9-7-8-29-37(32)42(59)53(41(29)58)31-14-15-33(54)47-40(31)57/h7-13,30-31H,4-6,14-23H2,1-3H3,(H,45,55)(H,47,54,57)/t30-,31?/m0/s1",SDWUURRMSCHVOR-FSRLHOSWSA-N
4878,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)OCC(=O)NCCCCOC1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)OCC(=O)NCCCCO,C1=CC=CC3=C1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2C1=CC=C(Cl)C=C1,62.0,86.0,1,Degradation of BRD4 in MDA-MB-231 cells after 8h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01218,786.267,785.2034598,3.8,55,7,13,2,12,191.25,C38H36ClN7O8S,"InChI=1S/C38H36ClN7O8S/c1-19-20(2)55-38-31(19)33(22-9-11-23(39)12-10-22)41-25(34-44-43-21(3)45(34)38)17-30(49)54-18-29(48)40-15-4-5-16-53-27-8-6-7-24-32(27)37(52)46(36(24)51)26-13-14-28(47)42-35(26)50/h6-12,25-26H,4-5,13-18H2,1-3H3,(H,40,48)(H,42,47,50)/t25-,26?/m0/s1",PLVCAPPHMNXCHP-PMCHYTPCSA-N
4884,P43490,NAMPT,CRBN,,,O=C(/C=C/C1=CC=CN=C1)NCCCCC1CCN(C(=O)C2=CC=C(N3CCN(C(=O)CCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C=C2)CC1,O=C(/C=C/C1=CC=CN=C1)NCCCCC1CCN(C(=O)C2=CC=C(N3CCN(,C(=O)CCCCN,C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C=C2)CC1,1.443,57.4,0,Degradation of NAMPT in Jurkat cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2022.10.007,830.987,830.4115461,4.19,61,7,10,3,16,181.43,C46H54N8O7,"InChI=1S/C46H54N8O7/c55-39(18-12-33-8-6-22-47-31-33)49-24-3-1-7-32-20-25-53(26-21-32)44(59)34-13-15-35(16-14-34)51-27-29-52(30-28-51)41(57)11-2-4-23-48-37-10-5-9-36-42(37)46(61)54(45(36)60)38-17-19-40(56)50-43(38)58/h5-6,8-10,12-16,18,22,31-32,38,48H,1-4,7,11,17,19-21,23-30H2,(H,49,55)(H,50,56,58)/b18-12+",ZCFIVZIHMGWOER-LDADJPATSA-N
4885,P43490,NAMPT,CRBN,,,O=C(/C=C/C1=CC=CN=C1)NCCCCC1CCN(C(=O)C2=CC=C(N3CCN(C(=O)CCCCCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C=C2)CC1,O=C(/C=C/C1=CC=CN=C1)NCCCCC1CCN(C(=O)C2=CC=C(N3CCN(,C(=O)CCCCCCN,C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)C=C2)CC1,1.0,74.9,0,Degradation of NAMPT in Jurkat cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2022.10.007,859.041,858.4428462,5.09,63,7,10,3,18,181.43,C48H58N8O7,"InChI=1S/C48H58N8O7/c57-41(20-14-35-10-8-24-49-33-35)51-26-6-4-9-34-22-27-55(28-23-34)46(61)36-15-17-37(18-16-36)53-29-31-54(32-30-53)43(59)13-3-1-2-5-25-50-39-12-7-11-38-44(39)48(63)56(47(38)62)40-19-21-42(58)52-45(40)60/h7-8,10-12,14-18,20,24,33-34,40,50H,1-6,9,13,19,21-23,25-32H2,(H,51,57)(H,52,58,60)/b20-14+",GFYHVYLOXRVHDM-XSFVSMFZSA-N
4891,P43490,NAMPT,CRBN,,,O=C(/C=C/C1=CC=CN=C1)NCCCCC1CCN(C(=O)C2=CC=C(N3CCN(C(=O)CCCCCCNC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)CC3)C=C2)CC1,O=C(/C=C/C1=CC=CN=C1)NCCCCC1CCN(C(=O)C2=CC=C(N3CCN(,C(=O)CCCCCCN,C4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)CC3)C=C2)CC1,5.85,73.4,0,Degradation of NAMPT in Jurkat cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.chembiol.2022.10.007,845.058,844.4635816,4.59,62,7,9,3,18,164.36,C48H60N8O6,"InChI=1S/C48H60N8O6/c57-43(20-14-36-10-8-24-49-33-36)51-26-6-4-9-35-22-27-55(28-23-35)47(61)37-15-17-38(18-16-37)53-29-31-54(32-30-53)45(59)13-3-1-2-5-25-50-41-12-7-11-39-40(41)34-56(48(39)62)42-19-21-44(58)52-46(42)60/h7-8,10-12,14-18,20,24,33,35,42,50H,1-6,9,13,19,21-23,25-32,34H2,(H,51,57)(H,52,58,60)/b20-14+",KBASXKZKMMUHSI-XSFVSMFZSA-N
4892,P43490,NAMPT,CRBN,,SIAIS630120,O=C(/C=C/C1=CC=CN=C1)NCCCCC1CCN(C(=O)C2=CC=C(N3CCN(CCCCCC#CC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)CC3)C=C2)CC1,O=C(/C=C/C1=CC=CN=C1)NCCCCC1CCN(C(=O)C2=CC=C(N3CCN(,CCCCCC#C,C4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)CC3)C=C2)CC1,1.0,93.3,1,Degradation of NAMPT in Jurkat cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.456/8.565/2.964,Degradation potency of endogenous NAMPT protein in Jurkat cells/ CTG luminescent cell viability assay in  HL60 and MOLT4 cells,,,,,,,,,,,,,,,10.1016/j.chembiol.2022.10.007,812.028,811.4421179,5.51,60,7,8,2,15,135.26,C48H57N7O5,"InChI=1S/C48H57N7O5/c56-44(21-15-37-11-9-25-49-34-37)50-26-6-5-10-36-23-28-54(29-24-36)47(59)39-16-18-40(19-17-39)53-32-30-52(31-33-53)27-7-3-1-2-4-12-38-13-8-14-41-42(38)35-55(48(41)60)43-20-22-45(57)51-46(43)58/h8-9,11,13-19,21,25,34,36,43H,1-3,5-7,10,20,22-24,26-33,35H2,(H,50,56)(H,51,57,58)/b21-15+",MQVBARDYXLTACJ-RCCKNPSSSA-N
4893,P43490,NAMPT,CRBN,,SIAIS630121,O=C(/C=C/C1=CC=CN=C1)NCCCCC1CCN(C(=O)C2=CC=C(N3CCN(CCCCCCC#CC4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)CC3)C=C2)CC1,O=C(/C=C/C1=CC=CN=C1)NCCCCC1CCN(C(=O)C2=CC=C(N3CCN(,CCCCCCC#C,C4=CC=CC5=C4CN(C4CCC(=O)NC4=O)C5=O)CC3)C=C2)CC1,1.0,92.5,1,Degradation of NAMPT in Jurkat cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.968/8.497/4.681,Degradation potency of endogenous NAMPT protein in Jurkat cells/ CTG luminescent cell viability assay in  HL60 and MOLT4 cells,,,,,,,,,,,,,,,10.1016/j.chembiol.2022.10.007,826.055,825.457768,6.05,61,7,8,2,16,135.26,C49H59N7O5,"InChI=1S/C49H59N7O5/c57-45(22-16-38-12-10-26-50-35-38)51-27-7-6-11-37-24-29-55(30-25-37)48(60)40-17-19-41(20-18-40)54-33-31-53(32-34-54)28-8-4-2-1-3-5-13-39-14-9-15-42-43(39)36-56(49(42)61)44-21-23-46(58)52-47(44)59/h9-10,12,14-20,22,26,35,37,44H,1-4,6-8,11,21,23-25,27-34,36H2,(H,51,57)(H,52,58,59)/b22-16+",JTTGVFCANBFLCE-CJLVFECKSA-N
4971,O60885,BRD4,CRBN,,dBRD4-BD1,CC1=CC=C(C(C)C)C=C1OC1=NC=CC(C2=C(C3=CC=C(C(F)(F)F)C=C3)N=CN2C2CCN(CCOCCOCCNC(=O)COC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,CC1=CC=C(C(C)C)C=C1OC1=NC=CC(C2=C(C3=CC=C(C(F)(F)F)C=C3)N=CN2C2CCN(,CCOCCOCCNC(=O)CO,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)=N1,280.0,77.0,0,Degradation of BRD4 in MM.1S cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acsmedchemlett.2c00300,967.015,966.3887599,5.31,70,8,14,2,19,196.41,C50H53F3N8O9,"InChI=1S/C50H53F3N8O9/c1-30(2)33-8-7-31(3)40(27-33)70-49-55-18-15-37(57-49)45-44(32-9-11-34(12-10-32)50(51,52)53)56-29-60(45)35-16-20-59(21-17-35)22-24-68-26-25-67-23-19-54-42(63)28-69-39-6-4-5-36-43(39)48(66)61(47(36)65)38-13-14-41(62)58-46(38)64/h4-12,15,18,27,29-30,35,38H,13-14,16-17,19-26,28H2,1-3H3,(H,54,63)(H,58,62,64)",JNAQDGFRVGMPDL-UHFFFAOYSA-N
4995,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(NC(=O)CCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(,NC(=O)CCCCC(=O)N,[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,330.0,62.6,0,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10090/46830/13040,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1074.2,1073.419349,6.75,77,8,12,7,18,245.43,C55H58F3N11O7S,"InChI=1S/C55H58F3N11O7S/c1-31-10-18-39(23-42(31)55(56,57)58)63-47(73)29-68-27-37(26-61-68)36-17-21-41-43(22-36)66-67-50(41)65-51(74)35-15-19-38(20-16-35)62-45(71)8-6-7-9-46(72)64-49(54(3,4)5)53(76)69-28-40(70)24-44(69)52(75)59-25-33-11-13-34(14-12-33)48-32(2)60-30-77-48/h10-23,26-27,30,40,44,49,70H,6-9,24-25,28-29H2,1-5H3,(H,59,75)(H,62,71)(H,63,73)(H,64,72)(H2,65,66,67,74)/t40-,44+,49-/m1/s1",XYPXCLNICDKSPC-VINRIKPSSA-N
4996,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(NC(=O)CCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(,NC(=O)CCCCCC(=O)N,[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,3330.0,0.0,0,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7260/>100000/>50000,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1088.227,1087.434999,7.3,78,8,12,7,19,245.43,C56H60F3N11O7S,"InChI=1S/C56H60F3N11O7S/c1-32-11-19-40(24-43(32)56(57,58)59)64-48(74)30-69-28-38(27-62-69)37-18-22-42-44(23-37)67-68-51(42)66-52(75)36-16-20-39(21-17-36)63-46(72)9-7-6-8-10-47(73)65-50(55(3,4)5)54(77)70-29-41(71)25-45(70)53(76)60-26-34-12-14-35(15-13-34)49-33(2)61-31-78-49/h11-24,27-28,31,41,45,50,71H,6-10,25-26,29-30H2,1-5H3,(H,60,76)(H,63,72)(H,64,74)(H,65,73)(H2,66,67,68,75)/t41-,45+,50-/m1/s1",POPKVZNHGKPLMU-VTRKIVCCSA-N
4997,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(NC(=O)CCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(,NC(=O)CCCCCCC(=O)N,[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,280.0,48.0,0,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4360/17870/4130,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1102.254,1101.450649,7.84,79,8,12,7,20,245.43,C57H62F3N11O7S,"InChI=1S/C57H62F3N11O7S/c1-33-12-20-41(25-44(33)57(58,59)60)65-49(75)31-70-29-39(28-63-70)38-19-23-43-45(24-38)68-69-52(43)67-53(76)37-17-21-40(22-18-37)64-47(73)10-8-6-7-9-11-48(74)66-51(56(3,4)5)55(78)71-30-42(72)26-46(71)54(77)61-27-35-13-15-36(16-14-35)50-34(2)62-32-79-50/h12-25,28-29,32,42,46,51,72H,6-11,26-27,30-31H2,1-5H3,(H,61,77)(H,64,73)(H,65,75)(H,66,74)(H2,67,68,69,76)/t42-,46+,51-/m1/s1",WLTPLZGGRXBLKV-DRHKINIBSA-N
4998,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(NC(=O)CCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(,NC(=O)CCCCCCCC(=O)N,[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,3330.0,13.5,0,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10720/>100000/>50000,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1116.281,1115.466299,8.38,80,8,12,7,21,245.43,C58H64F3N11O7S,"InChI=1S/C58H64F3N11O7S/c1-34-13-21-42(26-45(34)58(59,60)61)66-50(76)32-71-30-40(29-64-71)39-20-24-44-46(25-39)69-70-53(44)68-54(77)38-18-22-41(23-19-38)65-48(74)11-9-7-6-8-10-12-49(75)67-52(57(3,4)5)56(79)72-31-43(73)27-47(72)55(78)62-28-36-14-16-37(17-15-36)51-35(2)63-33-80-51/h13-26,29-30,33,43,47,52,73H,6-12,27-28,31-32H2,1-5H3,(H,62,78)(H,65,74)(H,66,76)(H,67,75)(H2,68,69,70,77)/t43-,47+,52-/m1/s1",NFWQAJIASJIBNX-ORZXESOZSA-N
4999,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(NC(=O)CCCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(,NC(=O)CCCCCCCCC(=O)N,[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,84.0,73.7,0,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2030/14470/7070,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1130.308,1129.481949,8.92,81,8,12,7,22,245.43,C59H66F3N11O7S,"InChI=1S/C59H66F3N11O7S/c1-35-14-22-43(27-46(35)59(60,61)62)67-51(77)33-72-31-41(30-65-72)40-21-25-45-47(26-40)70-71-54(45)69-55(78)39-19-23-42(24-20-39)66-49(75)12-10-8-6-7-9-11-13-50(76)68-53(58(3,4)5)57(80)73-32-44(74)28-48(73)56(79)63-29-37-15-17-38(18-16-37)52-36(2)64-34-81-52/h14-27,30-31,34,44,48,53,74H,6-13,28-29,32-33H2,1-5H3,(H,63,79)(H,66,75)(H,67,77)(H,68,76)(H2,69,70,71,78)/t44-,48+,53-/m1/s1",OMBFZCSGOOTQOG-WDXSTBBASA-N
5001,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(NC(=O)CCCCCCCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(,NC(=O)CCCCCCCCCCC(=O)N,[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCC6=CC=C(C7=C(C)N=CS7)C=C6)C(C)(C)C)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,890.0,42.9,0,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5130/9450/17630,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1158.362,1157.513249,10.0,83,8,12,7,24,245.43,C61H70F3N11O7S,"InChI=1S/C61H70F3N11O7S/c1-37-16-24-45(29-48(37)61(62,63)64)69-53(79)35-74-33-43(32-67-74)42-23-27-47-49(28-42)72-73-56(47)71-57(80)41-21-25-44(26-22-41)68-51(77)14-12-10-8-6-7-9-11-13-15-52(78)70-55(60(3,4)5)59(82)75-34-46(76)30-50(75)58(81)65-31-39-17-19-40(20-18-39)54-38(2)66-36-83-54/h16-29,32-33,36,46,50,55,76H,6-15,30-31,34-35H2,1-5H3,(H,65,81)(H,68,77)(H,69,79)(H,70,78)(H2,71,72,73,80)/t46-,50+,55-/m1/s1",VRDKRKMMGPZFND-KVDJATBYSA-N
5003,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(NC(=O)CCCCC(=O)N6CCN(CCCCC(=O)N[C@H](C(=O)N7C[C@H](O)C[C@H]7C(=O)NCC7=CC=C(C8=C(C)N=CS8)C=C7)C(C)(C)C)CC6)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(,NC(=O)CCCCC(=O)N,6CCN(CCCCC(=O)N[C@H](C(=O)N7C[C@H](O)C[C@H]7C(=O)NCC7=CC=C(C8=C(C)N=CS8)C=C7)C(C)(C)C)CC6)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,640.0,38.5,0,Degradation of VEGFR-2 in HGC-27/HUVEC cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,23860/38680/9360,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1242.44,1241.545612,6.71,89,9,14,7,23,268.98,C64H74F3N13O8S,"InChI=1S/C64H74F3N13O8S/c1-39-13-21-47(31-50(39)64(65,66)67)72-55(84)37-79-35-45(34-70-79)44-20-24-49-51(30-44)75-76-59(49)74-60(86)43-18-22-46(23-19-43)71-53(82)10-6-7-12-56(85)78-28-26-77(27-29-78)25-9-8-11-54(83)73-58(63(3,4)5)62(88)80-36-48(81)32-52(80)61(87)68-33-41-14-16-42(17-15-41)57-40(2)69-38-89-57/h13-24,30-31,34-35,38,48,52,58,81H,6-12,25-29,32-33,36-37H2,1-5H3,(H,68,87)(H,71,82)(H,72,84)(H,73,83)(H2,74,75,76,86)/t48-,52+,58-/m1/s1",CYKIHYPQZUDKDD-PZCJAATJSA-N
5005,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(NC(=O)CCCCC(=O)N6CCN(CCCCCCC(=O)N[C@H](C(=O)N7C[C@H](O)C[C@H]7C(=O)NCC7=CC=C(C8=C(C)N=CS8)C=C7)C(C)(C)C)CC6)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(,NC(=O)CCCCC(=O)N,6CCN(CCCCCCC(=O)N[C@H](C(=O)N7C[C@H](O)C[C@H]7C(=O)NCC7=CC=C(C8=C(C)N=CS8)C=C7)C(C)(C)C)CC6)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,3330.0,31.0,0,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,20390/24140/29620,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1270.494,1269.576912,7.61,91,9,14,7,25,268.98,C66H78F3N13O8S,"InChI=1S/C66H78F3N13O8S/c1-41-15-23-49(33-52(41)66(67,68)69)74-57(86)39-81-37-47(36-72-81)46-22-26-51-53(32-46)77-78-61(51)76-62(88)45-20-24-48(25-21-45)73-55(84)13-9-10-14-58(87)80-30-28-79(29-31-80)27-11-7-6-8-12-56(85)75-60(65(3,4)5)64(90)82-38-50(83)34-54(82)63(89)70-35-43-16-18-44(19-17-43)59-42(2)71-40-91-59/h15-26,32-33,36-37,40,50,54,60,83H,6-14,27-31,34-35,38-39H2,1-5H3,(H,70,89)(H,73,84)(H,74,86)(H,75,85)(H2,76,77,78,88)/t50-,54+,60-/m1/s1",SVVPYQZZEPKRFE-DWIBGWASSA-N
5007,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(N6CCN(CCCCC(=O)N[C@H](C(=O)N7C[C@H](O)C[C@H]7C(=O)NCC7=CC=C(C8=C(C)N=CS8)C=C7)C(C)(C)C)CC6)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(N6CCN(,CCCCC(=O)N,[C@H](C(=O)N7C[C@H](O)C[C@H]7C(=O)NCC7=CC=C(C8=C(C)N=CS8)C=C7)C(C)(C)C)CC6)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,3330.0,8.7,0,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>50000/>100000/>50000,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1115.297,1114.482283,7.58,80,9,13,6,18,222.81,C58H65F3N12O6S,"InChI=1S/C58H65F3N12O6S/c1-35-9-17-42(27-46(35)58(59,60)61)65-50(76)33-72-31-41(30-64-72)40-16-20-45-47(26-40)68-69-53(45)67-54(77)39-14-18-43(19-15-39)71-24-22-70(23-25-71)21-7-6-8-49(75)66-52(57(3,4)5)56(79)73-32-44(74)28-48(73)55(78)62-29-37-10-12-38(13-11-37)51-36(2)63-34-80-51/h9-20,26-27,30-31,34,44,48,52,74H,6-8,21-25,28-29,32-33H2,1-5H3,(H,62,78)(H,65,76)(H,66,75)(H2,67,68,69,77)/t44-,48+,52-/m1/s1",AMUZAYCPNSMZKI-CPKYMOPRSA-N
5009,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(N6CCN(CCCCCCC(=O)N[C@H](C(=O)N7C[C@H](O)C[C@H]7C(=O)NCC7=CC=C(C8=C(C)N=CS8)C=C7)C(C)(C)C)CC6)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(N6CCN(,CCCCCCC(=O)N,[C@H](C(=O)N7C[C@H](O)C[C@H]7C(=O)NCC7=CC=C(C8=C(C)N=CS8)C=C7)C(C)(C)C)CC6)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,3330.0,38.2,0,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5500/38610/>50000,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1143.351,1142.513584,8.48,82,9,13,6,20,222.81,C60H69F3N12O6S,"InChI=1S/C60H69F3N12O6S/c1-37-11-19-44(29-48(37)60(61,62)63)67-52(78)35-74-33-43(32-66-74)42-18-22-47-49(28-42)70-71-55(47)69-56(79)41-16-20-45(21-17-41)73-26-24-72(25-27-73)23-9-7-6-8-10-51(77)68-54(59(3,4)5)58(81)75-34-46(76)30-50(75)57(80)64-31-39-12-14-40(15-13-39)53-38(2)65-36-82-53/h11-22,28-29,32-33,36,46,50,54,76H,6-10,23-27,30-31,34-35H2,1-5H3,(H,64,80)(H,67,78)(H,68,77)(H2,69,70,71,79)/t46-,50+,54-/m1/s1",IJVINXKSZVCULY-XAJGXQBMSA-N
5010,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(N6CCN(CCCCCCCC(=O)N[C@H](C(=O)N7C[C@H](O)C[C@H]7C(=O)NCC7=CC=C(C8=C(C)N=CS8)C=C7)C(C)(C)C)CC6)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(N6CCN(,CCCCCCCC(=O)N,[C@H](C(=O)N7C[C@H](O)C[C@H]7C(=O)NCC7=CC=C(C8=C(C)N=CS8)C=C7)C(C)(C)C)CC6)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,3330.0,0.0,0,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,22570/>100000/>50000,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1157.378,1156.529234,9.02,83,9,13,6,21,222.81,C61H71F3N12O6S,"InChI=1S/C61H71F3N12O6S/c1-38-12-20-45(30-49(38)61(62,63)64)68-53(79)36-75-34-44(33-67-75)43-19-23-48-50(29-43)71-72-56(48)70-57(80)42-17-21-46(22-18-42)74-27-25-73(26-28-74)24-10-8-6-7-9-11-52(78)69-55(60(3,4)5)59(82)76-35-47(77)31-51(76)58(81)65-32-40-13-15-41(16-14-40)54-39(2)66-37-83-54/h12-23,29-30,33-34,37,47,51,55,77H,6-11,24-28,31-32,35-36H2,1-5H3,(H,65,81)(H,68,79)(H,69,78)(H2,70,71,72,80)/t47-,51+,55-/m1/s1",QPBZMFJPACIGBT-IGYHCSNNSA-N
5011,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(N6CCN(C(=O)CCCCC(=O)N[C@H](C(=O)N7C[C@H](O)C[C@H]7C(=O)NCC7=CC=C(C8=C(C)N=CS8)C=C7)C(C)(C)C)CC6)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(N6CCN(,C(=O)CCCCC(=O)N,[C@H](C(=O)N7C[C@H](O)C[C@H]7C(=O)NCC7=CC=C(C8=C(C)N=CS8)C=C7)C(C)(C)C)CC6)C=C5)=N[NH]C4=C3)C=N2)C=C1C(F)(F)F,3330.0,17.3,0,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,>50000/>100000/>100000,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1143.307,1142.477198,6.97,82,9,13,6,18,239.88,C59H65F3N12O7S,"InChI=1S/C59H65F3N12O7S/c1-35-10-18-42(27-46(35)59(60,61)62)66-50(77)33-73-31-41(30-65-73)40-17-21-45-47(26-40)69-70-54(45)68-55(79)39-15-19-43(20-16-39)71-22-24-72(25-23-71)51(78)9-7-6-8-49(76)67-53(58(3,4)5)57(81)74-32-44(75)28-48(74)56(80)63-29-37-11-13-38(14-12-37)52-36(2)64-34-82-52/h10-21,26-27,30-31,34,44,48,53,75H,6-9,22-25,28-29,32-33H2,1-5H3,(H,63,80)(H,66,77)(H,67,76)(H2,68,69,70,79)/t44-,48+,53-/m1/s1",CYJKOWYZBRAJJB-WDXSTBBASA-N
5015,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(N)C=C5)=NN(C(=O)CCCCCCCCC(=O)N[C@@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)C4=C3)C=N2)C=C1C(F)(F)F,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(N)C=C5)=NN(,C(=O)CCCCCCCCC(=O)N,[C@@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)C4=C3)C=N2)C=C1C(F)(F)F,3330.0,0.0,0,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12120/44890/5500,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1130.308,1129.481949,8.96,81,8,14,6,21,248.56,C59H66F3N11O7S,"InChI=1S/C59H66F3N11O7S/c1-35-14-24-43(27-46(35)59(60,61)62)67-50(76)33-71-31-41(30-66-71)40-21-25-45-47(26-40)73(70-54(45)69-55(78)39-19-22-42(63)23-20-39)51(77)13-11-9-7-6-8-10-12-49(75)68-53(58(3,4)5)57(80)72-32-44(74)28-48(72)56(79)64-29-37-15-17-38(18-16-37)52-36(2)65-34-81-52/h14-27,30-31,34,44,48,53,74H,6-13,28-29,32-33,63H2,1-5H3,(H,64,79)(H,67,76)(H,68,75)(H,69,70,78)/t44-,48+,53+/m1/s1",BPHRXUICXLKBKI-UASWIANHSA-N
5016,P35968,VEGFR-2,VHL,,,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(N)C=C5)=NN(C(=O)CCCCCCCCCCC(=O)N[C@@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)C4=C3)C=N2)C=C1C(F)(F)F,CC1=CC=C(NC(=O)CN2C=C(C3=CC=C4C(NC(=O)C5=CC=C(N)C=C5)=NN(,C(=O)CCCCCCCCCCC(=O)N,[C@@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)C4=C3)C=N2)C=C1C(F)(F)F,320.0,81.7,0,Degradation of VEGFR-2 in HGC-27 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1440/25860/34610,Inhibition of cell proliferation of HGC-27/HEK293T/HUVEC cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114821,1158.362,1157.513249,10.04,83,8,14,6,23,248.56,C61H70F3N11O7S,"InChI=1S/C61H70F3N11O7S/c1-37-16-26-45(29-48(37)61(62,63)64)69-52(78)35-73-33-43(32-68-73)42-23-27-47-49(28-42)75(72-56(47)71-57(80)41-21-24-44(65)25-22-41)53(79)15-13-11-9-7-6-8-10-12-14-51(77)70-55(60(3,4)5)59(82)74-34-46(76)30-50(74)58(81)66-31-39-17-19-40(20-18-39)54-38(2)67-36-83-54/h16-29,32-33,36,46,50,55,76H,6-15,30-31,34-35,65H2,1-5H3,(H,66,81)(H,69,78)(H,70,77)(H,71,72,80)/t46-,50+,55+/m1/s1",PLBNAPRUSKNYKK-RFZMQRKDSA-N
5023,P51531,SMARCA2,VHL,7Z6L,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCCN3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(,OCCCN,3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)=C2)SC=N1,78.0,46.0,0,Degradation of SMARCA2 in RKO cells after 18/4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,175,Inhibition of cell proliferation of NCI-H1568 cells,,,,,,,,,,,,,10.1038/s41467-022-33430-6,1038.098,1036.368043,7.75,70,10,12,3,14,163.4,C53H62BrFN8O6S,"InChI=1S/C53H62BrFN8O6S/c1-31-45(70-30-57-31)34-13-14-35(28-56-47(65)42-27-37(64)29-61(42)49(67)46(52(2,3)4)58-50(68)53(55)19-20-53)43(26-34)69-24-8-21-60-22-17-32(18-23-60)33-15-16-39-41(25-33)62(36-9-5-6-10-36)51-59-48(66)44-38(54)11-7-12-40(44)63(39)51/h7,11-16,25-26,30,32,36-37,42,46,64H,5-6,8-10,17-24,27-29H2,1-4H3,(H,56,65)(H,58,68)/t37-,42+,46-/m1/s1",YUFHVVATBPCYPQ-BQGOKDIQSA-N
5023,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(OCCCN3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C(,OCCCN,3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)=C2)SC=N1,25000.0,0.0,0,Degradation of SMARCA2 in RKO cells after 18/4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-022-33430-6,1038.098,1036.368043,7.75,70,10,12,3,14,163.4,C53H62BrFN8O6S,"InChI=1S/C53H62BrFN8O6S/c1-31-45(70-30-57-31)34-13-14-35(28-56-47(65)42-27-37(64)29-61(42)49(67)46(52(2,3)4)58-50(68)53(55)19-20-53)43(26-34)69-24-8-21-60-22-17-32(18-23-60)33-15-16-39-41(25-33)62(36-9-5-6-10-36)51-59-48(66)44-38(54)11-7-12-40(44)63(39)51/h7,11-16,25-26,30,32,36-37,42,46,64H,5-6,8-10,17-24,27-29H2,1-4H3,(H,56,65)(H,58,68)/t37-,42+,46-/m1/s1",YUFHVVATBPCYPQ-BQGOKDIQSA-N
5025,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](COCCN3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](,COCCN,3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C=C2)SC=N1,25000.0,0.0,0,Degradation of SMARCA2 in RKO cells after 18/4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-022-33430-6,1038.098,1036.368043,7.31,70,10,12,3,14,163.4,C53H62BrFN8O6S,"InChI=1S/C53H62BrFN8O6S/c1-31-45(70-30-56-31)34-14-12-33(13-15-34)39(57-47(65)43-27-37(64)28-61(43)49(67)46(52(2,3)4)58-50(68)53(55)20-21-53)29-69-25-24-60-22-18-32(19-23-60)35-16-17-40-42(26-35)62(36-8-5-6-9-36)51-59-48(66)44-38(54)10-7-11-41(44)63(40)51/h7,10-17,26,30,32,36-37,39,43,46,64H,5-6,8-9,18-25,27-29H2,1-4H3,(H,57,65)(H,58,68)/t37-,39+,43+,46-/m1/s1",HOBINWBQKZMFPS-BYIGUQMMSA-N
5026,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](CO[C@H](C)CN3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](,CO[C@H](C)CN,3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C=C2)SC=N1,25000.0,0.0,0,Degradation of SMARCA2 in RKO cells after 18/4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-022-33430-6,1052.125,1050.383693,7.74,71,10,12,3,14,163.4,C54H64BrFN8O6S,"InChI=1S/C54H64BrFN8O6S/c1-31(27-61-23-19-33(20-24-61)36-17-18-41-43(25-36)63(37-9-6-7-10-37)52-60-49(67)45-39(55)11-8-12-42(45)64(41)52)70-29-40(34-13-15-35(16-14-34)46-32(2)57-30-71-46)58-48(66)44-26-38(65)28-62(44)50(68)47(53(3,4)5)59-51(69)54(56)21-22-54/h8,11-18,25,30-31,33,37-38,40,44,47,65H,6-7,9-10,19-24,26-29H2,1-5H3,(H,58,66)(H,59,69)/t31-,38-,40+,44+,47-/m1/s1",BWFPCIGALPXWPF-BLVIHPBHSA-N
5027,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](CO[C@H](C)CN3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(N(C)C)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](,CO[C@H](C)CN,3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(N(C)C)CC3)C(C)(C)C)C=C2)SC=N1,174.0,68.0,0,Degradation of SMARCA2 in RKO cells after 18/4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-022-33430-6,1077.204,1075.435314,7.44,73,10,13,3,15,166.64,C56H70BrN9O6S,"InChI=1S/C56H70BrN9O6S/c1-33(29-63-25-21-35(22-26-63)38-19-20-43-45(27-38)65(39-11-8-9-12-39)54-61-51(69)47-41(57)13-10-14-44(47)66(43)54)72-31-42(36-15-17-37(18-16-36)48-34(2)58-32-73-48)59-50(68)46-28-40(67)30-64(46)52(70)49(55(3,4)5)60-53(71)56(23-24-56)62(6)7/h10,13-20,27,32-33,35,39-40,42,46,49,67H,8-9,11-12,21-26,28-31H2,1-7H3,(H,59,68)(H,60,71)/t33-,40-,42+,46+,49-/m1/s1",AYSNCSVZNJFPCS-JAHFJGENSA-N
5029,P51532,SMARCA4,VHL,,,CC1=C(C2=CC=C([C@H](CC[C@H](C)CCN3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C([C@H](,CC[C@H](C)CCN,3CCC(C4=CC=C5C(=C4)N(C4CCCC4)C4=NC(=O)C6=C(Br)C=CC=C6N54)CC3)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)C3(F)CC3)C(C)(C)C)C=C2)SC=N1,32.0,67.0,0,Degradation of SMARCA2 in RKO cells after 18/4h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-022-33430-6,1064.18,1062.420079,9.32,72,10,11,3,15,154.17,C56H68BrFN8O5S,"InChI=1S/C56H68BrFN8O5S/c1-33(21-26-63-27-22-35(23-28-63)38-18-20-43-45(29-38)65(39-9-6-7-10-39)54-62-51(69)47-41(57)11-8-12-44(47)66(43)54)13-19-42(36-14-16-37(17-15-36)48-34(2)59-32-72-48)60-50(68)46-30-40(67)31-64(46)52(70)49(55(3,4)5)61-53(71)56(58)24-25-56/h8,11-12,14-18,20,29,32-33,35,39-40,42,46,49,67H,6-7,9-10,13,19,21-28,30-31H2,1-5H3,(H,60,68)(H,61,71)/t33-,40+,42-,46-,49+/m0/s1",JBTHUOYYUUPUOZ-LIHPQFRDSA-N
5121,P56524,HDAC4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCC(F)(F)C3=CN=C(C4=CC=C(C(C(=O)NO)C5=CC=CC=C5F)C=C4)N=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCC(F)(F),C3=CN=C(C4=CC=C(C(C(=O)NO)C5=CC=CC=C5F)C=C4)N=C3)C(C)(C)C)C=C2)SC=N1,28.0,77.0,0,Degradation of HDAC4 in Jurkat E6-1 cells after 24h treatment,,,410,Inhibit of HDAC4	,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,150,Inhibition of class IIa Jurkat cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01149,962.061,961.365582,4.5,68,6,13,5,21,214.43,C48H54F3N7O9S,"InChI=1S/C48H54F3N7O9S/c1-29-41(68-28-55-29)32-11-9-30(10-12-32)22-54-44(61)38-21-35(59)25-58(38)46(63)42(47(2,3)4)56-39(60)26-66-19-17-65-18-20-67-27-48(50,51)34-23-52-43(53-24-34)33-15-13-31(14-16-33)40(45(62)57-64)36-7-5-6-8-37(36)49/h5-16,23-24,28,35,38,40,42,59,64H,17-22,25-27H2,1-4H3,(H,54,61)(H,56,60)(H,57,62)/t35-,38+,40?,42-/m1/s1",CUCLIKLMKDOFAE-PELIQRIMSA-N
5122,P56524,HDAC4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCC(F)(F)C3=CN=C(C4=CC=C(C(C(=O)NO)C5=CC=CC=C5F)C=C4)N=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCCOCC(F)(F),C3=CN=C(C4=CC=C(C(C(=O)NO)C5=CC=CC=C5F)C=C4)N=C3)C(C)(C)C)C=C2)SC=N1,48.0,82.0,1,Degradation of HDAC4 in Jurkat E6-1 cells after 24h treatment,,,560,Inhibit of HDAC4	,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,160,Inhibition of class IIa Jurkat cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01149,1006.114,1005.391797,4.35,71,6,14,5,24,223.66,C50H58F3N7O10S,"InChI=1S/C50H58F3N7O10S/c1-31-43(71-30-57-31)34-11-9-32(10-12-34)24-56-46(63)40-23-37(61)27-60(40)48(65)44(49(2,3)4)58-41(62)28-69-21-19-67-17-18-68-20-22-70-29-50(52,53)36-25-54-45(55-26-36)35-15-13-33(14-16-35)42(47(64)59-66)38-7-5-6-8-39(38)51/h5-16,25-26,30,37,40,42,44,61,66H,17-24,27-29H2,1-4H3,(H,56,63)(H,58,62)(H,59,64)/t37-,40+,42?,44-/m1/s1",JCIGJBGCHCAMMB-DGTRGAFGSA-N
5123,P56524,HDAC4,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOCC(F)(F)C3=CN=C(C4=CC=C(C(C(=O)NO)C5=CC=CC=C5F)C=C4)N=C3)C(C)(C)C)C=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](,NC(=O)COCCOCCOCCOCCOCC(F)(F),C3=CN=C(C4=CC=C(C(C(=O)NO)C5=CC=CC=C5F)C=C4)N=C3)C(C)(C)C)C=C2)SC=N1,37.0,83.0,1,Degradation of HDAC4 in Jurkat E6-1 cells after 24h treatment,,,1100,Inhibit of HDAC4	,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,120,Inhibition of class IIa Jurkat cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01149,1050.167,1049.418011,4.2,74,6,15,5,27,232.89,C52H62F3N7O11S,"InChI=1S/C52H62F3N7O11S/c1-33-45(74-32-59-33)36-11-9-34(10-12-36)26-58-48(65)42-25-39(63)29-62(42)50(67)46(51(2,3)4)60-43(64)30-72-23-21-70-19-17-69-18-20-71-22-24-73-31-52(54,55)38-27-56-47(57-28-38)37-15-13-35(14-16-37)44(49(66)61-68)40-7-5-6-8-41(40)53/h5-16,27-28,32,39,42,44,46,63,68H,17-26,29-31H2,1-4H3,(H,58,65)(H,60,64)(H,61,66)/t39-,42+,44?,46-/m1/s1",HCYVFIZSHJPMGM-BZWIJWRHSA-N
5124,P56524,HDAC4,VHL,,,CCCN(CCCCOCCOCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C)C[C@@H](C)NC(=O)C1=CC=C(C2=NOC(C(F)(F)F)=N2)C=C1,,CCCN(CCCCOCCOCCOCC(=O)N,[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C)C[C@@H](C)NC(=O)C1=CC=C(C2=NOC(C(F)(F)F)=N2)C=C1,3.0,72.0,0,Degradation of HDAC4 in Jurkat E6-1 cells after 24h treatment,,,90,Inhibit of HDAC4	,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,33,Inhibition of class IIa Jurkat cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01149,987.156,986.4547313,5.75,69,5,14,4,26,210.58,C48H65F3N8O9S,"InChI=1S/C48H65F3N8O9S/c1-7-18-58(27-31(2)54-43(62)36-16-14-35(15-17-36)42-56-46(68-57-42)48(49,50)51)19-8-9-20-65-21-22-66-23-24-67-29-39(61)55-41(47(4,5)6)45(64)59-28-37(60)25-38(59)44(63)52-26-33-10-12-34(13-11-33)40-32(3)53-30-69-40/h10-17,30-31,37-38,41,60H,7-9,18-29H2,1-6H3,(H,52,63)(H,54,62)(H,55,61)/t31-,37-,38+,41-/m1/s1",LNVXIMZTYRLPDR-UYNIEJFQSA-N
5125,P56524,HDAC4,VHL,,,CCCN(CCCCOCCOCCOCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C)C[C@@H](C)NC(=O)C1=CC=C(C2=NOC(C(F)(F)F)=N2)C=C1,,CCCN(CCCCOCCOCCOCCOCC(=O)N,[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C)C[C@@H](C)NC(=O)C1=CC=C(C2=NOC(C(F)(F)F)=N2)C=C1,4.0,85.0,1,Degradation of HDAC4 in Jurkat E6-1 cells after 24h treatment,,,100,Inhibit of HDAC4	,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,Inhibition of class IIa Jurkat cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01149,1031.209,1030.480946,5.6,72,5,15,4,29,219.81,C50H69F3N8O10S,"InChI=1S/C50H69F3N8O10S/c1-7-18-60(29-33(2)56-45(64)38-16-14-37(15-17-38)44-58-48(71-59-44)50(51,52)53)19-8-9-20-67-21-22-68-23-24-69-25-26-70-31-41(63)57-43(49(4,5)6)47(66)61-30-39(62)27-40(61)46(65)54-28-35-10-12-36(13-11-35)42-34(3)55-32-72-42/h10-17,32-33,39-40,43,62H,7-9,18-31H2,1-6H3,(H,54,65)(H,56,64)(H,57,63)/t33-,39-,40+,43-/m1/s1",QONCFSQPRCINOK-WIIHZIRBSA-N
5126,P56524,HDAC4,VHL,,,CCCN(CCCCOCCOCCOCCOCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C)C[C@@H](C)NC(=O)C1=CC=C(C2=NOC(C(F)(F)F)=N2)C=C1,,CCCN(CCCCOCCOCCOCCOCCOCC(=O)N,[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC1=CC=C(C2=C(C)N=CS2)C=C1)C(C)(C)C)C[C@@H](C)NC(=O)C1=CC=C(C2=NOC(C(F)(F)F)=N2)C=C1,4.0,78.0,0,Degradation of HDAC4 in Jurkat E6-1 cells after 24h treatment,,,92,Inhibit of HDAC4	,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6,Inhibition of class IIa Jurkat cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c01149,1075.262,1074.507161,5.45,75,5,16,4,32,229.04,C52H73F3N8O11S,"InChI=1S/C52H73F3N8O11S/c1-7-18-62(31-35(2)58-47(66)40-16-14-39(15-17-40)46-60-50(74-61-46)52(53,54)55)19-8-9-20-69-21-22-70-23-24-71-25-26-72-27-28-73-33-43(65)59-45(51(4,5)6)49(68)63-32-41(64)29-42(63)48(67)56-30-37-10-12-38(13-11-37)44-36(3)57-34-75-44/h10-17,34-35,41-42,45,64H,7-9,18-33H2,1-6H3,(H,56,67)(H,58,66)(H,59,65)/t35-,41-,42+,45-/m1/s1",KBDZFZJFGKYVBZ-KLSSUPLUSA-N
5190,P11802,CDK4,CRBN,,,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CCOC5=CC=C(CN6CCC(C7=CC=C8C(=O)N(C9CCC(=O)NC9=O)CC8=C7)CC6)C=C5)CC4)C=N3)N=C2N(C2CCCC2)C1=O,,CC(=O),C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CCOC5=CC=C(CN6CCC(C7=CC=C8C(=O)N(C9CCC(=O)NC9=O)CC8=C7)CC6)C=C5)CC4)C=N3)N=C2N(C2CCCC2)C1=O,10.0,45.0,0,Degradation of CDK4 in Jurkat cells after 4 h treatment,,,70,Inhibit of CDK4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.2c00439,907.089,906.4540796,4.28,67,10,14,2,13,175.2,C51H58N10O6,"InChI=1S/C51H58N10O6/c1-32-42-29-53-51(56-47(42)61(38-5-3-4-6-38)50(66)46(32)33(2)62)54-44-15-10-39(28-52-44)59-23-21-57(22-24-59)25-26-67-40-11-7-34(8-12-40)30-58-19-17-35(18-20-58)36-9-13-41-37(27-36)31-60(49(41)65)43-14-16-45(63)55-48(43)64/h7-13,15,27-29,35,38,43H,3-6,14,16-26,30-31H2,1-2H3,(H,55,63,64)(H,52,53,54,56)",PJLUKTVSGYDGFZ-UHFFFAOYSA-N
5190,Q00534,CDK6,CRBN,,,CC(=O)C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CCOC5=CC=C(CN6CCC(C7=CC=C8C(=O)N(C9CCC(=O)NC9=O)CC8=C7)CC6)C=C5)CC4)C=N3)N=C2N(C2CCCC2)C1=O,,CC(=O),C1=C(C)C2=CN=C(NC3=CC=C(N4CCN(CCOC5=CC=C(CN6CCC(C7=CC=C8C(=O)N(C9CCC(=O)NC9=O)CC8=C7)CC6)C=C5)CC4)C=N3)N=C2N(C2CCCC2)C1=O,2.0,78.0,0,Degradation of CDK6 in Jurkat cells after 4 h treatment,,,33,Inhibit of CDK6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acschembio.2c00439,907.089,906.4540796,4.28,67,10,14,2,13,175.2,C51H58N10O6,"InChI=1S/C51H58N10O6/c1-32-42-29-53-51(56-47(42)61(38-5-3-4-6-38)50(66)46(32)33(2)62)54-44-15-10-39(28-52-44)59-23-21-57(22-24-59)25-26-67-40-11-7-34(8-12-40)30-58-19-17-35(18-20-58)36-9-13-41-37(27-36)31-60(49(41)65)43-14-16-45(63)55-48(43)64/h7-13,15,27-29,35,38,43H,3-6,14,16-26,30-31H2,1-2H3,(H,55,63,64)(H,52,53,54,56)",PJLUKTVSGYDGFZ-UHFFFAOYSA-N
5215,Q5S007,LRRK2,VHL,,,CNC1=NC(NC2=CC=C(C(=O)N3CCN(C[C@H]4CC[C@H](CSC(C)(C)[C@H](NC(=O)C5(F)CC5)C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)CC4)CC3)C=C2OC)=NC=C1Cl,CNC1=NC(NC2=CC=C(C(=O)N3CCN(C[C@H]4CC[C@H](,CSC(C)(C),[C@H](NC(=O)C5(F)CC5)C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)CC4)CC3)C=C2OC)=NC=C1Cl,32.0,82.0,1,Degradation of LRRK2 in MEFs after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,54,Dephosphorylation of Rab10 in WT LRRK2 MEFs,,,,,,,,,0.74,Caco-2 permeability,1.43,Caco-2 permeability,10.1021/jacs.2c05499,1019.711,1018.412428,6.33,70,8,14,5,18,194.25,C50H64ClFN10O6S2,"InChI=1S/C50H64ClFN10O6S2/c1-30-41(69-29-56-30)34-12-10-31(11-13-34)24-54-44(64)39-23-36(63)27-62(39)46(66)42(58-47(67)50(52)16-17-50)49(2,3)70-28-33-8-6-32(7-9-33)26-60-18-20-61(21-19-60)45(65)35-14-15-38(40(22-35)68-5)57-48-55-25-37(51)43(53-4)59-48/h10-15,22,25,29,32-33,36,39,42,63H,6-9,16-21,23-24,26-28H2,1-5H3,(H,54,64)(H,58,67)(H2,53,55,57,59)/t32-,33-,36-,39+,42-/m1/s1",HKSBXNVKPFTBIG-SHFRUIRLSA-N
5215,Q5S007,LRRK2 G2019S,VHL,,,CNC1=NC(NC2=CC=C(C(=O)N3CCN(C[C@H]4CC[C@H](CSC(C)(C)[C@H](NC(=O)C5(F)CC5)C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)CC4)CC3)C=C2OC)=NC=C1Cl,CNC1=NC(NC2=CC=C(C(=O)N3CCN(C[C@H]4CC[C@H](,CSC(C)(C),[C@H](NC(=O)C5(F)CC5)C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)CC4)CC3)C=C2OC)=NC=C1Cl,14.0,90.0,1,Degradation of G2019S LRRK2 in MEFs after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15,Dephosphorylation of Rab10 in G2019S LRRK2 MEFs,,,,,,,,,,,,,10.1021/jacs.2c05499,1019.711,1018.412428,6.33,70,8,14,5,18,194.25,C50H64ClFN10O6S2,"InChI=1S/C50H64ClFN10O6S2/c1-30-41(69-29-56-30)34-12-10-31(11-13-34)24-54-44(64)39-23-36(63)27-62(39)46(66)42(58-47(67)50(52)16-17-50)49(2,3)70-28-33-8-6-32(7-9-33)26-60-18-20-61(21-19-60)45(65)35-14-15-38(40(22-35)68-5)57-48-55-25-37(51)43(53-4)59-48/h10-15,22,25,29,32-33,36,39,42,63H,6-9,16-21,23-24,26-28H2,1-5H3,(H,54,64)(H,58,67)(H2,53,55,57,59)/t32-,33-,36-,39+,42-/m1/s1",HKSBXNVKPFTBIG-SHFRUIRLSA-N
5216,Q5S007,LRRK2,VHL,,,CNC1=NC(NC2=CC=C(C(=O)N3CCN(C[C@H]4CC[C@@H](CSC(C)(C)[C@H](NC(=O)C5(F)CC5)C(=O)N5C[C@H](O)C[C@@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)CC4)CC3)C=C2OC)=NC=C1Cl,CNC1=NC(NC2=CC=C(C(=O)N3CCN(C[C@H]4CC[C@@H](,CSC(C)(C),[C@H](NC(=O)C5(F)CC5)C(=O)N5C[C@H](O)C[C@@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)CC4)CC3)C=C2OC)=NC=C1Cl,32.0,59.0,0,Degradation of LRRK2 in MEFs after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,74,Dephosphorylation of Rab10 in WT LRRK2 MEFs,,,,,,,,,,,,,,,10.1021/jacs.2c05499,1019.711,1018.412428,6.33,70,8,14,5,18,194.25,C50H64ClFN10O6S2,"InChI=1S/C50H64ClFN10O6S2/c1-30-41(69-29-56-30)34-12-10-31(11-13-34)24-54-44(64)39-23-36(63)27-62(39)46(66)42(58-47(67)50(52)16-17-50)49(2,3)70-28-33-8-6-32(7-9-33)26-60-18-20-61(21-19-60)45(65)35-14-15-38(40(22-35)68-5)57-48-55-25-37(51)43(53-4)59-48/h10-15,22,25,29,32-33,36,39,42,63H,6-9,16-21,23-24,26-28H2,1-5H3,(H,54,64)(H,58,67)(H2,53,55,57,59)/t32-,33+,36-,39-,42-/m1/s1",HKSBXNVKPFTBIG-SCXIOOGQSA-N
5216,Q5S007,LRRK2 G2019S,VHL,,,CNC1=NC(NC2=CC=C(C(=O)N3CCN(C[C@H]4CC[C@@H](CSC(C)(C)[C@H](NC(=O)C5(F)CC5)C(=O)N5C[C@H](O)C[C@@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)CC4)CC3)C=C2OC)=NC=C1Cl,CNC1=NC(NC2=CC=C(C(=O)N3CCN(C[C@H]4CC[C@@H](,CSC(C)(C),[C@H](NC(=O)C5(F)CC5)C(=O)N5C[C@H](O)C[C@@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)CC4)CC3)C=C2OC)=NC=C1Cl,7.0,81.0,1,Degradation of G2019S LRRK2 in MEFs after 4 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12,Dephosphorylation of Rab10 in G2019S LRRK2 MEFs,,,,,,,,,,,,,,,10.1021/jacs.2c05499,1019.711,1018.412428,6.33,70,8,14,5,18,194.25,C50H64ClFN10O6S2,"InChI=1S/C50H64ClFN10O6S2/c1-30-41(69-29-56-30)34-12-10-31(11-13-34)24-54-44(64)39-23-36(63)27-62(39)46(66)42(58-47(67)50(52)16-17-50)49(2,3)70-28-33-8-6-32(7-9-33)26-60-18-20-61(21-19-60)45(65)35-14-15-38(40(22-35)68-5)57-48-55-25-37(51)43(53-4)59-48/h10-15,22,25,29,32-33,36,39,42,63H,6-9,16-21,23-24,26-28H2,1-5H3,(H,54,64)(H,58,67)(H2,53,55,57,59)/t32-,33+,36-,39-,42-/m1/s1",HKSBXNVKPFTBIG-SCXIOOGQSA-N
5274,O96028,NSD2,CRBN,,MS159,O=C(CNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)NCCCOC1=CC=C(NC(=O)C2=CC=C(CN(C(=O)C3=CC=C4NC(=O)COC4=C3)C3CC3)C=C2)N=C1,O=C(CNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O),NCCCO,C1=CC=C(NC(=O)C2=CC=C(CN(C(=O)C3=CC=C4NC(=O)COC4=C3)C3CC3)C=C2)N=C1,5200.0,82.0,0,Degradation of NSD2 in 293FT cells after 48 h treatment,,,,,,,1100,Binding affinity of NSD2-PWWP1 domain,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c00807,828.839,828.2867395,2.59,61,8,12,5,15,234.54,C43H40N8O10,"InChI=1S/C43H40N8O10/c52-35-16-14-32(40(56)49-35)51-42(58)29-3-1-4-31(38(29)43(51)59)45-21-36(53)44-17-2-18-60-28-12-15-34(46-20-28)48-39(55)25-7-5-24(6-8-25)22-50(27-10-11-27)41(57)26-9-13-30-33(19-26)61-23-37(54)47-30/h1,3-9,12-13,15,19-20,27,32,45H,2,10-11,14,16-18,21-23H2,(H,44,53)(H,47,54)(H,46,48,55)(H,49,52,56)",OBZWKPGPTCBYOS-UHFFFAOYSA-N
5292,P03372,ERalpha,CRBN,,,CC(=O)N(CCOCCOCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)O[C@H]1C[C@@]2(C)C(CC[C@@H]2O)C2CCC3=CC(O)=CC=C3C21,CC(=O)N(,CCOCCOCCN,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)O[C@H]1C[C@@]2(C)C(CC[C@@H]2O)C2CCC3=CC(O)=CC=C3C21,67.0,90.0,1,Degradation of ERalpha in MCF-7 cells after 24 h treatment,68,% ERalpha degradation in MCF-7 cells after 24 h treatment at 100 nM,91.2,FP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,60.9,CCK-8 cell proliferation assay,,,,,,,,,,,10.1016/j.jsbmb.2022.106154,732.831,732.3370437,3.11,53,7,11,4,13,184.04,C39H48N4O10,"InChI=1S/C39H48N4O10/c1-22(44)42(53-31-21-39(2)28(10-12-32(39)46)26-8-6-23-20-24(45)7-9-25(23)34(26)31)15-17-52-19-18-51-16-14-40-29-5-3-4-27-35(29)38(50)43(37(27)49)30-11-13-33(47)41-36(30)48/h3-5,7,9,20,26,28,30-32,34,40,45-46H,6,8,10-19,21H2,1-2H3,(H,41,47,48)/t26?,28?,30?,31-,32-,34?,39-/m0/s1",UKYOBTPNHRPOON-FQBQYCNXSA-N
5358,Q93009,USP7,CRBN,,,C[C@H](CC(=O)N1CCC(O)(CN2C=NC3=CC(NC(=O)CCC4CCN(C(=O)C5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)=CC=C3C2=O)CC1)C1=CC=CC=C1,C[C@H](CC(=O)N1CCC(O)(CN2C=NC3=CC(,NC(=O)CCC,4CCN(C(=O)C5CCN(C6=CC=C7C(=O)N(C8CCC(=O)NC8=O)C(=O)C7=C6)CC5)CC4)=CC=C3C2=O)CC1)C1=CC=CC=C1,17.0,84.0,1,Degradation of USP7 in MM.1S cells after 24 h treatment,85,% USP7 degradation in MM.1S cells after 24 h treatment at 1000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1039/d2cc02094g,927.072,926.4326754,2.48,68,9,12,3,12,211.63,C51H58N8O9,"InChI=1S/C51H58N8O9/c1-32(34-5-3-2-4-6-34)27-45(62)56-25-19-51(68,20-26-56)30-58-31-52-41-28-36(8-10-39(41)48(58)65)53-43(60)13-7-33-15-21-57(22-16-33)47(64)35-17-23-55(24-18-35)37-9-11-38-40(29-37)50(67)59(49(38)66)42-12-14-44(61)54-46(42)63/h2-6,8-11,28-29,31-33,35,42,68H,7,12-27,30H2,1H3,(H,53,60)(H,54,61,63)/t32-,42?/m1/s1",REPLCRNGGWSKTN-JYQLQLLISA-N
5394,Q9BY41,HDAC8,CRBN,,,O=C(CCCCOC1=CC=C(CCNC(=O)C2=CC=CC(C(=O)NO)=C2)C=C1)NCCCCCCNC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,O=C(CCCCOC1=CC=C(CCNC(=O)C2=CC=CC(C(=O)NO)=C2)C=C1),NCCCCCCN,C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,147.0,93.0,0,Degradation of HDAC8 in HCT-116 cells after 10 h treatment,85,% HDAC8 degradation in HCT-116 cells at 5000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2022,754.841,754.3326271,3.74,55,5,10,6,20,212.34,C40H46N6O9,"InChI=1S/C40H46N6O9/c47-33(13-3-6-24-55-29-16-14-26(15-17-29)20-23-43-36(49)27-9-7-10-28(25-27)37(50)45-54)42-22-5-2-1-4-21-41-31-12-8-11-30-35(31)40(53)46(39(30)52)32-18-19-34(48)44-38(32)51/h7-12,14-17,25,32,41,54H,1-6,13,18-24H2,(H,42,47)(H,43,49)(H,45,50)(H,44,48,51)",WYWJHXKHDRJYLX-UHFFFAOYSA-N
5402,Q9BY41,HDAC8,CRBN,,,O=C1CCC(N2C(=O)C3=CC=CC(N4CCC(N5CCN(C(=O)CCCCOC6=CC=C(CCNC(=O)C7=CC=CC(C(=O)NO)=C7)C=C6)CC5)CC4)=C3C2=O)C(=O)N1,O=C1CCC(N2C(=O)C3=CC=CC(N4CCC(N5CCN(,C(=O)CCCCO,C6=CC=C(CCNC(=O)C7=CC=CC(C(=O)NO)=C7)C=C6)CC5)CC4)=C3C2=O)C(=O)N1,876.0,91.0,0,Degradation of HDAC8 in HCT-116 cells after 10 h treatment,74.4,% HDAC8 degradation in HCT-116 cells at 5000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2022,807.905,807.3591761,2.45,59,7,11,4,14,198.0,C43H49N7O9,"InChI=1S/C43H49N7O9/c51-36-15-14-35(41(55)45-36)50-42(56)33-7-4-8-34(38(33)43(50)57)48-20-17-31(18-21-48)47-22-24-49(25-23-47)37(52)9-1-2-26-59-32-12-10-28(11-13-32)16-19-44-39(53)29-5-3-6-30(27-29)40(54)46-58/h3-8,10-13,27,31,35,58H,1-2,9,14-26H2,(H,44,53)(H,46,54)(H,45,51,55)",QSDRZGJBNUYGJE-UHFFFAOYSA-N
5406,Q9BY41,HDAC8,CRBN,,,O=C(CCCCOC1=CC=C(CCNC(=O)C2=CC=CC(C(=O)NO)=C2)C=C1)NCCCCCCNC1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1,O=C(CCCCOC1=CC=C(CCNC(=O)C2=CC=CC(C(=O)NO)=C2)C=C1),NCCCCCCN,C1=CC=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=C1,441.0,77.0,0,Degradation of HDAC8 in HCT-116 cells after 10 h treatment,68.9,% HDAC8 degradation in HCT-116 cells at 5000 nM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2022,754.841,754.3326271,3.19,55,5,10,6,20,212.34,C40H46N6O9,"InChI=1S/C40H46N6O9/c47-34(10-3-6-23-55-30-14-11-26(12-15-30)19-22-43-36(49)27-8-7-9-28(24-27)37(50)45-54)42-21-5-2-1-4-20-41-29-13-16-31-32(25-29)40(53)46(39(31)52)33-17-18-35(48)44-38(33)51/h7-9,11-16,24-25,33,41,54H,1-6,10,17-23H2,(H,42,47)(H,43,49)(H,45,50)(H,44,48,51)",HIMPUSAONKTVMA-UHFFFAOYSA-N
5426,Q96C86,DcpS,VHL,,,CC1=C(C2=CC=C(CNC(=O)[C@H]3C[C@@H](O)CN3C(=O)[C@H](C(C)C)N3CC4=CC=CC=C4C3=O)C(OCCOCCOCCOCCOCCOCCOC3=CC=CC(CN4CCC(COC5=CC=CC6=NC(N)=NC(N)=C56)CC4)=C3)=C2)SC=N1,CC1=C(C2=CC=C(CNC(=O)[C@H]3C[C@@H](O)CN3C(=O)[C@H](C(C)C)N3CC4=CC=CC=C4C3=O)C(,OCCOCCOCCOCCOCCOCCO,C3=CC=CC(CN4CCC(COC5=CC=CC6=NC(N)=NC(N)=C56)CC4)=C3)=C2)SC=N1,87.0,98.0,1,Degradation of DcpS in MOLM-14 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1100,Inhibit proliferation of MOLM14 cells,,,,,,,,,,,,,,,10.1021/acschembio.2c00145,1174.432,1173.55689,5.4,84,9,19,4,32,257.74,C62H79N9O12S,"InChI=1S/C62H79N9O12S/c1-41(2)56(71-37-47-9-4-5-11-50(47)60(71)74)61(75)70-38-48(72)34-52(70)59(73)65-35-46-15-14-45(57-42(3)66-40-84-57)33-54(46)82-31-29-80-27-25-78-23-21-76-20-22-77-24-26-79-28-30-81-49-10-6-8-44(32-49)36-69-18-16-43(17-19-69)39-83-53-13-7-12-51-55(53)58(63)68-62(64)67-51/h4-15,32-33,40-41,43,48,52,56,72H,16-31,34-39H2,1-3H3,(H,65,73)(H4,63,64,67,68)/t48-,52-,56+/m1/s1",YDPSDENQMOVTAZ-QMZDZVJJSA-N
5546,Q06187,BTK,CRBN,,,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(C2CCN(CC#CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC2)CC1,NC1=NC=NC2=C1C(C1=CC=C(OC3=CC=CC=C3)C=C1)=NN2C1CCN(C2CCN(,CC#C,C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC2)CC1,5.84,96.0,1,Degradation of BTK in Mino cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,104.69,Inhibit cell growth of Jeko-1 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.2c00324,749.876,749.3438009,4.26,56,9,11,2,7,151.81,C43H43N9O4,"InChI=1S/C43H43N9O4/c44-40-38-39(29-9-11-34(12-10-29)56-33-6-2-1-3-7-33)48-52(41(38)46-27-45-40)32-18-23-50(24-19-32)31-16-21-49(22-17-31)20-4-5-28-8-13-35-30(25-28)26-51(43(35)55)36-14-15-37(53)47-42(36)54/h1-3,6-13,25,27,31-32,36H,14-24,26H2,(H2,44,45,46)(H,47,53,54)",VJBTZFUBOYQFGT-UHFFFAOYSA-N
5564,P31749,AKT1,CRBN,,,CN1N=CC(Cl)=C1C1=C(Cl)OC(C(=O)N[C@@H]2CN[C@H](CC(=O)NC3=CC=C(OCCOCCOCCNC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C=C3)C[C@H]2C2=CC=CC(F)=C2)=C1,CN1N=CC(Cl)=C1C1=C(Cl)OC(C(=O)N[C@@H]2CN[C@H](CC(=O)NC3=CC=C(,OCCOCCOCCN,C4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)C=C3)C[C@H]2C2=CC=CC(F)=C2)=C1,28.0,95.0,1,Degradation of AKT in Jeko-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,205.1/2274.33/23.45,Inhibit cell proliferation of Jeko-1 (7 days)/Mino (7 days)/MM.1S (7 days) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114459,973.843,972.2776233,4.76,68,8,14,5,19,224.46,C47H47Cl2FN8O10,"InChI=1S/C47H47Cl2FN8O10/c1-57-42(34(48)24-53-57)33-23-38(68-43(33)49)45(62)55-36-25-52-29(21-32(36)26-4-2-5-27(50)20-26)22-40(60)54-28-8-10-30(11-9-28)67-19-18-66-17-16-65-15-14-51-35-7-3-6-31-41(35)47(64)58(46(31)63)37-12-13-39(59)56-44(37)61/h2-11,20,23-24,29,32,36-37,51-52H,12-19,21-22,25H2,1H3,(H,54,60)(H,55,62)(H,56,59,61)/t29-,32-,36+,37?/m0/s1",LSIDXOKLOKUYHG-ADRGVZEMSA-N
5611,P00533,EGFR L858R/T790M,CRBN,,,C=CC(=O)NC1=CC=CC(NC2=NC(NC3=CC=C(N4CCN(CC(=O)NCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=C3OC)=NC=C2C(F)(F)F)=C1,C=CC(=O)NC1=CC=CC(NC2=NC(NC3=CC=C(N4CCN(,CC(=O)NCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)C=C3OC)=NC=C2C(F)(F)F)=C1,355.9,83.0,0,Degradation of EGFR L858R/T790M in H1975 cells after 48h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,750,Inhibit cell proliferation of PC-9 (EGFR Del19) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114455,869.862,869.3220773,4.29,63,7,14,6,15,219.33,C42H42F3N11O7,"InChI=1S/C42H42F3N11O7/c1-3-33(57)49-24-6-4-7-25(20-24)50-37-28(42(43,44)45)22-48-41(53-37)51-29-11-10-26(21-32(29)63-2)55-18-16-54(17-19-55)23-35(59)47-15-14-46-30-9-5-8-27-36(30)40(62)56(39(27)61)31-12-13-34(58)52-38(31)60/h3-11,20-22,31,46H,1,12-19,23H2,2H3,(H,47,59)(H,49,57)(H,52,58,60)(H2,48,50,51,53)",FVYDZXSZKLYSRY-UHFFFAOYSA-N
5634,P61964,WDR5,CRBN,,,CN1CCN(C2=CC=C(C3=CC=CC(CN4CCN(CCNC(=O)CCCCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=C3)C=C2NC(=O)C2=C[NH]C(=O)C=C2C(F)(F)F)CC1,CN1CCN(C2=CC=C(C3=CC=CC(CN4CCN(,CCNC(=O)CCCCCCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)=C3)C=C2NC(=O)C2=C[NH]C(=O)C=C2C(F)(F)F)CC1,42.0,77.0,0,Degradation of WDR5 in MV4;11 cells after 18h treatment,,,,,,,125,ITC,,,,-9.381,,ITC,,,,,,,,,14800,ITC,,,,-11.0,,ITC,,,,,,,,,63.7,ITC,,,,-8.327,,ITC,,,,,,,,,180/510/540,Inhibit cell growth of MV4;11/EOL1/RS4;11 cells,,,,,,,,,,,10.1038/s41388-022-02340-8,995.117,994.467679,4.24,72,8,12,5,19,199.6,C52H61F3N10O7,"InChI=1S/C52H61F3N10O7/c1-61-21-27-64(28-22-61)42-15-14-36(30-41(42)59-48(69)38-32-58-46(68)31-39(38)52(53,54)55)35-10-7-9-34(29-35)33-63-25-23-62(24-26-63)20-19-57-44(66)13-5-3-2-4-6-18-56-40-12-8-11-37-47(40)51(72)65(50(37)71)43-16-17-45(67)60-49(43)70/h7-12,14-15,29-32,43,56H,2-6,13,16-28,33H2,1H3,(H,57,66)(H,58,68)(H,59,69)(H,60,67,70)",STBAQMSNPQNEBZ-UHFFFAOYSA-N
5712,Q9UGN5,PARP2,DCAF16,,,O=C(COC1=CC=C2C(=C1)CCCN2C(=O)CCl)NCCCCCCCCC(=O)N1CCN(C(=O)C2=CC(CC3=N[NH]C(=O)C4=CC=CC=C34)=CC=C2F)CC1,O=C(COC1=CC=C2C(=C1)CCCN2C(=O)CCl,)NCCCCCCCCC(=O)N,1CCN(C(=O)C2=CC(CC3=N[NH]C(=O)C4=CC=CC=C34)=CC=C2F)CC1,2000.0,92.0,0,Degradation of PARP2 in MDA-MB-231 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,26/61/690,Inhibit cell proliferation of MDA-MB-436/Capan-1/MDA-MB-468 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2022.114321,787.333,786.3307892,5.46,56,6,7,2,16,145.01,C42H48ClFN6O6,"InChI=1S/C42H48ClFN6O6/c43-27-40(53)50-19-9-10-30-26-31(15-17-37(30)50)56-28-38(51)45-18-8-4-2-1-3-5-13-39(52)48-20-22-49(23-21-48)42(55)34-24-29(14-16-35(34)44)25-36-32-11-6-7-12-33(32)41(54)47-46-36/h6-7,11-12,14-17,24,26H,1-5,8-10,13,18-23,25,27-28H2,(H,45,51)(H,47,54)",GPQBXTHUVLRKEP-UHFFFAOYSA-N
5714,Q03111,MLLT1,CRBN,,,C[C@H]1CCCN1CC1=NC2=CC(NC(=O)C3=CC=C4C(=C3)C=NN4CCCCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=CC=C2[NH]1,C[C@H]1CCCN1CC1=NC2=CC(NC(=O)C3=CC=C4C(=C3)C=NN4,CCCCCCCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=CC=C2[NH]1,37.0,95.0,1,Degradation of ENL in MV4;11 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,320/570/1100,Inhibit cell proliferation of Molm-13/MV4;11/Kasumi-1 cells,,,,,,,,,,,,,10.1186/s13045-022-01258-8,757.896,757.3700156,5.64,56,8,10,4,15,174.42,C42H47N9O5,"InChI=1S/C42H47N9O5/c1-26-10-9-20-49(26)25-36-46-31-15-14-29(23-33(31)47-36)45-39(53)27-13-16-34-28(22-27)24-44-50(34)21-7-5-3-2-4-6-19-43-32-12-8-11-30-38(32)42(56)51(41(30)55)35-17-18-37(52)48-40(35)54/h8,11-16,22-24,26,35,43H,2-7,9-10,17-21,25H2,1H3,(H,45,53)(H,46,47)(H,48,52,54)/t26-,35?/m0/s1",SCZWWJDUQGVEMY-HJYWNDIWSA-N
5715,Q03111,MLLT1,CRBN,,,C[C@H]1CCCN1CC1=NC2=CC(NC(=O)C3=CC=C4C(=C3)C=NN4CCCCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=CC=C2[NH]1,C[C@H]1CCCN1CC1=NC2=CC(NC(=O)C3=CC=C4C(=C3)C=NN4,CCCCCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=CC=C2[NH]1,50.0,68.0,0,Degradation of ENL in MV4;11 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,490/1600/19000,Inhibit cell proliferation of Molm-13/MV4;11/Kasumi-1 cells,,,,,,,,,,,,,10.1186/s13045-022-01258-8,729.842,729.3387155,4.56,54,8,10,4,13,174.42,C40H43N9O5,"InChI=1S/C40H43N9O5/c1-24-8-7-18-47(24)23-34-44-29-13-12-27(21-31(29)45-34)43-37(51)25-11-14-32-26(20-25)22-42-48(32)19-5-3-2-4-17-41-30-10-6-9-28-36(30)40(54)49(39(28)53)33-15-16-35(50)46-38(33)52/h6,9-14,20-22,24,33,41H,2-5,7-8,15-19,23H2,1H3,(H,43,51)(H,44,45)(H,46,50,52)/t24-,33?/m0/s1",PCQKARKEVDFIEV-PPVAYSNCSA-N
5716,Q03111,MLLT1,CRBN,,,C[C@H]1CCCN1CC1=NC2=CC(NC(=O)C3=CC=C4C(=C3)C=NN4CCCCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=CC=C2[NH]1,C[C@H]1CCCN1CC1=NC2=CC(NC(=O)C3=CC=C4C(=C3)C=NN4,CCCCN,C3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)=CC=C2[NH]1,72.0,89.0,1,Degradation of ENL in MV4;11 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2100/1200/50000,Inhibit cell proliferation of Molm-13/MV4;11/Kasumi-1 cells,,,,,,,,,,,,,10.1186/s13045-022-01258-8,701.788,701.3074153,3.85,52,8,10,4,11,174.42,C38H39N9O5,"InChI=1S/C38H39N9O5/c1-22-6-5-16-45(22)21-32-42-27-11-10-25(19-29(27)43-32)41-35(49)23-9-12-30-24(18-23)20-40-46(30)17-3-2-15-39-28-8-4-7-26-34(28)38(52)47(37(26)51)31-13-14-33(48)44-36(31)50/h4,7-12,18-20,22,31,39H,2-3,5-6,13-17,21H2,1H3,(H,41,49)(H,42,43)(H,44,48,50)/t22-,31?/m0/s1",BQKBBOYUPLMTRW-DEUJGTPJSA-N
5720,P01116,KRAS G12C,VHL,,,C=CC(=O)N1CCN(C2=NC(=O)N(C3=C(C)C=CN=C3C(C)C)C3=NC(C4=C(F)C=CC=C4OCCCCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)=C(F)C=C23)[C@H](C)C1,C=CC(=O)N1CCN(C2=NC(=O)N(C3=C(C)C=CN=C3C(C)C)C3=NC(C4=C(F)C=CC=C4,OCCCCC(=O)N,[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCC4=CC=C(C5=C(C)N=CS5)C=C4)C(C)(C)C)=C(F)C=C23)[C@H](C)C1,76.0,95.0,1,Degradation of KRAS G12C in NCI-H358/MIA PaCa-2 cells after 72 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,310/78/>10000,Inhibit proliferation of NCI-H358 (KRAS G12C)/MIA PaCa-2 (KRAS G12C)/ASPC-1 (KRAS G12D) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115857,1073.281,1072.480472,7.02,77,8,14,3,17,205.08,C57H66F2N10O7S,"InChI=1S/C57H66F2N10O7S/c1-10-45(72)66-23-24-67(34(5)29-66)52-39-27-41(59)48(64-53(39)69(56(75)65-52)49-33(4)21-22-60-47(49)32(2)3)46-40(58)14-13-15-43(46)76-25-12-11-16-44(71)63-51(57(7,8)9)55(74)68-30-38(70)26-42(68)54(73)61-28-36-17-19-37(20-18-36)50-35(6)62-31-77-50/h10,13-15,17-22,27,31-32,34,38,42,51,70H,1,11-12,16,23-26,28-30H2,2-9H3,(H,61,73)(H,63,71)/t34-,38-,42+,51-/m1/s1",GOTQXALGADJXCG-MLGQTYOCSA-N
5730,P01116,KRAS G12C,VHL,,,C=CC(=O)N1CCN(C2=NC(=O)N(C3=C(C)C=CN=C3C(C)C)C3=NC(C4=C(F)C=CC=C4OCC4CCN(CCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)=C(F)C=C23)[C@@H](C)C1,C=CC(=O)N1CCN(C2=NC(=O)N(C3=C(C)C=CN=C3C(C)C)C3=NC(C4=C(F)C=CC=C4OCC4CCN(,CCCC(=O)N,[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCC5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)CC4)=C(F)C=C23)[C@@H](C)C1,28.0,95.0,1,Degradation of KRAS G12C in NCI-H358/MIA PaCa-2 cells after 72 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91/45/>10000,Inhibit proliferation of NCI-H358 (KRAS G12C)/MIA PaCa-2 (KRAS G12C)/ASPC-1 (KRAS G12D) cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115857,1156.415,1155.553971,7.45,83,9,15,3,18,208.32,C62H75F2N11O7S,"InChI=1S/C62H75F2N11O7S/c1-10-50(78)72-27-28-73(38(5)32-72)57-44-30-46(64)53(69-58(44)75(61(81)70-57)54-37(4)20-23-65-52(54)36(2)3)51-45(63)13-11-14-48(51)82-34-41-21-25-71(26-22-41)24-12-15-49(77)68-56(62(7,8)9)60(80)74-33-43(76)29-47(74)59(79)66-31-40-16-18-42(19-17-40)55-39(6)67-35-83-55/h10-11,13-14,16-20,23,30,35-36,38,41,43,47,56,76H,1,12,15,21-22,24-29,31-34H2,2-9H3,(H,66,79)(H,68,77)/t38-,43+,47-,56+/m0/s1",LRCAYGWAXRSIDX-ZNRZZSIMSA-N
5741,P50395,GDI2,cIAP1,,,CC1=CC(C)=CC(COC2=CC3=C(C=C2OCC2=CC(C)=CC(C)=C2)[C@H]2C[C@](O)(CC4=CN(CCOCCOCCOCCNC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)CC5=CC=CC=C5)N=N4)C[C@H](C)N2CC3)=C1,CC1=CC(C)=CC(COC2=CC3=C(C=C2OCC2=CC(C)=CC(C)=C2)[C@H]2C[C@](O)(CC4=CN(,CCOCCOCCOCCNC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)C,C5=CC=CC=C5)N=N4)C[C@H](C)N2CC3)=C1,1480.0,84.2,0,Degradation of GDI2 in AsPC-1 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/jacsau.3c00228,1032.337,1031.609577,6.43,75,7,14,5,28,204.78,C59H81N7O9,"InChI=1S/C59H81N7O9/c1-39(2)23-52(62-58(69)56(67)51(60)30-45-11-9-8-10-12-45)57(68)61-14-17-71-19-21-73-22-20-72-18-16-65-36-49(63-64-65)34-59(70)33-44(7)66-15-13-48-31-54(74-37-46-26-40(3)24-41(4)27-46)55(32-50(48)53(66)35-59)75-38-47-28-42(5)25-43(6)29-47/h8-12,24-29,31-32,36,39,44,51-53,56,67,70H,13-23,30,33-35,37-38,60H2,1-7H3,(H,61,68)(H,62,69)/t44-,51+,52+,53+,56-,59+/m0/s1",MJHIWLXBPBFJAP-UROWPWKKSA-N
5839,P36888,FLT3,CRBN,,,CCC1=NC(C(N)=O)=C(NC2=CC=C(N3CCC(N4CCN(C(=O)COC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)C(OC)=C2)N=C1NC1CCOCC1,CCC1=NC(C(N)=O)=C(NC2=CC=C(N3CCC(N4CCN(,C(=O)CO,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)C(OC)=C2)N=C1NC1CCOCC1,1.26,86.8,1,Degradation of FLT3 in MV4-11 cells after 24 h treatment,58,% FLT3 degradation in MV4-11 cells at 10 nM for 24h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115974,852.95,852.3918732,2.83,62,8,15,4,13,230.96,C43H52N10O9,"InChI=1S/C43H52N10O9/c1-3-29-39(45-25-13-21-61-22-14-25)49-40(37(47-29)38(44)56)46-26-7-8-30(33(23-26)60-2)51-15-11-27(12-16-51)50-17-19-52(20-18-50)35(55)24-62-32-6-4-5-28-36(32)43(59)53(42(28)58)31-9-10-34(54)48-41(31)57/h4-8,23,25,27,31H,3,9-22,24H2,1-2H3,(H2,44,56)(H2,45,46,49)(H,48,54,57)",RAPZFEJMNCDSTP-UHFFFAOYSA-N
5850,P36888,FLT3,CRBN,,,CCC1=NC(C(N)=O)=C(NC2=CC=C(N3CCC(N4CCN(C(=O)CNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)C(OC)=C2)N=C1NC1CCOCC1,CCC1=NC(C(N)=O)=C(NC2=CC=C(N3CCC(N4CCN(,C(=O)CN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)C(OC)=C2)N=C1NC1CCOCC1,0.98,85.0,1,Degradation of FLT3 in MV4-11 cells after 24 h treatment,60,% FLT3 degradation in MV4-11 cells at 10 nM for 24h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115974,851.966,851.4078577,3.4,62,8,15,5,13,233.76,C43H53N11O8,"InChI=1S/C43H53N11O8/c1-3-29-39(46-25-13-21-62-22-14-25)50-40(37(48-29)38(44)57)47-26-7-8-31(33(23-26)61-2)52-15-11-27(12-16-52)51-17-19-53(20-18-51)35(56)24-45-30-6-4-5-28-36(30)43(60)54(42(28)59)32-9-10-34(55)49-41(32)58/h4-8,23,25,27,32,45H,3,9-22,24H2,1-2H3,(H2,44,57)(H2,46,47,50)(H,49,55,58)",NSWZQYGDWCUSDT-UHFFFAOYSA-N
5852,P36888,FLT3,CRBN,,,CCC1=NC(C(N)=O)=C(NC2=CC=C(N3CCC(N4CCN(C(=O)CCCCCNC5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)C(OC)=C2)N=C1NC1CCOCC1,CCC1=NC(C(N)=O)=C(NC2=CC=C(N3CCC(N4CCN(,C(=O)CCCCCN,C5=CC=CC6=C5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)C(OC)=C2)N=C1NC1CCOCC1,2.26,77.2,0,Degradation of FLT3 in MV4-11 cells after 24 h treatment,66,% FLT3 degradation in MV4-11 cells at 10 nM for 24h,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115974,908.074,907.4704579,4.37,66,8,15,5,17,233.76,C47H61N11O8,"InChI=1S/C47H61N11O8/c1-3-33-43(50-29-17-26-66-27-18-29)54-44(41(52-33)42(48)61)51-30-11-12-35(37(28-30)65-2)56-20-15-31(16-21-56)55-22-24-57(25-23-55)39(60)10-5-4-6-19-49-34-9-7-8-32-40(34)47(64)58(46(32)63)36-13-14-38(59)53-45(36)62/h7-9,11-12,28-29,31,36,49H,3-6,10,13-27H2,1-2H3,(H2,48,61)(H2,50,51,54)(H,53,59,62)",FYKDAWGISLGSMC-UHFFFAOYSA-N
5860,P36888,FLT3,CRBN,,LWY713,CCC1=NC(C(N)=O)=C(NC2=CC=C(N3CCC(N4CCN(C(=O)COC5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)CC4)CC3)C(OC)=C2)N=C1NC1CCOCC1,CCC1=NC(C(N)=O)=C(NC2=CC=C(N3CCC(N4CCN(,C(=O)CO,C5=CC=CC6=C5CN(C5CCC(=O)NC5=O)C6=O)CC4)CC3)C(OC)=C2)N=C1NC1CCOCC1,0.64,94.8,1,Degradation of FLT3 in MV4-11 cells after 24 h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5,Inhibit proliferation of MV4-11 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.115974,838.967,838.4126087,2.89,61,8,14,4,13,213.89,C43H54N10O8,"InChI=1S/C43H54N10O8/c1-3-31-40(45-26-13-21-60-22-14-26)49-41(38(47-31)39(44)56)46-27-7-8-32(35(23-27)59-2)51-15-11-28(12-16-51)50-17-19-52(20-18-50)37(55)25-61-34-6-4-5-29-30(34)24-53(43(29)58)33-9-10-36(54)48-42(33)57/h4-8,23,26,28,33H,3,9-22,24-25H2,1-2H3,(H2,44,56)(H2,45,46,49)(H,48,54,57)",RVOJNJLWNBVPOR-UHFFFAOYSA-N
5942,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)N1CCC(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)N,1CCC(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC1)N=C2C1=CC=C(Cl)C=C1,9.1,97.0,1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,295.9,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,710.26,709.2238013,3.97,50,8,9,1,5,129.86,C37H36ClN7O4S,"InChI=1S/C37H36ClN7O4S/c1-19-20(2)50-37-32(19)33(23-4-7-26(38)8-5-23)39-28(34-42-41-21(3)45(34)37)17-31(47)43-14-12-22(13-15-43)24-6-9-27-25(16-24)18-44(36(27)49)29-10-11-30(46)40-35(29)48/h4-9,16,22,28-29H,10-15,17-18H2,1-3H3,(H,40,46,48)/t28-,29?/m0/s1",WXSOTMXNHJTFKS-XLTVJXRZSA-N
5943,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCN1CCC(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCCN,1CCC(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC1)N=C2C1=CC=C(Cl)C=C1,21.1,65.0,0,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,53.8,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,753.329,752.2660005,3.82,53,8,10,2,8,141.89,C39H41ClN8O4S,"InChI=1S/C39H41ClN8O4S/c1-21-22(2)53-39-34(21)35(25-4-7-28(40)8-5-25)42-30(36-45-44-23(3)48(36)39)19-33(50)41-14-17-46-15-12-24(13-16-46)26-6-9-29-27(18-26)20-47(38(29)52)31-10-11-32(49)43-37(31)51/h4-9,18,24,30-31H,10-17,19-20H2,1-3H3,(H,41,50)(H,43,49,51)/t30-,31?/m0/s1",DQGNINFYAAEZKL-FSRLHOSWSA-N
5944,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCN1CCC(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCCCN,1CCC(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC1)N=C2C1=CC=C(Cl)C=C1,2.3,98.0,1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,41.0,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,767.356,766.2816505,4.18,54,8,10,2,9,141.89,C40H43ClN8O4S,"InChI=1S/C40H43ClN8O4S/c1-22-23(2)54-40-35(22)36(26-5-8-29(41)9-6-26)43-31(37-46-45-24(3)49(37)40)20-34(51)42-15-4-16-47-17-13-25(14-18-47)27-7-10-30-28(19-27)21-48(39(30)53)32-11-12-33(50)44-38(32)52/h5-10,19,25,31-32H,4,11-18,20-21H2,1-3H3,(H,42,51)(H,44,50,52)/t31-,32?/m0/s1",ZCOPIRBPZIGHDU-CYZZXXEPSA-N
5945,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCN1CCC(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCCCCN,1CCC(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC1)N=C2C1=CC=C(Cl)C=C1,12.8,94.0,1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,43.2,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,781.383,780.2973006,4.54,55,8,10,2,10,141.89,C41H45ClN8O4S,"InChI=1S/C41H45ClN8O4S/c1-23-24(2)55-41-36(23)37(27-6-9-30(42)10-7-27)44-32(38-47-46-25(3)50(38)41)21-35(52)43-16-4-5-17-48-18-14-26(15-19-48)28-8-11-31-29(20-28)22-49(40(31)54)33-12-13-34(51)45-39(33)53/h6-11,20,26,32-33H,4-5,12-19,21-22H2,1-3H3,(H,43,52)(H,45,51,53)/t32-,33?/m0/s1",FOTJPEPDXXOTQF-JEFWXSHNSA-N
5946,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCN1CCC(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCCCCCN,1CCC(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC1)N=C2C1=CC=C(Cl)C=C1,1.8,97.0,1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,36.6,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,795.41,794.3129507,4.9,56,8,10,2,11,141.89,C42H47ClN8O4S,"InChI=1S/C42H47ClN8O4S/c1-24-25(2)56-42-37(24)38(28-7-10-31(43)11-8-28)45-33(39-48-47-26(3)51(39)42)22-36(53)44-17-5-4-6-18-49-19-15-27(16-20-49)29-9-12-32-30(21-29)23-50(41(32)55)34-13-14-35(52)46-40(34)54/h7-12,21,27,33-34H,4-6,13-20,22-23H2,1-3H3,(H,44,53)(H,46,52,54)/t33-,34?/m0/s1",OJBZGRZGVKAUHH-CDRRMRQFSA-N
5947,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCCN1CCC(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCCCCCCN,1CCC(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)CC1)N=C2C1=CC=C(Cl)C=C1,0.7,92.0,1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,36.8,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,809.437,808.3286007,5.25,57,8,10,2,12,141.89,C43H49ClN8O4S,"InChI=1S/C43H49ClN8O4S/c1-25-26(2)57-43-38(25)39(29-8-11-32(44)12-9-29)46-34(40-49-48-27(3)52(40)43)23-37(54)45-18-6-4-5-7-19-50-20-16-28(17-21-50)30-10-13-33-31(22-30)24-51(42(33)56)35-14-15-36(53)47-41(35)55/h8-13,22,28,34-35H,4-7,14-21,23-24H2,1-3H3,(H,45,54)(H,47,53,55)/t34-,35?/m0/s1",OKISKGIPUPRZPL-SFCXHYMASA-N
5948,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NC1=CC=C(CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)C=C1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)N,C1=CC=C(CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)C=C1)N=C2C1=CC=C(Cl)C=C1,10000.0,0.0,0,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,52.4,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,732.266,731.2081512,5.03,52,8,9,2,7,138.65,C39H34ClN7O4S,"InChI=1S/C39H34ClN7O4S/c1-20-21(2)52-39-34(20)35(25-7-9-27(40)10-8-25)42-30(36-45-44-22(3)47(36)39)18-33(49)41-28-11-4-23(5-12-28)16-24-6-13-29-26(17-24)19-46(38(29)51)31-14-15-32(48)43-37(31)50/h4-13,17,30-31H,14-16,18-19H2,1-3H3,(H,41,49)(H,43,48,50)/t30-,31?/m0/s1",NAJLKAMZDMZECA-FSRLHOSWSA-N
5949,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCNC1=CC=C(CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)C=C1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCCN,C1=CC=C(CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)C=C1)N=C2C1=CC=C(Cl)C=C1,10000.0,0.0,0,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,57.1,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,775.335,774.2503504,5.15,55,8,10,3,10,150.68,C41H39ClN8O4S,"InChI=1S/C41H39ClN8O4S/c1-22-23(2)55-41-36(22)37(27-7-9-29(42)10-8-27)45-32(38-48-47-24(3)50(38)41)20-35(52)44-17-16-43-30-11-4-25(5-12-30)18-26-6-13-31-28(19-26)21-49(40(31)54)33-14-15-34(51)46-39(33)53/h4-13,19,32-33,43H,14-18,20-21H2,1-3H3,(H,44,52)(H,46,51,53)/t32-,33?/m0/s1",SGHSUUSYNYZHKK-JEFWXSHNSA-N
5950,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCNC1=CC=C(CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)C=C1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCCCN,C1=CC=C(CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)C=C1)N=C2C1=CC=C(Cl)C=C1,16.7,48.0,0,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,72.3,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,789.362,788.2660005,6.06,56,8,10,3,11,150.68,C42H41ClN8O4S,"InChI=1S/C42H41ClN8O4S/c1-23-24(2)56-42-37(23)38(28-8-10-30(43)11-9-28)46-33(39-49-48-25(3)51(39)42)21-36(53)45-18-4-17-44-31-12-5-26(6-13-31)19-27-7-14-32-29(20-27)22-50(41(32)55)34-15-16-35(52)47-40(34)54/h5-14,20,33-34,44H,4,15-19,21-22H2,1-3H3,(H,45,53)(H,47,52,54)/t33-,34?/m0/s1",BNZBBHXKCFPTND-CDRRMRQFSA-N
5951,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCNC1=CC=C(CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)C=C1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCCCCN,C1=CC=C(CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)C=C1)N=C2C1=CC=C(Cl)C=C1,10000.0,0.0,0,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,59.4,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,803.389,802.2816505,5.87,57,8,10,3,12,150.68,C43H43ClN8O4S,"InChI=1S/C43H43ClN8O4S/c1-24-25(2)57-43-38(24)39(29-9-11-31(44)12-10-29)47-34(40-50-49-26(3)52(40)43)22-37(54)46-19-5-4-18-45-32-13-6-27(7-14-32)20-28-8-15-33-30(21-28)23-51(42(33)56)35-16-17-36(53)48-41(35)55/h6-15,21,34-35,45H,4-5,16-20,22-23H2,1-3H3,(H,46,54)(H,48,53,55)/t34-,35?/m0/s1",MFAVXSAHTAKLRF-SFCXHYMASA-N
5952,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCNC1=CC=C(CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)C=C1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCCCCCN,C1=CC=C(CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)C=C1)N=C2C1=CC=C(Cl)C=C1,2.6,62.0,0,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,79.2,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,817.416,816.2973006,6.22,58,8,10,3,13,150.68,C44H45ClN8O4S,"InChI=1S/C44H45ClN8O4S/c1-25-26(2)58-44-39(25)40(30-10-12-32(45)13-11-30)48-35(41-51-50-27(3)53(41)44)23-38(55)47-20-6-4-5-19-46-33-14-7-28(8-15-33)21-29-9-16-34-31(22-29)24-52(43(34)57)36-17-18-37(54)49-42(36)56/h7-16,22,35-36,46H,4-6,17-21,23-24H2,1-3H3,(H,47,55)(H,49,54,56)/t35-,36?/m0/s1",GUKINEBETXGZNQ-TYIYNAFKSA-N
5953,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCCCCCNC1=CC=C(CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)C=C1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCCCCCCN,C1=CC=C(CC3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3)C=C1)N=C2C1=CC=C(Cl)C=C1,2.0,59.0,0,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,96.6,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,831.443,830.3129507,6.58,59,8,10,3,14,150.68,C45H47ClN8O4S,"InChI=1S/C45H47ClN8O4S/c1-26-27(2)59-45-40(26)41(31-11-13-33(46)14-12-31)49-36(42-52-51-28(3)54(42)45)24-39(56)48-21-7-5-4-6-20-47-34-15-8-29(9-16-34)22-30-10-17-35-32(23-30)25-53(44(35)58)37-18-19-38(55)50-43(37)57/h8-17,23,36-37,47H,4-7,18-22,24-25H2,1-3H3,(H,48,56)(H,50,55,57)/t36-,37?/m0/s1",CZJSNFIBYLCJGN-NWDJCJOJSA-N
5954,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCN1CCC3(CCC(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)CC5=C4)CC3)CC1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCCN,1CCC3(CCC(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)CC5=C4)CC3)CC1)N=C2C1=CC=C(Cl)C=C1,1.9,95.0,1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,55.2,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,821.448,820.3286007,5.88,58,9,10,2,8,141.89,C44H49ClN8O4S,"InChI=1S/C44H49ClN8O4S/c1-25-26(2)58-43-38(25)39(29-4-7-32(45)8-5-29)47-34(40-50-49-27(3)53(40)43)23-37(55)46-18-21-51-19-16-44(17-20-51)14-12-28(13-15-44)30-6-9-33-31(22-30)24-52(42(33)57)35-10-11-36(54)48-41(35)56/h4-9,22,28,34-35H,10-21,23-24H2,1-3H3,(H,46,55)(H,48,54,56)/t34-,35?/m0/s1",ZKMPZGMDXOECHS-SFCXHYMASA-N
5955,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCN1CC3(CCC(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)CC5=C4)CC3)C1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCCN,1CC3(CCC(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)CC5=C4)CC3)C1)N=C2C1=CC=C(Cl)C=C1,11.2,99.0,1,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,53.8,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,793.394,792.2973006,4.8,56,9,10,2,8,141.89,C42H45ClN8O4S,"InChI=1S/C42H45ClN8O4S/c1-23-24(2)56-41-36(23)37(27-4-7-30(43)8-5-27)45-32(38-48-47-25(3)51(38)41)19-35(53)44-16-17-49-21-42(22-49)14-12-26(13-15-42)28-6-9-31-29(18-28)20-50(40(31)55)33-10-11-34(52)46-39(33)54/h4-9,18,26,32-33H,10-17,19-22H2,1-3H3,(H,44,53)(H,46,52,54)/t32-,33?/m0/s1",JFSVSFBLGUFRRC-JEFWXSHNSA-N
5956,O60885,BRD4,CRBN,,,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)NCCN1CC(N3CCC(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)CC5=C4)CC3)C1)N=C2C1=CC=C(Cl)C=C1,CC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](,CC(=O)NCCN,1CC(N3CCC(C4=CC=C5C(=O)N(C6CCC(=O)NC6=O)CC5=C4)CC3)C1)N=C2C1=CC=C(Cl)C=C1,11.2,55.0,0,Degradation of BRD4 in HEK293 cells after 4 h treatment,,,,,,,,,,,,,,,,,,,37.5,TR-FRET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01613,808.409,807.3081996,3.7,57,9,11,2,9,145.13,C42H46ClN9O4S,"InChI=1S/C42H46ClN9O4S/c1-23-24(2)57-42-37(23)38(27-4-7-30(43)8-5-27)45-33(39-48-47-25(3)52(39)42)19-36(54)44-14-17-49-21-31(22-49)50-15-12-26(13-16-50)28-6-9-32-29(18-28)20-51(41(32)56)34-10-11-35(53)46-40(34)55/h4-9,18,26,31,33-34H,10-17,19-22H2,1-3H3,(H,44,54)(H,46,53,55)/t33-,34?/m0/s1",LHUVKOFLIPGEIS-CDRRMRQFSA-N
5958,P53350,PLK1,UBR box,,,C[C@@H](OP(=O)(O)O)[C@@H]1NC(=O)[C@H](CC2=CN=CN2CCCCCCCCC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)CCCCCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)CCC(=O)NCCCC[C@@H](C(N)=O)NC1=O,C[C@@H](OP(=O)(O)O)[C@@H]1NC(=O)[C@H](CC2=CN=CN2CCCCCCCCC2=CC=CC=C2)NC(=O)[C@@H](,NC(=O)CCCCCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N,)CCC(=O)NCCCC[C@@H](C(N)=O)NC1=O,2500.0,80.0,0,Degradation of PLK1 in HeLa cells,,,,,,,3480,Binding affinity to PLK1 PBD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17980/20630/17050,Inhibit proliferation of HeLa/A549/PC9 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01493,2750.274,2748.680358,-14.49,193,3,35,57,93,1391.19,C113H210N57O22P,"InChI=1S/C113H210N57O22P/c1-65(192-193(189,190)191)85-101(188)156-69(86(115)173)32-12-14-47-141-83(171)46-45-81(99(186)168-82(100(187)169-85)62-67-63-140-64-170(67)61-15-5-3-2-4-8-28-66-29-9-6-10-30-66)155-84(172)44-11-7-13-48-142-88(175)70(33-17-50-144-103(118)119)158-90(177)72(35-19-52-146-105(122)123)160-92(179)74(37-21-54-148-107(126)127)162-94(181)76(39-23-56-150-109(130)131)164-96(183)78(41-25-58-152-111(134)135)166-98(185)80(43-27-60-154-113(138)139)167-97(184)79(42-26-59-153-112(136)137)165-95(182)77(40-24-57-151-110(132)133)163-93(180)75(38-22-55-149-108(128)129)161-91(178)73(36-20-53-147-106(124)125)159-89(176)71(34-18-51-145-104(120)121)157-87(174)68(114)31-16-49-143-102(116)117/h6,9-10,29-30,63-65,68-82,85H,2-5,7-8,11-28,31-62,114H2,1H3,(H2,115,173)(H,141,171)(H,142,175)(H,155,172)(H,156,188)(H,157,174)(H,158,177)(H,159,176)(H,160,179)(H,161,178)(H,162,181)(H,163,180)(H,164,183)(H,165,182)(H,166,185)(H,167,184)(H,168,186)(H,169,187)(H4,116,117,143)(H4,118,119,144)(H4,120,121,145)(H4,122,123,146)(H4,124,125,147)(H4,126,127,148)(H4,128,129,149)(H4,130,131,150)(H4,132,133,151)(H4,134,135,152)(H4,136,137,153)(H4,138,139,154)(H2,189,190,191)/t65-,68+,69+,70+,71+,72+,73+,74+,75+,76+,77+,78+,79+,80+,81+,82+,85+/m1/s1",QCRJOZUOMXHCMP-XSBYXYHJSA-N
5993,Q9H8M2,BRD9,DCAF1,,,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=C(OC)C=C1CN1CCC(OCCCCCC(=O)N2CCN(C3=CC=C4C(NCCN)=NC(C5(C6=CC=C(Cl)C=C6)CCCCC5)=NC4=C3)CC2)CC1,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=C(OC)C=C1CN1CCC(,OCCCCCC(=O)N,2CCN(C3=CC=C4C(NCCN)=NC(C5(C6=CC=C(Cl)C=C6)CCCCC5)=NC4=C3)CC2)CC1,90.0,17.0,0,Degradation of BRD9 in HEK293/BRD9-HiBiT cells after 2h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-023-44237-4,970.66,969.503194,7.4,70,9,13,2,18,153.2,C55H68ClN9O5,"InChI=1S/C55H68ClN9O5/c1-62-37-47(43-17-23-58-35-46(43)53(62)67)45-34-49(68-2)38(32-50(45)69-3)36-63-25-18-42(19-26-63)70-31-9-4-6-10-51(66)65-29-27-64(28-30-65)41-15-16-44-48(33-41)60-54(61-52(44)59-24-22-57)55(20-7-5-8-21-55)39-11-13-40(56)14-12-39/h11-17,23,32-35,37,42H,4-10,18-22,24-31,36,57H2,1-3H3,(H,59,60,61)",BJAVCRNLIDSYTK-UHFFFAOYSA-N
5993,Q9NPI1,BRD7,DCAF1,,,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=C(OC)C=C1CN1CCC(OCCCCCC(=O)N2CCN(C3=CC=C4C(NCCN)=NC(C5(C6=CC=C(Cl)C=C6)CCCCC5)=NC4=C3)CC2)CC1,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=C(OC)C=C1CN1CCC(,OCCCCCC(=O)N,2CCN(C3=CC=C4C(NCCN)=NC(C5(C6=CC=C(Cl)C=C6)CCCCC5)=NC4=C3)CC2)CC1,360.0,65.0,0,Degradation of BRD7 in HEK293/BRD7-HiBiT cells after 2h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1038/s41467-023-44237-4,970.66,969.503194,7.4,70,9,13,2,18,153.2,C55H68ClN9O5,"InChI=1S/C55H68ClN9O5/c1-62-37-47(43-17-23-58-35-46(43)53(62)67)45-34-49(68-2)38(32-50(45)69-3)36-63-25-18-42(19-26-63)70-31-9-4-6-10-51(66)65-29-27-64(28-30-65)41-15-16-44-48(33-41)60-54(61-52(44)59-24-22-57)55(20-7-5-8-21-55)39-11-13-40(56)14-12-39/h11-17,23,32-35,37,42H,4-10,18-22,24-31,36,57H2,1-3H3,(H,59,60,61)",BJAVCRNLIDSYTK-UHFFFAOYSA-N
6034,P36969,GPX4,cIAP1,,,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@@H](CC1=CC=CC=C1)NC(=O)CCCCCCCN1C=C(CNC(=O)C2=CC=C([C@H]3C4=C(C[C@H](C(=O)OC)N3C(=O)CCl)C3=CC=CC=C3[NH]4)C=C2)N=N1,,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O),[C@@H](CC1=CC=CC=C1)NC(=O)CCCCCCCN1C=C(CNC(=O)C2=CC=C([C@H]3C4=C(C[C@H](C(=O)OC)N3C(=O)CCl)C3=CC=CC=C3[NH]4)C=C2)N=N1,1680.0,85.0,0,Degradation of GPX4 in HT1080 cells after 48h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2370,Inhibit tumor of HT1080 cells,,,,,,,,,,,,,,,10.1016/j.ejmech.2023.116110,953.538,952.4250032,5.96,68,6,12,5,23,226.94,C50H61ClN8O9,"InChI=1S/C50H61ClN8O9/c1-31(2)25-40(49(65)67-3)55-48(64)46(62)39(26-32-15-9-8-10-16-32)53-42(60)19-11-6-5-7-14-24-58-30-35(56-57-58)29-52-47(63)34-22-20-33(21-23-34)45-44-37(36-17-12-13-18-38(36)54-44)27-41(50(66)68-4)59(45)43(61)28-51/h8-10,12-13,15-18,20-23,30-31,39-41,45-46,54,62H,5-7,11,14,19,24-29H2,1-4H3,(H,52,63)(H,53,60)(H,55,64)/t39-,40+,41-,45+,46+/m1/s1",LUTJVHXGXLJMAW-DDRZEDRFSA-N
6052,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5,CCCCC(=O)N,[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,1014.0,96.7,0,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1055.335,1054.526279,8.38,76,10,14,5,17,198.27,C58H71FN10O6S,"InChI=1S/C58H71FN10O6S/c1-7-35-12-10-13-38-24-42(70)25-44(48(35)38)50-49(59)51-45(27-60-50)54(68-28-39-20-21-40(29-68)63-39)66-57(65-51)75-31-41-14-11-23-67(41)22-9-8-15-47(72)64-53(58(4,5)6)56(74)69-30-43(71)26-46(69)55(73)62-33(2)36-16-18-37(19-17-36)52-34(3)61-32-76-52/h10,12-13,16-19,24-25,27,32-33,39-41,43,46,53,63,70-71H,7-9,11,14-15,20-23,26,28-31H2,1-6H3,(H,62,73)(H,64,72)/t33-,39-,40+,41-,43+,46-,53+/m0/s1",DZMRIRHUWOIDDQ-XEGPAKOCSA-N
6053,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5,CCCCCC(=O)N,[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,1204.0,89.7,0,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1069.362,1068.541929,8.73,77,10,14,5,18,198.27,C59H73FN10O6S,"InChI=1S/C59H73FN10O6S/c1-7-36-13-11-14-39-25-43(71)26-45(49(36)39)51-50(60)52-46(28-61-51)55(69-29-40-21-22-41(30-69)64-40)67-58(66-52)76-32-42-15-12-24-68(42)23-10-8-9-16-48(73)65-54(59(4,5)6)57(75)70-31-44(72)27-47(70)56(74)63-34(2)37-17-19-38(20-18-37)53-35(3)62-33-77-53/h11,13-14,17-20,25-26,28,33-34,40-42,44,47,54,64,71-72H,7-10,12,15-16,21-24,27,29-32H2,1-6H3,(H,63,74)(H,65,73)/t34-,40-,41+,42-,44+,47-,54+/m0/s1",MATWIHXEJKPGER-QRLWOCTNSA-N
6054,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5,CCCCCCC(=O)N,[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,571.9,98.9,0,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1083.389,1082.557579,9.27,78,10,14,5,19,198.27,C60H75FN10O6S,"InChI=1S/C60H75FN10O6S/c1-7-37-14-12-15-40-26-44(72)27-46(50(37)40)52-51(61)53-47(29-62-52)56(70-30-41-22-23-42(31-70)65-41)68-59(67-53)77-33-43-16-13-25-69(43)24-11-9-8-10-17-49(74)66-55(60(4,5)6)58(76)71-32-45(73)28-48(71)57(75)64-35(2)38-18-20-39(21-19-38)54-36(3)63-34-78-54/h12,14-15,18-21,26-27,29,34-35,41-43,45,48,55,65,72-73H,7-11,13,16-17,22-25,28,30-33H2,1-6H3,(H,64,75)(H,66,74)/t35-,41-,42+,43-,45+,48-,55+/m0/s1",YRFWMYLCBNWJEI-HYOUYKGQSA-N
6055,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCCCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5,CCCCCCCC(=O)N,[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,226.3,82.4,0,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1097.416,1096.573229,9.82,79,10,14,5,20,198.27,C61H77FN10O6S,"InChI=1S/C61H77FN10O6S/c1-7-38-15-13-16-41-27-45(73)28-47(51(38)41)53-52(62)54-48(30-63-53)57(71-31-42-23-24-43(32-71)66-42)69-60(68-54)78-34-44-17-14-26-70(44)25-12-10-8-9-11-18-50(75)67-56(61(4,5)6)59(77)72-33-46(74)29-49(72)58(76)65-36(2)39-19-21-40(22-20-39)55-37(3)64-35-79-55/h13,15-16,19-22,27-28,30,35-36,42-44,46,49,56,66,73-74H,7-12,14,17-18,23-26,29,31-34H2,1-6H3,(H,65,76)(H,67,75)/t36-,42-,43+,44-,46+,49-,56+/m0/s1",GZPJFHIWNQNNSD-XAZSKEIWSA-N
6056,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCCCCCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5,CCCCCCCCC(=O)N,[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,165.0,89.3,0,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1111.443,1110.588879,10.36,80,10,14,5,21,198.27,C62H79FN10O6S,"InChI=1S/C62H79FN10O6S/c1-7-39-16-14-17-42-28-46(74)29-48(52(39)42)54-53(63)55-49(31-64-54)58(72-32-43-24-25-44(33-72)67-43)70-61(69-55)79-35-45-18-15-27-71(45)26-13-11-9-8-10-12-19-51(76)68-57(62(4,5)6)60(78)73-34-47(75)30-50(73)59(77)66-37(2)40-20-22-41(23-21-40)56-38(3)65-36-80-56/h14,16-17,20-23,28-29,31,36-37,43-45,47,50,57,67,74-75H,7-13,15,18-19,24-27,30,32-35H2,1-6H3,(H,66,77)(H,68,76)/t37-,43-,44+,45-,47+,50-,57+/m0/s1",SQUXSHGWVMZWGG-FBNTUTAJSA-N
6057,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCOCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5,CCOCCC(=O)N,[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,1822.0,89.5,0,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1071.334,1070.521194,7.51,77,10,15,5,18,207.5,C58H71FN10O7S,"InChI=1S/C58H71FN10O7S/c1-7-35-10-8-11-38-24-42(70)25-44(48(35)38)50-49(59)51-45(27-60-50)54(68-28-39-17-18-40(29-68)63-39)66-57(65-51)76-31-41-12-9-20-67(41)21-23-75-22-19-47(72)64-53(58(4,5)6)56(74)69-30-43(71)26-46(69)55(73)62-33(2)36-13-15-37(16-14-36)52-34(3)61-32-77-52/h8,10-11,13-16,24-25,27,32-33,39-41,43,46,53,63,70-71H,7,9,12,17-23,26,28-31H2,1-6H3,(H,62,73)(H,64,72)/t33-,39-,40+,41-,43+,46-,53+/m0/s1",ZETUMISSKGCCDQ-XEGPAKOCSA-N
6058,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCCOCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5,CCCOCCC(=O)N,[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,131.6,98.1,0,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1085.361,1084.536844,7.87,78,10,15,5,19,207.5,C59H73FN10O7S,"InChI=1S/C59H73FN10O7S/c1-7-36-11-8-12-39-25-43(71)26-45(49(36)39)51-50(60)52-46(28-61-51)55(69-29-40-18-19-41(30-69)64-40)67-58(66-52)77-32-42-13-9-21-68(42)22-10-23-76-24-20-48(73)65-54(59(4,5)6)57(75)70-31-44(72)27-47(70)56(74)63-34(2)37-14-16-38(17-15-37)53-35(3)62-33-78-53/h8,11-12,14-17,25-26,28,33-34,40-42,44,47,54,64,71-72H,7,9-10,13,18-24,27,29-32H2,1-6H3,(H,63,74)(H,65,73)/t34-,40-,41+,42-,44+,47-,54+/m0/s1",DRTSZGVKXLJNNH-QRLWOCTNSA-N
6059,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCCCOCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5,CCCCOCCC(=O)N,[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,1310.0,90.2,0,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1099.388,1098.552494,8.23,79,10,15,5,20,207.5,C60H75FN10O7S,"InChI=1S/C60H75FN10O7S/c1-7-37-12-10-13-40-26-44(72)27-46(50(37)40)52-51(61)53-47(29-62-52)56(70-30-41-19-20-42(31-70)65-41)68-59(67-53)78-33-43-14-11-23-69(43)22-8-9-24-77-25-21-49(74)66-55(60(4,5)6)58(76)71-32-45(73)28-48(71)57(75)64-35(2)38-15-17-39(18-16-38)54-36(3)63-34-79-54/h10,12-13,15-18,26-27,29,34-35,41-43,45,48,55,65,72-73H,7-9,11,14,19-25,28,30-33H2,1-6H3,(H,64,75)(H,66,74)/t35-,41-,42+,43-,45+,48-,55+/m0/s1",CMAGYLGVBWUBOU-HYOUYKGQSA-N
6060,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCCCOCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5,CCCCOCC(=O)N,[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,164.4,99.4,0,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1085.361,1084.536844,8.32,78,10,15,5,19,207.5,C59H73FN10O7S,"InChI=1S/C59H73FN10O7S/c1-7-36-12-10-13-39-24-43(71)25-45(49(36)39)51-50(60)52-46(27-61-51)55(69-28-40-19-20-41(29-69)64-40)67-58(66-52)77-31-42-14-11-22-68(42)21-8-9-23-76-32-48(73)65-54(59(4,5)6)57(75)70-30-44(72)26-47(70)56(74)63-34(2)37-15-17-38(18-16-37)53-35(3)62-33-78-53/h10,12-13,15-18,24-25,27,33-34,40-42,44,47,54,64,71-72H,7-9,11,14,19-23,26,28-32H2,1-6H3,(H,63,74)(H,65,73)/t34-,40-,41+,42-,44+,47-,54+/m0/s1",KYHAJKMOOZHQFA-QRLWOCTNSA-N
6061,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCC(=O)NCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5,CCC(=O)NCCC(=O)N,[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,3813.0,83.6,0,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1098.36,1097.532093,6.91,79,10,15,6,18,227.37,C59H72FN11O7S,"InChI=1S/C59H72FN11O7S/c1-7-35-10-8-11-38-24-42(72)25-44(49(35)38)51-50(60)52-45(27-62-51)55(70-28-39-17-18-40(29-70)65-39)68-58(67-52)78-31-41-12-9-22-69(41)23-20-47(74)61-21-19-48(75)66-54(59(4,5)6)57(77)71-30-43(73)26-46(71)56(76)64-33(2)36-13-15-37(16-14-36)53-34(3)63-32-79-53/h8,10-11,13-16,24-25,27,32-33,39-41,43,46,54,65,72-73H,7,9,12,17-23,26,28-31H2,1-6H3,(H,61,74)(H,64,76)(H,66,75)/t33-,39-,40+,41-,43+,46-,54+/m0/s1",XSKRXFBHRXSSKG-YLHACEQSSA-N
6064,P01116,KRAS G12D,VHL,,,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5C5CC6(CCN(CC(=O)N[C@H](C(=O)N7C[C@H](O)C[C@H]7C(=O)N[C@@H](C)C7=CC=C(C8=C(C)N=CS8)C=C7)C(C)(C)C)CC6)C5)=NC4=C3F)=C12,CCC1=CC=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5C5CC6(CCN(,CC(=O)N,[C@H](C(=O)N7C[C@H](O)C[C@H]7C(=O)N[C@@H](C)C7=CC=C(C8=C(C)N=CS8)C=C7)C(C)(C)C)CC6)C5)=NC4=C3F)=C12,133.8,85.1,0,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1136.453,1135.584128,8.95,82,12,15,5,15,201.51,C63H78FN11O6S,"InChI=1S/C63H78FN11O6S/c1-7-38-10-8-11-41-24-46(76)25-48(52(38)41)54-53(64)55-49(29-65-54)58(73-30-42-17-18-43(31-73)68-42)71-61(70-55)81-34-44-12-9-21-74(44)45-27-63(28-45)19-22-72(23-20-63)33-51(78)69-57(62(4,5)6)60(80)75-32-47(77)26-50(75)59(79)67-36(2)39-13-15-40(16-14-39)56-37(3)66-35-82-56/h8,10-11,13-16,24-25,29,35-36,42-45,47,50,57,68,76-77H,7,9,12,17-23,26-28,30-34H2,1-6H3,(H,67,79)(H,69,78)/t36-,42-,43+,44-,47+,50-,57+/m0/s1",UKRCYNJTZLLRJJ-WMNQMRKPSA-N
6066,P01116,KRAS G12D,VHL,,,CCC1=C(F)C=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCCCOCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,CCC1=C(F)C=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5,CCCCOCC(=O)N,[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,38.06,98.9,1,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1103.351,1102.527422,8.43,79,10,15,5,19,207.5,C59H72F2N10O7S,"InChI=1S/C59H72F2N10O7S/c1-7-43-46(60)19-16-37-23-41(72)24-44(49(37)43)51-50(61)52-45(26-62-51)55(70-27-38-17-18-39(28-70)65-38)68-58(67-52)78-30-40-11-10-21-69(40)20-8-9-22-77-31-48(74)66-54(59(4,5)6)57(76)71-29-42(73)25-47(71)56(75)64-33(2)35-12-14-36(15-13-35)53-34(3)63-32-79-53/h12-16,19,23-24,26,32-33,38-40,42,47,54,65,72-73H,7-11,17-18,20-22,25,27-31H2,1-6H3,(H,64,75)(H,66,74)/t33-,38-,39+,40-,42+,47-,54+/m0/s1",KHIURKSPHCFKCV-XCACKJMTSA-N
6067,P01116,KRAS G12D,VHL,,,C#CC1=C(F)C=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5CCCCOCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,C#CC1=C(F)C=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5CCCN5,CCCCOCC(=O)N,[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,115.9,99.5,0,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1099.319,1098.496122,7.87,79,10,15,5,18,207.5,C59H68F2N10O7S,"InChI=1S/C59H68F2N10O7S/c1-7-43-46(60)19-16-37-23-41(72)24-44(49(37)43)51-50(61)52-45(26-62-51)55(70-27-38-17-18-39(28-70)65-38)68-58(67-52)78-30-40-11-10-21-69(40)20-8-9-22-77-31-48(74)66-54(59(4,5)6)57(76)71-29-42(73)25-47(71)56(75)64-33(2)35-12-14-36(15-13-35)53-34(3)63-32-79-53/h1,12-16,19,23-24,26,32-33,38-40,42,47,54,65,72-73H,8-11,17-18,20-22,25,27-31H2,2-6H3,(H,64,75)(H,66,74)/t33-,38-,39+,40-,42+,47-,54+/m0/s1",QJFDDWLFGZVIOI-XCACKJMTSA-N
6068,P01116,KRAS G12D,VHL,,,CCC1=C(F)C=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5C[C@@H](F)CN5CCCCOCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,CCC1=C(F)C=CC2=CC(O)=CC(C3=NC=C4C(N5C[C@@H]6CC[C@H](C5)N6)=NC(OC[C@@H]5C[C@@H](F)CN5,CCCCOCC(=O)N,[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)N[C@@H](C)C5=CC=C(C6=C(C)N=CS6)C=C5)C(C)(C)C)=NC4=C3F)=C12,87.2,96.2,1,Degradation of KRAS G12D in AsPC-1 cells after 24h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c01622,1121.341,1120.518,8.48,80,10,15,5,19,207.5,C59H71F3N10O7S,"InChI=1S/C59H71F3N10O7S/c1-7-43-46(61)17-14-36-20-41(73)22-44(49(36)43)51-50(62)52-45(24-63-51)55(71-26-38-15-16-39(27-71)66-38)69-58(68-52)79-29-40-21-37(60)25-70(40)18-8-9-19-78-30-48(75)67-54(59(4,5)6)57(77)72-28-42(74)23-47(72)56(76)65-32(2)34-10-12-35(13-11-34)53-33(3)64-31-80-53/h10-14,17,20,22,24,31-32,37-40,42,47,54,66,73-74H,7-9,15-16,18-19,21,23,25-30H2,1-6H3,(H,65,76)(H,67,75)/t32-,37+,38-,39+,40-,42+,47-,54+/m0/s1",BKPOBOXXAAENEJ-RTVISUOMSA-N
6072,Q07889,SOS1,CRBN,,,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1OCC1(CN(C)C(=O)CCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1OCC1(,CN(C)C(=O)CCCCCCN,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,13.0,88.0,1,Degradation of SOS1 in H358 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5,Inhibit cell growth of H358 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c02135,872.946,872.3832806,6.38,63,7,12,4,18,198.18,C45H51F3N8O7,"InChI=1S/C45H51F3N8O7/c1-25(27-18-28(45(46,47)48)20-29(49)19-27)51-40-31-21-36(35(62-4)22-33(31)52-26(2)53-40)63-24-44(15-16-44)23-55(3)38(58)12-7-5-6-8-17-50-32-11-9-10-30-39(32)43(61)56(42(30)60)34-13-14-37(57)54-41(34)59/h9-11,18-22,25,34,50H,5-8,12-17,23-24,49H2,1-4H3,(H,51,52,53)(H,54,57,59)/t25-,34?/m1/s1",WLWKNXUSLSOAGM-HSGLFRJESA-N
6081,Q07889,SOS1,CRBN,,,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)F)=C3)=C2C=C1OCC1(CN(C)C(=O)CCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)F)=C3)=C2C=C1OCC1(,CN(C)C(=O)CCCCCCN,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,45.0,73.0,0,Degradation of SOS1 in H358 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16,Inhibit cell growth of H358 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c02135,854.956,854.3927024,6.12,62,7,12,4,19,198.18,C45H52F2N8O7,"InChI=1S/C45H52F2N8O7/c1-25(27-18-28(40(46)47)20-29(48)19-27)50-41-31-21-36(35(61-4)22-33(31)51-26(2)52-41)62-24-45(15-16-45)23-54(3)38(57)12-7-5-6-8-17-49-32-11-9-10-30-39(32)44(60)55(43(30)59)34-13-14-37(56)53-42(34)58/h9-11,18-22,25,34,40,49H,5-8,12-17,23-24,48H2,1-4H3,(H,50,51,52)(H,53,56,58)/t25-,34?/m1/s1",RTYVSUBNYZYOJZ-HSGLFRJESA-N
6082,Q07889,SOS1,CRBN,,,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC=CC(C(F)F)=C3F)=C2C=C1OCC1(CN(C)C(=O)CCCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC=CC(C(F)F)=C3F)=C2C=C1OCC1(,CN(C)C(=O)CCCCCCN,C2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,540.0,72.0,0,Degradation of SOS1 in H358 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,216,Inhibit cell growth of H358 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c02135,857.931,857.3723816,6.9,62,7,11,3,19,172.16,C45H50F3N7O7,"InChI=1S/C45H50F3N7O7/c1-25(27-11-9-13-29(39(27)46)40(47)48)50-41-30-21-35(34(61-4)22-32(30)51-26(2)52-41)62-24-45(18-19-45)23-54(3)37(57)15-7-5-6-8-20-49-31-14-10-12-28-38(31)44(60)55(43(28)59)33-16-17-36(56)53-42(33)58/h9-14,21-22,25,33,40,49H,5-8,15-20,23-24H2,1-4H3,(H,50,51,52)(H,53,56,58)/t25-,33?/m1/s1",AXNIHWLGUQGCDA-NHYGQJMQSA-N
6087,Q07889,SOS1,CRBN,,,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1OCC1(CN(C)C(=O)CCCCCCNC2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)CC1,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1OCC1(,CN(C)C(=O)CCCCCCN,C2=CC=CC3=C2CN(C2CCC(=O)NC2=O)C3=O)CC1,151.0,81.0,0,Degradation of SOS1 in H358 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,47,Inhibit cell growth of H358 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c02135,858.963,858.4040161,5.88,62,7,11,4,18,181.11,C45H53F3N8O6,"InChI=1S/C45H53F3N8O6/c1-26(28-18-29(45(46,47)48)20-30(49)19-28)51-41-32-21-38(37(61-4)22-35(32)52-27(2)53-41)62-25-44(15-16-44)24-55(3)40(58)12-7-5-6-8-17-50-34-11-9-10-31-33(34)23-56(43(31)60)36-13-14-39(57)54-42(36)59/h9-11,18-22,26,36,50H,5-8,12-17,23-25,49H2,1-4H3,(H,51,52,53)(H,54,57,59)/t26-,36?/m1/s1",CKVSRIJZIQJZGE-IERCKHOLSA-N
6090,Q07889,SOS1,CRBN,,,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1OCC1(CN(C)C(=O)CCCCCCNC2=CC=C(F)C3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1OCC1(,CN(C)C(=O)CCCCCCN,C2=CC=C(F)C3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,63.0,90.0,1,Degradation of SOS1 in H358 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,23,Inhibit cell growth of H358 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c02135,890.936,890.3738588,6.48,64,7,12,4,18,198.18,C45H50F4N8O7,"InChI=1S/C45H50F4N8O7/c1-24(26-17-27(45(47,48)49)19-28(50)18-26)52-40-29-20-35(34(63-4)21-32(29)53-25(2)54-40)64-23-44(14-15-44)22-56(3)37(59)9-7-5-6-8-16-51-31-11-10-30(46)38-39(31)43(62)57(42(38)61)33-12-13-36(58)55-41(33)60/h10-11,17-21,24,33,51H,5-9,12-16,22-23,50H2,1-4H3,(H,52,53,54)(H,55,58,60)/t24-,33?/m1/s1",MPOBYMKETYQAHT-HVQYUPJGSA-N
6092,Q07889,SOS1,CRBN,,,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1OCC1(CN(C)C(=O)C2CCN(CCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)CC1,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1OCC1(,CN(C)C(=O)C,2CCN(CCNC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)CC1,44.0,90.0,1,Degradation of SOS1 in H358 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,18,Inhibit cell growth of H358 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c02135,899.972,899.3941797,5.33,65,8,13,4,15,201.42,C46H52F3N9O7,"InChI=1S/C46H52F3N9O7/c1-25(28-18-29(46(47,48)49)20-30(50)19-28)52-40-32-21-37(36(64-4)22-34(32)53-26(2)54-40)65-24-45(12-13-45)23-56(3)42(61)27-10-15-57(16-11-27)17-14-51-33-7-5-6-31-39(33)44(63)58(43(31)62)35-8-9-38(59)55-41(35)60/h5-7,18-22,25,27,35,51H,8-17,23-24,50H2,1-4H3,(H,52,53,54)(H,55,59,60)/t25-,35?/m1/s1",IFPXXFMXWDLQFQ-SUYFMZKJSA-N
6093,Q07889,SOS1,CRBN,,,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1OCC1(CN(C)C(=O)C2CCN(C3CCC(NC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)CC1,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1OCC1(,CN(C)C(=O)C,2CCN(C3CCC(NC4=CC=CC5=C4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)CC1,55.0,75.0,0,Degradation of SOS1 in H358 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,51,Inhibit cell growth of H358 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c02135,954.064,953.4411299,6.11,69,9,13,4,14,201.42,C50H58F3N9O7,"InChI=1S/C50H58F3N9O7/c1-27(30-20-31(50(51,52)53)22-32(54)21-30)55-44-36-23-41(40(68-4)24-38(36)56-28(2)57-44)69-26-49(16-17-49)25-60(3)46(65)29-14-18-61(19-15-29)34-10-8-33(9-11-34)58-37-7-5-6-35-43(37)48(67)62(47(35)66)39-12-13-42(63)59-45(39)64/h5-7,20-24,27,29,33-34,39,58H,8-19,25-26,54H2,1-4H3,(H,55,56,57)(H,59,63,64)/t27-,33?,34?,39?/m1/s1",UQTRNIWZKUJRCB-GCXJWZSHSA-N
6094,Q07889,SOS1,CRBN,,,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1OCC1(CN(C)C(=O)CCCOC2CCC(NC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)CC1,COC1=CC2=NC(C)=NC(N[C@H](C)C3=CC(N)=CC(C(F)(F)F)=C3)=C2C=C1OCC1(,CN(C)C(=O)CCCOC,2CCC(NC3=CC=CC4=C3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)CC1,35.0,90.0,1,Degradation of SOS1 in H358 cells after 6h treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15,Inhibit cell growth of H358 cells,,,,,,,,,,,,,,,10.1021/acs.jmedchem.3c02135,929.01,928.4094954,5.76,67,8,13,4,17,207.41,C48H55F3N8O8,"InChI=1S/C48H55F3N8O8/c1-26(28-19-29(48(49,50)51)21-30(52)20-28)53-43-34-22-39(38(65-4)23-36(34)54-27(2)55-43)67-25-47(16-17-47)24-58(3)41(61)9-6-18-66-32-12-10-31(11-13-32)56-35-8-5-7-33-42(35)46(64)59(45(33)63)37-14-15-40(60)57-44(37)62/h5,7-8,19-23,26,31-32,37,56H,6,9-18,24-25,52H2,1-4H3,(H,53,54,55)(H,57,60,62)/t26-,31?,32?,37?/m1/s1",TWINIHLSGOQBHE-HAMOUJOLSA-N
